data_1a63_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1a63 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.526 ' CA ' ' HA ' ' A' ' 49' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.661 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . 0.58 ' HB2' ' CE2' ' A' ' 50' ' ' PHE 0.25 4.2 t30 -78.38 116.74 19.01 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 120.555 -1.34 . . . . 0.0 109.402 -179.827 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.483 HD12 HD11 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -49.68 -46.54 49.96 Favored 'General case' 0 N--CA 1.517 2.915 0 O-C-N 120.157 -1.59 . . . . 0.0 110.352 -178.934 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.8 m -56.35 -34.92 67.06 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.742 -1.224 . . . . 0.0 108.186 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.5 ' HB3' ' HB3' ' A' ' 2' ' ' ASN . 0.0 OUTLIER -66.99 -45.7 76.83 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 177.73 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.522 HD12 ' CD1' ' A' ' 39' ' ' LEU 0.274 68.5 mt -53.3 -51.4 62.44 Favored 'General case' 0 C--N 1.313 -0.981 0 O-C-N 120.626 -1.296 . . . . 0.0 109.078 177.738 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.26 -33.61 69.57 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.044 -1.035 . . . . 0.0 109.726 178.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.497 ' HB2' ' O ' ' A' ' 5' ' ' GLU . 4.8 m-80 -61.42 -16.54 47.7 Favored 'General case' 0 N--CA 1.504 2.263 0 C-N-CA 119.013 -1.075 . . . . 0.0 110.357 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.536 ' HB ' ' CD2' ' A' ' 14' ' ' LEU . 2.6 m -89.48 121.32 69.37 Favored Pre-proline 0 N--CA 1.502 2.153 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.513 ' HG2' ' CG ' ' A' ' 13' ' ' GLU . 37.1 Cg_endo -57.79 151.3 57.07 Favored 'Trans proline' 0 CA--C 1.562 1.922 0 N-CA-C 109.971 -0.819 . . . . 0.0 109.971 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.506 HG11 ' N ' ' A' ' 12' ' ' SER . 1.6 p -41.85 -49.21 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.529 3.475 0 O-C-N 120.303 -1.498 . . . . 0.0 110.252 -178.071 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.506 ' N ' HG11 ' A' ' 11' ' ' VAL . 1.8 t -58.32 -41.97 85.69 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.314 -0.866 . . . . 0.0 111.161 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.531 ' HB3' ' CG2' ' A' ' 9' ' ' THR . 0.2 OUTLIER -68.97 -30.52 68.97 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 118.237 -1.385 . . . . 0.0 108.21 -179.964 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.536 ' CD2' ' HB ' ' A' ' 9' ' ' THR . 9.3 mt -68.76 -41.2 79.19 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 120.883 -1.136 . . . . 0.0 108.813 176.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.494 ' CG1' ' HB3' ' A' ' 26' ' ' LEU . 1.2 mp -66.68 -40.33 85.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 C-N-CA 117.892 -1.523 . . . . 0.0 108.678 178.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.488 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 84.8 m -64.25 -35.52 81.11 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.36 -1.462 . . . . 0.0 108.963 179.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.489 ' HA ' ' OD1' ' A' ' 20' ' ' ASN . 35.5 tp -64.99 -43.85 91.23 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 120.934 -1.104 . . . . 0.0 108.237 178.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.553 ' HA2' ' OE1' ' A' ' 41' ' ' GLN . . . -61.69 -43.56 99.09 Favored Glycine 1 N--CA 1.518 4.11 0 N-CA-C 108.15 -1.98 . . . . 0.0 108.15 178.43 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.459 ' OE2' ' HG2' ' A' ' 24' ' ' GLU . 1.0 OUTLIER -53.75 -44.3 69.86 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.999 -1.295 . . . . 0.0 107.517 178.188 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.489 ' OD1' ' HA ' ' A' ' 17' ' ' LEU . 27.7 m120 -59.57 -26.97 65.84 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 118.679 -1.208 . . . . 0.0 109.465 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.567 ' HE1' ' CD2' ' A' ' 42' ' ' HIS . 37.7 mmm -97.65 9.86 41.44 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.27 -0.894 . . . . 0.0 110.438 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 99.7 -18.23 56.37 Favored Glycine 0 N--CA 1.501 2.992 0 C-N-CA 118.802 -1.666 . . . . 0.0 111.352 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.558 ' O ' ' CD1' ' A' ' 26' ' ' LEU . 5.4 mp -79.56 94.91 5.72 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 120.359 -1.671 . . . . 0.0 109.753 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.511 ' O ' ' CB ' ' A' ' 25' ' ' ASN . 46.6 mt-10 -103.67 170.57 7.86 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.231 -0.918 . . . . 0.0 109.179 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.511 ' CB ' ' O ' ' A' ' 24' ' ' GLU . 1.3 t-20 70.37 18.15 6.79 Favored 'General case' 0 N--CA 1.511 2.578 0 O-C-N 121.528 -0.733 . . . . 0.0 111.785 179.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.558 ' CD1' ' O ' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -76.42 -8.66 57.61 Favored 'General case' 0 N--CA 1.505 2.304 0 O-C-N 120.983 -1.073 . . . . 0.0 111.419 -179.798 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 26' ' ' LEU . . . -46.85 -32.74 3.94 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.461 -1.399 . . . . 0.0 108.847 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.415 ' NH2' ' HB3' ' A' ' 25' ' ' ASN . 11.9 ptt180 -80.96 0.85 33.66 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 120.193 -0.603 . . . . 0.0 111.363 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.518 ' CE ' ' OD1' ' A' ' 33' ' ' ASP . 7.1 mtp -100.79 149.13 24.15 Favored 'General case' 0 C--N 1.314 -0.976 0 O-C-N 120.837 -1.165 . . . . 0.0 111.864 -178.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.469 ' HB2' ' OD2' ' A' ' 33' ' ' ASP . 2.4 mtt85 -89.12 142.13 27.91 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.449 -0.782 . . . . 0.0 110.772 178.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.566 ' O ' HG13 ' A' ' 35' ' ' ILE . 12.1 ptpt -35.91 -34.54 0.05 Allowed 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.707 -0.621 . . . . 0.0 111.582 179.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.464 ' OE1' ' HG3' ' A' ' 31' ' ' LYS . 1.6 mm100 -63.78 -59.84 4.05 Favored 'General case' 0 N--CA 1.517 2.91 0 O-C-N 120.568 -1.332 . . . . 0.0 109.869 -179.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.542 ' OD1' ' N ' ' A' ' 34' ' ' ILE . 2.5 p30 -66.11 -37.61 86.16 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.586 -0.696 . . . . 0.0 110.162 -178.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.542 ' N ' ' OD1' ' A' ' 33' ' ' ASP . 3.3 mt -61.15 -41.46 89.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 O-C-N 120.267 -1.521 . . . . 0.0 108.071 178.12 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.566 HG13 ' O ' ' A' ' 31' ' ' LYS . 96.8 mt -60.93 -48.48 88.8 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.778 0 O-C-N 120.057 -1.652 . . . . 0.0 109.443 177.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -52.7 -41.7 64.13 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 107.859 -1.164 . . . . 0.0 107.859 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.34 -55.55 26.94 Favored 'General case' 0 C--O 1.2 -1.506 0 O-C-N 120.911 -1.118 . . . . 0.0 108.456 177.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.542 ' HA ' ' CD ' ' A' ' 41' ' ' GLN . 0.4 OUTLIER -51.22 -27.86 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 C-N-CA 117.301 -1.76 . . . . 0.0 110.358 179.853 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.522 ' CD1' HD12 ' A' ' 6' ' ' LEU . 3.1 mp -71.59 -45.55 61.87 Favored 'General case' 0 N--CA 1.509 2.5 0 C-N-CA 117.762 -1.575 . . . . 0.0 109.551 178.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.515 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 1.2 mtpp -65.83 -40.86 92.18 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.191 -0.943 . . . . 0.0 111.377 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.565 ' HG2' ' N ' ' A' ' 42' ' ' HIS . 0.0 OUTLIER -79.07 -41.58 28.43 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.962 -1.086 . . . . 0.0 111.512 -178.605 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.567 ' CD2' ' HE1' ' A' ' 21' ' ' MET . 1.3 m-70 -69.77 -33.94 73.08 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 117.187 -1.805 . . . . 0.0 107.957 178.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.474 ' O ' ' N ' ' A' ' 46' ' ' GLY . . . -67.03 -51.66 52.03 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 120.641 -1.287 . . . . 0.0 107.842 177.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.515 ' HB2' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -49.31 -46.32 46.46 Favored 'General case' 0 N--CA 1.482 1.153 0 O-C-N 121.081 -1.012 . . . . 0.0 108.998 177.935 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 65.9 m -66.63 -6.35 15.04 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 120.039 -0.664 . . . . 0.0 109.797 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . 90.62 7.94 66.24 Favored Glycine 0 N--CA 1.496 2.678 0 C-N-CA 119.883 -1.151 . . . . 0.0 113.328 177.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -79.03 159.14 27.72 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 120.754 2.277 . . . . 0.0 108.781 179.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -88.64 150.36 23.06 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.899 -1.125 . . . . 0.0 110.038 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.534 HG13 HG13 ' A' ' 101' ' ' ILE . 0.7 OUTLIER -135.12 133.52 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 120.805 -1.185 . . . . 0.0 107.95 179.052 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.58 ' CE2' ' HB2' ' A' ' 2' ' ' ASN . 8.2 p90 -140.5 166.87 23.54 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 116.558 -2.057 . . . . 0.0 114.255 -178.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -122.13 170.67 15.1 Favored Glycine 0 N--CA 1.5 2.953 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -177.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.429 ' C ' ' CD2' ' A' ' 65' ' ' LEU . 2.7 p30 -170.04 163.94 9.35 Favored 'General case' 0 N--CA 1.482 1.155 0 O-C-N 120.681 -1.482 . . . . 0.0 110.138 -179.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 145.32 -140.25 8.91 Favored Glycine 0 N--CA 1.506 3.328 0 C-N-CA 118.356 -1.878 . . . . 0.0 110.962 178.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.508 ' HA ' ' O ' ' A' ' 95' ' ' ASP . 3.0 t -128.2 121.08 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.5 mt -62.79 163.91 8.68 Favored 'General case' 0 N--CA 1.505 2.277 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -175.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.469 ' HA ' ' OG1' ' A' ' 93' ' ' THR . 73.0 mm-40 -137.92 117.98 13.45 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 177.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.592 ' CG1' ' HB ' ' A' ' 93' ' ' THR . 1.3 mm -85.13 162.11 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 CA-C-N 121.001 1.728 . . . . 0.0 110.545 -178.043 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.575 HD21 ' CE1' ' A' ' 62' ' ' PHE . 5.1 mp -129.16 136.0 49.59 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.682 -1.261 . . . . 0.0 108.941 178.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.45 ' C ' ' O ' ' A' ' 58' ' ' LEU . 1.1 mt-30 -41.25 -34.01 0.44 Allowed 'General case' 0 N--CA 1.501 2.092 0 CA-C-O 121.972 0.892 . . . . 0.0 109.301 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -60.99 -7.82 2.75 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 119.928 -0.709 . . . . 0.0 112.247 -179.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.501 ' O ' ' HB3' ' A' ' 83' ' ' PRO . . . 93.55 4.35 64.03 Favored Glycine 1 N--CA 1.517 4.08 0 C-N-CA 118.817 -1.659 . . . . 0.0 112.43 177.758 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.575 ' CE1' HD21 ' A' ' 58' ' ' LEU . 5.0 p90 -127.66 179.92 5.27 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 104.808 -2.293 . . . . 0.0 104.808 178.131 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -161.05 176.82 37.6 Favored Glycine 0 N--CA 1.476 1.343 0 C-N-CA 117.187 -2.435 . . . . 0.0 111.486 -177.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.442 ' CE2' ' HE2' ' A' ' 62' ' ' PHE . 23.2 m-85 -129.53 152.47 49.02 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 119.968 1.884 . . . . 0.0 109.689 177.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.479 ' HB3' ' HB ' ' A' ' 79' ' ' ILE . 0.5 OUTLIER -97.72 156.28 16.63 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 176.542 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.476 ' HB3' ' O ' ' A' ' 65' ' ' LEU . 1.1 ptp85 177.12 -154.21 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.96 -1.087 . . . . 0.0 109.999 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.5 2.029 0 O-C-N 121.247 -0.908 . . . . 0.0 110.888 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.505 ' OD1' ' N ' ' A' ' 78' ' ' ASP . 2.0 m-20 . . . . . 0 N--CA 1.505 2.314 0 CA-C-O 121.075 0.464 . . . . 0.0 109.981 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.479 ' HB ' ' HB3' ' A' ' 65' ' ' LEU . 4.6 mm -128.35 133.83 66.03 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.657 0 O-C-N 121.06 -1.025 . . . . 0.0 109.891 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.497 ' HB3' ' HA ' ' A' ' 112' ' ' ALA . 81.4 t80 -78.45 147.51 33.94 Favored 'General case' 0 N--CA 1.516 2.846 0 O-C-N 119.399 -2.063 . . . . 0.0 109.347 179.13 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.2 t -140.58 114.09 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 O-C-N 120.12 -1.612 . . . . 0.0 110.664 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.53 ' O ' HG13 ' A' ' 86' ' ' ILE . 58.6 m -75.25 163.6 66.7 Favored Pre-proline 0 N--CA 1.512 2.651 0 O-C-N 120.442 -1.411 . . . . 0.0 112.18 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.539 ' HA ' HG13 ' A' ' 86' ' ' ILE . 38.0 Cg_endo -65.49 -52.75 0.96 Allowed 'Trans proline' 0 C--N 1.314 -1.289 0 O-C-N 124.701 1.895 . . . . 0.0 108.904 178.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.516 ' O ' ' HB2' ' A' ' 88' ' ' ARG . 0.3 OUTLIER -45.66 -40.98 9.81 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 178.242 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.499 ' HB2' ' O ' ' A' ' 82' ' ' SER . 7.4 mm100 -62.41 -58.85 6.15 Favored 'General case' 0 N--CA 1.51 2.556 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.549 ' HA ' ' CD1' ' A' ' 91' ' ' LEU . 0.4 OUTLIER -55.98 -55.06 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.273 0 O-C-N 121.128 -0.982 . . . . 0.0 108.837 178.469 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.482 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 1.6 mtt85 -58.13 -42.6 86.2 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-O 121.772 0.796 . . . . 0.0 111.644 -178.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.516 ' HB2' ' O ' ' A' ' 84' ' ' SER . 19.8 mtt-85 -60.76 -36.8 79.86 Favored 'General case' 0 N--CA 1.505 2.311 0 C-N-CA 119.34 -0.944 . . . . 0.0 111.884 -177.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.591 ' HB2' ' CD2' ' A' ' 91' ' ' LEU . 16.7 m-85 -110.99 13.02 22.08 Favored 'General case' 0 N--CA 1.503 2.189 0 C-N-CA 116.815 -1.954 . . . . 0.0 111.382 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 61.19 55.04 3.09 Favored 'General case' 0 N--CA 1.483 1.21 0 O-C-N 120.509 -1.369 . . . . 0.0 110.458 178.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.591 ' CD2' ' HB2' ' A' ' 89' ' ' PHE . 3.9 mt -89.2 -170.75 2.99 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 119.102 -1.039 . . . . 0.0 110.416 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.531 ' CG ' ' O ' ' A' ' 91' ' ' LEU . 86.5 mtt-85 -159.4 160.03 34.41 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.592 ' HB ' ' CG1' ' A' ' 57' ' ' ILE . 1.7 t -64.36 156.9 27.73 Favored 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 116.826 -1.949 . . . . 0.0 106.662 178.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.46 ' HA2' HG13 ' A' ' 54' ' ' VAL . . . 75.54 -9.44 15.34 Favored Glycine 0 N--CA 1.506 3.329 0 C-N-CA 117.122 -2.466 . . . . 0.0 110.191 179.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.513 ' OD2' ' N ' ' A' ' 92' ' ' ARG . 11.7 m-20 -66.79 147.98 52.53 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.235 -1.744 . . . . 0.0 110.778 -178.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.472 ' O ' HG12 ' A' ' 97' ' ' ILE . 0.2 OUTLIER -89.6 120.98 31.37 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.228 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.501 HG22 HD12 ' A' ' 97' ' ' ILE . 1.4 mt -144.06 162.05 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 119.934 -1.729 . . . . 0.0 112.803 -178.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.494 ' OG ' ' HB2' ' A' ' 118' ' ' GLU . 97.5 p -148.05 137.88 22.52 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.512 ' O ' ' HB2' ' A' ' 50' ' ' PHE . . . -168.05 -178.27 39.83 Favored Glycine 0 N--CA 1.507 3.415 0 C-N-CA 117.035 -2.507 . . . . 0.0 114.917 -178.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.525 ' CD ' ' HB3' ' A' ' 115' ' ' LYS . 1.8 ptmt -90.12 156.93 18.01 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.534 HG13 HG13 ' A' ' 49' ' ' ILE . 2.3 pt -125.61 155.75 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.523 0 CA-C-N 120.659 1.572 . . . . 0.0 113.227 -177.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.543 ' HB3' ' CD1' ' A' ' 114' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.356 0 O-C-N 120.58 -1.325 . . . . 0.0 109.25 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.449 ' HD3' ' C ' ' A' ' 109' ' ' ARG . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.688 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.426 ' CZ ' ' HD2' ' A' ' 109' ' ' ARG . 35.8 m-85 -109.04 144.26 37.27 Favored 'General case' 0 N--CA 1.515 2.805 0 O-C-N 120.32 -1.487 . . . . 0.0 108.082 176.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.452 ' O ' ' HB3' ' A' ' 80' ' ' TYR . 3.3 m-85 -68.33 165.74 18.0 Favored 'General case' 0 N--CA 1.506 2.348 0 O-C-N 119.321 -2.112 . . . . 0.0 107.957 178.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.497 ' HA ' ' HB3' ' A' ' 80' ' ' TYR . . . -122.7 150.68 42.4 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 119.955 -1.715 . . . . 0.0 110.957 -179.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.3 tp -60.11 147.56 39.08 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.543 ' CD1' ' HB3' ' A' ' 102' ' ' ARG . 14.3 tp -127.84 -55.48 1.3 Allowed 'General case' 0 N--CA 1.502 2.136 0 O-C-N 120.357 -1.464 . . . . 0.0 112.345 -178.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.525 ' HB3' ' CD ' ' A' ' 100' ' ' LYS . 0.6 OUTLIER -124.68 139.79 53.54 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 120.321 -1.487 . . . . 0.0 108.598 179.448 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.452 HG12 ' CG2' ' A' ' 119' ' ' VAL . 29.2 t -92.47 129.75 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.735 0 O-C-N 120.671 -1.268 . . . . 0.0 111.52 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -106.43 -39.81 5.78 Favored 'General case' 0 N--CA 1.506 2.339 0 O-C-N 121.409 -0.807 . . . . 0.0 109.496 178.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.494 ' HB2' ' OG ' ' A' ' 98' ' ' SER . 1.7 tt0 -143.31 154.49 43.83 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.797 -1.189 . . . . 0.0 109.515 178.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.49 HG21 HG22 ' A' ' 97' ' ' ILE . 83.3 t -159.99 128.21 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 C-N-CA 120.749 -0.38 . . . . 0.0 111.503 -178.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.419 ' C ' ' O ' ' A' ' 119' ' ' VAL . 0.6 OUTLIER . . . . . 0 N--CA 1.52 3.049 0 O-C-N 120.514 -1.366 . . . . 0.0 111.161 178.833 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.568 ' HA ' ' HA ' ' A' ' 49' ' ' ILE . 2.1 ptp . . . . . 0 N--CA 1.493 1.701 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . 0.559 ' HB2' ' CZ ' ' A' ' 50' ' ' PHE . 8.7 t-20 -78.21 94.28 4.74 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.819 -1.175 . . . . 0.0 108.635 179.118 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.468 ' HA ' HD13 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -41.41 -41.27 1.96 Allowed 'General case' 0 N--CA 1.517 2.917 0 O-C-N 120.679 -1.263 . . . . 0.0 110.031 -178.797 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.472 ' OG1' ' OD2' ' A' ' 52' ' ' ASP . 1.8 m -59.13 -35.36 73.34 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 120.819 -1.176 . . . . 0.0 108.564 -179.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.515 ' N ' ' OD1' ' A' ' 2' ' ' ASN . 0.1 OUTLIER -74.12 -45.39 49.26 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.027 -1.046 . . . . 0.0 108.747 178.209 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.52 ' CD1' HD23 ' A' ' 39' ' ' LEU 0.275 77.9 mt -50.94 -49.72 59.26 Favored 'General case' 0 C--N 1.317 -0.817 0 O-C-N 120.806 -1.184 . . . . 0.0 109.216 178.266 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -66.21 -39.78 89.86 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.046 -1.034 . . . . 0.0 110.142 178.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -63.25 -28.09 69.79 Favored 'General case' 0 N--CA 1.508 2.429 0 O-C-N 121.226 -0.921 . . . . 0.0 111.251 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.594 ' HB ' ' CD1' ' A' ' 14' ' ' LEU . 3.0 m -73.84 126.92 89.12 Favored Pre-proline 0 N--CA 1.505 2.321 0 O-C-N 121.538 -0.727 . . . . 0.0 109.549 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.526 ' HG2' ' CG ' ' A' ' 13' ' ' GLU . 40.1 Cg_endo -61.16 150.47 84.31 Favored 'Trans proline' 0 CA--C 1.566 2.096 0 O-C-N 122.315 0.64 . . . . 0.0 110.84 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.55 ' CG1' ' N ' ' A' ' 12' ' ' SER . 1.4 p -43.43 -50.74 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.525 3.276 0 O-C-N 120.493 -1.379 . . . . 0.0 109.471 -178.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.55 ' N ' ' CG1' ' A' ' 11' ' ' VAL . 0.8 OUTLIER -56.21 -39.95 73.28 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.418 -0.801 . . . . 0.0 111.056 -179.856 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.534 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 0.1 OUTLIER -69.26 -29.59 67.52 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 117.96 -1.496 . . . . 0.0 107.711 179.178 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.594 ' CD1' ' HB ' ' A' ' 9' ' ' THR . 0.0 OUTLIER -68.54 -44.32 74.79 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.13 -0.981 . . . . 0.0 108.89 176.845 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.5 mp -65.68 -37.17 79.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 C-N-CA 117.97 -1.492 . . . . 0.0 108.908 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.518 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 31.0 m -65.8 -38.64 89.53 Favored 'General case' 0 N--CA 1.484 1.247 0 O-C-N 120.338 -1.476 . . . . 0.0 109.123 178.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.534 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 3.7 mt -65.34 -38.13 89.19 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.887 -1.133 . . . . 0.0 108.764 178.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.48 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -67.61 -43.5 85.41 Favored Glycine 0 N--CA 1.513 3.787 0 N-CA-C 108.49 -1.844 . . . . 0.0 108.49 178.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.672 ' HG3' ' N ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -58.62 -38.84 78.91 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.463 -1.61 . . . . 0.0 108.175 178.925 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.672 ' N ' ' HG3' ' A' ' 19' ' ' GLU . 24.8 m120 -61.81 -27.76 68.99 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 118.13 -1.428 . . . . 0.0 109.313 178.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.517 ' CE ' ' NE2' ' A' ' 41' ' ' GLN . 21.5 mmm -102.5 10.81 38.64 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.314 -0.867 . . . . 0.0 111.511 -178.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.66 -18.23 50.99 Favored Glycine 0 N--CA 1.504 3.175 0 C-N-CA 118.537 -1.792 . . . . 0.0 112.102 179.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.562 ' O ' ' CD1' ' A' ' 26' ' ' LEU . 5.0 mp -78.4 95.01 4.99 Favored 'General case' 0 N--CA 1.508 2.449 0 O-C-N 120.193 -1.769 . . . . 0.0 110.121 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.474 ' O ' ' CB ' ' A' ' 25' ' ' ASN . 51.5 mt-10 -104.01 168.66 8.97 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.169 -0.957 . . . . 0.0 109.268 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.474 ' CB ' ' O ' ' A' ' 24' ' ' GLU . 0.1 OUTLIER 68.98 19.49 8.15 Favored 'General case' 0 N--CA 1.508 2.434 0 O-C-N 121.499 -0.751 . . . . 0.0 111.947 179.056 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.562 ' CD1' ' O ' ' A' ' 23' ' ' LEU . 0.4 OUTLIER -76.21 -13.62 60.17 Favored 'General case' 0 N--CA 1.505 2.283 0 O-C-N 120.76 -1.212 . . . . 0.0 111.381 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 26' ' ' LEU . . . -46.99 -35.61 6.81 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.464 -1.398 . . . . 0.0 109.061 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.6 mtt180 -81.16 2.48 27.39 Favored 'General case' 0 C--N 1.295 -1.79 0 C-N-CA 119.849 -0.74 . . . . 0.0 111.438 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.526 ' HB3' HG13 ' A' ' 34' ' ' ILE . 7.4 mtp -100.4 150.53 22.52 Favored 'General case' 0 C--N 1.313 -0.984 0 O-C-N 120.832 -1.167 . . . . 0.0 111.164 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.452 ' O ' ' C ' ' A' ' 31' ' ' LYS . 10.8 ttp85 -89.22 142.59 27.51 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.258 -0.901 . . . . 0.0 110.677 179.106 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.59 ' O ' ' CG1' ' A' ' 35' ' ' ILE . 7.7 tttp -31.95 -46.27 0.11 Allowed 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 116.264 -0.426 . . . . 0.0 112.051 179.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.524 ' OE1' ' N ' ' A' ' 33' ' ' ASP . 1.2 pp0? -61.6 -53.88 50.37 Favored 'General case' 0 N--CA 1.52 3.066 0 O-C-N 121.325 -0.86 . . . . 0.0 112.101 -177.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 34' ' ' ILE . 2.1 p30 -66.73 -37.32 84.43 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 120.732 -1.23 . . . . 0.0 108.964 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.556 ' CG2' ' HB3' ' A' ' 14' ' ' LEU . 4.8 mt -61.17 -39.44 82.45 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 O-C-N 120.328 -1.482 . . . . 0.0 108.043 177.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.59 ' CG1' ' O ' ' A' ' 31' ' ' LYS . 0.6 OUTLIER -57.58 -47.51 85.17 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.558 0 O-C-N 120.085 -1.635 . . . . 0.0 109.271 177.577 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -53.18 -41.15 64.95 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.405 -0.918 . . . . 0.0 108.526 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.512 ' HB3' ' CD2' ' A' ' 23' ' ' LEU . . . -70.29 -53.09 18.27 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.971 -1.081 . . . . 0.0 109.953 178.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.641 ' HA ' ' CG ' ' A' ' 41' ' ' GLN . 0.1 OUTLIER -53.78 -28.26 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 C-N-CA 117.437 -1.705 . . . . 0.0 110.362 -179.786 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.52 HD23 ' CD1' ' A' ' 6' ' ' LEU . 64.7 mt -72.33 -44.3 62.86 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 120.409 -1.432 . . . . 0.0 109.696 178.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 10.9 mmtt -64.21 -41.63 96.95 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.046 -1.034 . . . . 0.0 110.501 179.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.641 ' CG ' ' HA ' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -74.86 -46.41 36.54 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.065 -1.022 . . . . 0.0 111.359 -179.06 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.505 ' HA ' ' HE3' ' A' ' 21' ' ' MET . 0.3 OUTLIER -66.01 -34.47 78.17 Favored 'General case' 0 N--CA 1.505 2.309 0 O-C-N 120.543 -1.348 . . . . 0.0 108.984 179.539 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.565 ' O ' ' N ' ' A' ' 46' ' ' GLY . . . -67.32 -36.93 82.47 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 120.975 -1.078 . . . . 0.0 108.96 178.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.89 -43.73 28.89 Favored 'General case' 0 N--CA 1.482 1.162 0 O-C-N 120.799 -1.188 . . . . 0.0 108.966 178.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 70.8 m -66.66 -9.99 41.67 Favored 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 119.59 -0.844 . . . . 0.0 109.265 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.565 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . 64.57 36.03 92.66 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 178.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.514 ' OE1' ' N ' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -92.62 166.72 12.35 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.432 -1.628 . . . . 0.0 108.841 179.214 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.514 ' N ' ' OE1' ' A' ' 47' ' ' GLU . 17.0 m-20 -61.58 137.09 58.23 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.122 -0.986 . . . . 0.0 110.792 -178.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.568 ' HA ' ' HA ' ' A' ' 1' ' ' MET . 3.0 pt -141.26 135.19 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 120.986 -1.071 . . . . 0.0 108.224 178.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.641 ' CD1' ' N ' ' A' ' 50' ' ' PHE . 7.4 p90 -144.86 163.26 34.63 Favored 'General case' 0 C--N 1.31 -1.12 0 C-N-CA 116.014 -2.274 . . . . 0.0 115.794 -178.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -120.79 170.6 14.5 Favored Glycine 0 N--CA 1.505 3.243 0 N-CA-C 108.686 -1.766 . . . . 0.0 108.686 -179.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.483 ' C ' ' CD2' ' A' ' 65' ' ' LEU . 52.5 p-10 -170.22 167.5 8.57 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 120.383 -1.657 . . . . 0.0 110.741 -178.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.522 ' HA3' ' O ' ' A' ' 66' ' ' ARG . . . 144.09 -139.19 8.49 Favored Glycine 0 N--CA 1.507 3.418 0 C-N-CA 118.368 -1.872 . . . . 0.0 111.472 177.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.501 ' HA ' ' O ' ' A' ' 95' ' ' ASP . 2.8 t -127.75 120.12 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 O-C-N 121.258 -1.142 . . . . 0.0 108.092 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.2 mt -62.92 162.78 10.66 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -175.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.485 ' HA ' ' OG1' ' A' ' 93' ' ' THR . 0.0 OUTLIER -139.27 119.79 14.0 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.03 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.571 ' CG1' ' HB ' ' A' ' 93' ' ' THR . 1.2 mm -78.65 162.07 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 119.733 -1.854 . . . . 0.0 109.18 -178.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.645 ' CD2' ' CZ ' ' A' ' 62' ' ' PHE . 1.3 mp -131.39 126.06 34.2 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.301 -1.499 . . . . 0.0 109.752 179.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.509 ' C ' ' O ' ' A' ' 58' ' ' LEU . 6.9 mm-40 -32.74 -37.05 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.458 0 CA-C-O 122.018 0.913 . . . . 0.0 109.715 -179.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.535 ' HB2' ' CD2' ' A' ' 62' ' ' PHE . 3.1 m-20 -60.92 -6.21 1.72 Allowed 'General case' 0 N--CA 1.5 2.033 0 C-N-CA 120.271 -0.571 . . . . 0.0 112.489 -179.176 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 58' ' ' LEU . . . 89.14 11.9 64.22 Favored Glycine 1 N--CA 1.517 4.077 0 C-N-CA 118.672 -1.728 . . . . 0.0 111.944 178.365 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.645 ' CZ ' ' CD2' ' A' ' 58' ' ' LEU . 4.0 p90 -128.1 -178.85 4.69 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 104.18 -2.526 . . . . 0.0 104.18 177.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.554 ' HA2' ' CD1' ' A' ' 58' ' ' LEU . . . -152.75 162.87 30.2 Favored Glycine 0 N--CA 1.475 1.292 0 C-N-CA 117.322 -2.37 . . . . 0.0 111.272 -177.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.439 ' CD1' ' HE1' ' A' ' 62' ' ' PHE . 2.0 m-30 -127.81 150.96 49.59 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 120.136 1.968 . . . . 0.0 109.156 177.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.497 ' CB ' ' HB ' ' A' ' 79' ' ' ILE . 0.3 OUTLIER -98.34 166.37 11.41 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 176.768 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.522 ' O ' ' HA3' ' A' ' 53' ' ' GLY . 21.0 tpt180 -178.42 -179.97 0.73 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.057 -1.027 . . . . 0.0 109.02 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.7 m . . . . . 0 N--CA 1.496 1.867 0 O-C-N 120.45 -1.406 . . . . 0.0 109.86 179.658 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 78' ' ' ASP . 1.1 m-20 . . . . . 0 N--CA 1.506 2.343 0 CA-C-O 121.096 0.474 . . . . 0.0 109.77 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.497 ' HB ' ' CB ' ' A' ' 65' ' ' LEU . 3.9 mm -126.56 138.67 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.65 0 O-C-N 121.16 -0.963 . . . . 0.0 110.11 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.474 ' HB3' ' HA ' ' A' ' 112' ' ' ALA . 6.0 t80 -85.02 146.55 27.13 Favored 'General case' 0 N--CA 1.516 2.867 0 CA-C-N 121.502 1.955 . . . . 0.0 109.819 178.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.479 ' HB ' ' O ' ' A' ' 63' ' ' GLY . 25.2 t -141.65 115.77 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 120.078 -1.639 . . . . 0.0 110.226 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.53 ' O ' ' HB2' ' A' ' 85' ' ' GLN . 58.0 m -74.3 163.52 67.7 Favored Pre-proline 0 N--CA 1.515 2.799 0 O-C-N 120.262 -1.524 . . . . 0.0 112.131 -179.208 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.52 ' HA ' HG13 ' A' ' 86' ' ' ILE . 40.2 Cg_endo -66.62 -50.27 1.34 Allowed 'Trans proline' 0 C--N 1.314 -1.249 0 O-C-N 124.505 1.792 . . . . 0.0 108.958 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.539 ' O ' ' CG ' ' A' ' 88' ' ' ARG . 0.4 OUTLIER -47.2 -39.53 14.19 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 177.834 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.53 ' HB2' ' O ' ' A' ' 82' ' ' SER . 7.2 mm-40 -63.42 -57.78 9.2 Favored 'General case' 0 N--CA 1.511 2.587 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.535 ' HA ' ' CD2' ' A' ' 91' ' ' LEU . 0.8 OUTLIER -55.51 -53.59 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.336 0 O-C-N 120.938 -1.101 . . . . 0.0 108.647 178.848 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.468 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 0.1 OUTLIER -57.81 -41.72 82.76 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 121.865 0.84 . . . . 0.0 111.364 -179.459 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.539 ' CG ' ' O ' ' A' ' 84' ' ' SER . 12.5 mtt180 -59.37 -37.46 77.96 Favored 'General case' 0 N--CA 1.507 2.407 0 C-N-CA 119.883 -0.727 . . . . 0.0 111.928 -177.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.565 ' CD2' HG22 ' A' ' 116' ' ' VAL . 19.3 m-85 -113.97 14.53 18.46 Favored 'General case' 0 N--CA 1.505 2.318 0 C-N-CA 117.274 -1.771 . . . . 0.0 111.412 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 58.45 56.5 4.32 Favored 'General case' 0 N--CA 1.481 1.108 0 O-C-N 120.31 -1.493 . . . . 0.0 109.084 179.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.535 ' CD2' ' HA ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -88.37 173.91 8.46 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.431 -0.908 . . . . 0.0 109.338 -179.831 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.535 ' CD ' ' O ' ' A' ' 91' ' ' LEU . 3.7 mmm180 -147.0 157.51 43.64 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.997 -1.065 . . . . 0.0 108.86 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.571 ' HB ' ' CG1' ' A' ' 57' ' ' ILE . 2.4 t -63.73 156.29 27.54 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 116.948 -1.901 . . . . 0.0 106.993 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.4 ' HA2' HG13 ' A' ' 54' ' ' VAL . . . 76.34 -9.61 19.9 Favored Glycine 0 N--CA 1.504 3.189 0 C-N-CA 117.094 -2.479 . . . . 0.0 110.334 179.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.501 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 6.0 m-20 -69.36 147.75 50.63 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.228 -1.748 . . . . 0.0 110.752 -178.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.498 ' O ' HG12 ' A' ' 97' ' ' ILE . 0.2 OUTLIER -91.22 124.29 35.31 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.093 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.498 HG12 ' O ' ' A' ' 96' ' ' THR . 1.7 mt -146.73 166.3 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.034 -1.666 . . . . 0.0 112.408 -179.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.536 ' OG ' ' HB2' ' A' ' 118' ' ' GLU . 82.4 p -148.93 139.82 22.87 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.233 178.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 50' ' ' PHE . . . -164.6 179.55 39.27 Favored Glycine 0 N--CA 1.506 3.346 0 C-N-CA 117.039 -2.505 . . . . 0.0 114.987 -179.118 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.507 ' HG2' ' HB3' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -87.76 152.88 21.78 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 178.772 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.514 HG13 HG13 ' A' ' 49' ' ' ILE . 2.4 pt -122.87 159.17 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.462 0 CA-C-N 120.982 1.719 . . . . 0.0 113.603 -176.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.456 ' HB2' HD21 ' A' ' 114' ' ' LEU . 1.5 tmm_? . . . . . 0 N--CA 1.481 1.111 0 O-C-N 120.582 -1.324 . . . . 0.0 109.891 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.494 1.75 0 N-CA-C 111.245 0.091 . . . . 0.0 111.245 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.421 ' CD1' ' N ' ' A' ' 110' ' ' TYR . 3.6 m-85 -108.4 148.04 30.71 Favored 'General case' 0 N--CA 1.521 3.078 0 O-C-N 120.07 -1.644 . . . . 0.0 109.542 178.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.471 ' O ' ' HB3' ' A' ' 80' ' ' TYR . 54.4 m-85 -69.13 172.03 7.44 Favored 'General case' 0 N--CA 1.509 2.514 0 O-C-N 119.735 -1.853 . . . . 0.0 108.034 178.317 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.474 ' HA ' ' HB3' ' A' ' 80' ' ' TYR . . . -122.08 154.96 36.65 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 119.924 -1.735 . . . . 0.0 110.842 -179.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.12 153.7 43.28 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 179.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.456 ' HB3' ' HG3' ' A' ' 100' ' ' LYS . 11.1 tp -132.79 -59.55 0.89 Allowed 'General case' 0 N--CA 1.501 2.077 0 O-C-N 120.135 -1.603 . . . . 0.0 112.22 -179.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.507 ' HB3' ' HG2' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -114.18 141.7 47.19 Favored 'General case' 0 N--CA 1.511 2.615 0 O-C-N 120.272 -1.518 . . . . 0.0 109.074 179.401 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.565 HG22 ' CD2' ' A' ' 89' ' ' PHE . 34.7 t -93.05 129.25 43.83 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.908 0 O-C-N 120.543 -1.348 . . . . 0.0 111.63 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.441 ' C ' ' HG2' ' A' ' 118' ' ' GLU . 7.1 m-20 -106.93 -39.05 5.87 Favored 'General case' 0 N--CA 1.507 2.423 0 O-C-N 121.463 -0.773 . . . . 0.0 109.918 178.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.536 ' HB2' ' OG ' ' A' ' 98' ' ' SER . 6.0 mm-40 -143.52 156.37 44.59 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.595 -1.316 . . . . 0.0 109.041 179.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.521 ' CG2' ' C ' ' A' ' 118' ' ' GLU . 6.4 t -156.17 139.81 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -178.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.467 ' C ' ' O ' ' A' ' 119' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.519 2.978 0 O-C-N 121.106 -0.996 . . . . 0.0 111.197 -177.535 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.58 ' HE2' ' CG ' ' A' ' 42' ' ' HIS . 14.1 mmt . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.097 0.475 . . . . 0.0 109.925 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . 0.502 ' HB3' ' HB3' ' A' ' 5' ' ' GLU . 39.8 t30 -78.86 110.04 13.69 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.007 -1.058 . . . . 0.0 108.84 178.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.525 ' CD1' HD13 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -44.09 -41.17 5.4 Favored 'General case' 0 N--CA 1.514 2.74 0 O-C-N 120.339 -1.476 . . . . 0.0 110.493 -178.695 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.43 ' OG1' ' OD1' ' A' ' 52' ' ' ASP . 1.7 m -58.4 -36.88 74.24 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 120.696 -1.253 . . . . 0.0 108.264 -179.014 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.502 ' HB3' ' HB3' ' A' ' 2' ' ' ASN . 1.8 pt-20 -70.53 -45.84 64.75 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.089 -1.007 . . . . 0.0 108.543 178.053 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.489 ' HB3' HG13 ' A' ' 35' ' ' ILE 0.281 82.3 mt -51.65 -49.5 62.19 Favored 'General case' 0 C--N 1.315 -0.916 0 O-C-N 121.008 -1.058 . . . . 0.0 109.521 178.397 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.78 -38.58 91.65 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.288 -0.883 . . . . 0.0 110.094 179.137 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -62.58 -19.52 63.8 Favored 'General case' 0 N--CA 1.508 2.473 0 O-C-N 121.262 -0.899 . . . . 0.0 111.383 -179.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.62 ' HB ' ' CD1' ' A' ' 14' ' ' LEU . 3.2 m -83.17 117.85 69.87 Favored Pre-proline 0 C--N 1.284 -2.278 0 O-C-N 121.763 -0.585 . . . . 0.0 109.966 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.482 ' HG2' ' HG3' ' A' ' 13' ' ' GLU . 38.5 Cg_endo -59.61 155.14 43.98 Favored 'Trans proline' 0 CA--C 1.564 2.0 0 O-C-N 122.471 0.722 . . . . 0.0 110.899 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.519 ' CG1' ' N ' ' A' ' 12' ' ' SER . 1.7 p -42.81 -51.63 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.527 3.383 0 O-C-N 120.577 -1.327 . . . . 0.0 110.139 -178.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.519 ' N ' ' CG1' ' A' ' 11' ' ' VAL . 1.5 t -55.01 -43.23 73.45 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 121.12 -0.987 . . . . 0.0 111.239 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.55 ' HB3' ' CG2' ' A' ' 9' ' ' THR . 1.7 mm-40 -68.38 -27.32 66.13 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 117.947 -1.501 . . . . 0.0 107.59 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.62 ' CD1' ' HB ' ' A' ' 9' ' ' THR . 0.0 OUTLIER -70.61 -41.46 72.26 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.132 -0.98 . . . . 0.0 109.089 176.958 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.8 mp -69.81 -36.1 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 C-N-CA 117.824 -1.55 . . . . 0.0 109.216 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.498 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 86.8 m -69.31 -40.78 77.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.03 -1.669 . . . . 0.0 109.816 179.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.53 ' CD1' HG22 ' A' ' 9' ' ' THR . 1.9 mt -64.84 -37.62 88.22 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.696 -1.252 . . . . 0.0 108.923 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.637 ' HA3' HD22 ' A' ' 23' ' ' LEU . . . -68.2 -44.67 74.92 Favored Glycine 0 N--CA 1.507 3.395 0 N-CA-C 108.929 -1.668 . . . . 0.0 108.929 178.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.654 ' HG3' ' N ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -57.08 -37.11 71.42 Favored 'General case' 0 N--CA 1.484 1.232 0 O-C-N 120.496 -1.59 . . . . 0.0 107.463 178.896 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.654 ' N ' ' HG3' ' A' ' 19' ' ' GLU . 28.9 m120 -61.05 -24.44 66.2 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 118.293 -1.363 . . . . 0.0 109.532 178.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.612 ' CE ' ' CG ' ' A' ' 42' ' ' HIS . 69.6 mmm -97.33 2.18 50.32 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.188 -0.945 . . . . 0.0 111.595 -179.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.55 -3.66 65.9 Favored Glycine 0 N--CA 1.498 2.799 0 C-N-CA 118.249 -1.929 . . . . 0.0 114.142 177.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.637 HD22 ' HA3' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -103.52 63.98 0.8 Allowed 'General case' 0 N--CA 1.509 2.5 0 CA-C-N 121.644 2.722 . . . . 0.0 111.25 179.854 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.521 ' O ' ' CB ' ' A' ' 25' ' ' ASN . 5.1 pt-20 -57.11 -167.71 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.199 0 CA-C-O 122.367 1.08 . . . . 0.0 110.754 178.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.521 ' CB ' ' O ' ' A' ' 24' ' ' GLU . 0.7 OUTLIER 74.62 10.16 4.11 Favored 'General case' 0 N--CA 1.516 2.84 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.571 179.723 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.576 HD12 ' CD2' ' A' ' 23' ' ' LEU . 1.0 OUTLIER -77.14 -18.57 57.79 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.245 -0.909 . . . . 0.0 112.35 -179.358 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.408 ' C ' ' O ' ' A' ' 26' ' ' LEU . . . -46.99 -40.21 14.01 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.313 -1.492 . . . . 0.0 108.771 -179.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 28.0 mtt-85 -81.15 -0.56 40.82 Favored 'General case' 0 C--N 1.295 -1.786 0 C-N-CA 119.725 -0.79 . . . . 0.0 111.359 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.515 ' HB3' HG13 ' A' ' 34' ' ' ILE . 15.7 mtp -101.21 156.78 17.23 Favored 'General case' 0 C--N 1.312 -1.038 0 O-C-N 120.915 -1.116 . . . . 0.0 111.841 -178.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.511 ' O ' HD13 ' A' ' 34' ' ' ILE . 3.8 ttm180 -89.76 175.08 7.37 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.429 -0.794 . . . . 0.0 110.561 177.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.534 ' O ' HG21 ' A' ' 35' ' ' ILE . 9.2 pttm -66.41 -33.33 75.47 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.449 -0.782 . . . . 0.0 110.989 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.641 ' O ' HG21 ' A' ' 35' ' ' ILE . 1.3 mm100 -65.57 -55.02 19.98 Favored 'General case' 0 N--CA 1.523 3.192 0 CA-C-O 122.021 0.915 . . . . 0.0 110.018 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.55 ' OD1' ' N ' ' A' ' 34' ' ' ILE . 2.0 p30 -67.33 -41.91 84.45 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.074 -1.016 . . . . 0.0 109.685 -179.054 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.551 ' CG2' ' HB3' ' A' ' 14' ' ' LEU . 29.0 mt -61.79 -40.84 88.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 O-C-N 120.357 -1.464 . . . . 0.0 109.637 178.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.641 HG21 ' O ' ' A' ' 32' ' ' GLN . 0.2 OUTLIER -66.92 -37.26 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.557 0 O-C-N 120.113 -1.617 . . . . 0.0 109.049 178.149 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 9.2 m-30 -67.02 -45.57 77.1 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.377 -1.452 . . . . 0.0 108.716 178.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.443 ' O ' ' C ' ' A' ' 38' ' ' ILE . . . -67.01 -53.46 31.16 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.49 -1.381 . . . . 0.0 109.487 178.053 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.576 ' CD1' ' HA2' ' A' ' 18' ' ' GLY . 5.9 tp -48.46 -49.99 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 C-N-CA 117.536 -1.665 . . . . 0.0 108.093 179.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.537 ' N ' HG22 ' A' ' 38' ' ' ILE . 5.6 tp -53.87 -41.56 67.65 Favored 'General case' 0 N--CA 1.52 3.052 0 O-C-N 120.76 -1.213 . . . . 0.0 109.1 179.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.466 ' O ' ' HD2' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -60.59 -36.05 77.59 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 121.628 0.727 . . . . 0.0 109.739 179.271 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.57 ' HG3' ' CD1' ' A' ' 23' ' ' LEU . 11.8 mm-40 -79.34 -51.4 9.46 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.663 -0.648 . . . . 0.0 111.354 -179.024 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.612 ' CG ' ' CE ' ' A' ' 21' ' ' MET . 0.2 OUTLIER -61.38 -31.59 71.5 Favored 'General case' 0 N--CA 1.503 2.204 0 C-N-CA 117.736 -1.586 . . . . 0.0 108.425 179.406 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 46' ' ' GLY . . . -58.96 -44.56 91.5 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 177.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -49.22 -45.24 44.19 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 122.11 0.957 . . . . 0.0 108.944 177.952 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 65.5 m -66.8 -8.36 28.0 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 121.639 0.733 . . . . 0.0 109.581 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . 74.53 29.5 61.61 Favored Glycine 0 N--CA 1.495 2.621 0 C-N-CA 120.186 -1.006 . . . . 0.0 111.774 178.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.03 166.65 22.09 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.173 -1.781 . . . . 0.0 108.975 178.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -88.1 130.22 35.08 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.234 -0.916 . . . . 0.0 109.739 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.487 HG13 HG13 ' A' ' 101' ' ' ILE . 0.6 OUTLIER -131.0 135.8 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.562 -1.336 . . . . 0.0 107.655 178.97 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.491 ' O ' ' HA ' ' A' ' 2' ' ' ASN . 17.0 p90 -141.82 165.14 28.29 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 116.28 -2.168 . . . . 0.0 114.834 -177.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -114.21 164.8 12.03 Favored Glycine 0 N--CA 1.503 3.117 0 N-CA-C 108.307 -1.917 . . . . 0.0 108.307 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.461 ' N ' ' OD1' ' A' ' 52' ' ' ASP . 46.7 p-10 -169.79 164.63 9.91 Favored 'General case' 0 N--CA 1.48 1.047 0 O-C-N 120.36 -1.671 . . . . 0.0 110.298 -178.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.527 ' HA3' ' O ' ' A' ' 66' ' ' ARG . . . 140.87 -134.98 6.68 Favored Glycine 0 N--CA 1.504 3.227 0 C-N-CA 118.258 -1.925 . . . . 0.0 111.378 178.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.512 ' HA ' ' O ' ' A' ' 95' ' ' ASP . 2.6 t -128.17 119.85 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 O-C-N 121.414 -1.051 . . . . 0.0 108.265 -179.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.6 mt -62.29 161.61 11.15 Favored 'General case' 0 N--CA 1.501 2.124 0 C-N-CA 118.74 -1.184 . . . . 0.0 113.454 -175.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.465 ' HA ' ' OG1' ' A' ' 93' ' ' THR . 3.4 tp10 -137.31 116.35 12.45 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 178.119 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.587 ' CG1' ' HB ' ' A' ' 93' ' ' THR . 1.3 mm -84.31 159.35 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 120.151 -1.593 . . . . 0.0 108.811 -179.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.453 ' O ' ' C ' ' A' ' 59' ' ' GLN . 2.8 mp -130.96 138.82 49.9 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.348 -1.47 . . . . 0.0 109.961 179.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.453 ' C ' ' O ' ' A' ' 58' ' ' LEU . 3.7 tt0 -38.24 -36.72 0.24 Allowed 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.66 0.743 . . . . 0.0 110.414 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -60.99 -7.74 2.69 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.502 -0.749 . . . . 0.0 112.319 -179.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 91.34 8.39 64.39 Favored Glycine 1 N--CA 1.518 4.151 0 C-N-CA 118.729 -1.701 . . . . 0.0 112.255 177.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.595 ' C ' ' CD1' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -127.65 -179.68 5.06 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 104.883 -2.266 . . . . 0.0 104.883 178.098 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -158.56 170.77 35.22 Favored Glycine 0 N--CA 1.475 1.293 0 C-N-CA 116.712 -2.661 . . . . 0.0 111.784 -177.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.414 ' HE1' ' CE2' ' A' ' 62' ' ' PHE . 6.9 m-85 -129.9 153.0 48.76 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 119.858 1.829 . . . . 0.0 109.753 177.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.491 ' HB3' ' HB ' ' A' ' 79' ' ' ILE . 0.3 OUTLIER -98.9 160.14 14.47 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 176.567 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.527 ' O ' ' HA3' ' A' ' 53' ' ' GLY . 0.0 OUTLIER 178.26 -162.75 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.196 -0.94 . . . . 0.0 109.561 179.191 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' SER . . . . . 0.479 ' N ' ' CG ' ' A' ' 66' ' ' ARG . 1.1 m . . . . . 0 N--CA 1.497 1.923 0 O-C-N 120.98 -1.075 . . . . 0.0 110.282 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 78' ' ' ASP . 0.6 OUTLIER . . . . . 0 N--CA 1.509 2.515 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.491 ' HB ' ' HB3' ' A' ' 65' ' ' LEU . 1.7 mp -135.9 138.27 47.81 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.812 0 O-C-N 120.961 -1.087 . . . . 0.0 110.043 178.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.483 ' HB3' ' O ' ' A' ' 111' ' ' PHE . 5.9 t80 -80.8 146.34 30.99 Favored 'General case' 0 N--CA 1.518 2.955 0 O-C-N 119.685 -1.884 . . . . 0.0 110.028 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.451 ' N ' ' CD1' ' A' ' 80' ' ' TYR . 38.4 t -142.44 112.9 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 120.24 -1.537 . . . . 0.0 110.117 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.517 ' O ' HG13 ' A' ' 86' ' ' ILE . 22.0 m -74.86 166.82 42.16 Favored Pre-proline 0 N--CA 1.512 2.643 0 O-C-N 120.58 -1.325 . . . . 0.0 112.133 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.538 ' HA ' HG13 ' A' ' 86' ' ' ILE . 38.8 Cg_endo -65.19 -53.82 0.76 Allowed 'Trans proline' 0 C--N 1.314 -1.257 0 O-C-N 124.651 1.869 . . . . 0.0 109.08 178.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.56 ' O ' ' CG ' ' A' ' 88' ' ' ARG . 0.8 OUTLIER -45.14 -41.01 7.6 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 178.119 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.568 ' O ' ' CD2' ' A' ' 89' ' ' PHE . 6.6 mm100 -62.74 -57.81 9.65 Favored 'General case' 0 N--CA 1.509 2.517 0 C-N-CA 119.118 -1.033 . . . . 0.0 108.49 178.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.538 HG13 ' HA ' ' A' ' 83' ' ' PRO . 0.2 OUTLIER -59.15 -54.84 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.35 0 O-C-N 121.084 -1.01 . . . . 0.0 108.846 178.648 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.485 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 0.0 OUTLIER -56.22 -42.67 77.62 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-O 121.83 0.824 . . . . 0.0 111.225 -179.102 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.56 ' CG ' ' O ' ' A' ' 84' ' ' SER . 1.4 mmt85 -60.42 -36.42 78.11 Favored 'General case' 0 N--CA 1.507 2.382 0 C-N-CA 119.647 -0.821 . . . . 0.0 111.871 -177.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.568 ' CD2' ' O ' ' A' ' 85' ' ' GLN . 4.7 m-85 -109.74 12.75 23.98 Favored 'General case' 0 N--CA 1.503 2.218 0 C-N-CA 117.494 -1.682 . . . . 0.0 111.174 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 59.52 52.88 5.41 Favored 'General case' 0 N--CA 1.485 1.308 0 O-C-N 120.524 -1.36 . . . . 0.0 109.686 178.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.516 ' O ' ' HG2' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -90.12 174.39 7.66 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.486 -0.758 . . . . 0.0 109.757 179.867 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.516 ' HG2' ' O ' ' A' ' 91' ' ' LEU . 10.3 mtm180 -147.56 159.82 43.33 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.173 -0.955 . . . . 0.0 108.678 178.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.587 ' HB ' ' CG1' ' A' ' 57' ' ' ILE . 1.9 t -63.54 156.28 26.92 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 117.143 -1.823 . . . . 0.0 107.031 179.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.442 ' HA2' HG13 ' A' ' 54' ' ' VAL . . . 77.2 -11.21 17.34 Favored Glycine 0 N--CA 1.505 3.251 0 C-N-CA 117.177 -2.439 . . . . 0.0 110.107 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.512 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 12.5 m-20 -68.26 146.93 52.87 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.211 -1.758 . . . . 0.0 110.943 -178.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.49 ' O ' HG12 ' A' ' 97' ' ' ILE . 0.2 OUTLIER -90.05 120.91 31.64 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.179 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.497 HG22 HG21 ' A' ' 119' ' ' VAL . 1.5 mt -145.95 167.51 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 119.871 -1.768 . . . . 0.0 112.81 -178.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.502 ' OG ' ' HB2' ' A' ' 118' ' ' GLU . 99.8 p -149.25 138.95 21.8 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.483 ' O ' ' HB2' ' A' ' 50' ' ' PHE . . . -163.11 178.09 38.91 Favored Glycine 0 N--CA 1.507 3.42 0 C-N-CA 117.405 -2.331 . . . . 0.0 114.757 -178.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.509 ' HG2' ' HB3' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -88.06 155.88 19.58 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 178.982 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.487 HG13 HG13 ' A' ' 49' ' ' ILE . 1.7 pt -123.04 161.89 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.369 0 CA-C-N 120.636 1.562 . . . . 0.0 113.586 -177.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.439 ' HB2' ' CD2' ' A' ' 114' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.308 0 O-C-N 120.608 -1.307 . . . . 0.0 108.808 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 4.9 tpp180 . . . . . 0 N--CA 1.501 2.079 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -106.57 148.56 28.12 Favored 'General case' 0 N--CA 1.52 3.055 0 O-C-N 120.126 -1.609 . . . . 0.0 109.678 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.483 ' O ' ' HB3' ' A' ' 80' ' ' TYR . 3.4 m-30 -67.72 168.09 12.0 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 119.851 -1.781 . . . . 0.0 108.093 178.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.469 ' HA ' ' HB3' ' A' ' 80' ' ' TYR . . . -121.85 154.15 37.44 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.237 -1.539 . . . . 0.0 110.345 -179.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.54 150.52 46.62 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.439 ' CD2' ' HB2' ' A' ' 102' ' ' ARG . 20.0 tp -127.93 -55.9 1.28 Allowed 'General case' 0 N--CA 1.501 2.088 0 O-C-N 120.282 -1.511 . . . . 0.0 112.373 -178.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.509 ' HB3' ' HG2' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -123.98 142.58 51.04 Favored 'General case' 0 N--CA 1.509 2.513 0 O-C-N 120.32 -1.487 . . . . 0.0 109.263 179.417 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.8 t -92.98 130.7 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.831 0 O-C-N 120.468 -1.395 . . . . 0.0 111.057 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -107.17 -40.93 5.28 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 121.357 -0.839 . . . . 0.0 109.725 178.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.502 ' HB2' ' OG ' ' A' ' 98' ' ' SER . 0.0 OUTLIER -143.67 159.48 42.41 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.872 -1.142 . . . . 0.0 109.74 179.483 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.497 HG21 HG22 ' A' ' 97' ' ' ILE . 13.1 t -158.5 138.14 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -178.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.516 2.853 0 O-C-N 120.332 -1.48 . . . . 0.0 110.643 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.592 ' CE ' ' CG ' ' A' ' 42' ' ' HIS . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.664 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 . . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . 0.552 ' HA ' ' O ' ' A' ' 50' ' ' PHE . 63.5 t30 -78.5 91.06 4.5 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.725 -1.234 . . . . 0.0 108.444 178.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.462 ' CD1' HD13 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -41.59 -40.4 1.88 Allowed 'General case' 0 N--CA 1.52 3.035 0 O-C-N 120.598 -1.314 . . . . 0.0 110.371 -178.186 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.467 ' OG1' ' CG ' ' A' ' 52' ' ' ASP . 1.9 m -60.13 -35.07 74.45 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 118.601 -1.24 . . . . 0.0 108.288 -179.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.55 ' HB3' ' HB3' ' A' ' 2' ' ' ASN . 0.9 OUTLIER -72.65 -44.57 61.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.922 -1.112 . . . . 0.0 108.245 177.386 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.549 ' CG ' HG13 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -51.01 -51.4 53.36 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 120.834 -1.167 . . . . 0.0 108.68 178.37 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 8.1 mttm -62.5 -40.92 98.27 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.121 -0.987 . . . . 0.0 109.831 178.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -62.74 -20.65 65.15 Favored 'General case' 0 N--CA 1.508 2.456 0 CA-C-O 121.79 0.805 . . . . 0.0 111.141 -179.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.588 ' CG2' ' CD1' ' A' ' 14' ' ' LEU . 94.5 m -79.26 122.25 83.94 Favored Pre-proline 0 C--N 1.283 -2.289 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.525 ' HG2' ' CG ' ' A' ' 13' ' ' GLU . 37.2 Cg_endo -57.48 155.55 30.36 Favored 'Trans proline' 0 N--CA 1.503 2.068 0 C-N-CA 120.488 0.792 . . . . 0.0 112.219 -177.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.56 ' CG1' ' N ' ' A' ' 12' ' ' SER . 1.6 p -45.24 -51.73 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.541 0 O-C-N 120.502 -1.374 . . . . 0.0 110.44 -178.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.56 ' N ' ' CG1' ' A' ' 11' ' ' VAL . 0.9 OUTLIER -56.86 -41.57 78.19 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.081 -1.012 . . . . 0.0 110.646 -179.52 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.539 ' HB3' ' CG2' ' A' ' 9' ' ' THR . 48.2 mm-40 -68.95 -26.85 65.27 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 118.155 -1.418 . . . . 0.0 107.975 179.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.588 ' CD1' ' CG2' ' A' ' 9' ' ' THR . 0.9 OUTLIER -70.35 -43.14 70.82 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 120.96 -1.087 . . . . 0.0 108.439 177.381 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.425 HG21 ' HB2' ' A' ' 26' ' ' LEU . 1.4 mp -66.37 -40.15 85.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 C-N-CA 118.108 -1.437 . . . . 0.0 108.659 178.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.504 ' HA ' ' HG2' ' A' ' 19' ' ' GLU . 92.7 m -63.91 -38.03 89.59 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.394 -1.441 . . . . 0.0 109.267 179.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.534 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 0.7 OUTLIER -65.81 -37.79 87.22 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.85 -1.156 . . . . 0.0 108.779 178.553 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.453 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -67.36 -43.5 87.7 Favored Glycine 0 N--CA 1.513 3.794 0 N-CA-C 108.505 -1.838 . . . . 0.0 108.505 178.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.668 ' HG3' ' N ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -59.33 -37.98 79.16 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.507 -1.584 . . . . 0.0 108.117 178.922 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.668 ' N ' ' HG3' ' A' ' 19' ' ' GLU . 28.1 m120 -61.32 -29.01 69.62 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 118.201 -1.4 . . . . 0.0 109.405 178.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.499 ' HG3' ' O ' ' A' ' 17' ' ' LEU . 18.6 mtp -101.53 12.84 36.57 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.215 -0.928 . . . . 0.0 111.153 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.66 -22.9 34.29 Favored Glycine 0 N--CA 1.502 3.082 0 C-N-CA 118.632 -1.747 . . . . 0.0 111.299 179.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.575 ' O ' ' CD1' ' A' ' 26' ' ' LEU . 2.9 mp -79.45 93.63 5.42 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.396 -1.65 . . . . 0.0 109.776 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -108.1 175.79 5.36 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.141 -0.974 . . . . 0.0 109.285 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 62.99 21.1 12.7 Favored 'General case' 0 N--CA 1.507 2.404 0 O-C-N 121.914 -0.491 . . . . 0.0 111.549 178.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.575 ' CD1' ' O ' ' A' ' 23' ' ' LEU . 0.4 OUTLIER -77.19 -7.59 56.12 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 120.985 -1.072 . . . . 0.0 111.413 -179.86 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 26' ' ' LEU . . . -46.71 -31.73 3.12 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.441 -1.412 . . . . 0.0 108.977 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.558 ' C ' ' CD ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -80.82 -2.12 45.9 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 120.081 -0.648 . . . . 0.0 111.502 -179.99 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.498 ' HB3' HG13 ' A' ' 34' ' ' ILE . 14.8 mtp -100.85 162.78 12.67 Favored 'General case' 0 C--N 1.313 -0.989 0 O-C-N 120.639 -1.288 . . . . 0.0 111.636 -179.004 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.514 ' O ' HD13 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -89.71 164.26 14.77 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.647 0.737 . . . . 0.0 110.563 178.502 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.564 ' O ' HG23 ' A' ' 35' ' ' ILE . 2.6 ttmm -55.62 -41.95 74.22 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.509 -0.744 . . . . 0.0 111.082 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.54 ' O ' HG23 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -63.69 -53.46 50.96 Favored 'General case' 0 N--CA 1.521 3.086 0 O-C-N 121.495 -0.753 . . . . 0.0 112.194 -178.346 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 34' ' ' ILE . 1.7 p30 -67.23 -40.56 86.35 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 120.415 -1.428 . . . . 0.0 109.312 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.579 ' CG2' ' HB3' ' A' ' 14' ' ' LEU . 15.7 mt -61.91 -39.44 83.58 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 O-C-N 120.506 -1.371 . . . . 0.0 109.363 178.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.564 HG23 ' O ' ' A' ' 31' ' ' LYS . 0.1 OUTLIER -67.59 -38.12 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.435 0 O-C-N 120.238 -1.539 . . . . 0.0 109.221 178.519 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.435 ' HA ' HD11 ' A' ' 39' ' ' LEU . 5.3 m-85 -62.28 -43.54 98.59 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.594 -1.316 . . . . 0.0 108.86 178.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.558 ' CB ' ' CD2' ' A' ' 23' ' ' LEU . . . -57.2 -54.66 44.27 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.413 -1.429 . . . . 0.0 108.501 178.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.481 HG13 ' O ' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -54.59 -32.31 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 C-N-CA 117.402 -1.719 . . . . 0.0 109.345 179.088 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.491 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 11.1 mt -68.33 -40.66 81.52 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 120.299 -1.501 . . . . 0.0 109.35 178.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . 0.468 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 3.4 mtpp -66.23 -38.78 88.73 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.001 -1.062 . . . . 0.0 110.684 178.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.526 ' HG3' ' CD1' ' A' ' 23' ' ' LEU . 1.1 mm-40 -75.9 -52.87 9.38 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.24 -0.913 . . . . 0.0 111.13 -179.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.592 ' CG ' ' CE ' ' A' ' 1' ' ' MET . 2.8 t-80 -64.26 -36.38 83.92 Favored 'General case' 0 N--CA 1.51 2.54 0 O-C-N 120.951 -1.093 . . . . 0.0 109.37 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.591 ' O ' ' N ' ' A' ' 46' ' ' GLY . . . -77.28 -32.24 55.35 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.89 -1.131 . . . . 0.0 110.62 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -47.33 -44.04 23.39 Favored 'General case' 0 N--CA 1.481 1.116 0 O-C-N 120.411 -1.43 . . . . 0.0 108.972 178.548 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 25.4 m -66.81 -10.57 49.12 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 119.573 -0.851 . . . . 0.0 109.548 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . 65.78 31.53 80.09 Favored Glycine 0 N--CA 1.495 2.593 0 C-N-CA 120.401 -0.904 . . . . 0.0 111.156 178.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.555 ' OE2' ' ND1' ' A' ' 42' ' ' HIS . 3.4 pt-20 -85.15 170.13 13.2 Favored 'General case' 0 N--CA 1.484 1.226 0 O-C-N 120.408 -1.642 . . . . 0.0 109.225 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.474 ' C ' ' CG2' ' A' ' 49' ' ' ILE . 7.6 m-20 -61.54 138.07 58.27 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.14 -0.975 . . . . 0.0 111.934 -177.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.55 ' HA ' ' HA ' ' A' ' 1' ' ' MET . 0.5 OUTLIER -157.13 144.09 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 178.455 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.552 ' O ' ' HA ' ' A' ' 2' ' ' ASN . 24.6 p90 -141.93 168.17 20.38 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 115.616 -2.434 . . . . 0.0 115.504 -178.151 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -116.15 164.32 12.28 Favored Glycine 0 N--CA 1.499 2.867 0 N-CA-C 107.784 -2.126 . . . . 0.0 107.784 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.512 ' C ' ' CD2' ' A' ' 65' ' ' LEU . 5.8 p-10 -172.37 163.18 5.59 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 120.322 -1.693 . . . . 0.0 109.657 -179.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.443 ' HA3' ' O ' ' A' ' 66' ' ' ARG . . . 146.31 -139.74 8.31 Favored Glycine 0 N--CA 1.504 3.195 0 C-N-CA 117.991 -2.052 . . . . 0.0 111.131 179.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.53 ' HA ' ' O ' ' A' ' 95' ' ' ASP . 2.6 t -128.07 119.7 51.71 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.9 mt -62.76 164.25 8.14 Favored 'General case' 0 N--CA 1.504 2.254 0 C-N-CA 118.782 -1.167 . . . . 0.0 113.869 -175.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.483 ' HA ' ' OG1' ' A' ' 93' ' ' THR . 0.8 OUTLIER -141.78 119.35 11.67 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 178.384 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.578 ' CG1' ' HB ' ' A' ' 93' ' ' THR . 1.0 OUTLIER -80.19 162.63 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 119.903 -1.748 . . . . 0.0 109.265 -178.718 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.576 HD21 ' CE1' ' A' ' 62' ' ' PHE . 3.3 mp -132.12 136.19 46.96 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.426 -1.421 . . . . 0.0 109.675 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.453 ' C ' ' O ' ' A' ' 58' ' ' LEU . 2.0 tt0 -39.77 -36.37 0.42 Allowed 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.749 0.785 . . . . 0.0 110.102 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.437 ' HB2' ' CD1' ' A' ' 62' ' ' PHE . 66.6 m-20 -61.46 -5.94 2.04 Favored 'General case' 0 N--CA 1.501 2.092 0 C-N-CA 119.959 -0.696 . . . . 0.0 112.51 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.457 ' O ' ' HB3' ' A' ' 83' ' ' PRO . . . 89.85 11.91 62.95 Favored Glycine 1 N--CA 1.52 4.282 0 C-N-CA 118.71 -1.709 . . . . 0.0 112.185 178.089 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.576 ' CE1' HD21 ' A' ' 58' ' ' LEU . 2.8 p90 -132.95 -176.93 4.28 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 103.865 -2.642 . . . . 0.0 103.865 177.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.524 ' HA2' ' CD1' ' A' ' 58' ' ' LEU . . . -158.75 172.39 35.58 Favored Glycine 0 N--CA 1.474 1.216 0 C-N-CA 116.933 -2.556 . . . . 0.0 111.706 -177.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.544 ' CE2' ' CE2' ' A' ' 62' ' ' PHE . 43.5 m-85 -129.7 154.29 47.31 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 119.99 1.895 . . . . 0.0 109.708 177.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.512 ' CD2' ' C ' ' A' ' 52' ' ' ASP 0.255 0.2 OUTLIER -98.39 134.33 41.54 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 107.005 -1.479 . . . . 0.0 107.005 176.892 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.443 ' O ' ' HA3' ' A' ' 53' ' ' GLY . 0.4 OUTLIER -135.99 -173.04 3.27 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.225 -1.547 . . . . 0.0 109.658 179.446 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.5 m . . . . . 0 N--CA 1.497 1.886 0 O-C-N 121.036 -1.04 . . . . 0.0 110.573 179.921 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.462 ' OD1' ' N ' ' A' ' 78' ' ' ASP . 3.2 m-20 . . . . . 0 N--CA 1.508 2.429 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.438 ' HB ' ' CB ' ' A' ' 65' ' ' LEU . 4.4 mm -120.21 131.61 72.07 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.745 0 O-C-N 120.969 -1.082 . . . . 0.0 109.979 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.483 ' HB3' ' HA ' ' A' ' 112' ' ' ALA . 10.4 t80 -76.71 147.35 37.44 Favored 'General case' 0 N--CA 1.518 2.934 0 CA-C-N 121.85 2.114 . . . . 0.0 109.462 179.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.1 t -145.51 116.8 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 120.151 -1.593 . . . . 0.0 110.2 -179.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.531 ' O ' HG13 ' A' ' 86' ' ' ILE . 56.1 m -74.95 161.67 76.62 Favored Pre-proline 0 N--CA 1.51 2.555 0 O-C-N 120.34 -1.475 . . . . 0.0 112.248 -179.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.564 ' HA ' HG13 ' A' ' 86' ' ' ILE . 38.0 Cg_endo -65.19 -50.97 1.73 Allowed 'Trans proline' 0 C--N 1.313 -1.315 0 O-C-N 124.887 1.993 . . . . 0.0 108.554 178.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.572 ' O ' ' CG ' ' A' ' 88' ' ' ARG . 3.0 p -46.02 -41.53 12.08 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 177.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.516 ' HA ' ' OE1' ' A' ' 85' ' ' GLN . 6.6 mm100 -62.48 -58.07 8.92 Favored 'General case' 0 N--CA 1.511 2.586 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 178.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.564 HG13 ' HA ' ' A' ' 83' ' ' PRO . 0.4 OUTLIER -55.83 -56.26 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.262 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 178.386 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.485 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 9.7 mtt85 -58.41 -41.84 85.84 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-O 121.825 0.822 . . . . 0.0 111.731 -179.016 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.572 ' CG ' ' O ' ' A' ' 84' ' ' SER . 0.1 OUTLIER -60.04 -37.66 80.46 Favored 'General case' 0 N--CA 1.507 2.376 0 C-N-CA 119.612 -0.835 . . . . 0.0 111.938 -177.679 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.598 ' HB2' ' CD2' ' A' ' 91' ' ' LEU . 5.0 m-85 -109.58 11.85 24.59 Favored 'General case' 0 N--CA 1.503 2.206 0 C-N-CA 116.818 -1.953 . . . . 0.0 111.148 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.406 ' CB ' ' O ' ' A' ' 89' ' ' PHE . 1.5 t-20 63.74 53.6 1.97 Allowed 'General case' 0 N--CA 1.486 1.342 0 O-C-N 120.611 -1.306 . . . . 0.0 110.818 178.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.598 ' CD2' ' HB2' ' A' ' 89' ' ' PHE . 2.9 mt -89.7 -168.96 2.3 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 119.37 -0.932 . . . . 0.0 109.752 179.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.53 ' CG ' ' O ' ' A' ' 91' ' ' LEU . 0.2 OUTLIER -159.7 161.38 34.83 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 178.231 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.578 ' HB ' ' CG1' ' A' ' 57' ' ' ILE . 1.9 t -64.83 155.64 33.39 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 116.869 -1.932 . . . . 0.0 106.893 178.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.422 ' C ' HG11 ' A' ' 54' ' ' VAL . . . 75.29 -9.09 14.6 Favored Glycine 0 N--CA 1.506 3.338 0 C-N-CA 117.299 -2.382 . . . . 0.0 110.388 179.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.53 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 15.4 m-20 -68.1 149.66 49.34 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.137 -1.802 . . . . 0.0 110.724 -178.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.484 ' O ' HG12 ' A' ' 97' ' ' ILE . 0.3 OUTLIER -91.58 121.19 33.04 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.621 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.529 HG22 HG21 ' A' ' 119' ' ' VAL . 1.4 mt -144.82 166.61 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 119.93 -1.732 . . . . 0.0 112.885 -178.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.469 ' OG ' ' HB2' ' A' ' 118' ' ' GLU . 96.7 p -150.93 139.76 20.85 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.999 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.455 ' O ' ' HB2' ' A' ' 50' ' ' PHE . . . -164.47 -179.66 38.72 Favored Glycine 0 N--CA 1.509 3.545 0 C-N-CA 117.643 -2.218 . . . . 0.0 114.609 -179.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.5 ' HG2' ' HB3' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -87.23 155.39 20.11 Favored 'General case' 0 N--CA 1.504 2.239 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 178.589 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.447 HG12 ' HA ' ' A' ' 50' ' ' PHE . 2.2 pt -122.46 158.56 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.643 0 CA-C-N 121.228 1.831 . . . . 0.0 114.435 -176.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.459 ' HB2' ' CD2' ' A' ' 114' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.427 0 O-C-N 120.651 -1.281 . . . . 0.0 109.642 179.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? . . . . . 0 N--CA 1.513 2.712 0 CA-C-O 120.557 0.218 . . . . 0.0 111.357 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.536 ' CD1' ' N ' ' A' ' 110' ' ' TYR . 2.8 m-85 -109.26 154.75 22.0 Favored 'General case' 0 N--CA 1.518 2.938 0 O-C-N 120.581 -1.325 . . . . 0.0 107.72 177.066 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.481 ' O ' ' HB3' ' A' ' 80' ' ' TYR . 38.1 m-85 -66.9 165.56 15.18 Favored 'General case' 0 N--CA 1.508 2.427 0 O-C-N 119.135 -2.228 . . . . 0.0 107.273 178.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.483 ' HA ' ' HB3' ' A' ' 80' ' ' TYR . . . -123.24 152.87 40.88 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 119.905 -1.747 . . . . 0.0 111.216 -178.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.77 153.68 42.72 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 178.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.459 ' CD2' ' HB2' ' A' ' 102' ' ' ARG . 12.9 tp -130.86 -59.41 1.0 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 120.047 -1.658 . . . . 0.0 112.361 -178.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.5 ' HB3' ' HG2' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -114.05 139.97 48.85 Favored 'General case' 0 N--CA 1.512 2.646 0 O-C-N 120.383 -1.448 . . . . 0.0 108.767 179.206 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 23.7 t -92.27 128.78 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.804 0 O-C-N 120.477 -1.39 . . . . 0.0 111.37 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.401 ' CG ' ' HA2' ' A' ' 99' ' ' GLY . 4.8 m-20 -106.97 -38.5 6.03 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.355 -0.841 . . . . 0.0 109.947 178.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.49 ' C ' ' CG2' ' A' ' 119' ' ' VAL . 1.1 tt0 -143.5 157.21 44.62 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.786 -1.196 . . . . 0.0 109.803 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.529 HG21 HG22 ' A' ' 97' ' ' ILE . 17.8 t -159.74 130.99 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 122.387 -0.196 . . . . 0.0 110.511 -178.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.521 3.081 0 O-C-N 120.309 -1.495 . . . . 0.0 111.481 178.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.592 ' HA ' ' HA ' ' A' ' 49' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . 0.567 ' HB2' ' CE1' ' A' ' 50' ' ' PHE . 39.3 t30 -78.46 94.18 4.88 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 120.85 -1.156 . . . . 0.0 108.137 178.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.444 HD13 HD11 ' A' ' 6' ' ' LEU . 0.5 OUTLIER -41.81 -42.29 2.62 Favored 'General case' 0 N--CA 1.519 3.007 0 O-C-N 120.518 -1.364 . . . . 0.0 110.241 -178.399 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.7 m -56.33 -36.46 68.74 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.983 -1.073 . . . . 0.0 108.311 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.537 ' HB2' ' HB3' ' A' ' 2' ' ' ASN . 3.0 mt-10 -76.54 -39.26 53.38 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.9 -1.125 . . . . 0.0 109.317 178.06 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.444 HD11 HD13 ' A' ' 3' ' ' LEU 0.267 90.7 mt -54.82 -49.2 71.61 Favored 'General case' 0 C--O 1.215 -0.752 0 O-C-N 120.31 -1.494 . . . . 0.0 109.174 177.984 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.04 -39.16 75.9 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.936 -1.103 . . . . 0.0 110.769 179.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -63.14 -22.48 66.89 Favored 'General case' 0 N--CA 1.507 2.405 0 O-C-N 121.1 -1.0 . . . . 0.0 111.221 -179.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.568 ' CG2' ' CD1' ' A' ' 14' ' ' LEU . 22.7 m -81.12 140.02 49.36 Favored Pre-proline 0 N--CA 1.505 2.278 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.504 ' HG2' ' HB2' ' A' ' 13' ' ' GLU . 41.6 Cg_endo -63.75 152.23 81.48 Favored 'Trans proline' 0 CA--C 1.566 2.088 0 O-C-N 122.293 0.628 . . . . 0.0 111.773 -177.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.502 ' CG1' ' N ' ' A' ' 12' ' ' SER . 1.5 p -47.58 -50.42 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.337 0 O-C-N 120.517 -1.364 . . . . 0.0 109.997 -178.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.502 ' N ' ' CG1' ' A' ' 11' ' ' VAL . 1.6 t -54.48 -43.72 71.98 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.011 -1.055 . . . . 0.0 110.763 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.526 ' HB3' ' CG2' ' A' ' 9' ' ' THR . 1.0 OUTLIER -68.31 -27.12 66.01 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 118.158 -1.417 . . . . 0.0 107.967 179.631 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.595 HD11 ' N ' ' A' ' 14' ' ' LEU . 1.3 mp -70.11 -43.45 71.0 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.985 -1.072 . . . . 0.0 108.603 177.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.469 HG12 ' HB2' ' A' ' 26' ' ' LEU . 1.6 mp -66.55 -39.1 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 C-N-CA 118.148 -1.421 . . . . 0.0 108.822 178.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.502 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 58.8 m -64.89 -38.0 89.5 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 118.036 -1.466 . . . . 0.0 109.205 178.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.459 HD11 ' O ' ' A' ' 13' ' ' GLU . 0.2 OUTLIER -66.33 -36.82 83.91 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.792 -1.192 . . . . 0.0 108.907 178.709 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.477 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -67.91 -43.2 83.76 Favored Glycine 0 N--CA 1.515 3.961 0 N-CA-C 108.129 -1.989 . . . . 0.0 108.129 178.166 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -55.51 -46.39 76.98 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.631 -1.511 . . . . 0.0 107.685 178.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.502 ' OD1' ' O ' ' A' ' 16' ' ' THR . 25.2 m120 -59.53 -25.64 64.67 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 118.202 -1.399 . . . . 0.0 109.145 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.534 ' HB2' ' CD1' ' A' ' 23' ' ' LEU . 64.7 mmm -100.93 11.99 38.52 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.489 -0.757 . . . . 0.0 111.06 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 96.06 -17.15 59.82 Favored Glycine 0 N--CA 1.502 3.058 0 C-N-CA 118.804 -1.665 . . . . 0.0 111.408 179.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.588 ' O ' ' CD1' ' A' ' 26' ' ' LEU . 4.1 mp -79.41 102.76 8.89 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.471 -1.605 . . . . 0.0 109.782 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.474 ' O ' ' HB2' ' A' ' 25' ' ' ASN . 2.0 pt-20 -114.85 -179.72 3.71 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.28 -0.888 . . . . 0.0 109.1 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.474 ' HB2' ' O ' ' A' ' 24' ' ' GLU . 1.8 m120 62.38 18.48 10.32 Favored 'General case' 0 N--CA 1.51 2.53 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.7 178.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.588 ' CD1' ' O ' ' A' ' 23' ' ' LEU . 1.2 mt -76.29 -18.22 59.07 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.196 -0.94 . . . . 0.0 111.408 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -47.27 -29.5 2.48 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.213 -1.555 . . . . 0.0 109.524 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -78.88 -30.4 44.97 Favored 'General case' 0 C--N 1.295 -1.795 0 C-N-CA 120.11 -0.636 . . . . 0.0 112.2 -179.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.594 ' CG ' HG13 ' A' ' 34' ' ' ILE . 6.6 ptm -93.22 166.99 12.05 Favored 'General case' 0 C--N 1.311 -1.073 0 O-C-N 120.426 -1.421 . . . . 0.0 111.084 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.534 ' O ' ' CD1' ' A' ' 34' ' ' ILE . 1.0 OUTLIER -89.39 -173.65 4.08 Favored 'General case' 0 N--CA 1.506 2.358 0 CA-C-O 122.219 1.009 . . . . 0.0 112.864 -178.428 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.559 ' O ' HG13 ' A' ' 35' ' ' ILE . 0.3 OUTLIER -66.32 -35.67 80.97 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.522 -179.722 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -63.02 -58.82 6.01 Favored 'General case' 0 N--CA 1.515 2.796 0 O-C-N 120.766 -1.209 . . . . 0.0 109.667 -178.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.532 ' HB2' ' HE1' ' A' ' 29' ' ' MET . 3.6 p30 -66.3 -35.27 79.95 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.457 -0.777 . . . . 0.0 109.717 -179.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.594 HG13 ' CG ' ' A' ' 29' ' ' MET . 0.8 OUTLIER -60.9 -43.72 96.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 120.081 -1.637 . . . . 0.0 107.898 177.141 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.559 HG13 ' O ' ' A' ' 31' ' ' LYS . 86.7 mt -63.39 -45.38 98.19 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.854 0 O-C-N 120.318 -1.489 . . . . 0.0 110.357 178.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -53.59 -40.15 65.43 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 119.203 -0.999 . . . . 0.0 108.566 -179.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.513 ' C ' ' CD2' ' A' ' 23' ' ' LEU . . . -68.09 -54.28 19.36 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.614 -1.304 . . . . 0.0 109.606 178.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.496 HG13 ' O ' ' A' ' 34' ' ' ILE . 0.1 OUTLIER -53.49 -28.0 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 C-N-CA 117.545 -1.662 . . . . 0.0 110.007 -179.969 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.567 HD11 ' CE1' ' A' ' 111' ' ' PHE . 79.8 mt -71.13 -43.68 67.12 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 120.219 -1.551 . . . . 0.0 109.335 178.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.26 -39.69 92.98 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.979 -1.075 . . . . 0.0 110.581 178.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.487 ' HG2' HD13 ' A' ' 23' ' ' LEU . 1.4 mp0 -74.56 -51.22 15.24 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 121.146 -0.971 . . . . 0.0 110.726 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.64 ' CD2' ' CB ' ' A' ' 47' ' ' GLU . 9.9 t60 -61.99 -34.55 76.37 Favored 'General case' 0 N--CA 1.51 2.539 0 C-N-CA 118.65 -1.22 . . . . 0.0 108.573 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.532 ' O ' ' N ' ' A' ' 46' ' ' GLY . . . -70.51 -45.26 65.94 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.043 -1.036 . . . . 0.0 109.079 178.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -48.28 -45.66 34.97 Favored 'General case' 0 N--CA 1.484 1.252 0 O-C-N 120.752 -1.217 . . . . 0.0 109.138 178.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 68.4 m -66.99 -6.94 18.94 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-O 121.547 0.689 . . . . 0.0 109.696 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . 76.45 24.9 66.84 Favored Glycine 0 N--CA 1.498 2.801 0 C-N-CA 120.148 -1.025 . . . . 0.0 112.094 178.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.64 ' CB ' ' CD2' ' A' ' 42' ' ' HIS . 0.2 OUTLIER -79.42 166.74 21.71 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.129 -1.806 . . . . 0.0 109.086 178.817 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.432 ' C ' ' CG2' ' A' ' 49' ' ' ILE . 8.3 m-20 -88.66 150.02 23.23 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.07 -1.019 . . . . 0.0 109.391 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.592 ' HA ' ' HA ' ' A' ' 1' ' ' MET . 0.5 OUTLIER -148.98 143.28 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 120.668 -1.27 . . . . 0.0 108.46 179.246 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.567 ' CE1' ' HB2' ' A' ' 2' ' ' ASN . 23.6 p90 -142.75 172.07 13.2 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 116.088 -2.245 . . . . 0.0 114.918 -177.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -126.23 168.94 18.23 Favored Glycine 0 N--CA 1.508 3.445 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 -178.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -169.67 166.51 9.85 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 120.429 -1.63 . . . . 0.0 110.315 -178.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.575 ' HA3' ' O ' ' A' ' 66' ' ' ARG . . . 142.47 -135.75 6.79 Favored Glycine 0 N--CA 1.506 3.306 0 C-N-CA 118.349 -1.882 . . . . 0.0 111.591 178.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.491 ' HA ' ' O ' ' A' ' 95' ' ' ASP . 2.6 t -128.44 120.04 51.9 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 O-C-N 121.235 -1.156 . . . . 0.0 108.292 -179.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.0 mt -62.92 161.2 13.3 Favored 'General case' 0 N--CA 1.503 2.22 0 C-N-CA 118.645 -1.222 . . . . 0.0 113.681 -175.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.459 ' HA ' ' OG1' ' A' ' 93' ' ' THR . 18.1 mm-40 -137.14 117.89 14.05 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 177.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.591 ' CG1' ' HB ' ' A' ' 93' ' ' THR . 1.4 mm -82.3 162.67 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 O-C-N 119.959 -1.713 . . . . 0.0 109.624 -178.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.589 ' CD2' ' CZ ' ' A' ' 62' ' ' PHE . 5.8 mp -129.95 137.64 50.44 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.531 -1.356 . . . . 0.0 109.462 179.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.458 ' C ' ' O ' ' A' ' 58' ' ' LEU . 1.8 mt-30 -42.09 -34.69 0.77 Allowed 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.951 0.881 . . . . 0.0 109.143 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -61.34 -7.17 2.69 Favored 'General case' 0 N--CA 1.499 2.012 0 C-N-CA 120.213 -0.595 . . . . 0.0 112.341 -179.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 90.99 7.51 65.87 Favored Glycine 1 N--CA 1.52 4.252 0 C-N-CA 118.804 -1.665 . . . . 0.0 112.225 178.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.589 ' CZ ' ' CD2' ' A' ' 58' ' ' LEU . 2.0 p90 -127.8 179.77 5.37 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 104.469 -2.419 . . . . 0.0 104.469 178.087 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.55 ' N ' ' CD1' ' A' ' 62' ' ' PHE . . . -156.22 171.48 33.99 Favored Glycine 0 N--CA 1.477 1.387 0 C-N-CA 117.186 -2.435 . . . . 0.0 111.879 -178.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.461 ' CE2' ' HE1' ' A' ' 62' ' ' PHE . 14.5 m-85 -128.99 149.11 50.96 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 119.861 1.831 . . . . 0.0 109.25 177.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.535 ' HB3' ' HB ' ' A' ' 79' ' ' ILE . 0.6 OUTLIER -99.42 165.35 11.7 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 176.392 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.575 ' O ' ' HA3' ' A' ' 53' ' ' GLY . 0.0 OUTLIER 172.49 -169.73 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.97 -1.081 . . . . 0.0 109.712 178.525 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 17.1 m . . . . . 0 N--CA 1.5 2.067 0 O-C-N 120.716 -1.24 . . . . 0.0 109.949 179.691 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 78' ' ' ASP . 0.8 OUTLIER . . . . . 0 N--CA 1.504 2.271 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.535 ' HB ' ' HB3' ' A' ' 65' ' ' LEU . 1.3 mp -117.88 127.64 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.721 0 C-N-CA 119.169 -1.012 . . . . 0.0 108.507 177.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.495 ' HB3' ' HA ' ' A' ' 112' ' ' ALA . 6.8 t80 -73.61 146.19 44.83 Favored 'General case' 0 N--CA 1.515 2.796 0 O-C-N 119.689 -1.882 . . . . 0.0 110.125 -178.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.409 ' HB ' ' O ' ' A' ' 63' ' ' GLY . 34.5 t -140.36 112.02 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 120.324 -1.485 . . . . 0.0 110.603 -179.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.522 ' O ' ' HB2' ' A' ' 85' ' ' GLN . 57.9 m -74.67 165.99 49.0 Favored Pre-proline 0 N--CA 1.513 2.697 0 O-C-N 120.519 -1.363 . . . . 0.0 112.041 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.522 ' HD2' ' HB3' ' A' ' 82' ' ' SER . 40.1 Cg_endo -65.21 -50.24 2.17 Favored 'Trans proline' 0 C--N 1.315 -1.189 0 O-C-N 124.317 1.693 . . . . 0.0 109.287 179.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.554 ' O ' ' CG ' ' A' ' 88' ' ' ARG . 0.3 OUTLIER -47.92 -39.66 19.7 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 178.106 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.522 ' HB2' ' O ' ' A' ' 82' ' ' SER . 5.6 mm100 -63.56 -58.86 5.65 Favored 'General case' 0 N--CA 1.51 2.551 0 C-N-CA 119.375 -0.93 . . . . 0.0 108.68 178.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.507 HG13 ' O ' ' A' ' 82' ' ' SER . 0.3 OUTLIER -57.23 -54.22 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.417 0 O-C-N 121.076 -1.015 . . . . 0.0 108.76 178.848 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.453 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 0.2 OUTLIER -56.25 -43.83 79.06 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 121.924 0.869 . . . . 0.0 111.27 -179.519 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.554 ' CG ' ' O ' ' A' ' 84' ' ' SER . 0.1 OUTLIER -57.97 -36.71 72.98 Favored 'General case' 0 N--CA 1.506 2.369 0 C-N-CA 119.792 -0.763 . . . . 0.0 111.724 -177.694 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -113.73 13.76 18.62 Favored 'General case' 0 N--CA 1.502 2.153 0 C-N-CA 117.359 -1.736 . . . . 0.0 111.462 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 58.41 55.13 5.12 Favored 'General case' 0 N--CA 1.484 1.239 0 O-C-N 120.434 -1.416 . . . . 0.0 109.621 178.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.484 ' O ' ' HG2' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -89.11 -179.29 5.87 Favored 'General case' 0 N--CA 1.496 1.834 0 C-N-CA 119.521 -0.872 . . . . 0.0 109.968 -179.832 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.484 ' HG2' ' O ' ' A' ' 91' ' ' LEU . 10.6 mtt-85 -155.13 158.21 38.64 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.186 -0.946 . . . . 0.0 109.115 178.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.591 ' HB ' ' CG1' ' A' ' 57' ' ' ILE . 2.3 t -63.7 156.39 27.14 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 117.205 -1.798 . . . . 0.0 107.186 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.4 ' HA2' HG13 ' A' ' 54' ' ' VAL . . . 76.23 -10.33 16.24 Favored Glycine 0 N--CA 1.505 3.272 0 C-N-CA 117.007 -2.52 . . . . 0.0 110.233 179.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.491 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 25.4 m-20 -70.34 146.86 50.21 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.272 -1.723 . . . . 0.0 110.795 -178.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.485 ' O ' HG12 ' A' ' 97' ' ' ILE . 0.2 OUTLIER -90.09 121.22 31.95 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.209 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.564 HG21 HG21 ' A' ' 119' ' ' VAL . 1.5 mt -145.67 168.51 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 119.733 -1.854 . . . . 0.0 112.89 -178.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.484 ' OG ' ' HB2' ' A' ' 118' ' ' GLU . 98.5 p -148.49 137.55 21.74 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 178.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.547 ' O ' ' HB2' ' A' ' 50' ' ' PHE . . . -161.95 176.11 38.41 Favored Glycine 0 N--CA 1.506 3.324 0 C-N-CA 117.163 -2.446 . . . . 0.0 114.546 -178.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.492 ' HG2' ' HB3' ' A' ' 115' ' ' LYS . 2.9 ptmt -88.83 156.66 18.81 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 179.053 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.494 HG12 ' HA ' ' A' ' 50' ' ' PHE . 2.0 pt -125.55 156.36 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.432 0 CA-C-N 120.37 1.441 . . . . 0.0 113.588 -176.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.521 ' HB2' ' CD1' ' A' ' 114' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.466 0 O-C-N 120.56 -1.337 . . . . 0.0 109.5 179.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.497 1.919 0 N-CA-C 109.443 -0.576 . . . . 0.0 109.443 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.407 ' CD2' ' HZ ' ' A' ' 64' ' ' PHE . 22.7 m-85 -107.92 152.35 24.56 Favored 'General case' 0 N--CA 1.516 2.85 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 176.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.567 ' CE1' HD11 ' A' ' 39' ' ' LEU . 51.4 m-85 -67.32 168.16 11.11 Favored 'General case' 0 N--CA 1.507 2.424 0 O-C-N 119.246 -2.159 . . . . 0.0 108.252 179.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.495 ' HA ' ' HB3' ' A' ' 80' ' ' TYR . . . -122.87 154.93 37.64 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 119.994 -1.692 . . . . 0.0 110.883 -178.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.1 tp -68.38 148.41 50.73 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.521 ' CD1' ' HB2' ' A' ' 102' ' ' ARG . 9.7 tp -128.74 -55.18 1.22 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.315 -1.49 . . . . 0.0 112.616 -178.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.492 ' HB3' ' HG2' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -125.64 141.97 51.75 Favored 'General case' 0 N--CA 1.509 2.514 0 O-C-N 120.236 -1.54 . . . . 0.0 109.1 179.658 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.4 t -92.53 130.46 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.792 0 O-C-N 120.517 -1.364 . . . . 0.0 110.943 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -107.28 -38.73 5.88 Favored 'General case' 0 N--CA 1.506 2.375 0 O-C-N 121.393 -0.817 . . . . 0.0 110.012 178.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.488 ' O ' HG21 ' A' ' 97' ' ' ILE . 0.5 OUTLIER -143.24 158.33 43.72 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.853 -1.154 . . . . 0.0 109.435 179.722 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.564 HG21 HG21 ' A' ' 97' ' ' ILE . 44.3 t -158.8 133.62 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 -178.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 . . . . . 0 N--CA 1.521 3.102 0 O-C-N 120.313 -1.492 . . . . 0.0 111.231 179.706 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.592 ' HA ' ' HA ' ' A' ' 49' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 . . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . 0.503 ' HB3' ' HB3' ' A' ' 5' ' ' GLU . 52.5 t30 -78.44 96.73 5.45 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.919 -1.113 . . . . 0.0 108.356 178.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.546 ' CD2' ' CD1' ' A' ' 79' ' ' ILE . 0.6 OUTLIER -41.78 -41.89 2.47 Favored 'General case' 0 N--CA 1.516 2.863 0 O-C-N 120.405 -1.435 . . . . 0.0 110.501 -178.397 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.465 ' OG1' ' OD2' ' A' ' 52' ' ' ASP . 1.7 m -57.77 -37.55 73.87 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.577 -1.327 . . . . 0.0 108.151 -179.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.503 ' HB3' ' HB3' ' A' ' 2' ' ' ASN . 0.8 OUTLIER -70.4 -45.28 66.27 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.06 -1.025 . . . . 0.0 108.59 177.932 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.501 HD12 ' CD2' ' A' ' 39' ' ' LEU 0.278 84.0 mt -51.27 -50.04 60.04 Favored 'General case' 0 C--N 1.315 -0.893 0 O-C-N 120.886 -1.133 . . . . 0.0 109.476 178.15 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.417 ' NZ ' ' OE1' ' A' ' 32' ' ' GLN . 5.7 mmtt -64.06 -36.49 84.17 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.241 -0.912 . . . . 0.0 110.085 179.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -61.93 -25.52 67.63 Favored 'General case' 0 N--CA 1.508 2.455 0 C-N-CA 119.282 -0.967 . . . . 0.0 111.031 -179.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.604 ' HB ' ' CD1' ' A' ' 14' ' ' LEU . 4.4 m -74.49 132.84 77.93 Favored Pre-proline 0 N--CA 1.504 2.256 0 O-C-N 121.675 -0.641 . . . . 0.0 109.687 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.502 ' HG2' ' HB2' ' A' ' 13' ' ' GLU . 45.0 Cg_endo -65.16 150.84 87.19 Favored 'Trans proline' 0 CA--C 1.567 2.149 0 CA-C-N 118.767 0.595 . . . . 0.0 110.67 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.552 ' CG1' ' N ' ' A' ' 12' ' ' SER . 1.7 p -42.44 -50.28 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.527 3.391 0 O-C-N 120.542 -1.348 . . . . 0.0 110.162 -178.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.552 ' N ' ' CG1' ' A' ' 11' ' ' VAL . 1.0 OUTLIER -57.67 -41.84 82.36 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.294 -0.879 . . . . 0.0 111.174 -179.266 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.566 ' HB3' ' CG2' ' A' ' 9' ' ' THR . 0.2 OUTLIER -69.25 -27.7 65.68 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 117.69 -1.604 . . . . 0.0 107.682 179.233 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.604 ' CD1' ' HB ' ' A' ' 9' ' ' THR . 0.0 OUTLIER -69.29 -43.1 74.52 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.828 -1.17 . . . . 0.0 108.754 176.906 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.448 ' CD1' HD12 ' A' ' 34' ' ' ILE . 1.4 mp -65.61 -40.59 88.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 C-N-CA 117.752 -1.579 . . . . 0.0 108.599 178.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.498 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 33.0 m -62.61 -37.75 87.52 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 120.542 -1.349 . . . . 0.0 109.146 179.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.52 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 0.2 OUTLIER -65.58 -36.82 84.87 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.923 -1.111 . . . . 0.0 108.609 178.343 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.508 ' HA2' HD11 ' A' ' 38' ' ' ILE . . . -67.39 -44.5 84.3 Favored Glycine 0 N--CA 1.513 3.829 0 N-CA-C 108.427 -1.869 . . . . 0.0 108.427 178.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.673 ' HG3' ' N ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -59.09 -38.63 79.97 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.435 -1.626 . . . . 0.0 108.298 178.889 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.673 ' N ' ' HG3' ' A' ' 19' ' ' GLU . 26.3 m120 -61.61 -28.57 69.46 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.514 -1.366 . . . . 0.0 109.337 178.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.547 ' HB2' ' CD1' ' A' ' 23' ' ' LEU . 17.6 mtp -101.81 13.03 36.03 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.325 -0.859 . . . . 0.0 111.128 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.4 -19.78 53.06 Favored Glycine 0 N--CA 1.501 2.97 0 C-N-CA 118.67 -1.728 . . . . 0.0 111.249 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.575 ' O ' ' CD1' ' A' ' 26' ' ' LEU . 3.4 mp -79.17 92.79 5.11 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 120.39 -1.653 . . . . 0.0 109.313 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.407 ' O ' ' CB ' ' A' ' 25' ' ' ASN . 3.4 pt-20 -106.86 179.63 4.21 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.119 -0.988 . . . . 0.0 109.384 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.407 ' CB ' ' O ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER 65.75 14.09 9.34 Favored 'General case' 0 N--CA 1.51 2.539 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.916 179.053 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.575 ' CD1' ' O ' ' A' ' 23' ' ' LEU . 0.5 OUTLIER -77.14 -7.53 55.95 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.029 -1.044 . . . . 0.0 111.6 -179.839 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 26' ' ' LEU . . . -46.64 -35.02 5.52 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.45 -1.406 . . . . 0.0 109.076 -179.164 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.1 mmt-85 -82.65 1.36 38.74 Favored 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 120.059 -0.657 . . . . 0.0 111.644 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.496 ' HB3' ' OD1' ' A' ' 33' ' ' ASP . 11.4 mtp -101.01 159.5 15.17 Favored 'General case' 0 C--N 1.313 -0.979 0 O-C-N 120.659 -1.276 . . . . 0.0 112.08 -178.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.525 ' O ' HD13 ' A' ' 34' ' ' ILE . 3.8 ttm180 -89.81 173.88 8.01 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 121.965 0.888 . . . . 0.0 111.094 178.324 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.604 ' O ' HG21 ' A' ' 35' ' ' ILE . 3.4 mtpp -62.23 -40.15 95.17 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.663 -0.648 . . . . 0.0 111.309 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.55 ' O ' HG21 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -64.96 -54.79 25.07 Favored 'General case' 0 N--CA 1.524 3.263 0 CA-C-O 121.845 0.831 . . . . 0.0 110.876 -178.758 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.54 ' OD1' ' N ' ' A' ' 34' ' ' ILE . 1.9 p30 -65.81 -41.65 91.63 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.886 -1.134 . . . . 0.0 109.262 -178.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.573 ' CG2' ' HB3' ' A' ' 14' ' ' LEU . 9.0 mt -62.21 -40.05 86.24 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 O-C-N 120.27 -1.519 . . . . 0.0 109.498 178.016 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.604 HG21 ' O ' ' A' ' 31' ' ' LYS . 0.4 OUTLIER -67.48 -34.39 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.625 0 O-C-N 120.125 -1.609 . . . . 0.0 109.46 178.543 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.461 ' CD2' ' O ' ' A' ' 32' ' ' GLN . 17.9 m-85 -66.05 -44.22 85.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.498 -1.376 . . . . 0.0 109.05 179.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.523 ' HB2' ' CD2' ' A' ' 23' ' ' LEU . . . -66.41 -54.15 27.64 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 120.539 -1.351 . . . . 0.0 109.622 178.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.547 ' CG2' ' N ' ' A' ' 39' ' ' LEU . 8.6 tp -50.5 -46.86 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.43 0 C-N-CA 117.239 -1.784 . . . . 0.0 108.239 179.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.547 ' N ' ' CG2' ' A' ' 38' ' ' ILE . 58.9 mt -58.6 -40.01 82.05 Favored 'General case' 0 N--CA 1.508 2.432 0 O-C-N 120.851 -1.155 . . . . 0.0 109.669 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.2 mttm -63.38 -35.83 81.7 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.365 -0.834 . . . . 0.0 109.941 179.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.476 ' HG3' ' CG ' ' A' ' 23' ' ' LEU . 12.0 mm-40 -77.77 -52.26 9.21 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.581 -0.7 . . . . 0.0 111.106 -179.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.546 ' CG ' ' HE3' ' A' ' 1' ' ' MET . 17.6 t60 -62.23 -34.38 76.38 Favored 'General case' 0 N--CA 1.51 2.558 0 C-N-CA 118.374 -1.331 . . . . 0.0 108.612 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.492 ' O ' ' N ' ' A' ' 46' ' ' GLY . . . -64.16 -43.71 94.34 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.959 -1.088 . . . . 0.0 108.493 177.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.0 tptt -48.01 -44.72 31.05 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 121.051 -1.03 . . . . 0.0 109.187 178.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.448 ' HB3' ' OE2' ' A' ' 47' ' ' GLU . 74.1 m -66.79 -8.16 26.48 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 121.675 0.75 . . . . 0.0 109.726 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . 73.39 29.63 63.75 Favored Glycine 0 N--CA 1.495 2.586 0 C-N-CA 120.055 -1.069 . . . . 0.0 111.636 178.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.542 ' CB ' ' CD2' ' A' ' 42' ' ' HIS . 0.3 OUTLIER -79.41 166.87 21.58 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.211 -1.758 . . . . 0.0 108.821 178.899 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.451 ' O ' HG21 ' A' ' 49' ' ' ILE . 53.3 m-20 -85.96 143.13 28.33 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.042 -1.036 . . . . 0.0 109.653 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.592 ' HA ' ' HA ' ' A' ' 1' ' ' MET . 0.6 OUTLIER -149.21 147.88 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.724 -1.235 . . . . 0.0 108.417 179.529 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.568 ' CD1' ' N ' ' A' ' 50' ' ' PHE . 11.3 p90 -141.22 164.8 29.26 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 116.163 -2.215 . . . . 0.0 114.504 -178.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -119.29 169.75 13.75 Favored Glycine 0 N--CA 1.5 2.924 0 N-CA-C 108.502 -1.839 . . . . 0.0 108.502 -178.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.527 ' C ' ' CD2' ' A' ' 65' ' ' LEU . 3.6 p30 -170.98 163.03 7.43 Favored 'General case' 0 N--CA 1.482 1.14 0 O-C-N 120.445 -1.621 . . . . 0.0 109.923 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.484 ' HA3' ' O ' ' A' ' 66' ' ' ARG . . . 150.15 -142.46 9.7 Favored Glycine 0 N--CA 1.503 3.101 0 C-N-CA 117.856 -2.116 . . . . 0.0 111.389 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.496 ' HA ' ' O ' ' A' ' 95' ' ' ASP . 2.8 t -128.81 121.35 54.41 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.0 mt -62.63 161.72 11.76 Favored 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 118.514 -1.274 . . . . 0.0 113.481 -175.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.47 ' HA ' ' OG1' ' A' ' 93' ' ' THR . 4.3 tt0 -139.05 117.85 12.34 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 178.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.577 ' CG1' ' HB ' ' A' ' 93' ' ' THR . 1.3 mm -82.57 161.07 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 CA-C-N 120.868 1.667 . . . . 0.0 109.572 -178.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.571 HD21 ' CZ ' ' A' ' 62' ' ' PHE . 6.7 mp -130.31 134.9 47.54 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.602 -1.311 . . . . 0.0 109.288 179.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.478 ' C ' ' O ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -38.59 -36.25 0.24 Allowed 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.665 0.745 . . . . 0.0 109.946 -179.725 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -60.95 -7.08 2.17 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.689 -0.632 . . . . 0.0 112.53 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.438 ' O ' ' HB3' ' A' ' 83' ' ' PRO . . . 91.65 8.15 64.13 Favored Glycine 1 N--CA 1.518 4.113 0 C-N-CA 118.677 -1.725 . . . . 0.0 112.232 178.13 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.571 ' CZ ' HD21 ' A' ' 58' ' ' LEU . 2.2 p90 -127.9 -179.64 5.07 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 104.706 -2.331 . . . . 0.0 104.706 178.127 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.537 ' N ' ' CD1' ' A' ' 62' ' ' PHE . . . -157.88 172.33 35.06 Favored Glycine 0 N--CA 1.478 1.491 0 C-N-CA 117.38 -2.343 . . . . 0.0 111.841 -178.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.443 ' CE2' ' HE1' ' A' ' 62' ' ' PHE . 10.3 m-85 -128.83 153.83 47.05 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 119.882 1.841 . . . . 0.0 109.319 177.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.527 ' CD2' ' C ' ' A' ' 52' ' ' ASP . 0.5 OUTLIER -100.24 124.02 45.18 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 177.487 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.534 ' CB ' ' OD2' ' A' ' 78' ' ' ASP . 2.6 ptm180 -129.42 -169.22 2.06 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 119.629 -1.919 . . . . 0.0 110.281 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.498 1.947 0 O-C-N 120.961 -1.087 . . . . 0.0 110.469 179.95 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.534 ' OD2' ' CB ' ' A' ' 66' ' ' ARG . 89.2 m-20 . . . . . 0 N--CA 1.514 2.771 0 CA-C-O 121.16 0.505 . . . . 0.0 111.807 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.546 ' CD1' ' CD2' ' A' ' 3' ' ' LEU . 6.7 mm -76.73 130.81 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.701 0 O-C-N 121.058 -1.026 . . . . 0.0 110.576 -177.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.495 ' HB3' ' O ' ' A' ' 111' ' ' PHE . 79.9 t80 -77.2 145.18 37.77 Favored 'General case' 0 N--CA 1.513 2.72 0 O-C-N 119.549 -1.969 . . . . 0.0 109.42 179.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 38.7 t -142.38 114.66 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 120.301 -1.499 . . . . 0.0 110.817 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.539 ' O ' HG13 ' A' ' 86' ' ' ILE . 19.9 m -74.71 163.65 66.8 Favored Pre-proline 0 N--CA 1.512 2.665 0 O-C-N 120.357 -1.464 . . . . 0.0 111.708 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.525 ' HA ' HG13 ' A' ' 86' ' ' ILE . 38.0 Cg_endo -65.33 -48.83 3.01 Favored 'Trans proline' 0 C--N 1.315 -1.233 0 O-C-N 124.321 1.695 . . . . 0.0 108.827 179.005 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.554 ' O ' ' CG ' ' A' ' 88' ' ' ARG . 80.1 p -46.59 -41.1 13.99 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 177.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.521 ' HB2' ' O ' ' A' ' 82' ' ' SER . 4.2 mm-40 -62.16 -58.08 9.14 Favored 'General case' 0 N--CA 1.51 2.529 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 177.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.562 ' HA ' ' CD1' ' A' ' 91' ' ' LEU . 0.9 OUTLIER -55.35 -55.27 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 O-C-N 121.153 -0.967 . . . . 0.0 108.55 178.382 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.472 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 0.2 OUTLIER -57.99 -42.23 84.7 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-O 121.787 0.804 . . . . 0.0 111.466 -179.518 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.554 ' CG ' ' O ' ' A' ' 84' ' ' SER . 0.0 OUTLIER -60.44 -36.52 78.39 Favored 'General case' 0 N--CA 1.506 2.355 0 C-N-CA 119.76 -0.776 . . . . 0.0 111.725 -177.714 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.579 ' HB2' ' CD2' ' A' ' 91' ' ' LEU . 20.1 m-85 -112.12 13.13 20.58 Favored 'General case' 0 N--CA 1.507 2.378 0 C-N-CA 117.12 -1.832 . . . . 0.0 111.664 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 61.46 53.5 3.37 Favored 'General case' 0 N--CA 1.484 1.242 0 O-C-N 120.389 -1.445 . . . . 0.0 110.3 178.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.579 ' CD2' ' HB2' ' A' ' 89' ' ' PHE . 3.5 mt -89.61 -173.44 3.95 Favored 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 119.304 -0.959 . . . . 0.0 110.277 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.533 ' CG ' ' O ' ' A' ' 91' ' ' LEU . 12.0 mtt-85 -160.1 160.27 32.85 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 177.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.577 ' HB ' ' CG1' ' A' ' 57' ' ' ILE . 1.8 t -64.18 155.94 30.14 Favored 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 116.983 -1.887 . . . . 0.0 106.841 178.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 77.57 -11.54 18.64 Favored Glycine 0 N--CA 1.506 3.343 0 C-N-CA 117.042 -2.504 . . . . 0.0 110.263 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.496 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 7.9 m-20 -68.18 148.59 50.66 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.14 -1.8 . . . . 0.0 110.465 -179.038 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.51 ' O ' HG12 ' A' ' 97' ' ' ILE . 0.1 OUTLIER -93.92 125.58 38.62 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.16 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.51 HG12 ' O ' ' A' ' 96' ' ' THR . 1.5 mt -145.78 164.89 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 C-N-CA 118.07 -1.452 . . . . 0.0 112.375 -179.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 89.9 p -149.69 139.29 21.64 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.424 ' HA2' ' CG ' ' A' ' 117' ' ' ASN . . . -168.29 -175.41 37.89 Favored Glycine 0 N--CA 1.508 3.465 0 C-N-CA 116.859 -2.591 . . . . 0.0 115.406 -178.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.432 ' HG3' ' HG2' ' A' ' 115' ' ' LYS . 2.1 mtpt -88.23 150.98 22.98 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.446 HD13 HG13 ' A' ' 49' ' ' ILE . 2.8 pt -121.51 160.56 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.504 0 CA-C-N 121.463 1.938 . . . . 0.0 113.241 -177.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.46 ' HB2' HD21 ' A' ' 114' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.488 1.438 0 O-C-N 120.392 -1.442 . . . . 0.0 109.363 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.2 mmt85 . . . . . 0 N--CA 1.496 1.874 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -106.83 151.56 25.03 Favored 'General case' 0 N--CA 1.52 3.038 0 O-C-N 119.7 -1.875 . . . . 0.0 109.574 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.495 ' O ' ' HB3' ' A' ' 80' ' ' TYR . 3.3 m-85 -68.28 168.19 12.89 Favored 'General case' 0 N--CA 1.503 2.225 0 O-C-N 119.775 -1.828 . . . . 0.0 107.928 178.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.434 ' HA ' ' HB3' ' A' ' 80' ' ' TYR . . . -122.75 155.69 35.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.1 -1.625 . . . . 0.0 110.785 -179.015 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.97 153.71 39.77 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.46 HD21 ' HB2' ' A' ' 102' ' ' ARG . 14.5 tp -129.07 -56.36 1.18 Allowed 'General case' 0 N--CA 1.503 2.205 0 O-C-N 120.081 -1.637 . . . . 0.0 112.868 -178.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.432 ' HG2' ' HG3' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -125.28 142.77 51.31 Favored 'General case' 0 N--CA 1.507 2.404 0 O-C-N 120.343 -1.473 . . . . 0.0 108.536 179.666 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 37.4 t -92.89 130.55 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.955 0 O-C-N 120.406 -1.434 . . . . 0.0 112.091 -179.724 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.424 ' CG ' ' HA2' ' A' ' 99' ' ' GLY . 11.3 m-20 -107.02 -39.93 5.6 Favored 'General case' 0 N--CA 1.51 2.567 0 O-C-N 121.469 -0.769 . . . . 0.0 109.871 178.122 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.491 ' C ' ' CG2' ' A' ' 119' ' ' VAL . 0.9 OUTLIER -143.45 160.07 41.25 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.989 -1.069 . . . . 0.0 109.463 179.578 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.515 ' O ' ' C ' ' A' ' 120' ' ' ASN . 18.7 t -158.46 147.89 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -178.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.515 ' C ' ' O ' ' A' ' 119' ' ' VAL . 7.1 t-20 . . . . . 0 N--CA 1.524 3.273 0 O-C-N 121.456 -0.778 . . . . 0.0 111.481 -178.406 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.596 ' HA ' ' HA ' ' A' ' 49' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . 0.569 ' HB3' ' HB2' ' A' ' 5' ' ' GLU . 55.3 t30 -78.63 91.09 4.59 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.965 -1.085 . . . . 0.0 108.461 178.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.47 ' HA ' HD13 ' A' ' 6' ' ' LEU . 1.5 tp -42.19 -41.05 2.57 Favored 'General case' 0 N--CA 1.52 3.043 0 O-C-N 120.471 -1.393 . . . . 0.0 110.401 -178.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.453 ' OG1' ' OD1' ' A' ' 52' ' ' ASP . 1.8 m -57.35 -37.82 73.17 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.806 -1.183 . . . . 0.0 108.33 -179.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.569 ' HB2' ' HB3' ' A' ' 2' ' ' ASN . 0.3 OUTLIER -74.11 -39.31 63.44 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.783 -1.198 . . . . 0.0 108.776 178.021 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.534 ' CD1' HD23 ' A' ' 39' ' ' LEU 0.278 67.4 mt -54.77 -52.33 62.93 Favored 'General case' 0 C--O 1.215 -0.718 0 O-C-N 120.387 -1.445 . . . . 0.0 109.038 177.771 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.489 ' NZ ' ' HD2' ' A' ' 66' ' ' ARG . 0.2 OUTLIER -61.54 -40.35 94.35 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.019 -1.05 . . . . 0.0 109.264 178.468 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . 0.424 ' HB2' ' HA ' ' A' ' 5' ' ' GLU . 2.7 m-80 -62.08 -20.6 64.18 Favored 'General case' 0 N--CA 1.506 2.353 0 C-N-CA 119.438 -0.905 . . . . 0.0 110.732 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.552 ' HB ' ' CD2' ' A' ' 14' ' ' LEU . 2.6 m -75.01 118.28 69.24 Favored Pre-proline 0 C--N 1.287 -2.14 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.48 ' HG2' ' CG ' ' A' ' 13' ' ' GLU . 37.3 Cg_endo -57.47 152.33 48.02 Favored 'Trans proline' 0 CA--C 1.563 1.952 0 O-C-N 122.408 0.688 . . . . 0.0 110.515 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.536 ' CG1' ' N ' ' A' ' 12' ' ' SER . 1.7 p -41.31 -49.44 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.529 3.48 0 O-C-N 120.493 -1.379 . . . . 0.0 110.094 -178.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.536 ' N ' ' CG1' ' A' ' 11' ' ' VAL . 0.7 OUTLIER -60.56 -39.8 89.29 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.415 -0.803 . . . . 0.0 111.249 -179.629 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.545 ' HB3' ' CG2' ' A' ' 9' ' ' THR . 29.2 mt-10 -69.45 -32.21 71.0 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 118.015 -1.474 . . . . 0.0 108.488 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.552 ' CD2' ' HB ' ' A' ' 9' ' ' THR . 6.2 mt -68.62 -42.29 78.3 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 120.841 -1.162 . . . . 0.0 108.845 177.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.533 ' CG1' ' HB3' ' A' ' 26' ' ' LEU . 1.3 mp -64.64 -38.97 84.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 C-N-CA 117.714 -1.594 . . . . 0.0 108.451 178.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.501 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 59.0 m -64.24 -36.69 84.9 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 120.331 -1.481 . . . . 0.0 108.878 178.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.542 ' CD1' HG22 ' A' ' 9' ' ' THR . 0.3 OUTLIER -66.06 -38.82 89.3 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.822 -1.174 . . . . 0.0 108.936 178.432 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -68.0 -43.28 82.68 Favored Glycine 1 N--CA 1.521 4.305 0 N-CA-C 108.471 -1.852 . . . . 0.0 108.471 178.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.43 ' OE1' ' HG2' ' A' ' 24' ' ' GLU . 1.4 mm-40 -54.72 -44.9 73.9 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.886 -1.361 . . . . 0.0 107.737 178.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.501 ' OD1' ' O ' ' A' ' 16' ' ' THR . 28.8 m120 -59.57 -26.22 65.21 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 118.288 -1.365 . . . . 0.0 109.334 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.561 ' CE ' ' NE2' ' A' ' 41' ' ' GLN . 52.9 mmm -101.07 9.79 41.72 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.27 -0.894 . . . . 0.0 111.144 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.85 -21.11 39.31 Favored Glycine 0 N--CA 1.501 3.02 0 C-N-CA 118.634 -1.746 . . . . 0.0 111.589 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.563 ' O ' ' CD1' ' A' ' 26' ' ' LEU . 4.0 mp -78.57 96.48 5.48 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 120.152 -1.793 . . . . 0.0 109.934 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.496 ' O ' ' CB ' ' A' ' 25' ' ' ASN . 16.9 mt-10 -105.98 171.14 7.5 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.255 -0.903 . . . . 0.0 109.276 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.496 ' CB ' ' O ' ' A' ' 24' ' ' GLU . 0.7 OUTLIER 71.15 15.67 6.45 Favored 'General case' 0 N--CA 1.514 2.733 0 O-C-N 121.517 -0.739 . . . . 0.0 111.838 179.314 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.563 ' CD1' ' O ' ' A' ' 23' ' ' LEU . 0.4 OUTLIER -76.57 -10.88 59.71 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.005 -1.059 . . . . 0.0 111.672 -179.883 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 26' ' ' LEU . . . -46.57 -35.73 6.13 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.515 -1.366 . . . . 0.0 109.07 -179.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.92 3.53 25.98 Favored 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 119.849 -0.74 . . . . 0.0 111.545 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.534 ' HB3' HG13 ' A' ' 34' ' ' ILE . 7.5 mtp -99.97 156.61 17.06 Favored 'General case' 0 C--N 1.314 -0.95 0 O-C-N 120.72 -1.238 . . . . 0.0 111.774 -178.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.472 ' HB3' ' OD2' ' A' ' 33' ' ' ASP . 0.0 OUTLIER -89.46 139.22 30.74 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.413 -0.804 . . . . 0.0 110.936 179.239 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.581 ' O ' HG23 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -31.66 -44.81 0.08 Allowed 'General case' 0 N--CA 1.5 2.055 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.885 179.197 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.582 ' O ' ' CG2' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -63.27 -53.28 55.38 Favored 'General case' 0 N--CA 1.521 3.08 0 O-C-N 121.319 -0.863 . . . . 0.0 111.941 -178.233 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 34' ' ' ILE . 1.9 p30 -66.92 -39.73 87.46 Favored 'General case' 0 C--N 1.293 -1.873 0 O-C-N 119.965 -1.709 . . . . 0.0 109.226 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.538 ' N ' ' OD1' ' A' ' 33' ' ' ASP . 4.4 mt -61.93 -39.18 82.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 O-C-N 120.459 -1.401 . . . . 0.0 109.444 178.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.582 ' CG2' ' O ' ' A' ' 32' ' ' GLN . 0.3 OUTLIER -66.91 -40.6 86.09 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.555 0 O-C-N 120.345 -1.472 . . . . 0.0 109.246 178.518 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 6.1 m-30 -60.3 -43.9 95.88 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 120.803 -1.186 . . . . 0.0 108.531 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.28 -51.32 70.45 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.49 -1.381 . . . . 0.0 108.821 178.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.532 HG13 ' HA ' ' A' ' 35' ' ' ILE . 0.1 OUTLIER -56.17 -31.88 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 C-N-CA 117.618 -1.633 . . . . 0.0 109.643 179.23 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.564 HD11 ' CE1' ' A' ' 111' ' ' PHE . 98.6 mt -69.21 -44.88 71.19 Favored 'General case' 0 N--CA 1.505 2.308 0 O-C-N 120.07 -1.644 . . . . 0.0 109.557 178.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.65 -34.11 77.44 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.023 -1.048 . . . . 0.0 111.396 179.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.561 ' NE2' ' CE ' ' A' ' 21' ' ' MET . 0.0 OUTLIER -79.5 -51.71 8.97 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.212 -0.93 . . . . 0.0 109.977 -178.9 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.547 ' NE2' ' HG3' ' A' ' 47' ' ' GLU . 5.1 t-160 -64.95 -38.61 91.53 Favored 'General case' 0 N--CA 1.507 2.378 0 C-N-CA 117.619 -1.632 . . . . 0.0 109.141 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.544 ' O ' ' N ' ' A' ' 46' ' ' GLY . . . -61.58 -38.86 89.08 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 120.918 -1.113 . . . . 0.0 108.594 178.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 12.2 tptt -48.25 -45.0 33.86 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 121.003 -1.061 . . . . 0.0 108.567 177.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 52.0 m -66.49 -10.09 41.04 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 121.724 0.773 . . . . 0.0 109.493 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . 70.71 29.53 69.42 Favored Glycine 0 N--CA 1.496 2.652 0 C-N-CA 120.621 -0.8 . . . . 0.0 111.752 178.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.547 ' HG3' ' NE2' ' A' ' 42' ' ' HIS . 3.7 pm0 -82.82 158.08 22.91 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.178 -1.777 . . . . 0.0 108.793 178.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.442 ' O ' HG21 ' A' ' 49' ' ' ILE . 10.6 m-20 -71.55 147.65 47.46 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.912 -1.117 . . . . 0.0 110.334 -178.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.596 ' HA ' ' HA ' ' A' ' 1' ' ' MET . 0.8 OUTLIER -146.63 145.0 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.077 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.554 ' O ' ' HA ' ' A' ' 2' ' ' ASN . 10.5 p90 -141.31 170.28 16.01 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 116.268 -2.173 . . . . 0.0 115.583 -177.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -114.46 162.37 12.43 Favored Glycine 0 N--CA 1.501 3.003 0 N-CA-C 107.88 -2.088 . . . . 0.0 107.88 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.49 ' C ' ' CD2' ' A' ' 65' ' ' LEU . 7.5 p-10 -172.78 162.91 4.99 Favored 'General case' 0 N--CA 1.483 1.196 0 O-C-N 120.364 -1.668 . . . . 0.0 110.369 -178.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.546 ' HA3' ' O ' ' A' ' 66' ' ' ARG . . . 138.35 -134.59 6.94 Favored Glycine 0 N--CA 1.503 3.155 0 C-N-CA 118.28 -1.914 . . . . 0.0 111.54 177.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.54 ' HA ' ' O ' ' A' ' 95' ' ' ASP . 2.5 t -127.94 117.75 46.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 O-C-N 121.45 -1.029 . . . . 0.0 108.396 -179.124 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.493 ' HB2' ' OD1' ' A' ' 95' ' ' ASP . 6.2 mt -63.36 165.41 7.67 Favored 'General case' 0 N--CA 1.503 2.18 0 C-N-CA 118.622 -1.231 . . . . 0.0 113.561 -176.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.53 ' O ' ' CG ' ' A' ' 56' ' ' GLU . 8.2 pt-20 -141.52 123.03 15.02 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 177.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.563 ' CG1' ' HB ' ' A' ' 93' ' ' THR . 1.2 mm -83.07 164.31 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 119.857 -1.777 . . . . 0.0 109.275 -178.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.584 HD21 ' CE1' ' A' ' 62' ' ' PHE . 3.1 mp -130.98 136.46 48.55 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.433 -1.417 . . . . 0.0 109.672 179.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.445 ' C ' ' O ' ' A' ' 58' ' ' LEU . 7.7 tt0 -39.57 -36.99 0.44 Allowed 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.637 0.732 . . . . 0.0 110.128 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.452 ' OD1' ' N ' ' A' ' 60' ' ' ASP . 5.8 m-20 -61.52 -6.65 2.52 Favored 'General case' 0 N--CA 1.5 2.029 0 C-N-CA 119.905 -0.718 . . . . 0.0 112.576 -179.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 92.53 8.15 62.69 Favored Glycine 1 N--CA 1.519 4.224 0 C-N-CA 118.688 -1.72 . . . . 0.0 112.612 177.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.584 ' CE1' HD21 ' A' ' 58' ' ' LEU . 4.4 p90 -129.1 -177.04 4.06 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 104.29 -2.485 . . . . 0.0 104.29 177.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.508 ' HA2' ' CD1' ' A' ' 58' ' ' LEU . . . -157.63 172.75 34.97 Favored Glycine 0 N--CA 1.475 1.273 0 C-N-CA 116.672 -2.68 . . . . 0.0 112.109 -177.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.466 ' HB2' ' OE2' ' A' ' 56' ' ' GLU . 16.2 m-85 -130.25 151.97 50.18 Favored 'General case' 0 N--CA 1.483 1.215 0 O-C-N 120.223 -1.751 . . . . 0.0 109.574 177.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.49 ' CD2' ' C ' ' A' ' 52' ' ' ASP . 0.2 OUTLIER -97.91 168.23 10.42 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 176.221 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.546 ' O ' ' HA3' ' A' ' 53' ' ' GLY . 10.5 ttp85 177.09 -173.91 0.11 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.004 -1.06 . . . . 0.0 109.662 179.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.497 1.88 0 O-C-N 120.707 -1.246 . . . . 0.0 109.834 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.505 ' OD1' ' N ' ' A' ' 78' ' ' ASP . 3.7 m-20 . . . . . 0 N--CA 1.504 2.249 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.481 HG13 ' HB3' ' A' ' 65' ' ' LEU . 5.0 mm -111.6 129.15 67.51 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.599 0 O-C-N 121.137 -0.977 . . . . 0.0 109.224 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.476 ' HB3' ' HA ' ' A' ' 112' ' ' ALA . 15.2 t80 -74.87 147.22 41.25 Favored 'General case' 0 N--CA 1.518 2.928 0 CA-C-N 121.987 2.176 . . . . 0.0 110.052 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.455 ' HB ' ' O ' ' A' ' 63' ' ' GLY . 8.9 t -142.57 110.92 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 120.188 -1.57 . . . . 0.0 110.113 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.516 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 6.2 m -74.27 164.02 64.19 Favored Pre-proline 0 N--CA 1.511 2.597 0 O-C-N 120.361 -1.462 . . . . 0.0 111.983 -179.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.517 ' HA ' HG13 ' A' ' 86' ' ' ILE . 38.1 Cg_endo -65.26 -54.29 0.66 Allowed 'Trans proline' 0 C--N 1.315 -1.23 0 O-C-N 124.621 1.853 . . . . 0.0 109.182 178.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.558 ' O ' ' CG ' ' A' ' 88' ' ' ARG . 52.9 p -46.34 -39.33 10.06 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 178.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.5 ' HB2' ' O ' ' A' ' 82' ' ' SER . 6.7 mm100 -63.23 -58.92 5.58 Favored 'General case' 0 N--CA 1.51 2.536 0 C-N-CA 119.421 -0.912 . . . . 0.0 108.742 178.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.517 HG13 ' HA ' ' A' ' 83' ' ' PRO . 0.2 OUTLIER -55.83 -54.03 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.313 0 O-C-N 121.107 -0.996 . . . . 0.0 108.601 178.801 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.465 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 0.1 OUTLIER -56.69 -43.39 80.43 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-O 121.933 0.873 . . . . 0.0 110.876 -179.659 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.558 ' CG ' ' O ' ' A' ' 84' ' ' SER . 1.3 mmm180 -59.6 -36.63 76.66 Favored 'General case' 0 N--CA 1.505 2.281 0 C-N-CA 119.795 -0.762 . . . . 0.0 111.702 -177.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.431 ' CD2' ' O ' ' A' ' 85' ' ' GLN . 5.4 m-85 -109.81 11.89 24.17 Favored 'General case' 0 N--CA 1.501 2.116 0 C-N-CA 117.518 -1.673 . . . . 0.0 111.114 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 59.58 53.96 4.78 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 120.575 -1.328 . . . . 0.0 109.816 178.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.505 HD11 ' N ' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -90.04 -177.75 5.26 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 119.681 -0.807 . . . . 0.0 110.176 -179.948 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.47 ' O ' ' OD2' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -156.8 161.64 39.75 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.337 -0.852 . . . . 0.0 108.704 178.235 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.563 ' HB ' ' CG1' ' A' ' 57' ' ' ILE . 1.6 t -64.42 155.23 33.23 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 117.119 -1.833 . . . . 0.0 107.428 179.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.459 ' HA2' HG13 ' A' ' 54' ' ' VAL . . . 75.66 -8.56 20.05 Favored Glycine 0 N--CA 1.502 3.05 0 C-N-CA 117.123 -2.465 . . . . 0.0 110.114 179.1 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.54 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 7.8 p30 -69.57 149.04 48.62 Favored 'General case' 0 N--CA 1.483 1.222 0 O-C-N 120.127 -1.808 . . . . 0.0 110.515 -178.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.479 ' C ' ' CG1' ' A' ' 97' ' ' ILE . 0.3 OUTLIER -94.92 121.33 36.42 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.825 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.515 ' CG2' ' O ' ' A' ' 118' ' ' GLU . 2.3 mt -148.03 168.75 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 119.925 -1.734 . . . . 0.0 112.648 -178.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.502 ' OG ' ' HB2' ' A' ' 118' ' ' GLU . 92.1 p -148.54 137.89 21.91 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.502 ' O ' ' HB2' ' A' ' 50' ' ' PHE . . . -161.43 177.49 37.72 Favored Glycine 0 N--CA 1.51 3.599 0 C-N-CA 117.958 -2.068 . . . . 0.0 114.209 -178.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.495 ' HG2' ' HB3' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -87.73 157.02 19.16 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 178.594 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.5 HG12 ' HA ' ' A' ' 50' ' ' PHE . 1.5 pt -123.26 155.67 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.463 0 CA-C-N 120.815 1.643 . . . . 0.0 113.408 -177.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.518 ' HB2' ' CD1' ' A' ' 114' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.179 0 O-C-N 120.571 -1.331 . . . . 0.0 109.553 179.484 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . 0.579 ' HD2' ' CE1' ' A' ' 110' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.77 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.579 ' CE1' ' HD2' ' A' ' 109' ' ' ARG . 42.2 m-85 -107.73 149.14 28.51 Favored 'General case' 0 N--CA 1.522 3.141 0 O-C-N 120.179 -1.576 . . . . 0.0 107.704 176.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.564 ' CE1' HD11 ' A' ' 39' ' ' LEU . 78.2 m-85 -68.35 159.42 31.48 Favored 'General case' 0 N--CA 1.509 2.509 0 O-C-N 119.161 -2.212 . . . . 0.0 108.056 178.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.476 ' HA ' ' HB3' ' A' ' 80' ' ' TYR . . . -124.15 142.83 50.89 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 119.975 -1.703 . . . . 0.0 111.434 -178.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 113' ' ' LEU . 0.2 OUTLIER -51.2 147.02 5.9 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 179.117 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.518 ' CD1' ' HB2' ' A' ' 102' ' ' ARG . 6.4 tp -128.28 -58.32 1.2 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 120.22 -1.55 . . . . 0.0 111.549 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.495 ' HB3' ' HG2' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -120.73 140.09 52.14 Favored 'General case' 0 N--CA 1.509 2.487 0 O-C-N 120.336 -1.478 . . . . 0.0 108.405 178.835 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.6 t -92.53 134.16 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.854 0 O-C-N 120.215 -1.553 . . . . 0.0 111.318 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -107.5 -42.41 4.8 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.552 -0.718 . . . . 0.0 109.586 178.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.515 ' O ' ' CG2' ' A' ' 97' ' ' ILE . 1.2 mt-10 -143.71 159.84 41.77 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.879 -1.138 . . . . 0.0 109.783 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.503 ' CG2' ' C ' ' A' ' 118' ' ' GLU . 5.1 t -158.22 140.44 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.982 -0.449 . . . . 0.0 110.075 -178.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.516 2.869 0 O-C-N 120.34 -1.475 . . . . 0.0 110.666 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.576 ' HA ' ' CB ' ' A' ' 49' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.396 0.617 . . . . 0.0 110.083 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . 0.588 ' HB2' ' CZ ' ' A' ' 50' ' ' PHE . 19.6 t30 -77.91 101.35 6.78 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.303 -0.873 . . . . 0.0 109.049 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.477 HD12 HD11 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -41.5 -41.95 2.24 Favored 'General case' 0 N--CA 1.518 2.951 0 O-C-N 120.535 -1.353 . . . . 0.0 110.192 -178.753 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.472 ' OG1' ' OD1' ' A' ' 52' ' ' ASP . 1.6 m -58.65 -36.78 74.66 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.892 -1.13 . . . . 0.0 108.51 -179.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.508 ' HB3' ' HB3' ' A' ' 2' ' ' ASN . 0.7 OUTLIER -72.15 -45.41 60.56 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.149 -0.97 . . . . 0.0 108.682 178.245 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.477 HD11 HD12 ' A' ' 3' ' ' LEU 0.276 86.2 mt -51.37 -47.91 62.67 Favored 'General case' 0 C--N 1.315 -0.894 0 O-C-N 120.903 -1.123 . . . . 0.0 109.409 178.322 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . 0.517 ' NZ ' HD11 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -66.94 -39.82 87.39 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.028 -1.045 . . . . 0.0 110.142 178.869 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -63.12 -29.27 70.67 Favored 'General case' 0 N--CA 1.507 2.399 0 C-N-CA 119.352 -0.939 . . . . 0.0 111.191 -179.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.576 ' HB ' ' CD1' ' A' ' 14' ' ' LEU . 3.2 m -75.02 123.5 88.96 Favored Pre-proline 0 C--N 1.285 -2.198 0 O-C-N 121.613 -0.679 . . . . 0.0 109.596 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.535 ' HG2' ' CG ' ' A' ' 13' ' ' GLU . 39.8 Cg_endo -61.29 151.3 80.11 Favored 'Trans proline' 0 CA--C 1.567 2.148 0 O-C-N 122.372 0.67 . . . . 0.0 110.856 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.551 ' CG1' ' N ' ' A' ' 12' ' ' SER . 1.6 p -41.74 -49.86 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.525 3.318 0 O-C-N 120.643 -1.286 . . . . 0.0 109.707 -178.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.551 ' N ' ' CG1' ' A' ' 11' ' ' VAL . 0.7 OUTLIER -57.07 -40.78 77.56 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.294 -0.879 . . . . 0.0 111.076 -179.87 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.547 ' HB3' ' CG2' ' A' ' 9' ' ' THR . 52.6 mm-40 -68.95 -30.39 68.82 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 118.02 -1.472 . . . . 0.0 107.776 179.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.576 ' CD1' ' HB ' ' A' ' 9' ' ' THR . 0.0 OUTLIER -68.5 -42.31 78.78 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.993 -1.067 . . . . 0.0 109.058 177.104 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.4 mp -66.26 -38.67 82.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 C-N-CA 118.133 -1.427 . . . . 0.0 108.621 178.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.5 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 44.2 m -64.88 -37.58 88.12 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 120.379 -1.45 . . . . 0.0 109.163 178.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.539 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 0.9 OUTLIER -66.11 -37.46 85.81 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.85 -1.156 . . . . 0.0 109.069 178.652 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.489 ' CA ' HD11 ' A' ' 23' ' ' LEU . . . -70.07 -42.76 66.97 Favored Glycine 0 N--CA 1.516 3.977 0 C-N-CA 118.6 -1.762 . . . . 0.0 108.864 178.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.672 ' HG3' ' N ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -59.81 -37.6 79.61 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.294 -1.71 . . . . 0.0 108.047 179.047 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.672 ' N ' ' HG3' ' A' ' 19' ' ' GLU . 28.2 m120 -61.05 -26.79 67.88 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 118.309 -1.356 . . . . 0.0 109.371 178.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.648 ' CE ' ' CG ' ' A' ' 42' ' ' HIS . 43.7 mmm -101.94 11.52 38.42 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.193 -0.942 . . . . 0.0 111.261 -179.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.21 -25.33 25.32 Favored Glycine 0 N--CA 1.497 2.758 0 C-N-CA 118.654 -1.736 . . . . 0.0 110.897 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.584 ' O ' ' CD1' ' A' ' 26' ' ' LEU . 1.7 mp -78.62 91.77 4.66 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.414 -1.639 . . . . 0.0 109.027 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.478 ' O ' ' CB ' ' A' ' 25' ' ' ASN . 41.7 mt-10 -106.23 169.9 8.24 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.311 -0.868 . . . . 0.0 108.93 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.478 ' CB ' ' O ' ' A' ' 24' ' ' GLU . 0.7 OUTLIER 69.06 21.17 7.45 Favored 'General case' 0 N--CA 1.507 2.417 0 O-C-N 121.518 -0.738 . . . . 0.0 111.532 179.505 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.584 ' CD1' ' O ' ' A' ' 23' ' ' LEU . 0.4 OUTLIER -76.78 -3.83 40.31 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 120.813 -1.179 . . . . 0.0 110.976 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.436 ' C ' ' O ' ' A' ' 26' ' ' LEU . . . -46.64 -32.92 3.81 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.602 -1.311 . . . . 0.0 108.685 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . 0.409 ' HD2' ' HA ' ' A' ' 28' ' ' ARG . 0.7 OUTLIER -80.84 -2.56 47.81 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.477 179.74 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.489 ' HB3' HG13 ' A' ' 34' ' ' ILE . 7.9 mtp -100.73 150.61 22.59 Favored 'General case' 0 C--N 1.311 -1.076 0 O-C-N 120.748 -1.22 . . . . 0.0 111.33 -178.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.47 ' O ' ' C ' ' A' ' 31' ' ' LYS . 17.4 tpp180 -89.32 141.23 28.73 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.252 -0.905 . . . . 0.0 110.407 178.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.558 ' O ' ' CG1' ' A' ' 35' ' ' ILE . 7.8 ttmt -29.88 -47.57 0.08 Allowed 'General case' 0 N--CA 1.501 2.082 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.774 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.53 ' OE1' ' N ' ' A' ' 33' ' ' ASP . 1.3 pp0? -59.57 -56.04 26.94 Favored 'General case' 0 N--CA 1.518 2.953 0 O-C-N 121.385 -0.822 . . . . 0.0 111.976 -177.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.53 ' N ' ' OE1' ' A' ' 32' ' ' GLN . 2.8 p30 -66.09 -35.95 81.88 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 120.795 -1.19 . . . . 0.0 109.112 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.564 ' CG2' ' HB3' ' A' ' 14' ' ' LEU . 3.3 mt -61.52 -37.79 78.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 O-C-N 120.313 -1.492 . . . . 0.0 108.094 177.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.558 ' CG1' ' O ' ' A' ' 31' ' ' LYS . 0.5 OUTLIER -60.21 -46.83 94.12 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.494 0 O-C-N 120.076 -1.64 . . . . 0.0 109.506 177.446 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -54.36 -40.56 68.22 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.751 -0.779 . . . . 0.0 109.525 -179.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.524 ' CB ' HD21 ' A' ' 23' ' ' LEU . . . -71.74 -52.02 19.85 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 120.745 -1.222 . . . . 0.0 110.626 179.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.426 ' H ' HG13 ' A' ' 38' ' ' ILE . 2.5 mt -58.41 -28.19 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 C-N-CA 117.131 -1.827 . . . . 0.0 109.999 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 25.7 mt -72.39 -41.95 65.74 Favored 'General case' 0 N--CA 1.506 2.341 0 O-C-N 120.06 -1.65 . . . . 0.0 109.451 178.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.33 -36.77 85.05 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.903 -1.123 . . . . 0.0 110.286 178.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.531 ' HG3' ' CG ' ' A' ' 23' ' ' LEU . 22.5 mm-40 -78.66 -51.69 9.5 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.273 -0.892 . . . . 0.0 111.2 -179.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.648 ' CG ' ' CE ' ' A' ' 21' ' ' MET . 0.2 OUTLIER -63.51 -36.48 83.91 Favored 'General case' 0 N--CA 1.505 2.279 0 C-N-CA 118.179 -1.408 . . . . 0.0 108.728 179.871 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.47 ' O ' ' N ' ' A' ' 46' ' ' GLY . . . -55.15 -45.06 75.64 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 177.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -49.98 -44.52 50.94 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-O 122.067 0.937 . . . . 0.0 108.65 177.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.46 ' HB2' ' O ' ' A' ' 42' ' ' HIS . 49.7 m -66.41 -8.14 23.84 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.579 0.704 . . . . 0.0 109.658 179.447 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . 80.98 20.98 64.04 Favored Glycine 0 N--CA 1.497 2.713 0 C-N-CA 120.107 -1.044 . . . . 0.0 112.642 178.028 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -78.72 164.75 24.31 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-N 120.298 2.049 . . . . 0.0 108.65 178.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.44 ' C ' HG21 ' A' ' 49' ' ' ILE . 4.2 m-20 -88.69 152.66 21.67 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.019 -1.05 . . . . 0.0 110.233 -179.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.576 ' CB ' ' HA ' ' A' ' 1' ' ' MET . 9.0 pt -141.47 133.37 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.024 -1.048 . . . . 0.0 108.601 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.588 ' CZ ' ' HB2' ' A' ' 2' ' ' ASN . 20.8 p90 -140.85 164.61 29.78 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 116.542 -2.063 . . . . 0.0 114.303 -179.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -121.97 166.83 14.61 Favored Glycine 0 N--CA 1.502 3.08 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -177.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.472 ' OD1' ' OG1' ' A' ' 4' ' ' THR . 43.4 p30 -167.54 164.48 14.77 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 120.587 -1.537 . . . . 0.0 109.57 -179.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.509 ' HA3' ' O ' ' A' ' 66' ' ' ARG . . . 141.61 -137.25 7.91 Favored Glycine 0 N--CA 1.501 2.998 0 C-N-CA 118.074 -2.012 . . . . 0.0 111.039 178.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' A' ' 95' ' ' ASP . 2.9 t -129.01 121.41 54.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 O-C-N 121.361 -1.081 . . . . 0.0 108.467 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.9 mt -62.81 165.98 6.06 Favored 'General case' 0 N--CA 1.504 2.23 0 C-N-CA 118.785 -1.166 . . . . 0.0 114.008 -175.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.449 ' HG3' ' NE ' ' A' ' 66' ' ' ARG . 2.0 mm-40 -139.64 117.66 11.81 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 178.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.566 ' CG1' ' HB ' ' A' ' 93' ' ' THR . 1.6 mm -84.92 161.91 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 CA-C-N 120.824 1.647 . . . . 0.0 110.316 -178.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.583 HD21 ' CE1' ' A' ' 62' ' ' PHE . 7.6 mp -130.97 143.68 50.91 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.496 -1.377 . . . . 0.0 109.691 178.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.41 ' C ' ' O ' ' A' ' 58' ' ' LEU . 0.9 OUTLIER -42.35 -37.06 1.43 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.304 -0.872 . . . . 0.0 110.337 -179.58 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.468 ' OD1' ' N ' ' A' ' 60' ' ' ASP . 4.5 m-20 -61.01 -6.79 2.05 Favored 'General case' 0 N--CA 1.502 2.126 0 C-N-CA 119.814 -0.754 . . . . 0.0 112.575 -178.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.438 ' O ' ' HB3' ' A' ' 83' ' ' PRO . . . 91.59 7.09 65.27 Favored Glycine 1 N--CA 1.519 4.204 0 C-N-CA 118.515 -1.803 . . . . 0.0 112.091 177.859 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.583 ' CE1' HD21 ' A' ' 58' ' ' LEU . 2.7 p90 -127.76 179.38 5.57 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 104.645 -2.354 . . . . 0.0 104.645 178.063 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -160.46 176.25 37.13 Favored Glycine 0 N--CA 1.477 1.427 0 C-N-CA 117.065 -2.493 . . . . 0.0 111.547 -177.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.5 ' CE2' ' CE2' ' A' ' 62' ' ' PHE . 55.2 m-85 -129.98 155.49 46.0 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 120.112 1.956 . . . . 0.0 109.926 177.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.541 ' HB3' ' HB ' ' A' ' 79' ' ' ILE . 0.3 OUTLIER -98.92 161.65 13.51 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 176.506 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.509 ' O ' ' HA3' ' A' ' 53' ' ' GLY . 0.0 OUTLIER 178.61 -163.45 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.351 -0.843 . . . . 0.0 109.313 179.38 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.497 1.898 0 O-C-N 121.008 -1.058 . . . . 0.0 110.462 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.463 ' OD1' ' N ' ' A' ' 78' ' ' ASP . 5.4 m-20 . . . . . 0 N--CA 1.516 2.845 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.541 ' HB ' ' HB3' ' A' ' 65' ' ' LEU . 1.4 mp -92.9 130.21 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.012 0 C-N-CA 117.479 -1.688 . . . . 0.0 108.956 179.008 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.494 ' HB3' ' O ' ' A' ' 111' ' ' PHE . 5.8 t80 -79.84 146.19 32.36 Favored 'General case' 0 N--CA 1.517 2.876 0 CA-C-N 121.263 1.847 . . . . 0.0 110.429 -179.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.465 HG21 ' O ' ' A' ' 80' ' ' TYR . 49.8 t -140.8 113.47 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 120.278 -1.513 . . . . 0.0 110.622 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.545 ' O ' HG13 ' A' ' 86' ' ' ILE . 14.0 m -74.99 162.81 71.9 Favored Pre-proline 0 N--CA 1.514 2.769 0 O-C-N 120.516 -1.365 . . . . 0.0 111.757 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.514 ' HA ' HG13 ' A' ' 86' ' ' ILE . 38.8 Cg_endo -66.02 -49.09 2.26 Favored 'Trans proline' 0 C--N 1.315 -1.193 0 O-C-N 124.465 1.771 . . . . 0.0 109.295 179.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.548 ' O ' ' CG ' ' A' ' 88' ' ' ARG . 23.3 t -47.27 -40.63 17.14 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 178.088 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.512 ' HA ' ' OE1' ' A' ' 85' ' ' GLN . 7.9 mm100 -63.58 -56.58 14.82 Favored 'General case' 0 N--CA 1.51 2.548 0 C-N-CA 119.498 -0.881 . . . . 0.0 108.642 178.067 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.545 HG13 ' O ' ' A' ' 82' ' ' SER . 1.0 OUTLIER -55.87 -54.67 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.245 0 O-C-N 120.942 -1.099 . . . . 0.0 108.871 178.679 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.453 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 0.0 OUTLIER -56.51 -41.95 77.55 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-O 121.941 0.877 . . . . 0.0 111.17 -179.384 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.548 ' CG ' ' O ' ' A' ' 84' ' ' SER . 2.5 mmt180 -60.3 -37.45 80.6 Favored 'General case' 0 N--CA 1.507 2.382 0 C-N-CA 119.739 -0.784 . . . . 0.0 111.9 -177.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -113.27 14.21 19.28 Favored 'General case' 0 N--CA 1.502 2.135 0 C-N-CA 117.507 -1.677 . . . . 0.0 111.459 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 58.95 53.27 5.75 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 120.363 -1.461 . . . . 0.0 109.543 178.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.509 HD11 ' N ' ' A' ' 91' ' ' LEU . 0.0 OUTLIER -89.41 173.66 8.23 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 119.862 -0.735 . . . . 0.0 109.503 179.883 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.502 ' HG3' ' O ' ' A' ' 91' ' ' LEU . 21.1 mtp180 -152.06 164.1 37.94 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.928 -1.108 . . . . 0.0 109.249 178.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.566 ' HB ' ' CG1' ' A' ' 57' ' ' ILE . 1.5 t -65.42 155.52 35.2 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 117.014 -1.874 . . . . 0.0 106.964 179.035 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.429 ' C ' HG11 ' A' ' 54' ' ' VAL . . . 76.66 -10.5 17.71 Favored Glycine 0 N--CA 1.505 3.235 0 C-N-CA 117.161 -2.447 . . . . 0.0 110.073 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.505 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 9.9 m-20 -67.04 144.75 55.97 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.216 -1.755 . . . . 0.0 110.706 -178.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.492 ' O ' HG12 ' A' ' 97' ' ' ILE . 0.2 OUTLIER -90.18 120.5 31.4 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.238 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.54 HG22 HG21 ' A' ' 119' ' ' VAL . 1.6 mt -146.43 168.66 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 119.845 -1.784 . . . . 0.0 112.985 -178.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.546 ' OG ' ' HB2' ' A' ' 118' ' ' GLU . 68.7 p -149.38 138.8 21.56 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.478 ' O ' ' HB2' ' A' ' 50' ' ' PHE . . . -165.88 179.56 40.03 Favored Glycine 0 N--CA 1.505 3.256 0 C-N-CA 117.379 -2.343 . . . . 0.0 114.422 -179.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.555 ' CD ' ' HB3' ' A' ' 115' ' ' LYS . 5.7 ptmt -90.6 156.0 18.45 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 179.154 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.482 HG12 ' HA ' ' A' ' 50' ' ' PHE . 2.3 pt -129.03 154.87 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.582 0 CA-C-N 121.02 1.736 . . . . 0.0 113.145 -177.216 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.43 ' HB2' ' CD2' ' A' ' 114' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.428 0 O-C-N 120.359 -1.463 . . . . 0.0 109.363 179.309 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 3.6 tpp85 . . . . . 0 N--CA 1.499 2.004 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -107.27 150.85 26.2 Favored 'General case' 0 N--CA 1.514 2.738 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 175.662 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.494 ' O ' ' HB3' ' A' ' 80' ' ' TYR . 53.4 m-85 -67.31 159.37 29.4 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 119.055 -2.278 . . . . 0.0 107.717 179.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.471 ' HA ' ' HB3' ' A' ' 80' ' ' TYR . . . -122.31 154.23 37.9 Favored 'General case' 0 N--CA 1.484 1.271 0 O-C-N 119.932 -1.73 . . . . 0.0 110.508 -179.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.4 tp -59.26 144.02 47.47 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.471 HD22 ' HD3' ' A' ' 100' ' ' LYS . 18.0 tp -121.89 -54.48 1.93 Allowed 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.593 -1.317 . . . . 0.0 111.867 -178.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.555 ' HB3' ' CD ' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -130.63 141.54 50.43 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 120.457 -1.402 . . . . 0.0 108.924 179.116 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.6 t -92.49 129.08 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.754 0 O-C-N 120.732 -1.23 . . . . 0.0 111.253 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . 0.432 ' C ' ' HG2' ' A' ' 118' ' ' GLU . 6.5 m-20 -106.64 -39.02 5.96 Favored 'General case' 0 N--CA 1.506 2.349 0 O-C-N 121.368 -0.833 . . . . 0.0 109.841 178.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.546 ' HB2' ' OG ' ' A' ' 98' ' ' SER . 12.6 mm-40 -143.15 155.87 44.65 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.817 -1.177 . . . . 0.0 109.339 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.54 HG21 HG22 ' A' ' 97' ' ' ILE . 16.7 t -158.33 132.59 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -178.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.517 2.907 0 O-C-N 120.255 -1.528 . . . . 0.0 110.874 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.541 ' HA ' ' HA ' ' A' ' 49' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.685 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . 0.553 ' HB2' ' CE2' ' A' ' 50' ' ' PHE . 34.8 t30 -78.29 94.23 4.78 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.884 -1.135 . . . . 0.0 108.675 178.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.491 ' CD2' ' CD1' ' A' ' 79' ' ' ILE . 1.0 OUTLIER -41.79 -40.61 2.1 Favored 'General case' 0 N--CA 1.517 2.889 0 O-C-N 120.599 -1.313 . . . . 0.0 110.357 -178.711 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.469 ' OG1' ' OD1' ' A' ' 52' ' ' ASP . 1.5 m -60.94 -36.44 79.35 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.891 -1.13 . . . . 0.0 108.239 -179.324 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.537 ' HB3' ' HB3' ' A' ' 2' ' ' ASN . 2.8 pt-20 -70.11 -45.37 67.05 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.981 -1.074 . . . . 0.0 108.432 178.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.527 ' CD1' HD22 ' A' ' 39' ' ' LEU 0.277 14.8 mt -52.77 -48.82 66.53 Favored 'General case' 0 C--N 1.315 -0.924 0 O-C-N 120.906 -1.121 . . . . 0.0 109.536 178.129 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 32.4 mttm -64.51 -34.92 79.34 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.227 -0.921 . . . . 0.0 110.332 179.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -62.08 -24.67 67.25 Favored 'General case' 0 N--CA 1.507 2.415 0 O-C-N 121.135 -0.978 . . . . 0.0 111.145 -179.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.632 ' HB ' ' CD1' ' A' ' 14' ' ' LEU . 2.8 m -73.52 133.64 80.06 Favored Pre-proline 0 N--CA 1.505 2.322 0 O-C-N 121.72 -0.613 . . . . 0.0 109.652 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.531 ' HG2' ' CG ' ' A' ' 13' ' ' GLU . 44.0 Cg_endo -64.12 151.86 83.53 Favored 'Trans proline' 0 CA--C 1.565 2.051 0 N-CA-C 110.036 -0.794 . . . . 0.0 110.036 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.534 ' CG1' ' N ' ' A' ' 12' ' ' SER . 1.7 p -43.25 -50.29 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.529 3.515 0 O-C-N 120.286 -1.509 . . . . 0.0 110.174 -178.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.534 ' N ' ' CG1' ' A' ' 11' ' ' VAL . 0.8 OUTLIER -57.5 -41.59 81.07 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.294 -0.879 . . . . 0.0 111.044 -179.485 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.547 ' HB3' ' CG2' ' A' ' 9' ' ' THR . 3.5 mm-40 -69.06 -26.77 65.12 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 118.115 -1.434 . . . . 0.0 107.662 179.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.632 ' CD1' ' HB ' ' A' ' 9' ' ' THR . 0.0 OUTLIER -70.44 -43.72 69.31 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.165 -0.959 . . . . 0.0 108.917 176.898 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.515 ' CG1' HD12 ' A' ' 34' ' ' ILE . 1.7 mp -67.22 -38.68 81.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 C-N-CA 117.653 -1.619 . . . . 0.0 108.952 178.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.497 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 62.9 m -64.94 -38.54 91.32 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.368 -1.458 . . . . 0.0 109.172 178.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.507 ' O ' ' HG3' ' A' ' 21' ' ' MET . 0.1 OUTLIER -65.09 -38.27 90.17 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.91 -1.119 . . . . 0.0 108.879 178.561 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.482 ' O ' HD11 ' A' ' 23' ' ' LEU . . . -67.67 -41.95 88.47 Favored Glycine 0 N--CA 1.515 3.936 0 N-CA-C 108.505 -1.838 . . . . 0.0 108.505 178.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.691 ' HG3' ' N ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -59.68 -38.5 81.7 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.286 -1.714 . . . . 0.0 108.035 178.855 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.691 ' N ' ' HG3' ' A' ' 19' ' ' GLU . 26.1 m120 -61.68 -28.9 69.73 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 118.429 -1.308 . . . . 0.0 109.609 178.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.559 ' HB2' ' CD1' ' A' ' 23' ' ' LEU . 21.1 mtp -100.28 10.79 40.71 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.187 -0.946 . . . . 0.0 111.207 -179.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.52 -17.02 57.29 Favored Glycine 0 N--CA 1.5 2.9 0 C-N-CA 118.446 -1.835 . . . . 0.0 111.843 179.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.601 ' O ' ' CD1' ' A' ' 26' ' ' LEU . 1.7 mp -79.06 104.61 9.81 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.079 -1.836 . . . . 0.0 109.385 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.404 ' O ' ' CB ' ' A' ' 25' ' ' ASN . 1.4 pt-20 -115.19 178.95 4.1 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.236 -0.915 . . . . 0.0 109.398 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.404 ' CB ' ' O ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER 65.88 15.28 10.0 Favored 'General case' 0 N--CA 1.512 2.634 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.716 178.963 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.601 ' CD1' ' O ' ' A' ' 23' ' ' LEU . 1.1 mt -76.79 -15.78 59.65 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.154 -0.966 . . . . 0.0 112.066 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -47.02 -28.49 1.69 Allowed 'General case' 0 N--CA 1.497 1.925 0 O-C-N 120.315 -1.491 . . . . 0.0 109.392 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.9 mtt180 -79.1 -37.82 37.74 Favored 'General case' 0 C--N 1.295 -1.798 0 C-N-CA 120.075 -0.65 . . . . 0.0 111.906 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.549 ' SD ' ' CD2' ' A' ' 26' ' ' LEU . 5.8 ptm -85.87 169.64 13.12 Favored 'General case' 0 N--CA 1.482 1.156 0 O-C-N 120.545 -1.347 . . . . 0.0 111.529 -179.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.547 ' O ' ' CD1' ' A' ' 34' ' ' ILE . 1.0 OUTLIER -89.67 -176.26 4.93 Favored 'General case' 0 N--CA 1.504 2.274 0 CA-C-O 122.534 1.159 . . . . 0.0 113.529 -178.238 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.598 ' O ' HG21 ' A' ' 35' ' ' ILE . 4.4 ptmt -68.14 -33.25 74.13 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.122 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.58 ' O ' ' CG2' ' A' ' 35' ' ' ILE . 3.2 mm100 -65.19 -55.26 19.57 Favored 'General case' 0 N--CA 1.525 3.297 0 CA-C-O 122.166 0.984 . . . . 0.0 109.753 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.532 ' OD1' ' HG3' ' A' ' 29' ' ' MET . 2.0 p30 -66.5 -39.36 88.66 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.904 -1.123 . . . . 0.0 108.967 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.583 ' CG2' ' HB3' ' A' ' 14' ' ' LEU . 1.7 mt -61.2 -40.83 87.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.194 -1.566 . . . . 0.0 109.281 177.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.598 HG21 ' O ' ' A' ' 31' ' ' LYS . 0.3 OUTLIER -66.79 -36.07 76.32 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.585 0 O-C-N 120.292 -1.505 . . . . 0.0 109.544 179.437 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.468 ' CD2' ' O ' ' A' ' 32' ' ' GLN . 21.6 m-85 -60.45 -43.63 96.66 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.813 -1.18 . . . . 0.0 108.78 179.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.514 ' CB ' ' CD2' ' A' ' 23' ' ' LEU . . . -65.44 -54.14 32.84 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.516 -1.365 . . . . 0.0 109.634 178.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.513 HG13 ' HA ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -53.76 -30.07 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 C-N-CA 117.541 -1.663 . . . . 0.0 109.743 179.57 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.527 HD22 ' CD1' ' A' ' 6' ' ' LEU . 34.2 mt -67.95 -42.53 80.8 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 119.865 -1.772 . . . . 0.0 109.224 178.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 mttt -66.0 -40.23 90.96 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.946 -1.096 . . . . 0.0 110.722 178.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.492 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 9.3 mm100 -73.51 -51.13 18.15 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.095 -1.003 . . . . 0.0 110.757 -179.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.452 ' CB ' ' HE3' ' A' ' 1' ' ' MET . 2.9 t-80 -62.51 -36.85 83.86 Favored 'General case' 0 N--CA 1.509 2.502 0 C-N-CA 118.885 -1.126 . . . . 0.0 108.739 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.61 ' O ' ' N ' ' A' ' 46' ' ' GLY . . . -67.01 -31.54 72.17 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.0 -1.063 . . . . 0.0 109.239 178.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.492 ' HB2' ' O ' ' A' ' 41' ' ' GLN . 9.0 tptt -47.54 -40.77 19.68 Favored 'General case' 0 N--CA 1.481 1.121 0 O-C-N 120.65 -1.281 . . . . 0.0 108.808 177.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 46.9 m -66.03 -11.07 45.65 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 119.452 -0.899 . . . . 0.0 109.056 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.61 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . 68.53 29.71 72.97 Favored Glycine 0 N--CA 1.496 2.642 0 C-N-CA 120.531 -0.842 . . . . 0.0 111.616 177.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.508 ' OE1' ' N ' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -88.82 169.17 11.83 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 120.105 -1.821 . . . . 0.0 108.788 178.921 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.508 ' N ' ' OE1' ' A' ' 47' ' ' GLU . 9.1 m-20 -71.66 151.08 43.98 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.024 -1.048 . . . . 0.0 111.226 -178.006 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.541 ' HA ' ' HA ' ' A' ' 1' ' ' MET . 0.5 OUTLIER -150.81 144.08 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 178.625 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.553 ' CE2' ' HB2' ' A' ' 2' ' ' ASN . 28.7 p90 -141.43 172.2 13.01 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 115.867 -2.333 . . . . 0.0 114.608 -177.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -124.77 166.71 17.33 Favored Glycine 0 N--CA 1.502 3.065 0 N-CA-C 108.762 -1.735 . . . . 0.0 108.762 -178.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.524 ' C ' ' CD2' ' A' ' 65' ' ' LEU . 3.0 p30 -172.28 163.48 5.74 Favored 'General case' 0 N--CA 1.485 1.281 0 O-C-N 120.346 -1.679 . . . . 0.0 110.065 -179.161 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 146.94 -139.66 8.1 Favored Glycine 0 N--CA 1.504 3.233 0 C-N-CA 118.146 -1.978 . . . . 0.0 110.986 178.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.509 ' HA ' ' O ' ' A' ' 95' ' ' ASP . 4.6 t -128.75 122.74 57.76 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.463 ' HB2' ' OD1' ' A' ' 95' ' ' ASP . 6.0 mt -62.9 161.24 13.17 Favored 'General case' 0 N--CA 1.502 2.17 0 C-N-CA 118.486 -1.286 . . . . 0.0 114.043 -175.099 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.466 ' HA ' ' OG1' ' A' ' 93' ' ' THR . 0.0 OUTLIER -137.7 116.24 12.06 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 177.998 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.588 ' CG1' ' HB ' ' A' ' 93' ' ' THR . 1.4 mm -84.14 159.74 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 CA-C-N 121.087 1.767 . . . . 0.0 109.616 -178.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.472 ' O ' ' C ' ' A' ' 59' ' ' GLN . 5.6 mp -130.1 135.76 48.58 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.443 -1.41 . . . . 0.0 109.602 179.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.472 ' C ' ' O ' ' A' ' 58' ' ' LEU . 0.8 OUTLIER -38.47 -35.15 0.16 Allowed 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.701 0.762 . . . . 0.0 109.909 -179.683 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.503 ' OD1' ' N ' ' A' ' 60' ' ' ASP . 1.0 OUTLIER -61.05 -7.66 2.72 Favored 'General case' 0 N--CA 1.499 2.012 0 C-N-CA 120.038 -0.665 . . . . 0.0 112.183 -179.531 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 90.64 8.6 65.46 Favored Glycine 1 N--CA 1.52 4.283 0 C-N-CA 118.845 -1.645 . . . . 0.0 112.184 178.146 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.525 ' CD1' ' N ' ' A' ' 63' ' ' GLY . 2.3 p90 -127.95 178.77 5.96 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 104.491 -2.411 . . . . 0.0 104.491 177.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.525 ' N ' ' CD1' ' A' ' 62' ' ' PHE . . . -155.49 172.67 33.65 Favored Glycine 0 N--CA 1.477 1.432 0 C-N-CA 117.142 -2.456 . . . . 0.0 111.63 -178.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.439 ' CE2' ' HE1' ' A' ' 62' ' ' PHE . 10.9 m-85 -128.88 154.78 46.16 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 119.851 1.826 . . . . 0.0 108.909 177.044 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.524 ' CD2' ' C ' ' A' ' 52' ' ' ASP . 0.2 OUTLIER -99.45 133.23 44.06 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 177.075 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.538 ' CB ' ' OD2' ' A' ' 78' ' ' ASP . 17.2 ptt180 -158.45 -148.34 0.19 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.544 -1.347 . . . . 0.0 110.065 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.497 1.912 0 O-C-N 121.384 -0.822 . . . . 0.0 110.235 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . 0.538 ' OD2' ' CB ' ' A' ' 66' ' ' ARG . 47.1 m-20 . . . . . 0 N--CA 1.513 2.713 0 CA-C-O 120.78 0.324 . . . . 0.0 111.073 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.522 ' HB ' ' CB ' ' A' ' 65' ' ' LEU . 5.5 mm -83.18 127.97 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.891 0 O-C-N 120.628 -1.295 . . . . 0.0 110.373 -178.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.48 ' HB3' ' HA ' ' A' ' 112' ' ' ALA . 8.6 t80 -74.62 145.4 43.31 Favored 'General case' 0 N--CA 1.515 2.807 0 CA-C-N 121.658 2.026 . . . . 0.0 109.81 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . 0.453 ' HB ' ' O ' ' A' ' 63' ' ' GLY . 17.2 t -138.34 112.44 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 120.26 -1.525 . . . . 0.0 110.57 -179.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.52 ' O ' HG13 ' A' ' 86' ' ' ILE . 49.9 m -75.28 164.6 60.01 Favored Pre-proline 0 N--CA 1.513 2.701 0 O-C-N 120.776 -1.203 . . . . 0.0 112.166 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.518 ' HD2' ' HB3' ' A' ' 82' ' ' SER . 39.8 Cg_endo -65.9 -50.05 1.87 Allowed 'Trans proline' 0 C--N 1.315 -1.21 0 O-C-N 124.443 1.759 . . . . 0.0 109.101 178.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.559 ' O ' ' CG ' ' A' ' 88' ' ' ARG . 0.5 OUTLIER -47.45 -40.28 17.75 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 178.156 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.513 ' HB2' ' O ' ' A' ' 82' ' ' SER . 6.4 mm100 -63.24 -57.21 11.21 Favored 'General case' 0 N--CA 1.511 2.582 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.52 HG13 ' O ' ' A' ' 82' ' ' SER . 0.6 OUTLIER -56.97 -54.95 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.42 0 O-C-N 120.891 -1.131 . . . . 0.0 108.792 178.649 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.408 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 6.8 mmt180 -57.67 -42.88 84.45 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-O 121.882 0.848 . . . . 0.0 111.568 -179.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.559 ' CG ' ' O ' ' A' ' 84' ' ' SER . 4.4 mtt180 -58.87 -36.02 73.95 Favored 'General case' 0 N--CA 1.506 2.329 0 C-N-CA 119.783 -0.767 . . . . 0.0 111.773 -177.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.585 ' CE2' HG22 ' A' ' 116' ' ' VAL . 18.7 m-85 -116.32 15.61 15.82 Favored 'General case' 0 N--CA 1.504 2.255 0 C-N-CA 117.268 -1.773 . . . . 0.0 111.755 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 57.84 56.12 4.97 Favored 'General case' 0 N--CA 1.482 1.159 0 O-C-N 120.339 -1.476 . . . . 0.0 109.193 178.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.515 ' CD2' ' HA ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -88.64 -178.78 5.89 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 119.852 -0.739 . . . . 0.0 109.601 -179.639 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.5 ' CG ' ' O ' ' A' ' 91' ' ' LEU . 68.5 mtt-85 -157.09 158.18 35.94 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.011 -1.056 . . . . 0.0 109.048 178.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.588 ' HB ' ' CG1' ' A' ' 57' ' ' ILE . 1.5 t -64.61 154.66 35.66 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 117.212 -1.795 . . . . 0.0 107.076 179.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 77.68 -11.18 20.76 Favored Glycine 0 N--CA 1.502 3.072 0 C-N-CA 116.961 -2.542 . . . . 0.0 110.442 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.551 ' OD2' ' CD1' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -74.45 156.79 36.59 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-N 120.097 1.948 . . . . 0.0 109.945 -179.192 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.496 ' O ' HG12 ' A' ' 97' ' ' ILE . 0.2 OUTLIER -97.34 127.12 43.03 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -179.201 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.551 ' CD1' ' OD2' ' A' ' 95' ' ' ASP . 1.9 mt -147.76 166.22 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 117.767 -1.573 . . . . 0.0 112.247 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.442 ' OG ' ' HB2' ' A' ' 118' ' ' GLU . 88.3 p -148.51 136.82 21.2 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.06 179.056 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . 0.495 ' O ' ' HB2' ' A' ' 50' ' ' PHE . . . -162.18 179.64 37.39 Favored Glycine 0 N--CA 1.505 3.257 0 C-N-CA 117.183 -2.437 . . . . 0.0 114.853 -178.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.6 mttt -88.77 151.68 22.25 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 178.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.48 HG12 ' HA ' ' A' ' 50' ' ' PHE . 2.6 pt -121.66 157.05 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.627 0 CA-C-N 121.514 1.961 . . . . 0.0 114.026 -176.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . 0.537 ' NE ' HD23 ' A' ' 114' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.422 0 O-C-N 120.523 -1.361 . . . . 0.0 109.397 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.502 2.133 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.412 ' CD2' ' HZ ' ' A' ' 64' ' ' PHE . 17.5 m-85 -106.62 152.52 23.64 Favored 'General case' 0 N--CA 1.522 3.168 0 O-C-N 119.967 -1.708 . . . . 0.0 109.422 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . 0.465 ' O ' ' HB3' ' A' ' 80' ' ' TYR . 11.6 m-85 -68.05 166.4 16.02 Favored 'General case' 0 N--CA 1.506 2.365 0 O-C-N 119.729 -1.857 . . . . 0.0 108.065 178.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.48 ' HA ' ' HB3' ' A' ' 80' ' ' TYR . . . -123.61 155.5 37.56 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.055 -1.653 . . . . 0.0 111.054 -179.08 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.02 153.99 40.7 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 106.287 -1.746 . . . . 0.0 106.287 178.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . 0.537 HD23 ' NE ' ' A' ' 102' ' ' ARG . 3.0 tp -130.99 -63.19 0.87 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.066 -1.646 . . . . 0.0 111.727 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.35 147.15 40.83 Favored 'General case' 0 N--CA 1.51 2.545 0 O-C-N 120.289 -1.507 . . . . 0.0 109.666 178.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.585 HG22 ' CE2' ' A' ' 89' ' ' PHE . 24.8 t -94.1 130.94 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.987 0 O-C-N 121.021 -1.049 . . . . 0.0 112.772 -179.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -107.33 -39.7 5.6 Favored 'General case' 0 N--CA 1.509 2.509 0 O-C-N 121.504 -0.747 . . . . 0.0 109.856 177.747 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.495 ' C ' ' CG2' ' A' ' 119' ' ' VAL . 1.3 tt0 -143.4 159.05 43.09 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.651 -1.281 . . . . 0.0 109.115 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.495 ' CG2' ' C ' ' A' ' 118' ' ' GLU . 17.9 t -156.84 143.06 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -178.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.469 ' C ' ' O ' ' A' ' 119' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.515 2.812 0 O-C-N 121.0 -1.062 . . . . 0.0 110.88 -177.581 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.579 ' HE2' ' CG ' ' A' ' 42' ' ' HIS . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 110.027 -0.361 . . . . 0.0 110.027 . . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' ASN . . . . . 0.584 ' HB3' ' HB3' ' A' ' 5' ' ' GLU . 47.5 t30 -78.75 92.73 4.83 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.802 -1.186 . . . . 0.0 108.42 178.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' LEU . . . . . 0.518 HD21 ' CD1' ' A' ' 79' ' ' ILE . 0.1 OUTLIER -42.55 -43.39 3.72 Favored 'General case' 0 N--CA 1.515 2.779 0 O-C-N 120.607 -1.308 . . . . 0.0 110.472 -178.594 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.5 ' OG1' ' OD1' ' A' ' 52' ' ' ASP . 1.9 m -57.29 -34.54 68.79 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.775 -1.203 . . . . 0.0 108.149 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . 0.584 ' HB3' ' HB3' ' A' ' 2' ' ' ASN . 0.0 OUTLIER -70.83 -44.35 66.69 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 177.498 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' LEU . . . . . 0.543 ' N ' ' HG3' ' A' ' 5' ' ' GLU 0.277 15.6 mt -52.33 -49.43 64.28 Favored 'General case' 0 C--N 1.316 -0.88 0 O-C-N 120.748 -1.22 . . . . 0.0 109.613 178.088 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 9.8 mttt -65.37 -37.66 87.69 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.08 -1.012 . . . . 0.0 110.589 179.192 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -63.01 -18.66 63.56 Favored 'General case' 0 N--CA 1.507 2.387 0 O-C-N 121.119 -0.988 . . . . 0.0 111.182 -179.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . 0.558 ' HB ' ' CD2' ' A' ' 14' ' ' LEU . 2.2 m -86.56 116.32 65.48 Favored Pre-proline 0 C--N 1.284 -2.249 0 O-C-N 121.761 -0.587 . . . . 0.0 109.642 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . 0.528 ' CG ' ' HG3' ' A' ' 13' ' ' GLU . 37.0 Cg_endo -58.51 155.1 38.04 Favored 'Trans proline' 0 CA--C 1.557 1.657 0 N-CA-C 109.288 -1.082 . . . . 0.0 109.288 179.127 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . 0.516 ' CG1' ' N ' ' A' ' 12' ' ' SER . 1.5 p -41.54 -50.11 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.532 3.657 0 O-C-N 120.173 -1.58 . . . . 0.0 110.463 -177.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.516 ' N ' ' CG1' ' A' ' 11' ' ' VAL . 1.9 t -58.96 -42.15 89.19 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.188 -0.945 . . . . 0.0 111.156 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLU . . . . . 0.538 ' HB3' ' CG2' ' A' ' 9' ' ' THR . 2.2 mm-40 -69.13 -27.79 65.88 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 118.15 -1.42 . . . . 0.0 108.336 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.558 ' CD2' ' HB ' ' A' ' 9' ' ' THR . 9.8 mt -71.56 -40.66 69.83 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 120.917 -1.114 . . . . 0.0 108.765 176.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' ILE . . . . . 0.496 ' CD1' HD12 ' A' ' 34' ' ' ILE . 1.4 mp -68.05 -40.49 83.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 C-N-CA 117.543 -1.663 . . . . 0.0 108.945 178.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' THR . . . . . 0.523 ' HA ' ' HG2' ' A' ' 19' ' ' GLU . 85.0 m -65.42 -37.22 86.27 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.272 -1.517 . . . . 0.0 109.413 179.334 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LEU . . . . . 0.473 ' O ' ' HG3' ' A' ' 21' ' ' MET . 1.3 tp -63.16 -45.04 93.71 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 120.912 -1.117 . . . . 0.0 108.048 178.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' GLY . . . . . 0.465 ' HA2' HD11 ' A' ' 23' ' ' LEU . . . -60.94 -43.72 99.03 Favored Glycine 0 N--CA 1.514 3.882 0 N-CA-C 108.288 -1.925 . . . . 0.0 108.288 179.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLU . . . . . 0.681 ' HG3' ' N ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -57.71 -38.73 75.74 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.582 -1.54 . . . . 0.0 107.845 178.904 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASN . . . . . 0.681 ' N ' ' HG3' ' A' ' 19' ' ' GLU . 28.7 m120 -61.1 -27.4 68.34 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 118.538 -1.265 . . . . 0.0 109.341 178.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.584 ' HE2' ' CD2' ' A' ' 42' ' ' HIS . 31.4 mtp -101.44 11.3 39.36 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.339 -0.851 . . . . 0.0 111.348 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.86 -22.75 35.97 Favored Glycine 0 N--CA 1.5 2.92 0 C-N-CA 118.547 -1.787 . . . . 0.0 111.143 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' LEU . . . . . 0.591 ' O ' ' CD1' ' A' ' 26' ' ' LEU . 3.0 mp -78.91 94.67 5.26 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 120.372 -1.663 . . . . 0.0 109.225 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLU . . . . . 0.519 ' O ' ' CB ' ' A' ' 25' ' ' ASN . 87.0 mt-10 -111.7 170.38 8.17 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.204 -0.935 . . . . 0.0 109.035 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.519 ' CB ' ' O ' ' A' ' 24' ' ' GLU . 0.9 OUTLIER 70.79 17.35 6.48 Favored 'General case' 0 N--CA 1.512 2.671 0 O-C-N 121.404 -0.81 . . . . 0.0 111.796 179.485 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.591 ' CD1' ' O ' ' A' ' 23' ' ' LEU . 1.1 mt -76.9 -6.05 50.92 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 120.841 -1.162 . . . . 0.0 111.372 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 26' ' ' LEU . . . -46.59 -31.21 2.68 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.477 -1.389 . . . . 0.0 108.81 -179.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 52.1 mtp180 -80.12 -6.57 57.93 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 120.047 -0.661 . . . . 0.0 111.386 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' MET . . . . . 0.468 ' C ' HD13 ' A' ' 34' ' ' ILE . 14.8 mtp -101.01 158.67 15.83 Favored 'General case' 0 C--N 1.313 -0.999 0 O-C-N 120.768 -1.208 . . . . 0.0 111.473 -179.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ARG . . . . . 0.499 ' O ' HD13 ' A' ' 34' ' ' ILE . 4.4 ttm180 -89.65 171.99 9.27 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.374 -0.829 . . . . 0.0 110.166 177.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LYS . . . . . 0.571 ' O ' ' CG1' ' A' ' 35' ' ' ILE . 11.0 pttm -60.5 -42.49 96.45 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.43 -0.794 . . . . 0.0 110.547 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLN . . . . . 0.497 ' OE1' ' HB3' ' A' ' 33' ' ' ASP . 0.0 OUTLIER -60.55 -56.45 21.21 Favored 'General case' 0 N--CA 1.517 2.918 0 O-C-N 121.306 -0.871 . . . . 0.0 111.632 -178.166 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 34' ' ' ILE . 2.1 p30 -65.74 -36.29 83.17 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.802 -1.186 . . . . 0.0 109.166 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ILE . . . . . 0.525 ' N ' ' OD1' ' A' ' 33' ' ' ASP . 2.0 mt -60.78 -38.49 79.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 O-C-N 120.348 -1.47 . . . . 0.0 107.569 177.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ILE . . . . . 0.571 ' CG1' ' O ' ' A' ' 31' ' ' LYS . 0.8 OUTLIER -59.3 -50.2 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.319 0 O-C-N 120.291 -1.506 . . . . 0.0 109.562 177.665 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -51.29 -41.6 60.57 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.514 -0.874 . . . . 0.0 109.154 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ALA . . . . . 0.491 ' CB ' HD21 ' A' ' 23' ' ' LEU . . . -63.49 -53.24 55.14 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.689 -1.257 . . . . 0.0 109.108 178.101 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 34' ' ' ILE . 0.2 OUTLIER -55.51 -27.45 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 C-N-CA 117.451 -1.7 . . . . 0.0 109.705 179.549 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' LEU . . . . . 0.478 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 23.7 mt -71.34 -42.33 68.67 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.129 -1.607 . . . . 0.0 109.115 177.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.2 mttt -64.11 -40.21 95.71 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.936 -1.103 . . . . 0.0 110.313 178.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLN . . . . . 0.519 ' HG2' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -75.96 -53.12 8.88 Favored 'General case' 0 N--CA 1.508 2.425 0 O-C-N 121.033 -1.042 . . . . 0.0 111.125 -179.261 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' HIS . . . . . 0.584 ' CD2' ' HE2' ' A' ' 21' ' ' MET . 1.4 t-80 -61.24 -35.18 76.53 Favored 'General case' 0 N--CA 1.513 2.72 0 O-C-N 121.229 -0.919 . . . . 0.0 109.192 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ALA . . . . . 0.544 ' O ' ' N ' ' A' ' 46' ' ' GLY . . . -81.15 -32.08 33.84 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.306 -0.871 . . . . 0.0 110.961 179.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . 0.596 ' HD3' ' N ' ' A' ' 45' ' ' SER 0.254 0.0 OUTLIER -49.08 -50.37 37.11 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.333 -1.48 . . . . 0.0 107.782 178.089 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' SER . . . . . 0.596 ' N ' ' HD3' ' A' ' 44' ' ' LYS . 72.5 m -65.61 -9.37 26.36 Favored 'General case' 0 C--N 1.287 -2.149 0 CA-C-N 114.57 -1.195 . . . . 0.0 109.302 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . 64.46 32.14 83.22 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 178.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . 0.52 ' CD ' ' ND1' ' A' ' 42' ' ' HIS . 9.8 pt-20 -87.19 166.85 14.64 Favored 'General case' 0 C--N 1.309 -1.183 0 O-C-N 120.46 -1.612 . . . . 0.0 109.2 179.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' ASP . . . . . 0.403 ' O ' HG21 ' A' ' 49' ' ' ILE . 1.2 m-20 -55.11 135.98 48.67 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.067 -1.021 . . . . 0.0 111.914 -177.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.51 ' HA ' ' HA ' ' A' ' 1' ' ' MET . 4.5 pt -146.57 137.8 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 178.14 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PHE . . . . . 0.569 ' CD1' ' N ' ' A' ' 50' ' ' PHE . 16.7 p90 -144.07 164.09 31.65 Favored 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 115.55 -2.46 . . . . 0.0 115.655 -178.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -119.19 166.17 13.15 Favored Glycine 0 N--CA 1.5 2.936 0 N-CA-C 107.425 -2.27 . . . . 0.0 107.425 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.5 ' OD1' ' OG1' ' A' ' 4' ' ' THR . 5.9 p-10 -171.88 167.98 6.13 Favored 'General case' 0 N--CA 1.482 1.156 0 O-C-N 120.132 -1.805 . . . . 0.0 109.617 -178.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' GLY . . . . . 0.453 ' N ' HD22 ' A' ' 65' ' ' LEU . . . 142.3 -137.18 7.68 Favored Glycine 0 N--CA 1.504 3.184 0 C-N-CA 118.247 -1.93 . . . . 0.0 110.741 178.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' A' ' 95' ' ' ASP . 3.3 t -128.28 120.62 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 O-C-N 121.382 -1.07 . . . . 0.0 108.419 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.5 mt -62.73 162.38 10.91 Favored 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 -175.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLU . . . . . 0.458 ' HA ' ' OG1' ' A' ' 93' ' ' THR . 1.4 tt0 -137.99 120.4 15.95 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 177.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ILE . . . . . 0.585 ' CG1' ' HB ' ' A' ' 93' ' ' THR . 1.2 mm -82.48 161.53 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 119.863 -1.773 . . . . 0.0 109.177 -179.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' LEU . . . . . 0.637 ' CD2' ' CZ ' ' A' ' 62' ' ' PHE . 7.1 mp -130.86 137.06 49.19 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.347 -1.47 . . . . 0.0 109.701 179.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLN . . . . . 0.463 ' C ' ' O ' ' A' ' 58' ' ' LEU . 1.4 tt0 -39.49 -36.54 0.39 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.525 -0.734 . . . . 0.0 110.006 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASP . . . . . 0.516 ' HB2' ' CD2' ' A' ' 62' ' ' PHE . 30.5 m-20 -61.4 -5.69 1.85 Allowed 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.676 -0.64 . . . . 0.0 112.574 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLY . . . . . 0.462 ' O ' ' HB3' ' A' ' 83' ' ' PRO . . . 88.25 11.37 67.07 Favored Glycine 1 N--CA 1.519 4.181 0 C-N-CA 118.601 -1.761 . . . . 0.0 111.954 178.307 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' PHE . . . . . 0.637 ' CZ ' ' CD2' ' A' ' 58' ' ' LEU . 4.0 p90 -127.94 -179.17 4.83 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 104.341 -2.466 . . . . 0.0 104.341 177.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' GLY . . . . . 0.481 ' HA2' HD11 ' A' ' 58' ' ' LEU . . . -156.07 168.08 33.43 Favored Glycine 0 N--CA 1.474 1.176 0 C-N-CA 117.181 -2.438 . . . . 0.0 111.577 -177.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PHE . . . . . 0.424 ' CD1' ' HE1' ' A' ' 62' ' ' PHE . 2.6 m-85 -129.07 151.18 50.04 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 119.926 1.863 . . . . 0.0 109.26 177.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . 0.498 ' HB3' ' HB ' ' A' ' 79' ' ' ILE . 0.3 OUTLIER -98.68 153.9 18.37 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 176.707 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.487 ' HB3' ' O ' ' A' ' 65' ' ' LEU . 0.5 OUTLIER 178.08 -151.71 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.246 -0.909 . . . . 0.0 109.657 179.364 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.6 m . . . . . 0 N--CA 1.5 2.047 0 O-C-N 121.383 -0.823 . . . . 0.0 110.64 -179.842 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 27.6 m-20 . . . . . 0 N--CA 1.505 2.28 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.518 ' CD1' HD21 ' A' ' 3' ' ' LEU . 2.1 mp -142.34 136.51 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.629 0 C-N-CA 119.241 -0.983 . . . . 0.0 109.928 178.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.497 ' HB3' ' HA ' ' A' ' 112' ' ' ALA . 12.2 t80 -78.11 147.46 34.64 Favored 'General case' 0 N--CA 1.52 3.049 0 O-C-N 119.635 -1.916 . . . . 0.0 110.014 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 39.8 t -143.36 115.89 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 120.157 -1.589 . . . . 0.0 110.505 -179.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' SER . . . . . 0.515 ' O ' HG13 ' A' ' 86' ' ' ILE . 68.0 m -74.65 163.42 68.39 Favored Pre-proline 0 N--CA 1.514 2.737 0 O-C-N 120.5 -1.375 . . . . 0.0 112.688 -179.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' PRO . . . . . 0.558 ' HA ' HG13 ' A' ' 86' ' ' ILE . 39.4 Cg_endo -65.33 -51.7 1.39 Allowed 'Trans proline' 0 C--N 1.315 -1.215 0 O-C-N 124.779 1.936 . . . . 0.0 108.571 178.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' SER . . . . . 0.537 ' O ' ' CG ' ' A' ' 88' ' ' ARG . 57.1 p -47.3 -39.94 15.77 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 177.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.51 ' HB2' ' O ' ' A' ' 82' ' ' SER . 4.9 mm-40 -62.38 -60.03 4.14 Favored 'General case' 0 N--CA 1.509 2.49 0 C-N-CA 119.089 -1.044 . . . . 0.0 108.225 178.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' ILE . . . . . 0.558 HG13 ' HA ' ' A' ' 83' ' ' PRO . 0.2 OUTLIER -55.42 -55.04 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.305 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.512 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ARG . . . . . 0.491 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 0.0 OUTLIER -57.39 -42.59 82.51 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-O 121.811 0.815 . . . . 0.0 111.238 -179.49 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . 0.537 ' CG ' ' O ' ' A' ' 84' ' ' SER . 10.8 mmm180 -59.4 -38.03 79.52 Favored 'General case' 0 N--CA 1.505 2.322 0 C-N-CA 119.84 -0.744 . . . . 0.0 111.816 -177.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . 0.57 ' HB2' ' CD2' ' A' ' 91' ' ' LEU . 9.1 m-85 -110.16 12.41 23.44 Favored 'General case' 0 N--CA 1.505 2.315 0 C-N-CA 116.976 -1.89 . . . . 0.0 111.359 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . 0.408 ' CB ' ' O ' ' A' ' 89' ' ' PHE . 0.1 OUTLIER 62.24 53.43 2.87 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 120.523 -1.36 . . . . 0.0 110.64 178.336 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' LEU . . . . . 0.57 ' CD2' ' HB2' ' A' ' 89' ' ' PHE . 2.8 mt -89.61 -169.45 2.48 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 119.199 -1.001 . . . . 0.0 110.043 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ARG . . . . . 0.532 ' CG ' ' O ' ' A' ' 91' ' ' LEU . 53.0 mtp180 -159.92 162.38 34.47 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.542 -0.724 . . . . 0.0 109.083 178.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' THR . . . . . 0.585 ' HB ' ' CG1' ' A' ' 57' ' ' ILE . 1.6 t -65.25 156.55 31.56 Favored 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 116.993 -1.883 . . . . 0.0 106.672 178.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' GLY . . . . . 0.449 ' C ' HG11 ' A' ' 54' ' ' VAL . . . 76.12 -10.3 15.77 Favored Glycine 0 N--CA 1.505 3.284 0 C-N-CA 116.954 -2.546 . . . . 0.0 110.191 179.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.505 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 7.7 m-20 -66.65 147.38 53.35 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.184 -1.774 . . . . 0.0 110.864 -178.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' THR . . . . . 0.472 ' O ' HG12 ' A' ' 97' ' ' ILE . 0.3 OUTLIER -90.52 120.36 31.55 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.193 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' ILE . . . . . 0.515 HG21 HG21 ' A' ' 119' ' ' VAL . 1.4 mt -144.11 167.84 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 119.778 -1.826 . . . . 0.0 112.929 -178.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' SER . . . . . 0.49 ' OG ' ' CB ' ' A' ' 118' ' ' GLU . 94.5 p -150.14 138.51 20.51 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.445 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -164.29 179.26 39.22 Favored Glycine 0 N--CA 1.506 3.319 0 C-N-CA 117.037 -2.506 . . . . 0.0 115.16 -179.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.9 mmtt -88.21 148.87 24.16 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.3 pt -124.59 153.54 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.706 0 CA-C-N 121.25 1.841 . . . . 0.0 113.566 -176.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.744 0 O-C-N 120.372 -1.455 . . . . 0.0 109.875 179.013 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.501 2.083 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -107.42 147.22 30.69 Favored 'General case' 0 N--CA 1.518 2.945 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 176.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -68.36 161.66 26.99 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 119.237 -2.165 . . . . 0.0 108.062 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' ALA . . . . . 0.497 ' HA ' ' HB3' ' A' ' 80' ' ' TYR . . . -122.18 154.74 37.05 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 119.979 -1.701 . . . . 0.0 110.049 -179.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . 0.424 HD22 ' CD ' ' A' ' 85' ' ' GLN . 3.0 tp -62.84 145.2 55.6 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 11.5 tp -123.45 -55.36 1.74 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.45 -1.406 . . . . 0.0 112.179 -178.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 8.0 tptp -127.68 144.28 51.09 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 120.318 -1.488 . . . . 0.0 108.84 179.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.507 HG23 ' CD2' ' A' ' 89' ' ' PHE . 33.7 t -93.08 129.89 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.901 0 O-C-N 120.707 -1.246 . . . . 0.0 111.458 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -107.69 -38.74 5.79 Favored 'General case' 0 N--CA 1.508 2.451 0 O-C-N 121.257 -0.902 . . . . 0.0 110.053 178.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' GLU . . . . . 0.49 ' CB ' ' OG ' ' A' ' 98' ' ' SER . 7.0 tt0 -143.24 157.92 44.07 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 120.948 -1.095 . . . . 0.0 109.619 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' VAL . . . . . 0.515 HG21 HG21 ' A' ' 97' ' ' ILE . 33.7 t -159.62 131.62 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -178.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.52 3.039 0 O-C-N 120.329 -1.482 . . . . 0.0 111.779 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.526 ' CA ' ' HA ' ' A' ' 49' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.661 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.58 ' HB2' ' CE2' ' A' ' 50' ' ' PHE 0.25 4.2 t30 -78.38 116.74 19.01 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 120.555 -1.34 . . . . 0.0 109.402 -179.827 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.483 HD12 HD11 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -49.68 -46.54 49.96 Favored 'General case' 0 N--CA 1.517 2.915 0 O-C-N 120.157 -1.59 . . . . 0.0 110.352 -178.934 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.8 m -56.35 -34.92 67.06 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.742 -1.224 . . . . 0.0 108.186 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.5 ' HB3' ' HB3' ' A' ' 2' ' ' ASN . 0.0 OUTLIER -66.99 -45.7 76.83 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 177.73 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.522 HD12 ' CD1' ' A' ' 39' ' ' LEU 0.274 68.5 mt -53.3 -51.4 62.44 Favored 'General case' 0 C--N 1.313 -0.981 0 O-C-N 120.626 -1.296 . . . . 0.0 109.078 177.738 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.26 -33.61 69.57 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.044 -1.035 . . . . 0.0 109.726 178.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.497 ' HB2' ' O ' ' A' ' 5' ' ' GLU . 4.8 m-80 -61.42 -16.54 47.7 Favored 'General case' 0 N--CA 1.504 2.263 0 C-N-CA 119.013 -1.075 . . . . 0.0 110.357 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.536 ' HB ' ' CD2' ' A' ' 14' ' ' LEU . 2.6 m -89.48 121.32 69.37 Favored Pre-proline 0 N--CA 1.502 2.153 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.513 ' HG2' ' CG ' ' A' ' 13' ' ' GLU . 37.1 Cg_endo -57.79 151.3 57.07 Favored 'Trans proline' 0 CA--C 1.562 1.922 0 N-CA-C 109.971 -0.819 . . . . 0.0 109.971 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.506 HG11 ' N ' ' A' ' 12' ' ' SER . 1.6 p -41.85 -49.21 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.529 3.475 0 O-C-N 120.303 -1.498 . . . . 0.0 110.252 -178.071 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.506 ' N ' HG11 ' A' ' 11' ' ' VAL . 1.8 t -58.32 -41.97 85.69 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.314 -0.866 . . . . 0.0 111.161 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.531 ' HB3' ' CG2' ' A' ' 9' ' ' THR . 0.2 OUTLIER -68.97 -30.52 68.97 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 118.237 -1.385 . . . . 0.0 108.21 -179.964 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.536 ' CD2' ' HB ' ' A' ' 9' ' ' THR . 9.3 mt -68.76 -41.2 79.19 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 120.883 -1.136 . . . . 0.0 108.813 176.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.494 ' CG1' ' HB3' ' A' ' 26' ' ' LEU . 1.2 mp -66.68 -40.33 85.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 C-N-CA 117.892 -1.523 . . . . 0.0 108.678 178.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.488 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 84.8 m -64.25 -35.52 81.11 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.36 -1.462 . . . . 0.0 108.963 179.088 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.489 ' HA ' ' OD1' ' A' ' 20' ' ' ASN . 35.5 tp -64.99 -43.85 91.23 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 120.934 -1.104 . . . . 0.0 108.237 178.365 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.553 ' HA2' ' OE1' ' A' ' 41' ' ' GLN . . . -61.69 -43.56 99.09 Favored Glycine 1 N--CA 1.518 4.11 0 N-CA-C 108.15 -1.98 . . . . 0.0 108.15 178.43 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.459 ' OE2' ' HG2' ' A' ' 24' ' ' GLU . 1.0 OUTLIER -53.75 -44.3 69.86 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.999 -1.295 . . . . 0.0 107.517 178.188 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.489 ' OD1' ' HA ' ' A' ' 17' ' ' LEU . 27.7 m120 -59.57 -26.97 65.84 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 118.679 -1.208 . . . . 0.0 109.465 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.567 ' HE1' ' CD2' ' A' ' 42' ' ' HIS . 37.7 mmm -97.65 9.86 41.44 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.27 -0.894 . . . . 0.0 110.438 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 99.7 -18.23 56.37 Favored Glycine 0 N--CA 1.501 2.992 0 C-N-CA 118.802 -1.666 . . . . 0.0 111.352 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.558 ' O ' ' CD1' ' A' ' 26' ' ' LEU . 5.4 mp -79.56 94.91 5.72 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 120.359 -1.671 . . . . 0.0 109.753 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.511 ' O ' ' CB ' ' A' ' 25' ' ' ASN . 46.6 mt-10 -103.67 170.57 7.86 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.231 -0.918 . . . . 0.0 109.179 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.511 ' CB ' ' O ' ' A' ' 24' ' ' GLU . 1.3 t-20 70.37 18.15 6.79 Favored 'General case' 0 N--CA 1.511 2.578 0 O-C-N 121.528 -0.733 . . . . 0.0 111.785 179.33 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.558 ' CD1' ' O ' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -76.42 -8.66 57.61 Favored 'General case' 0 N--CA 1.505 2.304 0 O-C-N 120.983 -1.073 . . . . 0.0 111.419 -179.798 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 26' ' ' LEU . . . -46.85 -32.74 3.94 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.461 -1.399 . . . . 0.0 108.847 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.415 ' NH2' ' HB3' ' A' ' 25' ' ' ASN . 11.9 ptt180 -80.96 0.85 33.66 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 120.193 -0.603 . . . . 0.0 111.363 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.518 ' CE ' ' OD1' ' A' ' 33' ' ' ASP . 7.1 mtp -100.79 149.13 24.15 Favored 'General case' 0 C--N 1.314 -0.976 0 O-C-N 120.837 -1.165 . . . . 0.0 111.864 -178.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.469 ' HB2' ' OD2' ' A' ' 33' ' ' ASP . 2.4 mtt85 -89.12 142.13 27.91 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.449 -0.782 . . . . 0.0 110.772 178.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.566 ' O ' HG13 ' A' ' 35' ' ' ILE . 12.1 ptpt -35.91 -34.54 0.05 Allowed 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.707 -0.621 . . . . 0.0 111.582 179.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.464 ' OE1' ' HG3' ' A' ' 31' ' ' LYS . 1.6 mm100 -63.78 -59.84 4.05 Favored 'General case' 0 N--CA 1.517 2.91 0 O-C-N 120.568 -1.332 . . . . 0.0 109.869 -179.105 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.542 ' OD1' ' N ' ' A' ' 34' ' ' ILE . 2.5 p30 -66.11 -37.61 86.16 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.586 -0.696 . . . . 0.0 110.162 -178.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.542 ' N ' ' OD1' ' A' ' 33' ' ' ASP . 3.3 mt -61.15 -41.46 89.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 O-C-N 120.267 -1.521 . . . . 0.0 108.071 178.12 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.566 HG13 ' O ' ' A' ' 31' ' ' LYS . 96.8 mt -60.93 -48.48 88.8 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.778 0 O-C-N 120.057 -1.652 . . . . 0.0 109.443 177.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -52.7 -41.7 64.13 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 107.859 -1.164 . . . . 0.0 107.859 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -62.34 -55.55 26.94 Favored 'General case' 0 C--O 1.2 -1.506 0 O-C-N 120.911 -1.118 . . . . 0.0 108.456 177.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.542 ' HA ' ' CD ' ' A' ' 41' ' ' GLN . 0.4 OUTLIER -51.22 -27.86 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 C-N-CA 117.301 -1.76 . . . . 0.0 110.358 179.853 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.522 ' CD1' HD12 ' A' ' 6' ' ' LEU . 3.1 mp -71.59 -45.55 61.87 Favored 'General case' 0 N--CA 1.509 2.5 0 C-N-CA 117.762 -1.575 . . . . 0.0 109.551 178.238 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.515 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 1.2 mtpp -65.83 -40.86 92.18 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.191 -0.943 . . . . 0.0 111.377 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.565 ' HG2' ' N ' ' A' ' 42' ' ' HIS . 0.0 OUTLIER -79.07 -41.58 28.43 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.962 -1.086 . . . . 0.0 111.512 -178.605 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.567 ' CD2' ' HE1' ' A' ' 21' ' ' MET . 1.3 m-70 -69.77 -33.94 73.08 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 117.187 -1.805 . . . . 0.0 107.957 178.79 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.474 ' O ' ' N ' ' A' ' 46' ' ' GLY . . . -67.03 -51.66 52.03 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 120.641 -1.287 . . . . 0.0 107.842 177.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.515 ' HB2' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -49.31 -46.32 46.46 Favored 'General case' 0 N--CA 1.482 1.153 0 O-C-N 121.081 -1.012 . . . . 0.0 108.998 177.935 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 65.9 m -66.63 -6.35 15.04 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 120.039 -0.664 . . . . 0.0 109.797 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . 90.62 7.94 66.24 Favored Glycine 0 N--CA 1.496 2.678 0 C-N-CA 119.883 -1.151 . . . . 0.0 113.328 177.662 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -79.03 159.14 27.72 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 120.754 2.277 . . . . 0.0 108.781 179.162 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -88.64 150.36 23.06 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.899 -1.125 . . . . 0.0 110.038 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.534 HG13 HG13 ' A' ' 101' ' ' ILE . 0.7 OUTLIER -135.12 133.52 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 120.805 -1.185 . . . . 0.0 107.95 179.052 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.58 ' CE2' ' HB2' ' A' ' 2' ' ' ASN . 8.2 p90 -140.5 166.87 23.54 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 116.558 -2.057 . . . . 0.0 114.255 -178.587 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -122.13 170.67 15.1 Favored Glycine 0 N--CA 1.5 2.953 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -177.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.429 ' C ' ' CD2' ' A' ' 65' ' ' LEU . 2.7 p30 -170.04 163.94 9.35 Favored 'General case' 0 N--CA 1.482 1.155 0 O-C-N 120.681 -1.482 . . . . 0.0 110.138 -179.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 145.32 -140.25 8.91 Favored Glycine 0 N--CA 1.506 3.328 0 C-N-CA 118.356 -1.878 . . . . 0.0 110.962 178.611 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.508 ' HA ' ' O ' ' A' ' 95' ' ' ASP . 3.0 t -128.2 121.08 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.5 mt -62.79 163.91 8.68 Favored 'General case' 0 N--CA 1.505 2.277 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -175.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.469 ' HA ' ' OG1' ' A' ' 93' ' ' THR . 73.0 mm-40 -137.92 117.98 13.45 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 177.764 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.592 ' CG1' ' HB ' ' A' ' 93' ' ' THR . 1.3 mm -85.13 162.11 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 CA-C-N 121.001 1.728 . . . . 0.0 110.545 -178.043 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.575 HD21 ' CE1' ' A' ' 62' ' ' PHE . 5.1 mp -129.16 136.0 49.59 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.682 -1.261 . . . . 0.0 108.941 178.503 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.45 ' C ' ' O ' ' A' ' 58' ' ' LEU . 1.1 mt-30 -41.25 -34.01 0.44 Allowed 'General case' 0 N--CA 1.501 2.092 0 CA-C-O 121.972 0.892 . . . . 0.0 109.301 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -60.99 -7.82 2.75 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 119.928 -0.709 . . . . 0.0 112.247 -179.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.501 ' O ' ' HB3' ' A' ' 83' ' ' PRO . . . 93.55 4.35 64.03 Favored Glycine 1 N--CA 1.517 4.08 0 C-N-CA 118.817 -1.659 . . . . 0.0 112.43 177.758 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.575 ' CE1' HD21 ' A' ' 58' ' ' LEU . 5.0 p90 -127.66 179.92 5.27 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 104.808 -2.293 . . . . 0.0 104.808 178.131 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -161.05 176.82 37.6 Favored Glycine 0 N--CA 1.476 1.343 0 C-N-CA 117.187 -2.435 . . . . 0.0 111.486 -177.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.442 ' CE2' ' HE2' ' A' ' 62' ' ' PHE . 23.2 m-85 -129.53 152.47 49.02 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 119.968 1.884 . . . . 0.0 109.689 177.476 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.479 ' HB3' ' HB ' ' A' ' 79' ' ' ILE . 0.5 OUTLIER -97.72 156.28 16.63 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 176.542 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.476 ' HB3' ' O ' ' A' ' 65' ' ' LEU . 1.1 ptp85 177.12 -154.21 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.96 -1.087 . . . . 0.0 109.999 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.2 -148.9 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.247 -0.908 . . . . 0.0 110.888 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -114.0 -18.25 11.77 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.553 -0.717 . . . . 0.0 111.581 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -65.64 -162.18 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.128 0 O-C-N 120.655 -1.278 . . . . 0.0 108.729 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.562 ' O ' ' CB ' ' A' ' 71' ' ' SER . 0.2 OUTLIER -126.74 -74.58 0.59 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 119.86 -1.775 . . . . 0.0 110.689 -179.788 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.62 ' O ' ' HB2' ' A' ' 72' ' ' TYR . 0.1 OUTLIER 78.2 -10.93 1.27 Allowed 'General case' 0 N--CA 1.52 3.062 0 O-C-N 121.778 -0.576 . . . . 0.0 110.51 -179.208 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.62 ' HB2' ' O ' ' A' ' 71' ' ' SER . 93.2 m-85 75.38 -45.06 0.54 Allowed 'General case' 0 N--CA 1.523 3.211 0 O-C-N 122.106 -0.372 . . . . 0.0 111.511 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 34.6 mt -99.01 -179.94 4.42 Favored 'General case' 0 C--N 1.309 -1.191 0 O-C-N 120.556 -1.34 . . . . 0.0 109.991 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.68 -148.63 0.06 Allowed 'General case' 0 C--N 1.291 -1.941 0 CA-C-O 122.386 1.089 . . . . 0.0 109.394 178.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.431 ' N ' ' OD2' ' A' ' 78' ' ' ASP . . . -158.2 157.73 28.56 Favored Glycine 0 C--N 1.279 -2.635 0 N-CA-C 107.054 -2.418 . . . . 0.0 107.054 178.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -65.51 -43.91 9.57 Favored 'Trans proline' 0 N--CA 1.488 1.17 0 CA-C-N 118.592 1.196 . . . . 0.0 112.202 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -89.4 18.86 4.86 Favored 'General case' 0 N--CA 1.507 2.417 0 O-C-N 120.973 -1.079 . . . . 0.0 112.342 -179.021 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.505 ' OD1' ' N ' ' A' ' 78' ' ' ASP . 2.0 m-20 -77.12 -158.44 0.11 Allowed 'General case' 0 N--CA 1.505 2.314 0 O-C-N 120.33 -1.481 . . . . 0.0 109.981 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.479 ' HB ' ' HB3' ' A' ' 65' ' ' LEU . 4.6 mm -128.35 133.83 66.03 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.657 0 O-C-N 121.06 -1.025 . . . . 0.0 109.891 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.497 ' HB3' ' HA ' ' A' ' 112' ' ' ALA . 81.4 t80 -78.45 147.51 33.94 Favored 'General case' 0 N--CA 1.516 2.846 0 O-C-N 119.399 -2.063 . . . . 0.0 109.347 179.13 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 10.2 t -140.58 114.09 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 O-C-N 120.12 -1.612 . . . . 0.0 110.664 -179.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.53 ' O ' HG13 ' A' ' 86' ' ' ILE . 58.6 m -75.25 163.6 66.7 Favored Pre-proline 0 N--CA 1.512 2.651 0 O-C-N 120.442 -1.411 . . . . 0.0 112.18 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.539 ' HA ' HG13 ' A' ' 86' ' ' ILE . 38.0 Cg_endo -65.49 -52.75 0.96 Allowed 'Trans proline' 0 C--N 1.314 -1.289 0 O-C-N 124.701 1.895 . . . . 0.0 108.904 178.589 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.516 ' O ' ' HB2' ' A' ' 88' ' ' ARG . 0.3 OUTLIER -45.66 -40.98 9.81 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 178.242 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.499 ' HB2' ' O ' ' A' ' 82' ' ' SER . 7.4 mm100 -62.41 -58.85 6.15 Favored 'General case' 0 N--CA 1.51 2.556 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.253 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.549 ' HA ' ' CD1' ' A' ' 91' ' ' LEU . 0.4 OUTLIER -55.98 -55.06 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.273 0 O-C-N 121.128 -0.982 . . . . 0.0 108.837 178.469 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.482 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 1.6 mtt85 -58.13 -42.6 86.2 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-O 121.772 0.796 . . . . 0.0 111.644 -178.928 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.516 ' HB2' ' O ' ' A' ' 84' ' ' SER . 19.8 mtt-85 -60.76 -36.8 79.86 Favored 'General case' 0 N--CA 1.505 2.311 0 C-N-CA 119.34 -0.944 . . . . 0.0 111.884 -177.545 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.591 ' HB2' ' CD2' ' A' ' 91' ' ' LEU . 16.7 m-85 -110.99 13.02 22.08 Favored 'General case' 0 N--CA 1.503 2.189 0 C-N-CA 116.815 -1.954 . . . . 0.0 111.382 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 61.19 55.04 3.09 Favored 'General case' 0 N--CA 1.483 1.21 0 O-C-N 120.509 -1.369 . . . . 0.0 110.458 178.307 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.591 ' CD2' ' HB2' ' A' ' 89' ' ' PHE . 3.9 mt -89.2 -170.75 2.99 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 119.102 -1.039 . . . . 0.0 110.416 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.531 ' CG ' ' O ' ' A' ' 91' ' ' LEU . 86.5 mtt-85 -159.4 160.03 34.41 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.679 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.592 ' HB ' ' CG1' ' A' ' 57' ' ' ILE . 1.7 t -64.36 156.9 27.73 Favored 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 116.826 -1.949 . . . . 0.0 106.662 178.459 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.46 ' HA2' HG13 ' A' ' 54' ' ' VAL . . . 75.54 -9.44 15.34 Favored Glycine 0 N--CA 1.506 3.329 0 C-N-CA 117.122 -2.466 . . . . 0.0 110.191 179.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.513 ' OD2' ' N ' ' A' ' 92' ' ' ARG . 11.7 m-20 -66.79 147.98 52.53 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.235 -1.744 . . . . 0.0 110.778 -178.789 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.472 ' O ' HG12 ' A' ' 97' ' ' ILE . 0.2 OUTLIER -89.6 120.98 31.37 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.228 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.501 HG22 HD12 ' A' ' 97' ' ' ILE . 1.4 mt -144.06 162.05 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 119.934 -1.729 . . . . 0.0 112.803 -178.305 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.494 ' OG ' ' HB2' ' A' ' 118' ' ' GLU . 97.5 p -148.05 137.88 22.52 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.512 ' O ' ' HB2' ' A' ' 50' ' ' PHE . . . -168.05 -178.27 39.83 Favored Glycine 0 N--CA 1.507 3.415 0 C-N-CA 117.035 -2.507 . . . . 0.0 114.917 -178.962 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.525 ' CD ' ' HB3' ' A' ' 115' ' ' LYS . 1.8 ptmt -90.12 156.93 18.01 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.534 HG13 HG13 ' A' ' 49' ' ' ILE . 2.3 pt -125.61 155.75 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.523 0 CA-C-N 120.659 1.572 . . . . 0.0 113.227 -177.529 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.543 ' HB3' ' CD1' ' A' ' 114' ' ' LEU . 0.0 OUTLIER -150.86 153.92 33.98 Favored Pre-proline 0 N--CA 1.486 1.356 0 O-C-N 120.58 -1.325 . . . . 0.0 109.25 179.765 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.532 ' N ' ' HG3' ' A' ' 102' ' ' ARG . 51.4 Cg_endo -82.5 136.09 8.46 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 O-C-N 123.965 1.508 . . . . 0.0 110.039 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.541 ' HD2' ' CG ' ' A' ' 108' ' ' GLU . 48.4 Cg_endo -72.17 -93.9 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.88 1.463 . . . . 0.0 110.284 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 2.4 tttt -139.56 -163.62 1.53 Allowed 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.472 -0.768 . . . . 0.0 109.919 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -52.24 -26.63 12.29 Favored 'General case' 0 C--N 1.313 -1.017 0 O-C-N 120.637 -1.289 . . . . 0.0 109.345 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -83.79 48.55 4.06 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 107.738 -2.145 . . . . 0.0 107.738 177.659 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.541 ' CG ' ' HD2' ' A' ' 104' ' ' PRO . 8.8 tm-20 -85.72 -78.68 0.26 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.832 -1.393 . . . . 0.0 111.571 -178.611 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.449 ' HD3' ' C ' ' A' ' 109' ' ' ARG . 0.0 OUTLIER 65.08 -59.91 0.25 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.176 -0.952 . . . . 0.0 109.076 -178.56 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.53 ' N ' ' O ' ' A' ' 108' ' ' GLU . 35.8 m-85 -109.04 144.26 37.27 Favored 'General case' 0 N--CA 1.515 2.805 0 O-C-N 120.32 -1.487 . . . . 0.0 108.082 176.734 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.452 ' O ' ' HB3' ' A' ' 80' ' ' TYR . 3.3 m-85 -68.33 165.74 18.0 Favored 'General case' 0 N--CA 1.506 2.348 0 O-C-N 119.321 -2.112 . . . . 0.0 107.957 178.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.497 ' HA ' ' HB3' ' A' ' 80' ' ' TYR . . . -122.7 150.68 42.4 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 119.955 -1.715 . . . . 0.0 110.957 -179.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.3 tp -60.11 147.56 39.08 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.543 ' CD1' ' HB3' ' A' ' 102' ' ' ARG . 14.3 tp -127.84 -55.48 1.3 Allowed 'General case' 0 N--CA 1.502 2.136 0 O-C-N 120.357 -1.464 . . . . 0.0 112.345 -178.793 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.525 ' HB3' ' CD ' ' A' ' 100' ' ' LYS . 0.6 OUTLIER -124.68 139.79 53.54 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 120.321 -1.487 . . . . 0.0 108.598 179.448 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.452 HG12 ' CG2' ' A' ' 119' ' ' VAL . 29.2 t -92.47 129.75 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.735 0 O-C-N 120.671 -1.268 . . . . 0.0 111.52 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 5.1 m-20 -106.43 -39.81 5.78 Favored 'General case' 0 N--CA 1.506 2.339 0 O-C-N 121.409 -0.807 . . . . 0.0 109.496 178.308 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.494 ' HB2' ' OG ' ' A' ' 98' ' ' SER . 1.7 tt0 -143.31 154.49 43.83 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.797 -1.189 . . . . 0.0 109.515 178.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.49 HG21 HG22 ' A' ' 97' ' ' ILE . 83.3 t -159.99 128.21 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 C-N-CA 120.749 -0.38 . . . . 0.0 111.503 -178.349 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.457 ' O ' ' C ' ' A' ' 121' ' ' PHE . 0.6 OUTLIER 39.61 51.61 2.32 Favored 'General case' 0 N--CA 1.52 3.049 0 O-C-N 120.514 -1.366 . . . . 0.0 111.161 178.833 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.475 ' O ' ' OD1' ' A' ' 122' ' ' ASP . 3.4 t80 41.45 32.01 0.2 Allowed 'General case' 0 N--CA 1.519 2.994 0 C-N-CA 118.974 -1.09 . . . . 0.0 110.349 179.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.475 ' OD1' ' O ' ' A' ' 121' ' ' PHE . 1.9 m-20 -145.72 168.18 21.35 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.057 -1.027 . . . . 0.0 108.602 178.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.2 mmtp -78.35 160.45 72.87 Favored Pre-proline 0 N--CA 1.504 2.227 0 O-C-N 120.908 -1.12 . . . . 0.0 109.15 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.453 ' O ' ' HB2' ' A' ' 125' ' ' GLU . 44.7 Cg_endo -71.79 44.73 0.65 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.837 1.441 . . . . 0.0 110.881 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.532 ' O ' ' ND2' ' A' ' 126' ' ' ASN . 3.9 tt0 -177.51 -153.4 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.616 -1.303 . . . . 0.0 108.627 -179.491 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.537 ' OD1' ' CZ ' ' A' ' 128' ' ' ARG . 0.3 OUTLIER 167.0 -150.38 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.168 0 O-C-N 120.603 -1.311 . . . . 0.0 109.247 179.543 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.455 ' CB ' ' O ' ' A' ' 126' ' ' ASN . . . 172.88 33.17 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.392 -1.443 . . . . 0.0 111.218 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.537 ' CZ ' ' OD1' ' A' ' 126' ' ' ASN . 0.2 OUTLIER -115.76 -27.02 7.18 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.963 -1.086 . . . . 0.0 110.197 179.661 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.524 ' N ' ' HG2' ' A' ' 128' ' ' ARG . 17.1 m-20 63.27 140.65 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.263 -0.898 . . . . 0.0 109.859 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.523 ' OXT' ' CG ' ' A' ' 130' ' ' LYS . 1.5 ptmt . . . . . 0 N--CA 1.481 1.097 0 O-C-N 120.623 -1.298 . . . . 0.0 109.604 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.568 ' HA ' ' HA ' ' A' ' 49' ' ' ILE . 2.1 ptp . . . . . 0 N--CA 1.493 1.701 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.559 ' HB2' ' CZ ' ' A' ' 50' ' ' PHE . 8.7 t-20 -78.21 94.28 4.74 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.819 -1.175 . . . . 0.0 108.635 179.118 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.468 ' HA ' HD13 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -41.41 -41.27 1.96 Allowed 'General case' 0 N--CA 1.517 2.917 0 O-C-N 120.679 -1.263 . . . . 0.0 110.031 -178.797 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.472 ' OG1' ' OD2' ' A' ' 52' ' ' ASP . 1.8 m -59.13 -35.36 73.34 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 120.819 -1.176 . . . . 0.0 108.564 -179.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.515 ' N ' ' OD1' ' A' ' 2' ' ' ASN . 0.1 OUTLIER -74.12 -45.39 49.26 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.027 -1.046 . . . . 0.0 108.747 178.209 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.52 ' CD1' HD23 ' A' ' 39' ' ' LEU 0.275 77.9 mt -50.94 -49.72 59.26 Favored 'General case' 0 C--N 1.317 -0.817 0 O-C-N 120.806 -1.184 . . . . 0.0 109.216 178.266 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -66.21 -39.78 89.86 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.046 -1.034 . . . . 0.0 110.142 178.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -63.25 -28.09 69.79 Favored 'General case' 0 N--CA 1.508 2.429 0 O-C-N 121.226 -0.921 . . . . 0.0 111.251 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.594 ' HB ' ' CD1' ' A' ' 14' ' ' LEU . 3.0 m -73.84 126.92 89.12 Favored Pre-proline 0 N--CA 1.505 2.321 0 O-C-N 121.538 -0.727 . . . . 0.0 109.549 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.526 ' HG2' ' CG ' ' A' ' 13' ' ' GLU . 40.1 Cg_endo -61.16 150.47 84.31 Favored 'Trans proline' 0 CA--C 1.566 2.096 0 O-C-N 122.315 0.64 . . . . 0.0 110.84 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.55 ' CG1' ' N ' ' A' ' 12' ' ' SER . 1.4 p -43.43 -50.74 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.525 3.276 0 O-C-N 120.493 -1.379 . . . . 0.0 109.471 -178.71 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.55 ' N ' ' CG1' ' A' ' 11' ' ' VAL . 0.8 OUTLIER -56.21 -39.95 73.28 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.418 -0.801 . . . . 0.0 111.056 -179.856 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.534 ' O ' ' CD1' ' A' ' 17' ' ' LEU . 0.1 OUTLIER -69.26 -29.59 67.52 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 117.96 -1.496 . . . . 0.0 107.711 179.178 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.594 ' CD1' ' HB ' ' A' ' 9' ' ' THR . 0.0 OUTLIER -68.54 -44.32 74.79 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.13 -0.981 . . . . 0.0 108.89 176.845 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.5 mp -65.68 -37.17 79.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 C-N-CA 117.97 -1.492 . . . . 0.0 108.908 179.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.518 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 31.0 m -65.8 -38.64 89.53 Favored 'General case' 0 N--CA 1.484 1.247 0 O-C-N 120.338 -1.476 . . . . 0.0 109.123 178.982 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.534 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 3.7 mt -65.34 -38.13 89.19 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.887 -1.133 . . . . 0.0 108.764 178.593 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.48 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -67.61 -43.5 85.41 Favored Glycine 0 N--CA 1.513 3.787 0 N-CA-C 108.49 -1.844 . . . . 0.0 108.49 178.467 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.672 ' HG3' ' N ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -58.62 -38.84 78.91 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.463 -1.61 . . . . 0.0 108.175 178.925 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.672 ' N ' ' HG3' ' A' ' 19' ' ' GLU . 24.8 m120 -61.81 -27.76 68.99 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 118.13 -1.428 . . . . 0.0 109.313 178.633 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.517 ' CE ' ' NE2' ' A' ' 41' ' ' GLN . 21.5 mmm -102.5 10.81 38.64 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.314 -0.867 . . . . 0.0 111.511 -178.983 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.66 -18.23 50.99 Favored Glycine 0 N--CA 1.504 3.175 0 C-N-CA 118.537 -1.792 . . . . 0.0 112.102 179.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.562 ' O ' ' CD1' ' A' ' 26' ' ' LEU . 5.0 mp -78.4 95.01 4.99 Favored 'General case' 0 N--CA 1.508 2.449 0 O-C-N 120.193 -1.769 . . . . 0.0 110.121 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.474 ' O ' ' CB ' ' A' ' 25' ' ' ASN . 51.5 mt-10 -104.01 168.66 8.97 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.169 -0.957 . . . . 0.0 109.268 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.474 ' CB ' ' O ' ' A' ' 24' ' ' GLU . 0.1 OUTLIER 68.98 19.49 8.15 Favored 'General case' 0 N--CA 1.508 2.434 0 O-C-N 121.499 -0.751 . . . . 0.0 111.947 179.056 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.562 ' CD1' ' O ' ' A' ' 23' ' ' LEU . 0.4 OUTLIER -76.21 -13.62 60.17 Favored 'General case' 0 N--CA 1.505 2.283 0 O-C-N 120.76 -1.212 . . . . 0.0 111.381 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 26' ' ' LEU . . . -46.99 -35.61 6.81 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.464 -1.398 . . . . 0.0 109.061 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.6 mtt180 -81.16 2.48 27.39 Favored 'General case' 0 C--N 1.295 -1.79 0 C-N-CA 119.849 -0.74 . . . . 0.0 111.438 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.526 ' HB3' HG13 ' A' ' 34' ' ' ILE . 7.4 mtp -100.4 150.53 22.52 Favored 'General case' 0 C--N 1.313 -0.984 0 O-C-N 120.832 -1.167 . . . . 0.0 111.164 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.452 ' O ' ' C ' ' A' ' 31' ' ' LYS . 10.8 ttp85 -89.22 142.59 27.51 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.258 -0.901 . . . . 0.0 110.677 179.106 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.59 ' O ' ' CG1' ' A' ' 35' ' ' ILE . 7.7 tttp -31.95 -46.27 0.11 Allowed 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 116.264 -0.426 . . . . 0.0 112.051 179.224 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.524 ' OE1' ' N ' ' A' ' 33' ' ' ASP . 1.2 pp0? -61.6 -53.88 50.37 Favored 'General case' 0 N--CA 1.52 3.066 0 O-C-N 121.325 -0.86 . . . . 0.0 112.101 -177.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 34' ' ' ILE . 2.1 p30 -66.73 -37.32 84.43 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 120.732 -1.23 . . . . 0.0 108.964 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.556 ' CG2' ' HB3' ' A' ' 14' ' ' LEU . 4.8 mt -61.17 -39.44 82.45 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 O-C-N 120.328 -1.482 . . . . 0.0 108.043 177.78 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.59 ' CG1' ' O ' ' A' ' 31' ' ' LYS . 0.6 OUTLIER -57.58 -47.51 85.17 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.558 0 O-C-N 120.085 -1.635 . . . . 0.0 109.271 177.577 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -53.18 -41.15 64.95 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.405 -0.918 . . . . 0.0 108.526 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.512 ' HB3' ' CD2' ' A' ' 23' ' ' LEU . . . -70.29 -53.09 18.27 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.971 -1.081 . . . . 0.0 109.953 178.114 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.641 ' HA ' ' CG ' ' A' ' 41' ' ' GLN . 0.1 OUTLIER -53.78 -28.26 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 C-N-CA 117.437 -1.705 . . . . 0.0 110.362 -179.786 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.52 HD23 ' CD1' ' A' ' 6' ' ' LEU . 64.7 mt -72.33 -44.3 62.86 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 120.409 -1.432 . . . . 0.0 109.696 178.477 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 10.9 mmtt -64.21 -41.63 96.95 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.046 -1.034 . . . . 0.0 110.501 179.014 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.641 ' CG ' ' HA ' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -74.86 -46.41 36.54 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.065 -1.022 . . . . 0.0 111.359 -179.06 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.505 ' HA ' ' HE3' ' A' ' 21' ' ' MET . 0.3 OUTLIER -66.01 -34.47 78.17 Favored 'General case' 0 N--CA 1.505 2.309 0 O-C-N 120.543 -1.348 . . . . 0.0 108.984 179.539 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.565 ' O ' ' N ' ' A' ' 46' ' ' GLY . . . -67.32 -36.93 82.47 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 120.975 -1.078 . . . . 0.0 108.96 178.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.89 -43.73 28.89 Favored 'General case' 0 N--CA 1.482 1.162 0 O-C-N 120.799 -1.188 . . . . 0.0 108.966 178.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 70.8 m -66.66 -9.99 41.67 Favored 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 119.59 -0.844 . . . . 0.0 109.265 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.565 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . 64.57 36.03 92.66 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 178.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.514 ' OE1' ' N ' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -92.62 166.72 12.35 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.432 -1.628 . . . . 0.0 108.841 179.214 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.514 ' N ' ' OE1' ' A' ' 47' ' ' GLU . 17.0 m-20 -61.58 137.09 58.23 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.122 -0.986 . . . . 0.0 110.792 -178.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.568 ' HA ' ' HA ' ' A' ' 1' ' ' MET . 3.0 pt -141.26 135.19 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 120.986 -1.071 . . . . 0.0 108.224 178.912 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.641 ' N ' ' CD1' ' A' ' 50' ' ' PHE . 7.4 p90 -144.86 163.26 34.63 Favored 'General case' 0 C--N 1.31 -1.12 0 C-N-CA 116.014 -2.274 . . . . 0.0 115.794 -178.422 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -120.79 170.6 14.5 Favored Glycine 0 N--CA 1.505 3.243 0 N-CA-C 108.686 -1.766 . . . . 0.0 108.686 -179.017 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.483 ' C ' ' CD2' ' A' ' 65' ' ' LEU . 52.5 p-10 -170.22 167.5 8.57 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 120.383 -1.657 . . . . 0.0 110.741 -178.574 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.522 ' HA3' ' O ' ' A' ' 66' ' ' ARG . . . 144.09 -139.19 8.49 Favored Glycine 0 N--CA 1.507 3.418 0 C-N-CA 118.368 -1.872 . . . . 0.0 111.472 177.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.501 ' HA ' ' O ' ' A' ' 95' ' ' ASP . 2.8 t -127.75 120.12 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 O-C-N 121.258 -1.142 . . . . 0.0 108.092 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.2 mt -62.92 162.78 10.66 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -175.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.485 ' HA ' ' OG1' ' A' ' 93' ' ' THR . 0.0 OUTLIER -139.27 119.79 14.0 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.03 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.571 ' CG1' ' HB ' ' A' ' 93' ' ' THR . 1.2 mm -78.65 162.07 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 119.733 -1.854 . . . . 0.0 109.18 -178.972 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.645 ' CD2' ' CZ ' ' A' ' 62' ' ' PHE . 1.3 mp -131.39 126.06 34.2 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.301 -1.499 . . . . 0.0 109.752 179.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.509 ' C ' ' O ' ' A' ' 58' ' ' LEU . 6.9 mm-40 -32.74 -37.05 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.458 0 CA-C-O 122.018 0.913 . . . . 0.0 109.715 -179.494 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.535 ' HB2' ' CD2' ' A' ' 62' ' ' PHE . 3.1 m-20 -60.92 -6.21 1.72 Allowed 'General case' 0 N--CA 1.5 2.033 0 C-N-CA 120.271 -0.571 . . . . 0.0 112.489 -179.176 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 58' ' ' LEU . . . 89.14 11.9 64.22 Favored Glycine 1 N--CA 1.517 4.077 0 C-N-CA 118.672 -1.728 . . . . 0.0 111.944 178.365 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.645 ' CZ ' ' CD2' ' A' ' 58' ' ' LEU . 4.0 p90 -128.1 -178.85 4.69 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 104.18 -2.526 . . . . 0.0 104.18 177.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.554 ' HA2' ' CD1' ' A' ' 58' ' ' LEU . . . -152.75 162.87 30.2 Favored Glycine 0 N--CA 1.475 1.292 0 C-N-CA 117.322 -2.37 . . . . 0.0 111.272 -177.885 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.439 ' CD1' ' HE1' ' A' ' 62' ' ' PHE . 2.0 m-30 -127.81 150.96 49.59 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 120.136 1.968 . . . . 0.0 109.156 177.728 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.497 ' CB ' ' HB ' ' A' ' 79' ' ' ILE . 0.3 OUTLIER -98.34 166.37 11.41 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 176.768 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.522 ' O ' ' HA3' ' A' ' 53' ' ' GLY . 21.0 tpt180 -178.42 -179.97 0.73 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.057 -1.027 . . . . 0.0 109.02 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.486 ' HB2' ' OG ' ' A' ' 70' ' ' SER . 1.7 m -71.51 -159.12 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.45 -1.406 . . . . 0.0 109.86 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -120.42 -85.76 0.66 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.32 -0.862 . . . . 0.0 110.212 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -69.09 56.06 0.1 Allowed 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.463 -0.773 . . . . 0.0 110.933 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.507 ' O ' ' CB ' ' A' ' 71' ' ' SER . 0.3 OUTLIER -126.31 -19.48 4.67 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.121 -1.612 . . . . 0.0 111.036 -179.399 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.664 ' O ' ' HB2' ' A' ' 72' ' ' TYR . 0.3 OUTLIER 169.47 -14.84 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.439 0 O-C-N 120.822 -1.174 . . . . 0.0 111.973 -179.531 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.664 ' HB2' ' O ' ' A' ' 71' ' ' SER . 95.9 m-85 76.64 -42.57 0.43 Allowed 'General case' 0 N--CA 1.529 3.51 0 O-C-N 121.842 -0.536 . . . . 0.0 111.951 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.456 ' CD1' ' N ' ' A' ' 73' ' ' LEU . 6.7 mp -80.67 -174.78 4.9 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 120.268 -1.52 . . . . 0.0 109.639 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.54 -156.86 0.12 Allowed 'General case' 0 C--N 1.29 -1.982 0 CA-C-O 122.366 1.079 . . . . 0.0 109.755 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.519 ' N ' ' OD2' ' A' ' 78' ' ' ASP . . . -178.54 163.16 30.88 Favored Glycine 0 C--N 1.281 -2.482 0 N-CA-C 107.891 -2.084 . . . . 0.0 107.891 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -64.98 -39.14 25.61 Favored 'Trans proline' 0 N--CA 1.492 1.388 0 CA-C-N 118.312 1.056 . . . . 0.0 112.027 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -86.5 18.32 3.36 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.118 -0.989 . . . . 0.0 112.101 -178.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.519 ' OD2' ' N ' ' A' ' 75' ' ' GLY . 1.1 m-20 -70.74 -154.05 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.343 0 O-C-N 120.531 -1.356 . . . . 0.0 109.77 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.497 ' HB ' ' CB ' ' A' ' 65' ' ' LEU . 3.9 mm -126.56 138.67 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.65 0 O-C-N 121.16 -0.963 . . . . 0.0 110.11 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.474 ' HB3' ' HA ' ' A' ' 112' ' ' ALA . 6.0 t80 -85.02 146.55 27.13 Favored 'General case' 0 N--CA 1.516 2.867 0 CA-C-N 121.502 1.955 . . . . 0.0 109.819 178.875 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.479 ' HB ' ' O ' ' A' ' 63' ' ' GLY . 25.2 t -141.65 115.77 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 120.078 -1.639 . . . . 0.0 110.226 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.53 ' O ' ' HB2' ' A' ' 85' ' ' GLN . 58.0 m -74.3 163.52 67.7 Favored Pre-proline 0 N--CA 1.515 2.799 0 O-C-N 120.262 -1.524 . . . . 0.0 112.131 -179.208 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.52 ' HA ' HG13 ' A' ' 86' ' ' ILE . 40.2 Cg_endo -66.62 -50.27 1.34 Allowed 'Trans proline' 0 C--N 1.314 -1.249 0 O-C-N 124.505 1.792 . . . . 0.0 108.958 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.539 ' O ' ' CG ' ' A' ' 88' ' ' ARG . 0.4 OUTLIER -47.2 -39.53 14.19 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 177.834 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.53 ' HB2' ' O ' ' A' ' 82' ' ' SER . 7.2 mm-40 -63.42 -57.78 9.2 Favored 'General case' 0 N--CA 1.511 2.587 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.215 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.535 ' HA ' ' CD2' ' A' ' 91' ' ' LEU . 0.8 OUTLIER -55.51 -53.59 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.336 0 O-C-N 120.938 -1.101 . . . . 0.0 108.647 178.848 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.468 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 0.1 OUTLIER -57.81 -41.72 82.76 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 121.865 0.84 . . . . 0.0 111.364 -179.459 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.539 ' CG ' ' O ' ' A' ' 84' ' ' SER . 12.5 mtt180 -59.37 -37.46 77.96 Favored 'General case' 0 N--CA 1.507 2.407 0 C-N-CA 119.883 -0.727 . . . . 0.0 111.928 -177.606 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.565 ' CD2' HG22 ' A' ' 116' ' ' VAL . 19.3 m-85 -113.97 14.53 18.46 Favored 'General case' 0 N--CA 1.505 2.318 0 C-N-CA 117.274 -1.771 . . . . 0.0 111.412 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 58.45 56.5 4.32 Favored 'General case' 0 N--CA 1.481 1.108 0 O-C-N 120.31 -1.493 . . . . 0.0 109.084 179.067 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.535 ' CD2' ' HA ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -88.37 173.91 8.46 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.431 -0.908 . . . . 0.0 109.338 -179.831 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.535 ' CD ' ' O ' ' A' ' 91' ' ' LEU . 3.7 mmm180 -147.0 157.51 43.64 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.997 -1.065 . . . . 0.0 108.86 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.571 ' HB ' ' CG1' ' A' ' 57' ' ' ILE . 2.4 t -63.73 156.29 27.54 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 116.948 -1.901 . . . . 0.0 106.993 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.4 ' HA2' HG13 ' A' ' 54' ' ' VAL . . . 76.34 -9.61 19.9 Favored Glycine 0 N--CA 1.504 3.189 0 C-N-CA 117.094 -2.479 . . . . 0.0 110.334 179.195 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.501 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 6.0 m-20 -69.36 147.75 50.63 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.228 -1.748 . . . . 0.0 110.752 -178.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.498 ' O ' HG12 ' A' ' 97' ' ' ILE . 0.2 OUTLIER -91.22 124.29 35.31 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.093 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.498 HG12 ' O ' ' A' ' 96' ' ' THR . 1.7 mt -146.73 166.3 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.034 -1.666 . . . . 0.0 112.408 -179.087 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.536 ' OG ' ' HB2' ' A' ' 118' ' ' GLU . 82.4 p -148.93 139.82 22.87 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.233 178.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.468 ' O ' ' HB2' ' A' ' 50' ' ' PHE . . . -164.6 179.55 39.27 Favored Glycine 0 N--CA 1.506 3.346 0 C-N-CA 117.039 -2.505 . . . . 0.0 114.987 -179.118 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.507 ' HG2' ' HB3' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -87.76 152.88 21.78 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 178.772 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.514 HG13 HG13 ' A' ' 49' ' ' ILE . 2.4 pt -122.87 159.17 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.462 0 CA-C-N 120.982 1.719 . . . . 0.0 113.603 -176.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.456 ' HB2' HD21 ' A' ' 114' ' ' LEU . 1.5 tmm_? -145.39 143.85 21.37 Favored Pre-proline 0 N--CA 1.481 1.111 0 O-C-N 120.582 -1.324 . . . . 0.0 109.891 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.473 ' HB3' ' CE1' ' A' ' 111' ' ' PHE . 52.2 Cg_endo -88.36 117.75 1.02 Allowed 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.246 1.656 . . . . 0.0 110.027 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.532 ' HG2' ' CB ' ' A' ' 108' ' ' GLU . 44.2 Cg_endo -68.48 -99.18 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 123.718 1.378 . . . . 0.0 109.592 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.434 ' O ' ' CD ' ' A' ' 108' ' ' GLU . 23.7 mttt -116.43 174.52 6.02 Favored 'General case' 0 C--N 1.293 -1.856 0 O-C-N 121.253 -0.905 . . . . 0.0 109.373 179.185 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.42 -23.78 63.75 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 120.838 -1.164 . . . . 0.0 109.774 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -85.16 34.94 3.17 Favored Glycine 0 N--CA 1.496 2.651 0 C-N-CA 118.68 -1.724 . . . . 0.0 109.923 179.025 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.532 ' CB ' ' HG2' ' A' ' 104' ' ' PRO . 0.7 OUTLIER -106.77 -23.94 12.25 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.487 -1.596 . . . . 0.0 110.235 179.831 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.526 ' N ' ' OE1' ' A' ' 108' ' ' GLU . 0.9 OUTLIER 66.37 -52.61 0.42 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.549 -0.719 . . . . 0.0 111.245 -179.949 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.421 ' CD1' ' N ' ' A' ' 110' ' ' TYR . 3.6 m-85 -108.4 148.04 30.71 Favored 'General case' 0 N--CA 1.521 3.078 0 O-C-N 120.07 -1.644 . . . . 0.0 109.542 178.625 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.473 ' CE1' ' HB3' ' A' ' 103' ' ' PRO . 54.4 m-85 -69.13 172.03 7.44 Favored 'General case' 0 N--CA 1.509 2.514 0 O-C-N 119.735 -1.853 . . . . 0.0 108.034 178.317 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.474 ' HA ' ' HB3' ' A' ' 80' ' ' TYR . . . -122.08 154.96 36.65 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 119.924 -1.735 . . . . 0.0 110.842 -179.169 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.12 153.7 43.28 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 179.375 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.456 ' HB3' ' HG3' ' A' ' 100' ' ' LYS . 11.1 tp -132.79 -59.55 0.89 Allowed 'General case' 0 N--CA 1.501 2.077 0 O-C-N 120.135 -1.603 . . . . 0.0 112.22 -179.276 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.507 ' HB3' ' HG2' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -114.18 141.7 47.19 Favored 'General case' 0 N--CA 1.511 2.615 0 O-C-N 120.272 -1.518 . . . . 0.0 109.074 179.401 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.565 HG22 ' CD2' ' A' ' 89' ' ' PHE . 34.7 t -93.05 129.25 43.83 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.908 0 O-C-N 120.543 -1.348 . . . . 0.0 111.63 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.542 ' O ' ' HB3' ' A' ' 124' ' ' PRO . 7.1 m-20 -106.93 -39.05 5.87 Favored 'General case' 0 N--CA 1.507 2.423 0 O-C-N 121.463 -0.773 . . . . 0.0 109.918 178.324 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.536 ' HB2' ' OG ' ' A' ' 98' ' ' SER . 6.0 mm-40 -143.52 156.37 44.59 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.595 -1.316 . . . . 0.0 109.041 179.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.545 ' O ' ' N ' ' A' ' 121' ' ' PHE . 6.4 t -156.17 139.81 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -178.229 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.467 ' C ' ' O ' ' A' ' 119' ' ' VAL . 0.1 OUTLIER -32.8 -31.54 0.01 OUTLIER 'General case' 0 N--CA 1.519 2.978 0 O-C-N 121.106 -0.996 . . . . 0.0 111.197 -177.535 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.545 ' N ' ' O ' ' A' ' 119' ' ' VAL . 0.4 OUTLIER -157.29 59.08 0.51 Allowed 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 118.313 -1.355 . . . . 0.0 111.272 179.439 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.524 ' HB2' ' HB ' ' A' ' 119' ' ' VAL . 0.4 OUTLIER -151.19 167.41 27.86 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 118.534 -1.267 . . . . 0.0 109.762 177.968 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 26.3 mmmt -79.04 156.3 76.94 Favored Pre-proline 0 N--CA 1.501 2.077 0 C-N-CA 119.458 -0.897 . . . . 0.0 108.884 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.542 ' HB3' ' O ' ' A' ' 117' ' ' ASN . 54.3 Cg_endo -79.58 31.24 0.48 Allowed 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.853 1.449 . . . . 0.0 111.102 -178.854 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.535 ' O ' ' CB ' ' A' ' 126' ' ' ASN . 1.2 tp10 -179.12 -134.67 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.535 ' CB ' ' O ' ' A' ' 125' ' ' GLU . 0.2 OUTLIER 167.58 -83.41 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.099 0 O-C-N 120.327 -1.483 . . . . 0.0 110.182 179.055 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.47 ' HB1' ' O ' ' A' ' 126' ' ' ASN . . . -179.55 -165.84 0.08 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.606 -0.683 . . . . 0.0 109.456 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.552 ' CG ' ' O ' ' A' ' 128' ' ' ARG . 2.0 ptp180 -158.23 113.22 2.62 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.482 -1.386 . . . . 0.0 110.267 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -65.02 163.09 15.36 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.073 -1.017 . . . . 0.0 110.185 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 118.003 -0.999 . . . . 0.0 109.952 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.58 ' HE2' ' CG ' ' A' ' 42' ' ' HIS . 14.1 mmt . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.097 0.475 . . . . 0.0 109.925 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.502 ' HB3' ' HB3' ' A' ' 5' ' ' GLU . 39.8 t30 -78.86 110.04 13.69 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.007 -1.058 . . . . 0.0 108.84 178.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.525 ' CD1' HD13 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -44.09 -41.17 5.4 Favored 'General case' 0 N--CA 1.514 2.74 0 O-C-N 120.339 -1.476 . . . . 0.0 110.493 -178.695 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.43 ' OG1' ' OD1' ' A' ' 52' ' ' ASP . 1.7 m -58.4 -36.88 74.24 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 120.696 -1.253 . . . . 0.0 108.264 -179.014 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.502 ' HB3' ' HB3' ' A' ' 2' ' ' ASN . 1.8 pt-20 -70.53 -45.84 64.75 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.089 -1.007 . . . . 0.0 108.543 178.053 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.489 ' HB3' HG13 ' A' ' 35' ' ' ILE 0.281 82.3 mt -51.65 -49.5 62.19 Favored 'General case' 0 C--N 1.315 -0.916 0 O-C-N 121.008 -1.058 . . . . 0.0 109.521 178.397 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.478 ' HD2' ' CB ' ' A' ' 77' ' ' ASP . 0.3 OUTLIER -63.78 -38.58 91.65 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.288 -0.883 . . . . 0.0 110.094 179.137 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -62.58 -19.52 63.8 Favored 'General case' 0 N--CA 1.508 2.473 0 O-C-N 121.262 -0.899 . . . . 0.0 111.383 -179.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.62 ' HB ' ' CD1' ' A' ' 14' ' ' LEU . 3.2 m -83.17 117.85 69.87 Favored Pre-proline 0 C--N 1.284 -2.278 0 O-C-N 121.763 -0.585 . . . . 0.0 109.966 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.482 ' HG2' ' HG3' ' A' ' 13' ' ' GLU . 38.5 Cg_endo -59.61 155.14 43.98 Favored 'Trans proline' 0 CA--C 1.564 2.0 0 O-C-N 122.471 0.722 . . . . 0.0 110.899 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.519 ' CG1' ' N ' ' A' ' 12' ' ' SER . 1.7 p -42.81 -51.63 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.527 3.383 0 O-C-N 120.577 -1.327 . . . . 0.0 110.139 -178.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.519 ' N ' ' CG1' ' A' ' 11' ' ' VAL . 1.5 t -55.01 -43.23 73.45 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 121.12 -0.987 . . . . 0.0 111.239 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.55 ' HB3' ' CG2' ' A' ' 9' ' ' THR . 1.7 mm-40 -68.38 -27.32 66.13 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 117.947 -1.501 . . . . 0.0 107.59 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.62 ' CD1' ' HB ' ' A' ' 9' ' ' THR . 0.0 OUTLIER -70.61 -41.46 72.26 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.132 -0.98 . . . . 0.0 109.089 176.958 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.8 mp -69.81 -36.1 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 C-N-CA 117.824 -1.55 . . . . 0.0 109.216 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.498 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 86.8 m -69.31 -40.78 77.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.03 -1.669 . . . . 0.0 109.816 179.063 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.53 ' CD1' HG22 ' A' ' 9' ' ' THR . 1.9 mt -64.84 -37.62 88.22 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.696 -1.252 . . . . 0.0 108.923 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.637 ' HA3' HD22 ' A' ' 23' ' ' LEU . . . -68.2 -44.67 74.92 Favored Glycine 0 N--CA 1.507 3.395 0 N-CA-C 108.929 -1.668 . . . . 0.0 108.929 178.473 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.654 ' HG3' ' N ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -57.08 -37.11 71.42 Favored 'General case' 0 N--CA 1.484 1.232 0 O-C-N 120.496 -1.59 . . . . 0.0 107.463 178.896 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.654 ' N ' ' HG3' ' A' ' 19' ' ' GLU . 28.9 m120 -61.05 -24.44 66.2 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 118.293 -1.363 . . . . 0.0 109.532 178.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.612 ' CE ' ' CG ' ' A' ' 42' ' ' HIS . 69.6 mmm -97.33 2.18 50.32 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.188 -0.945 . . . . 0.0 111.595 -179.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.55 -3.66 65.9 Favored Glycine 0 N--CA 1.498 2.799 0 C-N-CA 118.249 -1.929 . . . . 0.0 114.142 177.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.637 HD22 ' HA3' ' A' ' 18' ' ' GLY . 0.0 OUTLIER -103.52 63.98 0.8 Allowed 'General case' 0 N--CA 1.509 2.5 0 CA-C-N 121.644 2.722 . . . . 0.0 111.25 179.854 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.521 ' O ' ' CB ' ' A' ' 25' ' ' ASN . 5.1 pt-20 -57.11 -167.71 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.199 0 CA-C-O 122.367 1.08 . . . . 0.0 110.754 178.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.521 ' CB ' ' O ' ' A' ' 24' ' ' GLU . 0.7 OUTLIER 74.62 10.16 4.11 Favored 'General case' 0 N--CA 1.516 2.84 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.571 179.723 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.576 HD12 ' CD2' ' A' ' 23' ' ' LEU . 1.0 OUTLIER -77.14 -18.57 57.79 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.245 -0.909 . . . . 0.0 112.35 -179.358 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.408 ' C ' ' O ' ' A' ' 26' ' ' LEU . . . -46.99 -40.21 14.01 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.313 -1.492 . . . . 0.0 108.771 -179.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 28.0 mtt-85 -81.15 -0.56 40.82 Favored 'General case' 0 C--N 1.295 -1.786 0 C-N-CA 119.725 -0.79 . . . . 0.0 111.359 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.515 ' HB3' HG13 ' A' ' 34' ' ' ILE . 15.7 mtp -101.21 156.78 17.23 Favored 'General case' 0 C--N 1.312 -1.038 0 O-C-N 120.915 -1.116 . . . . 0.0 111.841 -178.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.511 ' O ' HD13 ' A' ' 34' ' ' ILE . 3.8 ttm180 -89.76 175.08 7.37 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.429 -0.794 . . . . 0.0 110.561 177.956 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.534 ' O ' HG21 ' A' ' 35' ' ' ILE . 9.2 pttm -66.41 -33.33 75.47 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.449 -0.782 . . . . 0.0 110.989 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.641 ' O ' HG21 ' A' ' 35' ' ' ILE . 1.3 mm100 -65.57 -55.02 19.98 Favored 'General case' 0 N--CA 1.523 3.192 0 CA-C-O 122.021 0.915 . . . . 0.0 110.018 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.55 ' OD1' ' N ' ' A' ' 34' ' ' ILE . 2.0 p30 -67.33 -41.91 84.45 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.074 -1.016 . . . . 0.0 109.685 -179.054 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.551 ' CG2' ' HB3' ' A' ' 14' ' ' LEU . 29.0 mt -61.79 -40.84 88.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 O-C-N 120.357 -1.464 . . . . 0.0 109.637 178.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.641 HG21 ' O ' ' A' ' 32' ' ' GLN . 0.2 OUTLIER -66.92 -37.26 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.557 0 O-C-N 120.113 -1.617 . . . . 0.0 109.049 178.149 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 9.2 m-30 -67.02 -45.57 77.1 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.377 -1.452 . . . . 0.0 108.716 178.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.443 ' O ' ' C ' ' A' ' 38' ' ' ILE . . . -67.01 -53.46 31.16 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.49 -1.381 . . . . 0.0 109.487 178.053 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.576 ' CD1' ' HA2' ' A' ' 18' ' ' GLY . 5.9 tp -48.46 -49.99 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 C-N-CA 117.536 -1.665 . . . . 0.0 108.093 179.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.537 ' N ' HG22 ' A' ' 38' ' ' ILE . 5.6 tp -53.87 -41.56 67.65 Favored 'General case' 0 N--CA 1.52 3.052 0 O-C-N 120.76 -1.213 . . . . 0.0 109.1 179.431 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.466 ' O ' ' HD2' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -60.59 -36.05 77.59 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 121.628 0.727 . . . . 0.0 109.739 179.271 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.57 ' HG3' ' CD1' ' A' ' 23' ' ' LEU . 11.8 mm-40 -79.34 -51.4 9.46 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.663 -0.648 . . . . 0.0 111.354 -179.024 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.612 ' CG ' ' CE ' ' A' ' 21' ' ' MET . 0.2 OUTLIER -61.38 -31.59 71.5 Favored 'General case' 0 N--CA 1.503 2.204 0 C-N-CA 117.736 -1.586 . . . . 0.0 108.425 179.406 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 46' ' ' GLY . . . -58.96 -44.56 91.5 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 177.822 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.482 ' HB2' ' O ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -49.22 -45.24 44.19 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 122.11 0.957 . . . . 0.0 108.944 177.952 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 65.5 m -66.8 -8.36 28.0 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 121.639 0.733 . . . . 0.0 109.581 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . 74.53 29.5 61.61 Favored Glycine 0 N--CA 1.495 2.621 0 C-N-CA 120.186 -1.006 . . . . 0.0 111.774 178.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.03 166.65 22.09 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.173 -1.781 . . . . 0.0 108.975 178.818 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -88.1 130.22 35.08 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.234 -0.916 . . . . 0.0 109.739 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.487 HG13 HG13 ' A' ' 101' ' ' ILE . 0.6 OUTLIER -131.0 135.8 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.562 -1.336 . . . . 0.0 107.655 178.97 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.491 ' O ' ' HA ' ' A' ' 2' ' ' ASN . 17.0 p90 -141.82 165.14 28.29 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 116.28 -2.168 . . . . 0.0 114.834 -177.915 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -114.21 164.8 12.03 Favored Glycine 0 N--CA 1.503 3.117 0 N-CA-C 108.307 -1.917 . . . . 0.0 108.307 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.461 ' N ' ' OD1' ' A' ' 52' ' ' ASP . 46.7 p-10 -169.79 164.63 9.91 Favored 'General case' 0 N--CA 1.48 1.047 0 O-C-N 120.36 -1.671 . . . . 0.0 110.298 -178.838 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.527 ' HA3' ' O ' ' A' ' 66' ' ' ARG . . . 140.87 -134.98 6.68 Favored Glycine 0 N--CA 1.504 3.227 0 C-N-CA 118.258 -1.925 . . . . 0.0 111.378 178.378 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.512 ' HA ' ' O ' ' A' ' 95' ' ' ASP . 2.6 t -128.17 119.85 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 O-C-N 121.414 -1.051 . . . . 0.0 108.265 -179.357 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.6 mt -62.29 161.61 11.15 Favored 'General case' 0 N--CA 1.501 2.124 0 C-N-CA 118.74 -1.184 . . . . 0.0 113.454 -175.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.465 ' HA ' ' OG1' ' A' ' 93' ' ' THR . 3.4 tp10 -137.31 116.35 12.45 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 178.119 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.587 ' CG1' ' HB ' ' A' ' 93' ' ' THR . 1.3 mm -84.31 159.35 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 120.151 -1.593 . . . . 0.0 108.811 -179.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.453 ' O ' ' C ' ' A' ' 59' ' ' GLN . 2.8 mp -130.96 138.82 49.9 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.348 -1.47 . . . . 0.0 109.961 179.27 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.453 ' C ' ' O ' ' A' ' 58' ' ' LEU . 3.7 tt0 -38.24 -36.72 0.24 Allowed 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.66 0.743 . . . . 0.0 110.414 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -60.99 -7.74 2.69 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.502 -0.749 . . . . 0.0 112.319 -179.209 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 91.34 8.39 64.39 Favored Glycine 1 N--CA 1.518 4.151 0 C-N-CA 118.729 -1.701 . . . . 0.0 112.255 177.863 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.595 ' C ' ' CD1' ' A' ' 62' ' ' PHE . 0.0 OUTLIER -127.65 -179.68 5.06 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 104.883 -2.266 . . . . 0.0 104.883 178.098 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -158.56 170.77 35.22 Favored Glycine 0 N--CA 1.475 1.293 0 C-N-CA 116.712 -2.661 . . . . 0.0 111.784 -177.884 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.414 ' HE1' ' CE2' ' A' ' 62' ' ' PHE . 6.9 m-85 -129.9 153.0 48.76 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 119.858 1.829 . . . . 0.0 109.753 177.478 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.491 ' HB3' ' HB ' ' A' ' 79' ' ' ILE . 0.3 OUTLIER -98.9 160.14 14.47 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 176.567 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.527 ' O ' ' HA3' ' A' ' 53' ' ' GLY . 0.0 OUTLIER 178.26 -162.75 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.196 -0.94 . . . . 0.0 109.561 179.191 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.479 ' N ' ' CG ' ' A' ' 66' ' ' ARG . 1.1 m -72.74 -156.8 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.98 -1.075 . . . . 0.0 110.282 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.455 ' HB3' HG23 ' A' ' 54' ' ' VAL . . . -127.3 -90.86 0.52 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.426 -0.796 . . . . 0.0 110.116 -179.824 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -73.36 48.36 0.24 Allowed 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.165 -0.959 . . . . 0.0 111.102 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -123.34 -15.6 7.13 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.32 -1.488 . . . . 0.0 110.423 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.55 ' O ' ' HB2' ' A' ' 72' ' ' TYR . 0.5 OUTLIER 177.86 -26.9 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.965 -1.084 . . . . 0.0 110.733 179.637 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.55 ' HB2' ' O ' ' A' ' 71' ' ' SER . 23.5 m-85 76.41 -43.54 0.46 Allowed 'General case' 0 N--CA 1.52 3.069 0 O-C-N 121.651 -0.656 . . . . 0.0 111.731 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.48 ' O ' ' HD2' ' A' ' 66' ' ' ARG . 6.9 mt -77.68 -172.09 2.46 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.355 -1.466 . . . . 0.0 109.626 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.18 -157.69 0.13 Allowed 'General case' 0 C--N 1.288 -2.095 0 CA-C-O 122.419 1.104 . . . . 0.0 109.571 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.414 ' CA ' ' OD1' ' A' ' 78' ' ' ASP . . . 176.49 164.93 31.32 Favored Glycine 0 C--N 1.278 -2.67 0 N-CA-C 107.789 -2.124 . . . . 0.0 107.789 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -64.86 -40.16 22.55 Favored 'Trans proline' 0 N--CA 1.489 1.263 0 CA-C-N 118.364 1.082 . . . . 0.0 112.156 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.478 ' CB ' ' HD2' ' A' ' 7' ' ' LYS . 2.2 m-20 -86.78 16.49 4.75 Favored 'General case' 0 N--CA 1.507 2.38 0 O-C-N 121.112 -0.992 . . . . 0.0 112.488 -178.651 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.518 ' OD1' ' N ' ' A' ' 78' ' ' ASP . 0.6 OUTLIER -76.37 -152.91 0.04 OUTLIER 'General case' 0 N--CA 1.509 2.515 0 O-C-N 120.528 -1.358 . . . . 0.0 109.462 179.371 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.491 ' HB ' ' HB3' ' A' ' 65' ' ' LEU . 1.7 mp -135.9 138.27 47.81 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.812 0 O-C-N 120.961 -1.087 . . . . 0.0 110.043 178.776 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.483 ' HB3' ' O ' ' A' ' 111' ' ' PHE . 5.9 t80 -80.8 146.34 30.99 Favored 'General case' 0 N--CA 1.518 2.955 0 O-C-N 119.685 -1.884 . . . . 0.0 110.028 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.451 ' N ' ' CD1' ' A' ' 80' ' ' TYR . 38.4 t -142.44 112.9 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 120.24 -1.537 . . . . 0.0 110.117 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.517 ' O ' HG13 ' A' ' 86' ' ' ILE . 22.0 m -74.86 166.82 42.16 Favored Pre-proline 0 N--CA 1.512 2.643 0 O-C-N 120.58 -1.325 . . . . 0.0 112.133 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.538 ' HA ' HG13 ' A' ' 86' ' ' ILE . 38.8 Cg_endo -65.19 -53.82 0.76 Allowed 'Trans proline' 0 C--N 1.314 -1.257 0 O-C-N 124.651 1.869 . . . . 0.0 109.08 178.823 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.56 ' O ' ' CG ' ' A' ' 88' ' ' ARG . 0.8 OUTLIER -45.14 -41.01 7.6 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 178.119 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.568 ' O ' ' CD2' ' A' ' 89' ' ' PHE . 6.6 mm100 -62.74 -57.81 9.65 Favored 'General case' 0 N--CA 1.509 2.517 0 C-N-CA 119.118 -1.033 . . . . 0.0 108.49 178.221 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.538 HG13 ' HA ' ' A' ' 83' ' ' PRO . 0.2 OUTLIER -59.15 -54.84 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.35 0 O-C-N 121.084 -1.01 . . . . 0.0 108.846 178.648 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.485 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 0.0 OUTLIER -56.22 -42.67 77.62 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-O 121.83 0.824 . . . . 0.0 111.225 -179.102 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.56 ' CG ' ' O ' ' A' ' 84' ' ' SER . 1.4 mmt85 -60.42 -36.42 78.11 Favored 'General case' 0 N--CA 1.507 2.382 0 C-N-CA 119.647 -0.821 . . . . 0.0 111.871 -177.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.568 ' CD2' ' O ' ' A' ' 85' ' ' GLN . 4.7 m-85 -109.74 12.75 23.98 Favored 'General case' 0 N--CA 1.503 2.218 0 C-N-CA 117.494 -1.682 . . . . 0.0 111.174 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 59.52 52.88 5.41 Favored 'General case' 0 N--CA 1.485 1.308 0 O-C-N 120.524 -1.36 . . . . 0.0 109.686 178.906 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.516 ' O ' ' HG2' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -90.12 174.39 7.66 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.486 -0.758 . . . . 0.0 109.757 179.867 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.516 ' HG2' ' O ' ' A' ' 91' ' ' LEU . 10.3 mtm180 -147.56 159.82 43.33 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.173 -0.955 . . . . 0.0 108.678 178.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.587 ' HB ' ' CG1' ' A' ' 57' ' ' ILE . 1.9 t -63.54 156.28 26.92 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 117.143 -1.823 . . . . 0.0 107.031 179.381 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.442 ' HA2' HG13 ' A' ' 54' ' ' VAL . . . 77.2 -11.21 17.34 Favored Glycine 0 N--CA 1.505 3.251 0 C-N-CA 117.177 -2.439 . . . . 0.0 110.107 179.34 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.512 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 12.5 m-20 -68.26 146.93 52.87 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.211 -1.758 . . . . 0.0 110.943 -178.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.49 ' O ' HG12 ' A' ' 97' ' ' ILE . 0.2 OUTLIER -90.05 120.91 31.64 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.179 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.497 HG22 HG21 ' A' ' 119' ' ' VAL . 1.5 mt -145.95 167.51 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 119.871 -1.768 . . . . 0.0 112.81 -178.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.502 ' OG ' ' HB2' ' A' ' 118' ' ' GLU . 99.8 p -149.25 138.95 21.8 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.988 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.483 ' O ' ' HB2' ' A' ' 50' ' ' PHE . . . -163.11 178.09 38.91 Favored Glycine 0 N--CA 1.507 3.42 0 C-N-CA 117.405 -2.331 . . . . 0.0 114.757 -178.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.509 ' HG2' ' HB3' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -88.06 155.88 19.58 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 178.982 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.487 HG13 HG13 ' A' ' 49' ' ' ILE . 1.7 pt -123.04 161.89 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.369 0 CA-C-N 120.636 1.562 . . . . 0.0 113.586 -177.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.522 ' CD ' ' HD2' ' A' ' 103' ' ' PRO . 0.0 OUTLIER -143.71 129.47 9.97 Favored Pre-proline 0 N--CA 1.485 1.308 0 O-C-N 120.608 -1.307 . . . . 0.0 108.808 179.695 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.522 ' HD2' ' CD ' ' A' ' 102' ' ' ARG . 49.7 Cg_endo -75.89 115.6 4.21 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 124.204 1.634 . . . . 0.0 110.853 -179.154 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.65 -152.06 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.979 1.515 . . . . 0.0 109.346 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 8.3 mttm -83.26 168.8 16.37 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.837 -1.165 . . . . 0.0 109.209 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.86 -22.76 65.8 Favored 'General case' 0 C--N 1.309 -1.174 0 O-C-N 120.683 -1.26 . . . . 0.0 109.896 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -67.26 2.79 4.99 Favored Glycine 0 N--CA 1.501 2.984 0 C-N-CA 119.054 -1.546 . . . . 0.0 111.387 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.512 ' O ' ' HB3' ' A' ' 109' ' ' ARG . 0.5 OUTLIER -106.87 -26.42 11.24 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-N 120.236 2.018 . . . . 0.0 110.078 179.819 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.512 ' HB3' ' O ' ' A' ' 108' ' ' GLU . 4.9 tpp180 68.84 -41.42 0.47 Allowed 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.529 -0.732 . . . . 0.0 112.628 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -106.57 148.56 28.12 Favored 'General case' 0 N--CA 1.52 3.055 0 O-C-N 120.126 -1.609 . . . . 0.0 109.678 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.483 ' O ' ' HB3' ' A' ' 80' ' ' TYR . 3.4 m-30 -67.72 168.09 12.0 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 119.851 -1.781 . . . . 0.0 108.093 178.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.469 ' HA ' ' HB3' ' A' ' 80' ' ' TYR . . . -121.85 154.15 37.44 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.237 -1.539 . . . . 0.0 110.345 -179.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.54 150.52 46.62 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.439 ' CD2' ' HB2' ' A' ' 102' ' ' ARG . 20.0 tp -127.93 -55.9 1.28 Allowed 'General case' 0 N--CA 1.501 2.088 0 O-C-N 120.282 -1.511 . . . . 0.0 112.373 -178.945 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.509 ' HB3' ' HG2' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -123.98 142.58 51.04 Favored 'General case' 0 N--CA 1.509 2.513 0 O-C-N 120.32 -1.487 . . . . 0.0 109.263 179.417 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.8 t -92.98 130.7 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.831 0 O-C-N 120.468 -1.395 . . . . 0.0 111.057 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -107.17 -40.93 5.28 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 121.357 -0.839 . . . . 0.0 109.725 178.653 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.502 ' HB2' ' OG ' ' A' ' 98' ' ' SER . 0.0 OUTLIER -143.67 159.48 42.41 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.872 -1.142 . . . . 0.0 109.74 179.483 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.497 HG21 HG22 ' A' ' 97' ' ' ILE . 13.1 t -158.5 138.14 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -178.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.472 ' O ' ' C ' ' A' ' 121' ' ' PHE . 0.1 OUTLIER 48.28 41.5 16.25 Favored 'General case' 0 N--CA 1.516 2.853 0 O-C-N 120.332 -1.48 . . . . 0.0 110.643 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.472 ' C ' ' O ' ' A' ' 120' ' ' ASN . 0.1 OUTLIER 38.12 33.45 0.06 Allowed 'General case' 0 N--CA 1.52 3.049 0 O-C-N 121.048 -1.033 . . . . 0.0 110.01 179.827 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.425 ' N ' ' O ' ' A' ' 120' ' ' ASN . 0.1 OUTLIER -154.67 174.87 14.4 Favored 'General case' 0 N--CA 1.484 1.255 0 O-C-N 120.989 -1.069 . . . . 0.0 109.228 179.386 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.508 ' HB3' ' HD2' ' A' ' 124' ' ' PRO . 11.6 mmtt -60.63 168.39 2.55 Favored Pre-proline 0 N--CA 1.506 2.328 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.508 ' HD2' ' HB3' ' A' ' 123' ' ' LYS . 44.8 Cg_endo -72.66 41.75 0.55 Allowed 'Trans proline' 0 C--N 1.308 -1.58 0 O-C-N 123.399 1.21 . . . . 0.0 111.168 -179.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.518 ' O ' ' ND2' ' A' ' 126' ' ' ASN . 3.0 tp10 -178.17 -135.22 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.946 -1.096 . . . . 0.0 108.213 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.518 ' ND2' ' O ' ' A' ' 125' ' ' GLU . 0.2 OUTLIER 167.69 -66.68 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.145 0 O-C-N 120.412 -1.43 . . . . 0.0 109.71 179.32 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.519 ' O ' ' HB3' ' A' ' 128' ' ' ARG . . . -150.52 177.61 9.86 Favored 'General case' 0 C--N 1.295 -1.798 0 C-N-CA 119.883 -0.727 . . . . 0.0 109.519 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.519 ' HB3' ' O ' ' A' ' 127' ' ' ALA . 0.0 OUTLIER 174.29 -30.11 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.47 -1.394 . . . . 0.0 110.129 -179.724 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -82.75 163.65 21.14 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.485 -0.76 . . . . 0.0 110.65 -179.221 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 2.1 mmtt . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.604 179.625 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.592 ' CE ' ' CG ' ' A' ' 42' ' ' HIS . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.664 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 . . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.552 ' HA ' ' O ' ' A' ' 50' ' ' PHE . 63.5 t30 -78.5 91.06 4.5 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.725 -1.234 . . . . 0.0 108.444 178.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.462 ' CD1' HD13 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -41.59 -40.4 1.88 Allowed 'General case' 0 N--CA 1.52 3.035 0 O-C-N 120.598 -1.314 . . . . 0.0 110.371 -178.186 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.467 ' OG1' ' CG ' ' A' ' 52' ' ' ASP . 1.9 m -60.13 -35.07 74.45 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 118.601 -1.24 . . . . 0.0 108.288 -179.083 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.55 ' HB3' ' HB3' ' A' ' 2' ' ' ASN . 0.9 OUTLIER -72.65 -44.57 61.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.922 -1.112 . . . . 0.0 108.245 177.386 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.549 ' CG ' HG13 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -51.01 -51.4 53.36 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 120.834 -1.167 . . . . 0.0 108.68 178.37 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 8.1 mttm -62.5 -40.92 98.27 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.121 -0.987 . . . . 0.0 109.831 178.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.7 m-80 -62.74 -20.65 65.15 Favored 'General case' 0 N--CA 1.508 2.456 0 CA-C-O 121.79 0.805 . . . . 0.0 111.141 -179.072 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.588 ' CG2' ' CD1' ' A' ' 14' ' ' LEU . 94.5 m -79.26 122.25 83.94 Favored Pre-proline 0 C--N 1.283 -2.289 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.525 ' HG2' ' CG ' ' A' ' 13' ' ' GLU . 37.2 Cg_endo -57.48 155.55 30.36 Favored 'Trans proline' 0 N--CA 1.503 2.068 0 C-N-CA 120.488 0.792 . . . . 0.0 112.219 -177.609 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.56 ' CG1' ' N ' ' A' ' 12' ' ' SER . 1.6 p -45.24 -51.73 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.541 0 O-C-N 120.502 -1.374 . . . . 0.0 110.44 -178.843 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.56 ' N ' ' CG1' ' A' ' 11' ' ' VAL . 0.9 OUTLIER -56.86 -41.57 78.19 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.081 -1.012 . . . . 0.0 110.646 -179.52 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.539 ' HB3' ' CG2' ' A' ' 9' ' ' THR . 48.2 mm-40 -68.95 -26.85 65.27 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 118.155 -1.418 . . . . 0.0 107.975 179.375 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.588 ' CD1' ' CG2' ' A' ' 9' ' ' THR . 0.9 OUTLIER -70.35 -43.14 70.82 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 120.96 -1.087 . . . . 0.0 108.439 177.381 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.425 HG21 ' HB2' ' A' ' 26' ' ' LEU . 1.4 mp -66.37 -40.15 85.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 C-N-CA 118.108 -1.437 . . . . 0.0 108.659 178.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.504 ' HA ' ' HG2' ' A' ' 19' ' ' GLU . 92.7 m -63.91 -38.03 89.59 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.394 -1.441 . . . . 0.0 109.267 179.16 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.534 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 0.7 OUTLIER -65.81 -37.79 87.22 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.85 -1.156 . . . . 0.0 108.779 178.553 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.453 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -67.36 -43.5 87.7 Favored Glycine 0 N--CA 1.513 3.794 0 N-CA-C 108.505 -1.838 . . . . 0.0 108.505 178.51 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.668 ' HG3' ' N ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -59.33 -37.98 79.16 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.507 -1.584 . . . . 0.0 108.117 178.922 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.668 ' N ' ' HG3' ' A' ' 19' ' ' GLU . 28.1 m120 -61.32 -29.01 69.62 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 118.201 -1.4 . . . . 0.0 109.405 178.633 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.499 ' HG3' ' O ' ' A' ' 17' ' ' LEU . 18.6 mtp -101.53 12.84 36.57 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.215 -0.928 . . . . 0.0 111.153 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.66 -22.9 34.29 Favored Glycine 0 N--CA 1.502 3.082 0 C-N-CA 118.632 -1.747 . . . . 0.0 111.299 179.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.575 ' O ' ' CD1' ' A' ' 26' ' ' LEU . 2.9 mp -79.45 93.63 5.42 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.396 -1.65 . . . . 0.0 109.776 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -108.1 175.79 5.36 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.141 -0.974 . . . . 0.0 109.285 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 62.99 21.1 12.7 Favored 'General case' 0 N--CA 1.507 2.404 0 O-C-N 121.914 -0.491 . . . . 0.0 111.549 178.998 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.575 ' CD1' ' O ' ' A' ' 23' ' ' LEU . 0.4 OUTLIER -77.19 -7.59 56.12 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 120.985 -1.072 . . . . 0.0 111.413 -179.86 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 26' ' ' LEU . . . -46.71 -31.73 3.12 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.441 -1.412 . . . . 0.0 108.977 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.558 ' CD ' ' C ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -80.82 -2.12 45.9 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 120.081 -0.648 . . . . 0.0 111.502 -179.99 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.498 ' HB3' HG13 ' A' ' 34' ' ' ILE . 14.8 mtp -100.85 162.78 12.67 Favored 'General case' 0 C--N 1.313 -0.989 0 O-C-N 120.639 -1.288 . . . . 0.0 111.636 -179.004 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.514 ' O ' HD13 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -89.71 164.26 14.77 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.647 0.737 . . . . 0.0 110.563 178.502 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.564 ' O ' HG23 ' A' ' 35' ' ' ILE . 2.6 ttmm -55.62 -41.95 74.22 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.509 -0.744 . . . . 0.0 111.082 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.54 ' O ' HG23 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -63.69 -53.46 50.96 Favored 'General case' 0 N--CA 1.521 3.086 0 O-C-N 121.495 -0.753 . . . . 0.0 112.194 -178.346 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 34' ' ' ILE . 1.7 p30 -67.23 -40.56 86.35 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 120.415 -1.428 . . . . 0.0 109.312 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.579 ' CG2' ' HB3' ' A' ' 14' ' ' LEU . 15.7 mt -61.91 -39.44 83.58 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 O-C-N 120.506 -1.371 . . . . 0.0 109.363 178.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.564 HG23 ' O ' ' A' ' 31' ' ' LYS . 0.1 OUTLIER -67.59 -38.12 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.435 0 O-C-N 120.238 -1.539 . . . . 0.0 109.221 178.519 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.435 ' HA ' HD11 ' A' ' 39' ' ' LEU . 5.3 m-85 -62.28 -43.54 98.59 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.594 -1.316 . . . . 0.0 108.86 178.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.558 ' CB ' ' CD2' ' A' ' 23' ' ' LEU . . . -57.2 -54.66 44.27 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.413 -1.429 . . . . 0.0 108.501 178.044 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.481 HG13 ' O ' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -54.59 -32.31 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 C-N-CA 117.402 -1.719 . . . . 0.0 109.345 179.088 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.491 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 11.1 mt -68.33 -40.66 81.52 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 120.299 -1.501 . . . . 0.0 109.35 178.22 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . 0.468 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 3.4 mtpp -66.23 -38.78 88.73 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.001 -1.062 . . . . 0.0 110.684 178.795 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.526 ' HG3' ' CD1' ' A' ' 23' ' ' LEU . 1.1 mm-40 -75.9 -52.87 9.38 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.24 -0.913 . . . . 0.0 111.13 -179.132 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.592 ' CG ' ' CE ' ' A' ' 1' ' ' MET . 2.8 t-80 -64.26 -36.38 83.92 Favored 'General case' 0 N--CA 1.51 2.54 0 O-C-N 120.951 -1.093 . . . . 0.0 109.37 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.591 ' O ' ' N ' ' A' ' 46' ' ' GLY . . . -77.28 -32.24 55.35 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.89 -1.131 . . . . 0.0 110.62 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.468 ' HB2' ' O ' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -47.33 -44.04 23.39 Favored 'General case' 0 N--CA 1.481 1.116 0 O-C-N 120.411 -1.43 . . . . 0.0 108.972 178.548 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 25.4 m -66.81 -10.57 49.12 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 119.573 -0.851 . . . . 0.0 109.548 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.591 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . 65.78 31.53 80.09 Favored Glycine 0 N--CA 1.495 2.593 0 C-N-CA 120.401 -0.904 . . . . 0.0 111.156 178.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.555 ' OE2' ' ND1' ' A' ' 42' ' ' HIS . 3.4 pt-20 -85.15 170.13 13.2 Favored 'General case' 0 N--CA 1.484 1.226 0 O-C-N 120.408 -1.642 . . . . 0.0 109.225 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.474 ' C ' ' CG2' ' A' ' 49' ' ' ILE . 7.6 m-20 -61.54 138.07 58.27 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.14 -0.975 . . . . 0.0 111.934 -177.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.55 ' HA ' ' HA ' ' A' ' 1' ' ' MET . 0.5 OUTLIER -157.13 144.09 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 178.455 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.552 ' O ' ' HA ' ' A' ' 2' ' ' ASN . 24.6 p90 -141.93 168.17 20.38 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 115.616 -2.434 . . . . 0.0 115.504 -178.151 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -116.15 164.32 12.28 Favored Glycine 0 N--CA 1.499 2.867 0 N-CA-C 107.784 -2.126 . . . . 0.0 107.784 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.512 ' C ' ' CD2' ' A' ' 65' ' ' LEU . 5.8 p-10 -172.37 163.18 5.59 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 120.322 -1.693 . . . . 0.0 109.657 -179.102 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.443 ' HA3' ' O ' ' A' ' 66' ' ' ARG . . . 146.31 -139.74 8.31 Favored Glycine 0 N--CA 1.504 3.195 0 C-N-CA 117.991 -2.052 . . . . 0.0 111.131 179.131 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.53 ' HA ' ' O ' ' A' ' 95' ' ' ASP . 2.6 t -128.07 119.7 51.71 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.9 mt -62.76 164.25 8.14 Favored 'General case' 0 N--CA 1.504 2.254 0 C-N-CA 118.782 -1.167 . . . . 0.0 113.869 -175.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.483 ' HA ' ' OG1' ' A' ' 93' ' ' THR . 0.8 OUTLIER -141.78 119.35 11.67 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 178.384 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.578 ' CG1' ' HB ' ' A' ' 93' ' ' THR . 1.0 OUTLIER -80.19 162.63 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 119.903 -1.748 . . . . 0.0 109.265 -178.718 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.576 HD21 ' CE1' ' A' ' 62' ' ' PHE . 3.3 mp -132.12 136.19 46.96 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.426 -1.421 . . . . 0.0 109.675 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.453 ' C ' ' O ' ' A' ' 58' ' ' LEU . 2.0 tt0 -39.77 -36.37 0.42 Allowed 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.749 0.785 . . . . 0.0 110.102 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.437 ' HB2' ' CD1' ' A' ' 62' ' ' PHE . 66.6 m-20 -61.46 -5.94 2.04 Favored 'General case' 0 N--CA 1.501 2.092 0 C-N-CA 119.959 -0.696 . . . . 0.0 112.51 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.457 ' O ' ' HB3' ' A' ' 83' ' ' PRO . . . 89.85 11.91 62.95 Favored Glycine 1 N--CA 1.52 4.282 0 C-N-CA 118.71 -1.709 . . . . 0.0 112.185 178.089 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.576 ' CE1' HD21 ' A' ' 58' ' ' LEU . 2.8 p90 -132.95 -176.93 4.28 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 103.865 -2.642 . . . . 0.0 103.865 177.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.524 ' HA2' ' CD1' ' A' ' 58' ' ' LEU . . . -158.75 172.39 35.58 Favored Glycine 0 N--CA 1.474 1.216 0 C-N-CA 116.933 -2.556 . . . . 0.0 111.706 -177.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.544 ' CE2' ' CE2' ' A' ' 62' ' ' PHE . 43.5 m-85 -129.7 154.29 47.31 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 119.99 1.895 . . . . 0.0 109.708 177.48 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.512 ' CD2' ' C ' ' A' ' 52' ' ' ASP 0.255 0.2 OUTLIER -98.39 134.33 41.54 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 107.005 -1.479 . . . . 0.0 107.005 176.892 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.443 ' O ' ' HA3' ' A' ' 53' ' ' GLY . 0.4 OUTLIER -135.99 -173.04 3.27 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.225 -1.547 . . . . 0.0 109.658 179.446 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.477 ' CB ' ' OG ' ' A' ' 70' ' ' SER . 6.5 m -76.71 -161.17 0.18 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.036 -1.04 . . . . 0.0 110.573 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -127.68 -89.73 0.53 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.445 -0.785 . . . . 0.0 109.659 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -77.24 44.69 0.42 Allowed 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.148 -0.97 . . . . 0.0 111.245 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.477 ' OG ' ' CB ' ' A' ' 67' ' ' SER . 0.1 OUTLIER -126.35 -7.68 6.4 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 120.17 -1.581 . . . . 0.0 110.464 -179.665 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.669 ' O ' ' HB2' ' A' ' 72' ' ' TYR . 0.6 OUTLIER 175.37 -20.45 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.229 0 O-C-N 120.851 -1.156 . . . . 0.0 111.537 -179.831 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.669 ' HB2' ' O ' ' A' ' 71' ' ' SER . 10.2 m-30 75.0 -40.76 0.45 Allowed 'General case' 0 N--CA 1.528 3.459 0 O-C-N 121.849 -0.532 . . . . 0.0 112.104 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 7.0 mt -88.37 -173.57 4.25 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.279 -1.513 . . . . 0.0 109.904 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.03 -153.01 0.08 Allowed 'General case' 0 C--N 1.292 -1.934 0 CA-C-O 122.46 1.124 . . . . 0.0 109.725 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.521 ' N ' ' OD2' ' A' ' 78' ' ' ASP . . . -176.29 162.5 31.31 Favored Glycine 0 C--N 1.28 -2.532 0 N-CA-C 107.724 -2.15 . . . . 0.0 107.724 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -65.16 -41.2 17.19 Favored 'Trans proline' 0 N--CA 1.489 1.215 0 CA-C-N 118.608 1.204 . . . . 0.0 112.077 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.471 ' O ' ' O ' ' A' ' 78' ' ' ASP . 4.7 m-20 -87.45 19.83 3.13 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 120.93 -1.106 . . . . 0.0 112.461 -178.648 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.521 ' OD2' ' N ' ' A' ' 75' ' ' GLY . 3.2 m-20 -58.97 -154.65 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.429 0 O-C-N 120.415 -1.428 . . . . 0.0 109.632 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.438 ' HB ' ' CB ' ' A' ' 65' ' ' LEU . 4.4 mm -120.21 131.61 72.07 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.745 0 O-C-N 120.969 -1.082 . . . . 0.0 109.979 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.483 ' HB3' ' HA ' ' A' ' 112' ' ' ALA . 10.4 t80 -76.71 147.35 37.44 Favored 'General case' 0 N--CA 1.518 2.934 0 CA-C-N 121.85 2.114 . . . . 0.0 109.462 179.261 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 11.1 t -145.51 116.8 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 120.151 -1.593 . . . . 0.0 110.2 -179.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.531 ' O ' HG13 ' A' ' 86' ' ' ILE . 56.1 m -74.95 161.67 76.62 Favored Pre-proline 0 N--CA 1.51 2.555 0 O-C-N 120.34 -1.475 . . . . 0.0 112.248 -179.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.564 ' HA ' HG13 ' A' ' 86' ' ' ILE . 38.0 Cg_endo -65.19 -50.97 1.73 Allowed 'Trans proline' 0 C--N 1.313 -1.315 0 O-C-N 124.887 1.993 . . . . 0.0 108.554 178.569 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.572 ' O ' ' CG ' ' A' ' 88' ' ' ARG . 3.0 p -46.02 -41.53 12.08 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 177.718 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.516 ' OE1' ' HA ' ' A' ' 85' ' ' GLN . 6.6 mm100 -62.48 -58.07 8.92 Favored 'General case' 0 N--CA 1.511 2.586 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 178.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.564 HG13 ' HA ' ' A' ' 83' ' ' PRO . 0.4 OUTLIER -55.83 -56.26 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.262 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 178.386 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.485 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 9.7 mtt85 -58.41 -41.84 85.84 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-O 121.825 0.822 . . . . 0.0 111.731 -179.016 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.572 ' CG ' ' O ' ' A' ' 84' ' ' SER . 0.1 OUTLIER -60.04 -37.66 80.46 Favored 'General case' 0 N--CA 1.507 2.376 0 C-N-CA 119.612 -0.835 . . . . 0.0 111.938 -177.679 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.598 ' HB2' ' CD2' ' A' ' 91' ' ' LEU . 5.0 m-85 -109.58 11.85 24.59 Favored 'General case' 0 N--CA 1.503 2.206 0 C-N-CA 116.818 -1.953 . . . . 0.0 111.148 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.406 ' CB ' ' O ' ' A' ' 89' ' ' PHE . 1.5 t-20 63.74 53.6 1.97 Allowed 'General case' 0 N--CA 1.486 1.342 0 O-C-N 120.611 -1.306 . . . . 0.0 110.818 178.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.598 ' CD2' ' HB2' ' A' ' 89' ' ' PHE . 2.9 mt -89.7 -168.96 2.3 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 119.37 -0.932 . . . . 0.0 109.752 179.259 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.53 ' CG ' ' O ' ' A' ' 91' ' ' LEU . 0.2 OUTLIER -159.7 161.38 34.83 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 178.231 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.578 ' HB ' ' CG1' ' A' ' 57' ' ' ILE . 1.9 t -64.83 155.64 33.39 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 116.869 -1.932 . . . . 0.0 106.893 178.505 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.422 ' C ' HG11 ' A' ' 54' ' ' VAL . . . 75.29 -9.09 14.6 Favored Glycine 0 N--CA 1.506 3.338 0 C-N-CA 117.299 -2.382 . . . . 0.0 110.388 179.329 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.53 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 15.4 m-20 -68.1 149.66 49.34 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.137 -1.802 . . . . 0.0 110.724 -178.784 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.484 ' O ' HG12 ' A' ' 97' ' ' ILE . 0.3 OUTLIER -91.58 121.19 33.04 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.621 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.529 HG22 HG21 ' A' ' 119' ' ' VAL . 1.4 mt -144.82 166.61 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 119.93 -1.732 . . . . 0.0 112.885 -178.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.469 ' OG ' ' HB2' ' A' ' 118' ' ' GLU . 96.7 p -150.93 139.76 20.85 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.999 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.455 ' O ' ' HB2' ' A' ' 50' ' ' PHE . . . -164.47 -179.66 38.72 Favored Glycine 0 N--CA 1.509 3.545 0 C-N-CA 117.643 -2.218 . . . . 0.0 114.609 -179.214 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.5 ' HG2' ' HB3' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -87.23 155.39 20.11 Favored 'General case' 0 N--CA 1.504 2.239 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 178.589 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.447 HG12 ' HA ' ' A' ' 50' ' ' PHE . 2.2 pt -122.46 158.56 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.643 0 CA-C-N 121.228 1.831 . . . . 0.0 114.435 -176.846 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.459 ' HB2' ' CD2' ' A' ' 114' ' ' LEU . 0.1 OUTLIER -163.89 167.47 10.87 Favored Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 120.651 -1.281 . . . . 0.0 109.642 179.311 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.409 ' HD2' ' HD3' ' A' ' 102' ' ' ARG . 48.6 Cg_endo -89.62 122.8 1.17 Allowed 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 124.068 1.562 . . . . 0.0 110.391 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.506 ' HD2' ' HB2' ' A' ' 108' ' ' GLU . 43.2 Cg_endo -68.31 -93.11 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 123.903 1.475 . . . . 0.0 111.019 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 2.9 mmtp -116.76 -177.96 3.31 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.401 -0.812 . . . . 0.0 110.464 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -56.34 -25.97 50.95 Favored 'General case' 0 C--N 1.313 -1.01 0 O-C-N 120.693 -1.255 . . . . 0.0 109.357 179.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -85.13 43.3 3.23 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 108.504 -1.838 . . . . 0.0 108.504 178.154 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.566 ' O ' ' C ' ' A' ' 109' ' ' ARG . 0.7 OUTLIER -93.51 35.02 1.13 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.709 -1.465 . . . . 0.0 111.397 -179.004 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.566 ' C ' ' O ' ' A' ' 108' ' ' GLU . 3.6 mmp_? -25.13 -45.08 0.01 OUTLIER 'General case' 0 N--CA 1.513 2.712 0 O-C-N 121.793 -0.567 . . . . 0.0 111.357 -179.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.536 ' N ' ' CD1' ' A' ' 110' ' ' TYR . 2.8 m-85 -109.26 154.75 22.0 Favored 'General case' 0 N--CA 1.518 2.938 0 O-C-N 120.581 -1.325 . . . . 0.0 107.72 177.066 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.481 ' O ' ' HB3' ' A' ' 80' ' ' TYR . 38.1 m-85 -66.9 165.56 15.18 Favored 'General case' 0 N--CA 1.508 2.427 0 O-C-N 119.135 -2.228 . . . . 0.0 107.273 178.58 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.483 ' HA ' ' HB3' ' A' ' 80' ' ' TYR . . . -123.24 152.87 40.88 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 119.905 -1.747 . . . . 0.0 111.216 -178.504 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.77 153.68 42.72 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 178.753 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.459 ' CD2' ' HB2' ' A' ' 102' ' ' ARG . 12.9 tp -130.86 -59.41 1.0 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 120.047 -1.658 . . . . 0.0 112.361 -178.313 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.5 ' HB3' ' HG2' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -114.05 139.97 48.85 Favored 'General case' 0 N--CA 1.512 2.646 0 O-C-N 120.383 -1.448 . . . . 0.0 108.767 179.206 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 23.7 t -92.27 128.78 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.804 0 O-C-N 120.477 -1.39 . . . . 0.0 111.37 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.401 ' CG ' ' HA2' ' A' ' 99' ' ' GLY . 4.8 m-20 -106.97 -38.5 6.03 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.355 -0.841 . . . . 0.0 109.947 178.624 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.49 ' C ' ' CG2' ' A' ' 119' ' ' VAL . 1.1 tt0 -143.5 157.21 44.62 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.786 -1.196 . . . . 0.0 109.803 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.529 HG21 HG22 ' A' ' 97' ' ' ILE . 17.8 t -159.74 130.99 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 122.387 -0.196 . . . . 0.0 110.511 -178.532 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.43 ' O ' ' C ' ' A' ' 121' ' ' PHE . 0.1 OUTLIER 47.95 48.24 18.11 Favored 'General case' 0 N--CA 1.521 3.081 0 O-C-N 120.309 -1.495 . . . . 0.0 111.481 178.902 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.43 ' C ' ' O ' ' A' ' 120' ' ' ASN . 0.6 OUTLIER 42.81 32.16 0.37 Allowed 'General case' 0 N--CA 1.52 3.056 0 O-C-N 120.557 -1.339 . . . . 0.0 110.43 179.152 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -139.61 165.87 26.1 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.05 -1.031 . . . . 0.0 108.455 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -78.47 143.73 64.45 Favored Pre-proline 0 N--CA 1.504 2.229 0 O-C-N 120.564 -1.335 . . . . 0.0 109.109 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.481 ' O ' ' HB2' ' A' ' 125' ' ' GLU . 46.6 Cg_endo -73.65 42.63 0.71 Allowed 'Trans proline' 0 C--N 1.309 -1.536 0 O-C-N 123.879 1.462 . . . . 0.0 110.855 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.561 ' O ' ' CB ' ' A' ' 126' ' ' ASN . 5.3 tp10 -179.25 -144.73 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.561 ' CB ' ' O ' ' A' ' 125' ' ' GLU . 0.3 OUTLIER 162.74 -90.14 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.266 0 O-C-N 120.874 -1.141 . . . . 0.0 109.29 179.428 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.504 ' C ' ' HG2' ' A' ' 128' ' ' ARG . . . -149.32 6.72 0.67 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.206 -0.934 . . . . 0.0 111.099 179.566 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.504 ' HG2' ' C ' ' A' ' 127' ' ' ALA . 0.8 OUTLIER -139.8 166.86 23.5 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.462 -0.774 . . . . 0.0 109.655 179.569 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -117.78 145.6 44.4 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.114 -0.991 . . . . 0.0 109.621 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.482 1.129 0 O-C-N 120.708 -1.245 . . . . 0.0 109.755 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.592 ' HA ' ' HA ' ' A' ' 49' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.567 ' HB2' ' CE1' ' A' ' 50' ' ' PHE . 39.3 t30 -78.46 94.18 4.88 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 120.85 -1.156 . . . . 0.0 108.137 178.836 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.444 HD13 HD11 ' A' ' 6' ' ' LEU . 0.5 OUTLIER -41.81 -42.29 2.62 Favored 'General case' 0 N--CA 1.519 3.007 0 O-C-N 120.518 -1.364 . . . . 0.0 110.241 -178.399 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.7 m -56.33 -36.46 68.74 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.983 -1.073 . . . . 0.0 108.311 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.537 ' HB2' ' HB3' ' A' ' 2' ' ' ASN . 3.0 mt-10 -76.54 -39.26 53.38 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.9 -1.125 . . . . 0.0 109.317 178.06 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.444 HD11 HD13 ' A' ' 3' ' ' LEU 0.267 90.7 mt -54.82 -49.2 71.61 Favored 'General case' 0 C--O 1.215 -0.752 0 O-C-N 120.31 -1.494 . . . . 0.0 109.174 177.984 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.04 -39.16 75.9 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.936 -1.103 . . . . 0.0 110.769 179.15 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -63.14 -22.48 66.89 Favored 'General case' 0 N--CA 1.507 2.405 0 O-C-N 121.1 -1.0 . . . . 0.0 111.221 -179.119 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.568 ' CG2' ' CD1' ' A' ' 14' ' ' LEU . 22.7 m -81.12 140.02 49.36 Favored Pre-proline 0 N--CA 1.505 2.278 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.504 ' HG2' ' HB2' ' A' ' 13' ' ' GLU . 41.6 Cg_endo -63.75 152.23 81.48 Favored 'Trans proline' 0 CA--C 1.566 2.088 0 O-C-N 122.293 0.628 . . . . 0.0 111.773 -177.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.502 ' CG1' ' N ' ' A' ' 12' ' ' SER . 1.5 p -47.58 -50.42 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.337 0 O-C-N 120.517 -1.364 . . . . 0.0 109.997 -178.811 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.502 ' N ' ' CG1' ' A' ' 11' ' ' VAL . 1.6 t -54.48 -43.72 71.98 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.011 -1.055 . . . . 0.0 110.763 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.526 ' HB3' ' CG2' ' A' ' 9' ' ' THR . 1.0 OUTLIER -68.31 -27.12 66.01 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 118.158 -1.417 . . . . 0.0 107.967 179.631 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.595 HD11 ' N ' ' A' ' 14' ' ' LEU . 1.3 mp -70.11 -43.45 71.0 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.985 -1.072 . . . . 0.0 108.603 177.492 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.469 HG12 ' HB2' ' A' ' 26' ' ' LEU . 1.6 mp -66.55 -39.1 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 C-N-CA 118.148 -1.421 . . . . 0.0 108.822 178.945 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.502 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 58.8 m -64.89 -38.0 89.5 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 118.036 -1.466 . . . . 0.0 109.205 178.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.459 HD11 ' O ' ' A' ' 13' ' ' GLU . 0.2 OUTLIER -66.33 -36.82 83.91 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.792 -1.192 . . . . 0.0 108.907 178.709 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.477 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -67.91 -43.2 83.76 Favored Glycine 0 N--CA 1.515 3.961 0 N-CA-C 108.129 -1.989 . . . . 0.0 108.129 178.166 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -55.51 -46.39 76.98 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.631 -1.511 . . . . 0.0 107.685 178.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.502 ' OD1' ' O ' ' A' ' 16' ' ' THR . 25.2 m120 -59.53 -25.64 64.67 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 118.202 -1.399 . . . . 0.0 109.145 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.534 ' HB2' ' CD1' ' A' ' 23' ' ' LEU . 64.7 mmm -100.93 11.99 38.52 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.489 -0.757 . . . . 0.0 111.06 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 96.06 -17.15 59.82 Favored Glycine 0 N--CA 1.502 3.058 0 C-N-CA 118.804 -1.665 . . . . 0.0 111.408 179.31 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.588 ' O ' ' CD1' ' A' ' 26' ' ' LEU . 4.1 mp -79.41 102.76 8.89 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.471 -1.605 . . . . 0.0 109.782 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.474 ' O ' ' HB2' ' A' ' 25' ' ' ASN . 2.0 pt-20 -114.85 -179.72 3.71 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.28 -0.888 . . . . 0.0 109.1 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.474 ' HB2' ' O ' ' A' ' 24' ' ' GLU . 1.8 m120 62.38 18.48 10.32 Favored 'General case' 0 N--CA 1.51 2.53 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.7 178.851 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.588 ' CD1' ' O ' ' A' ' 23' ' ' LEU . 1.2 mt -76.29 -18.22 59.07 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.196 -0.94 . . . . 0.0 111.408 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -47.27 -29.5 2.48 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.213 -1.555 . . . . 0.0 109.524 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -78.88 -30.4 44.97 Favored 'General case' 0 C--N 1.295 -1.795 0 C-N-CA 120.11 -0.636 . . . . 0.0 112.2 -179.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.594 ' CG ' HG13 ' A' ' 34' ' ' ILE . 6.6 ptm -93.22 166.99 12.05 Favored 'General case' 0 C--N 1.311 -1.073 0 O-C-N 120.426 -1.421 . . . . 0.0 111.084 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.534 ' O ' ' CD1' ' A' ' 34' ' ' ILE . 1.0 OUTLIER -89.39 -173.65 4.08 Favored 'General case' 0 N--CA 1.506 2.358 0 CA-C-O 122.219 1.009 . . . . 0.0 112.864 -178.428 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.559 ' O ' HG13 ' A' ' 35' ' ' ILE . 0.3 OUTLIER -66.32 -35.67 80.97 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.522 -179.722 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -63.02 -58.82 6.01 Favored 'General case' 0 N--CA 1.515 2.796 0 O-C-N 120.766 -1.209 . . . . 0.0 109.667 -178.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.532 ' HB2' ' HE1' ' A' ' 29' ' ' MET . 3.6 p30 -66.3 -35.27 79.95 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.457 -0.777 . . . . 0.0 109.717 -179.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.594 HG13 ' CG ' ' A' ' 29' ' ' MET . 0.8 OUTLIER -60.9 -43.72 96.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 120.081 -1.637 . . . . 0.0 107.898 177.141 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.559 HG13 ' O ' ' A' ' 31' ' ' LYS . 86.7 mt -63.39 -45.38 98.19 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.854 0 O-C-N 120.318 -1.489 . . . . 0.0 110.357 178.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 3.6 m-30 -53.59 -40.15 65.43 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 119.203 -0.999 . . . . 0.0 108.566 -179.051 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.513 ' C ' ' CD2' ' A' ' 23' ' ' LEU . . . -68.09 -54.28 19.36 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.614 -1.304 . . . . 0.0 109.606 178.221 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.496 HG13 ' O ' ' A' ' 34' ' ' ILE . 0.1 OUTLIER -53.49 -28.0 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 C-N-CA 117.545 -1.662 . . . . 0.0 110.007 -179.969 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.567 HD11 ' CE1' ' A' ' 111' ' ' PHE . 79.8 mt -71.13 -43.68 67.12 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 120.219 -1.551 . . . . 0.0 109.335 178.191 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.26 -39.69 92.98 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.979 -1.075 . . . . 0.0 110.581 178.832 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.487 ' HG2' HD13 ' A' ' 23' ' ' LEU . 1.4 mp0 -74.56 -51.22 15.24 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 121.146 -0.971 . . . . 0.0 110.726 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.64 ' CD2' ' CB ' ' A' ' 47' ' ' GLU . 9.9 t60 -61.99 -34.55 76.37 Favored 'General case' 0 N--CA 1.51 2.539 0 C-N-CA 118.65 -1.22 . . . . 0.0 108.573 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.532 ' O ' ' N ' ' A' ' 46' ' ' GLY . . . -70.51 -45.26 65.94 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.043 -1.036 . . . . 0.0 109.079 178.349 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -48.28 -45.66 34.97 Favored 'General case' 0 N--CA 1.484 1.252 0 O-C-N 120.752 -1.217 . . . . 0.0 109.138 178.274 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 68.4 m -66.99 -6.94 18.94 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-O 121.547 0.689 . . . . 0.0 109.696 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.532 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . 76.45 24.9 66.84 Favored Glycine 0 N--CA 1.498 2.801 0 C-N-CA 120.148 -1.025 . . . . 0.0 112.094 178.329 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.64 ' CB ' ' CD2' ' A' ' 42' ' ' HIS . 0.2 OUTLIER -79.42 166.74 21.71 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.129 -1.806 . . . . 0.0 109.086 178.817 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.432 ' C ' ' CG2' ' A' ' 49' ' ' ILE . 8.3 m-20 -88.66 150.02 23.23 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.07 -1.019 . . . . 0.0 109.391 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.592 ' HA ' ' HA ' ' A' ' 1' ' ' MET . 0.5 OUTLIER -148.98 143.28 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 120.668 -1.27 . . . . 0.0 108.46 179.246 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.567 ' CE1' ' HB2' ' A' ' 2' ' ' ASN . 23.6 p90 -142.75 172.07 13.2 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 116.088 -2.245 . . . . 0.0 114.918 -177.992 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -126.23 168.94 18.23 Favored Glycine 0 N--CA 1.508 3.445 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 -178.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -169.67 166.51 9.85 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 120.429 -1.63 . . . . 0.0 110.315 -178.904 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.575 ' HA3' ' O ' ' A' ' 66' ' ' ARG . . . 142.47 -135.75 6.79 Favored Glycine 0 N--CA 1.506 3.306 0 C-N-CA 118.349 -1.882 . . . . 0.0 111.591 178.326 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.491 ' HA ' ' O ' ' A' ' 95' ' ' ASP . 2.6 t -128.44 120.04 51.9 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 O-C-N 121.235 -1.156 . . . . 0.0 108.292 -179.467 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.0 mt -62.92 161.2 13.3 Favored 'General case' 0 N--CA 1.503 2.22 0 C-N-CA 118.645 -1.222 . . . . 0.0 113.681 -175.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.459 ' HA ' ' OG1' ' A' ' 93' ' ' THR . 18.1 mm-40 -137.14 117.89 14.05 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 177.86 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.591 ' CG1' ' HB ' ' A' ' 93' ' ' THR . 1.4 mm -82.3 162.67 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 O-C-N 119.959 -1.713 . . . . 0.0 109.624 -178.591 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.589 ' CD2' ' CZ ' ' A' ' 62' ' ' PHE . 5.8 mp -129.95 137.64 50.44 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.531 -1.356 . . . . 0.0 109.462 179.107 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.458 ' C ' ' O ' ' A' ' 58' ' ' LEU . 1.8 mt-30 -42.09 -34.69 0.77 Allowed 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.951 0.881 . . . . 0.0 109.143 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -61.34 -7.17 2.69 Favored 'General case' 0 N--CA 1.499 2.012 0 C-N-CA 120.213 -0.595 . . . . 0.0 112.341 -179.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 90.99 7.51 65.87 Favored Glycine 1 N--CA 1.52 4.252 0 C-N-CA 118.804 -1.665 . . . . 0.0 112.225 178.112 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.589 ' CZ ' ' CD2' ' A' ' 58' ' ' LEU . 2.0 p90 -127.8 179.77 5.37 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 104.469 -2.419 . . . . 0.0 104.469 178.087 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.55 ' N ' ' CD1' ' A' ' 62' ' ' PHE . . . -156.22 171.48 33.99 Favored Glycine 0 N--CA 1.477 1.387 0 C-N-CA 117.186 -2.435 . . . . 0.0 111.879 -178.111 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.461 ' CE2' ' HE1' ' A' ' 62' ' ' PHE . 14.5 m-85 -128.99 149.11 50.96 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 119.861 1.831 . . . . 0.0 109.25 177.238 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.535 ' HB3' ' HB ' ' A' ' 79' ' ' ILE . 0.6 OUTLIER -99.42 165.35 11.7 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 176.392 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.575 ' O ' ' HA3' ' A' ' 53' ' ' GLY . 0.0 OUTLIER 172.49 -169.73 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.97 -1.081 . . . . 0.0 109.712 178.525 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.454 ' HB2' ' OG ' ' A' ' 70' ' ' SER . 17.1 m -71.94 -159.96 0.06 Allowed 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.716 -1.24 . . . . 0.0 109.949 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -107.03 -76.02 0.62 Allowed 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 119.697 -0.801 . . . . 0.0 110.048 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -73.28 51.39 0.32 Allowed 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.305 -0.872 . . . . 0.0 110.824 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.546 ' O ' ' CB ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -110.56 -18.62 13.15 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.399 -1.438 . . . . 0.0 110.3 -179.717 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.609 ' O ' ' HB2' ' A' ' 72' ' ' TYR . 0.4 OUTLIER 165.65 -12.95 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.423 0 O-C-N 121.282 -0.886 . . . . 0.0 111.184 -179.689 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.609 ' HB2' ' O ' ' A' ' 71' ' ' SER . 69.7 m-85 77.52 -45.94 0.46 Allowed 'General case' 0 N--CA 1.524 3.234 0 O-C-N 121.798 -0.564 . . . . 0.0 110.764 -179.265 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.2 mt -87.77 -171.49 3.45 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 120.63 -1.294 . . . . 0.0 108.794 178.827 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.03 -162.21 0.37 Allowed 'General case' 0 C--N 1.289 -2.055 0 CA-C-O 122.026 0.917 . . . . 0.0 109.113 179.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -174.3 162.37 32.7 Favored Glycine 0 C--N 1.278 -2.64 0 N-CA-C 107.876 -2.09 . . . . 0.0 107.876 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.524 ' O ' ' CD1' ' A' ' 110' ' ' TYR . 35.7 Cg_endo -65.27 -41.49 15.99 Favored 'Trans proline' 0 N--CA 1.49 1.324 0 CA-C-N 118.352 1.076 . . . . 0.0 112.42 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -86.42 13.88 7.57 Favored 'General case' 0 N--CA 1.509 2.484 0 O-C-N 120.894 -1.129 . . . . 0.0 112.51 -178.471 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 78' ' ' ASP . 0.8 OUTLIER -77.43 -150.03 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.271 0 O-C-N 120.451 -1.405 . . . . 0.0 109.174 179.296 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.535 ' HB ' ' HB3' ' A' ' 65' ' ' LEU . 1.3 mp -117.88 127.64 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.721 0 C-N-CA 119.169 -1.012 . . . . 0.0 108.507 177.548 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.495 ' HB3' ' HA ' ' A' ' 112' ' ' ALA . 6.8 t80 -73.61 146.19 44.83 Favored 'General case' 0 N--CA 1.515 2.796 0 O-C-N 119.689 -1.882 . . . . 0.0 110.125 -178.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.409 ' HB ' ' O ' ' A' ' 63' ' ' GLY . 34.5 t -140.36 112.02 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 120.324 -1.485 . . . . 0.0 110.603 -179.563 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.522 ' O ' ' HB2' ' A' ' 85' ' ' GLN . 57.9 m -74.67 165.99 49.0 Favored Pre-proline 0 N--CA 1.513 2.697 0 O-C-N 120.519 -1.363 . . . . 0.0 112.041 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.522 ' HD2' ' HB3' ' A' ' 82' ' ' SER . 40.1 Cg_endo -65.21 -50.24 2.17 Favored 'Trans proline' 0 C--N 1.315 -1.189 0 O-C-N 124.317 1.693 . . . . 0.0 109.287 179.092 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.554 ' O ' ' CG ' ' A' ' 88' ' ' ARG . 0.3 OUTLIER -47.92 -39.66 19.7 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 178.106 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.522 ' HB2' ' O ' ' A' ' 82' ' ' SER . 5.6 mm100 -63.56 -58.86 5.65 Favored 'General case' 0 N--CA 1.51 2.551 0 C-N-CA 119.375 -0.93 . . . . 0.0 108.68 178.378 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.507 HG13 ' O ' ' A' ' 82' ' ' SER . 0.3 OUTLIER -57.23 -54.22 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.417 0 O-C-N 121.076 -1.015 . . . . 0.0 108.76 178.848 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.453 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 0.2 OUTLIER -56.25 -43.83 79.06 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 121.924 0.869 . . . . 0.0 111.27 -179.519 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.554 ' CG ' ' O ' ' A' ' 84' ' ' SER . 0.1 OUTLIER -57.97 -36.71 72.98 Favored 'General case' 0 N--CA 1.506 2.369 0 C-N-CA 119.792 -0.763 . . . . 0.0 111.724 -177.694 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -113.73 13.76 18.62 Favored 'General case' 0 N--CA 1.502 2.153 0 C-N-CA 117.359 -1.736 . . . . 0.0 111.462 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 58.41 55.13 5.12 Favored 'General case' 0 N--CA 1.484 1.239 0 O-C-N 120.434 -1.416 . . . . 0.0 109.621 178.656 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.484 ' O ' ' HG2' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -89.11 -179.29 5.87 Favored 'General case' 0 N--CA 1.496 1.834 0 C-N-CA 119.521 -0.872 . . . . 0.0 109.968 -179.832 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.484 ' HG2' ' O ' ' A' ' 91' ' ' LEU . 10.6 mtt-85 -155.13 158.21 38.64 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.186 -0.946 . . . . 0.0 109.115 178.95 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.591 ' HB ' ' CG1' ' A' ' 57' ' ' ILE . 2.3 t -63.7 156.39 27.14 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 117.205 -1.798 . . . . 0.0 107.186 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.4 ' HA2' HG13 ' A' ' 54' ' ' VAL . . . 76.23 -10.33 16.24 Favored Glycine 0 N--CA 1.505 3.272 0 C-N-CA 117.007 -2.52 . . . . 0.0 110.233 179.133 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.491 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 25.4 m-20 -70.34 146.86 50.21 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.272 -1.723 . . . . 0.0 110.795 -178.9 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.485 ' O ' HG12 ' A' ' 97' ' ' ILE . 0.2 OUTLIER -90.09 121.22 31.95 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.209 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.564 HG21 HG21 ' A' ' 119' ' ' VAL . 1.5 mt -145.67 168.51 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 119.733 -1.854 . . . . 0.0 112.89 -178.109 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.484 ' OG ' ' HB2' ' A' ' 118' ' ' GLU . 98.5 p -148.49 137.55 21.74 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 178.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.547 ' O ' ' HB2' ' A' ' 50' ' ' PHE . . . -161.95 176.11 38.41 Favored Glycine 0 N--CA 1.506 3.324 0 C-N-CA 117.163 -2.446 . . . . 0.0 114.546 -178.893 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.492 ' HG2' ' HB3' ' A' ' 115' ' ' LYS . 2.9 ptmt -88.83 156.66 18.81 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 179.053 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.494 HG12 ' HA ' ' A' ' 50' ' ' PHE . 2.0 pt -125.55 156.36 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.432 0 CA-C-N 120.37 1.441 . . . . 0.0 113.588 -176.965 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.521 ' HB2' ' CD1' ' A' ' 114' ' ' LEU . 0.0 OUTLIER -154.34 169.24 10.38 Favored Pre-proline 0 N--CA 1.488 1.466 0 O-C-N 120.56 -1.337 . . . . 0.0 109.5 179.289 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -83.98 133.97 5.98 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 O-C-N 123.964 1.507 . . . . 0.0 110.495 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.479 ' HD2' ' HG3' ' A' ' 108' ' ' GLU . 49.5 Cg_endo -80.12 -95.77 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.985 1.519 . . . . 0.0 110.448 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.59 -175.79 4.0 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.49 -0.756 . . . . 0.0 110.067 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -50.43 -26.45 5.04 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 120.517 -1.364 . . . . 0.0 109.179 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -84.64 46.79 3.73 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 107.735 -2.146 . . . . 0.0 107.735 177.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.558 ' O ' ' N ' ' A' ' 110' ' ' TYR . 4.2 tm-20 -86.01 -71.32 0.54 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.879 -1.365 . . . . 0.0 111.077 -178.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.484 ' HB3' ' O ' ' A' ' 108' ' ' GLU . 0.4 OUTLIER 64.22 -58.06 0.22 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.535 -0.728 . . . . 0.0 109.443 -178.803 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.558 ' N ' ' O ' ' A' ' 108' ' ' GLU . 22.7 m-85 -107.92 152.35 24.56 Favored 'General case' 0 N--CA 1.516 2.85 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 176.71 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.567 ' CE1' HD11 ' A' ' 39' ' ' LEU . 51.4 m-85 -67.32 168.16 11.11 Favored 'General case' 0 N--CA 1.507 2.424 0 O-C-N 119.246 -2.159 . . . . 0.0 108.252 179.275 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.495 ' HA ' ' HB3' ' A' ' 80' ' ' TYR . . . -122.87 154.93 37.64 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 119.994 -1.692 . . . . 0.0 110.883 -178.872 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.1 tp -68.38 148.41 50.73 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.521 ' CD1' ' HB2' ' A' ' 102' ' ' ARG . 9.7 tp -128.74 -55.18 1.22 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.315 -1.49 . . . . 0.0 112.616 -178.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.492 ' HB3' ' HG2' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -125.64 141.97 51.75 Favored 'General case' 0 N--CA 1.509 2.514 0 O-C-N 120.236 -1.54 . . . . 0.0 109.1 179.658 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.4 t -92.53 130.46 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.792 0 O-C-N 120.517 -1.364 . . . . 0.0 110.943 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -107.28 -38.73 5.88 Favored 'General case' 0 N--CA 1.506 2.375 0 O-C-N 121.393 -0.817 . . . . 0.0 110.012 178.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.488 ' O ' HG21 ' A' ' 97' ' ' ILE . 0.5 OUTLIER -143.24 158.33 43.72 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.853 -1.154 . . . . 0.0 109.435 179.722 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.564 HG21 HG21 ' A' ' 97' ' ' ILE . 44.3 t -158.8 133.62 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 -178.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.467 ' O ' ' C ' ' A' ' 121' ' ' PHE . 4.9 t-20 51.03 44.95 28.4 Favored 'General case' 0 N--CA 1.521 3.102 0 O-C-N 120.313 -1.492 . . . . 0.0 111.231 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.467 ' C ' ' O ' ' A' ' 120' ' ' ASN . 0.5 OUTLIER 39.41 35.9 0.19 Allowed 'General case' 0 N--CA 1.521 3.102 0 O-C-N 120.795 -1.19 . . . . 0.0 110.19 179.546 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -154.46 175.87 13.06 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.17 -0.956 . . . . 0.0 108.989 179.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.475 ' HB3' ' HD2' ' A' ' 124' ' ' PRO . 0.0 OUTLIER -64.04 166.91 8.96 Favored Pre-proline 0 N--CA 1.506 2.371 0 O-C-N 121.023 -1.048 . . . . 0.0 108.935 -179.974 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.475 ' HD2' ' HB3' ' A' ' 123' ' ' LYS . 45.7 Cg_endo -72.86 44.13 0.75 Allowed 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.816 1.429 . . . . 0.0 111.17 -179.343 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.526 ' O ' ' ND2' ' A' ' 126' ' ' ASN . 0.7 OUTLIER -176.55 -153.29 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.526 ' ND2' ' O ' ' A' ' 125' ' ' GLU . 0.2 OUTLIER 168.34 31.15 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.302 0 O-C-N 120.339 -1.476 . . . . 0.0 110.5 179.734 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -124.83 15.43 8.64 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.716 -1.24 . . . . 0.0 110.52 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.477 ' HD3' ' OE1' ' A' ' 125' ' ' GLU . 0.2 OUTLIER -159.0 165.04 34.94 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.41 -0.806 . . . . 0.0 110.546 -179.962 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -128.3 165.76 19.93 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.4 -0.813 . . . . 0.0 110.148 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.402 ' OXT' ' HG2' ' A' ' 130' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.304 -1.389 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.796 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.592 ' HA ' ' HA ' ' A' ' 49' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.503 ' HB3' ' HB3' ' A' ' 5' ' ' GLU . 52.5 t30 -78.44 96.73 5.45 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.919 -1.113 . . . . 0.0 108.356 178.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.546 ' CD2' ' CD1' ' A' ' 79' ' ' ILE . 0.6 OUTLIER -41.78 -41.89 2.47 Favored 'General case' 0 N--CA 1.516 2.863 0 O-C-N 120.405 -1.435 . . . . 0.0 110.501 -178.397 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.465 ' OG1' ' OD2' ' A' ' 52' ' ' ASP . 1.7 m -57.77 -37.55 73.87 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.577 -1.327 . . . . 0.0 108.151 -179.489 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.503 ' HB3' ' HB3' ' A' ' 2' ' ' ASN . 0.8 OUTLIER -70.4 -45.28 66.27 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.06 -1.025 . . . . 0.0 108.59 177.932 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.501 HD12 ' CD2' ' A' ' 39' ' ' LEU 0.278 84.0 mt -51.27 -50.04 60.04 Favored 'General case' 0 C--N 1.315 -0.893 0 O-C-N 120.886 -1.133 . . . . 0.0 109.476 178.15 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.425 ' HE3' ' HA ' ' A' ' 74' ' ' ALA . 5.7 mmtt -64.06 -36.49 84.17 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.241 -0.912 . . . . 0.0 110.085 179.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -61.93 -25.52 67.63 Favored 'General case' 0 N--CA 1.508 2.455 0 C-N-CA 119.282 -0.967 . . . . 0.0 111.031 -179.035 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.604 ' HB ' ' CD1' ' A' ' 14' ' ' LEU . 4.4 m -74.49 132.84 77.93 Favored Pre-proline 0 N--CA 1.504 2.256 0 O-C-N 121.675 -0.641 . . . . 0.0 109.687 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.502 ' HG2' ' HB2' ' A' ' 13' ' ' GLU . 45.0 Cg_endo -65.16 150.84 87.19 Favored 'Trans proline' 0 CA--C 1.567 2.149 0 CA-C-N 118.767 0.595 . . . . 0.0 110.67 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.552 ' CG1' ' N ' ' A' ' 12' ' ' SER . 1.7 p -42.44 -50.28 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.527 3.391 0 O-C-N 120.542 -1.348 . . . . 0.0 110.162 -178.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.552 ' N ' ' CG1' ' A' ' 11' ' ' VAL . 1.0 OUTLIER -57.67 -41.84 82.36 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.294 -0.879 . . . . 0.0 111.174 -179.266 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.566 ' HB3' ' CG2' ' A' ' 9' ' ' THR . 0.2 OUTLIER -69.25 -27.7 65.68 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 117.69 -1.604 . . . . 0.0 107.682 179.233 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.604 ' CD1' ' HB ' ' A' ' 9' ' ' THR . 0.0 OUTLIER -69.29 -43.1 74.52 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.828 -1.17 . . . . 0.0 108.754 176.906 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.448 ' CD1' HD12 ' A' ' 34' ' ' ILE . 1.4 mp -65.61 -40.59 88.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 C-N-CA 117.752 -1.579 . . . . 0.0 108.599 178.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.498 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 33.0 m -62.61 -37.75 87.52 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 120.542 -1.349 . . . . 0.0 109.146 179.198 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.52 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 0.2 OUTLIER -65.58 -36.82 84.87 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.923 -1.111 . . . . 0.0 108.609 178.343 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.508 ' HA2' HD11 ' A' ' 38' ' ' ILE . . . -67.39 -44.5 84.3 Favored Glycine 0 N--CA 1.513 3.829 0 N-CA-C 108.427 -1.869 . . . . 0.0 108.427 178.296 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.673 ' HG3' ' N ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -59.09 -38.63 79.97 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.435 -1.626 . . . . 0.0 108.298 178.889 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.673 ' N ' ' HG3' ' A' ' 19' ' ' GLU . 26.3 m120 -61.61 -28.57 69.46 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.514 -1.366 . . . . 0.0 109.337 178.563 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.547 ' HB2' ' CD1' ' A' ' 23' ' ' LEU . 17.6 mtp -101.81 13.03 36.03 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.325 -0.859 . . . . 0.0 111.128 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.4 -19.78 53.06 Favored Glycine 0 N--CA 1.501 2.97 0 C-N-CA 118.67 -1.728 . . . . 0.0 111.249 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.575 ' O ' ' CD1' ' A' ' 26' ' ' LEU . 3.4 mp -79.17 92.79 5.11 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 120.39 -1.653 . . . . 0.0 109.313 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.407 ' O ' ' CB ' ' A' ' 25' ' ' ASN . 3.4 pt-20 -106.86 179.63 4.21 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.119 -0.988 . . . . 0.0 109.384 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.407 ' CB ' ' O ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER 65.75 14.09 9.34 Favored 'General case' 0 N--CA 1.51 2.539 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.916 179.053 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.575 ' CD1' ' O ' ' A' ' 23' ' ' LEU . 0.5 OUTLIER -77.14 -7.53 55.95 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.029 -1.044 . . . . 0.0 111.6 -179.839 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 26' ' ' LEU . . . -46.64 -35.02 5.52 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.45 -1.406 . . . . 0.0 109.076 -179.164 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.1 mmt-85 -82.65 1.36 38.74 Favored 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 120.059 -0.657 . . . . 0.0 111.644 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.496 ' HB3' ' OD1' ' A' ' 33' ' ' ASP . 11.4 mtp -101.01 159.5 15.17 Favored 'General case' 0 C--N 1.313 -0.979 0 O-C-N 120.659 -1.276 . . . . 0.0 112.08 -178.551 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.525 ' O ' HD13 ' A' ' 34' ' ' ILE . 3.8 ttm180 -89.81 173.88 8.01 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 121.965 0.888 . . . . 0.0 111.094 178.324 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.604 ' O ' HG21 ' A' ' 35' ' ' ILE . 3.4 mtpp -62.23 -40.15 95.17 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.663 -0.648 . . . . 0.0 111.309 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.55 ' O ' HG21 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -64.96 -54.79 25.07 Favored 'General case' 0 N--CA 1.524 3.263 0 CA-C-O 121.845 0.831 . . . . 0.0 110.876 -178.758 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.54 ' OD1' ' N ' ' A' ' 34' ' ' ILE . 1.9 p30 -65.81 -41.65 91.63 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.886 -1.134 . . . . 0.0 109.262 -178.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.573 ' CG2' ' HB3' ' A' ' 14' ' ' LEU . 9.0 mt -62.21 -40.05 86.24 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 O-C-N 120.27 -1.519 . . . . 0.0 109.498 178.016 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.604 HG21 ' O ' ' A' ' 31' ' ' LYS . 0.4 OUTLIER -67.48 -34.39 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.625 0 O-C-N 120.125 -1.609 . . . . 0.0 109.46 178.543 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.461 ' CD2' ' O ' ' A' ' 32' ' ' GLN . 17.9 m-85 -66.05 -44.22 85.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.498 -1.376 . . . . 0.0 109.05 179.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.523 ' HB2' ' CD2' ' A' ' 23' ' ' LEU . . . -66.41 -54.15 27.64 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 120.539 -1.351 . . . . 0.0 109.622 178.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.547 ' CG2' ' N ' ' A' ' 39' ' ' LEU . 8.6 tp -50.5 -46.86 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.43 0 C-N-CA 117.239 -1.784 . . . . 0.0 108.239 179.194 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.547 ' N ' ' CG2' ' A' ' 38' ' ' ILE . 58.9 mt -58.6 -40.01 82.05 Favored 'General case' 0 N--CA 1.508 2.432 0 O-C-N 120.851 -1.155 . . . . 0.0 109.669 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.2 mttm -63.38 -35.83 81.7 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.365 -0.834 . . . . 0.0 109.941 179.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.476 ' HG3' ' CG ' ' A' ' 23' ' ' LEU . 12.0 mm-40 -77.77 -52.26 9.21 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.581 -0.7 . . . . 0.0 111.106 -179.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.546 ' CG ' ' HE3' ' A' ' 1' ' ' MET . 17.6 t60 -62.23 -34.38 76.38 Favored 'General case' 0 N--CA 1.51 2.558 0 C-N-CA 118.374 -1.331 . . . . 0.0 108.612 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.492 ' O ' ' N ' ' A' ' 46' ' ' GLY . . . -64.16 -43.71 94.34 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.959 -1.088 . . . . 0.0 108.493 177.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.0 tptt -48.01 -44.72 31.05 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 121.051 -1.03 . . . . 0.0 109.187 178.275 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.448 ' HB3' ' OE2' ' A' ' 47' ' ' GLU . 74.1 m -66.79 -8.16 26.48 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 121.675 0.75 . . . . 0.0 109.726 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . 73.39 29.63 63.75 Favored Glycine 0 N--CA 1.495 2.586 0 C-N-CA 120.055 -1.069 . . . . 0.0 111.636 178.601 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.542 ' CB ' ' CD2' ' A' ' 42' ' ' HIS . 0.3 OUTLIER -79.41 166.87 21.58 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.211 -1.758 . . . . 0.0 108.821 178.899 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.451 ' O ' HG21 ' A' ' 49' ' ' ILE . 53.3 m-20 -85.96 143.13 28.33 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.042 -1.036 . . . . 0.0 109.653 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.592 ' HA ' ' HA ' ' A' ' 1' ' ' MET . 0.6 OUTLIER -149.21 147.88 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.724 -1.235 . . . . 0.0 108.417 179.529 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.568 ' N ' ' CD1' ' A' ' 50' ' ' PHE . 11.3 p90 -141.22 164.8 29.26 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 116.163 -2.215 . . . . 0.0 114.504 -178.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -119.29 169.75 13.75 Favored Glycine 0 N--CA 1.5 2.924 0 N-CA-C 108.502 -1.839 . . . . 0.0 108.502 -178.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.527 ' C ' ' CD2' ' A' ' 65' ' ' LEU . 3.6 p30 -170.98 163.03 7.43 Favored 'General case' 0 N--CA 1.482 1.14 0 O-C-N 120.445 -1.621 . . . . 0.0 109.923 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.484 ' HA3' ' O ' ' A' ' 66' ' ' ARG . . . 150.15 -142.46 9.7 Favored Glycine 0 N--CA 1.503 3.101 0 C-N-CA 117.856 -2.116 . . . . 0.0 111.389 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.496 ' HA ' ' O ' ' A' ' 95' ' ' ASP . 2.8 t -128.81 121.35 54.41 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.0 mt -62.63 161.72 11.76 Favored 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 118.514 -1.274 . . . . 0.0 113.481 -175.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.47 ' HA ' ' OG1' ' A' ' 93' ' ' THR . 4.3 tt0 -139.05 117.85 12.34 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 178.041 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.577 ' CG1' ' HB ' ' A' ' 93' ' ' THR . 1.3 mm -82.57 161.07 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 CA-C-N 120.868 1.667 . . . . 0.0 109.572 -178.436 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.571 HD21 ' CZ ' ' A' ' 62' ' ' PHE . 6.7 mp -130.31 134.9 47.54 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.602 -1.311 . . . . 0.0 109.288 179.088 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.478 ' C ' ' O ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -38.59 -36.25 0.24 Allowed 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.665 0.745 . . . . 0.0 109.946 -179.725 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -60.95 -7.08 2.17 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.689 -0.632 . . . . 0.0 112.53 -179.408 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.438 ' O ' ' HB3' ' A' ' 83' ' ' PRO . . . 91.65 8.15 64.13 Favored Glycine 1 N--CA 1.518 4.113 0 C-N-CA 118.677 -1.725 . . . . 0.0 112.232 178.13 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.571 ' CZ ' HD21 ' A' ' 58' ' ' LEU . 2.2 p90 -127.9 -179.64 5.07 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 104.706 -2.331 . . . . 0.0 104.706 178.127 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.537 ' N ' ' CD1' ' A' ' 62' ' ' PHE . . . -157.88 172.33 35.06 Favored Glycine 0 N--CA 1.478 1.491 0 C-N-CA 117.38 -2.343 . . . . 0.0 111.841 -178.133 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.443 ' CE2' ' HE1' ' A' ' 62' ' ' PHE . 10.3 m-85 -128.83 153.83 47.05 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 119.882 1.841 . . . . 0.0 109.319 177.282 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.527 ' CD2' ' C ' ' A' ' 52' ' ' ASP . 0.5 OUTLIER -100.24 124.02 45.18 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 177.487 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.534 ' CB ' ' OD2' ' A' ' 78' ' ' ASP . 2.6 ptm180 -129.42 -169.22 2.06 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 119.629 -1.919 . . . . 0.0 110.281 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.422 ' CB ' HD21 ' A' ' 73' ' ' LEU . 1.5 m -76.76 -153.66 0.05 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.961 -1.087 . . . . 0.0 110.469 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -129.43 -6.88 4.72 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.467 -0.77 . . . . 0.0 110.663 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.474 ' HB2' HD23 ' A' ' 73' ' ' LEU . 8.9 t0 -78.54 -155.52 0.09 Allowed 'General case' 0 N--CA 1.513 2.702 0 O-C-N 121.019 -1.05 . . . . 0.0 109.452 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -123.76 -14.65 7.18 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 120.211 -1.556 . . . . 0.0 110.82 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.668 ' O ' ' HB2' ' A' ' 72' ' ' TYR . 1.0 OUTLIER -163.77 178.1 8.13 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 120.885 -1.134 . . . . 0.0 109.7 179.654 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.668 ' HB2' ' O ' ' A' ' 71' ' ' SER . 38.5 m-85 72.63 -38.25 0.41 Allowed 'General case' 0 N--CA 1.525 3.314 0 CA-C-N 119.869 1.213 . . . . 0.0 111.103 179.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.474 HD23 ' HB2' ' A' ' 69' ' ' ASP . 6.2 mp -82.41 -160.89 0.41 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.806 -1.184 . . . . 0.0 109.62 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.499 ' HB2' ' OD2' ' A' ' 78' ' ' ASP . . . -57.16 -153.66 0.0 OUTLIER 'General case' 0 C--N 1.29 -1.994 0 CA-C-O 122.225 1.012 . . . . 0.0 110.396 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.49 ' O ' ' CG ' ' A' ' 78' ' ' ASP . . . -147.37 -163.48 10.61 Favored Glycine 0 N--CA 1.504 3.214 0 C-N-CA 120.433 -0.889 . . . . 0.0 111.182 -178.272 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -69.09 -36.04 13.4 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 O-C-N 122.655 0.818 . . . . 0.0 112.291 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.565 ' HB3' ' CE1' ' A' ' 110' ' ' TYR . 23.4 m-20 -85.42 25.11 1.07 Allowed 'General case' 0 N--CA 1.509 2.477 0 O-C-N 121.228 -0.92 . . . . 0.0 111.294 -178.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.534 ' OD2' ' CB ' ' A' ' 66' ' ' ARG . 89.2 m-20 -54.07 -115.03 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.771 0 O-C-N 120.983 -1.073 . . . . 0.0 111.807 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.546 ' CD1' ' CD2' ' A' ' 3' ' ' LEU . 6.7 mm -76.73 130.81 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.701 0 O-C-N 121.058 -1.026 . . . . 0.0 110.576 -177.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.495 ' HB3' ' O ' ' A' ' 111' ' ' PHE . 79.9 t80 -77.2 145.18 37.77 Favored 'General case' 0 N--CA 1.513 2.72 0 O-C-N 119.549 -1.969 . . . . 0.0 109.42 179.123 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 38.7 t -142.38 114.66 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 120.301 -1.499 . . . . 0.0 110.817 -179.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.539 ' O ' HG13 ' A' ' 86' ' ' ILE . 19.9 m -74.71 163.65 66.8 Favored Pre-proline 0 N--CA 1.512 2.665 0 O-C-N 120.357 -1.464 . . . . 0.0 111.708 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.525 ' HA ' HG13 ' A' ' 86' ' ' ILE . 38.0 Cg_endo -65.33 -48.83 3.01 Favored 'Trans proline' 0 C--N 1.315 -1.233 0 O-C-N 124.321 1.695 . . . . 0.0 108.827 179.005 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.554 ' O ' ' CG ' ' A' ' 88' ' ' ARG . 80.1 p -46.59 -41.1 13.99 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 177.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.521 ' HB2' ' O ' ' A' ' 82' ' ' SER . 4.2 mm-40 -62.16 -58.08 9.14 Favored 'General case' 0 N--CA 1.51 2.529 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 177.849 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.562 ' HA ' ' CD1' ' A' ' 91' ' ' LEU . 0.9 OUTLIER -55.35 -55.27 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 O-C-N 121.153 -0.967 . . . . 0.0 108.55 178.382 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.472 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 0.2 OUTLIER -57.99 -42.23 84.7 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-O 121.787 0.804 . . . . 0.0 111.466 -179.518 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.554 ' CG ' ' O ' ' A' ' 84' ' ' SER . 0.0 OUTLIER -60.44 -36.52 78.39 Favored 'General case' 0 N--CA 1.506 2.355 0 C-N-CA 119.76 -0.776 . . . . 0.0 111.725 -177.714 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.579 ' HB2' ' CD2' ' A' ' 91' ' ' LEU . 20.1 m-85 -112.12 13.13 20.58 Favored 'General case' 0 N--CA 1.507 2.378 0 C-N-CA 117.12 -1.832 . . . . 0.0 111.664 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 61.46 53.5 3.37 Favored 'General case' 0 N--CA 1.484 1.242 0 O-C-N 120.389 -1.445 . . . . 0.0 110.3 178.58 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.579 ' CD2' ' HB2' ' A' ' 89' ' ' PHE . 3.5 mt -89.61 -173.44 3.95 Favored 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 119.304 -0.959 . . . . 0.0 110.277 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.533 ' CG ' ' O ' ' A' ' 91' ' ' LEU . 12.0 mtt-85 -160.1 160.27 32.85 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 177.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.577 ' HB ' ' CG1' ' A' ' 57' ' ' ILE . 1.8 t -64.18 155.94 30.14 Favored 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 116.983 -1.887 . . . . 0.0 106.841 178.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 77.57 -11.54 18.64 Favored Glycine 0 N--CA 1.506 3.343 0 C-N-CA 117.042 -2.504 . . . . 0.0 110.263 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.496 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 7.9 m-20 -68.18 148.59 50.66 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.14 -1.8 . . . . 0.0 110.465 -179.038 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.51 ' O ' HG12 ' A' ' 97' ' ' ILE . 0.1 OUTLIER -93.92 125.58 38.62 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.16 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.51 HG12 ' O ' ' A' ' 96' ' ' THR . 1.5 mt -145.78 164.89 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 C-N-CA 118.07 -1.452 . . . . 0.0 112.375 -179.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 89.9 p -149.69 139.29 21.64 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.424 ' HA2' ' CG ' ' A' ' 117' ' ' ASN . . . -168.29 -175.41 37.89 Favored Glycine 0 N--CA 1.508 3.465 0 C-N-CA 116.859 -2.591 . . . . 0.0 115.406 -178.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.432 ' HG3' ' HG2' ' A' ' 115' ' ' LYS . 2.1 mtpt -88.23 150.98 22.98 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.446 HD13 HG13 ' A' ' 49' ' ' ILE . 2.8 pt -121.51 160.56 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.504 0 CA-C-N 121.463 1.938 . . . . 0.0 113.241 -177.322 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.46 ' HB2' HD21 ' A' ' 114' ' ' LEU . 0.6 OUTLIER -144.68 132.97 10.79 Favored Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 120.392 -1.442 . . . . 0.0 109.363 179.374 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -75.34 119.45 5.56 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.949 1.5 . . . . 0.0 110.513 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -71.56 -152.68 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.024 1.539 . . . . 0.0 109.588 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.463 ' O ' ' O ' ' A' ' 106' ' ' GLU . 7.5 mttp -106.05 179.52 4.24 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.838 -1.164 . . . . 0.0 109.747 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.463 ' O ' ' O ' ' A' ' 105' ' ' LYS 0.253 0.0 OUTLIER -51.56 178.32 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.152 0 O-C-N 120.792 -1.193 . . . . 0.0 108.321 179.128 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 77.92 -37.76 1.72 Allowed Glycine 0 N--CA 1.499 2.835 0 C-N-CA 118.014 -2.041 . . . . 0.0 110.3 -179.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.491 ' O ' ' HB2' ' A' ' 109' ' ' ARG . 1.3 mt-10 -84.46 -29.77 25.8 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.183 -1.774 . . . . 0.0 110.355 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.491 ' HB2' ' O ' ' A' ' 108' ' ' GLU . 2.2 mmt85 59.54 -37.25 0.07 Allowed 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 178.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.565 ' CE1' ' HB3' ' A' ' 77' ' ' ASP . 10.3 m-85 -106.83 151.56 25.03 Favored 'General case' 0 N--CA 1.52 3.038 0 O-C-N 119.7 -1.875 . . . . 0.0 109.574 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.495 ' O ' ' HB3' ' A' ' 80' ' ' TYR . 3.3 m-85 -68.28 168.19 12.89 Favored 'General case' 0 N--CA 1.503 2.225 0 O-C-N 119.775 -1.828 . . . . 0.0 107.928 178.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.434 ' HA ' ' HB3' ' A' ' 80' ' ' TYR . . . -122.75 155.69 35.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.1 -1.625 . . . . 0.0 110.785 -179.015 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.97 153.71 39.77 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.46 HD21 ' HB2' ' A' ' 102' ' ' ARG . 14.5 tp -129.07 -56.36 1.18 Allowed 'General case' 0 N--CA 1.503 2.205 0 O-C-N 120.081 -1.637 . . . . 0.0 112.868 -178.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.432 ' HG2' ' HG3' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -125.28 142.77 51.31 Favored 'General case' 0 N--CA 1.507 2.404 0 O-C-N 120.343 -1.473 . . . . 0.0 108.536 179.666 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.458 ' O ' ' CB ' ' A' ' 124' ' ' PRO . 37.4 t -92.89 130.55 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.955 0 O-C-N 120.406 -1.434 . . . . 0.0 112.091 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.53 ' HA ' ' HB3' ' A' ' 124' ' ' PRO . 11.3 m-20 -107.02 -39.93 5.6 Favored 'General case' 0 N--CA 1.51 2.567 0 O-C-N 121.469 -0.769 . . . . 0.0 109.871 178.122 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.491 ' C ' ' CG2' ' A' ' 119' ' ' VAL . 0.9 OUTLIER -143.45 160.07 41.25 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.989 -1.069 . . . . 0.0 109.463 179.578 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.563 ' O ' ' N ' ' A' ' 121' ' ' PHE . 18.7 t -158.46 147.89 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -178.755 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.515 ' C ' ' O ' ' A' ' 119' ' ' VAL . 7.1 t-20 -24.48 -41.98 0.01 OUTLIER 'General case' 0 N--CA 1.524 3.273 0 O-C-N 121.456 -0.778 . . . . 0.0 111.481 -178.406 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.563 ' N ' ' O ' ' A' ' 119' ' ' VAL . 0.3 OUTLIER -160.91 56.72 0.31 Allowed 'General case' 0 N--CA 1.499 2.009 0 C-N-CA 118.776 -1.17 . . . . 0.0 111.055 179.149 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.476 ' OD1' ' O ' ' A' ' 121' ' ' PHE . 0.3 OUTLIER -156.02 156.43 34.42 Favored 'General case' 0 N--CA 1.485 1.292 0 O-C-N 120.878 -1.139 . . . . 0.0 109.535 178.291 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.526 ' CB ' ' CD ' ' A' ' 124' ' ' PRO . 0.2 OUTLIER -80.64 -170.67 0.25 Allowed Pre-proline 0 N--CA 1.497 1.913 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.343 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.53 ' HB3' ' HA ' ' A' ' 117' ' ' ASN . 50.5 Cg_endo -85.45 21.56 1.07 Allowed 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 123.409 1.215 . . . . 0.0 110.867 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.484 ' HB2' ' O ' ' A' ' 124' ' ' PRO . 1.5 tt0 -177.79 -127.35 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.442 -0.786 . . . . 0.0 108.961 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.46 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 0.4 OUTLIER 173.65 -143.72 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.09 0 O-C-N 120.083 -1.636 . . . . 0.0 109.721 179.664 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.464 ' O ' ' HG2' ' A' ' 128' ' ' ARG . . . -137.42 14.32 2.99 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.681 -1.262 . . . . 0.0 110.01 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.464 ' HG2' ' O ' ' A' ' 127' ' ' ALA . 0.6 OUTLIER -141.76 -50.39 0.4 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.659 -0.651 . . . . 0.0 109.778 179.61 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -73.4 164.05 27.21 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.397 -0.814 . . . . 0.0 110.067 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.45 ' HG2' ' O ' ' A' ' 130' ' ' LYS . 0.6 OUTLIER . . . . . 0 N--CA 1.487 1.415 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.679 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.596 ' HA ' ' HA ' ' A' ' 49' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 . . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.569 ' HB3' ' HB2' ' A' ' 5' ' ' GLU . 55.3 t30 -78.63 91.09 4.59 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.965 -1.085 . . . . 0.0 108.461 178.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.47 ' HA ' HD13 ' A' ' 6' ' ' LEU . 1.5 tp -42.19 -41.05 2.57 Favored 'General case' 0 N--CA 1.52 3.043 0 O-C-N 120.471 -1.393 . . . . 0.0 110.401 -178.267 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.453 ' OG1' ' OD1' ' A' ' 52' ' ' ASP . 1.8 m -57.35 -37.82 73.17 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.806 -1.183 . . . . 0.0 108.33 -179.269 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.569 ' HB2' ' HB3' ' A' ' 2' ' ' ASN . 0.3 OUTLIER -74.11 -39.31 63.44 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.783 -1.198 . . . . 0.0 108.776 178.021 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.534 ' CD1' HD23 ' A' ' 39' ' ' LEU 0.278 67.4 mt -54.77 -52.33 62.93 Favored 'General case' 0 C--O 1.215 -0.718 0 O-C-N 120.387 -1.445 . . . . 0.0 109.038 177.771 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.489 ' NZ ' ' HD2' ' A' ' 66' ' ' ARG . 0.2 OUTLIER -61.54 -40.35 94.35 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.019 -1.05 . . . . 0.0 109.264 178.468 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . 0.424 ' HB2' ' HA ' ' A' ' 5' ' ' GLU . 2.7 m-80 -62.08 -20.6 64.18 Favored 'General case' 0 N--CA 1.506 2.353 0 C-N-CA 119.438 -0.905 . . . . 0.0 110.732 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.552 ' HB ' ' CD2' ' A' ' 14' ' ' LEU . 2.6 m -75.01 118.28 69.24 Favored Pre-proline 0 C--N 1.287 -2.14 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.48 ' HG2' ' CG ' ' A' ' 13' ' ' GLU . 37.3 Cg_endo -57.47 152.33 48.02 Favored 'Trans proline' 0 CA--C 1.563 1.952 0 O-C-N 122.408 0.688 . . . . 0.0 110.515 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.536 ' CG1' ' N ' ' A' ' 12' ' ' SER . 1.7 p -41.31 -49.44 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.529 3.48 0 O-C-N 120.493 -1.379 . . . . 0.0 110.094 -178.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.536 ' N ' ' CG1' ' A' ' 11' ' ' VAL . 0.7 OUTLIER -60.56 -39.8 89.29 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.415 -0.803 . . . . 0.0 111.249 -179.629 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.545 ' HB3' ' CG2' ' A' ' 9' ' ' THR . 29.2 mt-10 -69.45 -32.21 71.0 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 118.015 -1.474 . . . . 0.0 108.488 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.552 ' CD2' ' HB ' ' A' ' 9' ' ' THR . 6.2 mt -68.62 -42.29 78.3 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 120.841 -1.162 . . . . 0.0 108.845 177.171 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.533 ' CG1' ' HB3' ' A' ' 26' ' ' LEU . 1.3 mp -64.64 -38.97 84.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 C-N-CA 117.714 -1.594 . . . . 0.0 108.451 178.433 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.501 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 59.0 m -64.24 -36.69 84.9 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 120.331 -1.481 . . . . 0.0 108.878 178.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.542 ' CD1' HG22 ' A' ' 9' ' ' THR . 0.3 OUTLIER -66.06 -38.82 89.3 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.822 -1.174 . . . . 0.0 108.936 178.432 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -68.0 -43.28 82.68 Favored Glycine 1 N--CA 1.521 4.305 0 N-CA-C 108.471 -1.852 . . . . 0.0 108.471 178.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.43 ' OE1' ' HG2' ' A' ' 24' ' ' GLU . 1.4 mm-40 -54.72 -44.9 73.9 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.886 -1.361 . . . . 0.0 107.737 178.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.501 ' OD1' ' O ' ' A' ' 16' ' ' THR . 28.8 m120 -59.57 -26.22 65.21 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 118.288 -1.365 . . . . 0.0 109.334 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.561 ' CE ' ' NE2' ' A' ' 41' ' ' GLN . 52.9 mmm -101.07 9.79 41.72 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.27 -0.894 . . . . 0.0 111.144 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.85 -21.11 39.31 Favored Glycine 0 N--CA 1.501 3.02 0 C-N-CA 118.634 -1.746 . . . . 0.0 111.589 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.563 ' O ' ' CD1' ' A' ' 26' ' ' LEU . 4.0 mp -78.57 96.48 5.48 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 120.152 -1.793 . . . . 0.0 109.934 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.496 ' O ' ' CB ' ' A' ' 25' ' ' ASN . 16.9 mt-10 -105.98 171.14 7.5 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.255 -0.903 . . . . 0.0 109.276 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.496 ' CB ' ' O ' ' A' ' 24' ' ' GLU . 0.7 OUTLIER 71.15 15.67 6.45 Favored 'General case' 0 N--CA 1.514 2.733 0 O-C-N 121.517 -0.739 . . . . 0.0 111.838 179.314 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.563 ' CD1' ' O ' ' A' ' 23' ' ' LEU . 0.4 OUTLIER -76.57 -10.88 59.71 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.005 -1.059 . . . . 0.0 111.672 -179.883 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 26' ' ' LEU . . . -46.57 -35.73 6.13 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.515 -1.366 . . . . 0.0 109.07 -179.225 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.92 3.53 25.98 Favored 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 119.849 -0.74 . . . . 0.0 111.545 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.534 ' HB3' HG13 ' A' ' 34' ' ' ILE . 7.5 mtp -99.97 156.61 17.06 Favored 'General case' 0 C--N 1.314 -0.95 0 O-C-N 120.72 -1.238 . . . . 0.0 111.774 -178.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.472 ' HB3' ' OD2' ' A' ' 33' ' ' ASP . 0.0 OUTLIER -89.46 139.22 30.74 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.413 -0.804 . . . . 0.0 110.936 179.239 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.581 ' O ' HG23 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -31.66 -44.81 0.08 Allowed 'General case' 0 N--CA 1.5 2.055 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.885 179.197 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.582 ' O ' ' CG2' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -63.27 -53.28 55.38 Favored 'General case' 0 N--CA 1.521 3.08 0 O-C-N 121.319 -0.863 . . . . 0.0 111.941 -178.233 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.538 ' OD1' ' N ' ' A' ' 34' ' ' ILE . 1.9 p30 -66.92 -39.73 87.46 Favored 'General case' 0 C--N 1.293 -1.873 0 O-C-N 119.965 -1.709 . . . . 0.0 109.226 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.538 ' N ' ' OD1' ' A' ' 33' ' ' ASP . 4.4 mt -61.93 -39.18 82.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 O-C-N 120.459 -1.401 . . . . 0.0 109.444 178.457 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.582 ' CG2' ' O ' ' A' ' 32' ' ' GLN . 0.3 OUTLIER -66.91 -40.6 86.09 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.555 0 O-C-N 120.345 -1.472 . . . . 0.0 109.246 178.518 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.574 ' CE1' ' OD1' ' A' ' 77' ' ' ASP . 6.1 m-30 -60.3 -43.9 95.88 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 120.803 -1.186 . . . . 0.0 108.531 179.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . . . . . . . . . . . -59.28 -51.32 70.45 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.49 -1.381 . . . . 0.0 108.821 178.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.532 HG13 ' HA ' ' A' ' 35' ' ' ILE . 0.1 OUTLIER -56.17 -31.88 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 C-N-CA 117.618 -1.633 . . . . 0.0 109.643 179.23 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.564 HD11 ' CE1' ' A' ' 111' ' ' PHE . 98.6 mt -69.21 -44.88 71.19 Favored 'General case' 0 N--CA 1.505 2.308 0 O-C-N 120.07 -1.644 . . . . 0.0 109.557 178.759 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.65 -34.11 77.44 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.023 -1.048 . . . . 0.0 111.396 179.114 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.561 ' NE2' ' CE ' ' A' ' 21' ' ' MET . 0.0 OUTLIER -79.5 -51.71 8.97 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.212 -0.93 . . . . 0.0 109.977 -178.9 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.547 ' NE2' ' HG3' ' A' ' 47' ' ' GLU . 5.1 t-160 -64.95 -38.61 91.53 Favored 'General case' 0 N--CA 1.507 2.378 0 C-N-CA 117.619 -1.632 . . . . 0.0 109.141 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.544 ' O ' ' N ' ' A' ' 46' ' ' GLY . . . -61.58 -38.86 89.08 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 120.918 -1.113 . . . . 0.0 108.594 178.311 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 12.2 tptt -48.25 -45.0 33.86 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 121.003 -1.061 . . . . 0.0 108.567 177.774 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 52.0 m -66.49 -10.09 41.04 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 121.724 0.773 . . . . 0.0 109.493 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . 70.71 29.53 69.42 Favored Glycine 0 N--CA 1.496 2.652 0 C-N-CA 120.621 -0.8 . . . . 0.0 111.752 178.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.547 ' HG3' ' NE2' ' A' ' 42' ' ' HIS . 3.7 pm0 -82.82 158.08 22.91 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.178 -1.777 . . . . 0.0 108.793 178.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.442 ' O ' HG21 ' A' ' 49' ' ' ILE . 10.6 m-20 -71.55 147.65 47.46 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.912 -1.117 . . . . 0.0 110.334 -178.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.596 ' HA ' ' HA ' ' A' ' 1' ' ' MET . 0.8 OUTLIER -146.63 145.0 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.077 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.554 ' O ' ' HA ' ' A' ' 2' ' ' ASN . 10.5 p90 -141.31 170.28 16.01 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 116.268 -2.173 . . . . 0.0 115.583 -177.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -114.46 162.37 12.43 Favored Glycine 0 N--CA 1.501 3.003 0 N-CA-C 107.88 -2.088 . . . . 0.0 107.88 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.49 ' C ' ' CD2' ' A' ' 65' ' ' LEU . 7.5 p-10 -172.78 162.91 4.99 Favored 'General case' 0 N--CA 1.483 1.196 0 O-C-N 120.364 -1.668 . . . . 0.0 110.369 -178.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.546 ' HA3' ' O ' ' A' ' 66' ' ' ARG . . . 138.35 -134.59 6.94 Favored Glycine 0 N--CA 1.503 3.155 0 C-N-CA 118.28 -1.914 . . . . 0.0 111.54 177.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.54 ' HA ' ' O ' ' A' ' 95' ' ' ASP . 2.5 t -127.94 117.75 46.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 O-C-N 121.45 -1.029 . . . . 0.0 108.396 -179.124 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.493 ' HB2' ' OD1' ' A' ' 95' ' ' ASP . 6.2 mt -63.36 165.41 7.67 Favored 'General case' 0 N--CA 1.503 2.18 0 C-N-CA 118.622 -1.231 . . . . 0.0 113.561 -176.145 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.53 ' O ' ' CG ' ' A' ' 56' ' ' GLU . 8.2 pt-20 -141.52 123.03 15.02 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 177.654 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.563 ' CG1' ' HB ' ' A' ' 93' ' ' THR . 1.2 mm -83.07 164.31 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 119.857 -1.777 . . . . 0.0 109.275 -178.544 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.584 HD21 ' CE1' ' A' ' 62' ' ' PHE . 3.1 mp -130.98 136.46 48.55 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.433 -1.417 . . . . 0.0 109.672 179.239 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.445 ' C ' ' O ' ' A' ' 58' ' ' LEU . 7.7 tt0 -39.57 -36.99 0.44 Allowed 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.637 0.732 . . . . 0.0 110.128 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.452 ' OD1' ' N ' ' A' ' 60' ' ' ASP . 5.8 m-20 -61.52 -6.65 2.52 Favored 'General case' 0 N--CA 1.5 2.029 0 C-N-CA 119.905 -0.718 . . . . 0.0 112.576 -179.157 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 92.53 8.15 62.69 Favored Glycine 1 N--CA 1.519 4.224 0 C-N-CA 118.688 -1.72 . . . . 0.0 112.612 177.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.584 ' CE1' HD21 ' A' ' 58' ' ' LEU . 4.4 p90 -129.1 -177.04 4.06 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 104.29 -2.485 . . . . 0.0 104.29 177.834 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.508 ' HA2' ' CD1' ' A' ' 58' ' ' LEU . . . -157.63 172.75 34.97 Favored Glycine 0 N--CA 1.475 1.273 0 C-N-CA 116.672 -2.68 . . . . 0.0 112.109 -177.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.466 ' HB2' ' OE2' ' A' ' 56' ' ' GLU . 16.2 m-85 -130.25 151.97 50.18 Favored 'General case' 0 N--CA 1.483 1.215 0 O-C-N 120.223 -1.751 . . . . 0.0 109.574 177.602 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.49 ' CD2' ' C ' ' A' ' 52' ' ' ASP . 0.2 OUTLIER -97.91 168.23 10.42 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 176.221 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.546 ' O ' ' HA3' ' A' ' 53' ' ' GLY . 10.5 ttp85 177.09 -173.91 0.11 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.004 -1.06 . . . . 0.0 109.662 179.336 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' SER . . . . . 0.497 ' HB2' ' OG ' ' A' ' 70' ' ' SER . 0.7 OUTLIER -74.72 -155.51 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.707 -1.246 . . . . 0.0 109.834 179.554 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -117.72 -87.35 0.62 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.301 -0.874 . . . . 0.0 110.517 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -78.05 60.99 2.51 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.344 -0.847 . . . . 0.0 111.599 -179.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.497 ' OG ' ' HB2' ' A' ' 67' ' ' SER . 0.1 OUTLIER -125.98 -4.94 6.86 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 119.971 -1.706 . . . . 0.0 110.46 -179.879 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.577 ' O ' ' HB2' ' A' ' 72' ' ' TYR . 0.3 OUTLIER 170.74 -21.13 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.192 0 O-C-N 120.928 -1.108 . . . . 0.0 111.15 -179.997 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.577 ' HB2' ' O ' ' A' ' 71' ' ' SER . 24.6 m-85 77.24 -43.65 0.43 Allowed 'General case' 0 N--CA 1.523 3.196 0 O-C-N 121.769 -0.582 . . . . 0.0 111.853 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.7 mp -87.31 -173.81 4.56 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.38 -1.45 . . . . 0.0 109.573 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.421 ' HB3' ' OE2' ' A' ' 56' ' ' GLU . . . -79.66 -156.82 0.12 Allowed 'General case' 0 C--N 1.291 -1.975 0 CA-C-O 122.522 1.153 . . . . 0.0 109.775 179.387 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.54 ' N ' ' OD2' ' A' ' 78' ' ' ASP . . . -177.43 156.6 20.42 Favored Glycine 0 C--N 1.28 -2.574 0 N-CA-C 107.18 -2.368 . . . . 0.0 107.18 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.19 -38.24 28.39 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 CA-C-N 118.742 1.271 . . . . 0.0 112.382 -179.672 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.574 ' OD1' ' CE1' ' A' ' 36' ' ' PHE . 13.6 m-20 -86.59 15.77 5.28 Favored 'General case' 0 N--CA 1.506 2.337 0 O-C-N 121.089 -1.007 . . . . 0.0 112.953 -178.15 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.54 ' OD2' ' N ' ' A' ' 75' ' ' GLY . 3.7 m-20 -67.18 -155.74 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.249 0 O-C-N 120.224 -1.547 . . . . 0.0 109.424 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.481 HG13 ' HB3' ' A' ' 65' ' ' LEU . 5.0 mm -111.6 129.15 67.51 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.599 0 O-C-N 121.137 -0.977 . . . . 0.0 109.224 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.476 ' HB3' ' HA ' ' A' ' 112' ' ' ALA . 15.2 t80 -74.87 147.22 41.25 Favored 'General case' 0 N--CA 1.518 2.928 0 CA-C-N 121.987 2.176 . . . . 0.0 110.052 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.455 ' HB ' ' O ' ' A' ' 63' ' ' GLY . 8.9 t -142.57 110.92 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 120.188 -1.57 . . . . 0.0 110.113 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.516 ' HB3' ' HD2' ' A' ' 83' ' ' PRO . 6.2 m -74.27 164.02 64.19 Favored Pre-proline 0 N--CA 1.511 2.597 0 O-C-N 120.361 -1.462 . . . . 0.0 111.983 -179.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.517 ' HA ' HG13 ' A' ' 86' ' ' ILE . 38.1 Cg_endo -65.26 -54.29 0.66 Allowed 'Trans proline' 0 C--N 1.315 -1.23 0 O-C-N 124.621 1.853 . . . . 0.0 109.182 178.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.558 ' O ' ' CG ' ' A' ' 88' ' ' ARG . 52.9 p -46.34 -39.33 10.06 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 178.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.5 ' HB2' ' O ' ' A' ' 82' ' ' SER . 6.7 mm100 -63.23 -58.92 5.58 Favored 'General case' 0 N--CA 1.51 2.536 0 C-N-CA 119.421 -0.912 . . . . 0.0 108.742 178.499 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.517 HG13 ' HA ' ' A' ' 83' ' ' PRO . 0.2 OUTLIER -55.83 -54.03 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.313 0 O-C-N 121.107 -0.996 . . . . 0.0 108.601 178.801 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.465 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 0.1 OUTLIER -56.69 -43.39 80.43 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-O 121.933 0.873 . . . . 0.0 110.876 -179.659 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.558 ' CG ' ' O ' ' A' ' 84' ' ' SER . 1.3 mmm180 -59.6 -36.63 76.66 Favored 'General case' 0 N--CA 1.505 2.281 0 C-N-CA 119.795 -0.762 . . . . 0.0 111.702 -177.86 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.431 ' CD2' ' O ' ' A' ' 85' ' ' GLN . 5.4 m-85 -109.81 11.89 24.17 Favored 'General case' 0 N--CA 1.501 2.116 0 C-N-CA 117.518 -1.673 . . . . 0.0 111.114 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 59.58 53.96 4.78 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 120.575 -1.328 . . . . 0.0 109.816 178.669 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.505 ' N ' HD11 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -90.04 -177.75 5.26 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 119.681 -0.807 . . . . 0.0 110.176 -179.948 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.47 ' O ' ' OD2' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -156.8 161.64 39.75 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.337 -0.852 . . . . 0.0 108.704 178.235 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.563 ' HB ' ' CG1' ' A' ' 57' ' ' ILE . 1.6 t -64.42 155.23 33.23 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 117.119 -1.833 . . . . 0.0 107.428 179.583 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.459 ' HA2' HG13 ' A' ' 54' ' ' VAL . . . 75.66 -8.56 20.05 Favored Glycine 0 N--CA 1.502 3.05 0 C-N-CA 117.123 -2.465 . . . . 0.0 110.114 179.1 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.54 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 7.8 p30 -69.57 149.04 48.62 Favored 'General case' 0 N--CA 1.483 1.222 0 O-C-N 120.127 -1.808 . . . . 0.0 110.515 -178.711 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.479 ' C ' ' CG1' ' A' ' 97' ' ' ILE . 0.3 OUTLIER -94.92 121.33 36.42 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.825 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.515 ' CG2' ' O ' ' A' ' 118' ' ' GLU . 2.3 mt -148.03 168.75 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 119.925 -1.734 . . . . 0.0 112.648 -178.713 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.502 ' OG ' ' HB2' ' A' ' 118' ' ' GLU . 92.1 p -148.54 137.89 21.91 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.889 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.502 ' O ' ' HB2' ' A' ' 50' ' ' PHE . . . -161.43 177.49 37.72 Favored Glycine 0 N--CA 1.51 3.599 0 C-N-CA 117.958 -2.068 . . . . 0.0 114.209 -178.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.495 ' HG2' ' HB3' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -87.73 157.02 19.16 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 178.594 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.5 HG12 ' HA ' ' A' ' 50' ' ' PHE . 1.5 pt -123.26 155.67 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.463 0 CA-C-N 120.815 1.643 . . . . 0.0 113.408 -177.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.518 ' HB2' ' CD1' ' A' ' 114' ' ' LEU . 0.0 OUTLIER -157.54 170.13 9.46 Favored Pre-proline 0 N--CA 1.483 1.179 0 O-C-N 120.571 -1.331 . . . . 0.0 109.553 179.484 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.469 ' HA ' ' OE2' ' A' ' 108' ' ' GLU . 51.2 Cg_endo -92.71 140.35 1.94 Allowed 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 121.798 1.666 . . . . 0.0 110.368 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.474 ' CD ' ' OE1' ' A' ' 108' ' ' GLU . 47.7 Cg_endo -81.43 -89.71 0.0 OUTLIER 'Trans proline' 0 C--N 1.303 -1.824 0 O-C-N 123.961 1.506 . . . . 0.0 109.752 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 5.8 ttmt -136.89 -160.13 1.03 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.641 -0.662 . . . . 0.0 109.95 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.83 -22.77 39.04 Favored 'General case' 0 C--N 1.31 -1.13 0 O-C-N 120.76 -1.212 . . . . 0.0 109.589 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -84.37 44.85 3.4 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 108.571 -1.812 . . . . 0.0 108.571 178.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.542 ' HG3' ' N ' ' A' ' 109' ' ' ARG . 3.1 tp10 -85.56 -81.34 0.2 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.649 -1.501 . . . . 0.0 111.044 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.579 ' HD2' ' CE1' ' A' ' 110' ' ' TYR . 0.0 OUTLIER 64.4 -55.29 0.26 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.37 -0.831 . . . . 0.0 109.834 -178.653 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.579 ' CE1' ' HD2' ' A' ' 109' ' ' ARG . 42.2 m-85 -107.73 149.14 28.51 Favored 'General case' 0 N--CA 1.522 3.141 0 O-C-N 120.179 -1.576 . . . . 0.0 107.704 176.943 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.564 ' CE1' HD11 ' A' ' 39' ' ' LEU . 78.2 m-85 -68.35 159.42 31.48 Favored 'General case' 0 N--CA 1.509 2.509 0 O-C-N 119.161 -2.212 . . . . 0.0 108.056 178.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.476 ' HA ' ' HB3' ' A' ' 80' ' ' TYR . . . -124.15 142.83 50.89 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 119.975 -1.703 . . . . 0.0 111.434 -178.863 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.414 HD23 ' HA ' ' A' ' 113' ' ' LEU . 0.2 OUTLIER -51.2 147.02 5.9 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 179.117 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.518 ' CD1' ' HB2' ' A' ' 102' ' ' ARG . 6.4 tp -128.28 -58.32 1.2 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 120.22 -1.55 . . . . 0.0 111.549 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.495 ' HB3' ' HG2' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -120.73 140.09 52.14 Favored 'General case' 0 N--CA 1.509 2.487 0 O-C-N 120.336 -1.478 . . . . 0.0 108.405 178.835 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.6 t -92.53 134.16 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.854 0 O-C-N 120.215 -1.553 . . . . 0.0 111.318 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 2.8 m-20 -107.5 -42.41 4.8 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.552 -0.718 . . . . 0.0 109.586 178.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.515 ' O ' ' CG2' ' A' ' 97' ' ' ILE . 1.2 mt-10 -143.71 159.84 41.77 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.879 -1.138 . . . . 0.0 109.783 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.503 ' CG2' ' C ' ' A' ' 118' ' ' GLU . 5.1 t -158.22 140.44 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.982 -0.449 . . . . 0.0 110.075 -178.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.479 ' O ' ' C ' ' A' ' 121' ' ' PHE . 0.1 OUTLIER 46.52 40.01 7.58 Favored 'General case' 0 N--CA 1.516 2.869 0 O-C-N 120.34 -1.475 . . . . 0.0 110.666 179.715 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.479 ' C ' ' O ' ' A' ' 120' ' ' ASN . 0.3 OUTLIER 38.23 33.57 0.06 Allowed 'General case' 0 N--CA 1.518 2.934 0 O-C-N 121.054 -1.029 . . . . 0.0 109.622 179.857 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.46 ' HB2' ' O ' ' A' ' 120' ' ' ASN . 0.2 OUTLIER -154.93 175.6 13.58 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.02 -1.05 . . . . 0.0 109.767 179.772 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.435 ' HB2' ' ND2' ' A' ' 126' ' ' ASN . 1.1 mmmm -58.58 158.14 16.4 Favored Pre-proline 0 N--CA 1.506 2.362 0 C-N-CA 119.544 -0.862 . . . . 0.0 109.066 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.69 48.59 1.36 Allowed 'Trans proline' 0 C--N 1.304 -1.8 0 O-C-N 124.071 1.564 . . . . 0.0 110.746 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -170.69 -122.49 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.62 -1.3 . . . . 0.0 110.365 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.435 ' ND2' ' HB2' ' A' ' 123' ' ' LYS . 11.5 m-80 50.68 -132.7 1.83 Allowed 'General case' 0 N--CA 1.508 2.475 0 O-C-N 120.17 -1.581 . . . . 0.0 109.531 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.484 ' O ' ' HG2' ' A' ' 128' ' ' ARG . . . -170.13 -172.27 1.29 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.706 -1.246 . . . . 0.0 109.532 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.484 ' HG2' ' O ' ' A' ' 127' ' ' ALA . 1.2 mtp-105 -140.64 -169.39 2.78 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.445 -1.41 . . . . 0.0 110.052 179.73 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . 0.525 ' O ' ' C ' ' A' ' 130' ' ' LYS . 54.2 t30 -114.28 166.88 11.2 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.16 -0.963 . . . . 0.0 110.006 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . 0.525 ' C ' ' O ' ' A' ' 129' ' ' ASN . 0.9 OUTLIER . . . . . 0 N--CA 1.514 2.768 0 CA-C-O 118.0 -1.0 . . . . 0.0 111.162 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.576 ' HA ' ' CB ' ' A' ' 49' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.396 0.617 . . . . 0.0 110.083 . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.588 ' HB2' ' CZ ' ' A' ' 50' ' ' PHE . 19.6 t30 -77.91 101.35 6.78 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.303 -0.873 . . . . 0.0 109.049 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.477 HD12 HD11 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -41.5 -41.95 2.24 Favored 'General case' 0 N--CA 1.518 2.951 0 O-C-N 120.535 -1.353 . . . . 0.0 110.192 -178.753 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.472 ' OG1' ' OD1' ' A' ' 52' ' ' ASP . 1.6 m -58.65 -36.78 74.66 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.892 -1.13 . . . . 0.0 108.51 -179.345 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.508 ' HB3' ' HB3' ' A' ' 2' ' ' ASN . 0.7 OUTLIER -72.15 -45.41 60.56 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.149 -0.97 . . . . 0.0 108.682 178.245 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.477 HD11 HD12 ' A' ' 3' ' ' LEU 0.276 86.2 mt -51.37 -47.91 62.67 Favored 'General case' 0 C--N 1.315 -0.894 0 O-C-N 120.903 -1.123 . . . . 0.0 109.409 178.322 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.517 ' NZ ' HD11 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -66.94 -39.82 87.39 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.028 -1.045 . . . . 0.0 110.142 178.869 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -63.12 -29.27 70.67 Favored 'General case' 0 N--CA 1.507 2.399 0 C-N-CA 119.352 -0.939 . . . . 0.0 111.191 -179.111 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.576 ' HB ' ' CD1' ' A' ' 14' ' ' LEU . 3.2 m -75.02 123.5 88.96 Favored Pre-proline 0 C--N 1.285 -2.198 0 O-C-N 121.613 -0.679 . . . . 0.0 109.596 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.535 ' HG2' ' CG ' ' A' ' 13' ' ' GLU . 39.8 Cg_endo -61.29 151.3 80.11 Favored 'Trans proline' 0 CA--C 1.567 2.148 0 O-C-N 122.372 0.67 . . . . 0.0 110.856 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.551 ' CG1' ' N ' ' A' ' 12' ' ' SER . 1.6 p -41.74 -49.86 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.525 3.318 0 O-C-N 120.643 -1.286 . . . . 0.0 109.707 -178.997 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.551 ' N ' ' CG1' ' A' ' 11' ' ' VAL . 0.7 OUTLIER -57.07 -40.78 77.56 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.294 -0.879 . . . . 0.0 111.076 -179.87 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.547 ' HB3' ' CG2' ' A' ' 9' ' ' THR . 52.6 mm-40 -68.95 -30.39 68.82 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 118.02 -1.472 . . . . 0.0 107.776 179.402 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.576 ' CD1' ' HB ' ' A' ' 9' ' ' THR . 0.0 OUTLIER -68.5 -42.31 78.78 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.993 -1.067 . . . . 0.0 109.058 177.104 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . . . . . . . . . 1.4 mp -66.26 -38.67 82.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 C-N-CA 118.133 -1.427 . . . . 0.0 108.621 178.734 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.5 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 44.2 m -64.88 -37.58 88.12 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 120.379 -1.45 . . . . 0.0 109.163 178.928 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.539 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 0.9 OUTLIER -66.11 -37.46 85.81 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.85 -1.156 . . . . 0.0 109.069 178.652 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.489 ' CA ' HD11 ' A' ' 23' ' ' LEU . . . -70.07 -42.76 66.97 Favored Glycine 0 N--CA 1.516 3.977 0 C-N-CA 118.6 -1.762 . . . . 0.0 108.864 178.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.672 ' HG3' ' N ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -59.81 -37.6 79.61 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.294 -1.71 . . . . 0.0 108.047 179.047 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.672 ' N ' ' HG3' ' A' ' 19' ' ' GLU . 28.2 m120 -61.05 -26.79 67.88 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 118.309 -1.356 . . . . 0.0 109.371 178.613 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.648 ' CE ' ' CG ' ' A' ' 42' ' ' HIS . 43.7 mmm -101.94 11.52 38.42 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.193 -0.942 . . . . 0.0 111.261 -179.366 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.21 -25.33 25.32 Favored Glycine 0 N--CA 1.497 2.758 0 C-N-CA 118.654 -1.736 . . . . 0.0 110.897 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.584 ' O ' ' CD1' ' A' ' 26' ' ' LEU . 1.7 mp -78.62 91.77 4.66 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.414 -1.639 . . . . 0.0 109.027 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.478 ' O ' ' CB ' ' A' ' 25' ' ' ASN . 41.7 mt-10 -106.23 169.9 8.24 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.311 -0.868 . . . . 0.0 108.93 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.478 ' CB ' ' O ' ' A' ' 24' ' ' GLU . 0.7 OUTLIER 69.06 21.17 7.45 Favored 'General case' 0 N--CA 1.507 2.417 0 O-C-N 121.518 -0.738 . . . . 0.0 111.532 179.505 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.584 ' CD1' ' O ' ' A' ' 23' ' ' LEU . 0.4 OUTLIER -76.78 -3.83 40.31 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 120.813 -1.179 . . . . 0.0 110.976 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.436 ' C ' ' O ' ' A' ' 26' ' ' LEU . . . -46.64 -32.92 3.81 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.602 -1.311 . . . . 0.0 108.685 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . 0.409 ' HD2' ' HA ' ' A' ' 28' ' ' ARG . 0.7 OUTLIER -80.84 -2.56 47.81 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.477 179.74 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.489 ' HB3' HG13 ' A' ' 34' ' ' ILE . 7.9 mtp -100.73 150.61 22.59 Favored 'General case' 0 C--N 1.311 -1.076 0 O-C-N 120.748 -1.22 . . . . 0.0 111.33 -178.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.47 ' O ' ' C ' ' A' ' 31' ' ' LYS . 17.4 tpp180 -89.32 141.23 28.73 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.252 -0.905 . . . . 0.0 110.407 178.796 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.558 ' O ' ' CG1' ' A' ' 35' ' ' ILE . 7.8 ttmt -29.88 -47.57 0.08 Allowed 'General case' 0 N--CA 1.501 2.082 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.774 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.53 ' OE1' ' N ' ' A' ' 33' ' ' ASP . 1.3 pp0? -59.57 -56.04 26.94 Favored 'General case' 0 N--CA 1.518 2.953 0 O-C-N 121.385 -0.822 . . . . 0.0 111.976 -177.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.53 ' N ' ' OE1' ' A' ' 32' ' ' GLN . 2.8 p30 -66.09 -35.95 81.88 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 120.795 -1.19 . . . . 0.0 109.112 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.564 ' CG2' ' HB3' ' A' ' 14' ' ' LEU . 3.3 mt -61.52 -37.79 78.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 O-C-N 120.313 -1.492 . . . . 0.0 108.094 177.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.558 ' CG1' ' O ' ' A' ' 31' ' ' LYS . 0.5 OUTLIER -60.21 -46.83 94.12 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.494 0 O-C-N 120.076 -1.64 . . . . 0.0 109.506 177.446 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -54.36 -40.56 68.22 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.751 -0.779 . . . . 0.0 109.525 -179.325 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.524 ' CB ' HD21 ' A' ' 23' ' ' LEU . . . -71.74 -52.02 19.85 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 120.745 -1.222 . . . . 0.0 110.626 179.187 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.426 ' H ' HG13 ' A' ' 38' ' ' ILE . 2.5 mt -58.41 -28.19 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 C-N-CA 117.131 -1.827 . . . . 0.0 109.999 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . . . . . . . . . 25.7 mt -72.39 -41.95 65.74 Favored 'General case' 0 N--CA 1.506 2.341 0 O-C-N 120.06 -1.65 . . . . 0.0 109.451 178.054 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.33 -36.77 85.05 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.903 -1.123 . . . . 0.0 110.286 178.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.531 ' HG3' ' CG ' ' A' ' 23' ' ' LEU . 22.5 mm-40 -78.66 -51.69 9.5 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.273 -0.892 . . . . 0.0 111.2 -179.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.648 ' CG ' ' CE ' ' A' ' 21' ' ' MET . 0.2 OUTLIER -63.51 -36.48 83.91 Favored 'General case' 0 N--CA 1.505 2.279 0 C-N-CA 118.179 -1.408 . . . . 0.0 108.728 179.871 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.47 ' O ' ' N ' ' A' ' 46' ' ' GLY . . . -55.15 -45.06 75.64 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 177.582 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -49.98 -44.52 50.94 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-O 122.067 0.937 . . . . 0.0 108.65 177.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.46 ' HB2' ' O ' ' A' ' 42' ' ' HIS . 49.7 m -66.41 -8.14 23.84 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.579 0.704 . . . . 0.0 109.658 179.447 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . 80.98 20.98 64.04 Favored Glycine 0 N--CA 1.497 2.713 0 C-N-CA 120.107 -1.044 . . . . 0.0 112.642 178.028 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -78.72 164.75 24.31 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-N 120.298 2.049 . . . . 0.0 108.65 178.612 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.44 ' C ' HG21 ' A' ' 49' ' ' ILE . 4.2 m-20 -88.69 152.66 21.67 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.019 -1.05 . . . . 0.0 110.233 -179.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.576 ' CB ' ' HA ' ' A' ' 1' ' ' MET . 9.0 pt -141.47 133.37 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.024 -1.048 . . . . 0.0 108.601 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.588 ' CZ ' ' HB2' ' A' ' 2' ' ' ASN . 20.8 p90 -140.85 164.61 29.78 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 116.542 -2.063 . . . . 0.0 114.303 -179.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -121.97 166.83 14.61 Favored Glycine 0 N--CA 1.502 3.08 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -177.859 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.472 ' OD1' ' OG1' ' A' ' 4' ' ' THR . 43.4 p30 -167.54 164.48 14.77 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 120.587 -1.537 . . . . 0.0 109.57 -179.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.509 ' HA3' ' O ' ' A' ' 66' ' ' ARG . . . 141.61 -137.25 7.91 Favored Glycine 0 N--CA 1.501 2.998 0 C-N-CA 118.074 -2.012 . . . . 0.0 111.039 178.807 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' A' ' 95' ' ' ASP . 2.9 t -129.01 121.41 54.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 O-C-N 121.361 -1.081 . . . . 0.0 108.467 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.9 mt -62.81 165.98 6.06 Favored 'General case' 0 N--CA 1.504 2.23 0 C-N-CA 118.785 -1.166 . . . . 0.0 114.008 -175.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.449 ' HG3' ' NE ' ' A' ' 66' ' ' ARG . 2.0 mm-40 -139.64 117.66 11.81 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 178.055 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.566 ' CG1' ' HB ' ' A' ' 93' ' ' THR . 1.6 mm -84.92 161.91 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 CA-C-N 120.824 1.647 . . . . 0.0 110.316 -178.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.583 HD21 ' CE1' ' A' ' 62' ' ' PHE . 7.6 mp -130.97 143.68 50.91 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.496 -1.377 . . . . 0.0 109.691 178.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.41 ' C ' ' O ' ' A' ' 58' ' ' LEU . 0.9 OUTLIER -42.35 -37.06 1.43 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.304 -0.872 . . . . 0.0 110.337 -179.58 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.468 ' OD1' ' N ' ' A' ' 60' ' ' ASP . 4.5 m-20 -61.01 -6.79 2.05 Favored 'General case' 0 N--CA 1.502 2.126 0 C-N-CA 119.814 -0.754 . . . . 0.0 112.575 -178.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.438 ' O ' ' HB3' ' A' ' 83' ' ' PRO . . . 91.59 7.09 65.27 Favored Glycine 1 N--CA 1.519 4.204 0 C-N-CA 118.515 -1.803 . . . . 0.0 112.091 177.859 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.583 ' CE1' HD21 ' A' ' 58' ' ' LEU . 2.7 p90 -127.76 179.38 5.57 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 104.645 -2.354 . . . . 0.0 104.645 178.063 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -160.46 176.25 37.13 Favored Glycine 0 N--CA 1.477 1.427 0 C-N-CA 117.065 -2.493 . . . . 0.0 111.547 -177.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.59 ' CE1' ' O ' ' A' ' 76' ' ' PRO . 55.2 m-85 -129.98 155.49 46.0 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 120.112 1.956 . . . . 0.0 109.926 177.667 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.541 ' HB3' ' HB ' ' A' ' 79' ' ' ILE . 0.3 OUTLIER -98.92 161.65 13.51 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 176.506 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.509 ' O ' ' HA3' ' A' ' 53' ' ' GLY . 0.0 OUTLIER 178.61 -163.45 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.351 -0.843 . . . . 0.0 109.313 179.38 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.43 -155.25 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.008 -1.058 . . . . 0.0 110.462 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . 0.45 ' O ' ' O ' ' A' ' 69' ' ' ASP . . . -100.55 -47.67 4.8 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.552 -0.717 . . . . 0.0 110.208 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.45 ' O ' ' O ' ' A' ' 68' ' ' ALA . 3.0 p-10 -62.97 -141.03 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.25 -0.906 . . . . 0.0 108.576 179.3 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.515 ' O ' ' CB ' ' A' ' 71' ' ' SER . 0.2 OUTLIER -62.55 -71.23 0.16 Allowed 'General case' 0 N--CA 1.503 2.224 0 O-C-N 120.044 -1.66 . . . . 0.0 109.327 179.514 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.643 ' O ' ' HB2' ' A' ' 72' ' ' TYR . 0.5 OUTLIER 167.2 -23.89 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.425 -0.797 . . . . 0.0 110.437 179.449 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.643 ' HB2' ' O ' ' A' ' 71' ' ' SER . 3.3 m-85 74.22 -41.09 0.47 Allowed 'General case' 0 N--CA 1.526 3.334 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 179.446 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 5.0 mt -90.56 -168.83 2.2 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.448 -1.407 . . . . 0.0 109.964 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.606 ' O ' ' N ' ' A' ' 76' ' ' PRO . . . -78.81 60.84 2.91 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.39 -179.474 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.493 ' C ' ' O ' ' A' ' 74' ' ' ALA . . . 12.76 -71.39 0.0 OUTLIER Glycine 1 N--CA 1.543 5.816 0 CA-C-O 119.398 -0.668 . . . . 0.0 112.714 178.823 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.606 ' N ' ' O ' ' A' ' 74' ' ' ALA . 23.3 Cg_endo -53.19 -31.31 54.73 Favored 'Trans proline' 0 N--CA 1.487 1.11 0 N-CA-C 109.549 -0.981 . . . . 0.0 109.549 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.534 ' O ' ' O ' ' A' ' 78' ' ' ASP . 6.8 m-20 -84.42 -2.48 57.25 Favored 'General case' 0 C--N 1.285 -2.202 0 C-N-CA 119.996 -0.681 . . . . 0.0 112.089 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.534 ' O ' ' O ' ' A' ' 77' ' ' ASP . 5.4 m-20 -58.6 -137.95 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.845 0 O-C-N 120.287 -1.508 . . . . 0.0 109.382 178.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.541 ' HB ' ' HB3' ' A' ' 65' ' ' LEU . 1.4 mp -92.9 130.21 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.012 0 C-N-CA 117.479 -1.688 . . . . 0.0 108.956 179.008 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.494 ' HB3' ' O ' ' A' ' 111' ' ' PHE . 5.8 t80 -79.84 146.19 32.36 Favored 'General case' 0 N--CA 1.517 2.876 0 CA-C-N 121.263 1.847 . . . . 0.0 110.429 -179.211 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.465 HG21 ' O ' ' A' ' 80' ' ' TYR . 49.8 t -140.8 113.47 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 120.278 -1.513 . . . . 0.0 110.622 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.545 ' O ' HG13 ' A' ' 86' ' ' ILE . 14.0 m -74.99 162.81 71.9 Favored Pre-proline 0 N--CA 1.514 2.769 0 O-C-N 120.516 -1.365 . . . . 0.0 111.757 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.514 ' HA ' HG13 ' A' ' 86' ' ' ILE . 38.8 Cg_endo -66.02 -49.09 2.26 Favored 'Trans proline' 0 C--N 1.315 -1.193 0 O-C-N 124.465 1.771 . . . . 0.0 109.295 179.044 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.548 ' O ' ' CG ' ' A' ' 88' ' ' ARG . 23.3 t -47.27 -40.63 17.14 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 178.088 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.512 ' OE1' ' HA ' ' A' ' 85' ' ' GLN . 7.9 mm100 -63.58 -56.58 14.82 Favored 'General case' 0 N--CA 1.51 2.548 0 C-N-CA 119.498 -0.881 . . . . 0.0 108.642 178.067 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.545 HG13 ' O ' ' A' ' 82' ' ' SER . 1.0 OUTLIER -55.87 -54.67 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.245 0 O-C-N 120.942 -1.099 . . . . 0.0 108.871 178.679 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.453 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 0.0 OUTLIER -56.51 -41.95 77.55 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-O 121.941 0.877 . . . . 0.0 111.17 -179.384 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.548 ' CG ' ' O ' ' A' ' 84' ' ' SER . 2.5 mmt180 -60.3 -37.45 80.6 Favored 'General case' 0 N--CA 1.507 2.382 0 C-N-CA 119.739 -0.784 . . . . 0.0 111.9 -177.773 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -113.27 14.21 19.28 Favored 'General case' 0 N--CA 1.502 2.135 0 C-N-CA 117.507 -1.677 . . . . 0.0 111.459 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 58.95 53.27 5.75 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 120.363 -1.461 . . . . 0.0 109.543 178.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.509 ' N ' HD11 ' A' ' 91' ' ' LEU . 0.0 OUTLIER -89.41 173.66 8.23 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 119.862 -0.735 . . . . 0.0 109.503 179.883 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.502 ' HG3' ' O ' ' A' ' 91' ' ' LEU . 21.1 mtp180 -152.06 164.1 37.94 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.928 -1.108 . . . . 0.0 109.249 178.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.566 ' HB ' ' CG1' ' A' ' 57' ' ' ILE . 1.5 t -65.42 155.52 35.2 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 117.014 -1.874 . . . . 0.0 106.964 179.035 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.429 ' C ' HG11 ' A' ' 54' ' ' VAL . . . 76.66 -10.5 17.71 Favored Glycine 0 N--CA 1.505 3.235 0 C-N-CA 117.161 -2.447 . . . . 0.0 110.073 179.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.505 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 9.9 m-20 -67.04 144.75 55.97 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.216 -1.755 . . . . 0.0 110.706 -178.745 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.492 ' O ' HG12 ' A' ' 97' ' ' ILE . 0.2 OUTLIER -90.18 120.5 31.4 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.238 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.54 HG22 HG21 ' A' ' 119' ' ' VAL . 1.6 mt -146.43 168.66 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 119.845 -1.784 . . . . 0.0 112.985 -178.284 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.546 ' OG ' ' HB2' ' A' ' 118' ' ' GLU . 68.7 p -149.38 138.8 21.56 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.478 ' O ' ' HB2' ' A' ' 50' ' ' PHE . . . -165.88 179.56 40.03 Favored Glycine 0 N--CA 1.505 3.256 0 C-N-CA 117.379 -2.343 . . . . 0.0 114.422 -179.382 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.555 ' CD ' ' HB3' ' A' ' 115' ' ' LYS . 5.7 ptmt -90.6 156.0 18.45 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 179.154 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.482 HG12 ' HA ' ' A' ' 50' ' ' PHE . 2.3 pt -129.03 154.87 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.582 0 CA-C-N 121.02 1.736 . . . . 0.0 113.145 -177.216 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.624 ' HB3' ' CD ' ' A' ' 104' ' ' PRO . 0.0 OUTLIER -160.65 151.17 15.12 Favored Pre-proline 0 N--CA 1.488 1.428 0 O-C-N 120.359 -1.463 . . . . 0.0 109.363 179.309 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.639 ' N ' ' HD3' ' A' ' 104' ' ' PRO . 54.9 Cg_endo -101.35 19.14 0.25 Allowed 'Trans proline' 0 CA--C 1.558 1.72 0 C-N-CA 121.527 1.484 . . . . 0.0 114.193 -178.994 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.639 ' HD3' ' N ' ' A' ' 103' ' ' PRO . 56.1 Cg_endo -86.96 47.62 1.65 Allowed 'Trans proline' 0 N--CA 1.489 1.228 0 CA-C-N 119.343 0.801 . . . . 0.0 111.893 -178.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.99 -171.53 3.68 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.078 -1.639 . . . . 0.0 110.809 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.72 -15.52 30.06 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 178.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -79.95 48.24 3.49 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 108.722 -1.751 . . . . 0.0 108.722 178.299 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.541 ' O ' ' N ' ' A' ' 110' ' ' TYR . 2.4 tt0 -82.83 -169.48 2.52 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.626 -1.514 . . . . 0.0 108.855 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.512 ' HB3' ' O ' ' A' ' 108' ' ' GLU . 3.6 tpp85 64.48 -59.11 0.23 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.222 -0.924 . . . . 0.0 108.518 -177.571 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.541 ' N ' ' O ' ' A' ' 108' ' ' GLU . 13.7 m-85 -107.27 150.85 26.2 Favored 'General case' 0 N--CA 1.514 2.738 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 175.662 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.494 ' O ' ' HB3' ' A' ' 80' ' ' TYR . 53.4 m-85 -67.31 159.37 29.4 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 119.055 -2.278 . . . . 0.0 107.717 179.542 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.471 ' HA ' ' HB3' ' A' ' 80' ' ' TYR . . . -122.31 154.23 37.9 Favored 'General case' 0 N--CA 1.484 1.271 0 O-C-N 119.932 -1.73 . . . . 0.0 110.508 -179.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.4 tp -59.26 144.02 47.47 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.471 HD22 ' HD3' ' A' ' 100' ' ' LYS . 18.0 tp -121.89 -54.48 1.93 Allowed 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.593 -1.317 . . . . 0.0 111.867 -178.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.555 ' HB3' ' CD ' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -130.63 141.54 50.43 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 120.457 -1.402 . . . . 0.0 108.924 179.116 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.6 t -92.49 129.08 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.754 0 O-C-N 120.732 -1.23 . . . . 0.0 111.253 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.432 ' C ' ' HG2' ' A' ' 118' ' ' GLU . 6.5 m-20 -106.64 -39.02 5.96 Favored 'General case' 0 N--CA 1.506 2.349 0 O-C-N 121.368 -0.833 . . . . 0.0 109.841 178.552 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.546 ' HB2' ' OG ' ' A' ' 98' ' ' SER . 12.6 mm-40 -143.15 155.87 44.65 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.817 -1.177 . . . . 0.0 109.339 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.54 HG21 HG22 ' A' ' 97' ' ' ILE . 16.7 t -158.33 132.59 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -178.739 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.468 ' O ' ' C ' ' A' ' 121' ' ' PHE . 0.1 OUTLIER 49.56 44.93 24.42 Favored 'General case' 0 N--CA 1.517 2.907 0 O-C-N 120.255 -1.528 . . . . 0.0 110.874 -179.981 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.468 ' C ' ' O ' ' A' ' 120' ' ' ASN . 0.1 OUTLIER 38.24 34.19 0.07 Allowed 'General case' 0 N--CA 1.521 3.111 0 O-C-N 120.89 -1.132 . . . . 0.0 110.314 179.722 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.408 ' N ' ' O ' ' A' ' 120' ' ' ASN . 5.1 m-20 -154.57 172.87 17.13 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.123 -0.985 . . . . 0.0 109.474 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.581 ' HB3' ' HD2' ' A' ' 124' ' ' PRO . 39.9 mmtt -57.32 169.4 0.75 Allowed Pre-proline 0 N--CA 1.51 2.569 0 O-C-N 121.083 -1.01 . . . . 0.0 108.547 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.581 ' HD2' ' HB3' ' A' ' 123' ' ' LYS . 40.6 Cg_endo -67.29 48.08 0.32 Allowed 'Trans proline' 0 C--N 1.31 -1.456 0 O-C-N 123.375 1.197 . . . . 0.0 111.332 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.499 ' O ' ' CB ' ' A' ' 126' ' ' ASN . 0.2 OUTLIER -177.21 -171.87 0.36 Allowed 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 179.668 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.499 ' CB ' ' O ' ' A' ' 125' ' ' GLU . 0.3 OUTLIER 171.06 -146.14 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.183 0 O-C-N 120.112 -1.617 . . . . 0.0 110.227 179.726 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.419 ' C ' ' HG2' ' A' ' 128' ' ' ARG . . . -138.52 -160.69 1.09 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.861 -1.149 . . . . 0.0 109.009 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.419 ' HG2' ' C ' ' A' ' 127' ' ' ALA . 13.4 mmt180 -134.12 -172.09 2.91 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.228 -1.545 . . . . 0.0 110.708 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -90.18 172.68 8.63 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.557 -0.714 . . . . 0.0 110.721 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 118.024 -0.989 . . . . 0.0 109.826 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.541 ' HA ' ' HA ' ' A' ' 49' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.685 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.553 ' HB2' ' CE2' ' A' ' 50' ' ' PHE . 34.8 t30 -78.29 94.23 4.78 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.884 -1.135 . . . . 0.0 108.675 178.949 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.491 ' CD2' ' CD1' ' A' ' 79' ' ' ILE . 1.0 OUTLIER -41.79 -40.61 2.1 Favored 'General case' 0 N--CA 1.517 2.889 0 O-C-N 120.599 -1.313 . . . . 0.0 110.357 -178.711 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.469 ' OG1' ' OD1' ' A' ' 52' ' ' ASP . 1.5 m -60.94 -36.44 79.35 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.891 -1.13 . . . . 0.0 108.239 -179.324 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.537 ' HB3' ' HB3' ' A' ' 2' ' ' ASN . 2.8 pt-20 -70.11 -45.37 67.05 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.981 -1.074 . . . . 0.0 108.432 178.033 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.527 ' CD1' HD22 ' A' ' 39' ' ' LEU 0.277 14.8 mt -52.77 -48.82 66.53 Favored 'General case' 0 C--N 1.315 -0.924 0 O-C-N 120.906 -1.121 . . . . 0.0 109.536 178.129 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 32.4 mttm -64.51 -34.92 79.34 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.227 -0.921 . . . . 0.0 110.332 179.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -62.08 -24.67 67.25 Favored 'General case' 0 N--CA 1.507 2.415 0 O-C-N 121.135 -0.978 . . . . 0.0 111.145 -179.053 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.632 ' HB ' ' CD1' ' A' ' 14' ' ' LEU . 2.8 m -73.52 133.64 80.06 Favored Pre-proline 0 N--CA 1.505 2.322 0 O-C-N 121.72 -0.613 . . . . 0.0 109.652 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.531 ' HG2' ' CG ' ' A' ' 13' ' ' GLU . 44.0 Cg_endo -64.12 151.86 83.53 Favored 'Trans proline' 0 CA--C 1.565 2.051 0 N-CA-C 110.036 -0.794 . . . . 0.0 110.036 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.534 ' CG1' ' N ' ' A' ' 12' ' ' SER . 1.7 p -43.25 -50.29 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.529 3.515 0 O-C-N 120.286 -1.509 . . . . 0.0 110.174 -178.672 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.534 ' N ' ' CG1' ' A' ' 11' ' ' VAL . 0.8 OUTLIER -57.5 -41.59 81.07 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.294 -0.879 . . . . 0.0 111.044 -179.485 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.547 ' HB3' ' CG2' ' A' ' 9' ' ' THR . 3.5 mm-40 -69.06 -26.77 65.12 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 118.115 -1.434 . . . . 0.0 107.662 179.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.632 ' CD1' ' HB ' ' A' ' 9' ' ' THR . 0.0 OUTLIER -70.44 -43.72 69.31 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.165 -0.959 . . . . 0.0 108.917 176.898 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.515 ' CG1' HD12 ' A' ' 34' ' ' ILE . 1.7 mp -67.22 -38.68 81.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 C-N-CA 117.653 -1.619 . . . . 0.0 108.952 178.993 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.497 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 62.9 m -64.94 -38.54 91.32 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.368 -1.458 . . . . 0.0 109.172 178.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.507 ' O ' ' HG3' ' A' ' 21' ' ' MET . 0.1 OUTLIER -65.09 -38.27 90.17 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.91 -1.119 . . . . 0.0 108.879 178.561 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.482 ' O ' HD11 ' A' ' 23' ' ' LEU . . . -67.67 -41.95 88.47 Favored Glycine 0 N--CA 1.515 3.936 0 N-CA-C 108.505 -1.838 . . . . 0.0 108.505 178.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.691 ' HG3' ' N ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -59.68 -38.5 81.7 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.286 -1.714 . . . . 0.0 108.035 178.855 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.691 ' N ' ' HG3' ' A' ' 19' ' ' GLU . 26.1 m120 -61.68 -28.9 69.73 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 118.429 -1.308 . . . . 0.0 109.609 178.844 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.559 ' HB2' ' CD1' ' A' ' 23' ' ' LEU . 21.1 mtp -100.28 10.79 40.71 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.187 -0.946 . . . . 0.0 111.207 -179.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.52 -17.02 57.29 Favored Glycine 0 N--CA 1.5 2.9 0 C-N-CA 118.446 -1.835 . . . . 0.0 111.843 179.192 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.601 ' O ' ' CD1' ' A' ' 26' ' ' LEU . 1.7 mp -79.06 104.61 9.81 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.079 -1.836 . . . . 0.0 109.385 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.404 ' O ' ' CB ' ' A' ' 25' ' ' ASN . 1.4 pt-20 -115.19 178.95 4.1 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.236 -0.915 . . . . 0.0 109.398 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.404 ' CB ' ' O ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER 65.88 15.28 10.0 Favored 'General case' 0 N--CA 1.512 2.634 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.716 178.963 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.601 ' CD1' ' O ' ' A' ' 23' ' ' LEU . 1.1 mt -76.79 -15.78 59.65 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.154 -0.966 . . . . 0.0 112.066 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -47.02 -28.49 1.69 Allowed 'General case' 0 N--CA 1.497 1.925 0 O-C-N 120.315 -1.491 . . . . 0.0 109.392 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.9 mtt180 -79.1 -37.82 37.74 Favored 'General case' 0 C--N 1.295 -1.798 0 C-N-CA 120.075 -0.65 . . . . 0.0 111.906 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.549 ' SD ' ' CD2' ' A' ' 26' ' ' LEU . 5.8 ptm -85.87 169.64 13.12 Favored 'General case' 0 N--CA 1.482 1.156 0 O-C-N 120.545 -1.347 . . . . 0.0 111.529 -179.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.547 ' O ' ' CD1' ' A' ' 34' ' ' ILE . 1.0 OUTLIER -89.67 -176.26 4.93 Favored 'General case' 0 N--CA 1.504 2.274 0 CA-C-O 122.534 1.159 . . . . 0.0 113.529 -178.238 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.598 ' O ' HG21 ' A' ' 35' ' ' ILE . 4.4 ptmt -68.14 -33.25 74.13 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.122 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.58 ' O ' ' CG2' ' A' ' 35' ' ' ILE . 3.2 mm100 -65.19 -55.26 19.57 Favored 'General case' 0 N--CA 1.525 3.297 0 CA-C-O 122.166 0.984 . . . . 0.0 109.753 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.532 ' OD1' ' HG3' ' A' ' 29' ' ' MET . 2.0 p30 -66.5 -39.36 88.66 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.904 -1.123 . . . . 0.0 108.967 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.583 ' CG2' ' HB3' ' A' ' 14' ' ' LEU . 1.7 mt -61.2 -40.83 87.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.194 -1.566 . . . . 0.0 109.281 177.627 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.598 HG21 ' O ' ' A' ' 31' ' ' LYS . 0.3 OUTLIER -66.79 -36.07 76.32 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.585 0 O-C-N 120.292 -1.505 . . . . 0.0 109.544 179.437 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.468 ' CD2' ' O ' ' A' ' 32' ' ' GLN . 21.6 m-85 -60.45 -43.63 96.66 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.813 -1.18 . . . . 0.0 108.78 179.259 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.514 ' CB ' ' CD2' ' A' ' 23' ' ' LEU . . . -65.44 -54.14 32.84 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.516 -1.365 . . . . 0.0 109.634 178.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.513 HG13 ' HA ' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -53.76 -30.07 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 C-N-CA 117.541 -1.663 . . . . 0.0 109.743 179.57 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.527 HD22 ' CD1' ' A' ' 6' ' ' LEU . 34.2 mt -67.95 -42.53 80.8 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 119.865 -1.772 . . . . 0.0 109.224 178.189 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 mttt -66.0 -40.23 90.96 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.946 -1.096 . . . . 0.0 110.722 178.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.492 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 9.3 mm100 -73.51 -51.13 18.15 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.095 -1.003 . . . . 0.0 110.757 -179.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.452 ' CB ' ' HE3' ' A' ' 1' ' ' MET . 2.9 t-80 -62.51 -36.85 83.86 Favored 'General case' 0 N--CA 1.509 2.502 0 C-N-CA 118.885 -1.126 . . . . 0.0 108.739 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.61 ' O ' ' N ' ' A' ' 46' ' ' GLY . . . -67.01 -31.54 72.17 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.0 -1.063 . . . . 0.0 109.239 178.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.492 ' HB2' ' O ' ' A' ' 41' ' ' GLN . 9.0 tptt -47.54 -40.77 19.68 Favored 'General case' 0 N--CA 1.481 1.121 0 O-C-N 120.65 -1.281 . . . . 0.0 108.808 177.98 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 46.9 m -66.03 -11.07 45.65 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 119.452 -0.899 . . . . 0.0 109.056 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.61 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . 68.53 29.71 72.97 Favored Glycine 0 N--CA 1.496 2.642 0 C-N-CA 120.531 -0.842 . . . . 0.0 111.616 177.972 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.508 ' OE1' ' N ' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -88.82 169.17 11.83 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 120.105 -1.821 . . . . 0.0 108.788 178.921 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.508 ' N ' ' OE1' ' A' ' 47' ' ' GLU . 9.1 m-20 -71.66 151.08 43.98 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.024 -1.048 . . . . 0.0 111.226 -178.006 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.541 ' HA ' ' HA ' ' A' ' 1' ' ' MET . 0.5 OUTLIER -150.81 144.08 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 178.625 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.553 ' CE2' ' HB2' ' A' ' 2' ' ' ASN . 28.7 p90 -141.43 172.2 13.01 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 115.867 -2.333 . . . . 0.0 114.608 -177.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -124.77 166.71 17.33 Favored Glycine 0 N--CA 1.502 3.065 0 N-CA-C 108.762 -1.735 . . . . 0.0 108.762 -178.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.524 ' C ' ' CD2' ' A' ' 65' ' ' LEU . 3.0 p30 -172.28 163.48 5.74 Favored 'General case' 0 N--CA 1.485 1.281 0 O-C-N 120.346 -1.679 . . . . 0.0 110.065 -179.161 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . . . . . . . . . . . 146.94 -139.66 8.1 Favored Glycine 0 N--CA 1.504 3.233 0 C-N-CA 118.146 -1.978 . . . . 0.0 110.986 178.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.509 ' HA ' ' O ' ' A' ' 95' ' ' ASP . 4.6 t -128.75 122.74 57.76 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.463 ' HB2' ' OD1' ' A' ' 95' ' ' ASP . 6.0 mt -62.9 161.24 13.17 Favored 'General case' 0 N--CA 1.502 2.17 0 C-N-CA 118.486 -1.286 . . . . 0.0 114.043 -175.099 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.466 ' HA ' ' OG1' ' A' ' 93' ' ' THR . 0.0 OUTLIER -137.7 116.24 12.06 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 177.998 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.588 ' CG1' ' HB ' ' A' ' 93' ' ' THR . 1.4 mm -84.14 159.74 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 CA-C-N 121.087 1.767 . . . . 0.0 109.616 -178.485 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.472 ' O ' ' C ' ' A' ' 59' ' ' GLN . 5.6 mp -130.1 135.76 48.58 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.443 -1.41 . . . . 0.0 109.602 179.262 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.472 ' C ' ' O ' ' A' ' 58' ' ' LEU . 0.8 OUTLIER -38.47 -35.15 0.16 Allowed 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.701 0.762 . . . . 0.0 109.909 -179.683 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.503 ' OD1' ' N ' ' A' ' 60' ' ' ASP . 1.0 OUTLIER -61.05 -7.66 2.72 Favored 'General case' 0 N--CA 1.499 2.012 0 C-N-CA 120.038 -0.665 . . . . 0.0 112.183 -179.531 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 90.64 8.6 65.46 Favored Glycine 1 N--CA 1.52 4.283 0 C-N-CA 118.845 -1.645 . . . . 0.0 112.184 178.146 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.525 ' CD1' ' N ' ' A' ' 63' ' ' GLY . 2.3 p90 -127.95 178.77 5.96 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 104.491 -2.411 . . . . 0.0 104.491 177.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.525 ' N ' ' CD1' ' A' ' 62' ' ' PHE . . . -155.49 172.67 33.65 Favored Glycine 0 N--CA 1.477 1.432 0 C-N-CA 117.142 -2.456 . . . . 0.0 111.63 -178.31 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.574 ' CD2' ' O ' ' A' ' 76' ' ' PRO . 10.9 m-85 -128.88 154.78 46.16 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 119.851 1.826 . . . . 0.0 108.909 177.044 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.524 ' CD2' ' C ' ' A' ' 52' ' ' ASP . 0.2 OUTLIER -99.45 133.23 44.06 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 177.075 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.538 ' CB ' ' OD2' ' A' ' 78' ' ' ASP . 17.2 ptt180 -158.45 -148.34 0.19 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.544 -1.347 . . . . 0.0 110.065 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -70.66 -153.64 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.384 -0.822 . . . . 0.0 110.235 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -112.47 -69.42 0.87 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.452 -0.78 . . . . 0.0 110.424 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.503 ' OD1' ' N ' ' A' ' 70' ' ' SER . 1.1 p30 -78.34 -152.09 0.06 Allowed 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.314 -0.867 . . . . 0.0 109.141 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.533 ' O ' ' CB ' ' A' ' 71' ' ' SER . 0.7 OUTLIER -68.78 -134.84 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.266 0 O-C-N 120.166 -1.584 . . . . 0.0 109.404 179.628 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.548 ' O ' ' CB ' ' A' ' 72' ' ' TYR . 0.3 OUTLIER 167.61 -22.93 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.256 0 O-C-N 120.877 -1.139 . . . . 0.0 110.828 179.75 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.548 ' CB ' ' O ' ' A' ' 71' ' ' SER . 4.0 m-85 76.6 -43.57 0.46 Allowed 'General case' 0 N--CA 1.521 3.106 0 O-C-N 121.578 -0.701 . . . . 0.0 111.127 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.475 ' O ' ' O ' ' A' ' 74' ' ' ALA . 3.9 mp -77.44 -162.69 0.32 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.65 -1.281 . . . . 0.0 109.732 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.508 ' HB1' ' NE2' ' A' ' 32' ' ' GLN . . . -57.82 -145.96 0.0 OUTLIER 'General case' 0 C--N 1.291 -1.969 0 CA-C-O 122.282 1.039 . . . . 0.0 109.848 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.541 ' N ' ' HD2' ' A' ' 76' ' ' PRO . . . 141.11 -52.53 0.68 Allowed Glycine 0 N--CA 1.508 3.439 0 C-N-CA 119.823 -1.18 . . . . 0.0 112.526 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . 0.574 ' O ' ' CD2' ' A' ' 64' ' ' PHE . 24.7 Cg_endo -54.13 -36.96 87.0 Favored 'Trans proline' 0 N--CA 1.49 1.28 0 O-C-N 122.751 0.869 . . . . 0.0 110.761 -178.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.506 ' CG ' ' CE1' ' A' ' 110' ' ' TYR . 97.7 m-20 -86.58 13.59 8.27 Favored 'General case' 0 C--N 1.283 -2.302 0 C-N-CA 119.816 -0.754 . . . . 0.0 111.517 179.547 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.538 ' OD2' ' CB ' ' A' ' 66' ' ' ARG . 47.1 m-20 -58.9 -124.77 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.713 0 O-C-N 120.655 -1.278 . . . . 0.0 111.073 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.522 ' HB ' ' CB ' ' A' ' 65' ' ' LEU . 5.5 mm -83.18 127.97 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.891 0 O-C-N 120.628 -1.295 . . . . 0.0 110.373 -178.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.48 ' HB3' ' HA ' ' A' ' 112' ' ' ALA . 8.6 t80 -74.62 145.4 43.31 Favored 'General case' 0 N--CA 1.515 2.807 0 CA-C-N 121.658 2.026 . . . . 0.0 109.81 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . 0.453 ' HB ' ' O ' ' A' ' 63' ' ' GLY . 17.2 t -138.34 112.44 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 120.26 -1.525 . . . . 0.0 110.57 -179.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.52 ' O ' HG13 ' A' ' 86' ' ' ILE . 49.9 m -75.28 164.6 60.01 Favored Pre-proline 0 N--CA 1.513 2.701 0 O-C-N 120.776 -1.203 . . . . 0.0 112.166 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.518 ' HD2' ' HB3' ' A' ' 82' ' ' SER . 39.8 Cg_endo -65.9 -50.05 1.87 Allowed 'Trans proline' 0 C--N 1.315 -1.21 0 O-C-N 124.443 1.759 . . . . 0.0 109.101 178.824 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.559 ' O ' ' CG ' ' A' ' 88' ' ' ARG . 0.5 OUTLIER -47.45 -40.28 17.75 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 178.156 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.513 ' HB2' ' O ' ' A' ' 82' ' ' SER . 6.4 mm100 -63.24 -57.21 11.21 Favored 'General case' 0 N--CA 1.511 2.582 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.323 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.52 HG13 ' O ' ' A' ' 82' ' ' SER . 0.6 OUTLIER -56.97 -54.95 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.42 0 O-C-N 120.891 -1.131 . . . . 0.0 108.792 178.649 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.408 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 6.8 mmt180 -57.67 -42.88 84.45 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-O 121.882 0.848 . . . . 0.0 111.568 -179.243 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.559 ' CG ' ' O ' ' A' ' 84' ' ' SER . 4.4 mtt180 -58.87 -36.02 73.95 Favored 'General case' 0 N--CA 1.506 2.329 0 C-N-CA 119.783 -0.767 . . . . 0.0 111.773 -177.508 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.585 ' CE2' HG22 ' A' ' 116' ' ' VAL . 18.7 m-85 -116.32 15.61 15.82 Favored 'General case' 0 N--CA 1.504 2.255 0 C-N-CA 117.268 -1.773 . . . . 0.0 111.755 -179.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 57.84 56.12 4.97 Favored 'General case' 0 N--CA 1.482 1.159 0 O-C-N 120.339 -1.476 . . . . 0.0 109.193 178.821 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.515 ' CD2' ' HA ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -88.64 -178.78 5.89 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 119.852 -0.739 . . . . 0.0 109.601 -179.639 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.5 ' CG ' ' O ' ' A' ' 91' ' ' LEU . 68.5 mtt-85 -157.09 158.18 35.94 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.011 -1.056 . . . . 0.0 109.048 178.752 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.588 ' HB ' ' CG1' ' A' ' 57' ' ' ILE . 1.5 t -64.61 154.66 35.66 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 117.212 -1.795 . . . . 0.0 107.076 179.325 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 77.68 -11.18 20.76 Favored Glycine 0 N--CA 1.502 3.072 0 C-N-CA 116.961 -2.542 . . . . 0.0 110.442 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.551 ' OD2' ' CD1' ' A' ' 97' ' ' ILE . 0.0 OUTLIER -74.45 156.79 36.59 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-N 120.097 1.948 . . . . 0.0 109.945 -179.192 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.496 ' O ' HG12 ' A' ' 97' ' ' ILE . 0.2 OUTLIER -97.34 127.12 43.03 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -179.201 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.551 ' CD1' ' OD2' ' A' ' 95' ' ' ASP . 1.9 mt -147.76 166.22 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 117.767 -1.573 . . . . 0.0 112.247 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.442 ' OG ' ' HB2' ' A' ' 118' ' ' GLU . 88.3 p -148.51 136.82 21.2 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.06 179.056 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . 0.495 ' O ' ' HB2' ' A' ' 50' ' ' PHE . . . -162.18 179.64 37.39 Favored Glycine 0 N--CA 1.505 3.257 0 C-N-CA 117.183 -2.437 . . . . 0.0 114.853 -178.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.6 mttt -88.77 151.68 22.25 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 178.904 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.48 HG12 ' HA ' ' A' ' 50' ' ' PHE . 2.6 pt -121.66 157.05 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.627 0 CA-C-N 121.514 1.961 . . . . 0.0 114.026 -176.383 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.537 ' NE ' HD23 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -145.89 146.22 27.94 Favored Pre-proline 0 N--CA 1.487 1.422 0 O-C-N 120.523 -1.361 . . . . 0.0 109.397 179.282 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.484 ' HD2' ' HG3' ' A' ' 102' ' ' ARG . 49.5 Cg_endo -90.7 110.37 0.36 Allowed 'Trans proline' 0 C--N 1.307 -1.627 0 O-C-N 123.876 1.461 . . . . 0.0 110.996 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.528 ' HG2' ' HG2' ' A' ' 108' ' ' GLU . 37.2 Cg_endo -62.58 -139.08 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.921 1.485 . . . . 0.0 109.889 179.034 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . 0.546 ' O ' ' HG2' ' A' ' 108' ' ' GLU . 1.4 mppt? -106.74 177.4 4.87 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 120.47 -1.394 . . . . 0.0 110.832 -178.642 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . 0.502 ' O ' ' O ' ' A' ' 105' ' ' LYS 0.255 0.1 OUTLIER -50.08 179.77 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.173 0 O-C-N 120.747 -1.22 . . . . 0.0 108.546 179.148 . . . . . . . . 4 4 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 79.98 -33.16 2.19 Favored Glycine 0 N--CA 1.498 2.831 0 C-N-CA 117.877 -2.106 . . . . 0.0 110.332 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.55 ' OE1' ' N ' ' A' ' 110' ' ' TYR . 0.0 OUTLIER -83.08 -36.26 25.02 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.151 -1.794 . . . . 0.0 111.063 -179.233 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.491 ' N ' ' OE1' ' A' ' 108' ' ' GLU . 0.4 OUTLIER 66.19 -40.31 0.34 Allowed 'General case' 0 N--CA 1.502 2.133 0 O-C-N 120.692 -1.255 . . . . 0.0 113.143 178.633 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.55 ' N ' ' OE1' ' A' ' 108' ' ' GLU . 17.5 m-85 -106.62 152.52 23.64 Favored 'General case' 0 N--CA 1.522 3.168 0 O-C-N 119.967 -1.708 . . . . 0.0 109.422 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . 0.465 ' O ' ' HB3' ' A' ' 80' ' ' TYR . 11.6 m-85 -68.05 166.4 16.02 Favored 'General case' 0 N--CA 1.506 2.365 0 O-C-N 119.729 -1.857 . . . . 0.0 108.065 178.914 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.48 ' HA ' ' HB3' ' A' ' 80' ' ' TYR . . . -123.61 155.5 37.56 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.055 -1.653 . . . . 0.0 111.054 -179.08 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.02 153.99 40.7 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 106.287 -1.746 . . . . 0.0 106.287 178.928 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . 0.537 HD23 ' NE ' ' A' ' 102' ' ' ARG . 3.0 tp -130.99 -63.19 0.87 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.066 -1.646 . . . . 0.0 111.727 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.35 147.15 40.83 Favored 'General case' 0 N--CA 1.51 2.545 0 O-C-N 120.289 -1.507 . . . . 0.0 109.666 178.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.585 HG22 ' CE2' ' A' ' 89' ' ' PHE . 24.8 t -94.1 130.94 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.987 0 O-C-N 121.021 -1.049 . . . . 0.0 112.772 -179.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . 0.542 ' O ' ' HB3' ' A' ' 124' ' ' PRO . 7.9 m-20 -107.33 -39.7 5.6 Favored 'General case' 0 N--CA 1.509 2.509 0 O-C-N 121.504 -0.747 . . . . 0.0 109.856 177.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.495 ' C ' ' CG2' ' A' ' 119' ' ' VAL . 1.3 tt0 -143.4 159.05 43.09 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.651 -1.281 . . . . 0.0 109.115 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.531 ' O ' ' N ' ' A' ' 121' ' ' PHE . 17.9 t -156.84 143.06 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -178.663 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.469 ' C ' ' O ' ' A' ' 119' ' ' VAL . 0.1 OUTLIER -35.08 -29.97 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.812 0 O-C-N 121.0 -1.062 . . . . 0.0 110.88 -177.581 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.531 ' N ' ' O ' ' A' ' 119' ' ' VAL . 0.1 OUTLIER -160.45 59.15 0.33 Allowed 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 118.401 -1.32 . . . . 0.0 111.136 179.157 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.505 ' HB2' ' HB ' ' A' ' 119' ' ' VAL . 0.2 OUTLIER -154.25 164.37 38.66 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 120.562 -1.336 . . . . 0.0 109.982 178.12 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.481 ' HB3' ' HD2' ' A' ' 124' ' ' PRO . 12.4 mmtp -79.72 166.02 43.81 Favored Pre-proline 0 N--CA 1.502 2.131 0 O-C-N 121.47 -0.769 . . . . 0.0 109.037 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . 0.542 ' HB3' ' O ' ' A' ' 117' ' ' ASN . 50.7 Cg_endo -77.16 40.66 0.84 Allowed 'Trans proline' 0 C--N 1.302 -1.902 0 O-C-N 123.769 1.405 . . . . 0.0 110.511 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.541 ' O ' ' CB ' ' A' ' 126' ' ' ASN . 1.7 tp10 -176.47 -143.99 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.38 0 O-C-N 120.769 -1.207 . . . . 0.0 108.706 -179.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.541 ' CB ' ' O ' ' A' ' 125' ' ' GLU . 0.2 OUTLIER 166.22 29.37 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.225 0 O-C-N 120.491 -1.38 . . . . 0.0 110.357 179.793 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -149.79 28.88 0.76 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.698 -1.251 . . . . 0.0 110.262 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 8.6 mtm180 -128.23 -76.3 0.56 Allowed 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.387 -0.821 . . . . 0.0 110.142 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -64.55 160.61 19.15 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.146 -0.971 . . . . 0.0 109.969 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.307 -1.26 0 O-C-N 121.134 -0.979 . . . . 0.0 109.867 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.579 ' HE2' ' CG ' ' A' ' 42' ' ' HIS . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 110.027 -0.361 . . . . 0.0 110.027 . . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' ASN . . . . . 0.584 ' HB3' ' HB3' ' A' ' 5' ' ' GLU . 47.5 t30 -78.75 92.73 4.83 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.802 -1.186 . . . . 0.0 108.42 178.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.518 HD21 ' CD1' ' A' ' 79' ' ' ILE . 0.1 OUTLIER -42.55 -43.39 3.72 Favored 'General case' 0 N--CA 1.515 2.779 0 O-C-N 120.607 -1.308 . . . . 0.0 110.472 -178.594 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.5 ' OG1' ' OD1' ' A' ' 52' ' ' ASP . 1.9 m -57.29 -34.54 68.79 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.775 -1.203 . . . . 0.0 108.149 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . 0.584 ' HB3' ' HB3' ' A' ' 2' ' ' ASN . 0.0 OUTLIER -70.83 -44.35 66.69 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 177.498 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' LEU . . . . . 0.543 ' N ' ' HG3' ' A' ' 5' ' ' GLU 0.277 15.6 mt -52.33 -49.43 64.28 Favored 'General case' 0 C--N 1.316 -0.88 0 O-C-N 120.748 -1.22 . . . . 0.0 109.613 178.088 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LYS . . . . . 0.438 ' HE2' ' HB2' ' A' ' 77' ' ' ASP . 9.8 mttt -65.37 -37.66 87.69 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.08 -1.012 . . . . 0.0 110.589 179.192 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -63.01 -18.66 63.56 Favored 'General case' 0 N--CA 1.507 2.387 0 O-C-N 121.119 -0.988 . . . . 0.0 111.182 -179.176 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . 0.558 ' HB ' ' CD2' ' A' ' 14' ' ' LEU . 2.2 m -86.56 116.32 65.48 Favored Pre-proline 0 C--N 1.284 -2.249 0 O-C-N 121.761 -0.587 . . . . 0.0 109.642 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . 0.528 ' CG ' ' HG3' ' A' ' 13' ' ' GLU . 37.0 Cg_endo -58.51 155.1 38.04 Favored 'Trans proline' 0 CA--C 1.557 1.657 0 N-CA-C 109.288 -1.082 . . . . 0.0 109.288 179.127 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . 0.516 ' CG1' ' N ' ' A' ' 12' ' ' SER . 1.5 p -41.54 -50.11 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.532 3.657 0 O-C-N 120.173 -1.58 . . . . 0.0 110.463 -177.689 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.516 ' N ' ' CG1' ' A' ' 11' ' ' VAL . 1.9 t -58.96 -42.15 89.19 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.188 -0.945 . . . . 0.0 111.156 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLU . . . . . 0.538 ' HB3' ' CG2' ' A' ' 9' ' ' THR . 2.2 mm-40 -69.13 -27.79 65.88 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 118.15 -1.42 . . . . 0.0 108.336 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.558 ' CD2' ' HB ' ' A' ' 9' ' ' THR . 9.8 mt -71.56 -40.66 69.83 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 120.917 -1.114 . . . . 0.0 108.765 176.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' ILE . . . . . 0.496 ' CD1' HD12 ' A' ' 34' ' ' ILE . 1.4 mp -68.05 -40.49 83.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 C-N-CA 117.543 -1.663 . . . . 0.0 108.945 178.764 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' THR . . . . . 0.523 ' HA ' ' HG2' ' A' ' 19' ' ' GLU . 85.0 m -65.42 -37.22 86.27 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.272 -1.517 . . . . 0.0 109.413 179.334 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LEU . . . . . 0.473 ' O ' ' HG3' ' A' ' 21' ' ' MET . 1.3 tp -63.16 -45.04 93.71 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 120.912 -1.117 . . . . 0.0 108.048 178.414 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' GLY . . . . . 0.465 ' HA2' HD11 ' A' ' 23' ' ' LEU . . . -60.94 -43.72 99.03 Favored Glycine 0 N--CA 1.514 3.882 0 N-CA-C 108.288 -1.925 . . . . 0.0 108.288 179.051 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLU . . . . . 0.681 ' HG3' ' N ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -57.71 -38.73 75.74 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.582 -1.54 . . . . 0.0 107.845 178.904 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASN . . . . . 0.681 ' N ' ' HG3' ' A' ' 19' ' ' GLU . 28.7 m120 -61.1 -27.4 68.34 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 118.538 -1.265 . . . . 0.0 109.341 178.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.584 ' HE2' ' CD2' ' A' ' 42' ' ' HIS . 31.4 mtp -101.44 11.3 39.36 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.339 -0.851 . . . . 0.0 111.348 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.86 -22.75 35.97 Favored Glycine 0 N--CA 1.5 2.92 0 C-N-CA 118.547 -1.787 . . . . 0.0 111.143 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' LEU . . . . . 0.591 ' O ' ' CD1' ' A' ' 26' ' ' LEU . 3.0 mp -78.91 94.67 5.26 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 120.372 -1.663 . . . . 0.0 109.225 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLU . . . . . 0.519 ' O ' ' CB ' ' A' ' 25' ' ' ASN . 87.0 mt-10 -111.7 170.38 8.17 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.204 -0.935 . . . . 0.0 109.035 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.519 ' CB ' ' O ' ' A' ' 24' ' ' GLU . 0.9 OUTLIER 70.79 17.35 6.48 Favored 'General case' 0 N--CA 1.512 2.671 0 O-C-N 121.404 -0.81 . . . . 0.0 111.796 179.485 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.591 ' CD1' ' O ' ' A' ' 23' ' ' LEU . 1.1 mt -76.9 -6.05 50.92 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 120.841 -1.162 . . . . 0.0 111.372 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 26' ' ' LEU . . . -46.59 -31.21 2.68 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.477 -1.389 . . . . 0.0 108.81 -179.373 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 52.1 mtp180 -80.12 -6.57 57.93 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 120.047 -0.661 . . . . 0.0 111.386 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' MET . . . . . 0.468 ' C ' HD13 ' A' ' 34' ' ' ILE . 14.8 mtp -101.01 158.67 15.83 Favored 'General case' 0 C--N 1.313 -0.999 0 O-C-N 120.768 -1.208 . . . . 0.0 111.473 -179.208 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ARG . . . . . 0.499 ' O ' HD13 ' A' ' 34' ' ' ILE . 4.4 ttm180 -89.65 171.99 9.27 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.374 -0.829 . . . . 0.0 110.166 177.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LYS . . . . . 0.571 ' O ' ' CG1' ' A' ' 35' ' ' ILE . 11.0 pttm -60.5 -42.49 96.45 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.43 -0.794 . . . . 0.0 110.547 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLN . . . . . 0.497 ' OE1' ' HB3' ' A' ' 33' ' ' ASP . 0.0 OUTLIER -60.55 -56.45 21.21 Favored 'General case' 0 N--CA 1.517 2.918 0 O-C-N 121.306 -0.871 . . . . 0.0 111.632 -178.166 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.525 ' OD1' ' N ' ' A' ' 34' ' ' ILE . 2.1 p30 -65.74 -36.29 83.17 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.802 -1.186 . . . . 0.0 109.166 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ILE . . . . . 0.525 ' N ' ' OD1' ' A' ' 33' ' ' ASP . 2.0 mt -60.78 -38.49 79.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 O-C-N 120.348 -1.47 . . . . 0.0 107.569 177.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ILE . . . . . 0.571 ' CG1' ' O ' ' A' ' 31' ' ' LYS . 0.8 OUTLIER -59.3 -50.2 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.319 0 O-C-N 120.291 -1.506 . . . . 0.0 109.562 177.665 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -51.29 -41.6 60.57 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.514 -0.874 . . . . 0.0 109.154 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ALA . . . . . 0.491 ' CB ' HD21 ' A' ' 23' ' ' LEU . . . -63.49 -53.24 55.14 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.689 -1.257 . . . . 0.0 109.108 178.101 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . 0.472 HG13 ' O ' ' A' ' 34' ' ' ILE . 0.2 OUTLIER -55.51 -27.45 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 C-N-CA 117.451 -1.7 . . . . 0.0 109.705 179.549 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' LEU . . . . . 0.478 ' O ' ' CB ' ' A' ' 43' ' ' ALA . 23.7 mt -71.34 -42.33 68.67 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.129 -1.607 . . . . 0.0 109.115 177.704 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.2 mttt -64.11 -40.21 95.71 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.936 -1.103 . . . . 0.0 110.313 178.462 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLN . . . . . 0.519 ' HG2' ' CD1' ' A' ' 23' ' ' LEU . 0.0 OUTLIER -75.96 -53.12 8.88 Favored 'General case' 0 N--CA 1.508 2.425 0 O-C-N 121.033 -1.042 . . . . 0.0 111.125 -179.261 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' HIS . . . . . 0.584 ' CD2' ' HE2' ' A' ' 21' ' ' MET . 1.4 t-80 -61.24 -35.18 76.53 Favored 'General case' 0 N--CA 1.513 2.72 0 O-C-N 121.229 -0.919 . . . . 0.0 109.192 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ALA . . . . . 0.544 ' O ' ' N ' ' A' ' 46' ' ' GLY . . . -81.15 -32.08 33.84 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.306 -0.871 . . . . 0.0 110.961 179.615 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.596 ' HD3' ' N ' ' A' ' 45' ' ' SER 0.254 0.0 OUTLIER -49.08 -50.37 37.11 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.333 -1.48 . . . . 0.0 107.782 178.089 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' SER . . . . . 0.596 ' N ' ' HD3' ' A' ' 44' ' ' LYS . 72.5 m -65.61 -9.37 26.36 Favored 'General case' 0 C--N 1.287 -2.149 0 CA-C-N 114.57 -1.195 . . . . 0.0 109.302 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . 64.46 32.14 83.22 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 178.427 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . 0.52 ' CD ' ' ND1' ' A' ' 42' ' ' HIS . 9.8 pt-20 -87.19 166.85 14.64 Favored 'General case' 0 C--N 1.309 -1.183 0 O-C-N 120.46 -1.612 . . . . 0.0 109.2 179.286 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' ASP . . . . . 0.403 ' O ' HG21 ' A' ' 49' ' ' ILE . 1.2 m-20 -55.11 135.98 48.67 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.067 -1.021 . . . . 0.0 111.914 -177.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.51 ' HA ' ' HA ' ' A' ' 1' ' ' MET . 4.5 pt -146.57 137.8 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 178.14 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PHE . . . . . 0.569 ' N ' ' CD1' ' A' ' 50' ' ' PHE . 16.7 p90 -144.07 164.09 31.65 Favored 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 115.55 -2.46 . . . . 0.0 115.655 -178.224 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -119.19 166.17 13.15 Favored Glycine 0 N--CA 1.5 2.936 0 N-CA-C 107.425 -2.27 . . . . 0.0 107.425 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.5 ' OD1' ' OG1' ' A' ' 4' ' ' THR . 5.9 p-10 -171.88 167.98 6.13 Favored 'General case' 0 N--CA 1.482 1.156 0 O-C-N 120.132 -1.805 . . . . 0.0 109.617 -178.747 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' GLY . . . . . 0.453 ' N ' HD22 ' A' ' 65' ' ' LEU . . . 142.3 -137.18 7.68 Favored Glycine 0 N--CA 1.504 3.184 0 C-N-CA 118.247 -1.93 . . . . 0.0 110.741 178.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' A' ' 95' ' ' ASP . 3.3 t -128.28 120.62 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 O-C-N 121.382 -1.07 . . . . 0.0 108.419 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.5 mt -62.73 162.38 10.91 Favored 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 -175.642 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLU . . . . . 0.458 ' HA ' ' OG1' ' A' ' 93' ' ' THR . 1.4 tt0 -137.99 120.4 15.95 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 177.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ILE . . . . . 0.585 ' CG1' ' HB ' ' A' ' 93' ' ' THR . 1.2 mm -82.48 161.53 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 119.863 -1.773 . . . . 0.0 109.177 -179.081 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' LEU . . . . . 0.637 ' CD2' ' CZ ' ' A' ' 62' ' ' PHE . 7.1 mp -130.86 137.06 49.19 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.347 -1.47 . . . . 0.0 109.701 179.06 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLN . . . . . 0.463 ' C ' ' O ' ' A' ' 58' ' ' LEU . 1.4 tt0 -39.49 -36.54 0.39 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.525 -0.734 . . . . 0.0 110.006 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASP . . . . . 0.516 ' HB2' ' CD2' ' A' ' 62' ' ' PHE . 30.5 m-20 -61.4 -5.69 1.85 Allowed 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.676 -0.64 . . . . 0.0 112.574 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLY . . . . . 0.462 ' O ' ' HB3' ' A' ' 83' ' ' PRO . . . 88.25 11.37 67.07 Favored Glycine 1 N--CA 1.519 4.181 0 C-N-CA 118.601 -1.761 . . . . 0.0 111.954 178.307 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' PHE . . . . . 0.637 ' CZ ' ' CD2' ' A' ' 58' ' ' LEU . 4.0 p90 -127.94 -179.17 4.83 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 104.341 -2.466 . . . . 0.0 104.341 177.774 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' GLY . . . . . 0.481 ' HA2' HD11 ' A' ' 58' ' ' LEU . . . -156.07 168.08 33.43 Favored Glycine 0 N--CA 1.474 1.176 0 C-N-CA 117.181 -2.438 . . . . 0.0 111.577 -177.815 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PHE . . . . . 0.528 ' CD2' ' HB3' ' A' ' 74' ' ' ALA . 2.6 m-85 -129.07 151.18 50.04 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 119.926 1.863 . . . . 0.0 109.26 177.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . 0.498 ' HB3' ' HB ' ' A' ' 79' ' ' ILE . 0.3 OUTLIER -98.68 153.9 18.37 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 176.707 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.487 ' HB3' ' O ' ' A' ' 65' ' ' LEU . 0.5 OUTLIER 178.08 -151.71 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.246 -0.909 . . . . 0.0 109.657 179.364 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.6 m -65.7 -151.08 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.383 -0.823 . . . . 0.0 110.64 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -118.47 -14.95 9.68 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.471 -0.768 . . . . 0.0 111.321 -179.101 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -70.66 -153.0 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.187 0 O-C-N 120.888 -1.132 . . . . 0.0 108.816 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.59 ' O ' ' CB ' ' A' ' 71' ' ' SER . 0.1 OUTLIER -125.66 -154.07 0.6 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 119.9 -1.75 . . . . 0.0 109.708 179.652 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.649 ' O ' ' HB2' ' A' ' 72' ' ' TYR . 0.6 OUTLIER 159.55 -19.83 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.486 0 O-C-N 121.382 -0.824 . . . . 0.0 110.046 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.649 ' HB2' ' O ' ' A' ' 71' ' ' SER . 80.1 m-85 75.69 -48.9 0.61 Allowed 'General case' 0 N--CA 1.524 3.241 0 O-C-N 122.266 -0.271 . . . . 0.0 110.775 -179.468 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' LEU . . . . . 0.417 HD21 ' HA ' ' A' ' 73' ' ' LEU . 47.2 mt -99.17 -178.33 3.89 Favored 'General case' 0 C--N 1.308 -1.205 0 O-C-N 120.554 -1.341 . . . . 0.0 109.304 179.141 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.528 ' HB3' ' CD2' ' A' ' 64' ' ' PHE . . . -80.01 -150.73 0.07 Allowed 'General case' 0 C--N 1.292 -1.93 0 CA-C-O 122.33 1.062 . . . . 0.0 109.137 178.463 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLY . . . . . 0.49 ' N ' ' OD2' ' A' ' 78' ' ' ASP . . . -166.85 153.18 22.69 Favored Glycine 0 C--N 1.277 -2.719 0 N-CA-C 107.304 -2.318 . . . . 0.0 107.304 178.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -64.18 -41.15 22.99 Favored 'Trans proline' 0 N--CA 1.489 1.246 0 CA-C-N 118.622 1.211 . . . . 0.0 112.488 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.438 ' HB2' ' HE2' ' A' ' 7' ' ' LYS . 73.6 m-20 -86.54 7.68 25.18 Favored 'General case' 0 N--CA 1.508 2.465 0 O-C-N 120.957 -1.089 . . . . 0.0 113.27 -178.128 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . 0.49 ' OD2' ' N ' ' A' ' 75' ' ' GLY . 27.6 m-20 -78.27 -151.55 0.05 Allowed 'General case' 0 N--CA 1.505 2.28 0 O-C-N 120.092 -1.63 . . . . 0.0 109.458 179.197 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.518 ' CD1' HD21 ' A' ' 3' ' ' LEU . 2.1 mp -142.34 136.51 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.629 0 C-N-CA 119.241 -0.983 . . . . 0.0 109.928 178.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.497 ' HB3' ' HA ' ' A' ' 112' ' ' ALA . 12.2 t80 -78.11 147.46 34.64 Favored 'General case' 0 N--CA 1.52 3.049 0 O-C-N 119.635 -1.916 . . . . 0.0 110.014 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' VAL . . . . . . . . . . . . . 39.8 t -143.36 115.89 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 120.157 -1.589 . . . . 0.0 110.505 -179.407 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' SER . . . . . 0.515 ' O ' HG13 ' A' ' 86' ' ' ILE . 68.0 m -74.65 163.42 68.39 Favored Pre-proline 0 N--CA 1.514 2.737 0 O-C-N 120.5 -1.375 . . . . 0.0 112.688 -179.062 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PRO . . . . . 0.558 ' HA ' HG13 ' A' ' 86' ' ' ILE . 39.4 Cg_endo -65.33 -51.7 1.39 Allowed 'Trans proline' 0 C--N 1.315 -1.215 0 O-C-N 124.779 1.936 . . . . 0.0 108.571 178.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' SER . . . . . 0.537 ' O ' ' CG ' ' A' ' 88' ' ' ARG . 57.1 p -47.3 -39.94 15.77 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 177.93 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.51 ' HB2' ' O ' ' A' ' 82' ' ' SER . 4.9 mm-40 -62.38 -60.03 4.14 Favored 'General case' 0 N--CA 1.509 2.49 0 C-N-CA 119.089 -1.044 . . . . 0.0 108.225 178.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' ILE . . . . . 0.558 HG13 ' HA ' ' A' ' 83' ' ' PRO . 0.2 OUTLIER -55.42 -55.04 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.305 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.512 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ARG . . . . . 0.491 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 0.0 OUTLIER -57.39 -42.59 82.51 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-O 121.811 0.815 . . . . 0.0 111.238 -179.49 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . 0.537 ' CG ' ' O ' ' A' ' 84' ' ' SER . 10.8 mmm180 -59.4 -38.03 79.52 Favored 'General case' 0 N--CA 1.505 2.322 0 C-N-CA 119.84 -0.744 . . . . 0.0 111.816 -177.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . 0.57 ' HB2' ' CD2' ' A' ' 91' ' ' LEU . 9.1 m-85 -110.16 12.41 23.44 Favored 'General case' 0 N--CA 1.505 2.315 0 C-N-CA 116.976 -1.89 . . . . 0.0 111.359 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . 0.408 ' CB ' ' O ' ' A' ' 89' ' ' PHE . 0.1 OUTLIER 62.24 53.43 2.87 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 120.523 -1.36 . . . . 0.0 110.64 178.336 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' LEU . . . . . 0.57 ' CD2' ' HB2' ' A' ' 89' ' ' PHE . 2.8 mt -89.61 -169.45 2.48 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 119.199 -1.001 . . . . 0.0 110.043 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ARG . . . . . 0.532 ' CG ' ' O ' ' A' ' 91' ' ' LEU . 53.0 mtp180 -159.92 162.38 34.47 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.542 -0.724 . . . . 0.0 109.083 178.225 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.585 ' HB ' ' CG1' ' A' ' 57' ' ' ILE . 1.6 t -65.25 156.55 31.56 Favored 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 116.993 -1.883 . . . . 0.0 106.672 178.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLY . . . . . 0.449 ' C ' HG11 ' A' ' 54' ' ' VAL . . . 76.12 -10.3 15.77 Favored Glycine 0 N--CA 1.505 3.284 0 C-N-CA 116.954 -2.546 . . . . 0.0 110.191 179.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.505 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 7.7 m-20 -66.65 147.38 53.35 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.184 -1.774 . . . . 0.0 110.864 -178.874 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' THR . . . . . 0.472 ' O ' HG12 ' A' ' 97' ' ' ILE . 0.3 OUTLIER -90.52 120.36 31.55 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.193 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' ILE . . . . . 0.515 HG21 HG21 ' A' ' 119' ' ' VAL . 1.4 mt -144.11 167.84 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 119.778 -1.826 . . . . 0.0 112.929 -178.4 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' SER . . . . . 0.49 ' OG ' ' CB ' ' A' ' 118' ' ' GLU . 94.5 p -150.14 138.51 20.51 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.445 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -164.29 179.26 39.22 Favored Glycine 0 N--CA 1.506 3.319 0 C-N-CA 117.037 -2.506 . . . . 0.0 115.16 -179.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.9 mmtt -88.21 148.87 24.16 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.3 pt -124.59 153.54 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.706 0 CA-C-N 121.25 1.841 . . . . 0.0 113.566 -176.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ARG . . . . . 0.544 ' HB3' ' CD ' ' A' ' 104' ' ' PRO . 0.0 OUTLIER -160.28 154.48 19.85 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 120.372 -1.455 . . . . 0.0 109.875 179.013 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.642 ' N ' ' CD ' ' A' ' 104' ' ' PRO . 56.0 Cg_endo -103.38 20.26 0.16 Allowed 'Trans proline' 0 CA--C 1.557 1.628 0 C-N-CA 121.609 1.539 . . . . 0.0 113.513 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.642 ' CD ' ' N ' ' A' ' 103' ' ' PRO . 56.8 Cg_endo -81.74 34.33 0.55 Allowed 'Trans proline' 0 N--CA 1.493 1.454 0 CA-C-N 119.049 0.696 . . . . 0.0 111.855 -178.144 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -162.59 -153.85 0.28 Allowed 'General case' 0 N--CA 1.498 1.975 0 O-C-N 120.381 -1.449 . . . . 0.0 110.13 -179.41 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.39 -13.76 1.01 Allowed 'General case' 0 C--N 1.317 -0.826 0 O-C-N 120.496 -1.378 . . . . 0.0 108.838 178.26 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' GLY . . . . . 0.532 ' HA3' ' CB ' ' A' ' 112' ' ' ALA . . . -69.73 41.45 0.42 Allowed Glycine 0 N--CA 1.495 2.622 0 C-N-CA 119.633 -1.27 . . . . 0.0 110.897 179.116 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' GLU . . . . . 0.539 ' O ' ' N ' ' A' ' 110' ' ' TYR . 0.1 OUTLIER -83.83 164.51 19.45 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.13 -1.806 . . . . 0.0 107.72 178.266 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ARG . . . . . 0.538 ' HB3' ' O ' ' A' ' 108' ' ' GLU . 0.2 OUTLIER 64.46 -58.85 0.23 Allowed 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.163 -0.961 . . . . 0.0 108.936 -177.753 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.539 ' N ' ' O ' ' A' ' 108' ' ' GLU . 18.2 m-85 -107.42 147.22 30.69 Favored 'General case' 0 N--CA 1.518 2.945 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 176.238 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -68.36 161.66 26.99 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 119.237 -2.165 . . . . 0.0 108.062 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' ALA . . . . . 0.532 ' CB ' ' HA3' ' A' ' 107' ' ' GLY . . . -122.18 154.74 37.05 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 119.979 -1.701 . . . . 0.0 110.049 -179.572 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . 0.424 HD22 ' CD ' ' A' ' 85' ' ' GLN . 3.0 tp -62.84 145.2 55.6 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' LEU . . . . . . . . . . . . . 11.5 tp -123.45 -55.36 1.74 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.45 -1.406 . . . . 0.0 112.179 -178.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 8.0 tptp -127.68 144.28 51.09 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 120.318 -1.488 . . . . 0.0 108.84 179.13 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.507 HG23 ' CD2' ' A' ' 89' ' ' PHE . 33.7 t -93.08 129.89 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.901 0 O-C-N 120.707 -1.246 . . . . 0.0 111.458 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -107.69 -38.74 5.79 Favored 'General case' 0 N--CA 1.508 2.451 0 O-C-N 121.257 -0.902 . . . . 0.0 110.053 178.454 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' GLU . . . . . 0.49 ' CB ' ' OG ' ' A' ' 98' ' ' SER . 7.0 tt0 -143.24 157.92 44.07 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 120.948 -1.095 . . . . 0.0 109.619 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' VAL . . . . . 0.515 HG21 HG21 ' A' ' 97' ' ' ILE . 33.7 t -159.62 131.62 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -178.646 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.47 ' O ' ' C ' ' A' ' 121' ' ' PHE . 0.1 OUTLIER 55.66 46.31 22.92 Favored 'General case' 0 N--CA 1.52 3.039 0 O-C-N 120.329 -1.482 . . . . 0.0 111.779 179.28 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' PHE . . . . . 0.47 ' C ' ' O ' ' A' ' 120' ' ' ASN . 0.1 OUTLIER 40.73 40.83 1.02 Allowed 'General case' 0 N--CA 1.521 3.095 0 O-C-N 120.574 -1.329 . . . . 0.0 110.139 179.42 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -154.25 173.74 15.73 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.144 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LYS . . . . . 0.528 ' HD3' ' ND2' ' A' ' 126' ' ' ASN . 7.9 ptmt -74.18 154.55 88.39 Favored Pre-proline 0 N--CA 1.504 2.266 0 C-N-CA 118.496 -1.282 . . . . 0.0 108.851 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -78.51 22.86 0.62 Allowed 'Trans proline' 0 C--N 1.308 -1.573 0 O-C-N 123.994 1.523 . . . . 0.0 111.03 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' GLU . . . . . 0.502 ' O ' ' ND2' ' A' ' 126' ' ' ASN . 2.2 tt0 -168.15 -142.65 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . 0.528 ' ND2' ' HD3' ' A' ' 123' ' ' LYS . 0.3 OUTLIER 170.08 -51.87 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.144 0 O-C-N 120.129 -1.607 . . . . 0.0 110.471 179.317 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ALA . . . . . 0.407 ' C ' ' HG3' ' A' ' 128' ' ' ARG . . . -141.37 20.98 2.23 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-O 121.641 0.734 . . . . 0.0 109.956 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' ARG . . . . . 0.448 ' O ' ' OE2' ' A' ' 125' ' ' GLU . 2.4 mtp180 -128.95 46.84 2.56 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 119.904 -0.718 . . . . 0.0 109.873 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -47.17 164.31 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.303 -0.873 . . . . 0.0 110.13 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 22.6 pttt . . . . . 0 C--N 1.304 -1.391 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.697 179.972 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.538 ' CA ' ' HA ' ' A' ' 49' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.661 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 2' ' ' ASN . . . . . 0.583 ' HB2' ' CE2' ' A' ' 50' ' ' PHE 0.25 4.2 t30 -78.38 116.74 19.01 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 120.555 -1.34 . . . . 0.0 109.402 -179.827 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.833 HD13 HD12 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -49.68 -46.54 49.96 Favored 'General case' 0 N--CA 1.517 2.915 0 O-C-N 120.157 -1.59 . . . . 0.0 110.352 -178.934 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.8 m -56.35 -34.92 67.06 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.742 -1.224 . . . . 0.0 108.186 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.508 ' HB3' ' HB3' ' A' ' 2' ' ' ASN . 0.0 OUTLIER -66.99 -45.7 76.83 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 177.73 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.833 HD12 HD13 ' A' ' 3' ' ' LEU 0.274 68.5 mt -53.3 -51.4 62.44 Favored 'General case' 0 C--N 1.313 -0.981 0 O-C-N 120.626 -1.296 . . . . 0.0 109.078 177.738 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.26 -33.61 69.57 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.044 -1.035 . . . . 0.0 109.726 178.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.504 ' HB2' ' O ' ' A' ' 5' ' ' GLU . 4.8 m-80 -61.42 -16.54 47.7 Favored 'General case' 0 N--CA 1.504 2.263 0 C-N-CA 119.013 -1.075 . . . . 0.0 110.357 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.745 ' O ' HD11 ' A' ' 14' ' ' LEU . 2.6 m -89.48 121.32 69.37 Favored Pre-proline 0 N--CA 1.502 2.153 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.545 ' HG2' ' CG ' ' A' ' 13' ' ' GLU . 37.1 Cg_endo -57.79 151.3 57.07 Favored 'Trans proline' 0 CA--C 1.562 1.922 0 N-CA-C 109.971 -0.819 . . . . 0.0 109.971 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.799 ' HA ' HD12 ' A' ' 14' ' ' LEU . 1.6 p -41.85 -49.21 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.529 3.475 0 O-C-N 120.303 -1.498 . . . . 0.0 110.252 -178.071 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.504 ' N ' ' CG1' ' A' ' 11' ' ' VAL . 1.8 t -58.32 -41.97 85.69 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.314 -0.866 . . . . 0.0 111.161 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.675 ' CB ' HG22 ' A' ' 9' ' ' THR . 0.2 OUTLIER -68.97 -30.52 68.97 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 118.237 -1.385 . . . . 0.0 108.21 -179.964 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.799 HD12 ' HA ' ' A' ' 11' ' ' VAL . 9.3 mt -68.76 -41.2 79.19 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 120.883 -1.136 . . . . 0.0 108.813 176.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.633 HG23 ' HB2' ' A' ' 26' ' ' LEU . 1.2 mp -66.68 -40.33 85.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 C-N-CA 117.892 -1.523 . . . . 0.0 108.678 178.56 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.488 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 84.8 m -64.25 -35.52 81.11 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.36 -1.462 . . . . 0.0 108.963 179.088 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.504 ' O ' ' HG2' ' A' ' 21' ' ' MET . 35.5 tp -64.99 -43.85 91.23 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 120.934 -1.104 . . . . 0.0 108.237 178.365 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.566 ' HA2' ' OE1' ' A' ' 41' ' ' GLN . . . -61.69 -43.56 99.09 Favored Glycine 1 N--CA 1.518 4.11 0 N-CA-C 108.15 -1.98 . . . . 0.0 108.15 178.43 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.451 ' OE2' ' HG2' ' A' ' 24' ' ' GLU . 1.0 OUTLIER -53.75 -44.3 69.86 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.999 -1.295 . . . . 0.0 107.517 178.188 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.488 ' OD1' ' O ' ' A' ' 16' ' ' THR . 27.7 m120 -59.57 -26.97 65.84 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 118.679 -1.208 . . . . 0.0 109.465 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.571 ' HE2' ' HG3' ' A' ' 41' ' ' GLN . 37.7 mmm -97.65 9.86 41.44 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.27 -0.894 . . . . 0.0 110.438 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 99.7 -18.23 56.37 Favored Glycine 0 N--CA 1.501 2.992 0 C-N-CA 118.802 -1.666 . . . . 0.0 111.352 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.94 ' HB3' HD11 ' A' ' 26' ' ' LEU . 5.4 mp -79.56 94.91 5.72 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 120.359 -1.671 . . . . 0.0 109.753 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.511 ' O ' ' CB ' ' A' ' 25' ' ' ASN . 46.6 mt-10 -103.67 170.57 7.86 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.231 -0.918 . . . . 0.0 109.179 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.511 ' CB ' ' O ' ' A' ' 24' ' ' GLU . 1.3 t-20 70.37 18.15 6.79 Favored 'General case' 0 N--CA 1.511 2.578 0 O-C-N 121.528 -0.733 . . . . 0.0 111.785 179.33 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.94 HD11 ' HB3' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -76.42 -8.66 57.61 Favored 'General case' 0 N--CA 1.505 2.304 0 O-C-N 120.983 -1.073 . . . . 0.0 111.419 -179.798 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 26' ' ' LEU . . . -46.85 -32.74 3.94 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.461 -1.399 . . . . 0.0 108.847 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.413 ' NH2' ' HB3' ' A' ' 25' ' ' ASN . 11.9 ptt180 -80.96 0.85 33.66 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 120.193 -0.603 . . . . 0.0 111.363 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.637 ' HE2' ' OD1' ' A' ' 33' ' ' ASP . 7.1 mtp -100.79 149.13 24.15 Favored 'General case' 0 C--N 1.314 -0.976 0 O-C-N 120.837 -1.165 . . . . 0.0 111.864 -178.465 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.504 ' C ' HD12 ' A' ' 34' ' ' ILE . 2.4 mtt85 -89.12 142.13 27.91 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.449 -0.782 . . . . 0.0 110.772 178.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.565 ' O ' HG13 ' A' ' 35' ' ' ILE . 12.1 ptpt -35.91 -34.54 0.05 Allowed 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.707 -0.621 . . . . 0.0 111.582 179.276 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.457 ' OE1' ' HG3' ' A' ' 31' ' ' LYS . 1.6 mm100 -63.78 -59.84 4.05 Favored 'General case' 0 N--CA 1.517 2.91 0 O-C-N 120.568 -1.332 . . . . 0.0 109.869 -179.105 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.637 ' OD1' ' HE2' ' A' ' 29' ' ' MET . 2.5 p30 -66.11 -37.61 86.16 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.586 -0.696 . . . . 0.0 110.162 -178.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.56 HD11 ' O ' ' A' ' 29' ' ' MET . 3.3 mt -61.15 -41.46 89.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 O-C-N 120.267 -1.521 . . . . 0.0 108.071 178.12 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.609 HG23 HD13 ' A' ' 6' ' ' LEU . 96.8 mt -60.93 -48.48 88.8 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.778 0 O-C-N 120.057 -1.652 . . . . 0.0 109.443 177.559 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -52.7 -41.7 64.13 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 107.859 -1.164 . . . . 0.0 107.859 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.611 ' HB1' ' CD2' ' A' ' 23' ' ' LEU . . . -62.34 -55.55 26.94 Favored 'General case' 0 C--O 1.2 -1.506 0 O-C-N 120.911 -1.118 . . . . 0.0 108.456 177.367 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.557 ' HA ' ' CD ' ' A' ' 41' ' ' GLN . 0.4 OUTLIER -51.22 -27.86 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 C-N-CA 117.301 -1.76 . . . . 0.0 110.358 179.853 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.782 HD23 ' CE2' ' A' ' 111' ' ' PHE . 3.1 mp -71.59 -45.55 61.87 Favored 'General case' 0 N--CA 1.509 2.5 0 C-N-CA 117.762 -1.575 . . . . 0.0 109.551 178.238 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.514 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 1.2 mtpp -65.83 -40.86 92.18 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.191 -0.943 . . . . 0.0 111.377 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.683 HE22 HD22 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -79.07 -41.58 28.43 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.962 -1.086 . . . . 0.0 111.512 -178.605 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.598 ' N ' ' HG2' ' A' ' 41' ' ' GLN . 1.3 m-70 -69.77 -33.94 73.08 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 117.187 -1.805 . . . . 0.0 107.957 178.79 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.474 ' O ' ' N ' ' A' ' 46' ' ' GLY . . . -67.03 -51.66 52.03 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 120.641 -1.287 . . . . 0.0 107.842 177.007 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.514 ' HB2' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -49.31 -46.32 46.46 Favored 'General case' 0 N--CA 1.482 1.153 0 O-C-N 121.081 -1.012 . . . . 0.0 108.998 177.935 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 65.9 m -66.63 -6.35 15.04 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 120.039 -0.664 . . . . 0.0 109.797 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . 90.62 7.94 66.24 Favored Glycine 0 N--CA 1.496 2.678 0 C-N-CA 119.883 -1.151 . . . . 0.0 113.328 177.662 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -79.03 159.14 27.72 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 120.754 2.277 . . . . 0.0 108.781 179.162 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -88.64 150.36 23.06 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.899 -1.125 . . . . 0.0 110.038 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.574 HG13 HG13 ' A' ' 101' ' ' ILE . 0.7 OUTLIER -135.12 133.52 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 120.805 -1.185 . . . . 0.0 107.95 179.052 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.583 ' CE2' ' HB2' ' A' ' 2' ' ' ASN . 8.2 p90 -140.5 166.87 23.54 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 116.558 -2.057 . . . . 0.0 114.255 -178.587 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -122.13 170.67 15.1 Favored Glycine 0 N--CA 1.5 2.953 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -177.493 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.469 ' C ' HD21 ' A' ' 65' ' ' LEU . 2.7 p30 -170.04 163.94 9.35 Favored 'General case' 0 N--CA 1.482 1.155 0 O-C-N 120.681 -1.482 . . . . 0.0 110.138 -179.138 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.46 ' N ' HD21 ' A' ' 65' ' ' LEU . . . 145.32 -140.25 8.91 Favored Glycine 0 N--CA 1.506 3.328 0 C-N-CA 118.356 -1.878 . . . . 0.0 110.962 178.611 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.593 ' HA ' ' O ' ' A' ' 95' ' ' ASP . 3.0 t -128.2 121.08 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.975 HD21 HG21 ' A' ' 81' ' ' VAL . 6.5 mt -62.79 163.91 8.68 Favored 'General case' 0 N--CA 1.505 2.277 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -175.319 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.507 ' HA ' ' OG1' ' A' ' 93' ' ' THR . 73.0 mm-40 -137.92 117.98 13.45 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 177.764 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.614 ' CG1' ' HB ' ' A' ' 93' ' ' THR . 1.3 mm -85.13 162.11 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 CA-C-N 121.001 1.728 . . . . 0.0 110.545 -178.043 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.716 HD22 ' CZ ' ' A' ' 62' ' ' PHE . 5.1 mp -129.16 136.0 49.59 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.682 -1.261 . . . . 0.0 108.941 178.503 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.45 ' C ' ' O ' ' A' ' 58' ' ' LEU . 1.1 mt-30 -41.25 -34.01 0.44 Allowed 'General case' 0 N--CA 1.501 2.092 0 CA-C-O 121.972 0.892 . . . . 0.0 109.301 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -60.99 -7.82 2.75 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 119.928 -0.709 . . . . 0.0 112.247 -179.113 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.494 ' O ' ' HB3' ' A' ' 83' ' ' PRO . . . 93.55 4.35 64.03 Favored Glycine 1 N--CA 1.517 4.08 0 C-N-CA 118.817 -1.659 . . . . 0.0 112.43 177.758 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.716 ' CZ ' HD22 ' A' ' 58' ' ' LEU . 5.0 p90 -127.66 179.92 5.27 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 104.808 -2.293 . . . . 0.0 104.808 178.131 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.624 ' HA2' HD13 ' A' ' 58' ' ' LEU . . . -161.05 176.82 37.6 Favored Glycine 0 N--CA 1.476 1.343 0 C-N-CA 117.187 -2.435 . . . . 0.0 111.486 -177.727 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.447 ' CE2' ' HE2' ' A' ' 62' ' ' PHE . 23.2 m-85 -129.53 152.47 49.02 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 119.968 1.884 . . . . 0.0 109.689 177.476 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.503 ' HB3' ' HB ' ' A' ' 79' ' ' ILE . 0.5 OUTLIER -97.72 156.28 16.63 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 176.542 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.466 ' HB3' ' O ' ' A' ' 65' ' ' LEU . 1.1 ptp85 177.12 -154.21 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.96 -1.087 . . . . 0.0 109.999 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.5 2.029 0 O-C-N 121.247 -0.908 . . . . 0.0 110.888 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.505 ' OD1' ' N ' ' A' ' 78' ' ' ASP . 2.0 m-20 . . . . . 0 N--CA 1.505 2.314 0 CA-C-O 121.075 0.464 . . . . 0.0 109.981 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.503 ' HB ' ' HB3' ' A' ' 65' ' ' LEU . 4.6 mm -128.35 133.83 66.03 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.657 0 O-C-N 121.06 -1.025 . . . . 0.0 109.891 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.479 ' HB3' ' O ' ' A' ' 111' ' ' PHE . 81.4 t80 -78.45 147.51 33.94 Favored 'General case' 0 N--CA 1.516 2.846 0 O-C-N 119.399 -2.063 . . . . 0.0 109.347 179.13 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.975 HG21 HD21 ' A' ' 55' ' ' LEU . 10.2 t -140.58 114.09 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 O-C-N 120.12 -1.612 . . . . 0.0 110.664 -179.315 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.565 ' O ' HG13 ' A' ' 86' ' ' ILE . 58.6 m -75.25 163.6 66.7 Favored Pre-proline 0 N--CA 1.512 2.651 0 O-C-N 120.442 -1.411 . . . . 0.0 112.18 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.564 ' HA ' HG13 ' A' ' 86' ' ' ILE . 38.0 Cg_endo -65.49 -52.75 0.96 Allowed 'Trans proline' 0 C--N 1.314 -1.289 0 O-C-N 124.701 1.895 . . . . 0.0 108.904 178.589 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.527 ' O ' ' HB2' ' A' ' 88' ' ' ARG . 0.3 OUTLIER -45.66 -40.98 9.81 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 178.242 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.631 ' NE2' ' HA ' ' A' ' 85' ' ' GLN . 4.8 mm-40 -62.41 -58.85 6.15 Favored 'General case' 0 N--CA 1.51 2.556 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.253 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.566 ' HA ' ' CD1' ' A' ' 91' ' ' LEU . 0.4 OUTLIER -55.98 -55.06 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.273 0 O-C-N 121.128 -0.982 . . . . 0.0 108.837 178.469 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.485 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 1.6 mtt85 -58.13 -42.6 86.2 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-O 121.772 0.796 . . . . 0.0 111.644 -178.928 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.527 ' HB2' ' O ' ' A' ' 84' ' ' SER . 19.8 mtt-85 -60.76 -36.8 79.86 Favored 'General case' 0 N--CA 1.505 2.311 0 C-N-CA 119.34 -0.944 . . . . 0.0 111.884 -177.545 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 1.045 ' HB2' HD21 ' A' ' 91' ' ' LEU . 16.7 m-85 -110.99 13.02 22.08 Favored 'General case' 0 N--CA 1.503 2.189 0 C-N-CA 116.815 -1.954 . . . . 0.0 111.382 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 61.19 55.04 3.09 Favored 'General case' 0 N--CA 1.483 1.21 0 O-C-N 120.509 -1.369 . . . . 0.0 110.458 178.307 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 1.045 HD21 ' HB2' ' A' ' 89' ' ' PHE . 3.9 mt -89.2 -170.75 2.99 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 119.102 -1.039 . . . . 0.0 110.416 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.531 ' CG ' ' O ' ' A' ' 91' ' ' LEU . 86.5 mtt-85 -159.4 160.03 34.41 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.679 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.614 ' HB ' ' CG1' ' A' ' 57' ' ' ILE . 1.7 t -64.36 156.9 27.73 Favored 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 116.826 -1.949 . . . . 0.0 106.662 178.459 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.42 ' O ' ' CG1' ' A' ' 54' ' ' VAL . . . 75.54 -9.44 15.34 Favored Glycine 0 N--CA 1.506 3.329 0 C-N-CA 117.122 -2.466 . . . . 0.0 110.191 179.346 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.593 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 11.7 m-20 -66.79 147.98 52.53 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.235 -1.744 . . . . 0.0 110.778 -178.789 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.483 ' O ' HG12 ' A' ' 97' ' ' ILE . 0.2 OUTLIER -89.6 120.98 31.37 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.228 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.811 HG23 HG22 ' A' ' 119' ' ' VAL . 1.4 mt -144.06 162.05 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 119.934 -1.729 . . . . 0.0 112.803 -178.305 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.518 ' OG ' ' HB2' ' A' ' 118' ' ' GLU . 97.5 p -148.05 137.88 22.52 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.553 ' O ' ' HB2' ' A' ' 50' ' ' PHE . . . -168.05 -178.27 39.83 Favored Glycine 0 N--CA 1.507 3.415 0 C-N-CA 117.035 -2.507 . . . . 0.0 114.917 -178.962 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.619 ' CD ' HD23 ' A' ' 114' ' ' LEU . 1.8 ptmt -90.12 156.93 18.01 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.574 HG13 HG13 ' A' ' 49' ' ' ILE . 2.3 pt -125.61 155.75 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.523 0 CA-C-N 120.659 1.572 . . . . 0.0 113.227 -177.529 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.892 ' HB3' HD13 ' A' ' 114' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.356 0 O-C-N 120.58 -1.325 . . . . 0.0 109.25 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.46 ' HD2' ' CZ ' ' A' ' 110' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.688 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.46 ' CZ ' ' HD2' ' A' ' 109' ' ' ARG . 35.8 m-85 -109.04 144.26 37.27 Favored 'General case' 0 N--CA 1.515 2.805 0 O-C-N 120.32 -1.487 . . . . 0.0 108.082 176.734 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.782 ' CE2' HD23 ' A' ' 39' ' ' LEU . 3.3 m-85 -68.33 165.74 18.0 Favored 'General case' 0 N--CA 1.506 2.348 0 O-C-N 119.321 -2.112 . . . . 0.0 107.957 178.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.457 ' HA ' ' HB3' ' A' ' 80' ' ' TYR . . . -122.7 150.68 42.4 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 119.955 -1.715 . . . . 0.0 110.957 -179.063 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.3 tp -60.11 147.56 39.08 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.892 HD13 ' HB3' ' A' ' 102' ' ' ARG . 14.3 tp -127.84 -55.48 1.3 Allowed 'General case' 0 N--CA 1.502 2.136 0 O-C-N 120.357 -1.464 . . . . 0.0 112.345 -178.793 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.536 ' HB3' ' CD ' ' A' ' 100' ' ' LYS . 0.6 OUTLIER -124.68 139.79 53.54 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 120.321 -1.487 . . . . 0.0 108.598 179.448 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.41 HG11 HG21 ' A' ' 119' ' ' VAL . 29.2 t -92.47 129.75 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.735 0 O-C-N 120.671 -1.268 . . . . 0.0 111.52 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.414 ' CG ' ' HA2' ' A' ' 99' ' ' GLY . 5.1 m-20 -106.43 -39.81 5.78 Favored 'General case' 0 N--CA 1.506 2.339 0 O-C-N 121.409 -0.807 . . . . 0.0 109.496 178.308 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.579 ' C ' HG23 ' A' ' 119' ' ' VAL . 1.7 tt0 -143.31 154.49 43.83 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.797 -1.189 . . . . 0.0 109.515 178.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.811 HG22 HG23 ' A' ' 97' ' ' ILE . 83.3 t -159.99 128.21 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 C-N-CA 120.749 -0.38 . . . . 0.0 111.503 -178.349 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.419 ' C ' ' O ' ' A' ' 119' ' ' VAL . 0.6 OUTLIER . . . . . 0 N--CA 1.52 3.049 0 O-C-N 120.514 -1.366 . . . . 0.0 111.161 178.833 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.633 ' HA ' ' HA ' ' A' ' 49' ' ' ILE . 2.1 ptp . . . . . 0 N--CA 1.493 1.701 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' ASN . . . . . 0.562 ' HB2' ' CZ ' ' A' ' 50' ' ' PHE . 8.7 t-20 -78.21 94.28 4.74 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.819 -1.175 . . . . 0.0 108.635 179.118 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.547 ' HA ' HD12 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -41.41 -41.27 1.96 Allowed 'General case' 0 N--CA 1.517 2.917 0 O-C-N 120.679 -1.263 . . . . 0.0 110.031 -178.797 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.412 ' OG1' ' OD2' ' A' ' 52' ' ' ASP . 1.8 m -59.13 -35.36 73.34 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 120.819 -1.176 . . . . 0.0 108.564 -179.436 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.515 ' N ' ' OD1' ' A' ' 2' ' ' ASN . 0.1 OUTLIER -74.12 -45.39 49.26 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.027 -1.046 . . . . 0.0 108.747 178.209 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.816 ' CD1' HD21 ' A' ' 39' ' ' LEU 0.275 77.9 mt -50.94 -49.72 59.26 Favored 'General case' 0 C--N 1.317 -0.817 0 O-C-N 120.806 -1.184 . . . . 0.0 109.216 178.266 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -66.21 -39.78 89.86 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.046 -1.034 . . . . 0.0 110.142 178.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -63.25 -28.09 69.79 Favored 'General case' 0 N--CA 1.508 2.429 0 O-C-N 121.226 -0.921 . . . . 0.0 111.251 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.636 HG22 ' CB ' ' A' ' 13' ' ' GLU . 3.0 m -73.84 126.92 89.12 Favored Pre-proline 0 N--CA 1.505 2.321 0 O-C-N 121.538 -0.727 . . . . 0.0 109.549 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.561 ' HG2' ' CG ' ' A' ' 13' ' ' GLU . 40.1 Cg_endo -61.16 150.47 84.31 Favored 'Trans proline' 0 CA--C 1.566 2.096 0 O-C-N 122.315 0.64 . . . . 0.0 110.84 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.55 ' CG1' ' N ' ' A' ' 12' ' ' SER . 1.4 p -43.43 -50.74 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.525 3.276 0 O-C-N 120.493 -1.379 . . . . 0.0 109.471 -178.71 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.55 ' N ' ' CG1' ' A' ' 11' ' ' VAL . 0.8 OUTLIER -56.21 -39.95 73.28 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.418 -0.801 . . . . 0.0 111.056 -179.856 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.899 ' O ' HD12 ' A' ' 17' ' ' LEU . 0.1 OUTLIER -69.26 -29.59 67.52 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 117.96 -1.496 . . . . 0.0 107.711 179.178 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.711 ' HB3' HG21 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -68.54 -44.32 74.79 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.13 -0.981 . . . . 0.0 108.89 176.845 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.523 HD12 ' O ' ' A' ' 11' ' ' VAL . 1.5 mp -65.68 -37.17 79.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 C-N-CA 117.97 -1.492 . . . . 0.0 108.908 179.204 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.583 ' HA ' ' HG2' ' A' ' 19' ' ' GLU . 31.0 m -65.8 -38.64 89.53 Favored 'General case' 0 N--CA 1.484 1.247 0 O-C-N 120.338 -1.476 . . . . 0.0 109.123 178.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.899 HD12 ' O ' ' A' ' 13' ' ' GLU . 3.7 mt -65.34 -38.13 89.19 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.887 -1.133 . . . . 0.0 108.764 178.593 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.463 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -67.61 -43.5 85.41 Favored Glycine 0 N--CA 1.513 3.787 0 N-CA-C 108.49 -1.844 . . . . 0.0 108.49 178.467 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.697 ' HG3' ' N ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -58.62 -38.84 78.91 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.463 -1.61 . . . . 0.0 108.175 178.925 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.697 ' N ' ' HG3' ' A' ' 19' ' ' GLU . 24.8 m120 -61.81 -27.76 68.99 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 118.13 -1.428 . . . . 0.0 109.313 178.633 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.533 ' HE2' ' NE2' ' A' ' 41' ' ' GLN . 21.5 mmm -102.5 10.81 38.64 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.314 -0.867 . . . . 0.0 111.511 -178.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.66 -18.23 50.99 Favored Glycine 0 N--CA 1.504 3.175 0 C-N-CA 118.537 -1.792 . . . . 0.0 112.102 179.274 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.991 ' HB3' HD11 ' A' ' 26' ' ' LEU . 5.0 mp -78.4 95.01 4.99 Favored 'General case' 0 N--CA 1.508 2.449 0 O-C-N 120.193 -1.769 . . . . 0.0 110.121 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.474 ' O ' ' CB ' ' A' ' 25' ' ' ASN . 51.5 mt-10 -104.01 168.66 8.97 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.169 -0.957 . . . . 0.0 109.268 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.474 ' CB ' ' O ' ' A' ' 24' ' ' GLU . 3.4 t-20 68.98 19.49 8.15 Favored 'General case' 0 N--CA 1.508 2.434 0 O-C-N 121.499 -0.751 . . . . 0.0 111.947 179.056 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.991 HD11 ' HB3' ' A' ' 23' ' ' LEU . 0.4 OUTLIER -76.21 -13.62 60.17 Favored 'General case' 0 N--CA 1.505 2.283 0 O-C-N 120.76 -1.212 . . . . 0.0 111.381 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 26' ' ' LEU . . . -46.99 -35.61 6.81 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.464 -1.398 . . . . 0.0 109.061 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.6 mtt180 -81.16 2.48 27.39 Favored 'General case' 0 C--N 1.295 -1.79 0 C-N-CA 119.849 -0.74 . . . . 0.0 111.438 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.565 ' HB3' HG13 ' A' ' 34' ' ' ILE . 7.4 mtp -100.4 150.53 22.52 Favored 'General case' 0 C--N 1.313 -0.984 0 O-C-N 120.832 -1.167 . . . . 0.0 111.164 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.53 ' C ' HD12 ' A' ' 34' ' ' ILE . 10.8 ttp85 -89.22 142.59 27.51 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.258 -0.901 . . . . 0.0 110.677 179.106 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.59 ' O ' ' CG1' ' A' ' 35' ' ' ILE . 7.7 tttp -31.95 -46.27 0.11 Allowed 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 116.264 -0.426 . . . . 0.0 112.051 179.224 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.524 ' OE1' ' N ' ' A' ' 33' ' ' ASP . 1.2 pp0? -61.6 -53.88 50.37 Favored 'General case' 0 N--CA 1.52 3.066 0 O-C-N 121.325 -0.86 . . . . 0.0 112.101 -177.481 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.539 ' OD1' ' HE2' ' A' ' 29' ' ' MET . 2.1 p30 -66.73 -37.32 84.43 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 120.732 -1.23 . . . . 0.0 108.964 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.711 HG21 ' HB3' ' A' ' 14' ' ' LEU . 4.8 mt -61.17 -39.44 82.45 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 O-C-N 120.328 -1.482 . . . . 0.0 108.043 177.78 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.59 ' CG1' ' O ' ' A' ' 31' ' ' LYS . 0.6 OUTLIER -57.58 -47.51 85.17 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.558 0 O-C-N 120.085 -1.635 . . . . 0.0 109.271 177.577 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -53.18 -41.15 64.95 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.405 -0.918 . . . . 0.0 108.526 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.841 ' HB1' ' CD2' ' A' ' 23' ' ' LEU . . . -70.29 -53.09 18.27 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.971 -1.081 . . . . 0.0 109.953 178.114 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.662 ' HA ' ' CG ' ' A' ' 41' ' ' GLN . 0.1 OUTLIER -53.78 -28.26 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 C-N-CA 117.437 -1.705 . . . . 0.0 110.362 -179.786 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.816 HD21 ' CD1' ' A' ' 6' ' ' LEU . 64.7 mt -72.33 -44.3 62.86 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 120.409 -1.432 . . . . 0.0 109.696 178.477 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 10.9 mmtt -64.21 -41.63 96.95 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.046 -1.034 . . . . 0.0 110.501 179.014 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.662 ' CG ' ' HA ' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -74.86 -46.41 36.54 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.065 -1.022 . . . . 0.0 111.359 -179.06 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.492 ' HB2' ' O ' ' A' ' 38' ' ' ILE . 0.3 OUTLIER -66.01 -34.47 78.17 Favored 'General case' 0 N--CA 1.505 2.309 0 O-C-N 120.543 -1.348 . . . . 0.0 108.984 179.539 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.565 ' O ' ' N ' ' A' ' 46' ' ' GLY . . . -67.32 -36.93 82.47 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 120.975 -1.078 . . . . 0.0 108.96 178.301 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.89 -43.73 28.89 Favored 'General case' 0 N--CA 1.482 1.162 0 O-C-N 120.799 -1.188 . . . . 0.0 108.966 178.25 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 70.8 m -66.66 -9.99 41.67 Favored 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 119.59 -0.844 . . . . 0.0 109.265 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.565 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . 64.57 36.03 92.66 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 178.932 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.514 ' OE1' ' N ' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -92.62 166.72 12.35 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.432 -1.628 . . . . 0.0 108.841 179.214 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.514 ' N ' ' OE1' ' A' ' 47' ' ' GLU . 17.0 m-20 -61.58 137.09 58.23 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.122 -0.986 . . . . 0.0 110.792 -178.37 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.633 ' HA ' ' HA ' ' A' ' 1' ' ' MET . 3.0 pt -141.26 135.19 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 120.986 -1.071 . . . . 0.0 108.224 178.912 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.641 ' CD1' ' N ' ' A' ' 50' ' ' PHE . 7.4 p90 -144.86 163.26 34.63 Favored 'General case' 0 C--N 1.31 -1.12 0 C-N-CA 116.014 -2.274 . . . . 0.0 115.794 -178.422 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -120.79 170.6 14.5 Favored Glycine 0 N--CA 1.505 3.243 0 N-CA-C 108.686 -1.766 . . . . 0.0 108.686 -179.017 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.483 ' C ' ' CD2' ' A' ' 65' ' ' LEU . 52.5 p-10 -170.22 167.5 8.57 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 120.383 -1.657 . . . . 0.0 110.741 -178.574 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.536 ' HA3' ' O ' ' A' ' 66' ' ' ARG . . . 144.09 -139.19 8.49 Favored Glycine 0 N--CA 1.507 3.418 0 C-N-CA 118.368 -1.872 . . . . 0.0 111.472 177.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.58 ' HA ' ' O ' ' A' ' 95' ' ' ASP . 2.8 t -127.75 120.12 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 O-C-N 121.258 -1.142 . . . . 0.0 108.092 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.874 HD21 HG21 ' A' ' 81' ' ' VAL . 7.2 mt -62.92 162.78 10.66 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -175.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.528 ' HA ' ' OG1' ' A' ' 93' ' ' THR . 0.0 OUTLIER -139.27 119.79 14.0 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.03 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.584 ' CG1' ' HB ' ' A' ' 93' ' ' THR . 1.2 mm -78.65 162.07 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 119.733 -1.854 . . . . 0.0 109.18 -178.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 1.178 HD22 ' CZ ' ' A' ' 62' ' ' PHE . 1.3 mp -131.39 126.06 34.2 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.301 -1.499 . . . . 0.0 109.752 179.195 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.509 ' C ' ' O ' ' A' ' 58' ' ' LEU . 6.9 mm-40 -32.74 -37.05 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.458 0 CA-C-O 122.018 0.913 . . . . 0.0 109.715 -179.494 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.556 ' HB2' ' CD2' ' A' ' 62' ' ' PHE . 3.1 m-20 -60.92 -6.21 1.72 Allowed 'General case' 0 N--CA 1.5 2.033 0 C-N-CA 120.271 -0.571 . . . . 0.0 112.489 -179.176 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 58' ' ' LEU . . . 89.14 11.9 64.22 Favored Glycine 1 N--CA 1.517 4.077 0 C-N-CA 118.672 -1.728 . . . . 0.0 111.944 178.365 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 1.178 ' CZ ' HD22 ' A' ' 58' ' ' LEU . 4.0 p90 -128.1 -178.85 4.69 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 104.18 -2.526 . . . . 0.0 104.18 177.881 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.571 ' HA2' ' CD1' ' A' ' 58' ' ' LEU . . . -152.75 162.87 30.2 Favored Glycine 0 N--CA 1.475 1.292 0 C-N-CA 117.322 -2.37 . . . . 0.0 111.272 -177.885 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.442 ' CD1' ' HE1' ' A' ' 62' ' ' PHE . 2.0 m-30 -127.81 150.96 49.59 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 120.136 1.968 . . . . 0.0 109.156 177.728 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.502 ' HB3' ' HB ' ' A' ' 79' ' ' ILE . 0.3 OUTLIER -98.34 166.37 11.41 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 176.768 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.536 ' O ' ' HA3' ' A' ' 53' ' ' GLY . 21.0 tpt180 -178.42 -179.97 0.73 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.057 -1.027 . . . . 0.0 109.02 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.7 m . . . . . 0 N--CA 1.496 1.867 0 O-C-N 120.45 -1.406 . . . . 0.0 109.86 179.658 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 78' ' ' ASP . 1.1 m-20 . . . . . 0 N--CA 1.506 2.343 0 CA-C-O 121.096 0.474 . . . . 0.0 109.77 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.502 ' HB ' ' HB3' ' A' ' 65' ' ' LEU . 3.9 mm -126.56 138.67 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.65 0 O-C-N 121.16 -0.963 . . . . 0.0 110.11 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.5 ' HB3' ' O ' ' A' ' 111' ' ' PHE . 6.0 t80 -85.02 146.55 27.13 Favored 'General case' 0 N--CA 1.516 2.867 0 CA-C-N 121.502 1.955 . . . . 0.0 109.819 178.875 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.874 HG21 HD21 ' A' ' 55' ' ' LEU . 25.2 t -141.65 115.77 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 120.078 -1.639 . . . . 0.0 110.226 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.556 ' O ' HG13 ' A' ' 86' ' ' ILE . 58.0 m -74.3 163.52 67.7 Favored Pre-proline 0 N--CA 1.515 2.799 0 O-C-N 120.262 -1.524 . . . . 0.0 112.131 -179.208 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.535 ' HA ' HG13 ' A' ' 86' ' ' ILE . 40.2 Cg_endo -66.62 -50.27 1.34 Allowed 'Trans proline' 0 C--N 1.314 -1.249 0 O-C-N 124.505 1.792 . . . . 0.0 108.958 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.539 ' O ' ' CG ' ' A' ' 88' ' ' ARG . 0.4 OUTLIER -47.2 -39.53 14.19 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 177.834 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.547 ' HB2' ' O ' ' A' ' 82' ' ' SER . 7.2 mm-40 -63.42 -57.78 9.2 Favored 'General case' 0 N--CA 1.511 2.587 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.215 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.59 ' HA ' HD23 ' A' ' 91' ' ' LEU . 0.8 OUTLIER -55.51 -53.59 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.336 0 O-C-N 120.938 -1.101 . . . . 0.0 108.647 178.848 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.469 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 0.1 OUTLIER -57.81 -41.72 82.76 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 121.865 0.84 . . . . 0.0 111.364 -179.459 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.539 ' CG ' ' O ' ' A' ' 84' ' ' SER . 12.5 mtt180 -59.37 -37.46 77.96 Favored 'General case' 0 N--CA 1.507 2.407 0 C-N-CA 119.883 -0.727 . . . . 0.0 111.928 -177.606 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.453 ' CD2' HG21 ' A' ' 116' ' ' VAL . 19.3 m-85 -113.97 14.53 18.46 Favored 'General case' 0 N--CA 1.505 2.318 0 C-N-CA 117.274 -1.771 . . . . 0.0 111.412 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 58.45 56.5 4.32 Favored 'General case' 0 N--CA 1.481 1.108 0 O-C-N 120.31 -1.493 . . . . 0.0 109.084 179.067 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.59 HD23 ' HA ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -88.37 173.91 8.46 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.431 -0.908 . . . . 0.0 109.338 -179.831 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.535 ' CD ' ' O ' ' A' ' 91' ' ' LEU . 3.7 mmm180 -147.0 157.51 43.64 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.997 -1.065 . . . . 0.0 108.86 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.584 ' HB ' ' CG1' ' A' ' 57' ' ' ILE . 2.4 t -63.73 156.29 27.54 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 116.948 -1.901 . . . . 0.0 106.993 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 76.34 -9.61 19.9 Favored Glycine 0 N--CA 1.504 3.189 0 C-N-CA 117.094 -2.479 . . . . 0.0 110.334 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.58 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 6.0 m-20 -69.36 147.75 50.63 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.228 -1.748 . . . . 0.0 110.752 -178.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.51 ' O ' HG12 ' A' ' 97' ' ' ILE . 0.2 OUTLIER -91.22 124.29 35.31 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.093 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.529 HG23 ' O ' ' A' ' 118' ' ' GLU . 1.7 mt -146.73 166.3 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.034 -1.666 . . . . 0.0 112.408 -179.087 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.533 ' OG ' ' HB2' ' A' ' 118' ' ' GLU . 82.4 p -148.93 139.82 22.87 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.233 178.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.502 ' O ' ' HB2' ' A' ' 50' ' ' PHE . . . -164.6 179.55 39.27 Favored Glycine 0 N--CA 1.506 3.346 0 C-N-CA 117.039 -2.505 . . . . 0.0 114.987 -179.118 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.541 ' HG2' ' HB3' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -87.76 152.88 21.78 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 178.772 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.542 HG13 HG13 ' A' ' 49' ' ' ILE . 2.4 pt -122.87 159.17 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.462 0 CA-C-N 120.982 1.719 . . . . 0.0 113.603 -176.776 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.599 ' CB ' HD13 ' A' ' 114' ' ' LEU . 1.5 tmm_? . . . . . 0 N--CA 1.481 1.111 0 O-C-N 120.582 -1.324 . . . . 0.0 109.891 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.494 1.75 0 N-CA-C 111.245 0.091 . . . . 0.0 111.245 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.421 ' CD1' ' N ' ' A' ' 110' ' ' TYR . 3.6 m-85 -108.4 148.04 30.71 Favored 'General case' 0 N--CA 1.521 3.078 0 O-C-N 120.07 -1.644 . . . . 0.0 109.542 178.625 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.5 ' O ' ' HB3' ' A' ' 80' ' ' TYR . 54.4 m-85 -69.13 172.03 7.44 Favored 'General case' 0 N--CA 1.509 2.514 0 O-C-N 119.735 -1.853 . . . . 0.0 108.034 178.317 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.435 ' HA ' ' HB3' ' A' ' 80' ' ' TYR . . . -122.08 154.96 36.65 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 119.924 -1.735 . . . . 0.0 110.842 -179.169 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.12 153.7 43.28 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 179.375 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.599 HD13 ' CB ' ' A' ' 102' ' ' ARG . 11.1 tp -132.79 -59.55 0.89 Allowed 'General case' 0 N--CA 1.501 2.077 0 O-C-N 120.135 -1.603 . . . . 0.0 112.22 -179.276 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.541 ' HB3' ' HG2' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -114.18 141.7 47.19 Favored 'General case' 0 N--CA 1.511 2.615 0 O-C-N 120.272 -1.518 . . . . 0.0 109.074 179.401 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.453 HG21 ' CD2' ' A' ' 89' ' ' PHE . 34.7 t -93.05 129.25 43.83 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.908 0 O-C-N 120.543 -1.348 . . . . 0.0 111.63 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.431 ' C ' ' HG2' ' A' ' 118' ' ' GLU . 7.1 m-20 -106.93 -39.05 5.87 Favored 'General case' 0 N--CA 1.507 2.423 0 O-C-N 121.463 -0.773 . . . . 0.0 109.918 178.324 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.548 ' C ' HG23 ' A' ' 119' ' ' VAL . 6.0 mm-40 -143.52 156.37 44.59 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.595 -1.316 . . . . 0.0 109.041 179.417 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.548 HG23 ' C ' ' A' ' 118' ' ' GLU . 6.4 t -156.17 139.81 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -178.229 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.467 ' C ' ' O ' ' A' ' 119' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.519 2.978 0 O-C-N 121.106 -0.996 . . . . 0.0 111.197 -177.535 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.806 ' SD ' HG22 ' A' ' 49' ' ' ILE . 14.1 mmt . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.097 0.475 . . . . 0.0 109.925 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' ASN . . . . . 0.522 ' HA ' ' O ' ' A' ' 50' ' ' PHE . 39.8 t30 -78.86 110.04 13.69 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.007 -1.058 . . . . 0.0 108.84 178.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.662 ' HA ' HD12 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -44.09 -41.17 5.4 Favored 'General case' 0 N--CA 1.514 2.74 0 O-C-N 120.339 -1.476 . . . . 0.0 110.493 -178.695 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.43 ' OG1' ' OD1' ' A' ' 52' ' ' ASP . 1.7 m -58.4 -36.88 74.24 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 120.696 -1.253 . . . . 0.0 108.264 -179.014 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.51 ' HB3' ' HB3' ' A' ' 2' ' ' ASN . 1.8 pt-20 -70.53 -45.84 64.75 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.089 -1.007 . . . . 0.0 108.543 178.053 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.662 HD12 ' HA ' ' A' ' 3' ' ' LEU 0.281 82.3 mt -51.65 -49.5 62.19 Favored 'General case' 0 C--N 1.315 -0.916 0 O-C-N 121.008 -1.058 . . . . 0.0 109.521 178.397 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.78 -38.58 91.65 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.288 -0.883 . . . . 0.0 110.094 179.137 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -62.58 -19.52 63.8 Favored 'General case' 0 N--CA 1.508 2.473 0 O-C-N 121.262 -0.899 . . . . 0.0 111.383 -179.086 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.617 ' HB ' ' CD1' ' A' ' 14' ' ' LEU . 3.2 m -83.17 117.85 69.87 Favored Pre-proline 0 C--N 1.284 -2.278 0 O-C-N 121.763 -0.585 . . . . 0.0 109.966 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.53 ' HG2' ' HG3' ' A' ' 13' ' ' GLU . 38.5 Cg_endo -59.61 155.14 43.98 Favored 'Trans proline' 0 CA--C 1.564 2.0 0 O-C-N 122.471 0.722 . . . . 0.0 110.899 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.541 HG23 ' N ' ' A' ' 31' ' ' LYS . 1.7 p -42.81 -51.63 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.527 3.383 0 O-C-N 120.577 -1.327 . . . . 0.0 110.139 -178.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.519 ' N ' ' CG1' ' A' ' 11' ' ' VAL . 1.5 t -55.01 -43.23 73.45 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 121.12 -0.987 . . . . 0.0 111.239 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.74 ' O ' HD12 ' A' ' 17' ' ' LEU . 1.7 mm-40 -68.38 -27.32 66.13 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 117.947 -1.501 . . . . 0.0 107.59 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.617 ' CD1' ' HB ' ' A' ' 9' ' ' THR . 0.0 OUTLIER -70.61 -41.46 72.26 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.132 -0.98 . . . . 0.0 109.089 176.958 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.619 HG23 ' HB2' ' A' ' 26' ' ' LEU . 1.8 mp -69.81 -36.1 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 C-N-CA 117.824 -1.55 . . . . 0.0 109.216 179.11 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.568 ' HA ' ' HG2' ' A' ' 19' ' ' GLU . 86.8 m -69.31 -40.78 77.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.03 -1.669 . . . . 0.0 109.816 179.063 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.74 HD12 ' O ' ' A' ' 13' ' ' GLU . 1.9 mt -64.84 -37.62 88.22 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.696 -1.252 . . . . 0.0 108.923 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 1.041 ' HA2' HD13 ' A' ' 38' ' ' ILE . . . -68.2 -44.67 74.92 Favored Glycine 0 N--CA 1.507 3.395 0 N-CA-C 108.929 -1.668 . . . . 0.0 108.929 178.473 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.675 ' HG3' ' N ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -57.08 -37.11 71.42 Favored 'General case' 0 N--CA 1.484 1.232 0 O-C-N 120.496 -1.59 . . . . 0.0 107.463 178.896 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.675 ' N ' ' HG3' ' A' ' 19' ' ' GLU . 28.9 m120 -61.05 -24.44 66.2 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 118.293 -1.363 . . . . 0.0 109.532 178.357 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.949 ' HG3' HD11 ' A' ' 38' ' ' ILE . 69.6 mmm -97.33 2.18 50.32 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.188 -0.945 . . . . 0.0 111.595 -179.352 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.55 -3.66 65.9 Favored Glycine 0 N--CA 1.498 2.799 0 C-N-CA 118.249 -1.929 . . . . 0.0 114.142 177.211 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 1.025 ' H ' HD13 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -103.52 63.98 0.8 Allowed 'General case' 0 N--CA 1.509 2.5 0 CA-C-N 121.644 2.722 . . . . 0.0 111.25 179.854 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.521 ' O ' ' CB ' ' A' ' 25' ' ' ASN . 5.1 pt-20 -57.11 -167.71 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.199 0 CA-C-O 122.367 1.08 . . . . 0.0 110.754 178.563 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.521 ' CB ' ' O ' ' A' ' 24' ' ' GLU . 0.7 OUTLIER 74.62 10.16 4.11 Favored 'General case' 0 N--CA 1.516 2.84 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.571 179.723 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.833 HD11 ' O ' ' A' ' 23' ' ' LEU . 1.0 OUTLIER -77.14 -18.57 57.79 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.245 -0.909 . . . . 0.0 112.35 -179.358 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.408 ' C ' ' O ' ' A' ' 26' ' ' LEU . . . -46.99 -40.21 14.01 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.313 -1.492 . . . . 0.0 108.771 -179.324 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 28.0 mtt-85 -81.15 -0.56 40.82 Favored 'General case' 0 C--N 1.295 -1.786 0 C-N-CA 119.725 -0.79 . . . . 0.0 111.359 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.562 ' HB3' HG13 ' A' ' 34' ' ' ILE . 15.7 mtp -101.21 156.78 17.23 Favored 'General case' 0 C--N 1.312 -1.038 0 O-C-N 120.915 -1.116 . . . . 0.0 111.841 -178.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.834 ' O ' HD12 ' A' ' 34' ' ' ILE . 3.8 ttm180 -89.76 175.08 7.37 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.429 -0.794 . . . . 0.0 110.561 177.956 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.905 ' O ' HG22 ' A' ' 35' ' ' ILE . 9.2 pttm -66.41 -33.33 75.47 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.449 -0.782 . . . . 0.0 110.989 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.466 ' N ' ' HG3' ' A' ' 31' ' ' LYS . 1.3 mm100 -65.57 -55.02 19.98 Favored 'General case' 0 N--CA 1.523 3.192 0 CA-C-O 122.021 0.915 . . . . 0.0 110.018 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.55 ' OD1' ' N ' ' A' ' 34' ' ' ILE . 2.0 p30 -67.33 -41.91 84.45 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.074 -1.016 . . . . 0.0 109.685 -179.054 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.834 HD12 ' O ' ' A' ' 30' ' ' ARG . 29.0 mt -61.79 -40.84 88.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 O-C-N 120.357 -1.464 . . . . 0.0 109.637 178.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.905 HG22 ' O ' ' A' ' 31' ' ' LYS . 0.2 OUTLIER -66.92 -37.26 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.557 0 O-C-N 120.113 -1.617 . . . . 0.0 109.049 178.149 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 9.2 m-30 -67.02 -45.57 77.1 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.377 -1.452 . . . . 0.0 108.716 178.964 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.443 ' O ' ' C ' ' A' ' 38' ' ' ILE . . . -67.01 -53.46 31.16 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.49 -1.381 . . . . 0.0 109.487 178.053 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 1.041 HD13 ' HA2' ' A' ' 18' ' ' GLY . 5.9 tp -48.46 -49.99 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 C-N-CA 117.536 -1.665 . . . . 0.0 108.093 179.134 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.665 ' N ' HG23 ' A' ' 38' ' ' ILE . 5.6 tp -53.87 -41.56 67.65 Favored 'General case' 0 N--CA 1.52 3.052 0 O-C-N 120.76 -1.213 . . . . 0.0 109.1 179.431 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.48 ' O ' ' HD2' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -60.59 -36.05 77.59 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 121.628 0.727 . . . . 0.0 109.739 179.271 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.755 ' CG ' HD12 ' A' ' 23' ' ' LEU . 11.8 mm-40 -79.34 -51.4 9.46 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.663 -0.648 . . . . 0.0 111.354 -179.024 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.612 ' CG ' ' CE ' ' A' ' 21' ' ' MET . 0.2 OUTLIER -61.38 -31.59 71.5 Favored 'General case' 0 N--CA 1.503 2.204 0 C-N-CA 117.736 -1.586 . . . . 0.0 108.425 179.406 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 46' ' ' GLY . . . -58.96 -44.56 91.5 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 177.822 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.492 ' HB2' ' O ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -49.22 -45.24 44.19 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 122.11 0.957 . . . . 0.0 108.944 177.952 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 65.5 m -66.8 -8.36 28.0 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 121.639 0.733 . . . . 0.0 109.581 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . 74.53 29.5 61.61 Favored Glycine 0 N--CA 1.495 2.621 0 C-N-CA 120.186 -1.006 . . . . 0.0 111.774 178.755 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.03 166.65 22.09 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.173 -1.781 . . . . 0.0 108.975 178.818 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -88.1 130.22 35.08 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.234 -0.916 . . . . 0.0 109.739 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.806 HG22 ' SD ' ' A' ' 1' ' ' MET . 0.6 OUTLIER -131.0 135.8 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.562 -1.336 . . . . 0.0 107.655 178.97 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.522 ' O ' ' HA ' ' A' ' 2' ' ' ASN . 17.0 p90 -141.82 165.14 28.29 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 116.28 -2.168 . . . . 0.0 114.834 -177.915 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -114.21 164.8 12.03 Favored Glycine 0 N--CA 1.503 3.117 0 N-CA-C 108.307 -1.917 . . . . 0.0 108.307 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.461 ' N ' ' OD1' ' A' ' 52' ' ' ASP . 46.7 p-10 -169.79 164.63 9.91 Favored 'General case' 0 N--CA 1.48 1.047 0 O-C-N 120.36 -1.671 . . . . 0.0 110.298 -178.838 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.54 ' HA3' ' O ' ' A' ' 66' ' ' ARG . . . 140.87 -134.98 6.68 Favored Glycine 0 N--CA 1.504 3.227 0 C-N-CA 118.258 -1.925 . . . . 0.0 111.378 178.378 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.588 ' HA ' ' O ' ' A' ' 95' ' ' ASP . 2.6 t -128.17 119.85 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 O-C-N 121.414 -1.051 . . . . 0.0 108.265 -179.357 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.77 HD21 HG21 ' A' ' 81' ' ' VAL . 5.6 mt -62.29 161.61 11.15 Favored 'General case' 0 N--CA 1.501 2.124 0 C-N-CA 118.74 -1.184 . . . . 0.0 113.454 -175.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.512 ' HA ' ' OG1' ' A' ' 93' ' ' THR . 3.4 tp10 -137.31 116.35 12.45 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 178.119 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.608 ' CG1' ' HB ' ' A' ' 93' ' ' THR . 1.3 mm -84.31 159.35 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 120.151 -1.593 . . . . 0.0 108.811 -179.156 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.637 HD22 ' HE1' ' A' ' 62' ' ' PHE . 2.8 mp -130.96 138.82 49.9 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.348 -1.47 . . . . 0.0 109.961 179.27 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.453 ' C ' ' O ' ' A' ' 58' ' ' LEU . 3.7 tt0 -38.24 -36.72 0.24 Allowed 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.66 0.743 . . . . 0.0 110.414 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -60.99 -7.74 2.69 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.502 -0.749 . . . . 0.0 112.319 -179.209 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 91.34 8.39 64.39 Favored Glycine 1 N--CA 1.518 4.151 0 C-N-CA 118.729 -1.701 . . . . 0.0 112.255 177.863 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.637 ' HE1' HD22 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -127.65 -179.68 5.06 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 104.883 -2.266 . . . . 0.0 104.883 178.098 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.438 ' HA2' HD13 ' A' ' 58' ' ' LEU . . . -158.56 170.77 35.22 Favored Glycine 0 N--CA 1.475 1.293 0 C-N-CA 116.712 -2.661 . . . . 0.0 111.784 -177.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.417 ' HE1' ' CE2' ' A' ' 62' ' ' PHE . 6.9 m-85 -129.9 153.0 48.76 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 119.858 1.829 . . . . 0.0 109.753 177.478 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.513 ' HB3' ' HB ' ' A' ' 79' ' ' ILE . 0.3 OUTLIER -98.9 160.14 14.47 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 176.567 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.54 ' O ' ' HA3' ' A' ' 53' ' ' GLY . 0.0 OUTLIER 178.26 -162.75 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.196 -0.94 . . . . 0.0 109.561 179.191 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 67' ' ' SER . . . . . 0.487 ' N ' ' HG3' ' A' ' 66' ' ' ARG . 1.1 m . . . . . 0 N--CA 1.497 1.923 0 O-C-N 120.98 -1.075 . . . . 0.0 110.282 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.695 ' C ' HD12 ' A' ' 79' ' ' ILE . 0.6 OUTLIER . . . . . 0 N--CA 1.509 2.515 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.695 HD12 ' C ' ' A' ' 78' ' ' ASP . 1.7 mp -135.9 138.27 47.81 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.812 0 O-C-N 120.961 -1.087 . . . . 0.0 110.043 178.776 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.512 ' HB3' ' O ' ' A' ' 111' ' ' PHE . 5.9 t80 -80.8 146.34 30.99 Favored 'General case' 0 N--CA 1.518 2.955 0 O-C-N 119.685 -1.884 . . . . 0.0 110.028 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.77 HG21 HD21 ' A' ' 55' ' ' LEU . 38.4 t -142.44 112.9 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 120.24 -1.537 . . . . 0.0 110.117 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.552 ' O ' HG13 ' A' ' 86' ' ' ILE . 22.0 m -74.86 166.82 42.16 Favored Pre-proline 0 N--CA 1.512 2.643 0 O-C-N 120.58 -1.325 . . . . 0.0 112.133 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.572 ' HA ' HG13 ' A' ' 86' ' ' ILE . 38.8 Cg_endo -65.19 -53.82 0.76 Allowed 'Trans proline' 0 C--N 1.314 -1.257 0 O-C-N 124.651 1.869 . . . . 0.0 109.08 178.823 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.56 ' O ' ' CG ' ' A' ' 88' ' ' ARG . 0.8 OUTLIER -45.14 -41.01 7.6 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 178.119 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.568 ' O ' ' CD2' ' A' ' 89' ' ' PHE . 6.6 mm100 -62.74 -57.81 9.65 Favored 'General case' 0 N--CA 1.509 2.517 0 C-N-CA 119.118 -1.033 . . . . 0.0 108.49 178.221 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.572 HG13 ' HA ' ' A' ' 83' ' ' PRO . 0.2 OUTLIER -59.15 -54.84 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.35 0 O-C-N 121.084 -1.01 . . . . 0.0 108.846 178.648 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.483 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 0.0 OUTLIER -56.22 -42.67 77.62 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-O 121.83 0.824 . . . . 0.0 111.225 -179.102 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.56 ' CG ' ' O ' ' A' ' 84' ' ' SER . 1.4 mmt85 -60.42 -36.42 78.11 Favored 'General case' 0 N--CA 1.507 2.382 0 C-N-CA 119.647 -0.821 . . . . 0.0 111.871 -177.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.568 ' CD2' ' O ' ' A' ' 85' ' ' GLN . 4.7 m-85 -109.74 12.75 23.98 Favored 'General case' 0 N--CA 1.503 2.218 0 C-N-CA 117.494 -1.682 . . . . 0.0 111.174 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 59.52 52.88 5.41 Favored 'General case' 0 N--CA 1.485 1.308 0 O-C-N 120.524 -1.36 . . . . 0.0 109.686 178.906 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.55 ' HB2' HG22 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -90.12 174.39 7.66 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.486 -0.758 . . . . 0.0 109.757 179.867 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.533 ' HG2' ' O ' ' A' ' 91' ' ' LEU . 10.3 mtm180 -147.56 159.82 43.33 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.173 -0.955 . . . . 0.0 108.678 178.173 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.608 ' HB ' ' CG1' ' A' ' 57' ' ' ILE . 1.9 t -63.54 156.28 26.92 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 117.143 -1.823 . . . . 0.0 107.031 179.381 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 77.2 -11.21 17.34 Favored Glycine 0 N--CA 1.505 3.251 0 C-N-CA 117.177 -2.439 . . . . 0.0 110.107 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.588 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 12.5 m-20 -68.26 146.93 52.87 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.211 -1.758 . . . . 0.0 110.943 -178.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.499 ' O ' HG12 ' A' ' 97' ' ' ILE . 0.2 OUTLIER -90.05 120.91 31.64 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.179 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.519 HG23 ' O ' ' A' ' 118' ' ' GLU . 1.5 mt -145.95 167.51 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 119.871 -1.768 . . . . 0.0 112.81 -178.611 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.527 ' OG ' ' HB2' ' A' ' 118' ' ' GLU . 99.8 p -149.25 138.95 21.8 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.988 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.52 ' O ' ' HB2' ' A' ' 50' ' ' PHE . . . -163.11 178.09 38.91 Favored Glycine 0 N--CA 1.507 3.42 0 C-N-CA 117.405 -2.331 . . . . 0.0 114.757 -178.87 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.503 ' HG2' ' HB3' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -88.06 155.88 19.58 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 178.982 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.521 HG13 HG13 ' A' ' 49' ' ' ILE . 1.7 pt -123.04 161.89 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.369 0 CA-C-N 120.636 1.562 . . . . 0.0 113.586 -177.483 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.949 ' HB2' HD22 ' A' ' 114' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.308 0 O-C-N 120.608 -1.307 . . . . 0.0 108.808 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 4.9 tpp180 . . . . . 0 N--CA 1.501 2.079 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -106.57 148.56 28.12 Favored 'General case' 0 N--CA 1.52 3.055 0 O-C-N 120.126 -1.609 . . . . 0.0 109.678 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.64 ' CE2' HD23 ' A' ' 39' ' ' LEU . 3.4 m-30 -67.72 168.09 12.0 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 119.851 -1.781 . . . . 0.0 108.093 178.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.431 ' HA ' ' HB3' ' A' ' 80' ' ' TYR . . . -121.85 154.15 37.44 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.237 -1.539 . . . . 0.0 110.345 -179.195 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.54 150.52 46.62 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.949 HD22 ' HB2' ' A' ' 102' ' ' ARG . 20.0 tp -127.93 -55.9 1.28 Allowed 'General case' 0 N--CA 1.501 2.088 0 O-C-N 120.282 -1.511 . . . . 0.0 112.373 -178.945 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.503 ' HB3' ' HG2' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -123.98 142.58 51.04 Favored 'General case' 0 N--CA 1.509 2.513 0 O-C-N 120.32 -1.487 . . . . 0.0 109.263 179.417 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.8 t -92.98 130.7 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.831 0 O-C-N 120.468 -1.395 . . . . 0.0 111.057 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -107.17 -40.93 5.28 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 121.357 -0.839 . . . . 0.0 109.725 178.653 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.562 ' C ' HG23 ' A' ' 119' ' ' VAL . 0.0 OUTLIER -143.67 159.48 42.41 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.872 -1.142 . . . . 0.0 109.74 179.483 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.562 HG23 ' C ' ' A' ' 118' ' ' GLU . 13.1 t -158.5 138.14 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -178.498 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 . . . . . 0 N--CA 1.516 2.853 0 O-C-N 120.332 -1.48 . . . . 0.0 110.643 -179.985 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.629 ' HA ' ' HA ' ' A' ' 49' ' ' ILE . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.664 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 2' ' ' ASN . . . . . 0.584 ' HA ' ' O ' ' A' ' 50' ' ' PHE . 63.5 t30 -78.5 91.06 4.5 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.725 -1.234 . . . . 0.0 108.444 178.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.552 ' CD1' HD11 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -41.59 -40.4 1.88 Allowed 'General case' 0 N--CA 1.52 3.035 0 O-C-N 120.598 -1.314 . . . . 0.0 110.371 -178.186 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.467 ' OG1' ' CG ' ' A' ' 52' ' ' ASP . 1.9 m -60.13 -35.07 74.45 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 118.601 -1.24 . . . . 0.0 108.288 -179.083 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.566 ' HB3' ' HB3' ' A' ' 2' ' ' ASN . 0.9 OUTLIER -72.65 -44.57 61.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.922 -1.112 . . . . 0.0 108.245 177.386 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.639 HD12 HG13 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -51.01 -51.4 53.36 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 120.834 -1.167 . . . . 0.0 108.68 178.37 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 8.1 mttm -62.5 -40.92 98.27 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.121 -0.987 . . . . 0.0 109.831 178.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.405 ' HB2' ' HA ' ' A' ' 5' ' ' GLU . 2.7 m-80 -62.74 -20.65 65.15 Favored 'General case' 0 N--CA 1.508 2.456 0 CA-C-O 121.79 0.805 . . . . 0.0 111.141 -179.072 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.738 ' HB ' HD11 ' A' ' 14' ' ' LEU . 94.5 m -79.26 122.25 83.94 Favored Pre-proline 0 C--N 1.283 -2.289 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.555 ' HG2' ' CG ' ' A' ' 13' ' ' GLU . 37.2 Cg_endo -57.48 155.55 30.36 Favored 'Trans proline' 0 N--CA 1.503 2.068 0 C-N-CA 120.488 0.792 . . . . 0.0 112.219 -177.609 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.56 ' CG1' ' N ' ' A' ' 12' ' ' SER . 1.6 p -45.24 -51.73 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.541 0 O-C-N 120.502 -1.374 . . . . 0.0 110.44 -178.843 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.56 ' N ' ' CG1' ' A' ' 11' ' ' VAL . 0.9 OUTLIER -56.86 -41.57 78.19 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.081 -1.012 . . . . 0.0 110.646 -179.52 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.605 ' HB3' HG23 ' A' ' 9' ' ' THR . 48.2 mm-40 -68.95 -26.85 65.27 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 118.155 -1.418 . . . . 0.0 107.975 179.375 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.738 HD11 ' HB ' ' A' ' 9' ' ' THR . 0.9 OUTLIER -70.35 -43.14 70.82 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 120.96 -1.087 . . . . 0.0 108.439 177.381 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.548 HD12 ' O ' ' A' ' 11' ' ' VAL . 1.4 mp -66.37 -40.15 85.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 C-N-CA 118.108 -1.437 . . . . 0.0 108.659 178.648 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.577 ' HA ' ' HG2' ' A' ' 19' ' ' GLU . 92.7 m -63.91 -38.03 89.59 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.394 -1.441 . . . . 0.0 109.267 179.16 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.534 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 0.7 OUTLIER -65.81 -37.79 87.22 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.85 -1.156 . . . . 0.0 108.779 178.553 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.466 ' HA2' HD13 ' A' ' 23' ' ' LEU . . . -67.36 -43.5 87.7 Favored Glycine 0 N--CA 1.513 3.794 0 N-CA-C 108.505 -1.838 . . . . 0.0 108.505 178.51 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.687 ' HG3' ' N ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -59.33 -37.98 79.16 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.507 -1.584 . . . . 0.0 108.117 178.922 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.687 ' N ' ' HG3' ' A' ' 19' ' ' GLU . 28.1 m120 -61.32 -29.01 69.62 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 118.201 -1.4 . . . . 0.0 109.405 178.633 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.516 ' HG3' ' O ' ' A' ' 17' ' ' LEU . 18.6 mtp -101.53 12.84 36.57 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.215 -0.928 . . . . 0.0 111.153 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.66 -22.9 34.29 Favored Glycine 0 N--CA 1.502 3.082 0 C-N-CA 118.632 -1.747 . . . . 0.0 111.299 179.29 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 1.006 ' CD2' ' HB1' ' A' ' 37' ' ' ALA . 2.9 mp -79.45 93.63 5.42 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.396 -1.65 . . . . 0.0 109.776 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -108.1 175.79 5.36 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.141 -0.974 . . . . 0.0 109.285 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 62.99 21.1 12.7 Favored 'General case' 0 N--CA 1.507 2.404 0 O-C-N 121.914 -0.491 . . . . 0.0 111.549 178.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.743 HD11 ' HB3' ' A' ' 23' ' ' LEU . 0.4 OUTLIER -77.19 -7.59 56.12 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 120.985 -1.072 . . . . 0.0 111.413 -179.86 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 26' ' ' LEU . . . -46.71 -31.73 3.12 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.441 -1.412 . . . . 0.0 108.977 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' ARG . . . . . 0.558 ' CD ' ' C ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -80.82 -2.12 45.9 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 120.081 -0.648 . . . . 0.0 111.502 -179.99 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.541 ' HB3' HG13 ' A' ' 34' ' ' ILE . 14.8 mtp -100.85 162.78 12.67 Favored 'General case' 0 C--N 1.313 -0.989 0 O-C-N 120.639 -1.288 . . . . 0.0 111.636 -179.004 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.722 ' O ' HD12 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -89.71 164.26 14.77 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.647 0.737 . . . . 0.0 110.563 178.502 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.576 ' O ' HG22 ' A' ' 35' ' ' ILE . 2.6 ttmm -55.62 -41.95 74.22 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.509 -0.744 . . . . 0.0 111.082 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.55 ' O ' HG22 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -63.69 -53.46 50.96 Favored 'General case' 0 N--CA 1.521 3.086 0 O-C-N 121.495 -0.753 . . . . 0.0 112.194 -178.346 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 34' ' ' ILE . 1.7 p30 -67.23 -40.56 86.35 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 120.415 -1.428 . . . . 0.0 109.312 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.722 HD12 ' O ' ' A' ' 30' ' ' ARG . 15.7 mt -61.91 -39.44 83.58 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 O-C-N 120.506 -1.371 . . . . 0.0 109.363 178.416 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.639 HG13 HD12 ' A' ' 6' ' ' LEU . 0.1 OUTLIER -67.59 -38.12 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.435 0 O-C-N 120.238 -1.539 . . . . 0.0 109.221 178.519 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -62.28 -43.54 98.59 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.594 -1.316 . . . . 0.0 108.86 178.905 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 1.006 ' HB1' ' CD2' ' A' ' 23' ' ' LEU . . . -57.2 -54.66 44.27 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.413 -1.429 . . . . 0.0 108.501 178.044 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.632 HD12 HD11 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -54.59 -32.31 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 C-N-CA 117.402 -1.719 . . . . 0.0 109.345 179.088 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.553 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 11.1 mt -68.33 -40.66 81.52 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 120.299 -1.501 . . . . 0.0 109.35 178.22 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.463 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 3.4 mtpp -66.23 -38.78 88.73 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.001 -1.062 . . . . 0.0 110.684 178.795 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.845 ' HG3' HD11 ' A' ' 23' ' ' LEU . 1.1 mm-40 -75.9 -52.87 9.38 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.24 -0.913 . . . . 0.0 111.13 -179.132 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.755 ' CD2' ' OE2' ' A' ' 47' ' ' GLU . 3.7 t60 -64.26 -36.38 83.92 Favored 'General case' 0 N--CA 1.51 2.54 0 O-C-N 120.951 -1.093 . . . . 0.0 109.37 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.553 ' HB3' ' O ' ' A' ' 39' ' ' LEU . . . -77.28 -32.24 55.35 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.89 -1.131 . . . . 0.0 110.62 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -47.33 -44.04 23.39 Favored 'General case' 0 N--CA 1.481 1.116 0 O-C-N 120.411 -1.43 . . . . 0.0 108.972 178.548 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 25.4 m -66.81 -10.57 49.12 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 119.573 -0.851 . . . . 0.0 109.548 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . 65.78 31.53 80.09 Favored Glycine 0 N--CA 1.495 2.593 0 C-N-CA 120.401 -0.904 . . . . 0.0 111.156 178.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.755 ' OE2' ' CD2' ' A' ' 42' ' ' HIS . 3.4 pt-20 -85.15 170.13 13.2 Favored 'General case' 0 N--CA 1.484 1.226 0 O-C-N 120.408 -1.642 . . . . 0.0 109.225 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.543 ' C ' HG23 ' A' ' 49' ' ' ILE . 7.6 m-20 -61.54 138.07 58.27 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.14 -0.975 . . . . 0.0 111.934 -177.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.629 ' HA ' ' HA ' ' A' ' 1' ' ' MET . 0.5 OUTLIER -157.13 144.09 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 178.455 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.584 ' O ' ' HA ' ' A' ' 2' ' ' ASN . 24.6 p90 -141.93 168.17 20.38 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 115.616 -2.434 . . . . 0.0 115.504 -178.151 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -116.15 164.32 12.28 Favored Glycine 0 N--CA 1.499 2.867 0 N-CA-C 107.784 -2.126 . . . . 0.0 107.784 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.512 ' C ' ' CD2' ' A' ' 65' ' ' LEU . 5.8 p-10 -172.37 163.18 5.59 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 120.322 -1.693 . . . . 0.0 109.657 -179.102 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.45 ' HA3' ' O ' ' A' ' 66' ' ' ARG . . . 146.31 -139.74 8.31 Favored Glycine 0 N--CA 1.504 3.195 0 C-N-CA 117.991 -2.052 . . . . 0.0 111.131 179.131 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.611 ' HA ' ' O ' ' A' ' 95' ' ' ASP . 2.6 t -128.07 119.7 51.71 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.786 HD21 HG21 ' A' ' 81' ' ' VAL . 6.9 mt -62.76 164.25 8.14 Favored 'General case' 0 N--CA 1.504 2.254 0 C-N-CA 118.782 -1.167 . . . . 0.0 113.869 -175.701 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.528 ' HA ' ' OG1' ' A' ' 93' ' ' THR . 0.8 OUTLIER -141.78 119.35 11.67 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 178.384 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.583 ' CG1' ' HB ' ' A' ' 93' ' ' THR . 1.0 OUTLIER -80.19 162.63 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 119.903 -1.748 . . . . 0.0 109.265 -178.718 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.726 HD13 ' HA2' ' A' ' 63' ' ' GLY . 3.3 mp -132.12 136.19 46.96 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.426 -1.421 . . . . 0.0 109.675 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.453 ' C ' ' O ' ' A' ' 58' ' ' LEU . 11.9 tt0 -39.77 -36.37 0.42 Allowed 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.749 0.785 . . . . 0.0 110.102 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.458 ' HB2' ' CD1' ' A' ' 62' ' ' PHE . 66.6 m-20 -61.46 -5.94 2.04 Favored 'General case' 0 N--CA 1.501 2.092 0 C-N-CA 119.959 -0.696 . . . . 0.0 112.51 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.446 ' O ' ' HB3' ' A' ' 83' ' ' PRO . . . 89.85 11.91 62.95 Favored Glycine 1 N--CA 1.52 4.282 0 C-N-CA 118.71 -1.709 . . . . 0.0 112.185 178.089 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.616 ' CZ ' HD22 ' A' ' 58' ' ' LEU . 2.8 p90 -132.95 -176.93 4.28 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 103.865 -2.642 . . . . 0.0 103.865 177.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.726 ' HA2' HD13 ' A' ' 58' ' ' LEU . . . -158.75 172.39 35.58 Favored Glycine 0 N--CA 1.474 1.216 0 C-N-CA 116.933 -2.556 . . . . 0.0 111.706 -177.553 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.544 ' CE2' ' CE2' ' A' ' 62' ' ' PHE . 43.5 m-85 -129.7 154.29 47.31 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 119.99 1.895 . . . . 0.0 109.708 177.48 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.512 ' CD2' ' C ' ' A' ' 52' ' ' ASP 0.255 0.2 OUTLIER -98.39 134.33 41.54 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 107.005 -1.479 . . . . 0.0 107.005 176.892 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.45 ' O ' ' HA3' ' A' ' 53' ' ' GLY . 0.4 OUTLIER -135.99 -173.04 3.27 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.225 -1.547 . . . . 0.0 109.658 179.446 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.5 m . . . . . 0 N--CA 1.497 1.886 0 O-C-N 121.036 -1.04 . . . . 0.0 110.573 179.921 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.462 ' OD1' ' N ' ' A' ' 78' ' ' ASP . 3.2 m-20 . . . . . 0 N--CA 1.508 2.429 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.435 ' HB ' ' CB ' ' A' ' 65' ' ' LEU . 4.4 mm -120.21 131.61 72.07 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.745 0 O-C-N 120.969 -1.082 . . . . 0.0 109.979 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.508 ' HB3' ' O ' ' A' ' 111' ' ' PHE . 10.4 t80 -76.71 147.35 37.44 Favored 'General case' 0 N--CA 1.518 2.934 0 CA-C-N 121.85 2.114 . . . . 0.0 109.462 179.261 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.786 HG21 HD21 ' A' ' 55' ' ' LEU . 11.1 t -145.51 116.8 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 120.151 -1.593 . . . . 0.0 110.2 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.564 ' O ' HG13 ' A' ' 86' ' ' ILE . 56.1 m -74.95 161.67 76.62 Favored Pre-proline 0 N--CA 1.51 2.555 0 O-C-N 120.34 -1.475 . . . . 0.0 112.248 -179.294 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.583 ' HA ' HG13 ' A' ' 86' ' ' ILE . 38.0 Cg_endo -65.19 -50.97 1.73 Allowed 'Trans proline' 0 C--N 1.313 -1.315 0 O-C-N 124.887 1.993 . . . . 0.0 108.554 178.569 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.572 ' O ' ' CG ' ' A' ' 88' ' ' ARG . 3.0 p -46.02 -41.53 12.08 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 177.718 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.525 ' OE1' ' HA ' ' A' ' 85' ' ' GLN . 6.6 mm100 -62.48 -58.07 8.92 Favored 'General case' 0 N--CA 1.511 2.586 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 178.368 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.583 HG13 ' HA ' ' A' ' 83' ' ' PRO . 0.4 OUTLIER -55.83 -56.26 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.262 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 178.386 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.482 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 9.7 mtt85 -58.41 -41.84 85.84 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-O 121.825 0.822 . . . . 0.0 111.731 -179.016 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.572 ' CG ' ' O ' ' A' ' 84' ' ' SER . 0.1 OUTLIER -60.04 -37.66 80.46 Favored 'General case' 0 N--CA 1.507 2.376 0 C-N-CA 119.612 -0.835 . . . . 0.0 111.938 -177.679 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 1.019 ' HB2' HD21 ' A' ' 91' ' ' LEU . 5.0 m-85 -109.58 11.85 24.59 Favored 'General case' 0 N--CA 1.503 2.206 0 C-N-CA 116.818 -1.953 . . . . 0.0 111.148 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.406 ' CB ' ' O ' ' A' ' 89' ' ' PHE . 1.5 t-20 63.74 53.6 1.97 Allowed 'General case' 0 N--CA 1.486 1.342 0 O-C-N 120.611 -1.306 . . . . 0.0 110.818 178.405 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 1.019 HD21 ' HB2' ' A' ' 89' ' ' PHE . 2.9 mt -89.7 -168.96 2.3 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 119.37 -0.932 . . . . 0.0 109.752 179.259 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.53 ' CG ' ' O ' ' A' ' 91' ' ' LEU . 0.2 OUTLIER -159.7 161.38 34.83 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 178.231 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.583 ' HB ' ' CG1' ' A' ' 57' ' ' ILE . 1.9 t -64.83 155.64 33.39 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 116.869 -1.932 . . . . 0.0 106.893 178.505 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' GLY . . . . . 0.407 ' C ' HG12 ' A' ' 54' ' ' VAL . . . 75.29 -9.09 14.6 Favored Glycine 0 N--CA 1.506 3.338 0 C-N-CA 117.299 -2.382 . . . . 0.0 110.388 179.329 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.611 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 15.4 m-20 -68.1 149.66 49.34 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.137 -1.802 . . . . 0.0 110.724 -178.784 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.493 ' O ' HG12 ' A' ' 97' ' ' ILE . 0.3 OUTLIER -91.58 121.19 33.04 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.621 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.53 HG23 HG22 ' A' ' 119' ' ' VAL . 1.4 mt -144.82 166.61 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 119.93 -1.732 . . . . 0.0 112.885 -178.725 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.493 ' OG ' ' HB2' ' A' ' 118' ' ' GLU . 96.7 p -150.93 139.76 20.85 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.999 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.494 ' O ' ' HB2' ' A' ' 50' ' ' PHE . . . -164.47 -179.66 38.72 Favored Glycine 0 N--CA 1.509 3.545 0 C-N-CA 117.643 -2.218 . . . . 0.0 114.609 -179.214 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.506 ' HD3' HD23 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -87.23 155.39 20.11 Favored 'General case' 0 N--CA 1.504 2.239 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 178.589 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.507 HG12 ' HA ' ' A' ' 50' ' ' PHE . 2.2 pt -122.46 158.56 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.643 0 CA-C-N 121.228 1.831 . . . . 0.0 114.435 -176.846 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.782 ' HB2' HD22 ' A' ' 114' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.427 0 O-C-N 120.651 -1.281 . . . . 0.0 109.642 179.311 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? . . . . . 0 N--CA 1.513 2.712 0 CA-C-O 120.557 0.218 . . . . 0.0 111.357 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.536 ' N ' ' CD1' ' A' ' 110' ' ' TYR . 2.8 m-85 -109.26 154.75 22.0 Favored 'General case' 0 N--CA 1.518 2.938 0 O-C-N 120.581 -1.325 . . . . 0.0 107.72 177.066 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.508 ' O ' ' HB3' ' A' ' 80' ' ' TYR . 38.1 m-85 -66.9 165.56 15.18 Favored 'General case' 0 N--CA 1.508 2.427 0 O-C-N 119.135 -2.228 . . . . 0.0 107.273 178.58 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.433 ' HA ' ' HB3' ' A' ' 80' ' ' TYR . . . -123.24 152.87 40.88 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 119.905 -1.747 . . . . 0.0 111.216 -178.504 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.42 HD12 ' N ' ' A' ' 114' ' ' LEU . 0.1 OUTLIER -66.77 153.68 42.72 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 178.753 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.782 HD22 ' HB2' ' A' ' 102' ' ' ARG . 12.9 tp -130.86 -59.41 1.0 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 120.047 -1.658 . . . . 0.0 112.361 -178.313 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.49 ' HB3' ' HG2' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -114.05 139.97 48.85 Favored 'General case' 0 N--CA 1.512 2.646 0 O-C-N 120.383 -1.448 . . . . 0.0 108.767 179.206 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 23.7 t -92.27 128.78 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.804 0 O-C-N 120.477 -1.39 . . . . 0.0 111.37 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.423 ' CG ' ' HA2' ' A' ' 99' ' ' GLY . 4.8 m-20 -106.97 -38.5 6.03 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.355 -0.841 . . . . 0.0 109.947 178.624 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.574 ' C ' HG23 ' A' ' 119' ' ' VAL . 1.1 tt0 -143.5 157.21 44.62 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.786 -1.196 . . . . 0.0 109.803 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.574 HG23 ' C ' ' A' ' 118' ' ' GLU . 17.8 t -159.74 130.99 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 122.387 -0.196 . . . . 0.0 110.511 -178.532 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.521 3.081 0 O-C-N 120.309 -1.495 . . . . 0.0 111.481 178.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.668 ' HA ' ' HA ' ' A' ' 49' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 2' ' ' ASN . . . . . 0.621 ' ND2' ' CE2' ' A' ' 50' ' ' PHE . 7.7 t-20 -78.46 94.18 4.88 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 120.85 -1.156 . . . . 0.0 108.137 178.836 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.901 HD12 HD12 ' A' ' 6' ' ' LEU . 0.5 OUTLIER -41.81 -42.29 2.62 Favored 'General case' 0 N--CA 1.519 3.007 0 O-C-N 120.518 -1.364 . . . . 0.0 110.241 -178.399 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.7 m -56.33 -36.46 68.74 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.983 -1.073 . . . . 0.0 108.311 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.561 ' HB2' ' HB3' ' A' ' 2' ' ' ASN . 3.0 mt-10 -76.54 -39.26 53.38 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.9 -1.125 . . . . 0.0 109.317 178.06 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.901 HD12 HD12 ' A' ' 3' ' ' LEU 0.267 90.7 mt -54.82 -49.2 71.61 Favored 'General case' 0 C--O 1.215 -0.752 0 O-C-N 120.31 -1.494 . . . . 0.0 109.174 177.984 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.04 -39.16 75.9 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.936 -1.103 . . . . 0.0 110.769 179.15 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -63.14 -22.48 66.89 Favored 'General case' 0 N--CA 1.507 2.405 0 O-C-N 121.1 -1.0 . . . . 0.0 111.221 -179.119 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.727 ' HB ' HD11 ' A' ' 14' ' ' LEU . 22.7 m -81.12 140.02 49.36 Favored Pre-proline 0 N--CA 1.505 2.278 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.537 ' HG2' ' HG3' ' A' ' 13' ' ' GLU . 41.6 Cg_endo -63.75 152.23 81.48 Favored 'Trans proline' 0 CA--C 1.566 2.088 0 O-C-N 122.293 0.628 . . . . 0.0 111.773 -177.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.506 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 1.5 p -47.58 -50.42 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.337 0 O-C-N 120.517 -1.364 . . . . 0.0 109.997 -178.811 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.502 ' N ' ' CG1' ' A' ' 11' ' ' VAL . 1.6 t -54.48 -43.72 71.98 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.011 -1.055 . . . . 0.0 110.763 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.56 ' HB3' ' CG2' ' A' ' 9' ' ' THR . 1.0 OUTLIER -68.31 -27.12 66.01 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 118.158 -1.417 . . . . 0.0 107.967 179.631 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.806 HD23 ' HG2' ' A' ' 31' ' ' LYS . 1.3 mp -70.11 -43.45 71.0 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.985 -1.072 . . . . 0.0 108.603 177.492 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.499 HG12 ' HB2' ' A' ' 26' ' ' LEU . 1.6 mp -66.55 -39.1 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 C-N-CA 118.148 -1.421 . . . . 0.0 108.822 178.945 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.502 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 58.8 m -64.89 -38.0 89.5 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 118.036 -1.466 . . . . 0.0 109.205 178.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.33 -36.82 83.91 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.792 -1.192 . . . . 0.0 108.907 178.709 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.519 ' HA2' HD13 ' A' ' 23' ' ' LEU . . . -67.91 -43.2 83.76 Favored Glycine 0 N--CA 1.515 3.961 0 N-CA-C 108.129 -1.989 . . . . 0.0 108.129 178.166 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -55.51 -46.39 76.98 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.631 -1.511 . . . . 0.0 107.685 178.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.502 ' OD1' ' O ' ' A' ' 16' ' ' THR . 25.2 m120 -59.53 -25.64 64.67 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 118.202 -1.399 . . . . 0.0 109.145 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.552 ' HB2' ' CD1' ' A' ' 23' ' ' LEU . 64.7 mmm -100.93 11.99 38.52 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.489 -0.757 . . . . 0.0 111.06 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 96.06 -17.15 59.82 Favored Glycine 0 N--CA 1.502 3.058 0 C-N-CA 118.804 -1.665 . . . . 0.0 111.408 179.31 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 1.0 HD23 ' HB1' ' A' ' 37' ' ' ALA . 4.1 mp -79.41 102.76 8.89 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.471 -1.605 . . . . 0.0 109.782 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.478 ' O ' ' HB2' ' A' ' 25' ' ' ASN . 2.0 pt-20 -114.85 -179.72 3.71 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.28 -0.888 . . . . 0.0 109.1 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.478 ' HB2' ' O ' ' A' ' 24' ' ' GLU . 1.8 m120 62.38 18.48 10.32 Favored 'General case' 0 N--CA 1.51 2.53 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.7 178.851 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 1.071 HD23 ' SD ' ' A' ' 29' ' ' MET . 1.2 mt -76.29 -18.22 59.07 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.196 -0.94 . . . . 0.0 111.408 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -47.27 -29.5 2.48 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.213 -1.555 . . . . 0.0 109.524 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -78.88 -30.4 44.97 Favored 'General case' 0 C--N 1.295 -1.795 0 C-N-CA 120.11 -0.636 . . . . 0.0 112.2 -179.114 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' MET . . . . . 1.071 ' SD ' HD23 ' A' ' 26' ' ' LEU . 6.6 ptm -93.22 166.99 12.05 Favored 'General case' 0 C--N 1.311 -1.073 0 O-C-N 120.426 -1.421 . . . . 0.0 111.084 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.999 ' O ' HD12 ' A' ' 34' ' ' ILE . 1.0 OUTLIER -89.39 -173.65 4.08 Favored 'General case' 0 N--CA 1.506 2.358 0 CA-C-O 122.219 1.009 . . . . 0.0 112.864 -178.428 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.806 ' HG2' HD23 ' A' ' 14' ' ' LEU . 0.3 OUTLIER -66.32 -35.67 80.97 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.522 -179.722 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -63.02 -58.82 6.01 Favored 'General case' 0 N--CA 1.515 2.796 0 O-C-N 120.766 -1.209 . . . . 0.0 109.667 -178.791 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.523 ' CG ' ' HE2' ' A' ' 29' ' ' MET . 3.6 p30 -66.3 -35.27 79.95 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.457 -0.777 . . . . 0.0 109.717 -179.335 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.999 HD12 ' O ' ' A' ' 30' ' ' ARG . 0.8 OUTLIER -60.9 -43.72 96.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 120.081 -1.637 . . . . 0.0 107.898 177.141 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.56 HG13 ' O ' ' A' ' 31' ' ' LYS . 86.7 mt -63.39 -45.38 98.19 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.854 0 O-C-N 120.318 -1.489 . . . . 0.0 110.357 178.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.418 ' HA ' HD12 ' A' ' 39' ' ' LEU . 3.6 m-30 -53.59 -40.15 65.43 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 119.203 -0.999 . . . . 0.0 108.566 -179.051 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 1.0 ' HB1' HD23 ' A' ' 23' ' ' LEU . . . -68.09 -54.28 19.36 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.614 -1.304 . . . . 0.0 109.606 178.221 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.526 HG13 ' O ' ' A' ' 34' ' ' ILE . 0.1 OUTLIER -53.49 -28.0 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 C-N-CA 117.545 -1.662 . . . . 0.0 110.007 -179.969 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.487 HD11 HG22 ' A' ' 35' ' ' ILE . 79.8 mt -71.13 -43.68 67.12 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 120.219 -1.551 . . . . 0.0 109.335 178.191 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.26 -39.69 92.98 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.979 -1.075 . . . . 0.0 110.581 178.832 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.781 ' CB ' HD11 ' A' ' 23' ' ' LEU . 1.4 mp0 -74.56 -51.22 15.24 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 121.146 -0.971 . . . . 0.0 110.726 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.64 ' CD2' ' CB ' ' A' ' 47' ' ' GLU . 9.9 t60 -61.99 -34.55 76.37 Favored 'General case' 0 N--CA 1.51 2.539 0 C-N-CA 118.65 -1.22 . . . . 0.0 108.573 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.451 ' O ' ' N ' ' A' ' 46' ' ' GLY . . . -70.51 -45.26 65.94 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.043 -1.036 . . . . 0.0 109.079 178.349 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -48.28 -45.66 34.97 Favored 'General case' 0 N--CA 1.484 1.252 0 O-C-N 120.752 -1.217 . . . . 0.0 109.138 178.274 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 68.4 m -66.99 -6.94 18.94 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-O 121.547 0.689 . . . . 0.0 109.696 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . 76.45 24.9 66.84 Favored Glycine 0 N--CA 1.498 2.801 0 C-N-CA 120.148 -1.025 . . . . 0.0 112.094 178.329 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.64 ' CB ' ' CD2' ' A' ' 42' ' ' HIS . 0.2 OUTLIER -79.42 166.74 21.71 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.129 -1.806 . . . . 0.0 109.086 178.817 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.432 ' C ' ' CG2' ' A' ' 49' ' ' ILE . 8.3 m-20 -88.66 150.02 23.23 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.07 -1.019 . . . . 0.0 109.391 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.668 ' HA ' ' HA ' ' A' ' 1' ' ' MET . 0.5 OUTLIER -148.98 143.28 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 120.668 -1.27 . . . . 0.0 108.46 179.246 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.621 ' CE2' ' ND2' ' A' ' 2' ' ' ASN . 23.6 p90 -142.75 172.07 13.2 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 116.088 -2.245 . . . . 0.0 114.918 -177.992 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -126.23 168.94 18.23 Favored Glycine 0 N--CA 1.508 3.445 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 -178.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -169.67 166.51 9.85 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 120.429 -1.63 . . . . 0.0 110.315 -178.904 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.587 ' HA3' ' O ' ' A' ' 66' ' ' ARG . . . 142.47 -135.75 6.79 Favored Glycine 0 N--CA 1.506 3.306 0 C-N-CA 118.349 -1.882 . . . . 0.0 111.591 178.326 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.567 ' HA ' ' O ' ' A' ' 95' ' ' ASP . 2.6 t -128.44 120.04 51.9 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 O-C-N 121.235 -1.156 . . . . 0.0 108.292 -179.467 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.853 HD21 HG21 ' A' ' 81' ' ' VAL . 6.0 mt -62.92 161.2 13.3 Favored 'General case' 0 N--CA 1.503 2.22 0 C-N-CA 118.645 -1.222 . . . . 0.0 113.681 -175.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.504 ' HA ' ' OG1' ' A' ' 93' ' ' THR . 18.1 mm-40 -137.14 117.89 14.05 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 177.86 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.647 ' C ' HD12 ' A' ' 58' ' ' LEU . 1.4 mm -82.3 162.67 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 O-C-N 119.959 -1.713 . . . . 0.0 109.624 -178.591 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.956 HD22 ' CZ ' ' A' ' 62' ' ' PHE . 5.8 mp -129.95 137.64 50.44 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.531 -1.356 . . . . 0.0 109.462 179.107 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.458 ' C ' ' O ' ' A' ' 58' ' ' LEU . 1.8 mt-30 -42.09 -34.69 0.77 Allowed 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.951 0.881 . . . . 0.0 109.143 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -61.34 -7.17 2.69 Favored 'General case' 0 N--CA 1.499 2.012 0 C-N-CA 120.213 -0.595 . . . . 0.0 112.341 -179.279 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 90.99 7.51 65.87 Favored Glycine 1 N--CA 1.52 4.252 0 C-N-CA 118.804 -1.665 . . . . 0.0 112.225 178.112 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.956 ' CZ ' HD22 ' A' ' 58' ' ' LEU . 2.0 p90 -127.8 179.77 5.37 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 104.469 -2.419 . . . . 0.0 104.469 178.087 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.55 ' N ' ' CD1' ' A' ' 62' ' ' PHE . . . -156.22 171.48 33.99 Favored Glycine 0 N--CA 1.477 1.387 0 C-N-CA 117.186 -2.435 . . . . 0.0 111.879 -178.111 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.467 ' CE2' ' HE1' ' A' ' 62' ' ' PHE . 14.5 m-85 -128.99 149.11 50.96 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 119.861 1.831 . . . . 0.0 109.25 177.238 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.546 ' HB3' ' HB ' ' A' ' 79' ' ' ILE . 0.6 OUTLIER -99.42 165.35 11.7 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 176.392 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.587 ' O ' ' HA3' ' A' ' 53' ' ' GLY . 0.0 OUTLIER 172.49 -169.73 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.97 -1.081 . . . . 0.0 109.712 178.525 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 17.1 m . . . . . 0 N--CA 1.5 2.067 0 O-C-N 120.716 -1.24 . . . . 0.0 109.949 179.691 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 78' ' ' ASP . 0.8 OUTLIER . . . . . 0 N--CA 1.504 2.271 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.546 ' HB ' ' HB3' ' A' ' 65' ' ' LEU . 1.3 mp -117.88 127.64 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.721 0 C-N-CA 119.169 -1.012 . . . . 0.0 108.507 177.548 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.456 ' HB3' ' HA ' ' A' ' 112' ' ' ALA . 6.8 t80 -73.61 146.19 44.83 Favored 'General case' 0 N--CA 1.515 2.796 0 O-C-N 119.689 -1.882 . . . . 0.0 110.125 -178.425 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.853 HG21 HD21 ' A' ' 55' ' ' LEU . 34.5 t -140.36 112.02 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 120.324 -1.485 . . . . 0.0 110.603 -179.563 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.539 ' O ' HG13 ' A' ' 86' ' ' ILE . 57.9 m -74.67 165.99 49.0 Favored Pre-proline 0 N--CA 1.513 2.697 0 O-C-N 120.519 -1.363 . . . . 0.0 112.041 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.521 ' HD2' ' HB3' ' A' ' 82' ' ' SER . 40.1 Cg_endo -65.21 -50.24 2.17 Favored 'Trans proline' 0 C--N 1.315 -1.189 0 O-C-N 124.317 1.693 . . . . 0.0 109.287 179.092 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.554 ' O ' ' CG ' ' A' ' 88' ' ' ARG . 0.3 OUTLIER -47.92 -39.66 19.7 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 178.106 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.536 ' HB2' ' O ' ' A' ' 82' ' ' SER . 5.6 mm100 -63.56 -58.86 5.65 Favored 'General case' 0 N--CA 1.51 2.551 0 C-N-CA 119.375 -0.93 . . . . 0.0 108.68 178.378 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.539 HG13 ' O ' ' A' ' 82' ' ' SER . 0.3 OUTLIER -57.23 -54.22 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.417 0 O-C-N 121.076 -1.015 . . . . 0.0 108.76 178.848 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.46 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 0.2 OUTLIER -56.25 -43.83 79.06 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 121.924 0.869 . . . . 0.0 111.27 -179.519 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.554 ' CG ' ' O ' ' A' ' 84' ' ' SER . 0.1 OUTLIER -57.97 -36.71 72.98 Favored 'General case' 0 N--CA 1.506 2.369 0 C-N-CA 119.792 -0.763 . . . . 0.0 111.724 -177.694 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -113.73 13.76 18.62 Favored 'General case' 0 N--CA 1.502 2.153 0 C-N-CA 117.359 -1.736 . . . . 0.0 111.462 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 58.41 55.13 5.12 Favored 'General case' 0 N--CA 1.484 1.239 0 O-C-N 120.434 -1.416 . . . . 0.0 109.621 178.656 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.505 ' O ' ' HG2' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -89.11 -179.29 5.87 Favored 'General case' 0 N--CA 1.496 1.834 0 C-N-CA 119.521 -0.872 . . . . 0.0 109.968 -179.832 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.505 ' HG2' ' O ' ' A' ' 91' ' ' LEU . 10.6 mtt-85 -155.13 158.21 38.64 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.186 -0.946 . . . . 0.0 109.115 178.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.618 ' HB ' ' CG1' ' A' ' 57' ' ' ILE . 2.3 t -63.7 156.39 27.14 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 117.205 -1.798 . . . . 0.0 107.186 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 76.23 -10.33 16.24 Favored Glycine 0 N--CA 1.505 3.272 0 C-N-CA 117.007 -2.52 . . . . 0.0 110.233 179.133 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.567 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 25.4 m-20 -70.34 146.86 50.21 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.272 -1.723 . . . . 0.0 110.795 -178.9 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.497 ' O ' HG12 ' A' ' 97' ' ' ILE . 0.2 OUTLIER -90.09 121.22 31.95 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.209 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.56 HG23 HG22 ' A' ' 119' ' ' VAL . 1.5 mt -145.67 168.51 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 119.733 -1.854 . . . . 0.0 112.89 -178.109 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.51 ' OG ' ' HB2' ' A' ' 118' ' ' GLU . 98.5 p -148.49 137.55 21.74 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 178.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.584 ' O ' ' HB2' ' A' ' 50' ' ' PHE . . . -161.95 176.11 38.41 Favored Glycine 0 N--CA 1.506 3.324 0 C-N-CA 117.163 -2.446 . . . . 0.0 114.546 -178.893 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.801 ' HD3' HD23 ' A' ' 114' ' ' LEU . 2.9 ptmt -88.83 156.66 18.81 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 179.053 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.524 HG12 ' HA ' ' A' ' 50' ' ' PHE . 2.0 pt -125.55 156.36 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.432 0 CA-C-N 120.37 1.441 . . . . 0.0 113.588 -176.965 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.955 ' HG3' HD22 ' A' ' 114' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.466 0 O-C-N 120.56 -1.337 . . . . 0.0 109.5 179.289 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.497 1.919 0 N-CA-C 109.443 -0.576 . . . . 0.0 109.443 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -107.92 152.35 24.56 Favored 'General case' 0 N--CA 1.516 2.85 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 176.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.431 ' O ' ' HB3' ' A' ' 80' ' ' TYR . 51.4 m-85 -67.32 168.16 11.11 Favored 'General case' 0 N--CA 1.507 2.424 0 O-C-N 119.246 -2.159 . . . . 0.0 108.252 179.275 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.456 ' HA ' ' HB3' ' A' ' 80' ' ' TYR . . . -122.87 154.93 37.64 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 119.994 -1.692 . . . . 0.0 110.883 -178.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.1 tp -68.38 148.41 50.73 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.955 HD22 ' HG3' ' A' ' 102' ' ' ARG . 9.7 tp -128.74 -55.18 1.22 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.315 -1.49 . . . . 0.0 112.616 -178.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.498 ' HB3' ' CG ' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -125.64 141.97 51.75 Favored 'General case' 0 N--CA 1.509 2.514 0 O-C-N 120.236 -1.54 . . . . 0.0 109.1 179.658 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.4 t -92.53 130.46 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.792 0 O-C-N 120.517 -1.364 . . . . 0.0 110.943 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -107.28 -38.73 5.88 Favored 'General case' 0 N--CA 1.506 2.375 0 O-C-N 121.393 -0.817 . . . . 0.0 110.012 178.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.533 ' C ' HG23 ' A' ' 119' ' ' VAL . 0.5 OUTLIER -143.24 158.33 43.72 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.853 -1.154 . . . . 0.0 109.435 179.722 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.56 HG22 HG23 ' A' ' 97' ' ' ILE . 44.3 t -158.8 133.62 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 -178.402 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 . . . . . 0 N--CA 1.521 3.102 0 O-C-N 120.313 -1.492 . . . . 0.0 111.231 179.706 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.658 ' HA ' ' HA ' ' A' ' 49' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 . . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 2' ' ' ASN . . . . . 0.54 ' HA ' ' O ' ' A' ' 50' ' ' PHE . 52.5 t30 -78.44 96.73 5.45 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.919 -1.113 . . . . 0.0 108.356 178.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.941 HD23 ' CD1' ' A' ' 79' ' ' ILE . 0.6 OUTLIER -41.78 -41.89 2.47 Favored 'General case' 0 N--CA 1.516 2.863 0 O-C-N 120.405 -1.435 . . . . 0.0 110.501 -178.397 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.411 ' OG1' ' OD1' ' A' ' 52' ' ' ASP . 1.7 m -57.77 -37.55 73.87 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.577 -1.327 . . . . 0.0 108.151 -179.489 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.517 ' HB3' ' HB3' ' A' ' 2' ' ' ASN . 0.8 OUTLIER -70.4 -45.28 66.27 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.06 -1.025 . . . . 0.0 108.59 177.932 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.873 HD12 HD12 ' A' ' 3' ' ' LEU 0.278 84.0 mt -51.27 -50.04 60.04 Favored 'General case' 0 C--N 1.315 -0.893 0 O-C-N 120.886 -1.133 . . . . 0.0 109.476 178.15 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.417 ' NZ ' ' OE1' ' A' ' 32' ' ' GLN . 5.7 mmtt -64.06 -36.49 84.17 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.241 -0.912 . . . . 0.0 110.085 179.151 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -61.93 -25.52 67.63 Favored 'General case' 0 N--CA 1.508 2.455 0 C-N-CA 119.282 -0.967 . . . . 0.0 111.031 -179.035 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.605 ' CG2' ' HB3' ' A' ' 13' ' ' GLU . 4.4 m -74.49 132.84 77.93 Favored Pre-proline 0 N--CA 1.504 2.256 0 O-C-N 121.675 -0.641 . . . . 0.0 109.687 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.501 ' HG2' ' HB2' ' A' ' 13' ' ' GLU . 45.0 Cg_endo -65.16 150.84 87.19 Favored 'Trans proline' 0 CA--C 1.567 2.149 0 CA-C-N 118.767 0.595 . . . . 0.0 110.67 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.584 HG23 ' HG3' ' A' ' 31' ' ' LYS . 1.7 p -42.44 -50.28 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.527 3.391 0 O-C-N 120.542 -1.348 . . . . 0.0 110.162 -178.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.552 ' N ' ' CG1' ' A' ' 11' ' ' VAL . 1.0 OUTLIER -57.67 -41.84 82.36 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.294 -0.879 . . . . 0.0 111.174 -179.266 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.805 ' O ' HD12 ' A' ' 17' ' ' LEU . 0.2 OUTLIER -69.25 -27.7 65.68 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 117.69 -1.604 . . . . 0.0 107.682 179.233 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.615 ' HB3' HG21 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -69.29 -43.1 74.52 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.828 -1.17 . . . . 0.0 108.754 176.906 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.529 HD12 ' O ' ' A' ' 11' ' ' VAL . 1.4 mp -65.61 -40.59 88.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 C-N-CA 117.752 -1.579 . . . . 0.0 108.599 178.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.56 ' HA ' ' HG2' ' A' ' 19' ' ' GLU . 33.0 m -62.61 -37.75 87.52 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 120.542 -1.349 . . . . 0.0 109.146 179.198 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.805 HD12 ' O ' ' A' ' 13' ' ' GLU . 0.2 OUTLIER -65.58 -36.82 84.87 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.923 -1.111 . . . . 0.0 108.609 178.343 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.507 ' HA2' HD13 ' A' ' 38' ' ' ILE . . . -67.39 -44.5 84.3 Favored Glycine 0 N--CA 1.513 3.829 0 N-CA-C 108.427 -1.869 . . . . 0.0 108.427 178.296 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.694 ' HG3' ' N ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -59.09 -38.63 79.97 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.435 -1.626 . . . . 0.0 108.298 178.889 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.694 ' N ' ' HG3' ' A' ' 19' ' ' GLU . 26.3 m120 -61.61 -28.57 69.46 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.514 -1.366 . . . . 0.0 109.337 178.563 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.565 ' HB2' ' CD1' ' A' ' 23' ' ' LEU . 17.6 mtp -101.81 13.03 36.03 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.325 -0.859 . . . . 0.0 111.128 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.4 -19.78 53.06 Favored Glycine 0 N--CA 1.501 2.97 0 C-N-CA 118.67 -1.728 . . . . 0.0 111.249 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.798 ' H ' HD12 ' A' ' 23' ' ' LEU . 3.4 mp -79.17 92.79 5.11 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 120.39 -1.653 . . . . 0.0 109.313 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.407 ' O ' ' CB ' ' A' ' 25' ' ' ASN . 3.4 pt-20 -106.86 179.63 4.21 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.119 -0.988 . . . . 0.0 109.384 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.407 ' CB ' ' O ' ' A' ' 24' ' ' GLU . 1.1 m-20 65.75 14.09 9.34 Favored 'General case' 0 N--CA 1.51 2.539 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.916 179.053 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.63 HD11 ' HB3' ' A' ' 23' ' ' LEU . 0.5 OUTLIER -77.14 -7.53 55.95 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.029 -1.044 . . . . 0.0 111.6 -179.839 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 26' ' ' LEU . . . -46.64 -35.02 5.52 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.45 -1.406 . . . . 0.0 109.076 -179.164 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.1 mmt-85 -82.65 1.36 38.74 Favored 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 120.059 -0.657 . . . . 0.0 111.644 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.509 ' HB3' ' OD1' ' A' ' 33' ' ' ASP . 11.4 mtp -101.01 159.5 15.17 Favored 'General case' 0 C--N 1.313 -0.979 0 O-C-N 120.659 -1.276 . . . . 0.0 112.08 -178.551 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.873 ' O ' HD12 ' A' ' 34' ' ' ILE . 3.8 ttm180 -89.81 173.88 8.01 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 121.965 0.888 . . . . 0.0 111.094 178.324 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.635 ' O ' HG22 ' A' ' 35' ' ' ILE . 3.4 mtpp -62.23 -40.15 95.17 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.663 -0.648 . . . . 0.0 111.309 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.544 ' O ' ' CG2' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -64.96 -54.79 25.07 Favored 'General case' 0 N--CA 1.524 3.263 0 CA-C-O 121.845 0.831 . . . . 0.0 110.876 -178.758 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.54 ' OD1' ' N ' ' A' ' 34' ' ' ILE . 1.9 p30 -65.81 -41.65 91.63 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.886 -1.134 . . . . 0.0 109.262 -178.679 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.873 HD12 ' O ' ' A' ' 30' ' ' ARG . 9.0 mt -62.21 -40.05 86.24 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 O-C-N 120.27 -1.519 . . . . 0.0 109.498 178.016 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.635 HG22 ' O ' ' A' ' 31' ' ' LYS . 0.4 OUTLIER -67.48 -34.39 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.625 0 O-C-N 120.125 -1.609 . . . . 0.0 109.46 178.543 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.461 ' CD2' ' O ' ' A' ' 32' ' ' GLN . 17.9 m-85 -66.05 -44.22 85.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.498 -1.376 . . . . 0.0 109.05 179.006 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.633 ' HB1' HD23 ' A' ' 23' ' ' LEU . . . -66.41 -54.15 27.64 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 120.539 -1.351 . . . . 0.0 109.622 178.605 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.603 HG23 ' N ' ' A' ' 39' ' ' LEU . 8.6 tp -50.5 -46.86 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.43 0 C-N-CA 117.239 -1.784 . . . . 0.0 108.239 179.194 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.804 HD21 HD11 ' A' ' 6' ' ' LEU . 58.9 mt -58.6 -40.01 82.05 Favored 'General case' 0 N--CA 1.508 2.432 0 O-C-N 120.851 -1.155 . . . . 0.0 109.669 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.2 mttm -63.38 -35.83 81.7 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.365 -0.834 . . . . 0.0 109.941 179.133 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.58 ' HG3' HD11 ' A' ' 23' ' ' LEU . 12.0 mm-40 -77.77 -52.26 9.21 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.581 -0.7 . . . . 0.0 111.106 -179.396 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.544 ' CD2' ' HB2' ' A' ' 47' ' ' GLU . 17.6 t60 -62.23 -34.38 76.38 Favored 'General case' 0 N--CA 1.51 2.558 0 C-N-CA 118.374 -1.331 . . . . 0.0 108.612 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.492 ' O ' ' N ' ' A' ' 46' ' ' GLY . . . -64.16 -43.71 94.34 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.959 -1.088 . . . . 0.0 108.493 177.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.0 tptt -48.01 -44.72 31.05 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 121.051 -1.03 . . . . 0.0 109.187 178.275 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.463 ' HB3' ' OE2' ' A' ' 47' ' ' GLU . 74.1 m -66.79 -8.16 26.48 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 121.675 0.75 . . . . 0.0 109.726 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . 73.39 29.63 63.75 Favored Glycine 0 N--CA 1.495 2.586 0 C-N-CA 120.055 -1.069 . . . . 0.0 111.636 178.601 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.544 ' HB2' ' CD2' ' A' ' 42' ' ' HIS . 0.3 OUTLIER -79.41 166.87 21.58 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.211 -1.758 . . . . 0.0 108.821 178.899 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.431 ' C ' HG23 ' A' ' 49' ' ' ILE . 53.3 m-20 -85.96 143.13 28.33 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.042 -1.036 . . . . 0.0 109.653 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.658 ' HA ' ' HA ' ' A' ' 1' ' ' MET . 0.6 OUTLIER -149.21 147.88 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.724 -1.235 . . . . 0.0 108.417 179.529 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.568 ' CD1' ' N ' ' A' ' 50' ' ' PHE . 11.3 p90 -141.22 164.8 29.26 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 116.163 -2.215 . . . . 0.0 114.504 -178.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -119.29 169.75 13.75 Favored Glycine 0 N--CA 1.5 2.924 0 N-CA-C 108.502 -1.839 . . . . 0.0 108.502 -178.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.527 ' C ' ' CD2' ' A' ' 65' ' ' LEU . 3.6 p30 -170.98 163.03 7.43 Favored 'General case' 0 N--CA 1.482 1.14 0 O-C-N 120.445 -1.621 . . . . 0.0 109.923 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.6 ' N ' HD21 ' A' ' 65' ' ' LEU . . . 150.15 -142.46 9.7 Favored Glycine 0 N--CA 1.503 3.101 0 C-N-CA 117.856 -2.116 . . . . 0.0 111.389 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.577 ' HA ' ' O ' ' A' ' 95' ' ' ASP . 2.8 t -128.81 121.35 54.41 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.765 HD21 HG21 ' A' ' 81' ' ' VAL . 7.0 mt -62.63 161.72 11.76 Favored 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 118.514 -1.274 . . . . 0.0 113.481 -175.698 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.509 ' HA ' ' OG1' ' A' ' 93' ' ' THR . 4.3 tt0 -139.05 117.85 12.34 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 178.041 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.694 ' C ' HD12 ' A' ' 58' ' ' LEU . 1.3 mm -82.57 161.07 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 CA-C-N 120.868 1.667 . . . . 0.0 109.572 -178.436 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.944 HD22 ' CZ ' ' A' ' 62' ' ' PHE . 6.7 mp -130.31 134.9 47.54 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.602 -1.311 . . . . 0.0 109.288 179.088 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.478 ' C ' ' O ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -38.59 -36.25 0.24 Allowed 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.665 0.745 . . . . 0.0 109.946 -179.725 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.404 ' HB2' ' CD2' ' A' ' 62' ' ' PHE . 5.5 m-20 -60.95 -7.08 2.17 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.689 -0.632 . . . . 0.0 112.53 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.422 ' O ' ' HB3' ' A' ' 83' ' ' PRO . . . 91.65 8.15 64.13 Favored Glycine 1 N--CA 1.518 4.113 0 C-N-CA 118.677 -1.725 . . . . 0.0 112.232 178.13 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.944 ' CZ ' HD22 ' A' ' 58' ' ' LEU . 2.2 p90 -127.9 -179.64 5.07 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 104.706 -2.331 . . . . 0.0 104.706 178.127 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.711 ' HA2' HD13 ' A' ' 58' ' ' LEU . . . -157.88 172.33 35.06 Favored Glycine 0 N--CA 1.478 1.491 0 C-N-CA 117.38 -2.343 . . . . 0.0 111.841 -178.133 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.448 ' CE2' ' HE1' ' A' ' 62' ' ' PHE . 10.3 m-85 -128.83 153.83 47.05 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 119.882 1.841 . . . . 0.0 109.319 177.282 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.6 HD21 ' N ' ' A' ' 53' ' ' GLY . 0.5 OUTLIER -100.24 124.02 45.18 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 177.487 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.534 ' CB ' ' OD2' ' A' ' 78' ' ' ASP . 2.6 ptm180 -129.42 -169.22 2.06 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 119.629 -1.919 . . . . 0.0 110.281 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.498 1.947 0 O-C-N 120.961 -1.087 . . . . 0.0 110.469 179.95 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.534 ' OD2' ' CB ' ' A' ' 66' ' ' ARG . 89.2 m-20 . . . . . 0 N--CA 1.514 2.771 0 CA-C-O 121.16 0.505 . . . . 0.0 111.807 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.941 ' CD1' HD23 ' A' ' 3' ' ' LEU . 6.7 mm -76.73 130.81 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.701 0 O-C-N 121.058 -1.026 . . . . 0.0 110.576 -177.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.526 ' HB3' ' O ' ' A' ' 111' ' ' PHE . 79.9 t80 -77.2 145.18 37.77 Favored 'General case' 0 N--CA 1.513 2.72 0 O-C-N 119.549 -1.969 . . . . 0.0 109.42 179.123 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.765 HG21 HD21 ' A' ' 55' ' ' LEU . 38.7 t -142.38 114.66 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 120.301 -1.499 . . . . 0.0 110.817 -179.472 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.573 ' O ' HG13 ' A' ' 86' ' ' ILE . 19.9 m -74.71 163.65 66.8 Favored Pre-proline 0 N--CA 1.512 2.665 0 O-C-N 120.357 -1.464 . . . . 0.0 111.708 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.529 ' HA ' HG13 ' A' ' 86' ' ' ILE . 38.0 Cg_endo -65.33 -48.83 3.01 Favored 'Trans proline' 0 C--N 1.315 -1.233 0 O-C-N 124.321 1.695 . . . . 0.0 108.827 179.005 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.554 ' O ' ' CG ' ' A' ' 88' ' ' ARG . 80.1 p -46.59 -41.1 13.99 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 177.663 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.54 ' HB2' ' O ' ' A' ' 82' ' ' SER . 4.2 mm-40 -62.16 -58.08 9.14 Favored 'General case' 0 N--CA 1.51 2.529 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 177.849 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.596 HG23 ' HB2' ' A' ' 91' ' ' LEU . 0.9 OUTLIER -55.35 -55.27 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 O-C-N 121.153 -0.967 . . . . 0.0 108.55 178.382 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.467 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 0.2 OUTLIER -57.99 -42.23 84.7 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-O 121.787 0.804 . . . . 0.0 111.466 -179.518 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.554 ' CG ' ' O ' ' A' ' 84' ' ' SER . 0.0 OUTLIER -60.44 -36.52 78.39 Favored 'General case' 0 N--CA 1.506 2.355 0 C-N-CA 119.76 -0.776 . . . . 0.0 111.725 -177.714 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 1.032 ' HB2' HD21 ' A' ' 91' ' ' LEU . 20.1 m-85 -112.12 13.13 20.58 Favored 'General case' 0 N--CA 1.507 2.378 0 C-N-CA 117.12 -1.832 . . . . 0.0 111.664 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 61.46 53.5 3.37 Favored 'General case' 0 N--CA 1.484 1.242 0 O-C-N 120.389 -1.445 . . . . 0.0 110.3 178.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 1.032 HD21 ' HB2' ' A' ' 89' ' ' PHE . 3.5 mt -89.61 -173.44 3.95 Favored 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 119.304 -0.959 . . . . 0.0 110.277 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.533 ' CG ' ' O ' ' A' ' 91' ' ' LEU . 12.0 mtt-85 -160.1 160.27 32.85 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 177.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.594 ' HB ' ' CG1' ' A' ' 57' ' ' ILE . 1.8 t -64.18 155.94 30.14 Favored 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 116.983 -1.887 . . . . 0.0 106.841 178.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 77.57 -11.54 18.64 Favored Glycine 0 N--CA 1.506 3.343 0 C-N-CA 117.042 -2.504 . . . . 0.0 110.263 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.577 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 7.9 m-20 -68.18 148.59 50.66 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.14 -1.8 . . . . 0.0 110.465 -179.038 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.523 ' O ' HG12 ' A' ' 97' ' ' ILE . 0.1 OUTLIER -93.92 125.58 38.62 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.16 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.523 HG12 ' O ' ' A' ' 96' ' ' THR . 1.5 mt -145.78 164.89 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 C-N-CA 118.07 -1.452 . . . . 0.0 112.375 -179.134 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 89.9 p -149.69 139.29 21.64 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.45 ' O ' ' HB2' ' A' ' 50' ' ' PHE . . . -168.29 -175.41 37.89 Favored Glycine 0 N--CA 1.508 3.465 0 C-N-CA 116.859 -2.591 . . . . 0.0 115.406 -178.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.437 ' HG3' ' HG2' ' A' ' 115' ' ' LYS . 2.1 mtpt -88.23 150.98 22.98 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 2.8 pt -121.51 160.56 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.504 0 CA-C-N 121.463 1.938 . . . . 0.0 113.241 -177.322 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.847 ' CB ' HD13 ' A' ' 114' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.488 1.438 0 O-C-N 120.392 -1.442 . . . . 0.0 109.363 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.2 mmt85 . . . . . 0 N--CA 1.496 1.874 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -106.83 151.56 25.03 Favored 'General case' 0 N--CA 1.52 3.038 0 O-C-N 119.7 -1.875 . . . . 0.0 109.574 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.526 ' O ' ' HB3' ' A' ' 80' ' ' TYR . 3.3 m-85 -68.28 168.19 12.89 Favored 'General case' 0 N--CA 1.503 2.225 0 O-C-N 119.775 -1.828 . . . . 0.0 107.928 178.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -122.75 155.69 35.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.1 -1.625 . . . . 0.0 110.785 -179.015 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.97 153.71 39.77 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.847 HD13 ' CB ' ' A' ' 102' ' ' ARG . 14.5 tp -129.07 -56.36 1.18 Allowed 'General case' 0 N--CA 1.503 2.205 0 O-C-N 120.081 -1.637 . . . . 0.0 112.868 -178.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.437 ' HG2' ' HG3' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -125.28 142.77 51.31 Favored 'General case' 0 N--CA 1.507 2.404 0 O-C-N 120.343 -1.473 . . . . 0.0 108.536 179.666 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.474 HG21 ' CD2' ' A' ' 89' ' ' PHE . 37.4 t -92.89 130.55 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.955 0 O-C-N 120.406 -1.434 . . . . 0.0 112.091 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.447 ' CG ' ' HA2' ' A' ' 99' ' ' GLY . 11.3 m-20 -107.02 -39.93 5.6 Favored 'General case' 0 N--CA 1.51 2.567 0 O-C-N 121.469 -0.769 . . . . 0.0 109.871 178.122 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.584 ' C ' HG23 ' A' ' 119' ' ' VAL . 0.9 OUTLIER -143.45 160.07 41.25 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.989 -1.069 . . . . 0.0 109.463 179.578 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.584 HG23 ' C ' ' A' ' 118' ' ' GLU . 18.7 t -158.46 147.89 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -178.755 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.515 ' C ' ' O ' ' A' ' 119' ' ' VAL . 7.1 t-20 . . . . . 0 N--CA 1.524 3.273 0 O-C-N 121.456 -0.778 . . . . 0.0 111.481 -178.406 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.677 ' HA ' ' HA ' ' A' ' 49' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 2' ' ' ASN . . . . . 0.633 ' ND2' ' OD1' ' A' ' 52' ' ' ASP . 11.9 t-20 -78.63 91.09 4.59 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.965 -1.085 . . . . 0.0 108.461 178.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.823 HD23 HD13 ' A' ' 79' ' ' ILE . 1.5 tp -42.19 -41.05 2.57 Favored 'General case' 0 N--CA 1.52 3.043 0 O-C-N 120.471 -1.393 . . . . 0.0 110.401 -178.267 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.8 m -57.35 -37.82 73.17 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.806 -1.183 . . . . 0.0 108.33 -179.269 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.602 ' HB2' ' HB3' ' A' ' 2' ' ' ASN . 0.3 OUTLIER -74.11 -39.31 63.44 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.783 -1.198 . . . . 0.0 108.776 178.021 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.81 HD12 ' HA ' ' A' ' 3' ' ' LEU 0.278 67.4 mt -54.77 -52.33 62.93 Favored 'General case' 0 C--O 1.215 -0.718 0 O-C-N 120.387 -1.445 . . . . 0.0 109.038 177.771 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.487 ' NZ ' ' HD2' ' A' ' 66' ' ' ARG . 0.2 OUTLIER -61.54 -40.35 94.35 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.019 -1.05 . . . . 0.0 109.264 178.468 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ASN . . . . . 0.46 ' HB2' ' HA ' ' A' ' 5' ' ' GLU . 2.7 m-80 -62.08 -20.6 64.18 Favored 'General case' 0 N--CA 1.506 2.353 0 C-N-CA 119.438 -0.905 . . . . 0.0 110.732 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.804 ' O ' HD11 ' A' ' 14' ' ' LEU . 2.6 m -75.01 118.28 69.24 Favored Pre-proline 0 C--N 1.287 -2.14 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.512 ' HG2' ' CG ' ' A' ' 13' ' ' GLU . 37.3 Cg_endo -57.47 152.33 48.02 Favored 'Trans proline' 0 CA--C 1.563 1.952 0 O-C-N 122.408 0.688 . . . . 0.0 110.515 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.736 ' O ' HD12 ' A' ' 15' ' ' ILE . 1.7 p -41.31 -49.44 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.529 3.48 0 O-C-N 120.493 -1.379 . . . . 0.0 110.094 -178.279 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.536 ' N ' ' CG1' ' A' ' 11' ' ' VAL . 0.7 OUTLIER -60.56 -39.8 89.29 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.415 -0.803 . . . . 0.0 111.249 -179.629 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 1.028 ' O ' HD12 ' A' ' 17' ' ' LEU . 29.2 mt-10 -69.45 -32.21 71.0 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 118.015 -1.474 . . . . 0.0 108.488 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.804 HD11 ' O ' ' A' ' 9' ' ' THR . 6.2 mt -68.62 -42.29 78.3 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 120.841 -1.162 . . . . 0.0 108.845 177.171 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.736 HD12 ' O ' ' A' ' 11' ' ' VAL . 1.3 mp -64.64 -38.97 84.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 C-N-CA 117.714 -1.594 . . . . 0.0 108.451 178.433 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.501 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 59.0 m -64.24 -36.69 84.9 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 120.331 -1.481 . . . . 0.0 108.878 178.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 1.028 HD12 ' O ' ' A' ' 13' ' ' GLU . 0.3 OUTLIER -66.06 -38.82 89.3 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.822 -1.174 . . . . 0.0 108.936 178.432 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -68.0 -43.28 82.68 Favored Glycine 1 N--CA 1.521 4.305 0 N-CA-C 108.471 -1.852 . . . . 0.0 108.471 178.465 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.435 ' OE1' ' HG2' ' A' ' 24' ' ' GLU . 1.4 mm-40 -54.72 -44.9 73.9 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.886 -1.361 . . . . 0.0 107.737 178.495 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.501 ' OD1' ' O ' ' A' ' 16' ' ' THR . 28.8 m120 -59.57 -26.22 65.21 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 118.288 -1.365 . . . . 0.0 109.334 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.561 ' CE ' ' NE2' ' A' ' 41' ' ' GLN . 52.9 mmm -101.07 9.79 41.72 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.27 -0.894 . . . . 0.0 111.144 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.85 -21.11 39.31 Favored Glycine 0 N--CA 1.501 3.02 0 C-N-CA 118.634 -1.746 . . . . 0.0 111.589 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.834 ' HB3' HD11 ' A' ' 26' ' ' LEU . 4.0 mp -78.57 96.48 5.48 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 120.152 -1.793 . . . . 0.0 109.934 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.496 ' O ' ' CB ' ' A' ' 25' ' ' ASN . 16.9 mt-10 -105.98 171.14 7.5 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.255 -0.903 . . . . 0.0 109.276 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.496 ' CB ' ' O ' ' A' ' 24' ' ' GLU . 0.7 OUTLIER 71.15 15.67 6.45 Favored 'General case' 0 N--CA 1.514 2.733 0 O-C-N 121.517 -0.739 . . . . 0.0 111.838 179.314 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.834 HD11 ' HB3' ' A' ' 23' ' ' LEU . 0.4 OUTLIER -76.57 -10.88 59.71 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.005 -1.059 . . . . 0.0 111.672 -179.883 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 26' ' ' LEU . . . -46.57 -35.73 6.13 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.515 -1.366 . . . . 0.0 109.07 -179.225 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.92 3.53 25.98 Favored 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 119.849 -0.74 . . . . 0.0 111.545 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.593 ' HE2' ' OD1' ' A' ' 33' ' ' ASP . 7.5 mtp -99.97 156.61 17.06 Favored 'General case' 0 C--N 1.314 -0.95 0 O-C-N 120.72 -1.238 . . . . 0.0 111.774 -178.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.539 ' C ' HD12 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -89.46 139.22 30.74 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.413 -0.804 . . . . 0.0 110.936 179.239 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.58 ' O ' HG22 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -31.66 -44.81 0.08 Allowed 'General case' 0 N--CA 1.5 2.055 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.885 179.197 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.582 ' O ' ' CG2' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -63.27 -53.28 55.38 Favored 'General case' 0 N--CA 1.521 3.08 0 O-C-N 121.319 -0.863 . . . . 0.0 111.941 -178.233 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.593 ' OD1' ' HE2' ' A' ' 29' ' ' MET . 1.9 p30 -66.92 -39.73 87.46 Favored 'General case' 0 C--N 1.293 -1.873 0 O-C-N 119.965 -1.709 . . . . 0.0 109.226 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.574 HD11 ' HB2' ' A' ' 29' ' ' MET . 4.4 mt -61.93 -39.18 82.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 O-C-N 120.459 -1.401 . . . . 0.0 109.444 178.457 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.582 ' CG2' ' O ' ' A' ' 32' ' ' GLN . 0.3 OUTLIER -66.91 -40.6 86.09 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.555 0 O-C-N 120.345 -1.472 . . . . 0.0 109.246 178.518 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 6.1 m-30 -60.3 -43.9 95.88 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 120.803 -1.186 . . . . 0.0 108.531 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.718 ' HB1' ' CD2' ' A' ' 23' ' ' LEU . . . -59.28 -51.32 70.45 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.49 -1.381 . . . . 0.0 108.821 178.042 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.554 HG13 ' O ' ' A' ' 34' ' ' ILE . 0.1 OUTLIER -56.17 -31.88 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 C-N-CA 117.618 -1.633 . . . . 0.0 109.643 179.23 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.733 HD21 HD13 ' A' ' 6' ' ' LEU . 98.6 mt -69.21 -44.88 71.19 Favored 'General case' 0 N--CA 1.505 2.308 0 O-C-N 120.07 -1.644 . . . . 0.0 109.557 178.759 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.65 -34.11 77.44 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.023 -1.048 . . . . 0.0 111.396 179.114 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.561 ' NE2' ' CE ' ' A' ' 21' ' ' MET . 0.0 OUTLIER -79.5 -51.71 8.97 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.212 -0.93 . . . . 0.0 109.977 -178.9 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.539 ' CE1' ' HG3' ' A' ' 47' ' ' GLU . 5.1 t-160 -64.95 -38.61 91.53 Favored 'General case' 0 N--CA 1.507 2.378 0 C-N-CA 117.619 -1.632 . . . . 0.0 109.141 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.544 ' O ' ' N ' ' A' ' 46' ' ' GLY . . . -61.58 -38.86 89.08 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 120.918 -1.113 . . . . 0.0 108.594 178.311 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 12.2 tptt -48.25 -45.0 33.86 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 121.003 -1.061 . . . . 0.0 108.567 177.774 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 52.0 m -66.49 -10.09 41.04 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 121.724 0.773 . . . . 0.0 109.493 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . 70.71 29.53 69.42 Favored Glycine 0 N--CA 1.496 2.652 0 C-N-CA 120.621 -0.8 . . . . 0.0 111.752 178.508 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.539 ' HG3' ' CE1' ' A' ' 42' ' ' HIS . 3.7 pm0 -82.82 158.08 22.91 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.178 -1.777 . . . . 0.0 108.793 178.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -71.55 147.65 47.46 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.912 -1.117 . . . . 0.0 110.334 -178.797 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.677 ' HA ' ' HA ' ' A' ' 1' ' ' MET . 0.8 OUTLIER -146.63 145.0 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.077 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.6 ' O ' ' HA ' ' A' ' 2' ' ' ASN . 10.5 p90 -141.31 170.28 16.01 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 116.268 -2.173 . . . . 0.0 115.583 -177.768 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -114.46 162.37 12.43 Favored Glycine 0 N--CA 1.501 3.003 0 N-CA-C 107.88 -2.088 . . . . 0.0 107.88 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.633 ' OD1' ' ND2' ' A' ' 2' ' ' ASN . 7.5 p-10 -172.78 162.91 4.99 Favored 'General case' 0 N--CA 1.483 1.196 0 O-C-N 120.364 -1.668 . . . . 0.0 110.369 -178.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.561 ' HA3' ' O ' ' A' ' 66' ' ' ARG . . . 138.35 -134.59 6.94 Favored Glycine 0 N--CA 1.503 3.155 0 C-N-CA 118.28 -1.914 . . . . 0.0 111.54 177.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.62 ' HA ' ' O ' ' A' ' 95' ' ' ASP . 2.5 t -127.94 117.75 46.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 O-C-N 121.45 -1.029 . . . . 0.0 108.396 -179.124 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 1.018 HD21 HG21 ' A' ' 81' ' ' VAL . 6.2 mt -63.36 165.41 7.67 Favored 'General case' 0 N--CA 1.503 2.18 0 C-N-CA 118.622 -1.231 . . . . 0.0 113.561 -176.145 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.53 ' O ' ' CG ' ' A' ' 56' ' ' GLU . 8.2 pt-20 -141.52 123.03 15.02 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 177.654 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.57 ' CG1' ' HB ' ' A' ' 93' ' ' THR . 1.2 mm -83.07 164.31 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 119.857 -1.777 . . . . 0.0 109.275 -178.544 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.641 HD13 ' HA2' ' A' ' 63' ' ' GLY . 3.1 mp -130.98 136.46 48.55 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.433 -1.417 . . . . 0.0 109.672 179.239 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.445 ' C ' ' O ' ' A' ' 58' ' ' LEU . 7.7 tt0 -39.57 -36.99 0.44 Allowed 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.637 0.732 . . . . 0.0 110.128 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.452 ' OD1' ' N ' ' A' ' 60' ' ' ASP . 5.8 m-20 -61.52 -6.65 2.52 Favored 'General case' 0 N--CA 1.5 2.029 0 C-N-CA 119.905 -0.718 . . . . 0.0 112.576 -179.157 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 92.53 8.15 62.69 Favored Glycine 1 N--CA 1.519 4.224 0 C-N-CA 118.688 -1.72 . . . . 0.0 112.612 177.784 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.614 ' CZ ' HD22 ' A' ' 58' ' ' LEU . 4.4 p90 -129.1 -177.04 4.06 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 104.29 -2.485 . . . . 0.0 104.29 177.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.641 ' HA2' HD13 ' A' ' 58' ' ' LEU . . . -157.63 172.75 34.97 Favored Glycine 0 N--CA 1.475 1.273 0 C-N-CA 116.672 -2.68 . . . . 0.0 112.109 -177.562 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.488 ' HB2' ' OE2' ' A' ' 56' ' ' GLU . 16.2 m-85 -130.25 151.97 50.18 Favored 'General case' 0 N--CA 1.483 1.215 0 O-C-N 120.223 -1.751 . . . . 0.0 109.574 177.602 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.525 HD12 ' HG ' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -97.91 168.23 10.42 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 176.221 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.561 ' O ' ' HA3' ' A' ' 53' ' ' GLY . 10.5 ttp85 177.09 -173.91 0.11 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.004 -1.06 . . . . 0.0 109.662 179.336 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.497 1.88 0 O-C-N 120.707 -1.246 . . . . 0.0 109.834 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.507 ' OD2' ' HD3' ' A' ' 66' ' ' ARG . 3.7 m-20 . . . . . 0 N--CA 1.504 2.249 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.823 HD13 HD23 ' A' ' 3' ' ' LEU . 5.0 mm -111.6 129.15 67.51 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.599 0 O-C-N 121.137 -0.977 . . . . 0.0 109.224 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.417 ' HB3' ' HA ' ' A' ' 112' ' ' ALA . 15.2 t80 -74.87 147.22 41.25 Favored 'General case' 0 N--CA 1.518 2.928 0 CA-C-N 121.987 2.176 . . . . 0.0 110.052 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 1.018 HG21 HD21 ' A' ' 55' ' ' LEU . 8.9 t -142.57 110.92 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 120.188 -1.57 . . . . 0.0 110.113 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.535 ' O ' HG13 ' A' ' 86' ' ' ILE . 6.2 m -74.27 164.02 64.19 Favored Pre-proline 0 N--CA 1.511 2.597 0 O-C-N 120.361 -1.462 . . . . 0.0 111.983 -179.314 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.55 ' HA ' HG13 ' A' ' 86' ' ' ILE . 38.1 Cg_endo -65.26 -54.29 0.66 Allowed 'Trans proline' 0 C--N 1.315 -1.23 0 O-C-N 124.621 1.853 . . . . 0.0 109.182 178.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.558 ' O ' ' CG ' ' A' ' 88' ' ' ARG . 52.9 p -46.34 -39.33 10.06 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 178.19 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.515 ' HB2' ' O ' ' A' ' 82' ' ' SER . 6.7 mm100 -63.23 -58.92 5.58 Favored 'General case' 0 N--CA 1.51 2.536 0 C-N-CA 119.421 -0.912 . . . . 0.0 108.742 178.499 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.57 HG22 ' HB2' ' A' ' 91' ' ' LEU . 0.2 OUTLIER -55.83 -54.03 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.313 0 O-C-N 121.107 -0.996 . . . . 0.0 108.601 178.801 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.468 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 0.1 OUTLIER -56.69 -43.39 80.43 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-O 121.933 0.873 . . . . 0.0 110.876 -179.659 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.558 ' CG ' ' O ' ' A' ' 84' ' ' SER . 1.3 mmm180 -59.6 -36.63 76.66 Favored 'General case' 0 N--CA 1.505 2.281 0 C-N-CA 119.795 -0.762 . . . . 0.0 111.702 -177.86 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 0.431 ' CD2' ' O ' ' A' ' 85' ' ' GLN . 5.4 m-85 -109.81 11.89 24.17 Favored 'General case' 0 N--CA 1.501 2.116 0 C-N-CA 117.518 -1.673 . . . . 0.0 111.114 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 59.58 53.96 4.78 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 120.575 -1.328 . . . . 0.0 109.816 178.669 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.57 ' HB2' HG22 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -90.04 -177.75 5.26 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 119.681 -0.807 . . . . 0.0 110.176 -179.948 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.47 ' O ' ' OD2' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -156.8 161.64 39.75 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.337 -0.852 . . . . 0.0 108.704 178.235 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.57 ' HB ' ' CG1' ' A' ' 57' ' ' ILE . 1.6 t -64.42 155.23 33.23 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 117.119 -1.833 . . . . 0.0 107.428 179.583 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 75.66 -8.56 20.05 Favored Glycine 0 N--CA 1.502 3.05 0 C-N-CA 117.123 -2.465 . . . . 0.0 110.114 179.1 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.626 ' CG ' HD11 ' A' ' 97' ' ' ILE . 7.8 p30 -69.57 149.04 48.62 Favored 'General case' 0 N--CA 1.483 1.222 0 O-C-N 120.127 -1.808 . . . . 0.0 110.515 -178.711 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.479 ' C ' ' CG1' ' A' ' 97' ' ' ILE . 0.3 OUTLIER -94.92 121.33 36.42 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.825 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.626 HD11 ' CG ' ' A' ' 95' ' ' ASP . 2.3 mt -148.03 168.75 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 119.925 -1.734 . . . . 0.0 112.648 -178.713 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.522 ' OG ' ' HB2' ' A' ' 118' ' ' GLU . 92.1 p -148.54 137.89 21.91 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.889 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.544 ' O ' ' HB2' ' A' ' 50' ' ' PHE . . . -161.43 177.49 37.72 Favored Glycine 0 N--CA 1.51 3.599 0 C-N-CA 117.958 -2.068 . . . . 0.0 114.209 -178.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.805 ' HD3' HD23 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -87.73 157.02 19.16 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 178.594 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.538 HG12 ' HA ' ' A' ' 50' ' ' PHE . 1.5 pt -123.26 155.67 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.463 0 CA-C-N 120.815 1.643 . . . . 0.0 113.408 -177.586 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 1.001 ' CB ' HD13 ' A' ' 114' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.179 0 O-C-N 120.571 -1.331 . . . . 0.0 109.553 179.484 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ARG . . . . . 0.585 ' HD2' ' CE1' ' A' ' 110' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.77 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.585 ' CE1' ' HD2' ' A' ' 109' ' ' ARG . 42.2 m-85 -107.73 149.14 28.51 Favored 'General case' 0 N--CA 1.522 3.141 0 O-C-N 120.179 -1.576 . . . . 0.0 107.704 176.943 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.574 ' CE1' HD13 ' A' ' 39' ' ' LEU . 78.2 m-85 -68.35 159.42 31.48 Favored 'General case' 0 N--CA 1.509 2.509 0 O-C-N 119.161 -2.212 . . . . 0.0 108.056 178.965 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.417 ' HA ' ' HB3' ' A' ' 80' ' ' TYR . . . -124.15 142.83 50.89 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 119.975 -1.703 . . . . 0.0 111.434 -178.863 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.45 HD22 ' HA ' ' A' ' 113' ' ' LEU . 0.2 OUTLIER -51.2 147.02 5.9 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 179.117 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 1.001 HD13 ' CB ' ' A' ' 102' ' ' ARG . 6.4 tp -128.28 -58.32 1.2 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 120.22 -1.55 . . . . 0.0 111.549 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.501 ' HB3' ' HG2' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -120.73 140.09 52.14 Favored 'General case' 0 N--CA 1.509 2.487 0 O-C-N 120.336 -1.478 . . . . 0.0 108.405 178.835 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.6 t -92.53 134.16 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.854 0 O-C-N 120.215 -1.553 . . . . 0.0 111.318 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.41 ' CG ' ' HA2' ' A' ' 99' ' ' GLY . 2.8 m-20 -107.5 -42.41 4.8 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.552 -0.718 . . . . 0.0 109.586 178.643 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.591 ' O ' HG23 ' A' ' 97' ' ' ILE . 1.2 mt-10 -143.71 159.84 41.77 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.879 -1.138 . . . . 0.0 109.783 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.551 HG11 HD11 ' A' ' 91' ' ' LEU . 5.1 t -158.22 140.44 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.982 -0.449 . . . . 0.0 110.075 -178.253 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.516 2.869 0 O-C-N 120.34 -1.475 . . . . 0.0 110.666 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.983 ' HG3' HG22 ' A' ' 49' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.396 0.617 . . . . 0.0 110.083 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 2' ' ' ASN . . . . . 0.59 ' HB2' ' CZ ' ' A' ' 50' ' ' PHE . 19.6 t30 -77.91 101.35 6.78 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.303 -0.873 . . . . 0.0 109.049 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 0.657 ' HA ' HD12 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -41.5 -41.95 2.24 Favored 'General case' 0 N--CA 1.518 2.951 0 O-C-N 120.535 -1.353 . . . . 0.0 110.192 -178.753 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.472 ' OG1' ' OD1' ' A' ' 52' ' ' ASP . 1.6 m -58.65 -36.78 74.66 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.892 -1.13 . . . . 0.0 108.51 -179.345 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.512 ' HB3' ' HB3' ' A' ' 2' ' ' ASN . 0.7 OUTLIER -72.15 -45.41 60.56 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.149 -0.97 . . . . 0.0 108.682 178.245 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.874 HD22 HG23 ' A' ' 35' ' ' ILE 0.276 86.2 mt -51.37 -47.91 62.67 Favored 'General case' 0 C--N 1.315 -0.894 0 O-C-N 120.903 -1.123 . . . . 0.0 109.409 178.322 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 7' ' ' LYS . . . . . 0.647 ' HZ3' HD12 ' A' ' 3' ' ' LEU . 0.1 OUTLIER -66.94 -39.82 87.39 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.028 -1.045 . . . . 0.0 110.142 178.869 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -63.12 -29.27 70.67 Favored 'General case' 0 N--CA 1.507 2.399 0 C-N-CA 119.352 -0.939 . . . . 0.0 111.191 -179.111 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.681 HG22 ' CB ' ' A' ' 13' ' ' GLU . 3.2 m -75.02 123.5 88.96 Favored Pre-proline 0 C--N 1.285 -2.198 0 O-C-N 121.613 -0.679 . . . . 0.0 109.596 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.565 ' HG2' ' CG ' ' A' ' 13' ' ' GLU . 39.8 Cg_endo -61.29 151.3 80.11 Favored 'Trans proline' 0 CA--C 1.567 2.148 0 O-C-N 122.372 0.67 . . . . 0.0 110.856 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.6 ' O ' HD12 ' A' ' 15' ' ' ILE . 1.6 p -41.74 -49.86 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.525 3.318 0 O-C-N 120.643 -1.286 . . . . 0.0 109.707 -178.997 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.551 ' N ' ' CG1' ' A' ' 11' ' ' VAL . 0.7 OUTLIER -57.07 -40.78 77.56 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.294 -0.879 . . . . 0.0 111.076 -179.87 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 1.074 ' O ' HD12 ' A' ' 17' ' ' LEU . 52.6 mm-40 -68.95 -30.39 68.82 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 118.02 -1.472 . . . . 0.0 107.776 179.402 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.666 ' HB3' HG21 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -68.5 -42.31 78.78 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.993 -1.067 . . . . 0.0 109.058 177.104 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.6 HD12 ' O ' ' A' ' 11' ' ' VAL . 1.4 mp -66.26 -38.67 82.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 C-N-CA 118.133 -1.427 . . . . 0.0 108.621 178.734 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.561 ' HA ' ' HG2' ' A' ' 19' ' ' GLU . 44.2 m -64.88 -37.58 88.12 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 120.379 -1.45 . . . . 0.0 109.163 178.928 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 1.074 HD12 ' O ' ' A' ' 13' ' ' GLU . 0.9 OUTLIER -66.11 -37.46 85.81 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.85 -1.156 . . . . 0.0 109.069 178.652 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.452 ' O ' HD12 ' A' ' 23' ' ' LEU . . . -70.07 -42.76 66.97 Favored Glycine 0 N--CA 1.516 3.977 0 C-N-CA 118.6 -1.762 . . . . 0.0 108.864 178.721 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.69 ' HG3' ' N ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -59.81 -37.6 79.61 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.294 -1.71 . . . . 0.0 108.047 179.047 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.69 ' N ' ' HG3' ' A' ' 19' ' ' GLU . 28.2 m120 -61.05 -26.79 67.88 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 118.309 -1.356 . . . . 0.0 109.371 178.613 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.648 ' CE ' ' CG ' ' A' ' 42' ' ' HIS . 43.7 mmm -101.94 11.52 38.42 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.193 -0.942 . . . . 0.0 111.261 -179.366 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.21 -25.33 25.32 Favored Glycine 0 N--CA 1.497 2.758 0 C-N-CA 118.654 -1.736 . . . . 0.0 110.897 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.854 ' CD2' ' HB1' ' A' ' 37' ' ' ALA . 1.7 mp -78.62 91.77 4.66 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.414 -1.639 . . . . 0.0 109.027 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.478 ' O ' ' CB ' ' A' ' 25' ' ' ASN . 41.7 mt-10 -106.23 169.9 8.24 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.311 -0.868 . . . . 0.0 108.93 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.478 ' CB ' ' O ' ' A' ' 24' ' ' GLU . 0.7 OUTLIER 69.06 21.17 7.45 Favored 'General case' 0 N--CA 1.507 2.417 0 O-C-N 121.518 -0.738 . . . . 0.0 111.532 179.505 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.672 HD11 ' HB3' ' A' ' 23' ' ' LEU . 0.4 OUTLIER -76.78 -3.83 40.31 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 120.813 -1.179 . . . . 0.0 110.976 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.436 ' C ' ' O ' ' A' ' 26' ' ' LEU . . . -46.64 -32.92 3.81 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.602 -1.311 . . . . 0.0 108.685 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -80.84 -2.56 47.81 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.477 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.588 ' O ' HD11 ' A' ' 34' ' ' ILE . 7.9 mtp -100.73 150.61 22.59 Favored 'General case' 0 C--N 1.311 -1.076 0 O-C-N 120.748 -1.22 . . . . 0.0 111.33 -178.876 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.575 ' C ' HD12 ' A' ' 34' ' ' ILE . 17.4 tpp180 -89.32 141.23 28.73 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.252 -0.905 . . . . 0.0 110.407 178.796 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.609 ' HG3' HD23 ' A' ' 14' ' ' LEU . 7.8 ttmt -29.88 -47.57 0.08 Allowed 'General case' 0 N--CA 1.501 2.082 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.774 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.53 ' OE1' ' N ' ' A' ' 33' ' ' ASP . 1.3 pp0? -59.57 -56.04 26.94 Favored 'General case' 0 N--CA 1.518 2.953 0 O-C-N 121.385 -0.822 . . . . 0.0 111.976 -177.642 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.534 ' OD1' ' HE2' ' A' ' 29' ' ' MET . 2.8 p30 -66.09 -35.95 81.88 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 120.795 -1.19 . . . . 0.0 109.112 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.666 HG21 ' HB3' ' A' ' 14' ' ' LEU . 3.3 mt -61.52 -37.79 78.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 O-C-N 120.313 -1.492 . . . . 0.0 108.094 177.634 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.874 HG23 HD22 ' A' ' 6' ' ' LEU . 0.5 OUTLIER -60.21 -46.83 94.12 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.494 0 O-C-N 120.076 -1.64 . . . . 0.0 109.506 177.446 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -54.36 -40.56 68.22 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.751 -0.779 . . . . 0.0 109.525 -179.325 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.854 ' HB1' ' CD2' ' A' ' 23' ' ' LEU . . . -71.74 -52.02 19.85 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 120.745 -1.222 . . . . 0.0 110.626 179.187 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.567 HD11 HG22 ' A' ' 34' ' ' ILE . 2.5 mt -58.41 -28.19 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 C-N-CA 117.131 -1.827 . . . . 0.0 109.999 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.438 HD23 ' HA ' ' A' ' 39' ' ' LEU . 25.7 mt -72.39 -41.95 65.74 Favored 'General case' 0 N--CA 1.506 2.341 0 O-C-N 120.06 -1.65 . . . . 0.0 109.451 178.054 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.33 -36.77 85.05 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.903 -1.123 . . . . 0.0 110.286 178.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.629 ' CB ' HD11 ' A' ' 23' ' ' LEU . 10.0 mm100 -78.66 -51.69 9.5 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.273 -0.892 . . . . 0.0 111.2 -179.203 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.648 ' CG ' ' CE ' ' A' ' 21' ' ' MET . 0.2 OUTLIER -63.51 -36.48 83.91 Favored 'General case' 0 N--CA 1.505 2.279 0 C-N-CA 118.179 -1.408 . . . . 0.0 108.728 179.871 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.47 ' O ' ' N ' ' A' ' 46' ' ' GLY . . . -55.15 -45.06 75.64 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 177.582 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -49.98 -44.52 50.94 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-O 122.067 0.937 . . . . 0.0 108.65 177.54 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.45 ' HB2' ' O ' ' A' ' 42' ' ' HIS . 49.7 m -66.41 -8.14 23.84 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.579 0.704 . . . . 0.0 109.658 179.447 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . 80.98 20.98 64.04 Favored Glycine 0 N--CA 1.497 2.713 0 C-N-CA 120.107 -1.044 . . . . 0.0 112.642 178.028 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -78.72 164.75 24.31 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-N 120.298 2.049 . . . . 0.0 108.65 178.612 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.411 ' O ' ' CG ' ' A' ' 1' ' ' MET . 4.2 m-20 -88.69 152.66 21.67 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.019 -1.05 . . . . 0.0 110.233 -179.483 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.983 HG22 ' HG3' ' A' ' 1' ' ' MET . 9.0 pt -141.47 133.37 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.024 -1.048 . . . . 0.0 108.601 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.59 ' CZ ' ' HB2' ' A' ' 2' ' ' ASN . 20.8 p90 -140.85 164.61 29.78 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 116.542 -2.063 . . . . 0.0 114.303 -179.365 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -121.97 166.83 14.61 Favored Glycine 0 N--CA 1.502 3.08 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -177.859 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.472 ' OD1' ' OG1' ' A' ' 4' ' ' THR . 43.4 p30 -167.54 164.48 14.77 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 120.587 -1.537 . . . . 0.0 109.57 -179.178 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.519 ' HA3' ' O ' ' A' ' 66' ' ' ARG . . . 141.61 -137.25 7.91 Favored Glycine 0 N--CA 1.501 2.998 0 C-N-CA 118.074 -2.012 . . . . 0.0 111.039 178.807 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.583 ' HA ' ' O ' ' A' ' 95' ' ' ASP . 2.9 t -129.01 121.41 54.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 O-C-N 121.361 -1.081 . . . . 0.0 108.467 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.966 HD21 HG21 ' A' ' 81' ' ' VAL . 6.9 mt -62.81 165.98 6.06 Favored 'General case' 0 N--CA 1.504 2.23 0 C-N-CA 118.785 -1.166 . . . . 0.0 114.008 -175.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.492 ' HA ' ' OG1' ' A' ' 93' ' ' THR . 2.0 mm-40 -139.64 117.66 11.81 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 178.055 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.869 ' O ' HD12 ' A' ' 58' ' ' LEU . 1.6 mm -84.92 161.91 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 CA-C-N 120.824 1.647 . . . . 0.0 110.316 -178.44 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.869 HD12 ' O ' ' A' ' 57' ' ' ILE . 7.6 mp -130.97 143.68 50.91 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.496 -1.377 . . . . 0.0 109.691 178.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.41 ' C ' ' O ' ' A' ' 58' ' ' LEU . 0.9 OUTLIER -42.35 -37.06 1.43 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.304 -0.872 . . . . 0.0 110.337 -179.58 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.468 ' OD1' ' N ' ' A' ' 60' ' ' ASP . 4.5 m-20 -61.01 -6.79 2.05 Favored 'General case' 0 N--CA 1.502 2.126 0 C-N-CA 119.814 -0.754 . . . . 0.0 112.575 -178.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.423 ' O ' ' HB3' ' A' ' 83' ' ' PRO . . . 91.59 7.09 65.27 Favored Glycine 1 N--CA 1.519 4.204 0 C-N-CA 118.515 -1.803 . . . . 0.0 112.091 177.859 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.5 ' CE2' ' CE2' ' A' ' 64' ' ' PHE . 2.7 p90 -127.76 179.38 5.57 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 104.645 -2.354 . . . . 0.0 104.645 178.063 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -160.46 176.25 37.13 Favored Glycine 0 N--CA 1.477 1.427 0 C-N-CA 117.065 -2.493 . . . . 0.0 111.547 -177.929 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.5 ' CE2' ' CE2' ' A' ' 62' ' ' PHE . 55.2 m-85 -129.98 155.49 46.0 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 120.112 1.956 . . . . 0.0 109.926 177.667 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.557 ' HB3' ' HB ' ' A' ' 79' ' ' ILE . 0.3 OUTLIER -98.92 161.65 13.51 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 176.506 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.519 ' O ' ' HA3' ' A' ' 53' ' ' GLY . 0.0 OUTLIER 178.61 -163.45 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.351 -0.843 . . . . 0.0 109.313 179.38 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.497 1.898 0 O-C-N 121.008 -1.058 . . . . 0.0 110.462 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.475 ' HB3' ' O ' ' A' ' 65' ' ' LEU . 5.4 m-20 . . . . . 0 N--CA 1.516 2.845 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.557 ' HB ' ' HB3' ' A' ' 65' ' ' LEU . 1.4 mp -92.9 130.21 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.012 0 C-N-CA 117.479 -1.688 . . . . 0.0 108.956 179.008 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.524 ' HB3' ' O ' ' A' ' 111' ' ' PHE . 5.8 t80 -79.84 146.19 32.36 Favored 'General case' 0 N--CA 1.517 2.876 0 CA-C-N 121.263 1.847 . . . . 0.0 110.429 -179.211 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.966 HG21 HD21 ' A' ' 55' ' ' LEU . 49.8 t -140.8 113.47 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 120.278 -1.513 . . . . 0.0 110.622 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.581 ' O ' HG13 ' A' ' 86' ' ' ILE . 14.0 m -74.99 162.81 71.9 Favored Pre-proline 0 N--CA 1.514 2.769 0 O-C-N 120.516 -1.365 . . . . 0.0 111.757 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.518 ' HA ' HG13 ' A' ' 86' ' ' ILE . 38.8 Cg_endo -66.02 -49.09 2.26 Favored 'Trans proline' 0 C--N 1.315 -1.193 0 O-C-N 124.465 1.771 . . . . 0.0 109.295 179.044 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.548 ' O ' ' CG ' ' A' ' 88' ' ' ARG . 23.3 t -47.27 -40.63 17.14 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 178.088 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.522 ' HB2' ' O ' ' A' ' 82' ' ' SER . 7.9 mm100 -63.58 -56.58 14.82 Favored 'General case' 0 N--CA 1.51 2.548 0 C-N-CA 119.498 -0.881 . . . . 0.0 108.642 178.067 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.581 HG13 ' O ' ' A' ' 82' ' ' SER . 1.0 OUTLIER -55.87 -54.67 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.245 0 O-C-N 120.942 -1.099 . . . . 0.0 108.871 178.679 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.454 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 0.0 OUTLIER -56.51 -41.95 77.55 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-O 121.941 0.877 . . . . 0.0 111.17 -179.384 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.548 ' CG ' ' O ' ' A' ' 84' ' ' SER . 2.5 mmt180 -60.3 -37.45 80.6 Favored 'General case' 0 N--CA 1.507 2.382 0 C-N-CA 119.739 -0.784 . . . . 0.0 111.9 -177.773 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -113.27 14.21 19.28 Favored 'General case' 0 N--CA 1.502 2.135 0 C-N-CA 117.507 -1.677 . . . . 0.0 111.459 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 58.95 53.27 5.75 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 120.363 -1.461 . . . . 0.0 109.543 178.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.524 ' O ' ' HG3' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -89.41 173.66 8.23 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 119.862 -0.735 . . . . 0.0 109.503 179.883 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.524 ' HG3' ' O ' ' A' ' 91' ' ' LEU . 21.1 mtp180 -152.06 164.1 37.94 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.928 -1.108 . . . . 0.0 109.249 178.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.591 ' HB ' ' CG1' ' A' ' 57' ' ' ILE . 1.5 t -65.42 155.52 35.2 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 117.014 -1.874 . . . . 0.0 106.964 179.035 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 76.66 -10.5 17.71 Favored Glycine 0 N--CA 1.505 3.235 0 C-N-CA 117.161 -2.447 . . . . 0.0 110.073 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.583 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 9.9 m-20 -67.04 144.75 55.97 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.216 -1.755 . . . . 0.0 110.706 -178.745 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.504 ' O ' HG12 ' A' ' 97' ' ' ILE . 0.2 OUTLIER -90.18 120.5 31.4 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.238 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.542 HG23 HG22 ' A' ' 119' ' ' VAL . 1.6 mt -146.43 168.66 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 119.845 -1.784 . . . . 0.0 112.985 -178.284 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.545 ' OG ' ' HB2' ' A' ' 118' ' ' GLU . 68.7 p -149.38 138.8 21.56 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.516 ' O ' ' HB2' ' A' ' 50' ' ' PHE . . . -165.88 179.56 40.03 Favored Glycine 0 N--CA 1.505 3.256 0 C-N-CA 117.379 -2.343 . . . . 0.0 114.422 -179.382 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.566 ' HD3' HD23 ' A' ' 114' ' ' LEU . 5.7 ptmt -90.6 156.0 18.45 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 179.154 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.523 HG12 ' HA ' ' A' ' 50' ' ' PHE . 2.3 pt -129.03 154.87 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.582 0 CA-C-N 121.02 1.736 . . . . 0.0 113.145 -177.216 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.804 ' HB2' HD22 ' A' ' 114' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.428 0 O-C-N 120.359 -1.463 . . . . 0.0 109.363 179.309 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 3.6 tpp85 . . . . . 0 N--CA 1.499 2.004 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -107.27 150.85 26.2 Favored 'General case' 0 N--CA 1.514 2.738 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 175.662 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.524 ' O ' ' HB3' ' A' ' 80' ' ' TYR . 53.4 m-85 -67.31 159.37 29.4 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 119.055 -2.278 . . . . 0.0 107.717 179.542 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.429 ' HA ' ' HB3' ' A' ' 80' ' ' TYR . . . -122.31 154.23 37.9 Favored 'General case' 0 N--CA 1.484 1.271 0 O-C-N 119.932 -1.73 . . . . 0.0 110.508 -179.222 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.4 tp -59.26 144.02 47.47 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.804 HD22 ' HB2' ' A' ' 102' ' ' ARG . 18.0 tp -121.89 -54.48 1.93 Allowed 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.593 -1.317 . . . . 0.0 111.867 -178.617 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.564 ' HB3' ' CD ' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -130.63 141.54 50.43 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 120.457 -1.402 . . . . 0.0 108.924 179.116 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.6 t -92.49 129.08 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.754 0 O-C-N 120.732 -1.23 . . . . 0.0 111.253 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ASN . . . . . 0.42 ' C ' ' HG2' ' A' ' 118' ' ' GLU . 6.5 m-20 -106.64 -39.02 5.96 Favored 'General case' 0 N--CA 1.506 2.349 0 O-C-N 121.368 -0.833 . . . . 0.0 109.841 178.552 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.569 ' C ' HG23 ' A' ' 119' ' ' VAL . 12.6 mm-40 -143.15 155.87 44.65 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.817 -1.177 . . . . 0.0 109.339 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.569 HG23 ' C ' ' A' ' 118' ' ' GLU . 16.7 t -158.33 132.59 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -178.739 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 . . . . . 0 N--CA 1.517 2.907 0 O-C-N 120.255 -1.528 . . . . 0.0 110.874 -179.981 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.626 ' HA ' ' HA ' ' A' ' 49' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.685 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 2' ' ' ASN . . . . . 0.575 ' HA ' ' O ' ' A' ' 50' ' ' PHE . 34.8 t30 -78.29 94.23 4.78 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.884 -1.135 . . . . 0.0 108.675 178.949 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 1.047 HD23 HD13 ' A' ' 79' ' ' ILE . 1.0 OUTLIER -41.79 -40.61 2.1 Favored 'General case' 0 N--CA 1.517 2.889 0 O-C-N 120.599 -1.313 . . . . 0.0 110.357 -178.711 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.469 ' OG1' ' OD1' ' A' ' 52' ' ' ASP . 1.5 m -60.94 -36.44 79.35 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.891 -1.13 . . . . 0.0 108.239 -179.324 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.542 ' HB3' ' HB3' ' A' ' 2' ' ' ASN . 2.8 pt-20 -70.11 -45.37 67.05 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.981 -1.074 . . . . 0.0 108.432 178.033 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.528 HD12 HD12 ' A' ' 3' ' ' LEU 0.277 14.8 mt -52.77 -48.82 66.53 Favored 'General case' 0 C--N 1.315 -0.924 0 O-C-N 120.906 -1.121 . . . . 0.0 109.536 178.129 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 32.4 mttm -64.51 -34.92 79.34 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.227 -0.921 . . . . 0.0 110.332 179.466 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -62.08 -24.67 67.25 Favored 'General case' 0 N--CA 1.507 2.415 0 O-C-N 121.135 -0.978 . . . . 0.0 111.145 -179.053 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.724 HG22 ' CB ' ' A' ' 13' ' ' GLU . 2.8 m -73.52 133.64 80.06 Favored Pre-proline 0 N--CA 1.505 2.322 0 O-C-N 121.72 -0.613 . . . . 0.0 109.652 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.564 ' HG2' ' CG ' ' A' ' 13' ' ' GLU . 44.0 Cg_endo -64.12 151.86 83.53 Favored 'Trans proline' 0 CA--C 1.565 2.051 0 N-CA-C 110.036 -0.794 . . . . 0.0 110.036 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.534 ' CG1' ' N ' ' A' ' 12' ' ' SER . 1.7 p -43.25 -50.29 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.529 3.515 0 O-C-N 120.286 -1.509 . . . . 0.0 110.174 -178.672 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.534 ' N ' ' CG1' ' A' ' 11' ' ' VAL . 0.8 OUTLIER -57.5 -41.59 81.07 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.294 -0.879 . . . . 0.0 111.044 -179.485 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.724 ' CB ' HG22 ' A' ' 9' ' ' THR . 3.5 mm-40 -69.06 -26.77 65.12 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 118.115 -1.434 . . . . 0.0 107.662 179.47 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.759 ' HB3' HG21 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -70.44 -43.72 69.31 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.165 -0.959 . . . . 0.0 108.917 176.898 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.487 HD12 ' O ' ' A' ' 11' ' ' VAL . 1.7 mp -67.22 -38.68 81.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 C-N-CA 117.653 -1.619 . . . . 0.0 108.952 178.993 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.565 ' HA ' ' HG2' ' A' ' 19' ' ' GLU . 62.9 m -64.94 -38.54 91.32 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.368 -1.458 . . . . 0.0 109.172 178.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.522 ' O ' ' HG3' ' A' ' 21' ' ' MET . 0.1 OUTLIER -65.09 -38.27 90.17 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.91 -1.119 . . . . 0.0 108.879 178.561 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 18' ' ' GLY . . . . . 0.504 ' HA2' HD13 ' A' ' 23' ' ' LEU . . . -67.67 -41.95 88.47 Favored Glycine 0 N--CA 1.515 3.936 0 N-CA-C 108.505 -1.838 . . . . 0.0 108.505 178.445 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.713 ' HG3' ' N ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -59.68 -38.5 81.7 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.286 -1.714 . . . . 0.0 108.035 178.855 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.713 ' N ' ' HG3' ' A' ' 19' ' ' GLU . 26.1 m120 -61.68 -28.9 69.73 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 118.429 -1.308 . . . . 0.0 109.609 178.844 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.59 ' HB2' HD12 ' A' ' 23' ' ' LEU . 21.1 mtp -100.28 10.79 40.71 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.187 -0.946 . . . . 0.0 111.207 -179.511 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.52 -17.02 57.29 Favored Glycine 0 N--CA 1.5 2.9 0 C-N-CA 118.446 -1.835 . . . . 0.0 111.843 179.192 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.841 ' CD2' ' HB1' ' A' ' 37' ' ' ALA . 1.7 mp -79.06 104.61 9.81 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.079 -1.836 . . . . 0.0 109.385 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.404 ' O ' ' CB ' ' A' ' 25' ' ' ASN . 1.4 pt-20 -115.19 178.95 4.1 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.236 -0.915 . . . . 0.0 109.398 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.404 ' CB ' ' O ' ' A' ' 24' ' ' GLU . 1.0 OUTLIER 65.88 15.28 10.0 Favored 'General case' 0 N--CA 1.512 2.634 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.716 178.963 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 1.089 HD23 ' SD ' ' A' ' 29' ' ' MET . 1.1 mt -76.79 -15.78 59.65 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.154 -0.966 . . . . 0.0 112.066 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -47.02 -28.49 1.69 Allowed 'General case' 0 N--CA 1.497 1.925 0 O-C-N 120.315 -1.491 . . . . 0.0 109.392 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.9 mtt180 -79.1 -37.82 37.74 Favored 'General case' 0 C--N 1.295 -1.798 0 C-N-CA 120.075 -0.65 . . . . 0.0 111.906 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' MET . . . . . 1.089 ' SD ' HD23 ' A' ' 26' ' ' LEU . 5.8 ptm -85.87 169.64 13.12 Favored 'General case' 0 N--CA 1.482 1.156 0 O-C-N 120.545 -1.347 . . . . 0.0 111.529 -179.419 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 1.033 ' O ' HD12 ' A' ' 34' ' ' ILE . 1.0 OUTLIER -89.67 -176.26 4.93 Favored 'General case' 0 N--CA 1.504 2.274 0 CA-C-O 122.534 1.159 . . . . 0.0 113.529 -178.238 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.624 ' O ' HG22 ' A' ' 35' ' ' ILE . 4.4 ptmt -68.14 -33.25 74.13 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.122 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.58 ' O ' ' CG2' ' A' ' 35' ' ' ILE . 3.2 mm100 -65.19 -55.26 19.57 Favored 'General case' 0 N--CA 1.525 3.297 0 CA-C-O 122.166 0.984 . . . . 0.0 109.753 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 34' ' ' ILE . 2.0 p30 -66.5 -39.36 88.66 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.904 -1.123 . . . . 0.0 108.967 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 1.033 HD12 ' O ' ' A' ' 30' ' ' ARG . 1.7 mt -61.2 -40.83 87.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.194 -1.566 . . . . 0.0 109.281 177.627 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.624 HG22 ' O ' ' A' ' 31' ' ' LYS . 0.3 OUTLIER -66.79 -36.07 76.32 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.585 0 O-C-N 120.292 -1.505 . . . . 0.0 109.544 179.437 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.468 ' CD2' ' O ' ' A' ' 32' ' ' GLN . 21.6 m-85 -60.45 -43.63 96.66 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.813 -1.18 . . . . 0.0 108.78 179.259 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.841 ' HB1' ' CD2' ' A' ' 23' ' ' LEU . . . -65.44 -54.14 32.84 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.516 -1.365 . . . . 0.0 109.634 178.62 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.542 HG13 ' O ' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -53.76 -30.07 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 C-N-CA 117.541 -1.663 . . . . 0.0 109.743 179.57 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.721 HD11 HD11 ' A' ' 3' ' ' LEU . 34.2 mt -67.95 -42.53 80.8 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 119.865 -1.772 . . . . 0.0 109.224 178.189 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 mttt -66.0 -40.23 90.96 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.946 -1.096 . . . . 0.0 110.722 178.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.502 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 9.3 mm100 -73.51 -51.13 18.15 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.095 -1.003 . . . . 0.0 110.757 -179.32 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.526 ' HB3' ' HE2' ' A' ' 1' ' ' MET . 0.7 OUTLIER -62.51 -36.85 83.86 Favored 'General case' 0 N--CA 1.509 2.502 0 C-N-CA 118.885 -1.126 . . . . 0.0 108.739 179.51 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.579 ' O ' ' N ' ' A' ' 46' ' ' GLY . . . -67.01 -31.54 72.17 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.0 -1.063 . . . . 0.0 109.239 178.554 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.502 ' HB2' ' O ' ' A' ' 41' ' ' GLN . 9.0 tptt -47.54 -40.77 19.68 Favored 'General case' 0 N--CA 1.481 1.121 0 O-C-N 120.65 -1.281 . . . . 0.0 108.808 177.98 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 46.9 m -66.03 -11.07 45.65 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 119.452 -0.899 . . . . 0.0 109.056 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.579 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . 68.53 29.71 72.97 Favored Glycine 0 N--CA 1.496 2.642 0 C-N-CA 120.531 -0.842 . . . . 0.0 111.616 177.972 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.508 ' OE1' ' N ' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -88.82 169.17 11.83 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 120.105 -1.821 . . . . 0.0 108.788 178.921 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 48' ' ' ASP . . . . . 0.508 ' N ' ' OE1' ' A' ' 47' ' ' GLU . 9.1 m-20 -71.66 151.08 43.98 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.024 -1.048 . . . . 0.0 111.226 -178.006 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.626 ' HA ' ' HA ' ' A' ' 1' ' ' MET . 0.5 OUTLIER -150.81 144.08 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 178.625 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.575 ' O ' ' HA ' ' A' ' 2' ' ' ASN . 28.7 p90 -141.43 172.2 13.01 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 115.867 -2.333 . . . . 0.0 114.608 -177.481 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -124.77 166.71 17.33 Favored Glycine 0 N--CA 1.502 3.065 0 N-CA-C 108.762 -1.735 . . . . 0.0 108.762 -178.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.524 ' C ' ' CD2' ' A' ' 65' ' ' LEU . 3.0 p30 -172.28 163.48 5.74 Favored 'General case' 0 N--CA 1.485 1.281 0 O-C-N 120.346 -1.679 . . . . 0.0 110.065 -179.161 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.42 ' N ' HD21 ' A' ' 65' ' ' LEU . . . 146.94 -139.66 8.1 Favored Glycine 0 N--CA 1.504 3.233 0 C-N-CA 118.146 -1.978 . . . . 0.0 110.986 178.922 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.599 ' HA ' ' O ' ' A' ' 95' ' ' ASP . 4.6 t -128.75 122.74 57.76 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 1.025 HD21 HG21 ' A' ' 81' ' ' VAL . 6.0 mt -62.9 161.24 13.17 Favored 'General case' 0 N--CA 1.502 2.17 0 C-N-CA 118.486 -1.286 . . . . 0.0 114.043 -175.099 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.512 ' HA ' ' OG1' ' A' ' 93' ' ' THR . 0.0 OUTLIER -137.7 116.24 12.06 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 177.998 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.662 ' C ' HD12 ' A' ' 58' ' ' LEU . 1.4 mm -84.14 159.74 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 CA-C-N 121.087 1.767 . . . . 0.0 109.616 -178.485 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.864 HD22 ' CZ ' ' A' ' 62' ' ' PHE . 5.6 mp -130.1 135.76 48.58 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.443 -1.41 . . . . 0.0 109.602 179.262 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.472 ' C ' ' O ' ' A' ' 58' ' ' LEU . 0.8 OUTLIER -38.47 -35.15 0.16 Allowed 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.701 0.762 . . . . 0.0 109.909 -179.683 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.503 ' OD1' ' N ' ' A' ' 60' ' ' ASP . 1.0 OUTLIER -61.05 -7.66 2.72 Favored 'General case' 0 N--CA 1.499 2.012 0 C-N-CA 120.038 -0.665 . . . . 0.0 112.183 -179.531 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 90.64 8.6 65.46 Favored Glycine 1 N--CA 1.52 4.283 0 C-N-CA 118.845 -1.645 . . . . 0.0 112.184 178.146 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.864 ' CZ ' HD22 ' A' ' 58' ' ' LEU . 2.3 p90 -127.95 178.77 5.96 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 104.491 -2.411 . . . . 0.0 104.491 177.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.554 ' HA2' HD13 ' A' ' 58' ' ' LEU . . . -155.49 172.67 33.65 Favored Glycine 0 N--CA 1.477 1.432 0 C-N-CA 117.142 -2.456 . . . . 0.0 111.63 -178.31 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.441 ' CE2' ' HE1' ' A' ' 62' ' ' PHE . 10.9 m-85 -128.88 154.78 46.16 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 119.851 1.826 . . . . 0.0 108.909 177.044 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.528 ' CB ' ' HB ' ' A' ' 79' ' ' ILE . 0.2 OUTLIER -99.45 133.23 44.06 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 177.075 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.538 ' CB ' ' OD2' ' A' ' 78' ' ' ASP . 17.2 ptt180 -158.45 -148.34 0.19 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.544 -1.347 . . . . 0.0 110.065 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.497 1.912 0 O-C-N 121.384 -0.822 . . . . 0.0 110.235 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.538 ' OD2' ' CB ' ' A' ' 66' ' ' ARG . 47.1 m-20 . . . . . 0 N--CA 1.513 2.713 0 CA-C-O 120.78 0.324 . . . . 0.0 111.073 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 1.047 HD13 HD23 ' A' ' 3' ' ' LEU . 5.5 mm -83.18 127.97 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.891 0 O-C-N 120.628 -1.295 . . . . 0.0 110.373 -178.45 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.494 ' HB3' ' O ' ' A' ' 111' ' ' PHE . 8.6 t80 -74.62 145.4 43.31 Favored 'General case' 0 N--CA 1.515 2.807 0 CA-C-N 121.658 2.026 . . . . 0.0 109.81 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 1.025 HG21 HD21 ' A' ' 55' ' ' LEU . 17.2 t -138.34 112.44 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 120.26 -1.525 . . . . 0.0 110.57 -179.434 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.551 ' O ' HG13 ' A' ' 86' ' ' ILE . 49.9 m -75.28 164.6 60.01 Favored Pre-proline 0 N--CA 1.513 2.701 0 O-C-N 120.776 -1.203 . . . . 0.0 112.166 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.518 ' HD2' ' HB3' ' A' ' 82' ' ' SER . 39.8 Cg_endo -65.9 -50.05 1.87 Allowed 'Trans proline' 0 C--N 1.315 -1.21 0 O-C-N 124.443 1.759 . . . . 0.0 109.101 178.824 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.559 ' O ' ' CG ' ' A' ' 88' ' ' ARG . 0.5 OUTLIER -47.45 -40.28 17.75 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 178.156 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.527 ' HB2' ' O ' ' A' ' 82' ' ' SER . 6.4 mm100 -63.24 -57.21 11.21 Favored 'General case' 0 N--CA 1.511 2.582 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.323 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.558 ' HA ' HD23 ' A' ' 91' ' ' LEU . 0.6 OUTLIER -56.97 -54.95 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.42 0 O-C-N 120.891 -1.131 . . . . 0.0 108.792 178.649 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.8 mmt180 -57.67 -42.88 84.45 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-O 121.882 0.848 . . . . 0.0 111.568 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.559 ' CG ' ' O ' ' A' ' 84' ' ' SER . 4.4 mtt180 -58.87 -36.02 73.95 Favored 'General case' 0 N--CA 1.506 2.329 0 C-N-CA 119.783 -0.767 . . . . 0.0 111.773 -177.508 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -116.32 15.61 15.82 Favored 'General case' 0 N--CA 1.504 2.255 0 C-N-CA 117.268 -1.773 . . . . 0.0 111.755 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 57.84 56.12 4.97 Favored 'General case' 0 N--CA 1.482 1.159 0 O-C-N 120.339 -1.476 . . . . 0.0 109.193 178.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 0.558 HD23 ' HA ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -88.64 -178.78 5.89 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 119.852 -0.739 . . . . 0.0 109.601 -179.639 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.5 ' CG ' ' O ' ' A' ' 91' ' ' LEU . 68.5 mtt-85 -157.09 158.18 35.94 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.011 -1.056 . . . . 0.0 109.048 178.752 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.609 ' HB ' ' CG1' ' A' ' 57' ' ' ILE . 1.5 t -64.61 154.66 35.66 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 117.212 -1.795 . . . . 0.0 107.076 179.325 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 77.68 -11.18 20.76 Favored Glycine 0 N--CA 1.502 3.072 0 C-N-CA 116.961 -2.542 . . . . 0.0 110.442 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.702 ' OD2' HD11 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -74.45 156.79 36.59 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-N 120.097 1.948 . . . . 0.0 109.945 -179.192 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.505 ' O ' HG12 ' A' ' 97' ' ' ILE . 0.2 OUTLIER -97.34 127.12 43.03 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -179.201 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.702 HD11 ' OD2' ' A' ' 95' ' ' ASP . 1.9 mt -147.76 166.22 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 117.767 -1.573 . . . . 0.0 112.247 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.462 ' OG ' ' HB2' ' A' ' 118' ' ' GLU . 88.3 p -148.51 136.82 21.2 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.06 179.056 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' GLY . . . . . 0.532 ' O ' ' HB2' ' A' ' 50' ' ' PHE . . . -162.18 179.64 37.39 Favored Glycine 0 N--CA 1.505 3.257 0 C-N-CA 117.183 -2.437 . . . . 0.0 114.853 -178.729 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.6 mttt -88.77 151.68 22.25 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 178.904 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.56 HG12 ' HA ' ' A' ' 50' ' ' PHE . 2.6 pt -121.66 157.05 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.627 0 CA-C-N 121.514 1.961 . . . . 0.0 114.026 -176.383 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.973 ' CB ' HD13 ' A' ' 114' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.422 0 O-C-N 120.523 -1.361 . . . . 0.0 109.397 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.502 2.133 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.407 ' CD2' ' HZ ' ' A' ' 64' ' ' PHE . 17.5 m-85 -106.62 152.52 23.64 Favored 'General case' 0 N--CA 1.522 3.168 0 O-C-N 119.967 -1.708 . . . . 0.0 109.422 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' PHE . . . . . 0.494 ' O ' ' HB3' ' A' ' 80' ' ' TYR . 11.6 m-85 -68.05 166.4 16.02 Favored 'General case' 0 N--CA 1.506 2.365 0 O-C-N 119.729 -1.857 . . . . 0.0 108.065 178.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.454 ' HA ' ' HB3' ' A' ' 80' ' ' TYR . . . -123.61 155.5 37.56 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.055 -1.653 . . . . 0.0 111.054 -179.08 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.02 153.99 40.7 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 106.287 -1.746 . . . . 0.0 106.287 178.928 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.973 HD13 ' CB ' ' A' ' 102' ' ' ARG . 3.0 tp -130.99 -63.19 0.87 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.066 -1.646 . . . . 0.0 111.727 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.35 147.15 40.83 Favored 'General case' 0 N--CA 1.51 2.545 0 O-C-N 120.289 -1.507 . . . . 0.0 109.666 178.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 24.8 t -94.1 130.94 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.987 0 O-C-N 121.021 -1.049 . . . . 0.0 112.772 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -107.33 -39.7 5.6 Favored 'General case' 0 N--CA 1.509 2.509 0 O-C-N 121.504 -0.747 . . . . 0.0 109.856 177.747 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.577 ' C ' HG23 ' A' ' 119' ' ' VAL . 1.3 tt0 -143.4 159.05 43.09 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.651 -1.281 . . . . 0.0 109.115 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.577 HG23 ' C ' ' A' ' 118' ' ' GLU . 17.9 t -156.84 143.06 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -178.663 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.469 ' C ' ' O ' ' A' ' 119' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.515 2.812 0 O-C-N 121.0 -1.062 . . . . 0.0 110.88 -177.581 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.589 ' HA ' ' HA ' ' A' ' 49' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 110.027 -0.361 . . . . 0.0 110.027 . . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 2' ' ' ASN . . . . . 0.598 ' HB3' ' HB3' ' A' ' 5' ' ' GLU . 47.5 t30 -78.75 92.73 4.83 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.802 -1.186 . . . . 0.0 108.42 178.875 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' LEU . . . . . 1.065 HD23 HD11 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -42.55 -43.39 3.72 Favored 'General case' 0 N--CA 1.515 2.779 0 O-C-N 120.607 -1.308 . . . . 0.0 110.472 -178.594 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.487 ' OG1' ' OD2' ' A' ' 52' ' ' ASP . 1.9 m -57.29 -34.54 68.79 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.775 -1.203 . . . . 0.0 108.149 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.598 ' HB3' ' HB3' ' A' ' 2' ' ' ASN . 0.0 OUTLIER -70.83 -44.35 66.69 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 177.498 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 6' ' ' LEU . . . . . 0.875 HD22 HG23 ' A' ' 35' ' ' ILE 0.277 15.6 mt -52.33 -49.43 64.28 Favored 'General case' 0 C--N 1.316 -0.88 0 O-C-N 120.748 -1.22 . . . . 0.0 109.613 178.088 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 9.8 mttt -65.37 -37.66 87.69 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.08 -1.012 . . . . 0.0 110.589 179.192 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -63.01 -18.66 63.56 Favored 'General case' 0 N--CA 1.507 2.387 0 O-C-N 121.119 -0.988 . . . . 0.0 111.182 -179.176 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.717 ' O ' HD11 ' A' ' 14' ' ' LEU . 2.2 m -86.56 116.32 65.48 Favored Pre-proline 0 C--N 1.284 -2.249 0 O-C-N 121.761 -0.587 . . . . 0.0 109.642 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PRO . . . . . 0.541 ' CG ' ' HG3' ' A' ' 13' ' ' GLU . 37.0 Cg_endo -58.51 155.1 38.04 Favored 'Trans proline' 0 CA--C 1.557 1.657 0 N-CA-C 109.288 -1.082 . . . . 0.0 109.288 179.127 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' VAL . . . . . 0.703 ' HA ' HD12 ' A' ' 14' ' ' LEU . 1.5 p -41.54 -50.11 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.532 3.657 0 O-C-N 120.173 -1.58 . . . . 0.0 110.463 -177.689 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' SER . . . . . 0.516 ' N ' ' CG1' ' A' ' 11' ' ' VAL . 1.9 t -58.96 -42.15 89.19 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.188 -0.945 . . . . 0.0 111.156 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLU . . . . . 0.581 ' CB ' HG22 ' A' ' 9' ' ' THR . 2.2 mm-40 -69.13 -27.79 65.88 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 118.15 -1.42 . . . . 0.0 108.336 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.717 HD11 ' O ' ' A' ' 9' ' ' THR . 9.8 mt -71.56 -40.66 69.83 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 120.917 -1.114 . . . . 0.0 108.765 176.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' ILE . . . . . 0.612 HD12 ' O ' ' A' ' 11' ' ' VAL . 1.4 mp -68.05 -40.49 83.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 C-N-CA 117.543 -1.663 . . . . 0.0 108.945 178.764 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.602 ' HA ' ' HG2' ' A' ' 19' ' ' GLU . 85.0 m -65.42 -37.22 86.27 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.272 -1.517 . . . . 0.0 109.413 179.334 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LEU . . . . . 0.517 HD21 HG21 ' A' ' 38' ' ' ILE . 1.3 tp -63.16 -45.04 93.71 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 120.912 -1.117 . . . . 0.0 108.048 178.414 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -60.94 -43.72 99.03 Favored Glycine 0 N--CA 1.514 3.882 0 N-CA-C 108.288 -1.925 . . . . 0.0 108.288 179.051 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLU . . . . . 0.7 ' HG3' ' N ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -57.71 -38.73 75.74 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.582 -1.54 . . . . 0.0 107.845 178.904 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASN . . . . . 0.7 ' N ' ' HG3' ' A' ' 19' ' ' GLU . 28.7 m120 -61.1 -27.4 68.34 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 118.538 -1.265 . . . . 0.0 109.341 178.648 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.567 ' HB2' ' CD1' ' A' ' 23' ' ' LEU . 31.4 mtp -101.44 11.3 39.36 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.339 -0.851 . . . . 0.0 111.348 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.86 -22.75 35.97 Favored Glycine 0 N--CA 1.5 2.92 0 C-N-CA 118.547 -1.787 . . . . 0.0 111.143 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' LEU . . . . . 0.783 ' CD2' ' HB1' ' A' ' 37' ' ' ALA . 3.0 mp -78.91 94.67 5.26 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 120.372 -1.663 . . . . 0.0 109.225 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLU . . . . . 0.519 ' O ' ' CB ' ' A' ' 25' ' ' ASN . 87.0 mt-10 -111.7 170.38 8.17 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.204 -0.935 . . . . 0.0 109.035 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.519 ' CB ' ' O ' ' A' ' 24' ' ' GLU . 0.9 OUTLIER 70.79 17.35 6.48 Favored 'General case' 0 N--CA 1.512 2.671 0 O-C-N 121.404 -0.81 . . . . 0.0 111.796 179.485 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.591 ' CD1' ' O ' ' A' ' 23' ' ' LEU . 1.1 mt -76.9 -6.05 50.92 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 120.841 -1.162 . . . . 0.0 111.372 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 26' ' ' LEU . . . -46.59 -31.21 2.68 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.477 -1.389 . . . . 0.0 108.81 -179.373 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 52.1 mtp180 -80.12 -6.57 57.93 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 120.047 -0.661 . . . . 0.0 111.386 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' MET . . . . . 0.546 ' HE2' ' OD1' ' A' ' 33' ' ' ASP . 14.8 mtp -101.01 158.67 15.83 Favored 'General case' 0 C--N 1.313 -0.999 0 O-C-N 120.768 -1.208 . . . . 0.0 111.473 -179.208 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ARG . . . . . 0.96 ' O ' HD12 ' A' ' 34' ' ' ILE . 4.4 ttm180 -89.65 171.99 9.27 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.374 -0.829 . . . . 0.0 110.166 177.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LYS . . . . . 0.571 ' O ' ' CG1' ' A' ' 35' ' ' ILE . 11.0 pttm -60.5 -42.49 96.45 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.43 -0.794 . . . . 0.0 110.547 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLN . . . . . 0.471 ' OE1' ' HB3' ' A' ' 33' ' ' ASP . 0.0 OUTLIER -60.55 -56.45 21.21 Favored 'General case' 0 N--CA 1.517 2.918 0 O-C-N 121.306 -0.871 . . . . 0.0 111.632 -178.166 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.546 ' OD1' ' HE2' ' A' ' 29' ' ' MET . 2.1 p30 -65.74 -36.29 83.17 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.802 -1.186 . . . . 0.0 109.166 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ILE . . . . . 0.96 HD12 ' O ' ' A' ' 30' ' ' ARG . 2.0 mt -60.78 -38.49 79.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 O-C-N 120.348 -1.47 . . . . 0.0 107.569 177.438 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ILE . . . . . 0.875 HG23 HD22 ' A' ' 6' ' ' LEU . 0.8 OUTLIER -59.3 -50.2 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.319 0 O-C-N 120.291 -1.506 . . . . 0.0 109.562 177.665 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -51.29 -41.6 60.57 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.514 -0.874 . . . . 0.0 109.154 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ALA . . . . . 0.783 ' HB1' ' CD2' ' A' ' 23' ' ' LEU . . . -63.49 -53.24 55.14 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.689 -1.257 . . . . 0.0 109.108 178.101 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.517 HG21 HD21 ' A' ' 17' ' ' LEU . 0.2 OUTLIER -55.51 -27.45 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 C-N-CA 117.451 -1.7 . . . . 0.0 109.705 179.549 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 39' ' ' LEU . . . . . 0.672 HD21 HD11 ' A' ' 6' ' ' LEU . 23.7 mt -71.34 -42.33 68.67 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.129 -1.607 . . . . 0.0 109.115 177.704 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.2 mttt -64.11 -40.21 95.71 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.936 -1.103 . . . . 0.0 110.313 178.462 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLN . . . . . 0.738 ' HG2' HD11 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -75.96 -53.12 8.88 Favored 'General case' 0 N--CA 1.508 2.425 0 O-C-N 121.033 -1.042 . . . . 0.0 111.125 -179.261 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 42' ' ' HIS . . . . . 0.723 ' CD2' ' CD ' ' A' ' 47' ' ' GLU . 0.6 OUTLIER -61.24 -35.18 76.53 Favored 'General case' 0 N--CA 1.513 2.72 0 O-C-N 121.229 -0.919 . . . . 0.0 109.192 179.975 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ALA . . . . . 0.544 ' O ' ' N ' ' A' ' 46' ' ' GLY . . . -81.15 -32.08 33.84 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.306 -0.871 . . . . 0.0 110.961 179.615 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LYS . . . . . 0.597 ' HD3' ' N ' ' A' ' 45' ' ' SER 0.254 0.0 OUTLIER -49.08 -50.37 37.11 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.333 -1.48 . . . . 0.0 107.782 178.089 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 45' ' ' SER . . . . . 0.597 ' N ' ' HD3' ' A' ' 44' ' ' LYS . 72.5 m -65.61 -9.37 26.36 Favored 'General case' 0 C--N 1.287 -2.149 0 CA-C-N 114.57 -1.195 . . . . 0.0 109.302 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . 64.46 32.14 83.22 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 178.427 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . 0.723 ' CD ' ' CD2' ' A' ' 42' ' ' HIS . 9.8 pt-20 -87.19 166.85 14.64 Favored 'General case' 0 C--N 1.309 -1.183 0 O-C-N 120.46 -1.612 . . . . 0.0 109.2 179.286 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -55.11 135.98 48.67 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.067 -1.021 . . . . 0.0 111.914 -177.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.589 ' HA ' ' HA ' ' A' ' 1' ' ' MET . 4.5 pt -146.57 137.8 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 178.14 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PHE . . . . . 0.569 ' CD1' ' N ' ' A' ' 50' ' ' PHE . 16.7 p90 -144.07 164.09 31.65 Favored 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 115.55 -2.46 . . . . 0.0 115.655 -178.224 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -119.19 166.17 13.15 Favored Glycine 0 N--CA 1.5 2.936 0 N-CA-C 107.425 -2.27 . . . . 0.0 107.425 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.487 ' OD2' ' OG1' ' A' ' 4' ' ' THR . 5.9 p-10 -171.88 167.98 6.13 Favored 'General case' 0 N--CA 1.482 1.156 0 O-C-N 120.132 -1.805 . . . . 0.0 109.617 -178.747 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' GLY . . . . . 0.44 ' N ' HD21 ' A' ' 65' ' ' LEU . . . 142.3 -137.18 7.68 Favored Glycine 0 N--CA 1.504 3.184 0 C-N-CA 118.247 -1.93 . . . . 0.0 110.741 178.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' VAL . . . . . 0.583 ' HA ' ' O ' ' A' ' 95' ' ' ASP . 3.3 t -128.28 120.62 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 O-C-N 121.382 -1.07 . . . . 0.0 108.419 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.822 HD21 HG21 ' A' ' 81' ' ' VAL . 6.5 mt -62.73 162.38 10.91 Favored 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 -175.642 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLU . . . . . 0.504 ' HA ' ' OG1' ' A' ' 93' ' ' THR . 1.4 tt0 -137.99 120.4 15.95 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 177.777 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ILE . . . . . 0.739 ' C ' HD12 ' A' ' 58' ' ' LEU . 1.2 mm -82.48 161.53 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 119.863 -1.773 . . . . 0.0 109.177 -179.081 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' LEU . . . . . 0.895 HD22 ' CZ ' ' A' ' 62' ' ' PHE . 7.1 mp -130.86 137.06 49.19 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.347 -1.47 . . . . 0.0 109.701 179.06 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLN . . . . . 0.463 ' C ' ' O ' ' A' ' 58' ' ' LEU . 1.4 tt0 -39.49 -36.54 0.39 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.525 -0.734 . . . . 0.0 110.006 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASP . . . . . 0.538 ' HB2' ' CD2' ' A' ' 62' ' ' PHE . 30.5 m-20 -61.4 -5.69 1.85 Allowed 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.676 -0.64 . . . . 0.0 112.574 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLY . . . . . 0.449 ' O ' ' HB3' ' A' ' 83' ' ' PRO . . . 88.25 11.37 67.07 Favored Glycine 1 N--CA 1.519 4.181 0 C-N-CA 118.601 -1.761 . . . . 0.0 111.954 178.307 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 62' ' ' PHE . . . . . 0.895 ' CZ ' HD22 ' A' ' 58' ' ' LEU . 4.0 p90 -127.94 -179.17 4.83 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 104.341 -2.466 . . . . 0.0 104.341 177.774 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' GLY . . . . . 0.506 ' HA2' HD13 ' A' ' 58' ' ' LEU . . . -156.07 168.08 33.43 Favored Glycine 0 N--CA 1.474 1.176 0 C-N-CA 117.181 -2.438 . . . . 0.0 111.577 -177.815 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PHE . . . . . 0.425 ' CD1' ' HE1' ' A' ' 62' ' ' PHE . 2.6 m-85 -129.07 151.18 50.04 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 119.926 1.863 . . . . 0.0 109.26 177.597 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . 0.537 ' HB3' ' HB ' ' A' ' 79' ' ' ILE . 0.3 OUTLIER -98.68 153.9 18.37 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 176.707 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.479 ' HB3' ' O ' ' A' ' 65' ' ' LEU . 0.5 OUTLIER 178.08 -151.71 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.246 -0.909 . . . . 0.0 109.657 179.364 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.6 m . . . . . 0 N--CA 1.5 2.047 0 O-C-N 121.383 -0.823 . . . . 0.0 110.64 -179.842 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASP . . . . . 0.762 ' C ' HD12 ' A' ' 79' ' ' ILE . 27.6 m-20 . . . . . 0 N--CA 1.505 2.28 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 1.065 HD11 HD23 ' A' ' 3' ' ' LEU . 2.1 mp -142.34 136.51 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.629 0 C-N-CA 119.241 -0.983 . . . . 0.0 109.928 178.649 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.471 ' HB3' ' HA ' ' A' ' 112' ' ' ALA . 12.2 t80 -78.11 147.46 34.64 Favored 'General case' 0 N--CA 1.52 3.049 0 O-C-N 119.635 -1.916 . . . . 0.0 110.014 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' VAL . . . . . 0.822 HG21 HD21 ' A' ' 55' ' ' LEU . 39.8 t -143.36 115.89 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 120.157 -1.589 . . . . 0.0 110.505 -179.407 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' SER . . . . . 0.547 ' O ' HG13 ' A' ' 86' ' ' ILE . 68.0 m -74.65 163.42 68.39 Favored Pre-proline 0 N--CA 1.514 2.737 0 O-C-N 120.5 -1.375 . . . . 0.0 112.688 -179.062 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' PRO . . . . . 0.581 ' HA ' HG13 ' A' ' 86' ' ' ILE . 39.4 Cg_endo -65.33 -51.7 1.39 Allowed 'Trans proline' 0 C--N 1.315 -1.215 0 O-C-N 124.779 1.936 . . . . 0.0 108.571 178.701 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' SER . . . . . 0.537 ' O ' ' CG ' ' A' ' 88' ' ' ARG . 57.1 p -47.3 -39.94 15.77 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 177.93 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.528 ' HB2' ' O ' ' A' ' 82' ' ' SER . 4.9 mm-40 -62.38 -60.03 4.14 Favored 'General case' 0 N--CA 1.509 2.49 0 C-N-CA 119.089 -1.044 . . . . 0.0 108.225 178.509 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' ILE . . . . . 0.614 HG22 ' HB2' ' A' ' 91' ' ' LEU . 0.2 OUTLIER -55.42 -55.04 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.305 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.512 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ARG . . . . . 0.498 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 0.0 OUTLIER -57.39 -42.59 82.51 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-O 121.811 0.815 . . . . 0.0 111.238 -179.49 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ARG . . . . . 0.537 ' CG ' ' O ' ' A' ' 84' ' ' SER . 10.8 mmm180 -59.4 -38.03 79.52 Favored 'General case' 0 N--CA 1.505 2.322 0 C-N-CA 119.84 -0.744 . . . . 0.0 111.816 -177.648 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' PHE . . . . . 1.082 ' HB2' HD21 ' A' ' 91' ' ' LEU . 9.1 m-85 -110.16 12.41 23.44 Favored 'General case' 0 N--CA 1.505 2.315 0 C-N-CA 116.976 -1.89 . . . . 0.0 111.359 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ASN . . . . . 0.408 ' CB ' ' O ' ' A' ' 89' ' ' PHE . 2.6 t-20 62.24 53.43 2.87 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 120.523 -1.36 . . . . 0.0 110.64 178.336 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' LEU . . . . . 1.082 HD21 ' HB2' ' A' ' 89' ' ' PHE . 2.8 mt -89.61 -169.45 2.48 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 119.199 -1.001 . . . . 0.0 110.043 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ARG . . . . . 0.532 ' CG ' ' O ' ' A' ' 91' ' ' LEU . 53.0 mtp180 -159.92 162.38 34.47 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.542 -0.724 . . . . 0.0 109.083 178.225 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' THR . . . . . 0.598 ' HB ' ' CG1' ' A' ' 57' ' ' ILE . 1.6 t -65.25 156.55 31.56 Favored 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 116.993 -1.883 . . . . 0.0 106.672 178.431 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 76.12 -10.3 15.77 Favored Glycine 0 N--CA 1.505 3.284 0 C-N-CA 116.954 -2.546 . . . . 0.0 110.191 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.583 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 7.7 m-20 -66.65 147.38 53.35 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.184 -1.774 . . . . 0.0 110.864 -178.874 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' THR . . . . . 0.481 ' O ' HG12 ' A' ' 97' ' ' ILE . 0.3 OUTLIER -90.52 120.36 31.55 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.193 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 97' ' ' ILE . . . . . 0.508 HG23 HG22 ' A' ' 119' ' ' VAL . 1.4 mt -144.11 167.84 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 119.778 -1.826 . . . . 0.0 112.929 -178.4 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 98' ' ' SER . . . . . 0.49 ' OG ' ' CB ' ' A' ' 118' ' ' GLU . 94.5 p -150.14 138.51 20.51 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.445 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -164.29 179.26 39.22 Favored Glycine 0 N--CA 1.506 3.319 0 C-N-CA 117.037 -2.506 . . . . 0.0 115.16 -179.137 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.9 mmtt -88.21 148.87 24.16 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.3 pt -124.59 153.54 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.706 0 CA-C-N 121.25 1.841 . . . . 0.0 113.566 -176.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ARG . . . . . 0.745 ' HB2' HD22 ' A' ' 114' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.744 0 O-C-N 120.372 -1.455 . . . . 0.0 109.875 179.013 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.501 2.083 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -107.42 147.22 30.69 Favored 'General case' 0 N--CA 1.518 2.945 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 176.238 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -68.36 161.66 26.99 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 119.237 -2.165 . . . . 0.0 108.062 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' ALA . . . . . 0.471 ' HA ' ' HB3' ' A' ' 80' ' ' TYR . . . -122.18 154.74 37.05 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 119.979 -1.701 . . . . 0.0 110.049 -179.572 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.46 HD23 ' CG ' ' A' ' 85' ' ' GLN . 3.0 tp -62.84 145.2 55.6 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' LEU . . . . . 0.745 HD22 ' HB2' ' A' ' 102' ' ' ARG . 11.5 tp -123.45 -55.36 1.74 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.45 -1.406 . . . . 0.0 112.179 -178.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 8.0 tptp -127.68 144.28 51.09 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 120.318 -1.488 . . . . 0.0 108.84 179.13 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.632 HG21 ' CD2' ' A' ' 89' ' ' PHE . 33.7 t -93.08 129.89 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.901 0 O-C-N 120.707 -1.246 . . . . 0.0 111.458 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -107.69 -38.74 5.79 Favored 'General case' 0 N--CA 1.508 2.451 0 O-C-N 121.257 -0.902 . . . . 0.0 110.053 178.454 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' GLU . . . . . 0.594 ' C ' HG23 ' A' ' 119' ' ' VAL . 7.0 tt0 -143.24 157.92 44.07 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 120.948 -1.095 . . . . 0.0 109.619 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' VAL . . . . . 0.594 HG23 ' C ' ' A' ' 118' ' ' GLU . 33.7 t -159.62 131.62 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -178.646 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.52 3.039 0 O-C-N 120.329 -1.482 . . . . 0.0 111.779 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.538 ' CA ' ' HA ' ' A' ' 49' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.661 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.583 ' HB2' ' CE2' ' A' ' 50' ' ' PHE 0.25 4.2 t30 -78.38 116.74 19.01 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 120.555 -1.34 . . . . 0.0 109.402 -179.827 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.833 HD13 HD12 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -49.68 -46.54 49.96 Favored 'General case' 0 N--CA 1.517 2.915 0 O-C-N 120.157 -1.59 . . . . 0.0 110.352 -178.934 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.8 m -56.35 -34.92 67.06 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.742 -1.224 . . . . 0.0 108.186 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.508 ' HB3' ' HB3' ' A' ' 2' ' ' ASN . 0.0 OUTLIER -66.99 -45.7 76.83 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 177.73 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.833 HD12 HD13 ' A' ' 3' ' ' LEU 0.274 68.5 mt -53.3 -51.4 62.44 Favored 'General case' 0 C--N 1.313 -0.981 0 O-C-N 120.626 -1.296 . . . . 0.0 109.078 177.738 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.26 -33.61 69.57 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.044 -1.035 . . . . 0.0 109.726 178.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.504 ' HB2' ' O ' ' A' ' 5' ' ' GLU . 4.8 m-80 -61.42 -16.54 47.7 Favored 'General case' 0 N--CA 1.504 2.263 0 C-N-CA 119.013 -1.075 . . . . 0.0 110.357 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.745 ' O ' HD11 ' A' ' 14' ' ' LEU . 2.6 m -89.48 121.32 69.37 Favored Pre-proline 0 N--CA 1.502 2.153 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.545 ' HG2' ' CG ' ' A' ' 13' ' ' GLU . 37.1 Cg_endo -57.79 151.3 57.07 Favored 'Trans proline' 0 CA--C 1.562 1.922 0 N-CA-C 109.971 -0.819 . . . . 0.0 109.971 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.799 ' HA ' HD12 ' A' ' 14' ' ' LEU . 1.6 p -41.85 -49.21 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.529 3.475 0 O-C-N 120.303 -1.498 . . . . 0.0 110.252 -178.071 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.504 ' N ' ' CG1' ' A' ' 11' ' ' VAL . 1.8 t -58.32 -41.97 85.69 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.314 -0.866 . . . . 0.0 111.161 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.675 ' CB ' HG22 ' A' ' 9' ' ' THR . 0.2 OUTLIER -68.97 -30.52 68.97 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 118.237 -1.385 . . . . 0.0 108.21 -179.964 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.799 HD12 ' HA ' ' A' ' 11' ' ' VAL . 9.3 mt -68.76 -41.2 79.19 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 120.883 -1.136 . . . . 0.0 108.813 176.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.633 HG23 ' HB2' ' A' ' 26' ' ' LEU . 1.2 mp -66.68 -40.33 85.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 C-N-CA 117.892 -1.523 . . . . 0.0 108.678 178.56 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.488 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 84.8 m -64.25 -35.52 81.11 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.36 -1.462 . . . . 0.0 108.963 179.088 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.504 ' O ' ' HG2' ' A' ' 21' ' ' MET . 35.5 tp -64.99 -43.85 91.23 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 120.934 -1.104 . . . . 0.0 108.237 178.365 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.566 ' HA2' ' OE1' ' A' ' 41' ' ' GLN . . . -61.69 -43.56 99.09 Favored Glycine 1 N--CA 1.518 4.11 0 N-CA-C 108.15 -1.98 . . . . 0.0 108.15 178.43 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.451 ' OE2' ' HG2' ' A' ' 24' ' ' GLU . 1.0 OUTLIER -53.75 -44.3 69.86 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.999 -1.295 . . . . 0.0 107.517 178.188 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.488 ' OD1' ' O ' ' A' ' 16' ' ' THR . 27.7 m120 -59.57 -26.97 65.84 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 118.679 -1.208 . . . . 0.0 109.465 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.571 ' HE2' ' HG3' ' A' ' 41' ' ' GLN . 37.7 mmm -97.65 9.86 41.44 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.27 -0.894 . . . . 0.0 110.438 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 99.7 -18.23 56.37 Favored Glycine 0 N--CA 1.501 2.992 0 C-N-CA 118.802 -1.666 . . . . 0.0 111.352 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.94 ' HB3' HD11 ' A' ' 26' ' ' LEU . 5.4 mp -79.56 94.91 5.72 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 120.359 -1.671 . . . . 0.0 109.753 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.511 ' O ' ' CB ' ' A' ' 25' ' ' ASN . 46.6 mt-10 -103.67 170.57 7.86 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.231 -0.918 . . . . 0.0 109.179 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.511 ' CB ' ' O ' ' A' ' 24' ' ' GLU . 1.3 t-20 70.37 18.15 6.79 Favored 'General case' 0 N--CA 1.511 2.578 0 O-C-N 121.528 -0.733 . . . . 0.0 111.785 179.33 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.94 HD11 ' HB3' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -76.42 -8.66 57.61 Favored 'General case' 0 N--CA 1.505 2.304 0 O-C-N 120.983 -1.073 . . . . 0.0 111.419 -179.798 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 26' ' ' LEU . . . -46.85 -32.74 3.94 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.461 -1.399 . . . . 0.0 108.847 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.413 ' NH2' ' HB3' ' A' ' 25' ' ' ASN . 11.9 ptt180 -80.96 0.85 33.66 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 120.193 -0.603 . . . . 0.0 111.363 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.637 ' HE2' ' OD1' ' A' ' 33' ' ' ASP . 7.1 mtp -100.79 149.13 24.15 Favored 'General case' 0 C--N 1.314 -0.976 0 O-C-N 120.837 -1.165 . . . . 0.0 111.864 -178.465 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.504 ' C ' HD12 ' A' ' 34' ' ' ILE . 2.4 mtt85 -89.12 142.13 27.91 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.449 -0.782 . . . . 0.0 110.772 178.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.565 ' O ' HG13 ' A' ' 35' ' ' ILE . 12.1 ptpt -35.91 -34.54 0.05 Allowed 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.707 -0.621 . . . . 0.0 111.582 179.276 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.457 ' OE1' ' HG3' ' A' ' 31' ' ' LYS . 1.6 mm100 -63.78 -59.84 4.05 Favored 'General case' 0 N--CA 1.517 2.91 0 O-C-N 120.568 -1.332 . . . . 0.0 109.869 -179.105 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.637 ' OD1' ' HE2' ' A' ' 29' ' ' MET . 2.5 p30 -66.11 -37.61 86.16 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.586 -0.696 . . . . 0.0 110.162 -178.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.56 HD11 ' O ' ' A' ' 29' ' ' MET . 3.3 mt -61.15 -41.46 89.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 O-C-N 120.267 -1.521 . . . . 0.0 108.071 178.12 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.609 HG23 HD13 ' A' ' 6' ' ' LEU . 96.8 mt -60.93 -48.48 88.8 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.778 0 O-C-N 120.057 -1.652 . . . . 0.0 109.443 177.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -52.7 -41.7 64.13 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 107.859 -1.164 . . . . 0.0 107.859 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.611 ' HB1' ' CD2' ' A' ' 23' ' ' LEU . . . -62.34 -55.55 26.94 Favored 'General case' 0 C--O 1.2 -1.506 0 O-C-N 120.911 -1.118 . . . . 0.0 108.456 177.367 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.557 ' HA ' ' CD ' ' A' ' 41' ' ' GLN . 0.4 OUTLIER -51.22 -27.86 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 C-N-CA 117.301 -1.76 . . . . 0.0 110.358 179.853 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.782 HD23 ' CE2' ' A' ' 111' ' ' PHE . 3.1 mp -71.59 -45.55 61.87 Favored 'General case' 0 N--CA 1.509 2.5 0 C-N-CA 117.762 -1.575 . . . . 0.0 109.551 178.238 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.514 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 1.2 mtpp -65.83 -40.86 92.18 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.191 -0.943 . . . . 0.0 111.377 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.683 HE22 HD22 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -79.07 -41.58 28.43 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.962 -1.086 . . . . 0.0 111.512 -178.605 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.598 ' N ' ' HG2' ' A' ' 41' ' ' GLN . 1.3 m-70 -69.77 -33.94 73.08 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 117.187 -1.805 . . . . 0.0 107.957 178.79 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.474 ' O ' ' N ' ' A' ' 46' ' ' GLY . . . -67.03 -51.66 52.03 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 120.641 -1.287 . . . . 0.0 107.842 177.007 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.514 ' HB2' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -49.31 -46.32 46.46 Favored 'General case' 0 N--CA 1.482 1.153 0 O-C-N 121.081 -1.012 . . . . 0.0 108.998 177.935 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 65.9 m -66.63 -6.35 15.04 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 120.039 -0.664 . . . . 0.0 109.797 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . 90.62 7.94 66.24 Favored Glycine 0 N--CA 1.496 2.678 0 C-N-CA 119.883 -1.151 . . . . 0.0 113.328 177.662 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -79.03 159.14 27.72 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 120.754 2.277 . . . . 0.0 108.781 179.162 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -88.64 150.36 23.06 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.899 -1.125 . . . . 0.0 110.038 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.574 HG13 HG13 ' A' ' 101' ' ' ILE . 0.7 OUTLIER -135.12 133.52 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 120.805 -1.185 . . . . 0.0 107.95 179.052 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.583 ' CE2' ' HB2' ' A' ' 2' ' ' ASN . 8.2 p90 -140.5 166.87 23.54 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 116.558 -2.057 . . . . 0.0 114.255 -178.587 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -122.13 170.67 15.1 Favored Glycine 0 N--CA 1.5 2.953 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -177.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.469 ' C ' HD21 ' A' ' 65' ' ' LEU . 2.7 p30 -170.04 163.94 9.35 Favored 'General case' 0 N--CA 1.482 1.155 0 O-C-N 120.681 -1.482 . . . . 0.0 110.138 -179.138 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.46 ' N ' HD21 ' A' ' 65' ' ' LEU . . . 145.32 -140.25 8.91 Favored Glycine 0 N--CA 1.506 3.328 0 C-N-CA 118.356 -1.878 . . . . 0.0 110.962 178.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.593 ' HA ' ' O ' ' A' ' 95' ' ' ASP . 3.0 t -128.2 121.08 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.975 HD21 HG21 ' A' ' 81' ' ' VAL . 6.5 mt -62.79 163.91 8.68 Favored 'General case' 0 N--CA 1.505 2.277 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -175.319 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.507 ' HA ' ' OG1' ' A' ' 93' ' ' THR . 73.0 mm-40 -137.92 117.98 13.45 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 177.764 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.614 ' CG1' ' HB ' ' A' ' 93' ' ' THR . 1.3 mm -85.13 162.11 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 CA-C-N 121.001 1.728 . . . . 0.0 110.545 -178.043 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.716 HD22 ' CZ ' ' A' ' 62' ' ' PHE . 5.1 mp -129.16 136.0 49.59 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.682 -1.261 . . . . 0.0 108.941 178.503 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.45 ' C ' ' O ' ' A' ' 58' ' ' LEU . 1.1 mt-30 -41.25 -34.01 0.44 Allowed 'General case' 0 N--CA 1.501 2.092 0 CA-C-O 121.972 0.892 . . . . 0.0 109.301 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -60.99 -7.82 2.75 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 119.928 -0.709 . . . . 0.0 112.247 -179.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.494 ' O ' ' HB3' ' A' ' 83' ' ' PRO . . . 93.55 4.35 64.03 Favored Glycine 1 N--CA 1.517 4.08 0 C-N-CA 118.817 -1.659 . . . . 0.0 112.43 177.758 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.716 ' CZ ' HD22 ' A' ' 58' ' ' LEU . 5.0 p90 -127.66 179.92 5.27 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 104.808 -2.293 . . . . 0.0 104.808 178.131 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.624 ' HA2' HD13 ' A' ' 58' ' ' LEU . . . -161.05 176.82 37.6 Favored Glycine 0 N--CA 1.476 1.343 0 C-N-CA 117.187 -2.435 . . . . 0.0 111.486 -177.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.447 ' CE2' ' HE2' ' A' ' 62' ' ' PHE . 23.2 m-85 -129.53 152.47 49.02 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 119.968 1.884 . . . . 0.0 109.689 177.476 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.503 ' HB3' ' HB ' ' A' ' 79' ' ' ILE . 0.5 OUTLIER -97.72 156.28 16.63 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 176.542 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.466 ' HB3' ' O ' ' A' ' 65' ' ' LEU . 1.1 ptp85 177.12 -154.21 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.96 -1.087 . . . . 0.0 109.999 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.2 -148.9 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.247 -0.908 . . . . 0.0 110.888 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -114.0 -18.25 11.77 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.553 -0.717 . . . . 0.0 111.581 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -65.64 -162.18 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.128 0 O-C-N 120.655 -1.278 . . . . 0.0 108.729 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.562 ' O ' ' CB ' ' A' ' 71' ' ' SER . 0.2 OUTLIER -126.74 -74.58 0.59 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 119.86 -1.775 . . . . 0.0 110.689 -179.788 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.637 ' O ' ' HB2' ' A' ' 72' ' ' TYR . 0.1 OUTLIER 78.2 -10.93 1.27 Allowed 'General case' 0 N--CA 1.52 3.062 0 O-C-N 121.778 -0.576 . . . . 0.0 110.51 -179.208 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.637 ' HB2' ' O ' ' A' ' 71' ' ' SER . 93.2 m-85 75.38 -45.06 0.54 Allowed 'General case' 0 N--CA 1.523 3.211 0 O-C-N 122.106 -0.372 . . . . 0.0 111.511 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 34.6 mt -99.01 -179.94 4.42 Favored 'General case' 0 C--N 1.309 -1.191 0 O-C-N 120.556 -1.34 . . . . 0.0 109.991 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.68 -148.63 0.06 Allowed 'General case' 0 C--N 1.291 -1.941 0 CA-C-O 122.386 1.089 . . . . 0.0 109.394 178.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.431 ' N ' ' OD2' ' A' ' 78' ' ' ASP . . . -158.2 157.73 28.56 Favored Glycine 0 C--N 1.279 -2.635 0 N-CA-C 107.054 -2.418 . . . . 0.0 107.054 178.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -65.51 -43.91 9.57 Favored 'Trans proline' 0 N--CA 1.488 1.17 0 CA-C-N 118.592 1.196 . . . . 0.0 112.202 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -89.4 18.86 4.86 Favored 'General case' 0 N--CA 1.507 2.417 0 O-C-N 120.973 -1.079 . . . . 0.0 112.342 -179.021 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.505 ' OD1' ' N ' ' A' ' 78' ' ' ASP . 2.0 m-20 -77.12 -158.44 0.11 Allowed 'General case' 0 N--CA 1.505 2.314 0 O-C-N 120.33 -1.481 . . . . 0.0 109.981 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.503 ' HB ' ' HB3' ' A' ' 65' ' ' LEU . 4.6 mm -128.35 133.83 66.03 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.657 0 O-C-N 121.06 -1.025 . . . . 0.0 109.891 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.479 ' HB3' ' O ' ' A' ' 111' ' ' PHE . 81.4 t80 -78.45 147.51 33.94 Favored 'General case' 0 N--CA 1.516 2.846 0 O-C-N 119.399 -2.063 . . . . 0.0 109.347 179.13 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.975 HG21 HD21 ' A' ' 55' ' ' LEU . 10.2 t -140.58 114.09 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 O-C-N 120.12 -1.612 . . . . 0.0 110.664 -179.315 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.565 ' O ' HG13 ' A' ' 86' ' ' ILE . 58.6 m -75.25 163.6 66.7 Favored Pre-proline 0 N--CA 1.512 2.651 0 O-C-N 120.442 -1.411 . . . . 0.0 112.18 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.564 ' HA ' HG13 ' A' ' 86' ' ' ILE . 38.0 Cg_endo -65.49 -52.75 0.96 Allowed 'Trans proline' 0 C--N 1.314 -1.289 0 O-C-N 124.701 1.895 . . . . 0.0 108.904 178.589 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.527 ' O ' ' HB2' ' A' ' 88' ' ' ARG . 0.3 OUTLIER -45.66 -40.98 9.81 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 178.242 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.631 ' NE2' ' HA ' ' A' ' 85' ' ' GLN . 4.8 mm-40 -62.41 -58.85 6.15 Favored 'General case' 0 N--CA 1.51 2.556 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.253 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.566 ' HA ' ' CD1' ' A' ' 91' ' ' LEU . 0.4 OUTLIER -55.98 -55.06 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.273 0 O-C-N 121.128 -0.982 . . . . 0.0 108.837 178.469 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.485 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 1.6 mtt85 -58.13 -42.6 86.2 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-O 121.772 0.796 . . . . 0.0 111.644 -178.928 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.527 ' HB2' ' O ' ' A' ' 84' ' ' SER . 19.8 mtt-85 -60.76 -36.8 79.86 Favored 'General case' 0 N--CA 1.505 2.311 0 C-N-CA 119.34 -0.944 . . . . 0.0 111.884 -177.545 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 1.045 ' HB2' HD21 ' A' ' 91' ' ' LEU . 16.7 m-85 -110.99 13.02 22.08 Favored 'General case' 0 N--CA 1.503 2.189 0 C-N-CA 116.815 -1.954 . . . . 0.0 111.382 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 61.19 55.04 3.09 Favored 'General case' 0 N--CA 1.483 1.21 0 O-C-N 120.509 -1.369 . . . . 0.0 110.458 178.307 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 1.045 HD21 ' HB2' ' A' ' 89' ' ' PHE . 3.9 mt -89.2 -170.75 2.99 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 119.102 -1.039 . . . . 0.0 110.416 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.531 ' CG ' ' O ' ' A' ' 91' ' ' LEU . 86.5 mtt-85 -159.4 160.03 34.41 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.679 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.614 ' HB ' ' CG1' ' A' ' 57' ' ' ILE . 1.7 t -64.36 156.9 27.73 Favored 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 116.826 -1.949 . . . . 0.0 106.662 178.459 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.42 ' O ' ' CG1' ' A' ' 54' ' ' VAL . . . 75.54 -9.44 15.34 Favored Glycine 0 N--CA 1.506 3.329 0 C-N-CA 117.122 -2.466 . . . . 0.0 110.191 179.346 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.593 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 11.7 m-20 -66.79 147.98 52.53 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.235 -1.744 . . . . 0.0 110.778 -178.789 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.483 ' O ' HG12 ' A' ' 97' ' ' ILE . 0.2 OUTLIER -89.6 120.98 31.37 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.228 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.811 HG23 HG22 ' A' ' 119' ' ' VAL . 1.4 mt -144.06 162.05 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 119.934 -1.729 . . . . 0.0 112.803 -178.305 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.518 ' OG ' ' HB2' ' A' ' 118' ' ' GLU . 97.5 p -148.05 137.88 22.52 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.553 ' O ' ' HB2' ' A' ' 50' ' ' PHE . . . -168.05 -178.27 39.83 Favored Glycine 0 N--CA 1.507 3.415 0 C-N-CA 117.035 -2.507 . . . . 0.0 114.917 -178.962 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.619 ' CD ' HD23 ' A' ' 114' ' ' LEU . 1.8 ptmt -90.12 156.93 18.01 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.574 HG13 HG13 ' A' ' 49' ' ' ILE . 2.3 pt -125.61 155.75 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.523 0 CA-C-N 120.659 1.572 . . . . 0.0 113.227 -177.529 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.892 ' HB3' HD13 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -150.86 153.92 33.98 Favored Pre-proline 0 N--CA 1.486 1.356 0 O-C-N 120.58 -1.325 . . . . 0.0 109.25 179.765 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.545 ' N ' ' HG3' ' A' ' 102' ' ' ARG . 51.4 Cg_endo -82.5 136.09 8.46 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 O-C-N 123.965 1.508 . . . . 0.0 110.039 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.554 ' HD2' ' CG ' ' A' ' 108' ' ' GLU . 48.4 Cg_endo -72.17 -93.9 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.88 1.463 . . . . 0.0 110.284 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 2.4 tttt -139.56 -163.62 1.53 Allowed 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.472 -0.768 . . . . 0.0 109.919 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -52.24 -26.63 12.29 Favored 'General case' 0 C--N 1.313 -1.017 0 O-C-N 120.637 -1.289 . . . . 0.0 109.345 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -83.79 48.55 4.06 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 107.738 -2.145 . . . . 0.0 107.738 177.659 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.554 ' CG ' ' HD2' ' A' ' 104' ' ' PRO . 8.8 tm-20 -85.72 -78.68 0.26 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.832 -1.393 . . . . 0.0 111.571 -178.611 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.46 ' HD2' ' CZ ' ' A' ' 110' ' ' TYR . 0.0 OUTLIER 65.08 -59.91 0.25 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.176 -0.952 . . . . 0.0 109.076 -178.56 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.53 ' N ' ' O ' ' A' ' 108' ' ' GLU . 35.8 m-85 -109.04 144.26 37.27 Favored 'General case' 0 N--CA 1.515 2.805 0 O-C-N 120.32 -1.487 . . . . 0.0 108.082 176.734 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.782 ' CE2' HD23 ' A' ' 39' ' ' LEU . 3.3 m-85 -68.33 165.74 18.0 Favored 'General case' 0 N--CA 1.506 2.348 0 O-C-N 119.321 -2.112 . . . . 0.0 107.957 178.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.457 ' HA ' ' HB3' ' A' ' 80' ' ' TYR . . . -122.7 150.68 42.4 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 119.955 -1.715 . . . . 0.0 110.957 -179.063 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.3 tp -60.11 147.56 39.08 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 179.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.892 HD13 ' HB3' ' A' ' 102' ' ' ARG . 14.3 tp -127.84 -55.48 1.3 Allowed 'General case' 0 N--CA 1.502 2.136 0 O-C-N 120.357 -1.464 . . . . 0.0 112.345 -178.793 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.536 ' HB3' ' CD ' ' A' ' 100' ' ' LYS . 0.6 OUTLIER -124.68 139.79 53.54 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 120.321 -1.487 . . . . 0.0 108.598 179.448 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.41 HG11 HG21 ' A' ' 119' ' ' VAL . 29.2 t -92.47 129.75 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.735 0 O-C-N 120.671 -1.268 . . . . 0.0 111.52 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.414 ' CG ' ' HA2' ' A' ' 99' ' ' GLY . 5.1 m-20 -106.43 -39.81 5.78 Favored 'General case' 0 N--CA 1.506 2.339 0 O-C-N 121.409 -0.807 . . . . 0.0 109.496 178.308 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.579 ' C ' HG23 ' A' ' 119' ' ' VAL . 1.7 tt0 -143.31 154.49 43.83 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.797 -1.189 . . . . 0.0 109.515 178.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.811 HG22 HG23 ' A' ' 97' ' ' ILE . 83.3 t -159.99 128.21 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 C-N-CA 120.749 -0.38 . . . . 0.0 111.503 -178.349 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.457 ' O ' ' C ' ' A' ' 121' ' ' PHE . 0.6 OUTLIER 39.61 51.61 2.32 Favored 'General case' 0 N--CA 1.52 3.049 0 O-C-N 120.514 -1.366 . . . . 0.0 111.161 178.833 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.475 ' O ' ' OD1' ' A' ' 122' ' ' ASP . 3.4 t80 41.45 32.01 0.2 Allowed 'General case' 0 N--CA 1.519 2.994 0 C-N-CA 118.974 -1.09 . . . . 0.0 110.349 179.294 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.475 ' OD1' ' O ' ' A' ' 121' ' ' PHE . 1.9 m-20 -145.72 168.18 21.35 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.057 -1.027 . . . . 0.0 108.602 178.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.2 mmtp -78.35 160.45 72.87 Favored Pre-proline 0 N--CA 1.504 2.227 0 O-C-N 120.908 -1.12 . . . . 0.0 109.15 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.44 ' O ' ' HB2' ' A' ' 125' ' ' GLU . 44.7 Cg_endo -71.79 44.73 0.65 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.837 1.441 . . . . 0.0 110.881 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.532 ' O ' ' ND2' ' A' ' 126' ' ' ASN . 3.9 tt0 -177.51 -153.4 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.616 -1.303 . . . . 0.0 108.627 -179.491 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.699 ' O ' ' HB2' ' A' ' 127' ' ' ALA . 0.3 OUTLIER 167.0 -150.38 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.168 0 O-C-N 120.603 -1.311 . . . . 0.0 109.247 179.543 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.699 ' HB2' ' O ' ' A' ' 126' ' ' ASN . . . 172.88 33.17 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.392 -1.443 . . . . 0.0 111.218 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.537 ' CZ ' ' OD1' ' A' ' 126' ' ' ASN . 0.2 OUTLIER -115.76 -27.02 7.18 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.963 -1.086 . . . . 0.0 110.197 179.661 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.528 ' N ' ' HG2' ' A' ' 128' ' ' ARG . 17.1 m-20 63.27 140.65 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.263 -0.898 . . . . 0.0 109.859 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.523 ' OXT' ' CG ' ' A' ' 130' ' ' LYS . 1.5 ptmt . . . . . 0 N--CA 1.481 1.097 0 O-C-N 120.623 -1.298 . . . . 0.0 109.604 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.633 ' HA ' ' HA ' ' A' ' 49' ' ' ILE . 2.1 ptp . . . . . 0 N--CA 1.493 1.701 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.562 ' HB2' ' CZ ' ' A' ' 50' ' ' PHE . 8.7 t-20 -78.21 94.28 4.74 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.819 -1.175 . . . . 0.0 108.635 179.118 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.547 ' HA ' HD12 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -41.41 -41.27 1.96 Allowed 'General case' 0 N--CA 1.517 2.917 0 O-C-N 120.679 -1.263 . . . . 0.0 110.031 -178.797 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.412 ' OG1' ' OD2' ' A' ' 52' ' ' ASP . 1.8 m -59.13 -35.36 73.34 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 120.819 -1.176 . . . . 0.0 108.564 -179.436 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.515 ' N ' ' OD1' ' A' ' 2' ' ' ASN . 0.1 OUTLIER -74.12 -45.39 49.26 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.027 -1.046 . . . . 0.0 108.747 178.209 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.816 ' CD1' HD21 ' A' ' 39' ' ' LEU 0.275 77.9 mt -50.94 -49.72 59.26 Favored 'General case' 0 C--N 1.317 -0.817 0 O-C-N 120.806 -1.184 . . . . 0.0 109.216 178.266 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -66.21 -39.78 89.86 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.046 -1.034 . . . . 0.0 110.142 178.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -63.25 -28.09 69.79 Favored 'General case' 0 N--CA 1.508 2.429 0 O-C-N 121.226 -0.921 . . . . 0.0 111.251 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.636 HG22 ' CB ' ' A' ' 13' ' ' GLU . 3.0 m -73.84 126.92 89.12 Favored Pre-proline 0 N--CA 1.505 2.321 0 O-C-N 121.538 -0.727 . . . . 0.0 109.549 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.561 ' HG2' ' CG ' ' A' ' 13' ' ' GLU . 40.1 Cg_endo -61.16 150.47 84.31 Favored 'Trans proline' 0 CA--C 1.566 2.096 0 O-C-N 122.315 0.64 . . . . 0.0 110.84 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.55 ' CG1' ' N ' ' A' ' 12' ' ' SER . 1.4 p -43.43 -50.74 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.525 3.276 0 O-C-N 120.493 -1.379 . . . . 0.0 109.471 -178.71 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.55 ' N ' ' CG1' ' A' ' 11' ' ' VAL . 0.8 OUTLIER -56.21 -39.95 73.28 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.418 -0.801 . . . . 0.0 111.056 -179.856 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.899 ' O ' HD12 ' A' ' 17' ' ' LEU . 0.1 OUTLIER -69.26 -29.59 67.52 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 117.96 -1.496 . . . . 0.0 107.711 179.178 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.711 ' HB3' HG21 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -68.54 -44.32 74.79 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.13 -0.981 . . . . 0.0 108.89 176.845 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.523 HD12 ' O ' ' A' ' 11' ' ' VAL . 1.5 mp -65.68 -37.17 79.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 C-N-CA 117.97 -1.492 . . . . 0.0 108.908 179.204 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.583 ' HA ' ' HG2' ' A' ' 19' ' ' GLU . 31.0 m -65.8 -38.64 89.53 Favored 'General case' 0 N--CA 1.484 1.247 0 O-C-N 120.338 -1.476 . . . . 0.0 109.123 178.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.899 HD12 ' O ' ' A' ' 13' ' ' GLU . 3.7 mt -65.34 -38.13 89.19 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.887 -1.133 . . . . 0.0 108.764 178.593 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.463 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -67.61 -43.5 85.41 Favored Glycine 0 N--CA 1.513 3.787 0 N-CA-C 108.49 -1.844 . . . . 0.0 108.49 178.467 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.697 ' HG3' ' N ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -58.62 -38.84 78.91 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.463 -1.61 . . . . 0.0 108.175 178.925 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.697 ' N ' ' HG3' ' A' ' 19' ' ' GLU . 24.8 m120 -61.81 -27.76 68.99 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 118.13 -1.428 . . . . 0.0 109.313 178.633 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.533 ' HE2' ' NE2' ' A' ' 41' ' ' GLN . 21.5 mmm -102.5 10.81 38.64 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.314 -0.867 . . . . 0.0 111.511 -178.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.66 -18.23 50.99 Favored Glycine 0 N--CA 1.504 3.175 0 C-N-CA 118.537 -1.792 . . . . 0.0 112.102 179.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.991 ' HB3' HD11 ' A' ' 26' ' ' LEU . 5.0 mp -78.4 95.01 4.99 Favored 'General case' 0 N--CA 1.508 2.449 0 O-C-N 120.193 -1.769 . . . . 0.0 110.121 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.474 ' O ' ' CB ' ' A' ' 25' ' ' ASN . 51.5 mt-10 -104.01 168.66 8.97 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.169 -0.957 . . . . 0.0 109.268 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.474 ' CB ' ' O ' ' A' ' 24' ' ' GLU . 3.4 t-20 68.98 19.49 8.15 Favored 'General case' 0 N--CA 1.508 2.434 0 O-C-N 121.499 -0.751 . . . . 0.0 111.947 179.056 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.991 HD11 ' HB3' ' A' ' 23' ' ' LEU . 0.4 OUTLIER -76.21 -13.62 60.17 Favored 'General case' 0 N--CA 1.505 2.283 0 O-C-N 120.76 -1.212 . . . . 0.0 111.381 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 26' ' ' LEU . . . -46.99 -35.61 6.81 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.464 -1.398 . . . . 0.0 109.061 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.6 mtt180 -81.16 2.48 27.39 Favored 'General case' 0 C--N 1.295 -1.79 0 C-N-CA 119.849 -0.74 . . . . 0.0 111.438 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.565 ' HB3' HG13 ' A' ' 34' ' ' ILE . 7.4 mtp -100.4 150.53 22.52 Favored 'General case' 0 C--N 1.313 -0.984 0 O-C-N 120.832 -1.167 . . . . 0.0 111.164 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.53 ' C ' HD12 ' A' ' 34' ' ' ILE . 10.8 ttp85 -89.22 142.59 27.51 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.258 -0.901 . . . . 0.0 110.677 179.106 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.59 ' O ' ' CG1' ' A' ' 35' ' ' ILE . 7.7 tttp -31.95 -46.27 0.11 Allowed 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 116.264 -0.426 . . . . 0.0 112.051 179.224 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.524 ' OE1' ' N ' ' A' ' 33' ' ' ASP . 1.2 pp0? -61.6 -53.88 50.37 Favored 'General case' 0 N--CA 1.52 3.066 0 O-C-N 121.325 -0.86 . . . . 0.0 112.101 -177.481 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.539 ' OD1' ' HE2' ' A' ' 29' ' ' MET . 2.1 p30 -66.73 -37.32 84.43 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 120.732 -1.23 . . . . 0.0 108.964 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.711 HG21 ' HB3' ' A' ' 14' ' ' LEU . 4.8 mt -61.17 -39.44 82.45 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 O-C-N 120.328 -1.482 . . . . 0.0 108.043 177.78 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.59 ' CG1' ' O ' ' A' ' 31' ' ' LYS . 0.6 OUTLIER -57.58 -47.51 85.17 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.558 0 O-C-N 120.085 -1.635 . . . . 0.0 109.271 177.577 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -53.18 -41.15 64.95 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.405 -0.918 . . . . 0.0 108.526 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.841 ' HB1' ' CD2' ' A' ' 23' ' ' LEU . . . -70.29 -53.09 18.27 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.971 -1.081 . . . . 0.0 109.953 178.114 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.662 ' HA ' ' CG ' ' A' ' 41' ' ' GLN . 0.1 OUTLIER -53.78 -28.26 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 C-N-CA 117.437 -1.705 . . . . 0.0 110.362 -179.786 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.816 HD21 ' CD1' ' A' ' 6' ' ' LEU . 64.7 mt -72.33 -44.3 62.86 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 120.409 -1.432 . . . . 0.0 109.696 178.477 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 10.9 mmtt -64.21 -41.63 96.95 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.046 -1.034 . . . . 0.0 110.501 179.014 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.662 ' CG ' ' HA ' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -74.86 -46.41 36.54 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.065 -1.022 . . . . 0.0 111.359 -179.06 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.492 ' HB2' ' O ' ' A' ' 38' ' ' ILE . 0.3 OUTLIER -66.01 -34.47 78.17 Favored 'General case' 0 N--CA 1.505 2.309 0 O-C-N 120.543 -1.348 . . . . 0.0 108.984 179.539 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.565 ' O ' ' N ' ' A' ' 46' ' ' GLY . . . -67.32 -36.93 82.47 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 120.975 -1.078 . . . . 0.0 108.96 178.301 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.89 -43.73 28.89 Favored 'General case' 0 N--CA 1.482 1.162 0 O-C-N 120.799 -1.188 . . . . 0.0 108.966 178.25 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 70.8 m -66.66 -9.99 41.67 Favored 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 119.59 -0.844 . . . . 0.0 109.265 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.565 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . 64.57 36.03 92.66 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 178.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.514 ' OE1' ' N ' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -92.62 166.72 12.35 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.432 -1.628 . . . . 0.0 108.841 179.214 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.514 ' N ' ' OE1' ' A' ' 47' ' ' GLU . 17.0 m-20 -61.58 137.09 58.23 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.122 -0.986 . . . . 0.0 110.792 -178.37 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.633 ' HA ' ' HA ' ' A' ' 1' ' ' MET . 3.0 pt -141.26 135.19 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 120.986 -1.071 . . . . 0.0 108.224 178.912 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.641 ' N ' ' CD1' ' A' ' 50' ' ' PHE . 7.4 p90 -144.86 163.26 34.63 Favored 'General case' 0 C--N 1.31 -1.12 0 C-N-CA 116.014 -2.274 . . . . 0.0 115.794 -178.422 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -120.79 170.6 14.5 Favored Glycine 0 N--CA 1.505 3.243 0 N-CA-C 108.686 -1.766 . . . . 0.0 108.686 -179.017 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.483 ' C ' ' CD2' ' A' ' 65' ' ' LEU . 52.5 p-10 -170.22 167.5 8.57 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 120.383 -1.657 . . . . 0.0 110.741 -178.574 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.536 ' HA3' ' O ' ' A' ' 66' ' ' ARG . . . 144.09 -139.19 8.49 Favored Glycine 0 N--CA 1.507 3.418 0 C-N-CA 118.368 -1.872 . . . . 0.0 111.472 177.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.58 ' HA ' ' O ' ' A' ' 95' ' ' ASP . 2.8 t -127.75 120.12 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 O-C-N 121.258 -1.142 . . . . 0.0 108.092 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.874 HD21 HG21 ' A' ' 81' ' ' VAL . 7.2 mt -62.92 162.78 10.66 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -175.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.528 ' HA ' ' OG1' ' A' ' 93' ' ' THR . 0.0 OUTLIER -139.27 119.79 14.0 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.03 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.584 ' CG1' ' HB ' ' A' ' 93' ' ' THR . 1.2 mm -78.65 162.07 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 119.733 -1.854 . . . . 0.0 109.18 -178.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 1.178 HD22 ' CZ ' ' A' ' 62' ' ' PHE . 1.3 mp -131.39 126.06 34.2 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.301 -1.499 . . . . 0.0 109.752 179.195 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.509 ' C ' ' O ' ' A' ' 58' ' ' LEU . 6.9 mm-40 -32.74 -37.05 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.458 0 CA-C-O 122.018 0.913 . . . . 0.0 109.715 -179.494 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.556 ' HB2' ' CD2' ' A' ' 62' ' ' PHE . 3.1 m-20 -60.92 -6.21 1.72 Allowed 'General case' 0 N--CA 1.5 2.033 0 C-N-CA 120.271 -0.571 . . . . 0.0 112.489 -179.176 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 58' ' ' LEU . . . 89.14 11.9 64.22 Favored Glycine 1 N--CA 1.517 4.077 0 C-N-CA 118.672 -1.728 . . . . 0.0 111.944 178.365 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 1.178 ' CZ ' HD22 ' A' ' 58' ' ' LEU . 4.0 p90 -128.1 -178.85 4.69 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 104.18 -2.526 . . . . 0.0 104.18 177.881 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.571 ' HA2' ' CD1' ' A' ' 58' ' ' LEU . . . -152.75 162.87 30.2 Favored Glycine 0 N--CA 1.475 1.292 0 C-N-CA 117.322 -2.37 . . . . 0.0 111.272 -177.885 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.442 ' CD1' ' HE1' ' A' ' 62' ' ' PHE . 2.0 m-30 -127.81 150.96 49.59 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 120.136 1.968 . . . . 0.0 109.156 177.728 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.502 ' HB3' ' HB ' ' A' ' 79' ' ' ILE . 0.3 OUTLIER -98.34 166.37 11.41 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 176.768 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.536 ' O ' ' HA3' ' A' ' 53' ' ' GLY . 21.0 tpt180 -178.42 -179.97 0.73 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.057 -1.027 . . . . 0.0 109.02 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.506 ' HB2' ' OG ' ' A' ' 70' ' ' SER . 1.7 m -71.51 -159.12 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.45 -1.406 . . . . 0.0 109.86 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -120.42 -85.76 0.66 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.32 -0.862 . . . . 0.0 110.212 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -69.09 56.06 0.1 Allowed 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.463 -0.773 . . . . 0.0 110.933 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.507 ' O ' ' CB ' ' A' ' 71' ' ' SER . 0.3 OUTLIER -126.31 -19.48 4.67 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.121 -1.612 . . . . 0.0 111.036 -179.399 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.683 ' O ' ' HB2' ' A' ' 72' ' ' TYR . 0.3 OUTLIER 169.47 -14.84 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.439 0 O-C-N 120.822 -1.174 . . . . 0.0 111.973 -179.531 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.683 ' HB2' ' O ' ' A' ' 71' ' ' SER . 95.9 m-85 76.64 -42.57 0.43 Allowed 'General case' 0 N--CA 1.529 3.51 0 O-C-N 121.842 -0.536 . . . . 0.0 111.951 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.456 ' CD1' ' N ' ' A' ' 73' ' ' LEU . 6.7 mp -80.67 -174.78 4.9 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 120.268 -1.52 . . . . 0.0 109.639 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.54 -156.86 0.12 Allowed 'General case' 0 C--N 1.29 -1.982 0 CA-C-O 122.366 1.079 . . . . 0.0 109.755 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.519 ' N ' ' OD2' ' A' ' 78' ' ' ASP . . . -178.54 163.16 30.88 Favored Glycine 0 C--N 1.281 -2.482 0 N-CA-C 107.891 -2.084 . . . . 0.0 107.891 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -64.98 -39.14 25.61 Favored 'Trans proline' 0 N--CA 1.492 1.388 0 CA-C-N 118.312 1.056 . . . . 0.0 112.027 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -86.5 18.32 3.36 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.118 -0.989 . . . . 0.0 112.101 -178.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.519 ' OD2' ' N ' ' A' ' 75' ' ' GLY . 1.1 m-20 -70.74 -154.05 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.343 0 O-C-N 120.531 -1.356 . . . . 0.0 109.77 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.502 ' HB ' ' HB3' ' A' ' 65' ' ' LEU . 3.9 mm -126.56 138.67 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.65 0 O-C-N 121.16 -0.963 . . . . 0.0 110.11 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.5 ' HB3' ' O ' ' A' ' 111' ' ' PHE . 6.0 t80 -85.02 146.55 27.13 Favored 'General case' 0 N--CA 1.516 2.867 0 CA-C-N 121.502 1.955 . . . . 0.0 109.819 178.875 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.874 HG21 HD21 ' A' ' 55' ' ' LEU . 25.2 t -141.65 115.77 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 120.078 -1.639 . . . . 0.0 110.226 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.556 ' O ' HG13 ' A' ' 86' ' ' ILE . 58.0 m -74.3 163.52 67.7 Favored Pre-proline 0 N--CA 1.515 2.799 0 O-C-N 120.262 -1.524 . . . . 0.0 112.131 -179.208 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.535 ' HA ' HG13 ' A' ' 86' ' ' ILE . 40.2 Cg_endo -66.62 -50.27 1.34 Allowed 'Trans proline' 0 C--N 1.314 -1.249 0 O-C-N 124.505 1.792 . . . . 0.0 108.958 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.539 ' O ' ' CG ' ' A' ' 88' ' ' ARG . 0.4 OUTLIER -47.2 -39.53 14.19 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 177.834 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.547 ' HB2' ' O ' ' A' ' 82' ' ' SER . 7.2 mm-40 -63.42 -57.78 9.2 Favored 'General case' 0 N--CA 1.511 2.587 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.215 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.59 ' HA ' HD23 ' A' ' 91' ' ' LEU . 0.8 OUTLIER -55.51 -53.59 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.336 0 O-C-N 120.938 -1.101 . . . . 0.0 108.647 178.848 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.469 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 0.1 OUTLIER -57.81 -41.72 82.76 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 121.865 0.84 . . . . 0.0 111.364 -179.459 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.539 ' CG ' ' O ' ' A' ' 84' ' ' SER . 12.5 mtt180 -59.37 -37.46 77.96 Favored 'General case' 0 N--CA 1.507 2.407 0 C-N-CA 119.883 -0.727 . . . . 0.0 111.928 -177.606 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.453 ' CD2' HG21 ' A' ' 116' ' ' VAL . 19.3 m-85 -113.97 14.53 18.46 Favored 'General case' 0 N--CA 1.505 2.318 0 C-N-CA 117.274 -1.771 . . . . 0.0 111.412 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 58.45 56.5 4.32 Favored 'General case' 0 N--CA 1.481 1.108 0 O-C-N 120.31 -1.493 . . . . 0.0 109.084 179.067 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.59 HD23 ' HA ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -88.37 173.91 8.46 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.431 -0.908 . . . . 0.0 109.338 -179.831 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.535 ' CD ' ' O ' ' A' ' 91' ' ' LEU . 3.7 mmm180 -147.0 157.51 43.64 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.997 -1.065 . . . . 0.0 108.86 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.584 ' HB ' ' CG1' ' A' ' 57' ' ' ILE . 2.4 t -63.73 156.29 27.54 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 116.948 -1.901 . . . . 0.0 106.993 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 76.34 -9.61 19.9 Favored Glycine 0 N--CA 1.504 3.189 0 C-N-CA 117.094 -2.479 . . . . 0.0 110.334 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.58 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 6.0 m-20 -69.36 147.75 50.63 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.228 -1.748 . . . . 0.0 110.752 -178.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.51 ' O ' HG12 ' A' ' 97' ' ' ILE . 0.2 OUTLIER -91.22 124.29 35.31 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.093 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.529 HG23 ' O ' ' A' ' 118' ' ' GLU . 1.7 mt -146.73 166.3 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.034 -1.666 . . . . 0.0 112.408 -179.087 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.533 ' OG ' ' HB2' ' A' ' 118' ' ' GLU . 82.4 p -148.93 139.82 22.87 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.233 178.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.502 ' O ' ' HB2' ' A' ' 50' ' ' PHE . . . -164.6 179.55 39.27 Favored Glycine 0 N--CA 1.506 3.346 0 C-N-CA 117.039 -2.505 . . . . 0.0 114.987 -179.118 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.541 ' HG2' ' HB3' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -87.76 152.88 21.78 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 178.772 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.542 HG13 HG13 ' A' ' 49' ' ' ILE . 2.4 pt -122.87 159.17 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.462 0 CA-C-N 120.982 1.719 . . . . 0.0 113.603 -176.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.599 ' CB ' HD13 ' A' ' 114' ' ' LEU . 1.5 tmm_? -145.39 143.85 21.37 Favored Pre-proline 0 N--CA 1.481 1.111 0 O-C-N 120.582 -1.324 . . . . 0.0 109.891 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.486 ' HB3' ' CE1' ' A' ' 111' ' ' PHE . 52.2 Cg_endo -88.36 117.75 1.02 Allowed 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.246 1.656 . . . . 0.0 110.027 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.56 ' HG2' ' CB ' ' A' ' 108' ' ' GLU . 44.2 Cg_endo -68.48 -99.18 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 123.718 1.378 . . . . 0.0 109.592 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.434 ' O ' ' CD ' ' A' ' 108' ' ' GLU . 23.7 mttt -116.43 174.52 6.02 Favored 'General case' 0 C--N 1.293 -1.856 0 O-C-N 121.253 -0.905 . . . . 0.0 109.373 179.185 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.42 -23.78 63.75 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 120.838 -1.164 . . . . 0.0 109.774 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -85.16 34.94 3.17 Favored Glycine 0 N--CA 1.496 2.651 0 C-N-CA 118.68 -1.724 . . . . 0.0 109.923 179.025 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.56 ' CB ' ' HG2' ' A' ' 104' ' ' PRO . 0.7 OUTLIER -106.77 -23.94 12.25 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.487 -1.596 . . . . 0.0 110.235 179.831 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.526 ' N ' ' OE1' ' A' ' 108' ' ' GLU . 0.9 OUTLIER 66.37 -52.61 0.42 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.549 -0.719 . . . . 0.0 111.245 -179.949 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.424 ' N ' ' O ' ' A' ' 108' ' ' GLU . 3.6 m-85 -108.4 148.04 30.71 Favored 'General case' 0 N--CA 1.521 3.078 0 O-C-N 120.07 -1.644 . . . . 0.0 109.542 178.625 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.5 ' O ' ' HB3' ' A' ' 80' ' ' TYR . 54.4 m-85 -69.13 172.03 7.44 Favored 'General case' 0 N--CA 1.509 2.514 0 O-C-N 119.735 -1.853 . . . . 0.0 108.034 178.317 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.435 ' HA ' ' HB3' ' A' ' 80' ' ' TYR . . . -122.08 154.96 36.65 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 119.924 -1.735 . . . . 0.0 110.842 -179.169 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.12 153.7 43.28 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 179.375 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.599 HD13 ' CB ' ' A' ' 102' ' ' ARG . 11.1 tp -132.79 -59.55 0.89 Allowed 'General case' 0 N--CA 1.501 2.077 0 O-C-N 120.135 -1.603 . . . . 0.0 112.22 -179.276 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.541 ' HB3' ' HG2' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -114.18 141.7 47.19 Favored 'General case' 0 N--CA 1.511 2.615 0 O-C-N 120.272 -1.518 . . . . 0.0 109.074 179.401 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.453 HG21 ' CD2' ' A' ' 89' ' ' PHE . 34.7 t -93.05 129.25 43.83 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.908 0 O-C-N 120.543 -1.348 . . . . 0.0 111.63 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.57 ' O ' ' HB3' ' A' ' 124' ' ' PRO . 7.1 m-20 -106.93 -39.05 5.87 Favored 'General case' 0 N--CA 1.507 2.423 0 O-C-N 121.463 -0.773 . . . . 0.0 109.918 178.324 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.548 ' C ' HG23 ' A' ' 119' ' ' VAL . 6.0 mm-40 -143.52 156.37 44.59 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.595 -1.316 . . . . 0.0 109.041 179.417 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.548 HG23 ' C ' ' A' ' 118' ' ' GLU . 6.4 t -156.17 139.81 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -178.229 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.467 ' C ' ' O ' ' A' ' 119' ' ' VAL . 0.1 OUTLIER -32.8 -31.54 0.01 OUTLIER 'General case' 0 N--CA 1.519 2.978 0 O-C-N 121.106 -0.996 . . . . 0.0 111.197 -177.535 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.545 ' N ' ' O ' ' A' ' 119' ' ' VAL . 0.4 OUTLIER -157.29 59.08 0.51 Allowed 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 118.313 -1.355 . . . . 0.0 111.272 179.439 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.541 ' HB2' ' HB ' ' A' ' 119' ' ' VAL . 0.4 OUTLIER -151.19 167.41 27.86 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 118.534 -1.267 . . . . 0.0 109.762 177.968 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 26.3 mmmt -79.04 156.3 76.94 Favored Pre-proline 0 N--CA 1.501 2.077 0 C-N-CA 119.458 -0.897 . . . . 0.0 108.884 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.57 ' HB3' ' O ' ' A' ' 117' ' ' ASN . 54.3 Cg_endo -79.58 31.24 0.48 Allowed 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.853 1.449 . . . . 0.0 111.102 -178.854 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.535 ' O ' ' CB ' ' A' ' 126' ' ' ASN . 1.2 tp10 -179.12 -134.67 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.535 ' CB ' ' O ' ' A' ' 125' ' ' GLU . 0.9 OUTLIER 167.58 -83.41 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.099 0 O-C-N 120.327 -1.483 . . . . 0.0 110.182 179.055 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.501 ' HB2' ' O ' ' A' ' 126' ' ' ASN . . . -179.55 -165.84 0.08 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.606 -0.683 . . . . 0.0 109.456 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.552 ' CG ' ' O ' ' A' ' 128' ' ' ARG . 2.0 ptp180 -158.23 113.22 2.62 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.482 -1.386 . . . . 0.0 110.267 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -65.02 163.09 15.36 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.073 -1.017 . . . . 0.0 110.185 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 118.003 -0.999 . . . . 0.0 109.952 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.806 ' SD ' HG22 ' A' ' 49' ' ' ILE . 14.1 mmt . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.097 0.475 . . . . 0.0 109.925 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.522 ' HA ' ' O ' ' A' ' 50' ' ' PHE . 39.8 t30 -78.86 110.04 13.69 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.007 -1.058 . . . . 0.0 108.84 178.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.662 ' HA ' HD12 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -44.09 -41.17 5.4 Favored 'General case' 0 N--CA 1.514 2.74 0 O-C-N 120.339 -1.476 . . . . 0.0 110.493 -178.695 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.43 ' OG1' ' OD1' ' A' ' 52' ' ' ASP . 1.7 m -58.4 -36.88 74.24 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 120.696 -1.253 . . . . 0.0 108.264 -179.014 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.51 ' HB3' ' HB3' ' A' ' 2' ' ' ASN . 1.8 pt-20 -70.53 -45.84 64.75 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.089 -1.007 . . . . 0.0 108.543 178.053 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.662 HD12 ' HA ' ' A' ' 3' ' ' LEU 0.281 82.3 mt -51.65 -49.5 62.19 Favored 'General case' 0 C--N 1.315 -0.916 0 O-C-N 121.008 -1.058 . . . . 0.0 109.521 178.397 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.485 ' HD2' ' HB2' ' A' ' 77' ' ' ASP . 0.3 OUTLIER -63.78 -38.58 91.65 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.288 -0.883 . . . . 0.0 110.094 179.137 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -62.58 -19.52 63.8 Favored 'General case' 0 N--CA 1.508 2.473 0 O-C-N 121.262 -0.899 . . . . 0.0 111.383 -179.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.617 ' HB ' ' CD1' ' A' ' 14' ' ' LEU . 3.2 m -83.17 117.85 69.87 Favored Pre-proline 0 C--N 1.284 -2.278 0 O-C-N 121.763 -0.585 . . . . 0.0 109.966 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.53 ' HG2' ' HG3' ' A' ' 13' ' ' GLU . 38.5 Cg_endo -59.61 155.14 43.98 Favored 'Trans proline' 0 CA--C 1.564 2.0 0 O-C-N 122.471 0.722 . . . . 0.0 110.899 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.541 HG23 ' N ' ' A' ' 31' ' ' LYS . 1.7 p -42.81 -51.63 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.527 3.383 0 O-C-N 120.577 -1.327 . . . . 0.0 110.139 -178.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.519 ' N ' ' CG1' ' A' ' 11' ' ' VAL . 1.5 t -55.01 -43.23 73.45 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 121.12 -0.987 . . . . 0.0 111.239 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.74 ' O ' HD12 ' A' ' 17' ' ' LEU . 1.7 mm-40 -68.38 -27.32 66.13 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 117.947 -1.501 . . . . 0.0 107.59 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.617 ' CD1' ' HB ' ' A' ' 9' ' ' THR . 0.0 OUTLIER -70.61 -41.46 72.26 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.132 -0.98 . . . . 0.0 109.089 176.958 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.619 HG23 ' HB2' ' A' ' 26' ' ' LEU . 1.8 mp -69.81 -36.1 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 C-N-CA 117.824 -1.55 . . . . 0.0 109.216 179.11 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.568 ' HA ' ' HG2' ' A' ' 19' ' ' GLU . 86.8 m -69.31 -40.78 77.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.03 -1.669 . . . . 0.0 109.816 179.063 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.74 HD12 ' O ' ' A' ' 13' ' ' GLU . 1.9 mt -64.84 -37.62 88.22 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.696 -1.252 . . . . 0.0 108.923 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 1.041 ' HA2' HD13 ' A' ' 38' ' ' ILE . . . -68.2 -44.67 74.92 Favored Glycine 0 N--CA 1.507 3.395 0 N-CA-C 108.929 -1.668 . . . . 0.0 108.929 178.473 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.675 ' HG3' ' N ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -57.08 -37.11 71.42 Favored 'General case' 0 N--CA 1.484 1.232 0 O-C-N 120.496 -1.59 . . . . 0.0 107.463 178.896 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.675 ' N ' ' HG3' ' A' ' 19' ' ' GLU . 28.9 m120 -61.05 -24.44 66.2 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 118.293 -1.363 . . . . 0.0 109.532 178.357 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.949 ' HG3' HD11 ' A' ' 38' ' ' ILE . 69.6 mmm -97.33 2.18 50.32 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.188 -0.945 . . . . 0.0 111.595 -179.352 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.55 -3.66 65.9 Favored Glycine 0 N--CA 1.498 2.799 0 C-N-CA 118.249 -1.929 . . . . 0.0 114.142 177.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 1.025 ' H ' HD13 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -103.52 63.98 0.8 Allowed 'General case' 0 N--CA 1.509 2.5 0 CA-C-N 121.644 2.722 . . . . 0.0 111.25 179.854 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.521 ' O ' ' CB ' ' A' ' 25' ' ' ASN . 5.1 pt-20 -57.11 -167.71 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.199 0 CA-C-O 122.367 1.08 . . . . 0.0 110.754 178.563 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.521 ' CB ' ' O ' ' A' ' 24' ' ' GLU . 0.7 OUTLIER 74.62 10.16 4.11 Favored 'General case' 0 N--CA 1.516 2.84 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.571 179.723 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.833 HD11 ' O ' ' A' ' 23' ' ' LEU . 1.0 OUTLIER -77.14 -18.57 57.79 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.245 -0.909 . . . . 0.0 112.35 -179.358 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.408 ' C ' ' O ' ' A' ' 26' ' ' LEU . . . -46.99 -40.21 14.01 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.313 -1.492 . . . . 0.0 108.771 -179.324 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 28.0 mtt-85 -81.15 -0.56 40.82 Favored 'General case' 0 C--N 1.295 -1.786 0 C-N-CA 119.725 -0.79 . . . . 0.0 111.359 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.562 ' HB3' HG13 ' A' ' 34' ' ' ILE . 15.7 mtp -101.21 156.78 17.23 Favored 'General case' 0 C--N 1.312 -1.038 0 O-C-N 120.915 -1.116 . . . . 0.0 111.841 -178.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.834 ' O ' HD12 ' A' ' 34' ' ' ILE . 3.8 ttm180 -89.76 175.08 7.37 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.429 -0.794 . . . . 0.0 110.561 177.956 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.905 ' O ' HG22 ' A' ' 35' ' ' ILE . 9.2 pttm -66.41 -33.33 75.47 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.449 -0.782 . . . . 0.0 110.989 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.466 ' N ' ' HG3' ' A' ' 31' ' ' LYS . 1.3 mm100 -65.57 -55.02 19.98 Favored 'General case' 0 N--CA 1.523 3.192 0 CA-C-O 122.021 0.915 . . . . 0.0 110.018 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.55 ' OD1' ' N ' ' A' ' 34' ' ' ILE . 2.0 p30 -67.33 -41.91 84.45 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.074 -1.016 . . . . 0.0 109.685 -179.054 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.834 HD12 ' O ' ' A' ' 30' ' ' ARG . 29.0 mt -61.79 -40.84 88.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 O-C-N 120.357 -1.464 . . . . 0.0 109.637 178.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.905 HG22 ' O ' ' A' ' 31' ' ' LYS . 0.2 OUTLIER -66.92 -37.26 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.557 0 O-C-N 120.113 -1.617 . . . . 0.0 109.049 178.149 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 9.2 m-30 -67.02 -45.57 77.1 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.377 -1.452 . . . . 0.0 108.716 178.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.443 ' O ' ' C ' ' A' ' 38' ' ' ILE . . . -67.01 -53.46 31.16 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.49 -1.381 . . . . 0.0 109.487 178.053 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 1.041 HD13 ' HA2' ' A' ' 18' ' ' GLY . 5.9 tp -48.46 -49.99 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 C-N-CA 117.536 -1.665 . . . . 0.0 108.093 179.134 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.665 ' N ' HG23 ' A' ' 38' ' ' ILE . 5.6 tp -53.87 -41.56 67.65 Favored 'General case' 0 N--CA 1.52 3.052 0 O-C-N 120.76 -1.213 . . . . 0.0 109.1 179.431 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.48 ' O ' ' HD2' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -60.59 -36.05 77.59 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 121.628 0.727 . . . . 0.0 109.739 179.271 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.755 ' CG ' HD12 ' A' ' 23' ' ' LEU . 11.8 mm-40 -79.34 -51.4 9.46 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.663 -0.648 . . . . 0.0 111.354 -179.024 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.612 ' CG ' ' CE ' ' A' ' 21' ' ' MET . 0.2 OUTLIER -61.38 -31.59 71.5 Favored 'General case' 0 N--CA 1.503 2.204 0 C-N-CA 117.736 -1.586 . . . . 0.0 108.425 179.406 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 46' ' ' GLY . . . -58.96 -44.56 91.5 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 177.822 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.492 ' HB2' ' O ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -49.22 -45.24 44.19 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 122.11 0.957 . . . . 0.0 108.944 177.952 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 65.5 m -66.8 -8.36 28.0 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 121.639 0.733 . . . . 0.0 109.581 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . 74.53 29.5 61.61 Favored Glycine 0 N--CA 1.495 2.621 0 C-N-CA 120.186 -1.006 . . . . 0.0 111.774 178.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.03 166.65 22.09 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.173 -1.781 . . . . 0.0 108.975 178.818 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -88.1 130.22 35.08 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.234 -0.916 . . . . 0.0 109.739 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.806 HG22 ' SD ' ' A' ' 1' ' ' MET . 0.6 OUTLIER -131.0 135.8 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.562 -1.336 . . . . 0.0 107.655 178.97 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.522 ' O ' ' HA ' ' A' ' 2' ' ' ASN . 17.0 p90 -141.82 165.14 28.29 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 116.28 -2.168 . . . . 0.0 114.834 -177.915 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -114.21 164.8 12.03 Favored Glycine 0 N--CA 1.503 3.117 0 N-CA-C 108.307 -1.917 . . . . 0.0 108.307 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.461 ' OD1' ' N ' ' A' ' 52' ' ' ASP . 46.7 p-10 -169.79 164.63 9.91 Favored 'General case' 0 N--CA 1.48 1.047 0 O-C-N 120.36 -1.671 . . . . 0.0 110.298 -178.838 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.54 ' HA3' ' O ' ' A' ' 66' ' ' ARG . . . 140.87 -134.98 6.68 Favored Glycine 0 N--CA 1.504 3.227 0 C-N-CA 118.258 -1.925 . . . . 0.0 111.378 178.378 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.588 ' HA ' ' O ' ' A' ' 95' ' ' ASP . 2.6 t -128.17 119.85 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 O-C-N 121.414 -1.051 . . . . 0.0 108.265 -179.357 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.77 HD21 HG21 ' A' ' 81' ' ' VAL . 5.6 mt -62.29 161.61 11.15 Favored 'General case' 0 N--CA 1.501 2.124 0 C-N-CA 118.74 -1.184 . . . . 0.0 113.454 -175.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.512 ' HA ' ' OG1' ' A' ' 93' ' ' THR . 3.4 tp10 -137.31 116.35 12.45 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 178.119 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.608 ' CG1' ' HB ' ' A' ' 93' ' ' THR . 1.3 mm -84.31 159.35 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 120.151 -1.593 . . . . 0.0 108.811 -179.156 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.637 HD22 ' HE1' ' A' ' 62' ' ' PHE . 2.8 mp -130.96 138.82 49.9 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.348 -1.47 . . . . 0.0 109.961 179.27 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.453 ' C ' ' O ' ' A' ' 58' ' ' LEU . 3.7 tt0 -38.24 -36.72 0.24 Allowed 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.66 0.743 . . . . 0.0 110.414 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -60.99 -7.74 2.69 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.502 -0.749 . . . . 0.0 112.319 -179.209 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 91.34 8.39 64.39 Favored Glycine 1 N--CA 1.518 4.151 0 C-N-CA 118.729 -1.701 . . . . 0.0 112.255 177.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.637 ' HE1' HD22 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -127.65 -179.68 5.06 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 104.883 -2.266 . . . . 0.0 104.883 178.098 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.438 ' HA2' HD13 ' A' ' 58' ' ' LEU . . . -158.56 170.77 35.22 Favored Glycine 0 N--CA 1.475 1.293 0 C-N-CA 116.712 -2.661 . . . . 0.0 111.784 -177.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.417 ' HE1' ' CE2' ' A' ' 62' ' ' PHE . 6.9 m-85 -129.9 153.0 48.76 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 119.858 1.829 . . . . 0.0 109.753 177.478 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.513 ' HB3' ' HB ' ' A' ' 79' ' ' ILE . 0.3 OUTLIER -98.9 160.14 14.47 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 176.567 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.54 ' O ' ' HA3' ' A' ' 53' ' ' GLY . 0.0 OUTLIER 178.26 -162.75 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.196 -0.94 . . . . 0.0 109.561 179.191 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.487 ' N ' ' HG3' ' A' ' 66' ' ' ARG . 1.1 m -72.74 -156.8 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.98 -1.075 . . . . 0.0 110.282 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -127.3 -90.86 0.52 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.426 -0.796 . . . . 0.0 110.116 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -73.36 48.36 0.24 Allowed 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.165 -0.959 . . . . 0.0 111.102 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -123.34 -15.6 7.13 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.32 -1.488 . . . . 0.0 110.423 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.554 ' O ' ' HB2' ' A' ' 72' ' ' TYR . 0.5 OUTLIER 177.86 -26.9 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.965 -1.084 . . . . 0.0 110.733 179.637 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.554 ' HB2' ' O ' ' A' ' 71' ' ' SER . 23.5 m-85 76.41 -43.54 0.46 Allowed 'General case' 0 N--CA 1.52 3.069 0 O-C-N 121.651 -0.656 . . . . 0.0 111.731 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.506 ' O ' ' HD2' ' A' ' 66' ' ' ARG . 6.9 mt -77.68 -172.09 2.46 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.355 -1.466 . . . . 0.0 109.626 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.18 -157.69 0.13 Allowed 'General case' 0 C--N 1.288 -2.095 0 CA-C-O 122.419 1.104 . . . . 0.0 109.571 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.414 ' CA ' ' OD1' ' A' ' 78' ' ' ASP . . . 176.49 164.93 31.32 Favored Glycine 0 C--N 1.278 -2.67 0 N-CA-C 107.789 -2.124 . . . . 0.0 107.789 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -64.86 -40.16 22.55 Favored 'Trans proline' 0 N--CA 1.489 1.263 0 CA-C-N 118.364 1.082 . . . . 0.0 112.156 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.485 ' HB2' ' HD2' ' A' ' 7' ' ' LYS . 2.2 m-20 -86.78 16.49 4.75 Favored 'General case' 0 N--CA 1.507 2.38 0 O-C-N 121.112 -0.992 . . . . 0.0 112.488 -178.651 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.695 ' C ' HD12 ' A' ' 79' ' ' ILE . 0.6 OUTLIER -76.37 -152.91 0.04 OUTLIER 'General case' 0 N--CA 1.509 2.515 0 O-C-N 120.528 -1.358 . . . . 0.0 109.462 179.371 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.695 HD12 ' C ' ' A' ' 78' ' ' ASP . 1.7 mp -135.9 138.27 47.81 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.812 0 O-C-N 120.961 -1.087 . . . . 0.0 110.043 178.776 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.512 ' HB3' ' O ' ' A' ' 111' ' ' PHE . 5.9 t80 -80.8 146.34 30.99 Favored 'General case' 0 N--CA 1.518 2.955 0 O-C-N 119.685 -1.884 . . . . 0.0 110.028 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.77 HG21 HD21 ' A' ' 55' ' ' LEU . 38.4 t -142.44 112.9 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 120.24 -1.537 . . . . 0.0 110.117 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.552 ' O ' HG13 ' A' ' 86' ' ' ILE . 22.0 m -74.86 166.82 42.16 Favored Pre-proline 0 N--CA 1.512 2.643 0 O-C-N 120.58 -1.325 . . . . 0.0 112.133 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.572 ' HA ' HG13 ' A' ' 86' ' ' ILE . 38.8 Cg_endo -65.19 -53.82 0.76 Allowed 'Trans proline' 0 C--N 1.314 -1.257 0 O-C-N 124.651 1.869 . . . . 0.0 109.08 178.823 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.56 ' O ' ' CG ' ' A' ' 88' ' ' ARG . 0.8 OUTLIER -45.14 -41.01 7.6 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 178.119 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.568 ' O ' ' CD2' ' A' ' 89' ' ' PHE . 6.6 mm100 -62.74 -57.81 9.65 Favored 'General case' 0 N--CA 1.509 2.517 0 C-N-CA 119.118 -1.033 . . . . 0.0 108.49 178.221 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.572 HG13 ' HA ' ' A' ' 83' ' ' PRO . 0.2 OUTLIER -59.15 -54.84 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.35 0 O-C-N 121.084 -1.01 . . . . 0.0 108.846 178.648 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.483 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 0.0 OUTLIER -56.22 -42.67 77.62 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-O 121.83 0.824 . . . . 0.0 111.225 -179.102 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.56 ' CG ' ' O ' ' A' ' 84' ' ' SER . 1.4 mmt85 -60.42 -36.42 78.11 Favored 'General case' 0 N--CA 1.507 2.382 0 C-N-CA 119.647 -0.821 . . . . 0.0 111.871 -177.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.568 ' CD2' ' O ' ' A' ' 85' ' ' GLN . 4.7 m-85 -109.74 12.75 23.98 Favored 'General case' 0 N--CA 1.503 2.218 0 C-N-CA 117.494 -1.682 . . . . 0.0 111.174 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 59.52 52.88 5.41 Favored 'General case' 0 N--CA 1.485 1.308 0 O-C-N 120.524 -1.36 . . . . 0.0 109.686 178.906 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.55 ' HB2' HG22 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -90.12 174.39 7.66 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.486 -0.758 . . . . 0.0 109.757 179.867 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.533 ' HG2' ' O ' ' A' ' 91' ' ' LEU . 10.3 mtm180 -147.56 159.82 43.33 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.173 -0.955 . . . . 0.0 108.678 178.173 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.608 ' HB ' ' CG1' ' A' ' 57' ' ' ILE . 1.9 t -63.54 156.28 26.92 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 117.143 -1.823 . . . . 0.0 107.031 179.381 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 77.2 -11.21 17.34 Favored Glycine 0 N--CA 1.505 3.251 0 C-N-CA 117.177 -2.439 . . . . 0.0 110.107 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.588 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 12.5 m-20 -68.26 146.93 52.87 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.211 -1.758 . . . . 0.0 110.943 -178.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.499 ' O ' HG12 ' A' ' 97' ' ' ILE . 0.2 OUTLIER -90.05 120.91 31.64 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.179 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.519 HG23 ' O ' ' A' ' 118' ' ' GLU . 1.5 mt -145.95 167.51 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 119.871 -1.768 . . . . 0.0 112.81 -178.611 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.527 ' OG ' ' HB2' ' A' ' 118' ' ' GLU . 99.8 p -149.25 138.95 21.8 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.988 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.52 ' O ' ' HB2' ' A' ' 50' ' ' PHE . . . -163.11 178.09 38.91 Favored Glycine 0 N--CA 1.507 3.42 0 C-N-CA 117.405 -2.331 . . . . 0.0 114.757 -178.87 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.503 ' HG2' ' HB3' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -88.06 155.88 19.58 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 178.982 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.521 HG13 HG13 ' A' ' 49' ' ' ILE . 1.7 pt -123.04 161.89 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.369 0 CA-C-N 120.636 1.562 . . . . 0.0 113.586 -177.483 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.949 ' HB2' HD22 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -143.71 129.47 9.97 Favored Pre-proline 0 N--CA 1.485 1.308 0 O-C-N 120.608 -1.307 . . . . 0.0 108.808 179.695 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.517 ' HD2' ' CD ' ' A' ' 102' ' ' ARG . 49.7 Cg_endo -75.89 115.6 4.21 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 124.204 1.634 . . . . 0.0 110.853 -179.154 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.65 -152.06 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.979 1.515 . . . . 0.0 109.346 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 8.3 mttm -83.26 168.8 16.37 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.837 -1.165 . . . . 0.0 109.209 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.86 -22.76 65.8 Favored 'General case' 0 C--N 1.309 -1.174 0 O-C-N 120.683 -1.26 . . . . 0.0 109.896 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -67.26 2.79 4.99 Favored Glycine 0 N--CA 1.501 2.984 0 C-N-CA 119.054 -1.546 . . . . 0.0 111.387 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.53 ' O ' ' HB3' ' A' ' 109' ' ' ARG . 0.5 OUTLIER -106.87 -26.42 11.24 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-N 120.236 2.018 . . . . 0.0 110.078 179.819 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.53 ' HB3' ' O ' ' A' ' 108' ' ' GLU . 4.9 tpp180 68.84 -41.42 0.47 Allowed 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.529 -0.732 . . . . 0.0 112.628 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -106.57 148.56 28.12 Favored 'General case' 0 N--CA 1.52 3.055 0 O-C-N 120.126 -1.609 . . . . 0.0 109.678 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.64 ' CE2' HD23 ' A' ' 39' ' ' LEU . 3.4 m-30 -67.72 168.09 12.0 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 119.851 -1.781 . . . . 0.0 108.093 178.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.431 ' HA ' ' HB3' ' A' ' 80' ' ' TYR . . . -121.85 154.15 37.44 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.237 -1.539 . . . . 0.0 110.345 -179.195 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.54 150.52 46.62 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.949 HD22 ' HB2' ' A' ' 102' ' ' ARG . 20.0 tp -127.93 -55.9 1.28 Allowed 'General case' 0 N--CA 1.501 2.088 0 O-C-N 120.282 -1.511 . . . . 0.0 112.373 -178.945 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.503 ' HB3' ' HG2' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -123.98 142.58 51.04 Favored 'General case' 0 N--CA 1.509 2.513 0 O-C-N 120.32 -1.487 . . . . 0.0 109.263 179.417 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.8 t -92.98 130.7 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.831 0 O-C-N 120.468 -1.395 . . . . 0.0 111.057 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -107.17 -40.93 5.28 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 121.357 -0.839 . . . . 0.0 109.725 178.653 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.562 ' C ' HG23 ' A' ' 119' ' ' VAL . 0.0 OUTLIER -143.67 159.48 42.41 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.872 -1.142 . . . . 0.0 109.74 179.483 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.562 HG23 ' C ' ' A' ' 118' ' ' GLU . 13.1 t -158.5 138.14 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -178.498 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.472 ' O ' ' C ' ' A' ' 121' ' ' PHE . 1.4 m-20 48.28 41.5 16.25 Favored 'General case' 0 N--CA 1.516 2.853 0 O-C-N 120.332 -1.48 . . . . 0.0 110.643 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.472 ' C ' ' O ' ' A' ' 120' ' ' ASN . 0.1 OUTLIER 38.12 33.45 0.06 Allowed 'General case' 0 N--CA 1.52 3.049 0 O-C-N 121.048 -1.033 . . . . 0.0 110.01 179.827 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.425 ' N ' ' O ' ' A' ' 120' ' ' ASN . 0.1 OUTLIER -154.67 174.87 14.4 Favored 'General case' 0 N--CA 1.484 1.255 0 O-C-N 120.989 -1.069 . . . . 0.0 109.228 179.386 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.541 ' HB3' ' HD2' ' A' ' 124' ' ' PRO . 11.6 mmtt -60.63 168.39 2.55 Favored Pre-proline 0 N--CA 1.506 2.328 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.541 ' HD2' ' HB3' ' A' ' 123' ' ' LYS . 44.8 Cg_endo -72.66 41.75 0.55 Allowed 'Trans proline' 0 C--N 1.308 -1.58 0 O-C-N 123.399 1.21 . . . . 0.0 111.168 -179.398 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.495 ' O ' ' CB ' ' A' ' 126' ' ' ASN . 3.0 tp10 -178.17 -135.22 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.946 -1.096 . . . . 0.0 108.213 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.495 ' CB ' ' O ' ' A' ' 125' ' ' GLU . 1.0 OUTLIER 167.69 -66.68 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.145 0 O-C-N 120.412 -1.43 . . . . 0.0 109.71 179.32 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.513 ' O ' ' HB3' ' A' ' 128' ' ' ARG . . . -150.52 177.61 9.86 Favored 'General case' 0 C--N 1.295 -1.798 0 C-N-CA 119.883 -0.727 . . . . 0.0 109.519 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.513 ' HB3' ' O ' ' A' ' 127' ' ' ALA . 0.0 OUTLIER 174.29 -30.11 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.47 -1.394 . . . . 0.0 110.129 -179.724 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -82.75 163.65 21.14 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.485 -0.76 . . . . 0.0 110.65 -179.221 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 2.1 mmtt . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.604 179.625 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.629 ' HA ' ' HA ' ' A' ' 49' ' ' ILE . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.664 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 . . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.584 ' HA ' ' O ' ' A' ' 50' ' ' PHE . 63.5 t30 -78.5 91.06 4.5 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.725 -1.234 . . . . 0.0 108.444 178.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.552 ' CD1' HD11 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -41.59 -40.4 1.88 Allowed 'General case' 0 N--CA 1.52 3.035 0 O-C-N 120.598 -1.314 . . . . 0.0 110.371 -178.186 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.467 ' OG1' ' CG ' ' A' ' 52' ' ' ASP . 1.9 m -60.13 -35.07 74.45 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 118.601 -1.24 . . . . 0.0 108.288 -179.083 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.566 ' HB3' ' HB3' ' A' ' 2' ' ' ASN . 0.9 OUTLIER -72.65 -44.57 61.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.922 -1.112 . . . . 0.0 108.245 177.386 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.639 HD12 HG13 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -51.01 -51.4 53.36 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 120.834 -1.167 . . . . 0.0 108.68 178.37 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 8.1 mttm -62.5 -40.92 98.27 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.121 -0.987 . . . . 0.0 109.831 178.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.405 ' HB2' ' HA ' ' A' ' 5' ' ' GLU . 2.7 m-80 -62.74 -20.65 65.15 Favored 'General case' 0 N--CA 1.508 2.456 0 CA-C-O 121.79 0.805 . . . . 0.0 111.141 -179.072 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.738 ' HB ' HD11 ' A' ' 14' ' ' LEU . 94.5 m -79.26 122.25 83.94 Favored Pre-proline 0 C--N 1.283 -2.289 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.555 ' HG2' ' CG ' ' A' ' 13' ' ' GLU . 37.2 Cg_endo -57.48 155.55 30.36 Favored 'Trans proline' 0 N--CA 1.503 2.068 0 C-N-CA 120.488 0.792 . . . . 0.0 112.219 -177.609 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.56 ' CG1' ' N ' ' A' ' 12' ' ' SER . 1.6 p -45.24 -51.73 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.541 0 O-C-N 120.502 -1.374 . . . . 0.0 110.44 -178.843 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.56 ' N ' ' CG1' ' A' ' 11' ' ' VAL . 0.9 OUTLIER -56.86 -41.57 78.19 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.081 -1.012 . . . . 0.0 110.646 -179.52 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.605 ' HB3' HG23 ' A' ' 9' ' ' THR . 48.2 mm-40 -68.95 -26.85 65.27 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 118.155 -1.418 . . . . 0.0 107.975 179.375 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.738 HD11 ' HB ' ' A' ' 9' ' ' THR . 0.9 OUTLIER -70.35 -43.14 70.82 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 120.96 -1.087 . . . . 0.0 108.439 177.381 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.548 HD12 ' O ' ' A' ' 11' ' ' VAL . 1.4 mp -66.37 -40.15 85.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 C-N-CA 118.108 -1.437 . . . . 0.0 108.659 178.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.577 ' HA ' ' HG2' ' A' ' 19' ' ' GLU . 92.7 m -63.91 -38.03 89.59 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.394 -1.441 . . . . 0.0 109.267 179.16 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.534 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 0.7 OUTLIER -65.81 -37.79 87.22 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.85 -1.156 . . . . 0.0 108.779 178.553 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.466 ' HA2' HD13 ' A' ' 23' ' ' LEU . . . -67.36 -43.5 87.7 Favored Glycine 0 N--CA 1.513 3.794 0 N-CA-C 108.505 -1.838 . . . . 0.0 108.505 178.51 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.687 ' HG3' ' N ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -59.33 -37.98 79.16 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.507 -1.584 . . . . 0.0 108.117 178.922 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.687 ' N ' ' HG3' ' A' ' 19' ' ' GLU . 28.1 m120 -61.32 -29.01 69.62 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 118.201 -1.4 . . . . 0.0 109.405 178.633 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.516 ' HG3' ' O ' ' A' ' 17' ' ' LEU . 18.6 mtp -101.53 12.84 36.57 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.215 -0.928 . . . . 0.0 111.153 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.66 -22.9 34.29 Favored Glycine 0 N--CA 1.502 3.082 0 C-N-CA 118.632 -1.747 . . . . 0.0 111.299 179.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 1.006 ' CD2' ' HB1' ' A' ' 37' ' ' ALA . 2.9 mp -79.45 93.63 5.42 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.396 -1.65 . . . . 0.0 109.776 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -108.1 175.79 5.36 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.141 -0.974 . . . . 0.0 109.285 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 62.99 21.1 12.7 Favored 'General case' 0 N--CA 1.507 2.404 0 O-C-N 121.914 -0.491 . . . . 0.0 111.549 178.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.743 HD11 ' HB3' ' A' ' 23' ' ' LEU . 0.4 OUTLIER -77.19 -7.59 56.12 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 120.985 -1.072 . . . . 0.0 111.413 -179.86 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 26' ' ' LEU . . . -46.71 -31.73 3.12 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.441 -1.412 . . . . 0.0 108.977 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' ARG . . . . . 0.558 ' CD ' ' C ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -80.82 -2.12 45.9 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 120.081 -0.648 . . . . 0.0 111.502 -179.99 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.541 ' HB3' HG13 ' A' ' 34' ' ' ILE . 14.8 mtp -100.85 162.78 12.67 Favored 'General case' 0 C--N 1.313 -0.989 0 O-C-N 120.639 -1.288 . . . . 0.0 111.636 -179.004 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.722 ' O ' HD12 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -89.71 164.26 14.77 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.647 0.737 . . . . 0.0 110.563 178.502 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.576 ' O ' HG22 ' A' ' 35' ' ' ILE . 2.6 ttmm -55.62 -41.95 74.22 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.509 -0.744 . . . . 0.0 111.082 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.55 ' O ' HG22 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -63.69 -53.46 50.96 Favored 'General case' 0 N--CA 1.521 3.086 0 O-C-N 121.495 -0.753 . . . . 0.0 112.194 -178.346 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 34' ' ' ILE . 1.7 p30 -67.23 -40.56 86.35 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 120.415 -1.428 . . . . 0.0 109.312 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.722 HD12 ' O ' ' A' ' 30' ' ' ARG . 15.7 mt -61.91 -39.44 83.58 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 O-C-N 120.506 -1.371 . . . . 0.0 109.363 178.416 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.639 HG13 HD12 ' A' ' 6' ' ' LEU . 0.1 OUTLIER -67.59 -38.12 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.435 0 O-C-N 120.238 -1.539 . . . . 0.0 109.221 178.519 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.424 ' CZ ' ' OD1' ' A' ' 77' ' ' ASP . 5.3 m-85 -62.28 -43.54 98.59 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.594 -1.316 . . . . 0.0 108.86 178.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 1.006 ' HB1' ' CD2' ' A' ' 23' ' ' LEU . . . -57.2 -54.66 44.27 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.413 -1.429 . . . . 0.0 108.501 178.044 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.632 HD12 HD11 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -54.59 -32.31 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 C-N-CA 117.402 -1.719 . . . . 0.0 109.345 179.088 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.553 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 11.1 mt -68.33 -40.66 81.52 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 120.299 -1.501 . . . . 0.0 109.35 178.22 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.463 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 3.4 mtpp -66.23 -38.78 88.73 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.001 -1.062 . . . . 0.0 110.684 178.795 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.845 ' HG3' HD11 ' A' ' 23' ' ' LEU . 1.1 mm-40 -75.9 -52.87 9.38 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.24 -0.913 . . . . 0.0 111.13 -179.132 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.755 ' CD2' ' OE2' ' A' ' 47' ' ' GLU . 3.7 t60 -64.26 -36.38 83.92 Favored 'General case' 0 N--CA 1.51 2.54 0 O-C-N 120.951 -1.093 . . . . 0.0 109.37 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.553 ' HB3' ' O ' ' A' ' 39' ' ' LEU . . . -77.28 -32.24 55.35 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.89 -1.131 . . . . 0.0 110.62 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -47.33 -44.04 23.39 Favored 'General case' 0 N--CA 1.481 1.116 0 O-C-N 120.411 -1.43 . . . . 0.0 108.972 178.548 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 25.4 m -66.81 -10.57 49.12 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 119.573 -0.851 . . . . 0.0 109.548 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . 65.78 31.53 80.09 Favored Glycine 0 N--CA 1.495 2.593 0 C-N-CA 120.401 -0.904 . . . . 0.0 111.156 178.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.755 ' OE2' ' CD2' ' A' ' 42' ' ' HIS . 3.4 pt-20 -85.15 170.13 13.2 Favored 'General case' 0 N--CA 1.484 1.226 0 O-C-N 120.408 -1.642 . . . . 0.0 109.225 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.543 ' C ' HG23 ' A' ' 49' ' ' ILE . 7.6 m-20 -61.54 138.07 58.27 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.14 -0.975 . . . . 0.0 111.934 -177.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.629 ' HA ' ' HA ' ' A' ' 1' ' ' MET . 0.5 OUTLIER -157.13 144.09 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 178.455 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.584 ' O ' ' HA ' ' A' ' 2' ' ' ASN . 24.6 p90 -141.93 168.17 20.38 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 115.616 -2.434 . . . . 0.0 115.504 -178.151 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -116.15 164.32 12.28 Favored Glycine 0 N--CA 1.499 2.867 0 N-CA-C 107.784 -2.126 . . . . 0.0 107.784 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.512 ' C ' ' CD2' ' A' ' 65' ' ' LEU . 5.8 p-10 -172.37 163.18 5.59 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 120.322 -1.693 . . . . 0.0 109.657 -179.102 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.45 ' HA3' ' O ' ' A' ' 66' ' ' ARG . . . 146.31 -139.74 8.31 Favored Glycine 0 N--CA 1.504 3.195 0 C-N-CA 117.991 -2.052 . . . . 0.0 111.131 179.131 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.611 ' HA ' ' O ' ' A' ' 95' ' ' ASP . 2.6 t -128.07 119.7 51.71 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.786 HD21 HG21 ' A' ' 81' ' ' VAL . 6.9 mt -62.76 164.25 8.14 Favored 'General case' 0 N--CA 1.504 2.254 0 C-N-CA 118.782 -1.167 . . . . 0.0 113.869 -175.701 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.528 ' HA ' ' OG1' ' A' ' 93' ' ' THR . 0.8 OUTLIER -141.78 119.35 11.67 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 178.384 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.583 ' CG1' ' HB ' ' A' ' 93' ' ' THR . 1.0 OUTLIER -80.19 162.63 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 119.903 -1.748 . . . . 0.0 109.265 -178.718 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.726 HD13 ' HA2' ' A' ' 63' ' ' GLY . 3.3 mp -132.12 136.19 46.96 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.426 -1.421 . . . . 0.0 109.675 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.453 ' C ' ' O ' ' A' ' 58' ' ' LEU . 11.9 tt0 -39.77 -36.37 0.42 Allowed 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.749 0.785 . . . . 0.0 110.102 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.458 ' HB2' ' CD1' ' A' ' 62' ' ' PHE . 66.6 m-20 -61.46 -5.94 2.04 Favored 'General case' 0 N--CA 1.501 2.092 0 C-N-CA 119.959 -0.696 . . . . 0.0 112.51 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.446 ' O ' ' HB3' ' A' ' 83' ' ' PRO . . . 89.85 11.91 62.95 Favored Glycine 1 N--CA 1.52 4.282 0 C-N-CA 118.71 -1.709 . . . . 0.0 112.185 178.089 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.616 ' CZ ' HD22 ' A' ' 58' ' ' LEU . 2.8 p90 -132.95 -176.93 4.28 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 103.865 -2.642 . . . . 0.0 103.865 177.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.726 ' HA2' HD13 ' A' ' 58' ' ' LEU . . . -158.75 172.39 35.58 Favored Glycine 0 N--CA 1.474 1.216 0 C-N-CA 116.933 -2.556 . . . . 0.0 111.706 -177.553 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.544 ' CE2' ' CE2' ' A' ' 62' ' ' PHE . 43.5 m-85 -129.7 154.29 47.31 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 119.99 1.895 . . . . 0.0 109.708 177.48 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.512 ' CD2' ' C ' ' A' ' 52' ' ' ASP 0.255 0.2 OUTLIER -98.39 134.33 41.54 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 107.005 -1.479 . . . . 0.0 107.005 176.892 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.45 ' O ' ' HA3' ' A' ' 53' ' ' GLY . 0.4 OUTLIER -135.99 -173.04 3.27 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.225 -1.547 . . . . 0.0 109.658 179.446 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.479 ' HB2' ' OG ' ' A' ' 70' ' ' SER . 6.5 m -76.71 -161.17 0.18 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.036 -1.04 . . . . 0.0 110.573 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -127.68 -89.73 0.53 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.445 -0.785 . . . . 0.0 109.659 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -77.24 44.69 0.42 Allowed 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.148 -0.97 . . . . 0.0 111.245 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.479 ' OG ' ' HB2' ' A' ' 67' ' ' SER . 0.1 OUTLIER -126.35 -7.68 6.4 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 120.17 -1.581 . . . . 0.0 110.464 -179.665 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.69 ' O ' ' HB2' ' A' ' 72' ' ' TYR . 0.6 OUTLIER 175.37 -20.45 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.229 0 O-C-N 120.851 -1.156 . . . . 0.0 111.537 -179.831 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.69 ' HB2' ' O ' ' A' ' 71' ' ' SER . 10.2 m-30 75.0 -40.76 0.45 Allowed 'General case' 0 N--CA 1.528 3.459 0 O-C-N 121.849 -0.532 . . . . 0.0 112.104 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 73' ' ' LEU . 7.0 mt -88.37 -173.57 4.25 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.279 -1.513 . . . . 0.0 109.904 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.03 -153.01 0.08 Allowed 'General case' 0 C--N 1.292 -1.934 0 CA-C-O 122.46 1.124 . . . . 0.0 109.725 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.521 ' N ' ' OD2' ' A' ' 78' ' ' ASP . . . -176.29 162.5 31.31 Favored Glycine 0 C--N 1.28 -2.532 0 N-CA-C 107.724 -2.15 . . . . 0.0 107.724 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -65.16 -41.2 17.19 Favored 'Trans proline' 0 N--CA 1.489 1.215 0 CA-C-N 118.608 1.204 . . . . 0.0 112.077 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.471 ' O ' ' O ' ' A' ' 78' ' ' ASP . 4.7 m-20 -87.45 19.83 3.13 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 120.93 -1.106 . . . . 0.0 112.461 -178.648 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.521 ' OD2' ' N ' ' A' ' 75' ' ' GLY . 3.2 m-20 -58.97 -154.65 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.429 0 O-C-N 120.415 -1.428 . . . . 0.0 109.632 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.435 ' HB ' ' CB ' ' A' ' 65' ' ' LEU . 4.4 mm -120.21 131.61 72.07 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.745 0 O-C-N 120.969 -1.082 . . . . 0.0 109.979 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.508 ' HB3' ' O ' ' A' ' 111' ' ' PHE . 10.4 t80 -76.71 147.35 37.44 Favored 'General case' 0 N--CA 1.518 2.934 0 CA-C-N 121.85 2.114 . . . . 0.0 109.462 179.261 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.786 HG21 HD21 ' A' ' 55' ' ' LEU . 11.1 t -145.51 116.8 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 120.151 -1.593 . . . . 0.0 110.2 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.564 ' O ' HG13 ' A' ' 86' ' ' ILE . 56.1 m -74.95 161.67 76.62 Favored Pre-proline 0 N--CA 1.51 2.555 0 O-C-N 120.34 -1.475 . . . . 0.0 112.248 -179.294 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.583 ' HA ' HG13 ' A' ' 86' ' ' ILE . 38.0 Cg_endo -65.19 -50.97 1.73 Allowed 'Trans proline' 0 C--N 1.313 -1.315 0 O-C-N 124.887 1.993 . . . . 0.0 108.554 178.569 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.572 ' O ' ' CG ' ' A' ' 88' ' ' ARG . 3.0 p -46.02 -41.53 12.08 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 177.718 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.525 ' OE1' ' HA ' ' A' ' 85' ' ' GLN . 6.6 mm100 -62.48 -58.07 8.92 Favored 'General case' 0 N--CA 1.511 2.586 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 178.368 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.583 HG13 ' HA ' ' A' ' 83' ' ' PRO . 0.4 OUTLIER -55.83 -56.26 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.262 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 178.386 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.482 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 9.7 mtt85 -58.41 -41.84 85.84 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-O 121.825 0.822 . . . . 0.0 111.731 -179.016 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.572 ' CG ' ' O ' ' A' ' 84' ' ' SER . 0.1 OUTLIER -60.04 -37.66 80.46 Favored 'General case' 0 N--CA 1.507 2.376 0 C-N-CA 119.612 -0.835 . . . . 0.0 111.938 -177.679 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 1.019 ' HB2' HD21 ' A' ' 91' ' ' LEU . 5.0 m-85 -109.58 11.85 24.59 Favored 'General case' 0 N--CA 1.503 2.206 0 C-N-CA 116.818 -1.953 . . . . 0.0 111.148 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.406 ' CB ' ' O ' ' A' ' 89' ' ' PHE . 1.5 t-20 63.74 53.6 1.97 Allowed 'General case' 0 N--CA 1.486 1.342 0 O-C-N 120.611 -1.306 . . . . 0.0 110.818 178.405 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 1.019 HD21 ' HB2' ' A' ' 89' ' ' PHE . 2.9 mt -89.7 -168.96 2.3 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 119.37 -0.932 . . . . 0.0 109.752 179.259 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.53 ' CG ' ' O ' ' A' ' 91' ' ' LEU . 0.2 OUTLIER -159.7 161.38 34.83 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 178.231 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.583 ' HB ' ' CG1' ' A' ' 57' ' ' ILE . 1.9 t -64.83 155.64 33.39 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 116.869 -1.932 . . . . 0.0 106.893 178.505 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLY . . . . . 0.407 ' C ' HG12 ' A' ' 54' ' ' VAL . . . 75.29 -9.09 14.6 Favored Glycine 0 N--CA 1.506 3.338 0 C-N-CA 117.299 -2.382 . . . . 0.0 110.388 179.329 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.611 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 15.4 m-20 -68.1 149.66 49.34 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.137 -1.802 . . . . 0.0 110.724 -178.784 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.493 ' O ' HG12 ' A' ' 97' ' ' ILE . 0.3 OUTLIER -91.58 121.19 33.04 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.621 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.53 HG23 HG22 ' A' ' 119' ' ' VAL . 1.4 mt -144.82 166.61 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 119.93 -1.732 . . . . 0.0 112.885 -178.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.493 ' OG ' ' HB2' ' A' ' 118' ' ' GLU . 96.7 p -150.93 139.76 20.85 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.999 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.494 ' O ' ' HB2' ' A' ' 50' ' ' PHE . . . -164.47 -179.66 38.72 Favored Glycine 0 N--CA 1.509 3.545 0 C-N-CA 117.643 -2.218 . . . . 0.0 114.609 -179.214 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.506 ' HD3' HD23 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -87.23 155.39 20.11 Favored 'General case' 0 N--CA 1.504 2.239 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 178.589 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.507 HG12 ' HA ' ' A' ' 50' ' ' PHE . 2.2 pt -122.46 158.56 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.643 0 CA-C-N 121.228 1.831 . . . . 0.0 114.435 -176.846 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.782 ' HB2' HD22 ' A' ' 114' ' ' LEU . 0.1 OUTLIER -163.89 167.47 10.87 Favored Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 120.651 -1.281 . . . . 0.0 109.642 179.311 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.419 ' HD2' ' HD3' ' A' ' 102' ' ' ARG . 48.6 Cg_endo -89.62 122.8 1.17 Allowed 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 124.068 1.562 . . . . 0.0 110.391 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.538 ' HD2' ' HB2' ' A' ' 108' ' ' GLU . 43.2 Cg_endo -68.31 -93.11 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 123.903 1.475 . . . . 0.0 111.019 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 2.9 mmtp -116.76 -177.96 3.31 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.401 -0.812 . . . . 0.0 110.464 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -56.34 -25.97 50.95 Favored 'General case' 0 C--N 1.313 -1.01 0 O-C-N 120.693 -1.255 . . . . 0.0 109.357 179.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -85.13 43.3 3.23 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 108.504 -1.838 . . . . 0.0 108.504 178.154 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.566 ' O ' ' C ' ' A' ' 109' ' ' ARG . 0.7 OUTLIER -93.51 35.02 1.13 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.709 -1.465 . . . . 0.0 111.397 -179.004 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.566 ' C ' ' O ' ' A' ' 108' ' ' GLU . 3.6 mmp_? -25.13 -45.08 0.01 OUTLIER 'General case' 0 N--CA 1.513 2.712 0 O-C-N 121.793 -0.567 . . . . 0.0 111.357 -179.397 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.536 ' N ' ' CD1' ' A' ' 110' ' ' TYR . 2.8 m-85 -109.26 154.75 22.0 Favored 'General case' 0 N--CA 1.518 2.938 0 O-C-N 120.581 -1.325 . . . . 0.0 107.72 177.066 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.508 ' O ' ' HB3' ' A' ' 80' ' ' TYR . 38.1 m-85 -66.9 165.56 15.18 Favored 'General case' 0 N--CA 1.508 2.427 0 O-C-N 119.135 -2.228 . . . . 0.0 107.273 178.58 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.433 ' HA ' ' HB3' ' A' ' 80' ' ' TYR . . . -123.24 152.87 40.88 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 119.905 -1.747 . . . . 0.0 111.216 -178.504 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.42 HD12 ' N ' ' A' ' 114' ' ' LEU . 0.1 OUTLIER -66.77 153.68 42.72 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 178.753 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.782 HD22 ' HB2' ' A' ' 102' ' ' ARG . 12.9 tp -130.86 -59.41 1.0 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 120.047 -1.658 . . . . 0.0 112.361 -178.313 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.49 ' HB3' ' HG2' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -114.05 139.97 48.85 Favored 'General case' 0 N--CA 1.512 2.646 0 O-C-N 120.383 -1.448 . . . . 0.0 108.767 179.206 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 23.7 t -92.27 128.78 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.804 0 O-C-N 120.477 -1.39 . . . . 0.0 111.37 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.423 ' CG ' ' HA2' ' A' ' 99' ' ' GLY . 4.8 m-20 -106.97 -38.5 6.03 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.355 -0.841 . . . . 0.0 109.947 178.624 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.574 ' C ' HG23 ' A' ' 119' ' ' VAL . 1.1 tt0 -143.5 157.21 44.62 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.786 -1.196 . . . . 0.0 109.803 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.574 HG23 ' C ' ' A' ' 118' ' ' GLU . 17.8 t -159.74 130.99 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 122.387 -0.196 . . . . 0.0 110.511 -178.532 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.43 ' O ' ' C ' ' A' ' 121' ' ' PHE . 0.1 OUTLIER 47.95 48.24 18.11 Favored 'General case' 0 N--CA 1.521 3.081 0 O-C-N 120.309 -1.495 . . . . 0.0 111.481 178.902 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.43 ' C ' ' O ' ' A' ' 120' ' ' ASN . 0.6 OUTLIER 42.81 32.16 0.37 Allowed 'General case' 0 N--CA 1.52 3.056 0 O-C-N 120.557 -1.339 . . . . 0.0 110.43 179.152 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -139.61 165.87 26.1 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.05 -1.031 . . . . 0.0 108.455 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.451 ' CD ' ' H ' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -78.47 143.73 64.45 Favored Pre-proline 0 N--CA 1.504 2.229 0 O-C-N 120.564 -1.335 . . . . 0.0 109.109 -179.971 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.459 ' O ' ' HB2' ' A' ' 125' ' ' GLU . 46.6 Cg_endo -73.65 42.63 0.71 Allowed 'Trans proline' 0 C--N 1.309 -1.536 0 O-C-N 123.879 1.462 . . . . 0.0 110.855 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.561 ' O ' ' CB ' ' A' ' 126' ' ' ASN . 5.3 tp10 -179.25 -144.73 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.561 ' CB ' ' O ' ' A' ' 125' ' ' GLU . 1.3 m-20 162.74 -90.14 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.266 0 O-C-N 120.874 -1.141 . . . . 0.0 109.29 179.428 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.505 ' C ' ' HG2' ' A' ' 128' ' ' ARG . . . -149.32 6.72 0.67 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.206 -0.934 . . . . 0.0 111.099 179.566 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.505 ' HG2' ' C ' ' A' ' 127' ' ' ALA . 0.8 OUTLIER -139.8 166.86 23.5 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.462 -0.774 . . . . 0.0 109.655 179.569 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -117.78 145.6 44.4 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.114 -0.991 . . . . 0.0 109.621 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.482 1.129 0 O-C-N 120.708 -1.245 . . . . 0.0 109.755 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.668 ' HA ' ' HA ' ' A' ' 49' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.621 ' ND2' ' CE2' ' A' ' 50' ' ' PHE . 7.7 t-20 -78.46 94.18 4.88 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 120.85 -1.156 . . . . 0.0 108.137 178.836 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.901 HD12 HD12 ' A' ' 6' ' ' LEU . 0.5 OUTLIER -41.81 -42.29 2.62 Favored 'General case' 0 N--CA 1.519 3.007 0 O-C-N 120.518 -1.364 . . . . 0.0 110.241 -178.399 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.7 m -56.33 -36.46 68.74 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.983 -1.073 . . . . 0.0 108.311 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.561 ' HB2' ' HB3' ' A' ' 2' ' ' ASN . 3.0 mt-10 -76.54 -39.26 53.38 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.9 -1.125 . . . . 0.0 109.317 178.06 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.901 HD12 HD12 ' A' ' 3' ' ' LEU 0.267 90.7 mt -54.82 -49.2 71.61 Favored 'General case' 0 C--O 1.215 -0.752 0 O-C-N 120.31 -1.494 . . . . 0.0 109.174 177.984 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.04 -39.16 75.9 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.936 -1.103 . . . . 0.0 110.769 179.15 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -63.14 -22.48 66.89 Favored 'General case' 0 N--CA 1.507 2.405 0 O-C-N 121.1 -1.0 . . . . 0.0 111.221 -179.119 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.727 ' HB ' HD11 ' A' ' 14' ' ' LEU . 22.7 m -81.12 140.02 49.36 Favored Pre-proline 0 N--CA 1.505 2.278 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.537 ' HG2' ' HG3' ' A' ' 13' ' ' GLU . 41.6 Cg_endo -63.75 152.23 81.48 Favored 'Trans proline' 0 CA--C 1.566 2.088 0 O-C-N 122.293 0.628 . . . . 0.0 111.773 -177.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.506 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 1.5 p -47.58 -50.42 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.337 0 O-C-N 120.517 -1.364 . . . . 0.0 109.997 -178.811 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.502 ' N ' ' CG1' ' A' ' 11' ' ' VAL . 1.6 t -54.48 -43.72 71.98 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.011 -1.055 . . . . 0.0 110.763 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.56 ' HB3' ' CG2' ' A' ' 9' ' ' THR . 1.0 OUTLIER -68.31 -27.12 66.01 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 118.158 -1.417 . . . . 0.0 107.967 179.631 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.806 HD23 ' HG2' ' A' ' 31' ' ' LYS . 1.3 mp -70.11 -43.45 71.0 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.985 -1.072 . . . . 0.0 108.603 177.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.499 HG12 ' HB2' ' A' ' 26' ' ' LEU . 1.6 mp -66.55 -39.1 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 C-N-CA 118.148 -1.421 . . . . 0.0 108.822 178.945 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.502 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 58.8 m -64.89 -38.0 89.5 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 118.036 -1.466 . . . . 0.0 109.205 178.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.33 -36.82 83.91 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.792 -1.192 . . . . 0.0 108.907 178.709 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.519 ' HA2' HD13 ' A' ' 23' ' ' LEU . . . -67.91 -43.2 83.76 Favored Glycine 0 N--CA 1.515 3.961 0 N-CA-C 108.129 -1.989 . . . . 0.0 108.129 178.166 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -55.51 -46.39 76.98 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.631 -1.511 . . . . 0.0 107.685 178.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.502 ' OD1' ' O ' ' A' ' 16' ' ' THR . 25.2 m120 -59.53 -25.64 64.67 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 118.202 -1.399 . . . . 0.0 109.145 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.552 ' HB2' ' CD1' ' A' ' 23' ' ' LEU . 64.7 mmm -100.93 11.99 38.52 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.489 -0.757 . . . . 0.0 111.06 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 96.06 -17.15 59.82 Favored Glycine 0 N--CA 1.502 3.058 0 C-N-CA 118.804 -1.665 . . . . 0.0 111.408 179.31 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 1.0 HD23 ' HB1' ' A' ' 37' ' ' ALA . 4.1 mp -79.41 102.76 8.89 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.471 -1.605 . . . . 0.0 109.782 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.478 ' O ' ' HB2' ' A' ' 25' ' ' ASN . 2.0 pt-20 -114.85 -179.72 3.71 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.28 -0.888 . . . . 0.0 109.1 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.478 ' HB2' ' O ' ' A' ' 24' ' ' GLU . 1.8 m120 62.38 18.48 10.32 Favored 'General case' 0 N--CA 1.51 2.53 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.7 178.851 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 1.071 HD23 ' SD ' ' A' ' 29' ' ' MET . 1.2 mt -76.29 -18.22 59.07 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.196 -0.94 . . . . 0.0 111.408 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -47.27 -29.5 2.48 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.213 -1.555 . . . . 0.0 109.524 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -78.88 -30.4 44.97 Favored 'General case' 0 C--N 1.295 -1.795 0 C-N-CA 120.11 -0.636 . . . . 0.0 112.2 -179.114 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' MET . . . . . 1.071 ' SD ' HD23 ' A' ' 26' ' ' LEU . 6.6 ptm -93.22 166.99 12.05 Favored 'General case' 0 C--N 1.311 -1.073 0 O-C-N 120.426 -1.421 . . . . 0.0 111.084 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.999 ' O ' HD12 ' A' ' 34' ' ' ILE . 1.0 OUTLIER -89.39 -173.65 4.08 Favored 'General case' 0 N--CA 1.506 2.358 0 CA-C-O 122.219 1.009 . . . . 0.0 112.864 -178.428 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.806 ' HG2' HD23 ' A' ' 14' ' ' LEU . 0.3 OUTLIER -66.32 -35.67 80.97 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.522 -179.722 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -63.02 -58.82 6.01 Favored 'General case' 0 N--CA 1.515 2.796 0 O-C-N 120.766 -1.209 . . . . 0.0 109.667 -178.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.523 ' CG ' ' HE2' ' A' ' 29' ' ' MET . 3.6 p30 -66.3 -35.27 79.95 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.457 -0.777 . . . . 0.0 109.717 -179.335 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.999 HD12 ' O ' ' A' ' 30' ' ' ARG . 0.8 OUTLIER -60.9 -43.72 96.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 120.081 -1.637 . . . . 0.0 107.898 177.141 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.56 HG13 ' O ' ' A' ' 31' ' ' LYS . 86.7 mt -63.39 -45.38 98.19 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.854 0 O-C-N 120.318 -1.489 . . . . 0.0 110.357 178.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.418 ' HA ' HD12 ' A' ' 39' ' ' LEU . 3.6 m-30 -53.59 -40.15 65.43 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 119.203 -0.999 . . . . 0.0 108.566 -179.051 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 1.0 ' HB1' HD23 ' A' ' 23' ' ' LEU . . . -68.09 -54.28 19.36 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.614 -1.304 . . . . 0.0 109.606 178.221 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.526 HG13 ' O ' ' A' ' 34' ' ' ILE . 0.1 OUTLIER -53.49 -28.0 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 C-N-CA 117.545 -1.662 . . . . 0.0 110.007 -179.969 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.487 HD11 HG22 ' A' ' 35' ' ' ILE . 79.8 mt -71.13 -43.68 67.12 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 120.219 -1.551 . . . . 0.0 109.335 178.191 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.26 -39.69 92.98 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.979 -1.075 . . . . 0.0 110.581 178.832 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.781 ' CB ' HD11 ' A' ' 23' ' ' LEU . 1.4 mp0 -74.56 -51.22 15.24 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 121.146 -0.971 . . . . 0.0 110.726 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.64 ' CD2' ' CB ' ' A' ' 47' ' ' GLU . 9.9 t60 -61.99 -34.55 76.37 Favored 'General case' 0 N--CA 1.51 2.539 0 C-N-CA 118.65 -1.22 . . . . 0.0 108.573 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.451 ' O ' ' N ' ' A' ' 46' ' ' GLY . . . -70.51 -45.26 65.94 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.043 -1.036 . . . . 0.0 109.079 178.349 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -48.28 -45.66 34.97 Favored 'General case' 0 N--CA 1.484 1.252 0 O-C-N 120.752 -1.217 . . . . 0.0 109.138 178.274 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 68.4 m -66.99 -6.94 18.94 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-O 121.547 0.689 . . . . 0.0 109.696 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . 76.45 24.9 66.84 Favored Glycine 0 N--CA 1.498 2.801 0 C-N-CA 120.148 -1.025 . . . . 0.0 112.094 178.329 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.64 ' CB ' ' CD2' ' A' ' 42' ' ' HIS . 0.2 OUTLIER -79.42 166.74 21.71 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.129 -1.806 . . . . 0.0 109.086 178.817 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.432 ' C ' ' CG2' ' A' ' 49' ' ' ILE . 8.3 m-20 -88.66 150.02 23.23 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.07 -1.019 . . . . 0.0 109.391 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.668 ' HA ' ' HA ' ' A' ' 1' ' ' MET . 0.5 OUTLIER -148.98 143.28 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 120.668 -1.27 . . . . 0.0 108.46 179.246 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.621 ' CE2' ' ND2' ' A' ' 2' ' ' ASN . 23.6 p90 -142.75 172.07 13.2 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 116.088 -2.245 . . . . 0.0 114.918 -177.992 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -126.23 168.94 18.23 Favored Glycine 0 N--CA 1.508 3.445 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 -178.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -169.67 166.51 9.85 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 120.429 -1.63 . . . . 0.0 110.315 -178.904 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.587 ' HA3' ' O ' ' A' ' 66' ' ' ARG . . . 142.47 -135.75 6.79 Favored Glycine 0 N--CA 1.506 3.306 0 C-N-CA 118.349 -1.882 . . . . 0.0 111.591 178.326 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.567 ' HA ' ' O ' ' A' ' 95' ' ' ASP . 2.6 t -128.44 120.04 51.9 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 O-C-N 121.235 -1.156 . . . . 0.0 108.292 -179.467 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.853 HD21 HG21 ' A' ' 81' ' ' VAL . 6.0 mt -62.92 161.2 13.3 Favored 'General case' 0 N--CA 1.503 2.22 0 C-N-CA 118.645 -1.222 . . . . 0.0 113.681 -175.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.504 ' HA ' ' OG1' ' A' ' 93' ' ' THR . 18.1 mm-40 -137.14 117.89 14.05 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 177.86 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.647 ' C ' HD12 ' A' ' 58' ' ' LEU . 1.4 mm -82.3 162.67 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 O-C-N 119.959 -1.713 . . . . 0.0 109.624 -178.591 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.956 HD22 ' CZ ' ' A' ' 62' ' ' PHE . 5.8 mp -129.95 137.64 50.44 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.531 -1.356 . . . . 0.0 109.462 179.107 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.458 ' C ' ' O ' ' A' ' 58' ' ' LEU . 1.8 mt-30 -42.09 -34.69 0.77 Allowed 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.951 0.881 . . . . 0.0 109.143 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -61.34 -7.17 2.69 Favored 'General case' 0 N--CA 1.499 2.012 0 C-N-CA 120.213 -0.595 . . . . 0.0 112.341 -179.279 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 90.99 7.51 65.87 Favored Glycine 1 N--CA 1.52 4.252 0 C-N-CA 118.804 -1.665 . . . . 0.0 112.225 178.112 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.956 ' CZ ' HD22 ' A' ' 58' ' ' LEU . 2.0 p90 -127.8 179.77 5.37 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 104.469 -2.419 . . . . 0.0 104.469 178.087 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.55 ' N ' ' CD1' ' A' ' 62' ' ' PHE . . . -156.22 171.48 33.99 Favored Glycine 0 N--CA 1.477 1.387 0 C-N-CA 117.186 -2.435 . . . . 0.0 111.879 -178.111 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.467 ' CE2' ' HE1' ' A' ' 62' ' ' PHE . 14.5 m-85 -128.99 149.11 50.96 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 119.861 1.831 . . . . 0.0 109.25 177.238 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.546 ' HB3' ' HB ' ' A' ' 79' ' ' ILE . 0.6 OUTLIER -99.42 165.35 11.7 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 176.392 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.587 ' O ' ' HA3' ' A' ' 53' ' ' GLY . 0.0 OUTLIER 172.49 -169.73 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.97 -1.081 . . . . 0.0 109.712 178.525 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.465 ' HB2' ' OG ' ' A' ' 70' ' ' SER . 17.1 m -71.94 -159.96 0.06 Allowed 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.716 -1.24 . . . . 0.0 109.949 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -107.03 -76.02 0.62 Allowed 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 119.697 -0.801 . . . . 0.0 110.048 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -73.28 51.39 0.32 Allowed 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.305 -0.872 . . . . 0.0 110.824 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.546 ' O ' ' CB ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -110.56 -18.62 13.15 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.399 -1.438 . . . . 0.0 110.3 -179.717 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.623 ' O ' ' HB2' ' A' ' 72' ' ' TYR . 0.4 OUTLIER 165.65 -12.95 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.423 0 O-C-N 121.282 -0.886 . . . . 0.0 111.184 -179.689 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.623 ' HB2' ' O ' ' A' ' 71' ' ' SER . 69.7 m-85 77.52 -45.94 0.46 Allowed 'General case' 0 N--CA 1.524 3.234 0 O-C-N 121.798 -0.564 . . . . 0.0 110.764 -179.265 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.2 mt -87.77 -171.49 3.45 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 120.63 -1.294 . . . . 0.0 108.794 178.827 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.03 -162.21 0.37 Allowed 'General case' 0 C--N 1.289 -2.055 0 CA-C-O 122.026 0.917 . . . . 0.0 109.113 179.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -174.3 162.37 32.7 Favored Glycine 0 C--N 1.278 -2.64 0 N-CA-C 107.876 -2.09 . . . . 0.0 107.876 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.524 ' O ' ' CD1' ' A' ' 110' ' ' TYR . 35.7 Cg_endo -65.27 -41.49 15.99 Favored 'Trans proline' 0 N--CA 1.49 1.324 0 CA-C-N 118.352 1.076 . . . . 0.0 112.42 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -86.42 13.88 7.57 Favored 'General case' 0 N--CA 1.509 2.484 0 O-C-N 120.894 -1.129 . . . . 0.0 112.51 -178.471 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 78' ' ' ASP . 0.8 OUTLIER -77.43 -150.03 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.271 0 O-C-N 120.451 -1.405 . . . . 0.0 109.174 179.296 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.546 ' HB ' ' HB3' ' A' ' 65' ' ' LEU . 1.3 mp -117.88 127.64 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.721 0 C-N-CA 119.169 -1.012 . . . . 0.0 108.507 177.548 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.456 ' HB3' ' HA ' ' A' ' 112' ' ' ALA . 6.8 t80 -73.61 146.19 44.83 Favored 'General case' 0 N--CA 1.515 2.796 0 O-C-N 119.689 -1.882 . . . . 0.0 110.125 -178.425 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.853 HG21 HD21 ' A' ' 55' ' ' LEU . 34.5 t -140.36 112.02 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 120.324 -1.485 . . . . 0.0 110.603 -179.563 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.539 ' O ' HG13 ' A' ' 86' ' ' ILE . 57.9 m -74.67 165.99 49.0 Favored Pre-proline 0 N--CA 1.513 2.697 0 O-C-N 120.519 -1.363 . . . . 0.0 112.041 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.521 ' HD2' ' HB3' ' A' ' 82' ' ' SER . 40.1 Cg_endo -65.21 -50.24 2.17 Favored 'Trans proline' 0 C--N 1.315 -1.189 0 O-C-N 124.317 1.693 . . . . 0.0 109.287 179.092 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.554 ' O ' ' CG ' ' A' ' 88' ' ' ARG . 0.3 OUTLIER -47.92 -39.66 19.7 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 178.106 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.536 ' HB2' ' O ' ' A' ' 82' ' ' SER . 5.6 mm100 -63.56 -58.86 5.65 Favored 'General case' 0 N--CA 1.51 2.551 0 C-N-CA 119.375 -0.93 . . . . 0.0 108.68 178.378 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.539 HG13 ' O ' ' A' ' 82' ' ' SER . 0.3 OUTLIER -57.23 -54.22 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.417 0 O-C-N 121.076 -1.015 . . . . 0.0 108.76 178.848 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.46 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 0.2 OUTLIER -56.25 -43.83 79.06 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 121.924 0.869 . . . . 0.0 111.27 -179.519 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.554 ' CG ' ' O ' ' A' ' 84' ' ' SER . 0.1 OUTLIER -57.97 -36.71 72.98 Favored 'General case' 0 N--CA 1.506 2.369 0 C-N-CA 119.792 -0.763 . . . . 0.0 111.724 -177.694 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -113.73 13.76 18.62 Favored 'General case' 0 N--CA 1.502 2.153 0 C-N-CA 117.359 -1.736 . . . . 0.0 111.462 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 58.41 55.13 5.12 Favored 'General case' 0 N--CA 1.484 1.239 0 O-C-N 120.434 -1.416 . . . . 0.0 109.621 178.656 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.505 ' O ' ' HG2' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -89.11 -179.29 5.87 Favored 'General case' 0 N--CA 1.496 1.834 0 C-N-CA 119.521 -0.872 . . . . 0.0 109.968 -179.832 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.505 ' HG2' ' O ' ' A' ' 91' ' ' LEU . 10.6 mtt-85 -155.13 158.21 38.64 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.186 -0.946 . . . . 0.0 109.115 178.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.618 ' HB ' ' CG1' ' A' ' 57' ' ' ILE . 2.3 t -63.7 156.39 27.14 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 117.205 -1.798 . . . . 0.0 107.186 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 76.23 -10.33 16.24 Favored Glycine 0 N--CA 1.505 3.272 0 C-N-CA 117.007 -2.52 . . . . 0.0 110.233 179.133 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.567 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 25.4 m-20 -70.34 146.86 50.21 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.272 -1.723 . . . . 0.0 110.795 -178.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.497 ' O ' HG12 ' A' ' 97' ' ' ILE . 0.2 OUTLIER -90.09 121.22 31.95 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.209 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.56 HG23 HG22 ' A' ' 119' ' ' VAL . 1.5 mt -145.67 168.51 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 119.733 -1.854 . . . . 0.0 112.89 -178.109 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.51 ' OG ' ' HB2' ' A' ' 118' ' ' GLU . 98.5 p -148.49 137.55 21.74 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 178.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.584 ' O ' ' HB2' ' A' ' 50' ' ' PHE . . . -161.95 176.11 38.41 Favored Glycine 0 N--CA 1.506 3.324 0 C-N-CA 117.163 -2.446 . . . . 0.0 114.546 -178.893 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.801 ' HD3' HD23 ' A' ' 114' ' ' LEU . 2.9 ptmt -88.83 156.66 18.81 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 179.053 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.524 HG12 ' HA ' ' A' ' 50' ' ' PHE . 2.0 pt -125.55 156.36 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.432 0 CA-C-N 120.37 1.441 . . . . 0.0 113.588 -176.965 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.955 ' HG3' HD22 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -154.34 169.24 10.38 Favored Pre-proline 0 N--CA 1.488 1.466 0 O-C-N 120.56 -1.337 . . . . 0.0 109.5 179.289 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -83.98 133.97 5.98 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 O-C-N 123.964 1.507 . . . . 0.0 110.495 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.519 ' HD2' ' HG3' ' A' ' 108' ' ' GLU . 49.5 Cg_endo -80.12 -95.77 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.985 1.519 . . . . 0.0 110.448 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.59 -175.79 4.0 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.49 -0.756 . . . . 0.0 110.067 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -50.43 -26.45 5.04 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 120.517 -1.364 . . . . 0.0 109.179 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -84.64 46.79 3.73 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 107.735 -2.146 . . . . 0.0 107.735 177.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.558 ' O ' ' N ' ' A' ' 110' ' ' TYR . 4.2 tm-20 -86.01 -71.32 0.54 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.879 -1.365 . . . . 0.0 111.077 -178.837 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.501 ' HB3' ' O ' ' A' ' 108' ' ' GLU . 0.4 OUTLIER 64.22 -58.06 0.22 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.535 -0.728 . . . . 0.0 109.443 -178.803 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.558 ' N ' ' O ' ' A' ' 108' ' ' GLU . 22.7 m-85 -107.92 152.35 24.56 Favored 'General case' 0 N--CA 1.516 2.85 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 176.71 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.431 ' O ' ' HB3' ' A' ' 80' ' ' TYR . 51.4 m-85 -67.32 168.16 11.11 Favored 'General case' 0 N--CA 1.507 2.424 0 O-C-N 119.246 -2.159 . . . . 0.0 108.252 179.275 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.456 ' HA ' ' HB3' ' A' ' 80' ' ' TYR . . . -122.87 154.93 37.64 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 119.994 -1.692 . . . . 0.0 110.883 -178.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.1 tp -68.38 148.41 50.73 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.955 HD22 ' HG3' ' A' ' 102' ' ' ARG . 9.7 tp -128.74 -55.18 1.22 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.315 -1.49 . . . . 0.0 112.616 -178.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.498 ' HB3' ' CG ' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -125.64 141.97 51.75 Favored 'General case' 0 N--CA 1.509 2.514 0 O-C-N 120.236 -1.54 . . . . 0.0 109.1 179.658 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.4 t -92.53 130.46 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.792 0 O-C-N 120.517 -1.364 . . . . 0.0 110.943 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -107.28 -38.73 5.88 Favored 'General case' 0 N--CA 1.506 2.375 0 O-C-N 121.393 -0.817 . . . . 0.0 110.012 178.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.533 ' C ' HG23 ' A' ' 119' ' ' VAL . 0.5 OUTLIER -143.24 158.33 43.72 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.853 -1.154 . . . . 0.0 109.435 179.722 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.56 HG22 HG23 ' A' ' 97' ' ' ILE . 44.3 t -158.8 133.62 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 -178.402 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.467 ' O ' ' C ' ' A' ' 121' ' ' PHE . 4.9 t-20 51.03 44.95 28.4 Favored 'General case' 0 N--CA 1.521 3.102 0 O-C-N 120.313 -1.492 . . . . 0.0 111.231 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.467 ' C ' ' O ' ' A' ' 120' ' ' ASN . 0.5 OUTLIER 39.41 35.9 0.19 Allowed 'General case' 0 N--CA 1.521 3.102 0 O-C-N 120.795 -1.19 . . . . 0.0 110.19 179.546 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -154.46 175.87 13.06 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.17 -0.956 . . . . 0.0 108.989 179.245 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.494 ' HB3' ' HD2' ' A' ' 124' ' ' PRO . 0.0 OUTLIER -64.04 166.91 8.96 Favored Pre-proline 0 N--CA 1.506 2.371 0 O-C-N 121.023 -1.048 . . . . 0.0 108.935 -179.974 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.494 ' HD2' ' HB3' ' A' ' 123' ' ' LYS . 45.7 Cg_endo -72.86 44.13 0.75 Allowed 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.816 1.429 . . . . 0.0 111.17 -179.343 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.526 ' O ' ' ND2' ' A' ' 126' ' ' ASN . 0.7 OUTLIER -176.55 -153.29 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.526 ' ND2' ' O ' ' A' ' 125' ' ' GLU . 0.2 OUTLIER 168.34 31.15 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.302 0 O-C-N 120.339 -1.476 . . . . 0.0 110.5 179.734 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -124.83 15.43 8.64 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.716 -1.24 . . . . 0.0 110.52 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.482 ' HD3' ' OE1' ' A' ' 125' ' ' GLU . 0.2 OUTLIER -159.0 165.04 34.94 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.41 -0.806 . . . . 0.0 110.546 -179.962 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -128.3 165.76 19.93 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.4 -0.813 . . . . 0.0 110.148 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.414 ' OXT' ' HG2' ' A' ' 130' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.304 -1.389 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.796 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.658 ' HA ' ' HA ' ' A' ' 49' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 . . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.54 ' HA ' ' O ' ' A' ' 50' ' ' PHE . 52.5 t30 -78.44 96.73 5.45 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.919 -1.113 . . . . 0.0 108.356 178.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.941 HD23 ' CD1' ' A' ' 79' ' ' ILE . 0.6 OUTLIER -41.78 -41.89 2.47 Favored 'General case' 0 N--CA 1.516 2.863 0 O-C-N 120.405 -1.435 . . . . 0.0 110.501 -178.397 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.411 ' OG1' ' OD1' ' A' ' 52' ' ' ASP . 1.7 m -57.77 -37.55 73.87 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.577 -1.327 . . . . 0.0 108.151 -179.489 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.517 ' HB3' ' HB3' ' A' ' 2' ' ' ASN . 0.8 OUTLIER -70.4 -45.28 66.27 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.06 -1.025 . . . . 0.0 108.59 177.932 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.873 HD12 HD12 ' A' ' 3' ' ' LEU 0.278 84.0 mt -51.27 -50.04 60.04 Favored 'General case' 0 C--N 1.315 -0.893 0 O-C-N 120.886 -1.133 . . . . 0.0 109.476 178.15 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.467 ' HE3' ' HA ' ' A' ' 74' ' ' ALA . 5.7 mmtt -64.06 -36.49 84.17 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.241 -0.912 . . . . 0.0 110.085 179.151 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -61.93 -25.52 67.63 Favored 'General case' 0 N--CA 1.508 2.455 0 C-N-CA 119.282 -0.967 . . . . 0.0 111.031 -179.035 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.605 ' CG2' ' HB3' ' A' ' 13' ' ' GLU . 4.4 m -74.49 132.84 77.93 Favored Pre-proline 0 N--CA 1.504 2.256 0 O-C-N 121.675 -0.641 . . . . 0.0 109.687 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.501 ' HG2' ' HB2' ' A' ' 13' ' ' GLU . 45.0 Cg_endo -65.16 150.84 87.19 Favored 'Trans proline' 0 CA--C 1.567 2.149 0 CA-C-N 118.767 0.595 . . . . 0.0 110.67 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.584 HG23 ' HG3' ' A' ' 31' ' ' LYS . 1.7 p -42.44 -50.28 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.527 3.391 0 O-C-N 120.542 -1.348 . . . . 0.0 110.162 -178.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.552 ' N ' ' CG1' ' A' ' 11' ' ' VAL . 1.0 OUTLIER -57.67 -41.84 82.36 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.294 -0.879 . . . . 0.0 111.174 -179.266 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.805 ' O ' HD12 ' A' ' 17' ' ' LEU . 0.2 OUTLIER -69.25 -27.7 65.68 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 117.69 -1.604 . . . . 0.0 107.682 179.233 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.615 ' HB3' HG21 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -69.29 -43.1 74.52 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.828 -1.17 . . . . 0.0 108.754 176.906 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.529 HD12 ' O ' ' A' ' 11' ' ' VAL . 1.4 mp -65.61 -40.59 88.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 C-N-CA 117.752 -1.579 . . . . 0.0 108.599 178.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.56 ' HA ' ' HG2' ' A' ' 19' ' ' GLU . 33.0 m -62.61 -37.75 87.52 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 120.542 -1.349 . . . . 0.0 109.146 179.198 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.805 HD12 ' O ' ' A' ' 13' ' ' GLU . 0.2 OUTLIER -65.58 -36.82 84.87 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.923 -1.111 . . . . 0.0 108.609 178.343 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.507 ' HA2' HD13 ' A' ' 38' ' ' ILE . . . -67.39 -44.5 84.3 Favored Glycine 0 N--CA 1.513 3.829 0 N-CA-C 108.427 -1.869 . . . . 0.0 108.427 178.296 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.694 ' HG3' ' N ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -59.09 -38.63 79.97 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.435 -1.626 . . . . 0.0 108.298 178.889 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.694 ' N ' ' HG3' ' A' ' 19' ' ' GLU . 26.3 m120 -61.61 -28.57 69.46 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.514 -1.366 . . . . 0.0 109.337 178.563 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.565 ' HB2' ' CD1' ' A' ' 23' ' ' LEU . 17.6 mtp -101.81 13.03 36.03 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.325 -0.859 . . . . 0.0 111.128 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.4 -19.78 53.06 Favored Glycine 0 N--CA 1.501 2.97 0 C-N-CA 118.67 -1.728 . . . . 0.0 111.249 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.798 ' H ' HD12 ' A' ' 23' ' ' LEU . 3.4 mp -79.17 92.79 5.11 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 120.39 -1.653 . . . . 0.0 109.313 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.407 ' O ' ' CB ' ' A' ' 25' ' ' ASN . 3.4 pt-20 -106.86 179.63 4.21 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.119 -0.988 . . . . 0.0 109.384 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.407 ' CB ' ' O ' ' A' ' 24' ' ' GLU . 1.1 m-20 65.75 14.09 9.34 Favored 'General case' 0 N--CA 1.51 2.539 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.916 179.053 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.63 HD11 ' HB3' ' A' ' 23' ' ' LEU . 0.5 OUTLIER -77.14 -7.53 55.95 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.029 -1.044 . . . . 0.0 111.6 -179.839 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 26' ' ' LEU . . . -46.64 -35.02 5.52 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.45 -1.406 . . . . 0.0 109.076 -179.164 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.1 mmt-85 -82.65 1.36 38.74 Favored 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 120.059 -0.657 . . . . 0.0 111.644 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.509 ' HB3' ' OD1' ' A' ' 33' ' ' ASP . 11.4 mtp -101.01 159.5 15.17 Favored 'General case' 0 C--N 1.313 -0.979 0 O-C-N 120.659 -1.276 . . . . 0.0 112.08 -178.551 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.873 ' O ' HD12 ' A' ' 34' ' ' ILE . 3.8 ttm180 -89.81 173.88 8.01 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 121.965 0.888 . . . . 0.0 111.094 178.324 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.635 ' O ' HG22 ' A' ' 35' ' ' ILE . 3.4 mtpp -62.23 -40.15 95.17 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.663 -0.648 . . . . 0.0 111.309 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.544 ' O ' ' CG2' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -64.96 -54.79 25.07 Favored 'General case' 0 N--CA 1.524 3.263 0 CA-C-O 121.845 0.831 . . . . 0.0 110.876 -178.758 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.54 ' OD1' ' N ' ' A' ' 34' ' ' ILE . 1.9 p30 -65.81 -41.65 91.63 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.886 -1.134 . . . . 0.0 109.262 -178.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.873 HD12 ' O ' ' A' ' 30' ' ' ARG . 9.0 mt -62.21 -40.05 86.24 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 O-C-N 120.27 -1.519 . . . . 0.0 109.498 178.016 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.635 HG22 ' O ' ' A' ' 31' ' ' LYS . 0.4 OUTLIER -67.48 -34.39 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.625 0 O-C-N 120.125 -1.609 . . . . 0.0 109.46 178.543 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.461 ' CD2' ' O ' ' A' ' 32' ' ' GLN . 17.9 m-85 -66.05 -44.22 85.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.498 -1.376 . . . . 0.0 109.05 179.006 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.633 ' HB1' HD23 ' A' ' 23' ' ' LEU . . . -66.41 -54.15 27.64 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 120.539 -1.351 . . . . 0.0 109.622 178.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.603 HG23 ' N ' ' A' ' 39' ' ' LEU . 8.6 tp -50.5 -46.86 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.43 0 C-N-CA 117.239 -1.784 . . . . 0.0 108.239 179.194 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.804 HD21 HD11 ' A' ' 6' ' ' LEU . 58.9 mt -58.6 -40.01 82.05 Favored 'General case' 0 N--CA 1.508 2.432 0 O-C-N 120.851 -1.155 . . . . 0.0 109.669 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.2 mttm -63.38 -35.83 81.7 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.365 -0.834 . . . . 0.0 109.941 179.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.58 ' HG3' HD11 ' A' ' 23' ' ' LEU . 12.0 mm-40 -77.77 -52.26 9.21 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.581 -0.7 . . . . 0.0 111.106 -179.396 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.544 ' CD2' ' HB2' ' A' ' 47' ' ' GLU . 17.6 t60 -62.23 -34.38 76.38 Favored 'General case' 0 N--CA 1.51 2.558 0 C-N-CA 118.374 -1.331 . . . . 0.0 108.612 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.492 ' O ' ' N ' ' A' ' 46' ' ' GLY . . . -64.16 -43.71 94.34 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.959 -1.088 . . . . 0.0 108.493 177.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.0 tptt -48.01 -44.72 31.05 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 121.051 -1.03 . . . . 0.0 109.187 178.275 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.463 ' HB3' ' OE2' ' A' ' 47' ' ' GLU . 74.1 m -66.79 -8.16 26.48 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 121.675 0.75 . . . . 0.0 109.726 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . 73.39 29.63 63.75 Favored Glycine 0 N--CA 1.495 2.586 0 C-N-CA 120.055 -1.069 . . . . 0.0 111.636 178.601 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.544 ' HB2' ' CD2' ' A' ' 42' ' ' HIS . 0.3 OUTLIER -79.41 166.87 21.58 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.211 -1.758 . . . . 0.0 108.821 178.899 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.431 ' C ' HG23 ' A' ' 49' ' ' ILE . 53.3 m-20 -85.96 143.13 28.33 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.042 -1.036 . . . . 0.0 109.653 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.658 ' HA ' ' HA ' ' A' ' 1' ' ' MET . 0.6 OUTLIER -149.21 147.88 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.724 -1.235 . . . . 0.0 108.417 179.529 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.568 ' N ' ' CD1' ' A' ' 50' ' ' PHE . 11.3 p90 -141.22 164.8 29.26 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 116.163 -2.215 . . . . 0.0 114.504 -178.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -119.29 169.75 13.75 Favored Glycine 0 N--CA 1.5 2.924 0 N-CA-C 108.502 -1.839 . . . . 0.0 108.502 -178.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.527 ' C ' ' CD2' ' A' ' 65' ' ' LEU . 3.6 p30 -170.98 163.03 7.43 Favored 'General case' 0 N--CA 1.482 1.14 0 O-C-N 120.445 -1.621 . . . . 0.0 109.923 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.6 ' N ' HD21 ' A' ' 65' ' ' LEU . . . 150.15 -142.46 9.7 Favored Glycine 0 N--CA 1.503 3.101 0 C-N-CA 117.856 -2.116 . . . . 0.0 111.389 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.577 ' HA ' ' O ' ' A' ' 95' ' ' ASP . 2.8 t -128.81 121.35 54.41 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.765 HD21 HG21 ' A' ' 81' ' ' VAL . 7.0 mt -62.63 161.72 11.76 Favored 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 118.514 -1.274 . . . . 0.0 113.481 -175.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.509 ' HA ' ' OG1' ' A' ' 93' ' ' THR . 4.3 tt0 -139.05 117.85 12.34 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 178.041 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.694 ' C ' HD12 ' A' ' 58' ' ' LEU . 1.3 mm -82.57 161.07 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 CA-C-N 120.868 1.667 . . . . 0.0 109.572 -178.436 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.944 HD22 ' CZ ' ' A' ' 62' ' ' PHE . 6.7 mp -130.31 134.9 47.54 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.602 -1.311 . . . . 0.0 109.288 179.088 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.478 ' C ' ' O ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -38.59 -36.25 0.24 Allowed 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.665 0.745 . . . . 0.0 109.946 -179.725 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.404 ' HB2' ' CD2' ' A' ' 62' ' ' PHE . 5.5 m-20 -60.95 -7.08 2.17 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.689 -0.632 . . . . 0.0 112.53 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.422 ' O ' ' HB3' ' A' ' 83' ' ' PRO . . . 91.65 8.15 64.13 Favored Glycine 1 N--CA 1.518 4.113 0 C-N-CA 118.677 -1.725 . . . . 0.0 112.232 178.13 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.944 ' CZ ' HD22 ' A' ' 58' ' ' LEU . 2.2 p90 -127.9 -179.64 5.07 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 104.706 -2.331 . . . . 0.0 104.706 178.127 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.711 ' HA2' HD13 ' A' ' 58' ' ' LEU . . . -157.88 172.33 35.06 Favored Glycine 0 N--CA 1.478 1.491 0 C-N-CA 117.38 -2.343 . . . . 0.0 111.841 -178.133 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.448 ' CE2' ' HE1' ' A' ' 62' ' ' PHE . 10.3 m-85 -128.83 153.83 47.05 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 119.882 1.841 . . . . 0.0 109.319 177.282 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.6 HD21 ' N ' ' A' ' 53' ' ' GLY . 0.5 OUTLIER -100.24 124.02 45.18 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 177.487 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.534 ' CB ' ' OD2' ' A' ' 78' ' ' ASP . 2.6 ptm180 -129.42 -169.22 2.06 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 119.629 -1.919 . . . . 0.0 110.281 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.746 ' HB3' HD23 ' A' ' 73' ' ' LEU . 1.5 m -76.76 -153.66 0.05 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.961 -1.087 . . . . 0.0 110.469 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -129.43 -6.88 4.72 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.467 -0.77 . . . . 0.0 110.663 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.568 ' HB2' HD22 ' A' ' 73' ' ' LEU . 8.9 t0 -78.54 -155.52 0.09 Allowed 'General case' 0 N--CA 1.513 2.702 0 O-C-N 121.019 -1.05 . . . . 0.0 109.452 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -123.76 -14.65 7.18 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 120.211 -1.556 . . . . 0.0 110.82 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.688 ' O ' ' HB2' ' A' ' 72' ' ' TYR . 1.0 OUTLIER -163.77 178.1 8.13 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 120.885 -1.134 . . . . 0.0 109.7 179.654 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.688 ' HB2' ' O ' ' A' ' 71' ' ' SER . 38.5 m-85 72.63 -38.25 0.41 Allowed 'General case' 0 N--CA 1.525 3.314 0 CA-C-N 119.869 1.213 . . . . 0.0 111.103 179.661 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.746 HD23 ' HB3' ' A' ' 67' ' ' SER . 6.2 mp -82.41 -160.89 0.41 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.806 -1.184 . . . . 0.0 109.62 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.711 ' HB1' ' OD1' ' A' ' 78' ' ' ASP . . . -57.16 -153.66 0.0 OUTLIER 'General case' 0 C--N 1.29 -1.994 0 CA-C-O 122.225 1.012 . . . . 0.0 110.396 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.49 ' O ' ' CG ' ' A' ' 78' ' ' ASP . . . -147.37 -163.48 10.61 Favored Glycine 0 N--CA 1.504 3.214 0 C-N-CA 120.433 -0.889 . . . . 0.0 111.182 -178.272 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -69.09 -36.04 13.4 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 O-C-N 122.655 0.818 . . . . 0.0 112.291 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.569 ' HB3' ' CE1' ' A' ' 110' ' ' TYR . 23.4 m-20 -85.42 25.11 1.07 Allowed 'General case' 0 N--CA 1.509 2.477 0 O-C-N 121.228 -0.92 . . . . 0.0 111.294 -178.713 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.711 ' OD1' ' HB1' ' A' ' 74' ' ' ALA . 89.2 m-20 -54.07 -115.03 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.771 0 O-C-N 120.983 -1.073 . . . . 0.0 111.807 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.941 ' CD1' HD23 ' A' ' 3' ' ' LEU . 6.7 mm -76.73 130.81 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.701 0 O-C-N 121.058 -1.026 . . . . 0.0 110.576 -177.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.526 ' HB3' ' O ' ' A' ' 111' ' ' PHE . 79.9 t80 -77.2 145.18 37.77 Favored 'General case' 0 N--CA 1.513 2.72 0 O-C-N 119.549 -1.969 . . . . 0.0 109.42 179.123 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.765 HG21 HD21 ' A' ' 55' ' ' LEU . 38.7 t -142.38 114.66 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 120.301 -1.499 . . . . 0.0 110.817 -179.472 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.573 ' O ' HG13 ' A' ' 86' ' ' ILE . 19.9 m -74.71 163.65 66.8 Favored Pre-proline 0 N--CA 1.512 2.665 0 O-C-N 120.357 -1.464 . . . . 0.0 111.708 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.529 ' HA ' HG13 ' A' ' 86' ' ' ILE . 38.0 Cg_endo -65.33 -48.83 3.01 Favored 'Trans proline' 0 C--N 1.315 -1.233 0 O-C-N 124.321 1.695 . . . . 0.0 108.827 179.005 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.554 ' O ' ' CG ' ' A' ' 88' ' ' ARG . 80.1 p -46.59 -41.1 13.99 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 177.663 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.54 ' HB2' ' O ' ' A' ' 82' ' ' SER . 4.2 mm-40 -62.16 -58.08 9.14 Favored 'General case' 0 N--CA 1.51 2.529 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 177.849 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.596 HG23 ' HB2' ' A' ' 91' ' ' LEU . 0.9 OUTLIER -55.35 -55.27 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 O-C-N 121.153 -0.967 . . . . 0.0 108.55 178.382 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.467 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 0.2 OUTLIER -57.99 -42.23 84.7 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-O 121.787 0.804 . . . . 0.0 111.466 -179.518 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.554 ' CG ' ' O ' ' A' ' 84' ' ' SER . 0.0 OUTLIER -60.44 -36.52 78.39 Favored 'General case' 0 N--CA 1.506 2.355 0 C-N-CA 119.76 -0.776 . . . . 0.0 111.725 -177.714 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 1.032 ' HB2' HD21 ' A' ' 91' ' ' LEU . 20.1 m-85 -112.12 13.13 20.58 Favored 'General case' 0 N--CA 1.507 2.378 0 C-N-CA 117.12 -1.832 . . . . 0.0 111.664 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 61.46 53.5 3.37 Favored 'General case' 0 N--CA 1.484 1.242 0 O-C-N 120.389 -1.445 . . . . 0.0 110.3 178.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 1.032 HD21 ' HB2' ' A' ' 89' ' ' PHE . 3.5 mt -89.61 -173.44 3.95 Favored 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 119.304 -0.959 . . . . 0.0 110.277 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.533 ' CG ' ' O ' ' A' ' 91' ' ' LEU . 12.0 mtt-85 -160.1 160.27 32.85 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 177.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.594 ' HB ' ' CG1' ' A' ' 57' ' ' ILE . 1.8 t -64.18 155.94 30.14 Favored 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 116.983 -1.887 . . . . 0.0 106.841 178.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 77.57 -11.54 18.64 Favored Glycine 0 N--CA 1.506 3.343 0 C-N-CA 117.042 -2.504 . . . . 0.0 110.263 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.577 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 7.9 m-20 -68.18 148.59 50.66 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.14 -1.8 . . . . 0.0 110.465 -179.038 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.523 ' O ' HG12 ' A' ' 97' ' ' ILE . 0.1 OUTLIER -93.92 125.58 38.62 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.16 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.523 HG12 ' O ' ' A' ' 96' ' ' THR . 1.5 mt -145.78 164.89 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 C-N-CA 118.07 -1.452 . . . . 0.0 112.375 -179.134 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 89.9 p -149.69 139.29 21.64 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.45 ' O ' ' HB2' ' A' ' 50' ' ' PHE . . . -168.29 -175.41 37.89 Favored Glycine 0 N--CA 1.508 3.465 0 C-N-CA 116.859 -2.591 . . . . 0.0 115.406 -178.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.437 ' HG3' ' HG2' ' A' ' 115' ' ' LYS . 2.1 mtpt -88.23 150.98 22.98 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 2.8 pt -121.51 160.56 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.504 0 CA-C-N 121.463 1.938 . . . . 0.0 113.241 -177.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.847 ' CB ' HD13 ' A' ' 114' ' ' LEU . 0.6 OUTLIER -144.68 132.97 10.79 Favored Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 120.392 -1.442 . . . . 0.0 109.363 179.374 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -75.34 119.45 5.56 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.949 1.5 . . . . 0.0 110.513 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -71.56 -152.68 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.024 1.539 . . . . 0.0 109.588 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.463 ' O ' ' O ' ' A' ' 106' ' ' GLU . 7.5 mttp -106.05 179.52 4.24 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.838 -1.164 . . . . 0.0 109.747 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.463 ' O ' ' O ' ' A' ' 105' ' ' LYS 0.253 0.0 OUTLIER -51.56 178.32 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.152 0 O-C-N 120.792 -1.193 . . . . 0.0 108.321 179.128 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 77.92 -37.76 1.72 Allowed Glycine 0 N--CA 1.499 2.835 0 C-N-CA 118.014 -2.041 . . . . 0.0 110.3 -179.251 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.492 ' O ' ' N ' ' A' ' 110' ' ' TYR . 1.3 mt-10 -84.46 -29.77 25.8 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.183 -1.774 . . . . 0.0 110.355 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.482 ' HB2' ' O ' ' A' ' 108' ' ' GLU . 2.2 mmt85 59.54 -37.25 0.07 Allowed 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 178.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.569 ' CE1' ' HB3' ' A' ' 77' ' ' ASP . 10.3 m-85 -106.83 151.56 25.03 Favored 'General case' 0 N--CA 1.52 3.038 0 O-C-N 119.7 -1.875 . . . . 0.0 109.574 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.526 ' O ' ' HB3' ' A' ' 80' ' ' TYR . 3.3 m-85 -68.28 168.19 12.89 Favored 'General case' 0 N--CA 1.503 2.225 0 O-C-N 119.775 -1.828 . . . . 0.0 107.928 178.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -122.75 155.69 35.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.1 -1.625 . . . . 0.0 110.785 -179.015 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.97 153.71 39.77 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.847 HD13 ' CB ' ' A' ' 102' ' ' ARG . 14.5 tp -129.07 -56.36 1.18 Allowed 'General case' 0 N--CA 1.503 2.205 0 O-C-N 120.081 -1.637 . . . . 0.0 112.868 -178.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.437 ' HG2' ' HG3' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -125.28 142.77 51.31 Favored 'General case' 0 N--CA 1.507 2.404 0 O-C-N 120.343 -1.473 . . . . 0.0 108.536 179.666 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.474 HG21 ' CD2' ' A' ' 89' ' ' PHE . 37.4 t -92.89 130.55 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.955 0 O-C-N 120.406 -1.434 . . . . 0.0 112.091 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.57 ' HA ' ' HB3' ' A' ' 124' ' ' PRO . 11.3 m-20 -107.02 -39.93 5.6 Favored 'General case' 0 N--CA 1.51 2.567 0 O-C-N 121.469 -0.769 . . . . 0.0 109.871 178.122 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.584 ' C ' HG23 ' A' ' 119' ' ' VAL . 0.9 OUTLIER -143.45 160.07 41.25 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.989 -1.069 . . . . 0.0 109.463 179.578 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.584 HG23 ' C ' ' A' ' 118' ' ' GLU . 18.7 t -158.46 147.89 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -178.755 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.515 ' C ' ' O ' ' A' ' 119' ' ' VAL . 7.1 t-20 -24.48 -41.98 0.01 OUTLIER 'General case' 0 N--CA 1.524 3.273 0 O-C-N 121.456 -0.778 . . . . 0.0 111.481 -178.406 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.563 ' N ' ' O ' ' A' ' 119' ' ' VAL . 0.3 OUTLIER -160.91 56.72 0.31 Allowed 'General case' 0 N--CA 1.499 2.009 0 C-N-CA 118.776 -1.17 . . . . 0.0 111.055 179.149 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.476 ' OD1' ' O ' ' A' ' 121' ' ' PHE . 0.3 OUTLIER -156.02 156.43 34.42 Favored 'General case' 0 N--CA 1.485 1.292 0 O-C-N 120.878 -1.139 . . . . 0.0 109.535 178.291 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.536 ' HB3' ' HD2' ' A' ' 124' ' ' PRO . 0.2 OUTLIER -80.64 -170.67 0.25 Allowed Pre-proline 0 N--CA 1.497 1.913 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.343 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.57 ' HB3' ' HA ' ' A' ' 117' ' ' ASN . 50.5 Cg_endo -85.45 21.56 1.07 Allowed 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 123.409 1.215 . . . . 0.0 110.867 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.473 ' HB2' ' O ' ' A' ' 124' ' ' PRO . 1.5 tt0 -177.79 -127.35 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.442 -0.786 . . . . 0.0 108.961 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.449 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 0.4 OUTLIER 173.65 -143.72 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.09 0 O-C-N 120.083 -1.636 . . . . 0.0 109.721 179.664 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.477 ' O ' ' HG2' ' A' ' 128' ' ' ARG . . . -137.42 14.32 2.99 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.681 -1.262 . . . . 0.0 110.01 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.477 ' HG2' ' O ' ' A' ' 127' ' ' ALA . 0.6 OUTLIER -141.76 -50.39 0.4 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.659 -0.651 . . . . 0.0 109.778 179.61 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -73.4 164.05 27.21 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.397 -0.814 . . . . 0.0 110.067 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.46 ' HG2' ' O ' ' A' ' 130' ' ' LYS . 0.6 OUTLIER . . . . . 0 N--CA 1.487 1.415 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.679 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.677 ' HA ' ' HA ' ' A' ' 49' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 . . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.633 ' ND2' ' OD1' ' A' ' 52' ' ' ASP . 11.9 t-20 -78.63 91.09 4.59 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.965 -1.085 . . . . 0.0 108.461 178.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.823 HD23 HD13 ' A' ' 79' ' ' ILE . 1.5 tp -42.19 -41.05 2.57 Favored 'General case' 0 N--CA 1.52 3.043 0 O-C-N 120.471 -1.393 . . . . 0.0 110.401 -178.267 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.8 m -57.35 -37.82 73.17 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.806 -1.183 . . . . 0.0 108.33 -179.269 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.602 ' HB2' ' HB3' ' A' ' 2' ' ' ASN . 0.3 OUTLIER -74.11 -39.31 63.44 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.783 -1.198 . . . . 0.0 108.776 178.021 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.81 HD12 ' HA ' ' A' ' 3' ' ' LEU 0.278 67.4 mt -54.77 -52.33 62.93 Favored 'General case' 0 C--O 1.215 -0.718 0 O-C-N 120.387 -1.445 . . . . 0.0 109.038 177.771 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.487 ' NZ ' ' HD2' ' A' ' 66' ' ' ARG . 0.2 OUTLIER -61.54 -40.35 94.35 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.019 -1.05 . . . . 0.0 109.264 178.468 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ASN . . . . . 0.46 ' HB2' ' HA ' ' A' ' 5' ' ' GLU . 2.7 m-80 -62.08 -20.6 64.18 Favored 'General case' 0 N--CA 1.506 2.353 0 C-N-CA 119.438 -0.905 . . . . 0.0 110.732 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.804 ' O ' HD11 ' A' ' 14' ' ' LEU . 2.6 m -75.01 118.28 69.24 Favored Pre-proline 0 C--N 1.287 -2.14 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.512 ' HG2' ' CG ' ' A' ' 13' ' ' GLU . 37.3 Cg_endo -57.47 152.33 48.02 Favored 'Trans proline' 0 CA--C 1.563 1.952 0 O-C-N 122.408 0.688 . . . . 0.0 110.515 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.736 ' O ' HD12 ' A' ' 15' ' ' ILE . 1.7 p -41.31 -49.44 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.529 3.48 0 O-C-N 120.493 -1.379 . . . . 0.0 110.094 -178.279 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.536 ' N ' ' CG1' ' A' ' 11' ' ' VAL . 0.7 OUTLIER -60.56 -39.8 89.29 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.415 -0.803 . . . . 0.0 111.249 -179.629 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 1.028 ' O ' HD12 ' A' ' 17' ' ' LEU . 29.2 mt-10 -69.45 -32.21 71.0 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 118.015 -1.474 . . . . 0.0 108.488 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.804 HD11 ' O ' ' A' ' 9' ' ' THR . 6.2 mt -68.62 -42.29 78.3 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 120.841 -1.162 . . . . 0.0 108.845 177.171 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.736 HD12 ' O ' ' A' ' 11' ' ' VAL . 1.3 mp -64.64 -38.97 84.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 C-N-CA 117.714 -1.594 . . . . 0.0 108.451 178.433 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.501 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 59.0 m -64.24 -36.69 84.9 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 120.331 -1.481 . . . . 0.0 108.878 178.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 1.028 HD12 ' O ' ' A' ' 13' ' ' GLU . 0.3 OUTLIER -66.06 -38.82 89.3 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.822 -1.174 . . . . 0.0 108.936 178.432 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -68.0 -43.28 82.68 Favored Glycine 1 N--CA 1.521 4.305 0 N-CA-C 108.471 -1.852 . . . . 0.0 108.471 178.465 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.435 ' OE1' ' HG2' ' A' ' 24' ' ' GLU . 1.4 mm-40 -54.72 -44.9 73.9 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.886 -1.361 . . . . 0.0 107.737 178.495 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.501 ' OD1' ' O ' ' A' ' 16' ' ' THR . 28.8 m120 -59.57 -26.22 65.21 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 118.288 -1.365 . . . . 0.0 109.334 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.561 ' CE ' ' NE2' ' A' ' 41' ' ' GLN . 52.9 mmm -101.07 9.79 41.72 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.27 -0.894 . . . . 0.0 111.144 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.85 -21.11 39.31 Favored Glycine 0 N--CA 1.501 3.02 0 C-N-CA 118.634 -1.746 . . . . 0.0 111.589 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.834 ' HB3' HD11 ' A' ' 26' ' ' LEU . 4.0 mp -78.57 96.48 5.48 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 120.152 -1.793 . . . . 0.0 109.934 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.496 ' O ' ' CB ' ' A' ' 25' ' ' ASN . 16.9 mt-10 -105.98 171.14 7.5 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.255 -0.903 . . . . 0.0 109.276 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.496 ' CB ' ' O ' ' A' ' 24' ' ' GLU . 0.7 OUTLIER 71.15 15.67 6.45 Favored 'General case' 0 N--CA 1.514 2.733 0 O-C-N 121.517 -0.739 . . . . 0.0 111.838 179.314 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.834 HD11 ' HB3' ' A' ' 23' ' ' LEU . 0.4 OUTLIER -76.57 -10.88 59.71 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.005 -1.059 . . . . 0.0 111.672 -179.883 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 26' ' ' LEU . . . -46.57 -35.73 6.13 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.515 -1.366 . . . . 0.0 109.07 -179.225 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.92 3.53 25.98 Favored 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 119.849 -0.74 . . . . 0.0 111.545 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.593 ' HE2' ' OD1' ' A' ' 33' ' ' ASP . 7.5 mtp -99.97 156.61 17.06 Favored 'General case' 0 C--N 1.314 -0.95 0 O-C-N 120.72 -1.238 . . . . 0.0 111.774 -178.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.539 ' C ' HD12 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -89.46 139.22 30.74 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.413 -0.804 . . . . 0.0 110.936 179.239 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.58 ' O ' HG22 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -31.66 -44.81 0.08 Allowed 'General case' 0 N--CA 1.5 2.055 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.885 179.197 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.582 ' O ' ' CG2' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -63.27 -53.28 55.38 Favored 'General case' 0 N--CA 1.521 3.08 0 O-C-N 121.319 -0.863 . . . . 0.0 111.941 -178.233 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.593 ' OD1' ' HE2' ' A' ' 29' ' ' MET . 1.9 p30 -66.92 -39.73 87.46 Favored 'General case' 0 C--N 1.293 -1.873 0 O-C-N 119.965 -1.709 . . . . 0.0 109.226 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.574 HD11 ' HB2' ' A' ' 29' ' ' MET . 4.4 mt -61.93 -39.18 82.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 O-C-N 120.459 -1.401 . . . . 0.0 109.444 178.457 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.582 ' CG2' ' O ' ' A' ' 32' ' ' GLN . 0.3 OUTLIER -66.91 -40.6 86.09 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.555 0 O-C-N 120.345 -1.472 . . . . 0.0 109.246 178.518 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.574 ' CE1' ' OD1' ' A' ' 77' ' ' ASP . 6.1 m-30 -60.3 -43.9 95.88 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 120.803 -1.186 . . . . 0.0 108.531 179.28 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.718 ' HB1' ' CD2' ' A' ' 23' ' ' LEU . . . -59.28 -51.32 70.45 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.49 -1.381 . . . . 0.0 108.821 178.042 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.554 HG13 ' O ' ' A' ' 34' ' ' ILE . 0.1 OUTLIER -56.17 -31.88 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 C-N-CA 117.618 -1.633 . . . . 0.0 109.643 179.23 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.733 HD21 HD13 ' A' ' 6' ' ' LEU . 98.6 mt -69.21 -44.88 71.19 Favored 'General case' 0 N--CA 1.505 2.308 0 O-C-N 120.07 -1.644 . . . . 0.0 109.557 178.759 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.65 -34.11 77.44 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.023 -1.048 . . . . 0.0 111.396 179.114 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.561 ' NE2' ' CE ' ' A' ' 21' ' ' MET . 0.0 OUTLIER -79.5 -51.71 8.97 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.212 -0.93 . . . . 0.0 109.977 -178.9 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.539 ' CE1' ' HG3' ' A' ' 47' ' ' GLU . 5.1 t-160 -64.95 -38.61 91.53 Favored 'General case' 0 N--CA 1.507 2.378 0 C-N-CA 117.619 -1.632 . . . . 0.0 109.141 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.544 ' O ' ' N ' ' A' ' 46' ' ' GLY . . . -61.58 -38.86 89.08 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 120.918 -1.113 . . . . 0.0 108.594 178.311 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 12.2 tptt -48.25 -45.0 33.86 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 121.003 -1.061 . . . . 0.0 108.567 177.774 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 52.0 m -66.49 -10.09 41.04 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 121.724 0.773 . . . . 0.0 109.493 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . 70.71 29.53 69.42 Favored Glycine 0 N--CA 1.496 2.652 0 C-N-CA 120.621 -0.8 . . . . 0.0 111.752 178.508 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.539 ' HG3' ' CE1' ' A' ' 42' ' ' HIS . 3.7 pm0 -82.82 158.08 22.91 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.178 -1.777 . . . . 0.0 108.793 178.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -71.55 147.65 47.46 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.912 -1.117 . . . . 0.0 110.334 -178.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.677 ' HA ' ' HA ' ' A' ' 1' ' ' MET . 0.8 OUTLIER -146.63 145.0 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.077 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.6 ' O ' ' HA ' ' A' ' 2' ' ' ASN . 10.5 p90 -141.31 170.28 16.01 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 116.268 -2.173 . . . . 0.0 115.583 -177.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -114.46 162.37 12.43 Favored Glycine 0 N--CA 1.501 3.003 0 N-CA-C 107.88 -2.088 . . . . 0.0 107.88 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.633 ' OD1' ' ND2' ' A' ' 2' ' ' ASN . 7.5 p-10 -172.78 162.91 4.99 Favored 'General case' 0 N--CA 1.483 1.196 0 O-C-N 120.364 -1.668 . . . . 0.0 110.369 -178.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.561 ' HA3' ' O ' ' A' ' 66' ' ' ARG . . . 138.35 -134.59 6.94 Favored Glycine 0 N--CA 1.503 3.155 0 C-N-CA 118.28 -1.914 . . . . 0.0 111.54 177.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.62 ' HA ' ' O ' ' A' ' 95' ' ' ASP . 2.5 t -127.94 117.75 46.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 O-C-N 121.45 -1.029 . . . . 0.0 108.396 -179.124 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 1.018 HD21 HG21 ' A' ' 81' ' ' VAL . 6.2 mt -63.36 165.41 7.67 Favored 'General case' 0 N--CA 1.503 2.18 0 C-N-CA 118.622 -1.231 . . . . 0.0 113.561 -176.145 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.53 ' O ' ' CG ' ' A' ' 56' ' ' GLU . 8.2 pt-20 -141.52 123.03 15.02 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 177.654 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.57 ' CG1' ' HB ' ' A' ' 93' ' ' THR . 1.2 mm -83.07 164.31 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 119.857 -1.777 . . . . 0.0 109.275 -178.544 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.641 HD13 ' HA2' ' A' ' 63' ' ' GLY . 3.1 mp -130.98 136.46 48.55 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.433 -1.417 . . . . 0.0 109.672 179.239 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.445 ' C ' ' O ' ' A' ' 58' ' ' LEU . 7.7 tt0 -39.57 -36.99 0.44 Allowed 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.637 0.732 . . . . 0.0 110.128 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.452 ' OD1' ' N ' ' A' ' 60' ' ' ASP . 5.8 m-20 -61.52 -6.65 2.52 Favored 'General case' 0 N--CA 1.5 2.029 0 C-N-CA 119.905 -0.718 . . . . 0.0 112.576 -179.157 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 92.53 8.15 62.69 Favored Glycine 1 N--CA 1.519 4.224 0 C-N-CA 118.688 -1.72 . . . . 0.0 112.612 177.784 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.614 ' CZ ' HD22 ' A' ' 58' ' ' LEU . 4.4 p90 -129.1 -177.04 4.06 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 104.29 -2.485 . . . . 0.0 104.29 177.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.641 ' HA2' HD13 ' A' ' 58' ' ' LEU . . . -157.63 172.75 34.97 Favored Glycine 0 N--CA 1.475 1.273 0 C-N-CA 116.672 -2.68 . . . . 0.0 112.109 -177.562 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.488 ' HB2' ' OE2' ' A' ' 56' ' ' GLU . 16.2 m-85 -130.25 151.97 50.18 Favored 'General case' 0 N--CA 1.483 1.215 0 O-C-N 120.223 -1.751 . . . . 0.0 109.574 177.602 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.525 HD12 ' HG ' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -97.91 168.23 10.42 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 176.221 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.561 ' O ' ' HA3' ' A' ' 53' ' ' GLY . 10.5 ttp85 177.09 -173.91 0.11 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.004 -1.06 . . . . 0.0 109.662 179.336 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' SER . . . . . 0.509 ' HB2' ' OG ' ' A' ' 70' ' ' SER . 0.7 OUTLIER -74.72 -155.51 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.707 -1.246 . . . . 0.0 109.834 179.554 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -117.72 -87.35 0.62 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.301 -0.874 . . . . 0.0 110.517 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -78.05 60.99 2.51 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.344 -0.847 . . . . 0.0 111.599 -179.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.509 ' OG ' ' HB2' ' A' ' 67' ' ' SER . 0.1 OUTLIER -125.98 -4.94 6.86 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 119.971 -1.706 . . . . 0.0 110.46 -179.879 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.584 ' O ' ' HB2' ' A' ' 72' ' ' TYR . 0.3 OUTLIER 170.74 -21.13 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.192 0 O-C-N 120.928 -1.108 . . . . 0.0 111.15 -179.997 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.584 ' HB2' ' O ' ' A' ' 71' ' ' SER . 24.6 m-85 77.24 -43.65 0.43 Allowed 'General case' 0 N--CA 1.523 3.196 0 O-C-N 121.769 -0.582 . . . . 0.0 111.853 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.7 mp -87.31 -173.81 4.56 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.38 -1.45 . . . . 0.0 109.573 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.66 -156.82 0.12 Allowed 'General case' 0 C--N 1.291 -1.975 0 CA-C-O 122.522 1.153 . . . . 0.0 109.775 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.54 ' N ' ' OD2' ' A' ' 78' ' ' ASP . . . -177.43 156.6 20.42 Favored Glycine 0 C--N 1.28 -2.574 0 N-CA-C 107.18 -2.368 . . . . 0.0 107.18 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.19 -38.24 28.39 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 CA-C-N 118.742 1.271 . . . . 0.0 112.382 -179.672 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.574 ' OD1' ' CE1' ' A' ' 36' ' ' PHE . 13.6 m-20 -86.59 15.77 5.28 Favored 'General case' 0 N--CA 1.506 2.337 0 O-C-N 121.089 -1.007 . . . . 0.0 112.953 -178.15 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.54 ' OD2' ' N ' ' A' ' 75' ' ' GLY . 3.7 m-20 -67.18 -155.74 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.249 0 O-C-N 120.224 -1.547 . . . . 0.0 109.424 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.823 HD13 HD23 ' A' ' 3' ' ' LEU . 5.0 mm -111.6 129.15 67.51 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.599 0 O-C-N 121.137 -0.977 . . . . 0.0 109.224 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.417 ' HB3' ' HA ' ' A' ' 112' ' ' ALA . 15.2 t80 -74.87 147.22 41.25 Favored 'General case' 0 N--CA 1.518 2.928 0 CA-C-N 121.987 2.176 . . . . 0.0 110.052 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 1.018 HG21 HD21 ' A' ' 55' ' ' LEU . 8.9 t -142.57 110.92 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 120.188 -1.57 . . . . 0.0 110.113 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.535 ' O ' HG13 ' A' ' 86' ' ' ILE . 6.2 m -74.27 164.02 64.19 Favored Pre-proline 0 N--CA 1.511 2.597 0 O-C-N 120.361 -1.462 . . . . 0.0 111.983 -179.314 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.55 ' HA ' HG13 ' A' ' 86' ' ' ILE . 38.1 Cg_endo -65.26 -54.29 0.66 Allowed 'Trans proline' 0 C--N 1.315 -1.23 0 O-C-N 124.621 1.853 . . . . 0.0 109.182 178.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.558 ' O ' ' CG ' ' A' ' 88' ' ' ARG . 52.9 p -46.34 -39.33 10.06 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 178.19 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.515 ' HB2' ' O ' ' A' ' 82' ' ' SER . 6.7 mm100 -63.23 -58.92 5.58 Favored 'General case' 0 N--CA 1.51 2.536 0 C-N-CA 119.421 -0.912 . . . . 0.0 108.742 178.499 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.57 HG22 ' HB2' ' A' ' 91' ' ' LEU . 0.2 OUTLIER -55.83 -54.03 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.313 0 O-C-N 121.107 -0.996 . . . . 0.0 108.601 178.801 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.468 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 0.1 OUTLIER -56.69 -43.39 80.43 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-O 121.933 0.873 . . . . 0.0 110.876 -179.659 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.558 ' CG ' ' O ' ' A' ' 84' ' ' SER . 1.3 mmm180 -59.6 -36.63 76.66 Favored 'General case' 0 N--CA 1.505 2.281 0 C-N-CA 119.795 -0.762 . . . . 0.0 111.702 -177.86 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 0.431 ' CD2' ' O ' ' A' ' 85' ' ' GLN . 5.4 m-85 -109.81 11.89 24.17 Favored 'General case' 0 N--CA 1.501 2.116 0 C-N-CA 117.518 -1.673 . . . . 0.0 111.114 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 59.58 53.96 4.78 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 120.575 -1.328 . . . . 0.0 109.816 178.669 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.57 ' HB2' HG22 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -90.04 -177.75 5.26 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 119.681 -0.807 . . . . 0.0 110.176 -179.948 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.47 ' O ' ' OD2' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -156.8 161.64 39.75 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.337 -0.852 . . . . 0.0 108.704 178.235 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.57 ' HB ' ' CG1' ' A' ' 57' ' ' ILE . 1.6 t -64.42 155.23 33.23 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 117.119 -1.833 . . . . 0.0 107.428 179.583 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 75.66 -8.56 20.05 Favored Glycine 0 N--CA 1.502 3.05 0 C-N-CA 117.123 -2.465 . . . . 0.0 110.114 179.1 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.626 ' CG ' HD11 ' A' ' 97' ' ' ILE . 7.8 p30 -69.57 149.04 48.62 Favored 'General case' 0 N--CA 1.483 1.222 0 O-C-N 120.127 -1.808 . . . . 0.0 110.515 -178.711 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.479 ' C ' ' CG1' ' A' ' 97' ' ' ILE . 0.3 OUTLIER -94.92 121.33 36.42 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.825 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.626 HD11 ' CG ' ' A' ' 95' ' ' ASP . 2.3 mt -148.03 168.75 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 119.925 -1.734 . . . . 0.0 112.648 -178.713 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.522 ' OG ' ' HB2' ' A' ' 118' ' ' GLU . 92.1 p -148.54 137.89 21.91 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.889 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.544 ' O ' ' HB2' ' A' ' 50' ' ' PHE . . . -161.43 177.49 37.72 Favored Glycine 0 N--CA 1.51 3.599 0 C-N-CA 117.958 -2.068 . . . . 0.0 114.209 -178.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.805 ' HD3' HD23 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -87.73 157.02 19.16 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 178.594 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.538 HG12 ' HA ' ' A' ' 50' ' ' PHE . 1.5 pt -123.26 155.67 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.463 0 CA-C-N 120.815 1.643 . . . . 0.0 113.408 -177.586 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 1.001 ' CB ' HD13 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -157.54 170.13 9.46 Favored Pre-proline 0 N--CA 1.483 1.179 0 O-C-N 120.571 -1.331 . . . . 0.0 109.553 179.484 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.441 ' HD3' ' HG2' ' A' ' 102' ' ' ARG . 51.2 Cg_endo -92.71 140.35 1.94 Allowed 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 121.798 1.666 . . . . 0.0 110.368 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.479 ' HD2' ' CD ' ' A' ' 108' ' ' GLU . 47.7 Cg_endo -81.43 -89.71 0.0 OUTLIER 'Trans proline' 0 C--N 1.303 -1.824 0 O-C-N 123.961 1.506 . . . . 0.0 109.752 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 5.8 ttmt -136.89 -160.13 1.03 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.641 -0.662 . . . . 0.0 109.95 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.83 -22.77 39.04 Favored 'General case' 0 C--N 1.31 -1.13 0 O-C-N 120.76 -1.212 . . . . 0.0 109.589 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -84.37 44.85 3.4 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 108.571 -1.812 . . . . 0.0 108.571 178.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.546 ' HG3' ' N ' ' A' ' 109' ' ' ARG . 3.1 tp10 -85.56 -81.34 0.2 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.649 -1.501 . . . . 0.0 111.044 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.585 ' HD2' ' CE1' ' A' ' 110' ' ' TYR . 0.0 OUTLIER 64.4 -55.29 0.26 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.37 -0.831 . . . . 0.0 109.834 -178.653 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.585 ' CE1' ' HD2' ' A' ' 109' ' ' ARG . 42.2 m-85 -107.73 149.14 28.51 Favored 'General case' 0 N--CA 1.522 3.141 0 O-C-N 120.179 -1.576 . . . . 0.0 107.704 176.943 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.574 ' CE1' HD13 ' A' ' 39' ' ' LEU . 78.2 m-85 -68.35 159.42 31.48 Favored 'General case' 0 N--CA 1.509 2.509 0 O-C-N 119.161 -2.212 . . . . 0.0 108.056 178.965 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.417 ' HA ' ' HB3' ' A' ' 80' ' ' TYR . . . -124.15 142.83 50.89 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 119.975 -1.703 . . . . 0.0 111.434 -178.863 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.45 HD22 ' HA ' ' A' ' 113' ' ' LEU . 0.2 OUTLIER -51.2 147.02 5.9 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 179.117 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 1.001 HD13 ' CB ' ' A' ' 102' ' ' ARG . 6.4 tp -128.28 -58.32 1.2 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 120.22 -1.55 . . . . 0.0 111.549 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.501 ' HB3' ' HG2' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -120.73 140.09 52.14 Favored 'General case' 0 N--CA 1.509 2.487 0 O-C-N 120.336 -1.478 . . . . 0.0 108.405 178.835 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.6 t -92.53 134.16 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.854 0 O-C-N 120.215 -1.553 . . . . 0.0 111.318 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.41 ' CG ' ' HA2' ' A' ' 99' ' ' GLY . 2.8 m-20 -107.5 -42.41 4.8 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.552 -0.718 . . . . 0.0 109.586 178.643 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.591 ' O ' HG23 ' A' ' 97' ' ' ILE . 1.2 mt-10 -143.71 159.84 41.77 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.879 -1.138 . . . . 0.0 109.783 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.551 HG11 HD11 ' A' ' 91' ' ' LEU . 5.1 t -158.22 140.44 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.982 -0.449 . . . . 0.0 110.075 -178.253 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.479 ' O ' ' C ' ' A' ' 121' ' ' PHE . 0.1 OUTLIER 46.52 40.01 7.58 Favored 'General case' 0 N--CA 1.516 2.869 0 O-C-N 120.34 -1.475 . . . . 0.0 110.666 179.715 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.479 ' C ' ' O ' ' A' ' 120' ' ' ASN . 0.3 OUTLIER 38.23 33.57 0.06 Allowed 'General case' 0 N--CA 1.518 2.934 0 O-C-N 121.054 -1.029 . . . . 0.0 109.622 179.857 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' A' ' 120' ' ' ASN . 0.2 OUTLIER -154.93 175.6 13.58 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.02 -1.05 . . . . 0.0 109.767 179.772 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.1 mmmm -58.58 158.14 16.4 Favored Pre-proline 0 N--CA 1.506 2.362 0 C-N-CA 119.544 -0.862 . . . . 0.0 109.066 179.829 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.69 48.59 1.36 Allowed 'Trans proline' 0 C--N 1.304 -1.8 0 O-C-N 124.071 1.564 . . . . 0.0 110.746 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -170.69 -122.49 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.62 -1.3 . . . . 0.0 110.365 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 11.6 m120 50.68 -132.7 1.83 Allowed 'General case' 0 N--CA 1.508 2.475 0 O-C-N 120.17 -1.581 . . . . 0.0 109.531 -179.562 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.495 ' O ' ' HG2' ' A' ' 128' ' ' ARG . . . -170.13 -172.27 1.29 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.706 -1.246 . . . . 0.0 109.532 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.495 ' HG2' ' O ' ' A' ' 127' ' ' ALA . 1.2 mtp-105 -140.64 -169.39 2.78 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.445 -1.41 . . . . 0.0 110.052 179.73 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ASN . . . . . 0.525 ' O ' ' C ' ' A' ' 130' ' ' LYS . 54.2 t30 -114.28 166.88 11.2 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.16 -0.963 . . . . 0.0 110.006 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' LYS . . . . . 0.525 ' C ' ' O ' ' A' ' 129' ' ' ASN . 0.9 OUTLIER . . . . . 0 N--CA 1.514 2.768 0 CA-C-O 118.0 -1.0 . . . . 0.0 111.162 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.983 ' HG3' HG22 ' A' ' 49' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.396 0.617 . . . . 0.0 110.083 . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.59 ' HB2' ' CZ ' ' A' ' 50' ' ' PHE . 19.6 t30 -77.91 101.35 6.78 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.303 -0.873 . . . . 0.0 109.049 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.657 ' HA ' HD12 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -41.5 -41.95 2.24 Favored 'General case' 0 N--CA 1.518 2.951 0 O-C-N 120.535 -1.353 . . . . 0.0 110.192 -178.753 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.472 ' OG1' ' OD1' ' A' ' 52' ' ' ASP . 1.6 m -58.65 -36.78 74.66 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.892 -1.13 . . . . 0.0 108.51 -179.345 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.512 ' HB3' ' HB3' ' A' ' 2' ' ' ASN . 0.7 OUTLIER -72.15 -45.41 60.56 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.149 -0.97 . . . . 0.0 108.682 178.245 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.874 HD22 HG23 ' A' ' 35' ' ' ILE 0.276 86.2 mt -51.37 -47.91 62.67 Favored 'General case' 0 C--N 1.315 -0.894 0 O-C-N 120.903 -1.123 . . . . 0.0 109.409 178.322 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.64 ' NZ ' HD12 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -66.94 -39.82 87.39 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.028 -1.045 . . . . 0.0 110.142 178.869 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -63.12 -29.27 70.67 Favored 'General case' 0 N--CA 1.507 2.399 0 C-N-CA 119.352 -0.939 . . . . 0.0 111.191 -179.111 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.681 HG22 ' CB ' ' A' ' 13' ' ' GLU . 3.2 m -75.02 123.5 88.96 Favored Pre-proline 0 C--N 1.285 -2.198 0 O-C-N 121.613 -0.679 . . . . 0.0 109.596 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.565 ' HG2' ' CG ' ' A' ' 13' ' ' GLU . 39.8 Cg_endo -61.29 151.3 80.11 Favored 'Trans proline' 0 CA--C 1.567 2.148 0 O-C-N 122.372 0.67 . . . . 0.0 110.856 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.6 ' O ' HD12 ' A' ' 15' ' ' ILE . 1.6 p -41.74 -49.86 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.525 3.318 0 O-C-N 120.643 -1.286 . . . . 0.0 109.707 -178.997 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.551 ' N ' ' CG1' ' A' ' 11' ' ' VAL . 0.7 OUTLIER -57.07 -40.78 77.56 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.294 -0.879 . . . . 0.0 111.076 -179.87 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 1.074 ' O ' HD12 ' A' ' 17' ' ' LEU . 52.6 mm-40 -68.95 -30.39 68.82 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 118.02 -1.472 . . . . 0.0 107.776 179.402 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.666 ' HB3' HG21 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -68.5 -42.31 78.78 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.993 -1.067 . . . . 0.0 109.058 177.104 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.6 HD12 ' O ' ' A' ' 11' ' ' VAL . 1.4 mp -66.26 -38.67 82.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 C-N-CA 118.133 -1.427 . . . . 0.0 108.621 178.734 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.561 ' HA ' ' HG2' ' A' ' 19' ' ' GLU . 44.2 m -64.88 -37.58 88.12 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 120.379 -1.45 . . . . 0.0 109.163 178.928 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 1.074 HD12 ' O ' ' A' ' 13' ' ' GLU . 0.9 OUTLIER -66.11 -37.46 85.81 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.85 -1.156 . . . . 0.0 109.069 178.652 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.452 ' O ' HD12 ' A' ' 23' ' ' LEU . . . -70.07 -42.76 66.97 Favored Glycine 0 N--CA 1.516 3.977 0 C-N-CA 118.6 -1.762 . . . . 0.0 108.864 178.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.69 ' HG3' ' N ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -59.81 -37.6 79.61 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.294 -1.71 . . . . 0.0 108.047 179.047 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.69 ' N ' ' HG3' ' A' ' 19' ' ' GLU . 28.2 m120 -61.05 -26.79 67.88 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 118.309 -1.356 . . . . 0.0 109.371 178.613 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.648 ' CE ' ' CG ' ' A' ' 42' ' ' HIS . 43.7 mmm -101.94 11.52 38.42 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.193 -0.942 . . . . 0.0 111.261 -179.366 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.21 -25.33 25.32 Favored Glycine 0 N--CA 1.497 2.758 0 C-N-CA 118.654 -1.736 . . . . 0.0 110.897 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.854 ' CD2' ' HB1' ' A' ' 37' ' ' ALA . 1.7 mp -78.62 91.77 4.66 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.414 -1.639 . . . . 0.0 109.027 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.478 ' O ' ' CB ' ' A' ' 25' ' ' ASN . 41.7 mt-10 -106.23 169.9 8.24 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.311 -0.868 . . . . 0.0 108.93 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.478 ' CB ' ' O ' ' A' ' 24' ' ' GLU . 0.7 OUTLIER 69.06 21.17 7.45 Favored 'General case' 0 N--CA 1.507 2.417 0 O-C-N 121.518 -0.738 . . . . 0.0 111.532 179.505 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.672 HD11 ' HB3' ' A' ' 23' ' ' LEU . 0.4 OUTLIER -76.78 -3.83 40.31 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 120.813 -1.179 . . . . 0.0 110.976 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.436 ' C ' ' O ' ' A' ' 26' ' ' LEU . . . -46.64 -32.92 3.81 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.602 -1.311 . . . . 0.0 108.685 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -80.84 -2.56 47.81 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.477 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.588 ' O ' HD11 ' A' ' 34' ' ' ILE . 7.9 mtp -100.73 150.61 22.59 Favored 'General case' 0 C--N 1.311 -1.076 0 O-C-N 120.748 -1.22 . . . . 0.0 111.33 -178.876 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.575 ' C ' HD12 ' A' ' 34' ' ' ILE . 17.4 tpp180 -89.32 141.23 28.73 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.252 -0.905 . . . . 0.0 110.407 178.796 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.609 ' HG3' HD23 ' A' ' 14' ' ' LEU . 7.8 ttmt -29.88 -47.57 0.08 Allowed 'General case' 0 N--CA 1.501 2.082 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.774 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.53 ' OE1' ' N ' ' A' ' 33' ' ' ASP . 1.3 pp0? -59.57 -56.04 26.94 Favored 'General case' 0 N--CA 1.518 2.953 0 O-C-N 121.385 -0.822 . . . . 0.0 111.976 -177.642 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.534 ' OD1' ' HE2' ' A' ' 29' ' ' MET . 2.8 p30 -66.09 -35.95 81.88 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 120.795 -1.19 . . . . 0.0 109.112 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.666 HG21 ' HB3' ' A' ' 14' ' ' LEU . 3.3 mt -61.52 -37.79 78.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 O-C-N 120.313 -1.492 . . . . 0.0 108.094 177.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.874 HG23 HD22 ' A' ' 6' ' ' LEU . 0.5 OUTLIER -60.21 -46.83 94.12 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.494 0 O-C-N 120.076 -1.64 . . . . 0.0 109.506 177.446 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -54.36 -40.56 68.22 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.751 -0.779 . . . . 0.0 109.525 -179.325 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.854 ' HB1' ' CD2' ' A' ' 23' ' ' LEU . . . -71.74 -52.02 19.85 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 120.745 -1.222 . . . . 0.0 110.626 179.187 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.567 HD11 HG22 ' A' ' 34' ' ' ILE . 2.5 mt -58.41 -28.19 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 C-N-CA 117.131 -1.827 . . . . 0.0 109.999 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.438 HD23 ' HA ' ' A' ' 39' ' ' LEU . 25.7 mt -72.39 -41.95 65.74 Favored 'General case' 0 N--CA 1.506 2.341 0 O-C-N 120.06 -1.65 . . . . 0.0 109.451 178.054 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.33 -36.77 85.05 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.903 -1.123 . . . . 0.0 110.286 178.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.629 ' CB ' HD11 ' A' ' 23' ' ' LEU . 10.0 mm100 -78.66 -51.69 9.5 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.273 -0.892 . . . . 0.0 111.2 -179.203 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.648 ' CG ' ' CE ' ' A' ' 21' ' ' MET . 0.2 OUTLIER -63.51 -36.48 83.91 Favored 'General case' 0 N--CA 1.505 2.279 0 C-N-CA 118.179 -1.408 . . . . 0.0 108.728 179.871 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.47 ' O ' ' N ' ' A' ' 46' ' ' GLY . . . -55.15 -45.06 75.64 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 177.582 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -49.98 -44.52 50.94 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-O 122.067 0.937 . . . . 0.0 108.65 177.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.45 ' HB2' ' O ' ' A' ' 42' ' ' HIS . 49.7 m -66.41 -8.14 23.84 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.579 0.704 . . . . 0.0 109.658 179.447 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . 80.98 20.98 64.04 Favored Glycine 0 N--CA 1.497 2.713 0 C-N-CA 120.107 -1.044 . . . . 0.0 112.642 178.028 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -78.72 164.75 24.31 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-N 120.298 2.049 . . . . 0.0 108.65 178.612 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.411 ' O ' ' CG ' ' A' ' 1' ' ' MET . 4.2 m-20 -88.69 152.66 21.67 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.019 -1.05 . . . . 0.0 110.233 -179.483 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.983 HG22 ' HG3' ' A' ' 1' ' ' MET . 9.0 pt -141.47 133.37 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.024 -1.048 . . . . 0.0 108.601 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.59 ' CZ ' ' HB2' ' A' ' 2' ' ' ASN . 20.8 p90 -140.85 164.61 29.78 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 116.542 -2.063 . . . . 0.0 114.303 -179.365 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -121.97 166.83 14.61 Favored Glycine 0 N--CA 1.502 3.08 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -177.859 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.472 ' OD1' ' OG1' ' A' ' 4' ' ' THR . 43.4 p30 -167.54 164.48 14.77 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 120.587 -1.537 . . . . 0.0 109.57 -179.178 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.519 ' HA3' ' O ' ' A' ' 66' ' ' ARG . . . 141.61 -137.25 7.91 Favored Glycine 0 N--CA 1.501 2.998 0 C-N-CA 118.074 -2.012 . . . . 0.0 111.039 178.807 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.583 ' HA ' ' O ' ' A' ' 95' ' ' ASP . 2.9 t -129.01 121.41 54.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 O-C-N 121.361 -1.081 . . . . 0.0 108.467 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.966 HD21 HG21 ' A' ' 81' ' ' VAL . 6.9 mt -62.81 165.98 6.06 Favored 'General case' 0 N--CA 1.504 2.23 0 C-N-CA 118.785 -1.166 . . . . 0.0 114.008 -175.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.492 ' HA ' ' OG1' ' A' ' 93' ' ' THR . 2.0 mm-40 -139.64 117.66 11.81 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 178.055 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.869 ' O ' HD12 ' A' ' 58' ' ' LEU . 1.6 mm -84.92 161.91 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 CA-C-N 120.824 1.647 . . . . 0.0 110.316 -178.44 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.869 HD12 ' O ' ' A' ' 57' ' ' ILE . 7.6 mp -130.97 143.68 50.91 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.496 -1.377 . . . . 0.0 109.691 178.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.41 ' C ' ' O ' ' A' ' 58' ' ' LEU . 0.9 OUTLIER -42.35 -37.06 1.43 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.304 -0.872 . . . . 0.0 110.337 -179.58 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.468 ' OD1' ' N ' ' A' ' 60' ' ' ASP . 4.5 m-20 -61.01 -6.79 2.05 Favored 'General case' 0 N--CA 1.502 2.126 0 C-N-CA 119.814 -0.754 . . . . 0.0 112.575 -178.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.423 ' O ' ' HB3' ' A' ' 83' ' ' PRO . . . 91.59 7.09 65.27 Favored Glycine 1 N--CA 1.519 4.204 0 C-N-CA 118.515 -1.803 . . . . 0.0 112.091 177.859 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.5 ' CE2' ' CE2' ' A' ' 64' ' ' PHE . 2.7 p90 -127.76 179.38 5.57 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 104.645 -2.354 . . . . 0.0 104.645 178.063 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -160.46 176.25 37.13 Favored Glycine 0 N--CA 1.477 1.427 0 C-N-CA 117.065 -2.493 . . . . 0.0 111.547 -177.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.59 ' CE1' ' O ' ' A' ' 76' ' ' PRO . 55.2 m-85 -129.98 155.49 46.0 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 120.112 1.956 . . . . 0.0 109.926 177.667 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.557 ' HB3' ' HB ' ' A' ' 79' ' ' ILE . 0.3 OUTLIER -98.92 161.65 13.51 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 176.506 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.519 ' O ' ' HA3' ' A' ' 53' ' ' GLY . 0.0 OUTLIER 178.61 -163.45 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.351 -0.843 . . . . 0.0 109.313 179.38 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.43 -155.25 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.008 -1.058 . . . . 0.0 110.462 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ALA . . . . . 0.45 ' O ' ' O ' ' A' ' 69' ' ' ASP . . . -100.55 -47.67 4.8 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.552 -0.717 . . . . 0.0 110.208 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.45 ' O ' ' O ' ' A' ' 68' ' ' ALA . 3.0 p-10 -62.97 -141.03 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.25 -0.906 . . . . 0.0 108.576 179.3 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.515 ' O ' ' CB ' ' A' ' 71' ' ' SER . 0.2 OUTLIER -62.55 -71.23 0.16 Allowed 'General case' 0 N--CA 1.503 2.224 0 O-C-N 120.044 -1.66 . . . . 0.0 109.327 179.514 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.659 ' O ' ' HB2' ' A' ' 72' ' ' TYR . 0.5 OUTLIER 167.2 -23.89 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.425 -0.797 . . . . 0.0 110.437 179.449 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.659 ' HB2' ' O ' ' A' ' 71' ' ' SER . 3.3 m-85 74.22 -41.09 0.47 Allowed 'General case' 0 N--CA 1.526 3.334 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 179.446 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.516 ' HA ' HD23 ' A' ' 73' ' ' LEU . 5.0 mt -90.56 -168.83 2.2 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.448 -1.407 . . . . 0.0 109.964 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.826 ' HB3' ' HB2' ' A' ' 77' ' ' ASP . . . -78.81 60.84 2.91 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.39 -179.474 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.493 ' C ' ' O ' ' A' ' 74' ' ' ALA . . . 12.76 -71.39 0.0 OUTLIER Glycine 1 N--CA 1.543 5.816 0 CA-C-O 119.398 -0.668 . . . . 0.0 112.714 178.823 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.606 ' N ' ' O ' ' A' ' 74' ' ' ALA . 23.3 Cg_endo -53.19 -31.31 54.73 Favored 'Trans proline' 0 N--CA 1.487 1.11 0 N-CA-C 109.549 -0.981 . . . . 0.0 109.549 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.826 ' HB2' ' HB3' ' A' ' 74' ' ' ALA . 6.8 m-20 -84.42 -2.48 57.25 Favored 'General case' 0 C--N 1.285 -2.202 0 C-N-CA 119.996 -0.681 . . . . 0.0 112.089 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.534 ' O ' ' O ' ' A' ' 77' ' ' ASP . 5.4 m-20 -58.6 -137.95 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.845 0 O-C-N 120.287 -1.508 . . . . 0.0 109.382 178.588 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.557 ' HB ' ' HB3' ' A' ' 65' ' ' LEU . 1.4 mp -92.9 130.21 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.012 0 C-N-CA 117.479 -1.688 . . . . 0.0 108.956 179.008 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.524 ' HB3' ' O ' ' A' ' 111' ' ' PHE . 5.8 t80 -79.84 146.19 32.36 Favored 'General case' 0 N--CA 1.517 2.876 0 CA-C-N 121.263 1.847 . . . . 0.0 110.429 -179.211 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.966 HG21 HD21 ' A' ' 55' ' ' LEU . 49.8 t -140.8 113.47 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 120.278 -1.513 . . . . 0.0 110.622 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.581 ' O ' HG13 ' A' ' 86' ' ' ILE . 14.0 m -74.99 162.81 71.9 Favored Pre-proline 0 N--CA 1.514 2.769 0 O-C-N 120.516 -1.365 . . . . 0.0 111.757 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.518 ' HA ' HG13 ' A' ' 86' ' ' ILE . 38.8 Cg_endo -66.02 -49.09 2.26 Favored 'Trans proline' 0 C--N 1.315 -1.193 0 O-C-N 124.465 1.771 . . . . 0.0 109.295 179.044 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.548 ' O ' ' CG ' ' A' ' 88' ' ' ARG . 23.3 t -47.27 -40.63 17.14 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 178.088 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.522 ' HB2' ' O ' ' A' ' 82' ' ' SER . 7.9 mm100 -63.58 -56.58 14.82 Favored 'General case' 0 N--CA 1.51 2.548 0 C-N-CA 119.498 -0.881 . . . . 0.0 108.642 178.067 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.581 HG13 ' O ' ' A' ' 82' ' ' SER . 1.0 OUTLIER -55.87 -54.67 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.245 0 O-C-N 120.942 -1.099 . . . . 0.0 108.871 178.679 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.454 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 0.0 OUTLIER -56.51 -41.95 77.55 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-O 121.941 0.877 . . . . 0.0 111.17 -179.384 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.548 ' CG ' ' O ' ' A' ' 84' ' ' SER . 2.5 mmt180 -60.3 -37.45 80.6 Favored 'General case' 0 N--CA 1.507 2.382 0 C-N-CA 119.739 -0.784 . . . . 0.0 111.9 -177.773 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -113.27 14.21 19.28 Favored 'General case' 0 N--CA 1.502 2.135 0 C-N-CA 117.507 -1.677 . . . . 0.0 111.459 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 58.95 53.27 5.75 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 120.363 -1.461 . . . . 0.0 109.543 178.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.524 ' O ' ' HG3' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -89.41 173.66 8.23 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 119.862 -0.735 . . . . 0.0 109.503 179.883 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.524 ' HG3' ' O ' ' A' ' 91' ' ' LEU . 21.1 mtp180 -152.06 164.1 37.94 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.928 -1.108 . . . . 0.0 109.249 178.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.591 ' HB ' ' CG1' ' A' ' 57' ' ' ILE . 1.5 t -65.42 155.52 35.2 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 117.014 -1.874 . . . . 0.0 106.964 179.035 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 76.66 -10.5 17.71 Favored Glycine 0 N--CA 1.505 3.235 0 C-N-CA 117.161 -2.447 . . . . 0.0 110.073 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.583 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 9.9 m-20 -67.04 144.75 55.97 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.216 -1.755 . . . . 0.0 110.706 -178.745 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.504 ' O ' HG12 ' A' ' 97' ' ' ILE . 0.2 OUTLIER -90.18 120.5 31.4 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.238 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.542 HG23 HG22 ' A' ' 119' ' ' VAL . 1.6 mt -146.43 168.66 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 119.845 -1.784 . . . . 0.0 112.985 -178.284 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.545 ' OG ' ' HB2' ' A' ' 118' ' ' GLU . 68.7 p -149.38 138.8 21.56 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.516 ' O ' ' HB2' ' A' ' 50' ' ' PHE . . . -165.88 179.56 40.03 Favored Glycine 0 N--CA 1.505 3.256 0 C-N-CA 117.379 -2.343 . . . . 0.0 114.422 -179.382 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.566 ' HD3' HD23 ' A' ' 114' ' ' LEU . 5.7 ptmt -90.6 156.0 18.45 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 179.154 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.523 HG12 ' HA ' ' A' ' 50' ' ' PHE . 2.3 pt -129.03 154.87 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.582 0 CA-C-N 121.02 1.736 . . . . 0.0 113.145 -177.216 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.804 ' HB2' HD22 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -160.65 151.17 15.12 Favored Pre-proline 0 N--CA 1.488 1.428 0 O-C-N 120.359 -1.463 . . . . 0.0 109.363 179.309 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.672 ' N ' ' HD3' ' A' ' 104' ' ' PRO . 54.9 Cg_endo -101.35 19.14 0.25 Allowed 'Trans proline' 0 CA--C 1.558 1.72 0 C-N-CA 121.527 1.484 . . . . 0.0 114.193 -178.994 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.672 ' HD3' ' N ' ' A' ' 103' ' ' PRO . 56.1 Cg_endo -86.96 47.62 1.65 Allowed 'Trans proline' 0 N--CA 1.489 1.228 0 CA-C-N 119.343 0.801 . . . . 0.0 111.893 -178.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.99 -171.53 3.68 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.078 -1.639 . . . . 0.0 110.809 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.72 -15.52 30.06 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 178.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -79.95 48.24 3.49 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 108.722 -1.751 . . . . 0.0 108.722 178.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.584 ' O ' ' N ' ' A' ' 110' ' ' TYR . 2.4 tt0 -82.83 -169.48 2.52 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.626 -1.514 . . . . 0.0 108.855 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.527 ' HB3' ' O ' ' A' ' 108' ' ' GLU . 3.6 tpp85 64.48 -59.11 0.23 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.222 -0.924 . . . . 0.0 108.518 -177.571 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.584 ' N ' ' O ' ' A' ' 108' ' ' GLU . 13.7 m-85 -107.27 150.85 26.2 Favored 'General case' 0 N--CA 1.514 2.738 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 175.662 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.524 ' O ' ' HB3' ' A' ' 80' ' ' TYR . 53.4 m-85 -67.31 159.37 29.4 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 119.055 -2.278 . . . . 0.0 107.717 179.542 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.429 ' HA ' ' HB3' ' A' ' 80' ' ' TYR . . . -122.31 154.23 37.9 Favored 'General case' 0 N--CA 1.484 1.271 0 O-C-N 119.932 -1.73 . . . . 0.0 110.508 -179.222 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.4 tp -59.26 144.02 47.47 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.804 HD22 ' HB2' ' A' ' 102' ' ' ARG . 18.0 tp -121.89 -54.48 1.93 Allowed 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.593 -1.317 . . . . 0.0 111.867 -178.617 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.564 ' HB3' ' CD ' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -130.63 141.54 50.43 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 120.457 -1.402 . . . . 0.0 108.924 179.116 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.6 t -92.49 129.08 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.754 0 O-C-N 120.732 -1.23 . . . . 0.0 111.253 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.42 ' C ' ' HG2' ' A' ' 118' ' ' GLU . 6.5 m-20 -106.64 -39.02 5.96 Favored 'General case' 0 N--CA 1.506 2.349 0 O-C-N 121.368 -0.833 . . . . 0.0 109.841 178.552 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.569 ' C ' HG23 ' A' ' 119' ' ' VAL . 12.6 mm-40 -143.15 155.87 44.65 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.817 -1.177 . . . . 0.0 109.339 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.569 HG23 ' C ' ' A' ' 118' ' ' GLU . 16.7 t -158.33 132.59 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -178.739 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.468 ' O ' ' C ' ' A' ' 121' ' ' PHE . 1.3 m-20 49.56 44.93 24.42 Favored 'General case' 0 N--CA 1.517 2.907 0 O-C-N 120.255 -1.528 . . . . 0.0 110.874 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.468 ' C ' ' O ' ' A' ' 120' ' ' ASN . 0.1 OUTLIER 38.24 34.19 0.07 Allowed 'General case' 0 N--CA 1.521 3.111 0 O-C-N 120.89 -1.132 . . . . 0.0 110.314 179.722 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.408 ' N ' ' O ' ' A' ' 120' ' ' ASN . 5.1 m-20 -154.57 172.87 17.13 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.123 -0.985 . . . . 0.0 109.474 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.599 ' HB3' ' HD2' ' A' ' 124' ' ' PRO . 39.9 mmtt -57.32 169.4 0.75 Allowed Pre-proline 0 N--CA 1.51 2.569 0 O-C-N 121.083 -1.01 . . . . 0.0 108.547 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.599 ' HD2' ' HB3' ' A' ' 123' ' ' LYS . 40.6 Cg_endo -67.29 48.08 0.32 Allowed 'Trans proline' 0 C--N 1.31 -1.456 0 O-C-N 123.375 1.197 . . . . 0.0 111.332 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.499 ' O ' ' CB ' ' A' ' 126' ' ' ASN . 0.2 OUTLIER -177.21 -171.87 0.36 Allowed 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 179.668 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.499 ' CB ' ' O ' ' A' ' 125' ' ' GLU . 0.3 OUTLIER 171.06 -146.14 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.183 0 O-C-N 120.112 -1.617 . . . . 0.0 110.227 179.726 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.406 ' C ' ' HG2' ' A' ' 128' ' ' ARG . . . -138.52 -160.69 1.09 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.861 -1.149 . . . . 0.0 109.009 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.406 ' HG2' ' C ' ' A' ' 127' ' ' ALA . 13.4 mmt180 -134.12 -172.09 2.91 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.228 -1.545 . . . . 0.0 110.708 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -90.18 172.68 8.63 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.557 -0.714 . . . . 0.0 110.721 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 118.024 -0.989 . . . . 0.0 109.826 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.626 ' HA ' ' HA ' ' A' ' 49' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.685 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.575 ' HA ' ' O ' ' A' ' 50' ' ' PHE . 34.8 t30 -78.29 94.23 4.78 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.884 -1.135 . . . . 0.0 108.675 178.949 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 1.047 HD23 HD13 ' A' ' 79' ' ' ILE . 1.0 OUTLIER -41.79 -40.61 2.1 Favored 'General case' 0 N--CA 1.517 2.889 0 O-C-N 120.599 -1.313 . . . . 0.0 110.357 -178.711 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.469 ' OG1' ' OD1' ' A' ' 52' ' ' ASP . 1.5 m -60.94 -36.44 79.35 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.891 -1.13 . . . . 0.0 108.239 -179.324 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.542 ' HB3' ' HB3' ' A' ' 2' ' ' ASN . 2.8 pt-20 -70.11 -45.37 67.05 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.981 -1.074 . . . . 0.0 108.432 178.033 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.528 HD12 HD12 ' A' ' 3' ' ' LEU 0.277 14.8 mt -52.77 -48.82 66.53 Favored 'General case' 0 C--N 1.315 -0.924 0 O-C-N 120.906 -1.121 . . . . 0.0 109.536 178.129 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 32.4 mttm -64.51 -34.92 79.34 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.227 -0.921 . . . . 0.0 110.332 179.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -62.08 -24.67 67.25 Favored 'General case' 0 N--CA 1.507 2.415 0 O-C-N 121.135 -0.978 . . . . 0.0 111.145 -179.053 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.724 HG22 ' CB ' ' A' ' 13' ' ' GLU . 2.8 m -73.52 133.64 80.06 Favored Pre-proline 0 N--CA 1.505 2.322 0 O-C-N 121.72 -0.613 . . . . 0.0 109.652 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.564 ' HG2' ' CG ' ' A' ' 13' ' ' GLU . 44.0 Cg_endo -64.12 151.86 83.53 Favored 'Trans proline' 0 CA--C 1.565 2.051 0 N-CA-C 110.036 -0.794 . . . . 0.0 110.036 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.534 ' CG1' ' N ' ' A' ' 12' ' ' SER . 1.7 p -43.25 -50.29 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.529 3.515 0 O-C-N 120.286 -1.509 . . . . 0.0 110.174 -178.672 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.534 ' N ' ' CG1' ' A' ' 11' ' ' VAL . 0.8 OUTLIER -57.5 -41.59 81.07 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.294 -0.879 . . . . 0.0 111.044 -179.485 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.724 ' CB ' HG22 ' A' ' 9' ' ' THR . 3.5 mm-40 -69.06 -26.77 65.12 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 118.115 -1.434 . . . . 0.0 107.662 179.47 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.759 ' HB3' HG21 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -70.44 -43.72 69.31 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.165 -0.959 . . . . 0.0 108.917 176.898 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.487 HD12 ' O ' ' A' ' 11' ' ' VAL . 1.7 mp -67.22 -38.68 81.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 C-N-CA 117.653 -1.619 . . . . 0.0 108.952 178.993 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.565 ' HA ' ' HG2' ' A' ' 19' ' ' GLU . 62.9 m -64.94 -38.54 91.32 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.368 -1.458 . . . . 0.0 109.172 178.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.522 ' O ' ' HG3' ' A' ' 21' ' ' MET . 0.1 OUTLIER -65.09 -38.27 90.17 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.91 -1.119 . . . . 0.0 108.879 178.561 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 18' ' ' GLY . . . . . 0.504 ' HA2' HD13 ' A' ' 23' ' ' LEU . . . -67.67 -41.95 88.47 Favored Glycine 0 N--CA 1.515 3.936 0 N-CA-C 108.505 -1.838 . . . . 0.0 108.505 178.445 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.713 ' HG3' ' N ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -59.68 -38.5 81.7 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.286 -1.714 . . . . 0.0 108.035 178.855 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.713 ' N ' ' HG3' ' A' ' 19' ' ' GLU . 26.1 m120 -61.68 -28.9 69.73 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 118.429 -1.308 . . . . 0.0 109.609 178.844 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.59 ' HB2' HD12 ' A' ' 23' ' ' LEU . 21.1 mtp -100.28 10.79 40.71 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.187 -0.946 . . . . 0.0 111.207 -179.511 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.52 -17.02 57.29 Favored Glycine 0 N--CA 1.5 2.9 0 C-N-CA 118.446 -1.835 . . . . 0.0 111.843 179.192 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.841 ' CD2' ' HB1' ' A' ' 37' ' ' ALA . 1.7 mp -79.06 104.61 9.81 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.079 -1.836 . . . . 0.0 109.385 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.404 ' O ' ' CB ' ' A' ' 25' ' ' ASN . 1.4 pt-20 -115.19 178.95 4.1 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.236 -0.915 . . . . 0.0 109.398 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.404 ' CB ' ' O ' ' A' ' 24' ' ' GLU . 1.0 OUTLIER 65.88 15.28 10.0 Favored 'General case' 0 N--CA 1.512 2.634 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.716 178.963 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 1.089 HD23 ' SD ' ' A' ' 29' ' ' MET . 1.1 mt -76.79 -15.78 59.65 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.154 -0.966 . . . . 0.0 112.066 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -47.02 -28.49 1.69 Allowed 'General case' 0 N--CA 1.497 1.925 0 O-C-N 120.315 -1.491 . . . . 0.0 109.392 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.9 mtt180 -79.1 -37.82 37.74 Favored 'General case' 0 C--N 1.295 -1.798 0 C-N-CA 120.075 -0.65 . . . . 0.0 111.906 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' MET . . . . . 1.089 ' SD ' HD23 ' A' ' 26' ' ' LEU . 5.8 ptm -85.87 169.64 13.12 Favored 'General case' 0 N--CA 1.482 1.156 0 O-C-N 120.545 -1.347 . . . . 0.0 111.529 -179.419 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 1.033 ' O ' HD12 ' A' ' 34' ' ' ILE . 1.0 OUTLIER -89.67 -176.26 4.93 Favored 'General case' 0 N--CA 1.504 2.274 0 CA-C-O 122.534 1.159 . . . . 0.0 113.529 -178.238 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.624 ' O ' HG22 ' A' ' 35' ' ' ILE . 4.4 ptmt -68.14 -33.25 74.13 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.122 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.58 ' O ' ' CG2' ' A' ' 35' ' ' ILE . 3.2 mm100 -65.19 -55.26 19.57 Favored 'General case' 0 N--CA 1.525 3.297 0 CA-C-O 122.166 0.984 . . . . 0.0 109.753 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 34' ' ' ILE . 2.0 p30 -66.5 -39.36 88.66 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.904 -1.123 . . . . 0.0 108.967 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 1.033 HD12 ' O ' ' A' ' 30' ' ' ARG . 1.7 mt -61.2 -40.83 87.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.194 -1.566 . . . . 0.0 109.281 177.627 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.624 HG22 ' O ' ' A' ' 31' ' ' LYS . 0.3 OUTLIER -66.79 -36.07 76.32 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.585 0 O-C-N 120.292 -1.505 . . . . 0.0 109.544 179.437 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.468 ' CD2' ' O ' ' A' ' 32' ' ' GLN . 21.6 m-85 -60.45 -43.63 96.66 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.813 -1.18 . . . . 0.0 108.78 179.259 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.841 ' HB1' ' CD2' ' A' ' 23' ' ' LEU . . . -65.44 -54.14 32.84 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.516 -1.365 . . . . 0.0 109.634 178.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.542 HG13 ' O ' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -53.76 -30.07 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 C-N-CA 117.541 -1.663 . . . . 0.0 109.743 179.57 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.721 HD11 HD11 ' A' ' 3' ' ' LEU . 34.2 mt -67.95 -42.53 80.8 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 119.865 -1.772 . . . . 0.0 109.224 178.189 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 mttt -66.0 -40.23 90.96 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.946 -1.096 . . . . 0.0 110.722 178.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.502 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 9.3 mm100 -73.51 -51.13 18.15 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.095 -1.003 . . . . 0.0 110.757 -179.32 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.526 ' HB3' ' HE2' ' A' ' 1' ' ' MET . 0.7 OUTLIER -62.51 -36.85 83.86 Favored 'General case' 0 N--CA 1.509 2.502 0 C-N-CA 118.885 -1.126 . . . . 0.0 108.739 179.51 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.579 ' O ' ' N ' ' A' ' 46' ' ' GLY . . . -67.01 -31.54 72.17 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.0 -1.063 . . . . 0.0 109.239 178.554 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.502 ' HB2' ' O ' ' A' ' 41' ' ' GLN . 9.0 tptt -47.54 -40.77 19.68 Favored 'General case' 0 N--CA 1.481 1.121 0 O-C-N 120.65 -1.281 . . . . 0.0 108.808 177.98 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 46.9 m -66.03 -11.07 45.65 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 119.452 -0.899 . . . . 0.0 109.056 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.579 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . 68.53 29.71 72.97 Favored Glycine 0 N--CA 1.496 2.642 0 C-N-CA 120.531 -0.842 . . . . 0.0 111.616 177.972 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.508 ' OE1' ' N ' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -88.82 169.17 11.83 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 120.105 -1.821 . . . . 0.0 108.788 178.921 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 48' ' ' ASP . . . . . 0.508 ' N ' ' OE1' ' A' ' 47' ' ' GLU . 9.1 m-20 -71.66 151.08 43.98 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.024 -1.048 . . . . 0.0 111.226 -178.006 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.626 ' HA ' ' HA ' ' A' ' 1' ' ' MET . 0.5 OUTLIER -150.81 144.08 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 178.625 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.575 ' O ' ' HA ' ' A' ' 2' ' ' ASN . 28.7 p90 -141.43 172.2 13.01 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 115.867 -2.333 . . . . 0.0 114.608 -177.481 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -124.77 166.71 17.33 Favored Glycine 0 N--CA 1.502 3.065 0 N-CA-C 108.762 -1.735 . . . . 0.0 108.762 -178.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.524 ' C ' ' CD2' ' A' ' 65' ' ' LEU . 3.0 p30 -172.28 163.48 5.74 Favored 'General case' 0 N--CA 1.485 1.281 0 O-C-N 120.346 -1.679 . . . . 0.0 110.065 -179.161 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.42 ' N ' HD21 ' A' ' 65' ' ' LEU . . . 146.94 -139.66 8.1 Favored Glycine 0 N--CA 1.504 3.233 0 C-N-CA 118.146 -1.978 . . . . 0.0 110.986 178.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.599 ' HA ' ' O ' ' A' ' 95' ' ' ASP . 4.6 t -128.75 122.74 57.76 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 1.025 HD21 HG21 ' A' ' 81' ' ' VAL . 6.0 mt -62.9 161.24 13.17 Favored 'General case' 0 N--CA 1.502 2.17 0 C-N-CA 118.486 -1.286 . . . . 0.0 114.043 -175.099 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.512 ' HA ' ' OG1' ' A' ' 93' ' ' THR . 0.0 OUTLIER -137.7 116.24 12.06 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 177.998 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.662 ' C ' HD12 ' A' ' 58' ' ' LEU . 1.4 mm -84.14 159.74 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 CA-C-N 121.087 1.767 . . . . 0.0 109.616 -178.485 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.864 HD22 ' CZ ' ' A' ' 62' ' ' PHE . 5.6 mp -130.1 135.76 48.58 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.443 -1.41 . . . . 0.0 109.602 179.262 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.472 ' C ' ' O ' ' A' ' 58' ' ' LEU . 0.8 OUTLIER -38.47 -35.15 0.16 Allowed 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.701 0.762 . . . . 0.0 109.909 -179.683 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.503 ' OD1' ' N ' ' A' ' 60' ' ' ASP . 1.0 OUTLIER -61.05 -7.66 2.72 Favored 'General case' 0 N--CA 1.499 2.012 0 C-N-CA 120.038 -0.665 . . . . 0.0 112.183 -179.531 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 90.64 8.6 65.46 Favored Glycine 1 N--CA 1.52 4.283 0 C-N-CA 118.845 -1.645 . . . . 0.0 112.184 178.146 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.864 ' CZ ' HD22 ' A' ' 58' ' ' LEU . 2.3 p90 -127.95 178.77 5.96 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 104.491 -2.411 . . . . 0.0 104.491 177.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.554 ' HA2' HD13 ' A' ' 58' ' ' LEU . . . -155.49 172.67 33.65 Favored Glycine 0 N--CA 1.477 1.432 0 C-N-CA 117.142 -2.456 . . . . 0.0 111.63 -178.31 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.574 ' CD2' ' O ' ' A' ' 76' ' ' PRO . 10.9 m-85 -128.88 154.78 46.16 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 119.851 1.826 . . . . 0.0 108.909 177.044 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.528 ' CB ' ' HB ' ' A' ' 79' ' ' ILE . 0.2 OUTLIER -99.45 133.23 44.06 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 177.075 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.538 ' CB ' ' OD2' ' A' ' 78' ' ' ASP . 17.2 ptt180 -158.45 -148.34 0.19 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.544 -1.347 . . . . 0.0 110.065 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -70.66 -153.64 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.384 -0.822 . . . . 0.0 110.235 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -112.47 -69.42 0.87 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.452 -0.78 . . . . 0.0 110.424 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.503 ' OD1' ' N ' ' A' ' 70' ' ' SER . 1.1 p30 -78.34 -152.09 0.06 Allowed 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.314 -0.867 . . . . 0.0 109.141 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.533 ' O ' ' CB ' ' A' ' 71' ' ' SER . 0.7 OUTLIER -68.78 -134.84 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.266 0 O-C-N 120.166 -1.584 . . . . 0.0 109.404 179.628 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.548 ' O ' ' CB ' ' A' ' 72' ' ' TYR . 0.3 OUTLIER 167.61 -22.93 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.256 0 O-C-N 120.877 -1.139 . . . . 0.0 110.828 179.75 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.548 ' CB ' ' O ' ' A' ' 71' ' ' SER . 4.0 m-85 76.6 -43.57 0.46 Allowed 'General case' 0 N--CA 1.521 3.106 0 O-C-N 121.578 -0.701 . . . . 0.0 111.127 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' LEU . . . . . 0.475 ' O ' ' O ' ' A' ' 74' ' ' ALA . 3.9 mp -77.44 -162.69 0.32 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.65 -1.281 . . . . 0.0 109.732 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.475 ' O ' ' O ' ' A' ' 73' ' ' LEU . . . -57.82 -145.96 0.0 OUTLIER 'General case' 0 C--N 1.291 -1.969 0 CA-C-O 122.282 1.039 . . . . 0.0 109.848 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.559 ' N ' ' HD2' ' A' ' 76' ' ' PRO . . . 141.11 -52.53 0.68 Allowed Glycine 0 N--CA 1.508 3.439 0 C-N-CA 119.823 -1.18 . . . . 0.0 112.526 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' PRO . . . . . 0.574 ' O ' ' CD2' ' A' ' 64' ' ' PHE . 24.7 Cg_endo -54.13 -36.96 87.0 Favored 'Trans proline' 0 N--CA 1.49 1.28 0 O-C-N 122.751 0.869 . . . . 0.0 110.761 -178.694 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.506 ' CG ' ' CE1' ' A' ' 110' ' ' TYR . 97.7 m-20 -86.58 13.59 8.27 Favored 'General case' 0 C--N 1.283 -2.302 0 C-N-CA 119.816 -0.754 . . . . 0.0 111.517 179.547 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.538 ' OD2' ' CB ' ' A' ' 66' ' ' ARG . 47.1 m-20 -58.9 -124.77 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.713 0 O-C-N 120.655 -1.278 . . . . 0.0 111.073 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 1.047 HD13 HD23 ' A' ' 3' ' ' LEU . 5.5 mm -83.18 127.97 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.891 0 O-C-N 120.628 -1.295 . . . . 0.0 110.373 -178.45 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.494 ' HB3' ' O ' ' A' ' 111' ' ' PHE . 8.6 t80 -74.62 145.4 43.31 Favored 'General case' 0 N--CA 1.515 2.807 0 CA-C-N 121.658 2.026 . . . . 0.0 109.81 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 1.025 HG21 HD21 ' A' ' 55' ' ' LEU . 17.2 t -138.34 112.44 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 120.26 -1.525 . . . . 0.0 110.57 -179.434 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.551 ' O ' HG13 ' A' ' 86' ' ' ILE . 49.9 m -75.28 164.6 60.01 Favored Pre-proline 0 N--CA 1.513 2.701 0 O-C-N 120.776 -1.203 . . . . 0.0 112.166 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.518 ' HD2' ' HB3' ' A' ' 82' ' ' SER . 39.8 Cg_endo -65.9 -50.05 1.87 Allowed 'Trans proline' 0 C--N 1.315 -1.21 0 O-C-N 124.443 1.759 . . . . 0.0 109.101 178.824 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.559 ' O ' ' CG ' ' A' ' 88' ' ' ARG . 0.5 OUTLIER -47.45 -40.28 17.75 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 178.156 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.527 ' HB2' ' O ' ' A' ' 82' ' ' SER . 6.4 mm100 -63.24 -57.21 11.21 Favored 'General case' 0 N--CA 1.511 2.582 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.323 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.558 ' HA ' HD23 ' A' ' 91' ' ' LEU . 0.6 OUTLIER -56.97 -54.95 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.42 0 O-C-N 120.891 -1.131 . . . . 0.0 108.792 178.649 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.8 mmt180 -57.67 -42.88 84.45 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-O 121.882 0.848 . . . . 0.0 111.568 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.559 ' CG ' ' O ' ' A' ' 84' ' ' SER . 4.4 mtt180 -58.87 -36.02 73.95 Favored 'General case' 0 N--CA 1.506 2.329 0 C-N-CA 119.783 -0.767 . . . . 0.0 111.773 -177.508 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -116.32 15.61 15.82 Favored 'General case' 0 N--CA 1.504 2.255 0 C-N-CA 117.268 -1.773 . . . . 0.0 111.755 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 57.84 56.12 4.97 Favored 'General case' 0 N--CA 1.482 1.159 0 O-C-N 120.339 -1.476 . . . . 0.0 109.193 178.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 0.558 HD23 ' HA ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -88.64 -178.78 5.89 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 119.852 -0.739 . . . . 0.0 109.601 -179.639 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.5 ' CG ' ' O ' ' A' ' 91' ' ' LEU . 68.5 mtt-85 -157.09 158.18 35.94 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.011 -1.056 . . . . 0.0 109.048 178.752 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.609 ' HB ' ' CG1' ' A' ' 57' ' ' ILE . 1.5 t -64.61 154.66 35.66 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 117.212 -1.795 . . . . 0.0 107.076 179.325 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 77.68 -11.18 20.76 Favored Glycine 0 N--CA 1.502 3.072 0 C-N-CA 116.961 -2.542 . . . . 0.0 110.442 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.702 ' OD2' HD11 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -74.45 156.79 36.59 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-N 120.097 1.948 . . . . 0.0 109.945 -179.192 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.505 ' O ' HG12 ' A' ' 97' ' ' ILE . 0.2 OUTLIER -97.34 127.12 43.03 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -179.201 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.702 HD11 ' OD2' ' A' ' 95' ' ' ASP . 1.9 mt -147.76 166.22 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 117.767 -1.573 . . . . 0.0 112.247 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.462 ' OG ' ' HB2' ' A' ' 118' ' ' GLU . 88.3 p -148.51 136.82 21.2 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.06 179.056 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' GLY . . . . . 0.532 ' O ' ' HB2' ' A' ' 50' ' ' PHE . . . -162.18 179.64 37.39 Favored Glycine 0 N--CA 1.505 3.257 0 C-N-CA 117.183 -2.437 . . . . 0.0 114.853 -178.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.6 mttt -88.77 151.68 22.25 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 178.904 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.56 HG12 ' HA ' ' A' ' 50' ' ' PHE . 2.6 pt -121.66 157.05 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.627 0 CA-C-N 121.514 1.961 . . . . 0.0 114.026 -176.383 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.973 ' CB ' HD13 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -145.89 146.22 27.94 Favored Pre-proline 0 N--CA 1.487 1.422 0 O-C-N 120.523 -1.361 . . . . 0.0 109.397 179.282 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.528 ' HD2' ' HG3' ' A' ' 102' ' ' ARG . 49.5 Cg_endo -90.7 110.37 0.36 Allowed 'Trans proline' 0 C--N 1.307 -1.627 0 O-C-N 123.876 1.461 . . . . 0.0 110.996 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.539 ' HG2' ' CG ' ' A' ' 108' ' ' GLU . 37.2 Cg_endo -62.58 -139.08 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.921 1.485 . . . . 0.0 109.889 179.034 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.575 ' O ' ' HG2' ' A' ' 108' ' ' GLU . 1.4 mppt? -106.74 177.4 4.87 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 120.47 -1.394 . . . . 0.0 110.832 -178.642 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLU . . . . . 0.502 ' O ' ' O ' ' A' ' 105' ' ' LYS 0.255 0.1 OUTLIER -50.08 179.77 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.173 0 O-C-N 120.747 -1.22 . . . . 0.0 108.546 179.148 . . . . . . . . 4 4 . 1 . 009 nuclear build full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 79.98 -33.16 2.19 Favored Glycine 0 N--CA 1.498 2.831 0 C-N-CA 117.877 -2.106 . . . . 0.0 110.332 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.575 ' HG2' ' O ' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -83.08 -36.26 25.02 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.151 -1.794 . . . . 0.0 111.063 -179.233 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.491 ' N ' ' OE1' ' A' ' 108' ' ' GLU . 0.4 OUTLIER 66.19 -40.31 0.34 Allowed 'General case' 0 N--CA 1.502 2.133 0 O-C-N 120.692 -1.255 . . . . 0.0 113.143 178.633 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.55 ' N ' ' OE1' ' A' ' 108' ' ' GLU . 17.5 m-85 -106.62 152.52 23.64 Favored 'General case' 0 N--CA 1.522 3.168 0 O-C-N 119.967 -1.708 . . . . 0.0 109.422 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' PHE . . . . . 0.494 ' O ' ' HB3' ' A' ' 80' ' ' TYR . 11.6 m-85 -68.05 166.4 16.02 Favored 'General case' 0 N--CA 1.506 2.365 0 O-C-N 119.729 -1.857 . . . . 0.0 108.065 178.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.454 ' HA ' ' HB3' ' A' ' 80' ' ' TYR . . . -123.61 155.5 37.56 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.055 -1.653 . . . . 0.0 111.054 -179.08 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.02 153.99 40.7 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 106.287 -1.746 . . . . 0.0 106.287 178.928 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.973 HD13 ' CB ' ' A' ' 102' ' ' ARG . 3.0 tp -130.99 -63.19 0.87 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.066 -1.646 . . . . 0.0 111.727 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.35 147.15 40.83 Favored 'General case' 0 N--CA 1.51 2.545 0 O-C-N 120.289 -1.507 . . . . 0.0 109.666 178.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 24.8 t -94.1 130.94 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.987 0 O-C-N 121.021 -1.049 . . . . 0.0 112.772 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ASN . . . . . 0.561 ' O ' ' HB3' ' A' ' 124' ' ' PRO . 7.9 m-20 -107.33 -39.7 5.6 Favored 'General case' 0 N--CA 1.509 2.509 0 O-C-N 121.504 -0.747 . . . . 0.0 109.856 177.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.577 ' C ' HG23 ' A' ' 119' ' ' VAL . 1.3 tt0 -143.4 159.05 43.09 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.651 -1.281 . . . . 0.0 109.115 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.577 HG23 ' C ' ' A' ' 118' ' ' GLU . 17.9 t -156.84 143.06 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -178.663 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.469 ' C ' ' O ' ' A' ' 119' ' ' VAL . 0.1 OUTLIER -35.08 -29.97 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.812 0 O-C-N 121.0 -1.062 . . . . 0.0 110.88 -177.581 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.531 ' N ' ' O ' ' A' ' 119' ' ' VAL . 0.1 OUTLIER -160.45 59.15 0.33 Allowed 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 118.401 -1.32 . . . . 0.0 111.136 179.157 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.516 ' HB2' ' HB ' ' A' ' 119' ' ' VAL . 0.2 OUTLIER -154.25 164.37 38.66 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 120.562 -1.336 . . . . 0.0 109.982 178.12 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.501 ' HB3' ' HD2' ' A' ' 124' ' ' PRO . 12.4 mmtp -79.72 166.02 43.81 Favored Pre-proline 0 N--CA 1.502 2.131 0 O-C-N 121.47 -0.769 . . . . 0.0 109.037 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' PRO . . . . . 0.561 ' HB3' ' O ' ' A' ' 117' ' ' ASN . 50.7 Cg_endo -77.16 40.66 0.84 Allowed 'Trans proline' 0 C--N 1.302 -1.902 0 O-C-N 123.769 1.405 . . . . 0.0 110.511 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.541 ' O ' ' CB ' ' A' ' 126' ' ' ASN . 1.7 tp10 -176.47 -143.99 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.38 0 O-C-N 120.769 -1.207 . . . . 0.0 108.706 -179.111 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.541 ' CB ' ' O ' ' A' ' 125' ' ' GLU . 0.2 OUTLIER 166.22 29.37 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.225 0 O-C-N 120.491 -1.38 . . . . 0.0 110.357 179.793 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -149.79 28.88 0.76 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.698 -1.251 . . . . 0.0 110.262 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 8.6 mtm180 -128.23 -76.3 0.56 Allowed 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.387 -0.821 . . . . 0.0 110.142 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -64.55 160.61 19.15 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.146 -0.971 . . . . 0.0 109.969 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.307 -1.26 0 O-C-N 121.134 -0.979 . . . . 0.0 109.867 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.589 ' HA ' ' HA ' ' A' ' 49' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 110.027 -0.361 . . . . 0.0 110.027 . . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 2' ' ' ASN . . . . . 0.598 ' HB3' ' HB3' ' A' ' 5' ' ' GLU . 47.5 t30 -78.75 92.73 4.83 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.802 -1.186 . . . . 0.0 108.42 178.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 1.065 HD23 HD11 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -42.55 -43.39 3.72 Favored 'General case' 0 N--CA 1.515 2.779 0 O-C-N 120.607 -1.308 . . . . 0.0 110.472 -178.594 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.487 ' OG1' ' OD2' ' A' ' 52' ' ' ASP . 1.9 m -57.29 -34.54 68.79 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.775 -1.203 . . . . 0.0 108.149 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.598 ' HB3' ' HB3' ' A' ' 2' ' ' ASN . 0.0 OUTLIER -70.83 -44.35 66.69 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 177.498 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 6' ' ' LEU . . . . . 0.875 HD22 HG23 ' A' ' 35' ' ' ILE 0.277 15.6 mt -52.33 -49.43 64.28 Favored 'General case' 0 C--N 1.316 -0.88 0 O-C-N 120.748 -1.22 . . . . 0.0 109.613 178.088 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LYS . . . . . 0.468 ' HE2' ' HB2' ' A' ' 77' ' ' ASP . 9.8 mttt -65.37 -37.66 87.69 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.08 -1.012 . . . . 0.0 110.589 179.192 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -63.01 -18.66 63.56 Favored 'General case' 0 N--CA 1.507 2.387 0 O-C-N 121.119 -0.988 . . . . 0.0 111.182 -179.176 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.717 ' O ' HD11 ' A' ' 14' ' ' LEU . 2.2 m -86.56 116.32 65.48 Favored Pre-proline 0 C--N 1.284 -2.249 0 O-C-N 121.761 -0.587 . . . . 0.0 109.642 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PRO . . . . . 0.541 ' CG ' ' HG3' ' A' ' 13' ' ' GLU . 37.0 Cg_endo -58.51 155.1 38.04 Favored 'Trans proline' 0 CA--C 1.557 1.657 0 N-CA-C 109.288 -1.082 . . . . 0.0 109.288 179.127 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . 0.703 ' HA ' HD12 ' A' ' 14' ' ' LEU . 1.5 p -41.54 -50.11 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.532 3.657 0 O-C-N 120.173 -1.58 . . . . 0.0 110.463 -177.689 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . 0.516 ' N ' ' CG1' ' A' ' 11' ' ' VAL . 1.9 t -58.96 -42.15 89.19 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.188 -0.945 . . . . 0.0 111.156 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLU . . . . . 0.581 ' CB ' HG22 ' A' ' 9' ' ' THR . 2.2 mm-40 -69.13 -27.79 65.88 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 118.15 -1.42 . . . . 0.0 108.336 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.717 HD11 ' O ' ' A' ' 9' ' ' THR . 9.8 mt -71.56 -40.66 69.83 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 120.917 -1.114 . . . . 0.0 108.765 176.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' ILE . . . . . 0.612 HD12 ' O ' ' A' ' 11' ' ' VAL . 1.4 mp -68.05 -40.49 83.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 C-N-CA 117.543 -1.663 . . . . 0.0 108.945 178.764 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.602 ' HA ' ' HG2' ' A' ' 19' ' ' GLU . 85.0 m -65.42 -37.22 86.27 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.272 -1.517 . . . . 0.0 109.413 179.334 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LEU . . . . . 0.517 HD21 HG21 ' A' ' 38' ' ' ILE . 1.3 tp -63.16 -45.04 93.71 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 120.912 -1.117 . . . . 0.0 108.048 178.414 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -60.94 -43.72 99.03 Favored Glycine 0 N--CA 1.514 3.882 0 N-CA-C 108.288 -1.925 . . . . 0.0 108.288 179.051 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLU . . . . . 0.7 ' HG3' ' N ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -57.71 -38.73 75.74 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.582 -1.54 . . . . 0.0 107.845 178.904 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASN . . . . . 0.7 ' N ' ' HG3' ' A' ' 19' ' ' GLU . 28.7 m120 -61.1 -27.4 68.34 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 118.538 -1.265 . . . . 0.0 109.341 178.648 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.567 ' HB2' ' CD1' ' A' ' 23' ' ' LEU . 31.4 mtp -101.44 11.3 39.36 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.339 -0.851 . . . . 0.0 111.348 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.86 -22.75 35.97 Favored Glycine 0 N--CA 1.5 2.92 0 C-N-CA 118.547 -1.787 . . . . 0.0 111.143 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' LEU . . . . . 0.783 ' CD2' ' HB1' ' A' ' 37' ' ' ALA . 3.0 mp -78.91 94.67 5.26 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 120.372 -1.663 . . . . 0.0 109.225 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLU . . . . . 0.519 ' O ' ' CB ' ' A' ' 25' ' ' ASN . 87.0 mt-10 -111.7 170.38 8.17 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.204 -0.935 . . . . 0.0 109.035 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.519 ' CB ' ' O ' ' A' ' 24' ' ' GLU . 0.9 OUTLIER 70.79 17.35 6.48 Favored 'General case' 0 N--CA 1.512 2.671 0 O-C-N 121.404 -0.81 . . . . 0.0 111.796 179.485 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.591 ' CD1' ' O ' ' A' ' 23' ' ' LEU . 1.1 mt -76.9 -6.05 50.92 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 120.841 -1.162 . . . . 0.0 111.372 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 26' ' ' LEU . . . -46.59 -31.21 2.68 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.477 -1.389 . . . . 0.0 108.81 -179.373 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 52.1 mtp180 -80.12 -6.57 57.93 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 120.047 -0.661 . . . . 0.0 111.386 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' MET . . . . . 0.546 ' HE2' ' OD1' ' A' ' 33' ' ' ASP . 14.8 mtp -101.01 158.67 15.83 Favored 'General case' 0 C--N 1.313 -0.999 0 O-C-N 120.768 -1.208 . . . . 0.0 111.473 -179.208 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ARG . . . . . 0.96 ' O ' HD12 ' A' ' 34' ' ' ILE . 4.4 ttm180 -89.65 171.99 9.27 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.374 -0.829 . . . . 0.0 110.166 177.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LYS . . . . . 0.571 ' O ' ' CG1' ' A' ' 35' ' ' ILE . 11.0 pttm -60.5 -42.49 96.45 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.43 -0.794 . . . . 0.0 110.547 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLN . . . . . 0.471 ' OE1' ' HB3' ' A' ' 33' ' ' ASP . 0.0 OUTLIER -60.55 -56.45 21.21 Favored 'General case' 0 N--CA 1.517 2.918 0 O-C-N 121.306 -0.871 . . . . 0.0 111.632 -178.166 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.546 ' OD1' ' HE2' ' A' ' 29' ' ' MET . 2.1 p30 -65.74 -36.29 83.17 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.802 -1.186 . . . . 0.0 109.166 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ILE . . . . . 0.96 HD12 ' O ' ' A' ' 30' ' ' ARG . 2.0 mt -60.78 -38.49 79.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 O-C-N 120.348 -1.47 . . . . 0.0 107.569 177.438 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ILE . . . . . 0.875 HG23 HD22 ' A' ' 6' ' ' LEU . 0.8 OUTLIER -59.3 -50.2 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.319 0 O-C-N 120.291 -1.506 . . . . 0.0 109.562 177.665 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -51.29 -41.6 60.57 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.514 -0.874 . . . . 0.0 109.154 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ALA . . . . . 0.783 ' HB1' ' CD2' ' A' ' 23' ' ' LEU . . . -63.49 -53.24 55.14 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.689 -1.257 . . . . 0.0 109.108 178.101 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.517 HG21 HD21 ' A' ' 17' ' ' LEU . 0.2 OUTLIER -55.51 -27.45 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 C-N-CA 117.451 -1.7 . . . . 0.0 109.705 179.549 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' LEU . . . . . 0.672 HD21 HD11 ' A' ' 6' ' ' LEU . 23.7 mt -71.34 -42.33 68.67 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.129 -1.607 . . . . 0.0 109.115 177.704 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.2 mttt -64.11 -40.21 95.71 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.936 -1.103 . . . . 0.0 110.313 178.462 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLN . . . . . 0.738 ' HG2' HD11 ' A' ' 23' ' ' LEU . 0.3 OUTLIER -75.96 -53.12 8.88 Favored 'General case' 0 N--CA 1.508 2.425 0 O-C-N 121.033 -1.042 . . . . 0.0 111.125 -179.261 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 42' ' ' HIS . . . . . 0.723 ' CD2' ' CD ' ' A' ' 47' ' ' GLU . 0.6 OUTLIER -61.24 -35.18 76.53 Favored 'General case' 0 N--CA 1.513 2.72 0 O-C-N 121.229 -0.919 . . . . 0.0 109.192 179.975 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ALA . . . . . 0.544 ' O ' ' N ' ' A' ' 46' ' ' GLY . . . -81.15 -32.08 33.84 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.306 -0.871 . . . . 0.0 110.961 179.615 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.597 ' HD3' ' N ' ' A' ' 45' ' ' SER 0.254 0.0 OUTLIER -49.08 -50.37 37.11 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.333 -1.48 . . . . 0.0 107.782 178.089 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 45' ' ' SER . . . . . 0.597 ' N ' ' HD3' ' A' ' 44' ' ' LYS . 72.5 m -65.61 -9.37 26.36 Favored 'General case' 0 C--N 1.287 -2.149 0 CA-C-N 114.57 -1.195 . . . . 0.0 109.302 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . 64.46 32.14 83.22 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 178.427 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . 0.723 ' CD ' ' CD2' ' A' ' 42' ' ' HIS . 9.8 pt-20 -87.19 166.85 14.64 Favored 'General case' 0 C--N 1.309 -1.183 0 O-C-N 120.46 -1.612 . . . . 0.0 109.2 179.286 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -55.11 135.98 48.67 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.067 -1.021 . . . . 0.0 111.914 -177.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.589 ' HA ' ' HA ' ' A' ' 1' ' ' MET . 4.5 pt -146.57 137.8 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 178.14 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PHE . . . . . 0.569 ' N ' ' CD1' ' A' ' 50' ' ' PHE . 16.7 p90 -144.07 164.09 31.65 Favored 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 115.55 -2.46 . . . . 0.0 115.655 -178.224 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -119.19 166.17 13.15 Favored Glycine 0 N--CA 1.5 2.936 0 N-CA-C 107.425 -2.27 . . . . 0.0 107.425 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.487 ' OD2' ' OG1' ' A' ' 4' ' ' THR . 5.9 p-10 -171.88 167.98 6.13 Favored 'General case' 0 N--CA 1.482 1.156 0 O-C-N 120.132 -1.805 . . . . 0.0 109.617 -178.747 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' GLY . . . . . 0.44 ' N ' HD21 ' A' ' 65' ' ' LEU . . . 142.3 -137.18 7.68 Favored Glycine 0 N--CA 1.504 3.184 0 C-N-CA 118.247 -1.93 . . . . 0.0 110.741 178.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' VAL . . . . . 0.583 ' HA ' ' O ' ' A' ' 95' ' ' ASP . 3.3 t -128.28 120.62 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 O-C-N 121.382 -1.07 . . . . 0.0 108.419 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.822 HD21 HG21 ' A' ' 81' ' ' VAL . 6.5 mt -62.73 162.38 10.91 Favored 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 -175.642 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLU . . . . . 0.504 ' HA ' ' OG1' ' A' ' 93' ' ' THR . 1.4 tt0 -137.99 120.4 15.95 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 177.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ILE . . . . . 0.739 ' C ' HD12 ' A' ' 58' ' ' LEU . 1.2 mm -82.48 161.53 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 119.863 -1.773 . . . . 0.0 109.177 -179.081 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' LEU . . . . . 0.895 HD22 ' CZ ' ' A' ' 62' ' ' PHE . 7.1 mp -130.86 137.06 49.19 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.347 -1.47 . . . . 0.0 109.701 179.06 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLN . . . . . 0.463 ' C ' ' O ' ' A' ' 58' ' ' LEU . 1.4 tt0 -39.49 -36.54 0.39 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.525 -0.734 . . . . 0.0 110.006 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASP . . . . . 0.538 ' HB2' ' CD2' ' A' ' 62' ' ' PHE . 30.5 m-20 -61.4 -5.69 1.85 Allowed 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.676 -0.64 . . . . 0.0 112.574 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLY . . . . . 0.449 ' O ' ' HB3' ' A' ' 83' ' ' PRO . . . 88.25 11.37 67.07 Favored Glycine 1 N--CA 1.519 4.181 0 C-N-CA 118.601 -1.761 . . . . 0.0 111.954 178.307 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 62' ' ' PHE . . . . . 0.895 ' CZ ' HD22 ' A' ' 58' ' ' LEU . 4.0 p90 -127.94 -179.17 4.83 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 104.341 -2.466 . . . . 0.0 104.341 177.774 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' GLY . . . . . 0.506 ' HA2' HD13 ' A' ' 58' ' ' LEU . . . -156.07 168.08 33.43 Favored Glycine 0 N--CA 1.474 1.176 0 C-N-CA 117.181 -2.438 . . . . 0.0 111.577 -177.815 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PHE . . . . . 0.425 ' CD1' ' HE1' ' A' ' 62' ' ' PHE . 2.6 m-85 -129.07 151.18 50.04 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 119.926 1.863 . . . . 0.0 109.26 177.597 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . 0.537 ' HB3' ' HB ' ' A' ' 79' ' ' ILE . 0.3 OUTLIER -98.68 153.9 18.37 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 176.707 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.479 ' HB3' ' O ' ' A' ' 65' ' ' LEU . 0.5 OUTLIER 178.08 -151.71 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.246 -0.909 . . . . 0.0 109.657 179.364 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.6 m -65.7 -151.08 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.383 -0.823 . . . . 0.0 110.64 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -118.47 -14.95 9.68 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.471 -0.768 . . . . 0.0 111.321 -179.101 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -70.66 -153.0 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.187 0 O-C-N 120.888 -1.132 . . . . 0.0 108.816 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' SER . . . . . 0.59 ' O ' ' CB ' ' A' ' 71' ' ' SER . 0.1 OUTLIER -125.66 -154.07 0.6 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 119.9 -1.75 . . . . 0.0 109.708 179.652 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.669 ' O ' ' HB2' ' A' ' 72' ' ' TYR . 0.6 OUTLIER 159.55 -19.83 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.486 0 O-C-N 121.382 -0.824 . . . . 0.0 110.046 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.669 ' HB2' ' O ' ' A' ' 71' ' ' SER . 80.1 m-85 75.69 -48.9 0.61 Allowed 'General case' 0 N--CA 1.524 3.241 0 O-C-N 122.266 -0.271 . . . . 0.0 110.775 -179.468 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 47.2 mt -99.17 -178.33 3.89 Favored 'General case' 0 C--N 1.308 -1.205 0 O-C-N 120.554 -1.341 . . . . 0.0 109.304 179.141 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.01 -150.73 0.07 Allowed 'General case' 0 C--N 1.292 -1.93 0 CA-C-O 122.33 1.062 . . . . 0.0 109.137 178.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLY . . . . . 0.49 ' N ' ' OD2' ' A' ' 78' ' ' ASP . . . -166.85 153.18 22.69 Favored Glycine 0 C--N 1.277 -2.719 0 N-CA-C 107.304 -2.318 . . . . 0.0 107.304 178.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -64.18 -41.15 22.99 Favored 'Trans proline' 0 N--CA 1.489 1.246 0 CA-C-N 118.622 1.211 . . . . 0.0 112.488 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.468 ' HB2' ' HE2' ' A' ' 7' ' ' LYS . 73.6 m-20 -86.54 7.68 25.18 Favored 'General case' 0 N--CA 1.508 2.465 0 O-C-N 120.957 -1.089 . . . . 0.0 113.27 -178.128 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASP . . . . . 0.762 ' C ' HD12 ' A' ' 79' ' ' ILE . 27.6 m-20 -78.27 -151.55 0.05 Allowed 'General case' 0 N--CA 1.505 2.28 0 O-C-N 120.092 -1.63 . . . . 0.0 109.458 179.197 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 1.065 HD11 HD23 ' A' ' 3' ' ' LEU . 2.1 mp -142.34 136.51 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.629 0 C-N-CA 119.241 -0.983 . . . . 0.0 109.928 178.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.471 ' HB3' ' HA ' ' A' ' 112' ' ' ALA . 12.2 t80 -78.11 147.46 34.64 Favored 'General case' 0 N--CA 1.52 3.049 0 O-C-N 119.635 -1.916 . . . . 0.0 110.014 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' VAL . . . . . 0.822 HG21 HD21 ' A' ' 55' ' ' LEU . 39.8 t -143.36 115.89 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 120.157 -1.589 . . . . 0.0 110.505 -179.407 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' SER . . . . . 0.547 ' O ' HG13 ' A' ' 86' ' ' ILE . 68.0 m -74.65 163.42 68.39 Favored Pre-proline 0 N--CA 1.514 2.737 0 O-C-N 120.5 -1.375 . . . . 0.0 112.688 -179.062 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PRO . . . . . 0.581 ' HA ' HG13 ' A' ' 86' ' ' ILE . 39.4 Cg_endo -65.33 -51.7 1.39 Allowed 'Trans proline' 0 C--N 1.315 -1.215 0 O-C-N 124.779 1.936 . . . . 0.0 108.571 178.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' SER . . . . . 0.537 ' O ' ' CG ' ' A' ' 88' ' ' ARG . 57.1 p -47.3 -39.94 15.77 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 177.93 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.528 ' HB2' ' O ' ' A' ' 82' ' ' SER . 4.9 mm-40 -62.38 -60.03 4.14 Favored 'General case' 0 N--CA 1.509 2.49 0 C-N-CA 119.089 -1.044 . . . . 0.0 108.225 178.509 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' ILE . . . . . 0.614 HG22 ' HB2' ' A' ' 91' ' ' LEU . 0.2 OUTLIER -55.42 -55.04 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.305 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.512 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ARG . . . . . 0.498 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 0.0 OUTLIER -57.39 -42.59 82.51 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-O 121.811 0.815 . . . . 0.0 111.238 -179.49 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ARG . . . . . 0.537 ' CG ' ' O ' ' A' ' 84' ' ' SER . 10.8 mmm180 -59.4 -38.03 79.52 Favored 'General case' 0 N--CA 1.505 2.322 0 C-N-CA 119.84 -0.744 . . . . 0.0 111.816 -177.648 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PHE . . . . . 1.082 ' HB2' HD21 ' A' ' 91' ' ' LEU . 9.1 m-85 -110.16 12.41 23.44 Favored 'General case' 0 N--CA 1.505 2.315 0 C-N-CA 116.976 -1.89 . . . . 0.0 111.359 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASN . . . . . 0.408 ' CB ' ' O ' ' A' ' 89' ' ' PHE . 2.6 t-20 62.24 53.43 2.87 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 120.523 -1.36 . . . . 0.0 110.64 178.336 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' LEU . . . . . 1.082 HD21 ' HB2' ' A' ' 89' ' ' PHE . 2.8 mt -89.61 -169.45 2.48 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 119.199 -1.001 . . . . 0.0 110.043 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ARG . . . . . 0.532 ' CG ' ' O ' ' A' ' 91' ' ' LEU . 53.0 mtp180 -159.92 162.38 34.47 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.542 -0.724 . . . . 0.0 109.083 178.225 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.598 ' HB ' ' CG1' ' A' ' 57' ' ' ILE . 1.6 t -65.25 156.55 31.56 Favored 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 116.993 -1.883 . . . . 0.0 106.672 178.431 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 76.12 -10.3 15.77 Favored Glycine 0 N--CA 1.505 3.284 0 C-N-CA 116.954 -2.546 . . . . 0.0 110.191 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.583 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 7.7 m-20 -66.65 147.38 53.35 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.184 -1.774 . . . . 0.0 110.864 -178.874 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' THR . . . . . 0.481 ' O ' HG12 ' A' ' 97' ' ' ILE . 0.3 OUTLIER -90.52 120.36 31.55 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.193 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 97' ' ' ILE . . . . . 0.508 HG23 HG22 ' A' ' 119' ' ' VAL . 1.4 mt -144.11 167.84 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 119.778 -1.826 . . . . 0.0 112.929 -178.4 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 98' ' ' SER . . . . . 0.49 ' OG ' ' CB ' ' A' ' 118' ' ' GLU . 94.5 p -150.14 138.51 20.51 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.445 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -164.29 179.26 39.22 Favored Glycine 0 N--CA 1.506 3.319 0 C-N-CA 117.037 -2.506 . . . . 0.0 115.16 -179.137 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.9 mmtt -88.21 148.87 24.16 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.3 pt -124.59 153.54 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.706 0 CA-C-N 121.25 1.841 . . . . 0.0 113.566 -176.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ARG . . . . . 0.745 ' HB2' HD22 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -160.28 154.48 19.85 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 120.372 -1.455 . . . . 0.0 109.875 179.013 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.642 ' N ' ' CD ' ' A' ' 104' ' ' PRO . 56.0 Cg_endo -103.38 20.26 0.16 Allowed 'Trans proline' 0 CA--C 1.557 1.628 0 C-N-CA 121.609 1.539 . . . . 0.0 113.513 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.642 ' CD ' ' N ' ' A' ' 103' ' ' PRO . 56.8 Cg_endo -81.74 34.33 0.55 Allowed 'Trans proline' 0 N--CA 1.493 1.454 0 CA-C-N 119.049 0.696 . . . . 0.0 111.855 -178.144 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 105' ' ' LYS . . . . . 0.421 ' CG ' ' H ' ' A' ' 107' ' ' GLY . 0.3 OUTLIER -162.59 -153.85 0.28 Allowed 'General case' 0 N--CA 1.498 1.975 0 O-C-N 120.381 -1.449 . . . . 0.0 110.13 -179.41 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.39 -13.76 1.01 Allowed 'General case' 0 C--N 1.317 -0.826 0 O-C-N 120.496 -1.378 . . . . 0.0 108.838 178.26 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' GLY . . . . . 0.94 ' HA3' ' HB2' ' A' ' 112' ' ' ALA . . . -69.73 41.45 0.42 Allowed Glycine 0 N--CA 1.495 2.622 0 C-N-CA 119.633 -1.27 . . . . 0.0 110.897 179.116 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' GLU . . . . . 0.543 ' O ' ' HB3' ' A' ' 109' ' ' ARG . 0.1 OUTLIER -83.83 164.51 19.45 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.13 -1.806 . . . . 0.0 107.72 178.266 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ARG . . . . . 0.543 ' HB3' ' O ' ' A' ' 108' ' ' GLU . 0.2 OUTLIER 64.46 -58.85 0.23 Allowed 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.163 -0.961 . . . . 0.0 108.936 -177.753 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.539 ' N ' ' O ' ' A' ' 108' ' ' GLU . 18.2 m-85 -107.42 147.22 30.69 Favored 'General case' 0 N--CA 1.518 2.945 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 176.238 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -68.36 161.66 26.99 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 119.237 -2.165 . . . . 0.0 108.062 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' ALA . . . . . 0.94 ' HB2' ' HA3' ' A' ' 107' ' ' GLY . . . -122.18 154.74 37.05 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 119.979 -1.701 . . . . 0.0 110.049 -179.572 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.46 HD23 ' CG ' ' A' ' 85' ' ' GLN . 3.0 tp -62.84 145.2 55.6 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' LEU . . . . . 0.745 HD22 ' HB2' ' A' ' 102' ' ' ARG . 11.5 tp -123.45 -55.36 1.74 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.45 -1.406 . . . . 0.0 112.179 -178.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 8.0 tptp -127.68 144.28 51.09 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 120.318 -1.488 . . . . 0.0 108.84 179.13 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.632 HG21 ' CD2' ' A' ' 89' ' ' PHE . 33.7 t -93.08 129.89 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.901 0 O-C-N 120.707 -1.246 . . . . 0.0 111.458 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -107.69 -38.74 5.79 Favored 'General case' 0 N--CA 1.508 2.451 0 O-C-N 121.257 -0.902 . . . . 0.0 110.053 178.454 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' GLU . . . . . 0.594 ' C ' HG23 ' A' ' 119' ' ' VAL . 7.0 tt0 -143.24 157.92 44.07 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 120.948 -1.095 . . . . 0.0 109.619 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' VAL . . . . . 0.594 HG23 ' C ' ' A' ' 118' ' ' GLU . 33.7 t -159.62 131.62 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -178.646 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.47 ' O ' ' C ' ' A' ' 121' ' ' PHE . 0.1 OUTLIER 55.66 46.31 22.92 Favored 'General case' 0 N--CA 1.52 3.039 0 O-C-N 120.329 -1.482 . . . . 0.0 111.779 179.28 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 121' ' ' PHE . . . . . 0.47 ' C ' ' O ' ' A' ' 120' ' ' ASN . 0.1 OUTLIER 40.73 40.83 1.02 Allowed 'General case' 0 N--CA 1.521 3.095 0 O-C-N 120.574 -1.329 . . . . 0.0 110.139 179.42 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -154.25 173.74 15.73 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.144 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LYS . . . . . 0.539 ' HD3' ' ND2' ' A' ' 126' ' ' ASN . 7.9 ptmt -74.18 154.55 88.39 Favored Pre-proline 0 N--CA 1.504 2.266 0 C-N-CA 118.496 -1.282 . . . . 0.0 108.851 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -78.51 22.86 0.62 Allowed 'Trans proline' 0 C--N 1.308 -1.573 0 O-C-N 123.994 1.523 . . . . 0.0 111.03 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' GLU . . . . . 0.502 ' O ' ' ND2' ' A' ' 126' ' ' ASN . 2.2 tt0 -168.15 -142.65 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.539 ' ND2' ' HD3' ' A' ' 123' ' ' LYS . 0.3 OUTLIER 170.08 -51.87 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.144 0 O-C-N 120.129 -1.607 . . . . 0.0 110.471 179.317 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ALA . . . . . 0.421 ' C ' ' HG3' ' A' ' 128' ' ' ARG . . . -141.37 20.98 2.23 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-O 121.641 0.734 . . . . 0.0 109.956 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' ARG . . . . . 0.448 ' O ' ' OE2' ' A' ' 125' ' ' GLU . 2.4 mtp180 -128.95 46.84 2.56 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 119.904 -0.718 . . . . 0.0 109.873 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -47.17 164.31 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.303 -0.873 . . . . 0.0 110.13 -179.953 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 22.6 pttt . . . . . 0 C--N 1.304 -1.391 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.697 179.972 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.538 ' CA ' ' HA ' ' A' ' 49' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.661 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . 0.583 ' HB2' ' CE2' ' A' ' 50' ' ' PHE 0.25 4.2 t30 -78.38 116.74 19.01 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 120.555 -1.34 . . . . 0.0 109.402 -179.827 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.833 HD13 HD12 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -49.68 -46.54 49.96 Favored 'General case' 0 N--CA 1.517 2.915 0 O-C-N 120.157 -1.59 . . . . 0.0 110.352 -178.934 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.8 m -56.35 -34.92 67.06 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.742 -1.224 . . . . 0.0 108.186 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.508 ' HB3' ' HB3' ' A' ' 2' ' ' ASN . 0.0 OUTLIER -66.99 -45.7 76.83 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 177.73 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.833 HD12 HD13 ' A' ' 3' ' ' LEU 0.274 68.5 mt -53.3 -51.4 62.44 Favored 'General case' 0 C--N 1.313 -0.981 0 O-C-N 120.626 -1.296 . . . . 0.0 109.078 177.738 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.26 -33.61 69.57 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.044 -1.035 . . . . 0.0 109.726 178.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.504 ' HB2' ' O ' ' A' ' 5' ' ' GLU . 4.8 m-80 -61.42 -16.54 47.7 Favored 'General case' 0 N--CA 1.504 2.263 0 C-N-CA 119.013 -1.075 . . . . 0.0 110.357 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.745 ' O ' HD11 ' A' ' 14' ' ' LEU . 2.6 m -89.48 121.32 69.37 Favored Pre-proline 0 N--CA 1.502 2.153 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.545 ' HG2' ' CG ' ' A' ' 13' ' ' GLU . 37.1 Cg_endo -57.79 151.3 57.07 Favored 'Trans proline' 0 CA--C 1.562 1.922 0 N-CA-C 109.971 -0.819 . . . . 0.0 109.971 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.799 ' HA ' HD12 ' A' ' 14' ' ' LEU . 1.6 p -41.85 -49.21 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.529 3.475 0 O-C-N 120.303 -1.498 . . . . 0.0 110.252 -178.071 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.504 ' N ' ' CG1' ' A' ' 11' ' ' VAL . 1.8 t -58.32 -41.97 85.69 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.314 -0.866 . . . . 0.0 111.161 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.675 ' CB ' HG22 ' A' ' 9' ' ' THR . 0.2 OUTLIER -68.97 -30.52 68.97 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 118.237 -1.385 . . . . 0.0 108.21 -179.964 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.799 HD12 ' HA ' ' A' ' 11' ' ' VAL . 9.3 mt -68.76 -41.2 79.19 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 120.883 -1.136 . . . . 0.0 108.813 176.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.633 HG23 ' HB2' ' A' ' 26' ' ' LEU . 1.2 mp -66.68 -40.33 85.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 C-N-CA 117.892 -1.523 . . . . 0.0 108.678 178.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.488 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 84.8 m -64.25 -35.52 81.11 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.36 -1.462 . . . . 0.0 108.963 179.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.504 ' O ' ' HG2' ' A' ' 21' ' ' MET . 35.5 tp -64.99 -43.85 91.23 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 120.934 -1.104 . . . . 0.0 108.237 178.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.566 ' HA2' ' OE1' ' A' ' 41' ' ' GLN . . . -61.69 -43.56 99.09 Favored Glycine 1 N--CA 1.518 4.11 0 N-CA-C 108.15 -1.98 . . . . 0.0 108.15 178.43 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.451 ' OE2' ' HG2' ' A' ' 24' ' ' GLU . 1.0 OUTLIER -53.75 -44.3 69.86 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.999 -1.295 . . . . 0.0 107.517 178.188 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.488 ' OD1' ' O ' ' A' ' 16' ' ' THR . 27.7 m120 -59.57 -26.97 65.84 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 118.679 -1.208 . . . . 0.0 109.465 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.571 ' HE2' ' HG3' ' A' ' 41' ' ' GLN . 37.7 mmm -97.65 9.86 41.44 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.27 -0.894 . . . . 0.0 110.438 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 99.7 -18.23 56.37 Favored Glycine 0 N--CA 1.501 2.992 0 C-N-CA 118.802 -1.666 . . . . 0.0 111.352 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.94 ' HB3' HD11 ' A' ' 26' ' ' LEU . 5.4 mp -79.56 94.91 5.72 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 120.359 -1.671 . . . . 0.0 109.753 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.511 ' O ' ' CB ' ' A' ' 25' ' ' ASN . 46.6 mt-10 -103.67 170.57 7.86 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.231 -0.918 . . . . 0.0 109.179 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.511 ' CB ' ' O ' ' A' ' 24' ' ' GLU . 1.3 t-20 70.37 18.15 6.79 Favored 'General case' 0 N--CA 1.511 2.578 0 O-C-N 121.528 -0.733 . . . . 0.0 111.785 179.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.94 HD11 ' HB3' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -76.42 -8.66 57.61 Favored 'General case' 0 N--CA 1.505 2.304 0 O-C-N 120.983 -1.073 . . . . 0.0 111.419 -179.798 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 26' ' ' LEU . . . -46.85 -32.74 3.94 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.461 -1.399 . . . . 0.0 108.847 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.413 ' NH2' ' HB3' ' A' ' 25' ' ' ASN . 11.9 ptt180 -80.96 0.85 33.66 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 120.193 -0.603 . . . . 0.0 111.363 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.637 ' HE2' ' OD1' ' A' ' 33' ' ' ASP . 7.1 mtp -100.79 149.13 24.15 Favored 'General case' 0 C--N 1.314 -0.976 0 O-C-N 120.837 -1.165 . . . . 0.0 111.864 -178.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.504 ' C ' HD12 ' A' ' 34' ' ' ILE . 2.4 mtt85 -89.12 142.13 27.91 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.449 -0.782 . . . . 0.0 110.772 178.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.565 ' O ' HG13 ' A' ' 35' ' ' ILE . 12.1 ptpt -35.91 -34.54 0.05 Allowed 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.707 -0.621 . . . . 0.0 111.582 179.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.457 ' OE1' ' HG3' ' A' ' 31' ' ' LYS . 1.6 mm100 -63.78 -59.84 4.05 Favored 'General case' 0 N--CA 1.517 2.91 0 O-C-N 120.568 -1.332 . . . . 0.0 109.869 -179.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.637 ' OD1' ' HE2' ' A' ' 29' ' ' MET . 2.5 p30 -66.11 -37.61 86.16 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.586 -0.696 . . . . 0.0 110.162 -178.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.56 HD11 ' O ' ' A' ' 29' ' ' MET . 3.3 mt -61.15 -41.46 89.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 O-C-N 120.267 -1.521 . . . . 0.0 108.071 178.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.609 HG23 HD13 ' A' ' 6' ' ' LEU . 96.8 mt -60.93 -48.48 88.8 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.778 0 O-C-N 120.057 -1.652 . . . . 0.0 109.443 177.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -52.7 -41.7 64.13 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 107.859 -1.164 . . . . 0.0 107.859 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.611 ' HB1' ' CD2' ' A' ' 23' ' ' LEU . . . -62.34 -55.55 26.94 Favored 'General case' 0 C--O 1.2 -1.506 0 O-C-N 120.911 -1.118 . . . . 0.0 108.456 177.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.557 ' HA ' ' CD ' ' A' ' 41' ' ' GLN . 0.4 OUTLIER -51.22 -27.86 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 C-N-CA 117.301 -1.76 . . . . 0.0 110.358 179.853 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.782 HD23 ' CE2' ' A' ' 111' ' ' PHE . 3.1 mp -71.59 -45.55 61.87 Favored 'General case' 0 N--CA 1.509 2.5 0 C-N-CA 117.762 -1.575 . . . . 0.0 109.551 178.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.514 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 1.2 mtpp -65.83 -40.86 92.18 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.191 -0.943 . . . . 0.0 111.377 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.683 HE22 HD22 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -79.07 -41.58 28.43 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.962 -1.086 . . . . 0.0 111.512 -178.605 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.598 ' N ' ' HG2' ' A' ' 41' ' ' GLN . 1.3 m-70 -69.77 -33.94 73.08 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 117.187 -1.805 . . . . 0.0 107.957 178.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.474 ' O ' ' N ' ' A' ' 46' ' ' GLY . . . -67.03 -51.66 52.03 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 120.641 -1.287 . . . . 0.0 107.842 177.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.514 ' HB2' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -49.31 -46.32 46.46 Favored 'General case' 0 N--CA 1.482 1.153 0 O-C-N 121.081 -1.012 . . . . 0.0 108.998 177.935 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 65.9 m -66.63 -6.35 15.04 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 120.039 -0.664 . . . . 0.0 109.797 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . 90.62 7.94 66.24 Favored Glycine 0 N--CA 1.496 2.678 0 C-N-CA 119.883 -1.151 . . . . 0.0 113.328 177.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -79.03 159.14 27.72 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 120.754 2.277 . . . . 0.0 108.781 179.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -88.64 150.36 23.06 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.899 -1.125 . . . . 0.0 110.038 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.574 HG13 HG13 ' A' ' 101' ' ' ILE . 0.7 OUTLIER -135.12 133.52 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 120.805 -1.185 . . . . 0.0 107.95 179.052 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.583 ' CE2' ' HB2' ' A' ' 2' ' ' ASN . 8.2 p90 -140.5 166.87 23.54 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 116.558 -2.057 . . . . 0.0 114.255 -178.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -122.13 170.67 15.1 Favored Glycine 0 N--CA 1.5 2.953 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -177.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.469 ' C ' HD21 ' A' ' 65' ' ' LEU . 2.7 p30 -170.04 163.94 9.35 Favored 'General case' 0 N--CA 1.482 1.155 0 O-C-N 120.681 -1.482 . . . . 0.0 110.138 -179.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.46 ' N ' HD21 ' A' ' 65' ' ' LEU . . . 145.32 -140.25 8.91 Favored Glycine 0 N--CA 1.506 3.328 0 C-N-CA 118.356 -1.878 . . . . 0.0 110.962 178.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.593 ' HA ' ' O ' ' A' ' 95' ' ' ASP . 3.0 t -128.2 121.08 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.975 HD21 HG21 ' A' ' 81' ' ' VAL . 6.5 mt -62.79 163.91 8.68 Favored 'General case' 0 N--CA 1.505 2.277 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -175.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.507 ' HA ' ' OG1' ' A' ' 93' ' ' THR . 73.0 mm-40 -137.92 117.98 13.45 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 177.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.614 ' CG1' ' HB ' ' A' ' 93' ' ' THR . 1.3 mm -85.13 162.11 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 CA-C-N 121.001 1.728 . . . . 0.0 110.545 -178.043 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.716 HD22 ' CZ ' ' A' ' 62' ' ' PHE . 5.1 mp -129.16 136.0 49.59 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.682 -1.261 . . . . 0.0 108.941 178.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.45 ' C ' ' O ' ' A' ' 58' ' ' LEU . 1.1 mt-30 -41.25 -34.01 0.44 Allowed 'General case' 0 N--CA 1.501 2.092 0 CA-C-O 121.972 0.892 . . . . 0.0 109.301 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -60.99 -7.82 2.75 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 119.928 -0.709 . . . . 0.0 112.247 -179.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.494 ' O ' ' HB3' ' A' ' 83' ' ' PRO . . . 93.55 4.35 64.03 Favored Glycine 1 N--CA 1.517 4.08 0 C-N-CA 118.817 -1.659 . . . . 0.0 112.43 177.758 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.716 ' CZ ' HD22 ' A' ' 58' ' ' LEU . 5.0 p90 -127.66 179.92 5.27 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 104.808 -2.293 . . . . 0.0 104.808 178.131 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.624 ' HA2' HD13 ' A' ' 58' ' ' LEU . . . -161.05 176.82 37.6 Favored Glycine 0 N--CA 1.476 1.343 0 C-N-CA 117.187 -2.435 . . . . 0.0 111.486 -177.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.447 ' CE2' ' HE2' ' A' ' 62' ' ' PHE . 23.2 m-85 -129.53 152.47 49.02 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 119.968 1.884 . . . . 0.0 109.689 177.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.503 ' HB3' ' HB ' ' A' ' 79' ' ' ILE . 0.5 OUTLIER -97.72 156.28 16.63 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 176.542 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.466 ' HB3' ' O ' ' A' ' 65' ' ' LEU . 1.1 ptp85 177.12 -154.21 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.96 -1.087 . . . . 0.0 109.999 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.5 2.029 0 O-C-N 121.247 -0.908 . . . . 0.0 110.888 -179.752 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.505 ' OD1' ' N ' ' A' ' 78' ' ' ASP . 2.0 m-20 . . . . . 0 N--CA 1.505 2.314 0 CA-C-O 121.075 0.464 . . . . 0.0 109.981 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.503 ' HB ' ' HB3' ' A' ' 65' ' ' LEU . 4.6 mm -128.35 133.83 66.03 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.657 0 O-C-N 121.06 -1.025 . . . . 0.0 109.891 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.479 ' HB3' ' O ' ' A' ' 111' ' ' PHE . 81.4 t80 -78.45 147.51 33.94 Favored 'General case' 0 N--CA 1.516 2.846 0 O-C-N 119.399 -2.063 . . . . 0.0 109.347 179.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.975 HG21 HD21 ' A' ' 55' ' ' LEU . 10.2 t -140.58 114.09 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 O-C-N 120.12 -1.612 . . . . 0.0 110.664 -179.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.565 ' O ' HG13 ' A' ' 86' ' ' ILE . 58.6 m -75.25 163.6 66.7 Favored Pre-proline 0 N--CA 1.512 2.651 0 O-C-N 120.442 -1.411 . . . . 0.0 112.18 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.564 ' HA ' HG13 ' A' ' 86' ' ' ILE . 38.0 Cg_endo -65.49 -52.75 0.96 Allowed 'Trans proline' 0 C--N 1.314 -1.289 0 O-C-N 124.701 1.895 . . . . 0.0 108.904 178.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.527 ' O ' ' HB2' ' A' ' 88' ' ' ARG . 0.3 OUTLIER -45.66 -40.98 9.81 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 178.242 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.514 ' HB2' ' O ' ' A' ' 82' ' ' SER . 7.4 mm100 -62.41 -58.85 6.15 Favored 'General case' 0 N--CA 1.51 2.556 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.566 ' HA ' ' CD1' ' A' ' 91' ' ' LEU . 0.4 OUTLIER -55.98 -55.06 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.273 0 O-C-N 121.128 -0.982 . . . . 0.0 108.837 178.469 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.485 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 1.6 mtt85 -58.13 -42.6 86.2 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-O 121.772 0.796 . . . . 0.0 111.644 -178.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.527 ' HB2' ' O ' ' A' ' 84' ' ' SER . 19.8 mtt-85 -60.76 -36.8 79.86 Favored 'General case' 0 N--CA 1.505 2.311 0 C-N-CA 119.34 -0.944 . . . . 0.0 111.884 -177.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 1.045 ' HB2' HD21 ' A' ' 91' ' ' LEU . 16.7 m-85 -110.99 13.02 22.08 Favored 'General case' 0 N--CA 1.503 2.189 0 C-N-CA 116.815 -1.954 . . . . 0.0 111.382 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 61.19 55.04 3.09 Favored 'General case' 0 N--CA 1.483 1.21 0 O-C-N 120.509 -1.369 . . . . 0.0 110.458 178.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 1.045 HD21 ' HB2' ' A' ' 89' ' ' PHE . 3.9 mt -89.2 -170.75 2.99 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 119.102 -1.039 . . . . 0.0 110.416 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.531 ' CG ' ' O ' ' A' ' 91' ' ' LEU . 86.5 mtt-85 -159.4 160.03 34.41 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.614 ' HB ' ' CG1' ' A' ' 57' ' ' ILE . 1.7 t -64.36 156.9 27.73 Favored 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 116.826 -1.949 . . . . 0.0 106.662 178.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.42 ' O ' ' CG1' ' A' ' 54' ' ' VAL . . . 75.54 -9.44 15.34 Favored Glycine 0 N--CA 1.506 3.329 0 C-N-CA 117.122 -2.466 . . . . 0.0 110.191 179.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.593 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 11.7 m-20 -66.79 147.98 52.53 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.235 -1.744 . . . . 0.0 110.778 -178.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.483 ' O ' HG12 ' A' ' 97' ' ' ILE . 0.2 OUTLIER -89.6 120.98 31.37 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.228 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.811 HG23 HG22 ' A' ' 119' ' ' VAL . 1.4 mt -144.06 162.05 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 119.934 -1.729 . . . . 0.0 112.803 -178.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.518 ' OG ' ' HB2' ' A' ' 118' ' ' GLU . 97.5 p -148.05 137.88 22.52 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.553 ' O ' ' HB2' ' A' ' 50' ' ' PHE . . . -168.05 -178.27 39.83 Favored Glycine 0 N--CA 1.507 3.415 0 C-N-CA 117.035 -2.507 . . . . 0.0 114.917 -178.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.619 ' CD ' HD23 ' A' ' 114' ' ' LEU . 1.8 ptmt -90.12 156.93 18.01 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.574 HG13 HG13 ' A' ' 49' ' ' ILE . 2.3 pt -125.61 155.75 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.523 0 CA-C-N 120.659 1.572 . . . . 0.0 113.227 -177.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.892 ' HB3' HD13 ' A' ' 114' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.356 0 O-C-N 120.58 -1.325 . . . . 0.0 109.25 179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.46 ' HD2' ' CZ ' ' A' ' 110' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.688 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.46 ' CZ ' ' HD2' ' A' ' 109' ' ' ARG . 35.8 m-85 -109.04 144.26 37.27 Favored 'General case' 0 N--CA 1.515 2.805 0 O-C-N 120.32 -1.487 . . . . 0.0 108.082 176.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.782 ' CE2' HD23 ' A' ' 39' ' ' LEU . 3.3 m-85 -68.33 165.74 18.0 Favored 'General case' 0 N--CA 1.506 2.348 0 O-C-N 119.321 -2.112 . . . . 0.0 107.957 178.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.457 ' HA ' ' HB3' ' A' ' 80' ' ' TYR . . . -122.7 150.68 42.4 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 119.955 -1.715 . . . . 0.0 110.957 -179.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.41 ' CD2' HE21 ' A' ' 85' ' ' GLN . 4.3 tp -60.11 147.56 39.08 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.892 HD13 ' HB3' ' A' ' 102' ' ' ARG . 14.3 tp -127.84 -55.48 1.3 Allowed 'General case' 0 N--CA 1.502 2.136 0 O-C-N 120.357 -1.464 . . . . 0.0 112.345 -178.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.536 ' HB3' ' CD ' ' A' ' 100' ' ' LYS . 0.6 OUTLIER -124.68 139.79 53.54 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 120.321 -1.487 . . . . 0.0 108.598 179.448 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.41 HG11 HG21 ' A' ' 119' ' ' VAL . 29.2 t -92.47 129.75 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.735 0 O-C-N 120.671 -1.268 . . . . 0.0 111.52 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.414 ' CG ' ' HA2' ' A' ' 99' ' ' GLY . 5.1 m-20 -106.43 -39.81 5.78 Favored 'General case' 0 N--CA 1.506 2.339 0 O-C-N 121.409 -0.807 . . . . 0.0 109.496 178.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.579 ' C ' HG23 ' A' ' 119' ' ' VAL . 1.7 tt0 -143.31 154.49 43.83 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.797 -1.189 . . . . 0.0 109.515 178.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.811 HG22 HG23 ' A' ' 97' ' ' ILE . 83.3 t -159.99 128.21 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 C-N-CA 120.749 -0.38 . . . . 0.0 111.503 -178.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.419 ' C ' ' O ' ' A' ' 119' ' ' VAL . 0.6 OUTLIER . . . . . 0 N--CA 1.52 3.049 0 O-C-N 120.514 -1.366 . . . . 0.0 111.161 178.833 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.633 ' HA ' ' HA ' ' A' ' 49' ' ' ILE . 2.1 ptp . . . . . 0 N--CA 1.493 1.701 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . 0.562 ' HB2' ' CZ ' ' A' ' 50' ' ' PHE . 8.7 t-20 -78.21 94.28 4.74 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.819 -1.175 . . . . 0.0 108.635 179.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.547 ' HA ' HD12 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -41.41 -41.27 1.96 Allowed 'General case' 0 N--CA 1.517 2.917 0 O-C-N 120.679 -1.263 . . . . 0.0 110.031 -178.797 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.412 ' OG1' ' OD2' ' A' ' 52' ' ' ASP . 1.8 m -59.13 -35.36 73.34 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 120.819 -1.176 . . . . 0.0 108.564 -179.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.515 ' N ' ' OD1' ' A' ' 2' ' ' ASN . 0.1 OUTLIER -74.12 -45.39 49.26 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.027 -1.046 . . . . 0.0 108.747 178.209 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.816 ' CD1' HD21 ' A' ' 39' ' ' LEU 0.275 77.9 mt -50.94 -49.72 59.26 Favored 'General case' 0 C--N 1.317 -0.817 0 O-C-N 120.806 -1.184 . . . . 0.0 109.216 178.266 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -66.21 -39.78 89.86 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.046 -1.034 . . . . 0.0 110.142 178.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -63.25 -28.09 69.79 Favored 'General case' 0 N--CA 1.508 2.429 0 O-C-N 121.226 -0.921 . . . . 0.0 111.251 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.636 HG22 ' CB ' ' A' ' 13' ' ' GLU . 3.0 m -73.84 126.92 89.12 Favored Pre-proline 0 N--CA 1.505 2.321 0 O-C-N 121.538 -0.727 . . . . 0.0 109.549 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.561 ' HG2' ' CG ' ' A' ' 13' ' ' GLU . 40.1 Cg_endo -61.16 150.47 84.31 Favored 'Trans proline' 0 CA--C 1.566 2.096 0 O-C-N 122.315 0.64 . . . . 0.0 110.84 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.55 ' CG1' ' N ' ' A' ' 12' ' ' SER . 1.4 p -43.43 -50.74 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.525 3.276 0 O-C-N 120.493 -1.379 . . . . 0.0 109.471 -178.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.55 ' N ' ' CG1' ' A' ' 11' ' ' VAL . 0.8 OUTLIER -56.21 -39.95 73.28 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.418 -0.801 . . . . 0.0 111.056 -179.856 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.899 ' O ' HD12 ' A' ' 17' ' ' LEU . 0.1 OUTLIER -69.26 -29.59 67.52 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 117.96 -1.496 . . . . 0.0 107.711 179.178 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.711 ' HB3' HG21 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -68.54 -44.32 74.79 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.13 -0.981 . . . . 0.0 108.89 176.845 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.523 HD12 ' O ' ' A' ' 11' ' ' VAL . 1.5 mp -65.68 -37.17 79.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 C-N-CA 117.97 -1.492 . . . . 0.0 108.908 179.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.583 ' HA ' ' HG2' ' A' ' 19' ' ' GLU . 31.0 m -65.8 -38.64 89.53 Favored 'General case' 0 N--CA 1.484 1.247 0 O-C-N 120.338 -1.476 . . . . 0.0 109.123 178.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.899 HD12 ' O ' ' A' ' 13' ' ' GLU . 3.7 mt -65.34 -38.13 89.19 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.887 -1.133 . . . . 0.0 108.764 178.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.463 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -67.61 -43.5 85.41 Favored Glycine 0 N--CA 1.513 3.787 0 N-CA-C 108.49 -1.844 . . . . 0.0 108.49 178.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.697 ' HG3' ' N ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -58.62 -38.84 78.91 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.463 -1.61 . . . . 0.0 108.175 178.925 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.697 ' N ' ' HG3' ' A' ' 19' ' ' GLU . 24.8 m120 -61.81 -27.76 68.99 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 118.13 -1.428 . . . . 0.0 109.313 178.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.533 ' HE2' ' NE2' ' A' ' 41' ' ' GLN . 21.5 mmm -102.5 10.81 38.64 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.314 -0.867 . . . . 0.0 111.511 -178.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.66 -18.23 50.99 Favored Glycine 0 N--CA 1.504 3.175 0 C-N-CA 118.537 -1.792 . . . . 0.0 112.102 179.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.991 ' HB3' HD11 ' A' ' 26' ' ' LEU . 5.0 mp -78.4 95.01 4.99 Favored 'General case' 0 N--CA 1.508 2.449 0 O-C-N 120.193 -1.769 . . . . 0.0 110.121 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.474 ' O ' ' CB ' ' A' ' 25' ' ' ASN . 51.5 mt-10 -104.01 168.66 8.97 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.169 -0.957 . . . . 0.0 109.268 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.474 ' CB ' ' O ' ' A' ' 24' ' ' GLU . 0.1 OUTLIER 68.98 19.49 8.15 Favored 'General case' 0 N--CA 1.508 2.434 0 O-C-N 121.499 -0.751 . . . . 0.0 111.947 179.056 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.991 HD11 ' HB3' ' A' ' 23' ' ' LEU . 0.4 OUTLIER -76.21 -13.62 60.17 Favored 'General case' 0 N--CA 1.505 2.283 0 O-C-N 120.76 -1.212 . . . . 0.0 111.381 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 26' ' ' LEU . . . -46.99 -35.61 6.81 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.464 -1.398 . . . . 0.0 109.061 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.6 mtt180 -81.16 2.48 27.39 Favored 'General case' 0 C--N 1.295 -1.79 0 C-N-CA 119.849 -0.74 . . . . 0.0 111.438 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.565 ' HB3' HG13 ' A' ' 34' ' ' ILE . 7.4 mtp -100.4 150.53 22.52 Favored 'General case' 0 C--N 1.313 -0.984 0 O-C-N 120.832 -1.167 . . . . 0.0 111.164 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.53 ' C ' HD12 ' A' ' 34' ' ' ILE . 10.8 ttp85 -89.22 142.59 27.51 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.258 -0.901 . . . . 0.0 110.677 179.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.59 ' O ' ' CG1' ' A' ' 35' ' ' ILE . 7.7 tttp -31.95 -46.27 0.11 Allowed 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 116.264 -0.426 . . . . 0.0 112.051 179.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.524 ' OE1' ' N ' ' A' ' 33' ' ' ASP . 1.2 pp0? -61.6 -53.88 50.37 Favored 'General case' 0 N--CA 1.52 3.066 0 O-C-N 121.325 -0.86 . . . . 0.0 112.101 -177.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.539 ' OD1' ' HE2' ' A' ' 29' ' ' MET . 2.1 p30 -66.73 -37.32 84.43 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 120.732 -1.23 . . . . 0.0 108.964 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.711 HG21 ' HB3' ' A' ' 14' ' ' LEU . 4.8 mt -61.17 -39.44 82.45 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 O-C-N 120.328 -1.482 . . . . 0.0 108.043 177.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.59 ' CG1' ' O ' ' A' ' 31' ' ' LYS . 0.6 OUTLIER -57.58 -47.51 85.17 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.558 0 O-C-N 120.085 -1.635 . . . . 0.0 109.271 177.577 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -53.18 -41.15 64.95 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.405 -0.918 . . . . 0.0 108.526 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.841 ' HB1' ' CD2' ' A' ' 23' ' ' LEU . . . -70.29 -53.09 18.27 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.971 -1.081 . . . . 0.0 109.953 178.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.662 ' HA ' ' CG ' ' A' ' 41' ' ' GLN . 0.1 OUTLIER -53.78 -28.26 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 C-N-CA 117.437 -1.705 . . . . 0.0 110.362 -179.786 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.816 HD21 ' CD1' ' A' ' 6' ' ' LEU . 64.7 mt -72.33 -44.3 62.86 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 120.409 -1.432 . . . . 0.0 109.696 178.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 10.9 mmtt -64.21 -41.63 96.95 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.046 -1.034 . . . . 0.0 110.501 179.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.662 ' CG ' ' HA ' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -74.86 -46.41 36.54 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.065 -1.022 . . . . 0.0 111.359 -179.06 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.492 ' HB2' ' O ' ' A' ' 38' ' ' ILE . 0.3 OUTLIER -66.01 -34.47 78.17 Favored 'General case' 0 N--CA 1.505 2.309 0 O-C-N 120.543 -1.348 . . . . 0.0 108.984 179.539 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.565 ' O ' ' N ' ' A' ' 46' ' ' GLY . . . -67.32 -36.93 82.47 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 120.975 -1.078 . . . . 0.0 108.96 178.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.89 -43.73 28.89 Favored 'General case' 0 N--CA 1.482 1.162 0 O-C-N 120.799 -1.188 . . . . 0.0 108.966 178.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 70.8 m -66.66 -9.99 41.67 Favored 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 119.59 -0.844 . . . . 0.0 109.265 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.565 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . 64.57 36.03 92.66 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 178.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.514 ' OE1' ' N ' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -92.62 166.72 12.35 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.432 -1.628 . . . . 0.0 108.841 179.214 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.514 ' N ' ' OE1' ' A' ' 47' ' ' GLU . 17.0 m-20 -61.58 137.09 58.23 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.122 -0.986 . . . . 0.0 110.792 -178.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.633 ' HA ' ' HA ' ' A' ' 1' ' ' MET . 3.0 pt -141.26 135.19 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 120.986 -1.071 . . . . 0.0 108.224 178.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.641 ' CD1' ' N ' ' A' ' 50' ' ' PHE . 7.4 p90 -144.86 163.26 34.63 Favored 'General case' 0 C--N 1.31 -1.12 0 C-N-CA 116.014 -2.274 . . . . 0.0 115.794 -178.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -120.79 170.6 14.5 Favored Glycine 0 N--CA 1.505 3.243 0 N-CA-C 108.686 -1.766 . . . . 0.0 108.686 -179.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.483 ' C ' ' CD2' ' A' ' 65' ' ' LEU . 52.5 p-10 -170.22 167.5 8.57 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 120.383 -1.657 . . . . 0.0 110.741 -178.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.536 ' HA3' ' O ' ' A' ' 66' ' ' ARG . . . 144.09 -139.19 8.49 Favored Glycine 0 N--CA 1.507 3.418 0 C-N-CA 118.368 -1.872 . . . . 0.0 111.472 177.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.58 ' HA ' ' O ' ' A' ' 95' ' ' ASP . 2.8 t -127.75 120.12 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 O-C-N 121.258 -1.142 . . . . 0.0 108.092 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.874 HD21 HG21 ' A' ' 81' ' ' VAL . 7.2 mt -62.92 162.78 10.66 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -175.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.528 ' HA ' ' OG1' ' A' ' 93' ' ' THR . 0.0 OUTLIER -139.27 119.79 14.0 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.03 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.584 ' CG1' ' HB ' ' A' ' 93' ' ' THR . 1.2 mm -78.65 162.07 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 119.733 -1.854 . . . . 0.0 109.18 -178.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 1.178 HD22 ' CZ ' ' A' ' 62' ' ' PHE . 1.3 mp -131.39 126.06 34.2 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.301 -1.499 . . . . 0.0 109.752 179.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.509 ' C ' ' O ' ' A' ' 58' ' ' LEU . 6.9 mm-40 -32.74 -37.05 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.458 0 CA-C-O 122.018 0.913 . . . . 0.0 109.715 -179.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.556 ' HB2' ' CD2' ' A' ' 62' ' ' PHE . 3.1 m-20 -60.92 -6.21 1.72 Allowed 'General case' 0 N--CA 1.5 2.033 0 C-N-CA 120.271 -0.571 . . . . 0.0 112.489 -179.176 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 58' ' ' LEU . . . 89.14 11.9 64.22 Favored Glycine 1 N--CA 1.517 4.077 0 C-N-CA 118.672 -1.728 . . . . 0.0 111.944 178.365 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 1.178 ' CZ ' HD22 ' A' ' 58' ' ' LEU . 4.0 p90 -128.1 -178.85 4.69 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 104.18 -2.526 . . . . 0.0 104.18 177.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.571 ' HA2' ' CD1' ' A' ' 58' ' ' LEU . . . -152.75 162.87 30.2 Favored Glycine 0 N--CA 1.475 1.292 0 C-N-CA 117.322 -2.37 . . . . 0.0 111.272 -177.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.442 ' CD1' ' HE1' ' A' ' 62' ' ' PHE . 2.0 m-30 -127.81 150.96 49.59 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 120.136 1.968 . . . . 0.0 109.156 177.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.502 ' HB3' ' HB ' ' A' ' 79' ' ' ILE . 0.3 OUTLIER -98.34 166.37 11.41 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 176.768 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.536 ' O ' ' HA3' ' A' ' 53' ' ' GLY . 21.0 tpt180 -178.42 -179.97 0.73 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.057 -1.027 . . . . 0.0 109.02 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.7 m . . . . . 0 N--CA 1.496 1.867 0 O-C-N 120.45 -1.406 . . . . 0.0 109.86 179.658 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.499 ' OD1' ' N ' ' A' ' 78' ' ' ASP . 1.1 m-20 . . . . . 0 N--CA 1.506 2.343 0 CA-C-O 121.096 0.474 . . . . 0.0 109.77 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.502 ' HB ' ' HB3' ' A' ' 65' ' ' LEU . 3.9 mm -126.56 138.67 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.65 0 O-C-N 121.16 -0.963 . . . . 0.0 110.11 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.5 ' HB3' ' O ' ' A' ' 111' ' ' PHE . 6.0 t80 -85.02 146.55 27.13 Favored 'General case' 0 N--CA 1.516 2.867 0 CA-C-N 121.502 1.955 . . . . 0.0 109.819 178.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.874 HG21 HD21 ' A' ' 55' ' ' LEU . 25.2 t -141.65 115.77 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 120.078 -1.639 . . . . 0.0 110.226 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.556 ' O ' HG13 ' A' ' 86' ' ' ILE . 58.0 m -74.3 163.52 67.7 Favored Pre-proline 0 N--CA 1.515 2.799 0 O-C-N 120.262 -1.524 . . . . 0.0 112.131 -179.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.535 ' HA ' HG13 ' A' ' 86' ' ' ILE . 40.2 Cg_endo -66.62 -50.27 1.34 Allowed 'Trans proline' 0 C--N 1.314 -1.249 0 O-C-N 124.505 1.792 . . . . 0.0 108.958 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.539 ' O ' ' CG ' ' A' ' 88' ' ' ARG . 0.4 OUTLIER -47.2 -39.53 14.19 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 177.834 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.547 ' HB2' ' O ' ' A' ' 82' ' ' SER . 7.2 mm-40 -63.42 -57.78 9.2 Favored 'General case' 0 N--CA 1.511 2.587 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.59 ' HA ' HD23 ' A' ' 91' ' ' LEU . 0.8 OUTLIER -55.51 -53.59 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.336 0 O-C-N 120.938 -1.101 . . . . 0.0 108.647 178.848 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.469 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 0.1 OUTLIER -57.81 -41.72 82.76 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 121.865 0.84 . . . . 0.0 111.364 -179.459 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.539 ' CG ' ' O ' ' A' ' 84' ' ' SER . 12.5 mtt180 -59.37 -37.46 77.96 Favored 'General case' 0 N--CA 1.507 2.407 0 C-N-CA 119.883 -0.727 . . . . 0.0 111.928 -177.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.453 ' CD2' HG21 ' A' ' 116' ' ' VAL . 19.3 m-85 -113.97 14.53 18.46 Favored 'General case' 0 N--CA 1.505 2.318 0 C-N-CA 117.274 -1.771 . . . . 0.0 111.412 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 58.45 56.5 4.32 Favored 'General case' 0 N--CA 1.481 1.108 0 O-C-N 120.31 -1.493 . . . . 0.0 109.084 179.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.59 HD23 ' HA ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -88.37 173.91 8.46 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.431 -0.908 . . . . 0.0 109.338 -179.831 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.535 ' CD ' ' O ' ' A' ' 91' ' ' LEU . 3.7 mmm180 -147.0 157.51 43.64 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.997 -1.065 . . . . 0.0 108.86 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.584 ' HB ' ' CG1' ' A' ' 57' ' ' ILE . 2.4 t -63.73 156.29 27.54 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 116.948 -1.901 . . . . 0.0 106.993 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 76.34 -9.61 19.9 Favored Glycine 0 N--CA 1.504 3.189 0 C-N-CA 117.094 -2.479 . . . . 0.0 110.334 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.58 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 6.0 m-20 -69.36 147.75 50.63 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.228 -1.748 . . . . 0.0 110.752 -178.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.51 ' O ' HG12 ' A' ' 97' ' ' ILE . 0.2 OUTLIER -91.22 124.29 35.31 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.093 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.529 HG23 ' O ' ' A' ' 118' ' ' GLU . 1.7 mt -146.73 166.3 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.034 -1.666 . . . . 0.0 112.408 -179.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.533 ' OG ' ' HB2' ' A' ' 118' ' ' GLU . 82.4 p -148.93 139.82 22.87 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.233 178.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.502 ' O ' ' HB2' ' A' ' 50' ' ' PHE . . . -164.6 179.55 39.27 Favored Glycine 0 N--CA 1.506 3.346 0 C-N-CA 117.039 -2.505 . . . . 0.0 114.987 -179.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.541 ' HG2' ' HB3' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -87.76 152.88 21.78 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 178.772 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.542 HG13 HG13 ' A' ' 49' ' ' ILE . 2.4 pt -122.87 159.17 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.462 0 CA-C-N 120.982 1.719 . . . . 0.0 113.603 -176.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.599 ' CB ' HD13 ' A' ' 114' ' ' LEU . 1.5 tmm_? . . . . . 0 N--CA 1.481 1.111 0 O-C-N 120.582 -1.324 . . . . 0.0 109.891 179.783 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 N--CA 1.494 1.75 0 N-CA-C 111.245 0.091 . . . . 0.0 111.245 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.421 ' CD1' ' N ' ' A' ' 110' ' ' TYR . 3.6 m-85 -108.4 148.04 30.71 Favored 'General case' 0 N--CA 1.521 3.078 0 O-C-N 120.07 -1.644 . . . . 0.0 109.542 178.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.5 ' O ' ' HB3' ' A' ' 80' ' ' TYR . 54.4 m-85 -69.13 172.03 7.44 Favored 'General case' 0 N--CA 1.509 2.514 0 O-C-N 119.735 -1.853 . . . . 0.0 108.034 178.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.435 ' HA ' ' HB3' ' A' ' 80' ' ' TYR . . . -122.08 154.96 36.65 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 119.924 -1.735 . . . . 0.0 110.842 -179.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.12 153.7 43.28 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 179.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.599 HD13 ' CB ' ' A' ' 102' ' ' ARG . 11.1 tp -132.79 -59.55 0.89 Allowed 'General case' 0 N--CA 1.501 2.077 0 O-C-N 120.135 -1.603 . . . . 0.0 112.22 -179.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.541 ' HB3' ' HG2' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -114.18 141.7 47.19 Favored 'General case' 0 N--CA 1.511 2.615 0 O-C-N 120.272 -1.518 . . . . 0.0 109.074 179.401 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.453 HG21 ' CD2' ' A' ' 89' ' ' PHE . 34.7 t -93.05 129.25 43.83 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.908 0 O-C-N 120.543 -1.348 . . . . 0.0 111.63 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.431 ' C ' ' HG2' ' A' ' 118' ' ' GLU . 7.1 m-20 -106.93 -39.05 5.87 Favored 'General case' 0 N--CA 1.507 2.423 0 O-C-N 121.463 -0.773 . . . . 0.0 109.918 178.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.548 ' C ' HG23 ' A' ' 119' ' ' VAL . 6.0 mm-40 -143.52 156.37 44.59 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.595 -1.316 . . . . 0.0 109.041 179.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.548 HG23 ' C ' ' A' ' 118' ' ' GLU . 6.4 t -156.17 139.81 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -178.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.467 ' C ' ' O ' ' A' ' 119' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.519 2.978 0 O-C-N 121.106 -0.996 . . . . 0.0 111.197 -177.535 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.806 ' SD ' HG22 ' A' ' 49' ' ' ILE . 14.1 mmt . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.097 0.475 . . . . 0.0 109.925 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . 0.522 ' HA ' ' O ' ' A' ' 50' ' ' PHE . 39.8 t30 -78.86 110.04 13.69 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.007 -1.058 . . . . 0.0 108.84 178.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.662 ' HA ' HD12 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -44.09 -41.17 5.4 Favored 'General case' 0 N--CA 1.514 2.74 0 O-C-N 120.339 -1.476 . . . . 0.0 110.493 -178.695 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.43 ' OG1' ' OD1' ' A' ' 52' ' ' ASP . 1.7 m -58.4 -36.88 74.24 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 120.696 -1.253 . . . . 0.0 108.264 -179.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.51 ' HB3' ' HB3' ' A' ' 2' ' ' ASN . 1.8 pt-20 -70.53 -45.84 64.75 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.089 -1.007 . . . . 0.0 108.543 178.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.662 HD12 ' HA ' ' A' ' 3' ' ' LEU 0.281 82.3 mt -51.65 -49.5 62.19 Favored 'General case' 0 C--N 1.315 -0.916 0 O-C-N 121.008 -1.058 . . . . 0.0 109.521 178.397 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -63.78 -38.58 91.65 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.288 -0.883 . . . . 0.0 110.094 179.137 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -62.58 -19.52 63.8 Favored 'General case' 0 N--CA 1.508 2.473 0 O-C-N 121.262 -0.899 . . . . 0.0 111.383 -179.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.617 ' HB ' ' CD1' ' A' ' 14' ' ' LEU . 3.2 m -83.17 117.85 69.87 Favored Pre-proline 0 C--N 1.284 -2.278 0 O-C-N 121.763 -0.585 . . . . 0.0 109.966 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.53 ' HG2' ' HG3' ' A' ' 13' ' ' GLU . 38.5 Cg_endo -59.61 155.14 43.98 Favored 'Trans proline' 0 CA--C 1.564 2.0 0 O-C-N 122.471 0.722 . . . . 0.0 110.899 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.541 HG23 ' N ' ' A' ' 31' ' ' LYS . 1.7 p -42.81 -51.63 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.527 3.383 0 O-C-N 120.577 -1.327 . . . . 0.0 110.139 -178.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.519 ' N ' ' CG1' ' A' ' 11' ' ' VAL . 1.5 t -55.01 -43.23 73.45 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 121.12 -0.987 . . . . 0.0 111.239 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.74 ' O ' HD12 ' A' ' 17' ' ' LEU . 1.7 mm-40 -68.38 -27.32 66.13 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 117.947 -1.501 . . . . 0.0 107.59 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.617 ' CD1' ' HB ' ' A' ' 9' ' ' THR . 0.0 OUTLIER -70.61 -41.46 72.26 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.132 -0.98 . . . . 0.0 109.089 176.958 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.619 HG23 ' HB2' ' A' ' 26' ' ' LEU . 1.8 mp -69.81 -36.1 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 C-N-CA 117.824 -1.55 . . . . 0.0 109.216 179.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.568 ' HA ' ' HG2' ' A' ' 19' ' ' GLU . 86.8 m -69.31 -40.78 77.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.03 -1.669 . . . . 0.0 109.816 179.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.74 HD12 ' O ' ' A' ' 13' ' ' GLU . 1.9 mt -64.84 -37.62 88.22 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.696 -1.252 . . . . 0.0 108.923 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 1.041 ' HA2' HD13 ' A' ' 38' ' ' ILE . . . -68.2 -44.67 74.92 Favored Glycine 0 N--CA 1.507 3.395 0 N-CA-C 108.929 -1.668 . . . . 0.0 108.929 178.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.675 ' HG3' ' N ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -57.08 -37.11 71.42 Favored 'General case' 0 N--CA 1.484 1.232 0 O-C-N 120.496 -1.59 . . . . 0.0 107.463 178.896 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.675 ' N ' ' HG3' ' A' ' 19' ' ' GLU . 28.9 m120 -61.05 -24.44 66.2 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 118.293 -1.363 . . . . 0.0 109.532 178.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.949 ' HG3' HD11 ' A' ' 38' ' ' ILE . 69.6 mmm -97.33 2.18 50.32 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.188 -0.945 . . . . 0.0 111.595 -179.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.55 -3.66 65.9 Favored Glycine 0 N--CA 1.498 2.799 0 C-N-CA 118.249 -1.929 . . . . 0.0 114.142 177.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 1.025 ' H ' HD13 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -103.52 63.98 0.8 Allowed 'General case' 0 N--CA 1.509 2.5 0 CA-C-N 121.644 2.722 . . . . 0.0 111.25 179.854 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.521 ' O ' ' CB ' ' A' ' 25' ' ' ASN . 5.1 pt-20 -57.11 -167.71 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.199 0 CA-C-O 122.367 1.08 . . . . 0.0 110.754 178.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.521 ' CB ' ' O ' ' A' ' 24' ' ' GLU . 0.7 OUTLIER 74.62 10.16 4.11 Favored 'General case' 0 N--CA 1.516 2.84 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.571 179.723 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.833 HD11 ' O ' ' A' ' 23' ' ' LEU . 1.0 OUTLIER -77.14 -18.57 57.79 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.245 -0.909 . . . . 0.0 112.35 -179.358 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.408 ' C ' ' O ' ' A' ' 26' ' ' LEU . . . -46.99 -40.21 14.01 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.313 -1.492 . . . . 0.0 108.771 -179.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 28.0 mtt-85 -81.15 -0.56 40.82 Favored 'General case' 0 C--N 1.295 -1.786 0 C-N-CA 119.725 -0.79 . . . . 0.0 111.359 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.562 ' HB3' HG13 ' A' ' 34' ' ' ILE . 15.7 mtp -101.21 156.78 17.23 Favored 'General case' 0 C--N 1.312 -1.038 0 O-C-N 120.915 -1.116 . . . . 0.0 111.841 -178.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.834 ' O ' HD12 ' A' ' 34' ' ' ILE . 3.8 ttm180 -89.76 175.08 7.37 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.429 -0.794 . . . . 0.0 110.561 177.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.905 ' O ' HG22 ' A' ' 35' ' ' ILE . 9.2 pttm -66.41 -33.33 75.47 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.449 -0.782 . . . . 0.0 110.989 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.466 ' N ' ' HG3' ' A' ' 31' ' ' LYS . 1.3 mm100 -65.57 -55.02 19.98 Favored 'General case' 0 N--CA 1.523 3.192 0 CA-C-O 122.021 0.915 . . . . 0.0 110.018 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.55 ' OD1' ' N ' ' A' ' 34' ' ' ILE . 2.0 p30 -67.33 -41.91 84.45 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.074 -1.016 . . . . 0.0 109.685 -179.054 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.834 HD12 ' O ' ' A' ' 30' ' ' ARG . 29.0 mt -61.79 -40.84 88.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 O-C-N 120.357 -1.464 . . . . 0.0 109.637 178.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.905 HG22 ' O ' ' A' ' 31' ' ' LYS . 0.2 OUTLIER -66.92 -37.26 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.557 0 O-C-N 120.113 -1.617 . . . . 0.0 109.049 178.149 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 9.2 m-30 -67.02 -45.57 77.1 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.377 -1.452 . . . . 0.0 108.716 178.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.443 ' O ' ' C ' ' A' ' 38' ' ' ILE . . . -67.01 -53.46 31.16 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.49 -1.381 . . . . 0.0 109.487 178.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 1.041 HD13 ' HA2' ' A' ' 18' ' ' GLY . 5.9 tp -48.46 -49.99 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 C-N-CA 117.536 -1.665 . . . . 0.0 108.093 179.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.665 ' N ' HG23 ' A' ' 38' ' ' ILE . 5.6 tp -53.87 -41.56 67.65 Favored 'General case' 0 N--CA 1.52 3.052 0 O-C-N 120.76 -1.213 . . . . 0.0 109.1 179.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.48 ' O ' ' HD2' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -60.59 -36.05 77.59 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 121.628 0.727 . . . . 0.0 109.739 179.271 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.755 ' CG ' HD12 ' A' ' 23' ' ' LEU . 11.8 mm-40 -79.34 -51.4 9.46 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.663 -0.648 . . . . 0.0 111.354 -179.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.612 ' CG ' ' CE ' ' A' ' 21' ' ' MET . 0.2 OUTLIER -61.38 -31.59 71.5 Favored 'General case' 0 N--CA 1.503 2.204 0 C-N-CA 117.736 -1.586 . . . . 0.0 108.425 179.406 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 46' ' ' GLY . . . -58.96 -44.56 91.5 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 177.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.492 ' HB2' ' O ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -49.22 -45.24 44.19 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 122.11 0.957 . . . . 0.0 108.944 177.952 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 65.5 m -66.8 -8.36 28.0 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 121.639 0.733 . . . . 0.0 109.581 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . 74.53 29.5 61.61 Favored Glycine 0 N--CA 1.495 2.621 0 C-N-CA 120.186 -1.006 . . . . 0.0 111.774 178.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.03 166.65 22.09 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.173 -1.781 . . . . 0.0 108.975 178.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -88.1 130.22 35.08 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.234 -0.916 . . . . 0.0 109.739 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.806 HG22 ' SD ' ' A' ' 1' ' ' MET . 0.6 OUTLIER -131.0 135.8 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.562 -1.336 . . . . 0.0 107.655 178.97 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.522 ' O ' ' HA ' ' A' ' 2' ' ' ASN . 17.0 p90 -141.82 165.14 28.29 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 116.28 -2.168 . . . . 0.0 114.834 -177.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -114.21 164.8 12.03 Favored Glycine 0 N--CA 1.503 3.117 0 N-CA-C 108.307 -1.917 . . . . 0.0 108.307 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.461 ' N ' ' OD1' ' A' ' 52' ' ' ASP . 46.7 p-10 -169.79 164.63 9.91 Favored 'General case' 0 N--CA 1.48 1.047 0 O-C-N 120.36 -1.671 . . . . 0.0 110.298 -178.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.54 ' HA3' ' O ' ' A' ' 66' ' ' ARG . . . 140.87 -134.98 6.68 Favored Glycine 0 N--CA 1.504 3.227 0 C-N-CA 118.258 -1.925 . . . . 0.0 111.378 178.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.588 ' HA ' ' O ' ' A' ' 95' ' ' ASP . 2.6 t -128.17 119.85 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 O-C-N 121.414 -1.051 . . . . 0.0 108.265 -179.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.77 HD21 HG21 ' A' ' 81' ' ' VAL . 5.6 mt -62.29 161.61 11.15 Favored 'General case' 0 N--CA 1.501 2.124 0 C-N-CA 118.74 -1.184 . . . . 0.0 113.454 -175.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.512 ' HA ' ' OG1' ' A' ' 93' ' ' THR . 3.4 tp10 -137.31 116.35 12.45 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 178.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.608 ' CG1' ' HB ' ' A' ' 93' ' ' THR . 1.3 mm -84.31 159.35 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 120.151 -1.593 . . . . 0.0 108.811 -179.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.637 HD22 ' HE1' ' A' ' 62' ' ' PHE . 2.8 mp -130.96 138.82 49.9 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.348 -1.47 . . . . 0.0 109.961 179.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.453 ' C ' ' O ' ' A' ' 58' ' ' LEU . 3.7 tt0 -38.24 -36.72 0.24 Allowed 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.66 0.743 . . . . 0.0 110.414 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -60.99 -7.74 2.69 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.502 -0.749 . . . . 0.0 112.319 -179.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 91.34 8.39 64.39 Favored Glycine 1 N--CA 1.518 4.151 0 C-N-CA 118.729 -1.701 . . . . 0.0 112.255 177.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.637 ' HE1' HD22 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -127.65 -179.68 5.06 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 104.883 -2.266 . . . . 0.0 104.883 178.098 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.438 ' HA2' HD13 ' A' ' 58' ' ' LEU . . . -158.56 170.77 35.22 Favored Glycine 0 N--CA 1.475 1.293 0 C-N-CA 116.712 -2.661 . . . . 0.0 111.784 -177.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.417 ' HE1' ' CE2' ' A' ' 62' ' ' PHE . 6.9 m-85 -129.9 153.0 48.76 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 119.858 1.829 . . . . 0.0 109.753 177.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.513 ' HB3' ' HB ' ' A' ' 79' ' ' ILE . 0.3 OUTLIER -98.9 160.14 14.47 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 176.567 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.54 ' O ' ' HA3' ' A' ' 53' ' ' GLY . 0.0 OUTLIER 178.26 -162.75 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.196 -0.94 . . . . 0.0 109.561 179.191 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . 0.487 ' N ' ' HG3' ' A' ' 66' ' ' ARG . 1.1 m . . . . . 0 N--CA 1.497 1.923 0 O-C-N 120.98 -1.075 . . . . 0.0 110.282 179.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.695 ' C ' HD12 ' A' ' 79' ' ' ILE . 0.6 OUTLIER . . . . . 0 N--CA 1.509 2.515 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.695 HD12 ' C ' ' A' ' 78' ' ' ASP . 1.7 mp -135.9 138.27 47.81 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.812 0 O-C-N 120.961 -1.087 . . . . 0.0 110.043 178.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.512 ' HB3' ' O ' ' A' ' 111' ' ' PHE . 5.9 t80 -80.8 146.34 30.99 Favored 'General case' 0 N--CA 1.518 2.955 0 O-C-N 119.685 -1.884 . . . . 0.0 110.028 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.77 HG21 HD21 ' A' ' 55' ' ' LEU . 38.4 t -142.44 112.9 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 120.24 -1.537 . . . . 0.0 110.117 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.552 ' O ' HG13 ' A' ' 86' ' ' ILE . 22.0 m -74.86 166.82 42.16 Favored Pre-proline 0 N--CA 1.512 2.643 0 O-C-N 120.58 -1.325 . . . . 0.0 112.133 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.572 ' HA ' HG13 ' A' ' 86' ' ' ILE . 38.8 Cg_endo -65.19 -53.82 0.76 Allowed 'Trans proline' 0 C--N 1.314 -1.257 0 O-C-N 124.651 1.869 . . . . 0.0 109.08 178.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.56 ' O ' ' CG ' ' A' ' 88' ' ' ARG . 0.8 OUTLIER -45.14 -41.01 7.6 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 178.119 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.568 ' O ' ' CD2' ' A' ' 89' ' ' PHE . 6.6 mm100 -62.74 -57.81 9.65 Favored 'General case' 0 N--CA 1.509 2.517 0 C-N-CA 119.118 -1.033 . . . . 0.0 108.49 178.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.572 HG13 ' HA ' ' A' ' 83' ' ' PRO . 0.2 OUTLIER -59.15 -54.84 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.35 0 O-C-N 121.084 -1.01 . . . . 0.0 108.846 178.648 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.483 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 0.0 OUTLIER -56.22 -42.67 77.62 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-O 121.83 0.824 . . . . 0.0 111.225 -179.102 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.56 ' CG ' ' O ' ' A' ' 84' ' ' SER . 1.4 mmt85 -60.42 -36.42 78.11 Favored 'General case' 0 N--CA 1.507 2.382 0 C-N-CA 119.647 -0.821 . . . . 0.0 111.871 -177.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.568 ' CD2' ' O ' ' A' ' 85' ' ' GLN . 4.7 m-85 -109.74 12.75 23.98 Favored 'General case' 0 N--CA 1.503 2.218 0 C-N-CA 117.494 -1.682 . . . . 0.0 111.174 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 59.52 52.88 5.41 Favored 'General case' 0 N--CA 1.485 1.308 0 O-C-N 120.524 -1.36 . . . . 0.0 109.686 178.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.55 ' HB2' HG22 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -90.12 174.39 7.66 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.486 -0.758 . . . . 0.0 109.757 179.867 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.533 ' HG2' ' O ' ' A' ' 91' ' ' LEU . 10.3 mtm180 -147.56 159.82 43.33 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.173 -0.955 . . . . 0.0 108.678 178.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.608 ' HB ' ' CG1' ' A' ' 57' ' ' ILE . 1.9 t -63.54 156.28 26.92 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 117.143 -1.823 . . . . 0.0 107.031 179.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 77.2 -11.21 17.34 Favored Glycine 0 N--CA 1.505 3.251 0 C-N-CA 117.177 -2.439 . . . . 0.0 110.107 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.588 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 12.5 m-20 -68.26 146.93 52.87 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.211 -1.758 . . . . 0.0 110.943 -178.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.499 ' O ' HG12 ' A' ' 97' ' ' ILE . 0.2 OUTLIER -90.05 120.91 31.64 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.179 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.519 HG23 ' O ' ' A' ' 118' ' ' GLU . 1.5 mt -145.95 167.51 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 119.871 -1.768 . . . . 0.0 112.81 -178.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.527 ' OG ' ' HB2' ' A' ' 118' ' ' GLU . 99.8 p -149.25 138.95 21.8 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.52 ' O ' ' HB2' ' A' ' 50' ' ' PHE . . . -163.11 178.09 38.91 Favored Glycine 0 N--CA 1.507 3.42 0 C-N-CA 117.405 -2.331 . . . . 0.0 114.757 -178.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.503 ' HG2' ' HB3' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -88.06 155.88 19.58 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 178.982 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.521 HG13 HG13 ' A' ' 49' ' ' ILE . 1.7 pt -123.04 161.89 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.369 0 CA-C-N 120.636 1.562 . . . . 0.0 113.586 -177.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.949 ' HB2' HD22 ' A' ' 114' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.485 1.308 0 O-C-N 120.608 -1.307 . . . . 0.0 108.808 179.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 4.9 tpp180 . . . . . 0 N--CA 1.501 2.079 0 N-CA-C 112.628 0.603 . . . . 0.0 112.628 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -106.57 148.56 28.12 Favored 'General case' 0 N--CA 1.52 3.055 0 O-C-N 120.126 -1.609 . . . . 0.0 109.678 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.64 ' CE2' HD23 ' A' ' 39' ' ' LEU . 3.4 m-30 -67.72 168.09 12.0 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 119.851 -1.781 . . . . 0.0 108.093 178.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.431 ' HA ' ' HB3' ' A' ' 80' ' ' TYR . . . -121.85 154.15 37.44 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.237 -1.539 . . . . 0.0 110.345 -179.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.54 150.52 46.62 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.949 HD22 ' HB2' ' A' ' 102' ' ' ARG . 20.0 tp -127.93 -55.9 1.28 Allowed 'General case' 0 N--CA 1.501 2.088 0 O-C-N 120.282 -1.511 . . . . 0.0 112.373 -178.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.503 ' HB3' ' HG2' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -123.98 142.58 51.04 Favored 'General case' 0 N--CA 1.509 2.513 0 O-C-N 120.32 -1.487 . . . . 0.0 109.263 179.417 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.8 t -92.98 130.7 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.831 0 O-C-N 120.468 -1.395 . . . . 0.0 111.057 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -107.17 -40.93 5.28 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 121.357 -0.839 . . . . 0.0 109.725 178.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.562 ' C ' HG23 ' A' ' 119' ' ' VAL . 0.0 OUTLIER -143.67 159.48 42.41 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.872 -1.142 . . . . 0.0 109.74 179.483 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.562 HG23 ' C ' ' A' ' 118' ' ' GLU . 13.1 t -158.5 138.14 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -178.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.516 2.853 0 O-C-N 120.332 -1.48 . . . . 0.0 110.643 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.629 ' HA ' ' HA ' ' A' ' 49' ' ' ILE . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.664 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . 0.584 ' HA ' ' O ' ' A' ' 50' ' ' PHE . 63.5 t30 -78.5 91.06 4.5 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.725 -1.234 . . . . 0.0 108.444 178.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.552 ' CD1' HD11 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -41.59 -40.4 1.88 Allowed 'General case' 0 N--CA 1.52 3.035 0 O-C-N 120.598 -1.314 . . . . 0.0 110.371 -178.186 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.467 ' OG1' ' CG ' ' A' ' 52' ' ' ASP . 1.9 m -60.13 -35.07 74.45 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 118.601 -1.24 . . . . 0.0 108.288 -179.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.566 ' HB3' ' HB3' ' A' ' 2' ' ' ASN . 0.9 OUTLIER -72.65 -44.57 61.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.922 -1.112 . . . . 0.0 108.245 177.386 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.639 HD12 HG13 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -51.01 -51.4 53.36 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 120.834 -1.167 . . . . 0.0 108.68 178.37 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 8.1 mttm -62.5 -40.92 98.27 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.121 -0.987 . . . . 0.0 109.831 178.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.405 ' HB2' ' HA ' ' A' ' 5' ' ' GLU . 2.7 m-80 -62.74 -20.65 65.15 Favored 'General case' 0 N--CA 1.508 2.456 0 CA-C-O 121.79 0.805 . . . . 0.0 111.141 -179.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.738 ' HB ' HD11 ' A' ' 14' ' ' LEU . 94.5 m -79.26 122.25 83.94 Favored Pre-proline 0 C--N 1.283 -2.289 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.555 ' HG2' ' CG ' ' A' ' 13' ' ' GLU . 37.2 Cg_endo -57.48 155.55 30.36 Favored 'Trans proline' 0 N--CA 1.503 2.068 0 C-N-CA 120.488 0.792 . . . . 0.0 112.219 -177.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.56 ' CG1' ' N ' ' A' ' 12' ' ' SER . 1.6 p -45.24 -51.73 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.541 0 O-C-N 120.502 -1.374 . . . . 0.0 110.44 -178.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.56 ' N ' ' CG1' ' A' ' 11' ' ' VAL . 0.9 OUTLIER -56.86 -41.57 78.19 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.081 -1.012 . . . . 0.0 110.646 -179.52 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.605 ' HB3' HG23 ' A' ' 9' ' ' THR . 48.2 mm-40 -68.95 -26.85 65.27 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 118.155 -1.418 . . . . 0.0 107.975 179.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.738 HD11 ' HB ' ' A' ' 9' ' ' THR . 0.9 OUTLIER -70.35 -43.14 70.82 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 120.96 -1.087 . . . . 0.0 108.439 177.381 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.548 HD12 ' O ' ' A' ' 11' ' ' VAL . 1.4 mp -66.37 -40.15 85.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 C-N-CA 118.108 -1.437 . . . . 0.0 108.659 178.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.577 ' HA ' ' HG2' ' A' ' 19' ' ' GLU . 92.7 m -63.91 -38.03 89.59 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.394 -1.441 . . . . 0.0 109.267 179.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.534 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 0.7 OUTLIER -65.81 -37.79 87.22 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.85 -1.156 . . . . 0.0 108.779 178.553 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.466 ' HA2' HD13 ' A' ' 23' ' ' LEU . . . -67.36 -43.5 87.7 Favored Glycine 0 N--CA 1.513 3.794 0 N-CA-C 108.505 -1.838 . . . . 0.0 108.505 178.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.687 ' HG3' ' N ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -59.33 -37.98 79.16 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.507 -1.584 . . . . 0.0 108.117 178.922 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.687 ' N ' ' HG3' ' A' ' 19' ' ' GLU . 28.1 m120 -61.32 -29.01 69.62 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 118.201 -1.4 . . . . 0.0 109.405 178.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.516 ' HG3' ' O ' ' A' ' 17' ' ' LEU . 18.6 mtp -101.53 12.84 36.57 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.215 -0.928 . . . . 0.0 111.153 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.66 -22.9 34.29 Favored Glycine 0 N--CA 1.502 3.082 0 C-N-CA 118.632 -1.747 . . . . 0.0 111.299 179.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 1.006 ' CD2' ' HB1' ' A' ' 37' ' ' ALA . 2.9 mp -79.45 93.63 5.42 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.396 -1.65 . . . . 0.0 109.776 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -108.1 175.79 5.36 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.141 -0.974 . . . . 0.0 109.285 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 62.99 21.1 12.7 Favored 'General case' 0 N--CA 1.507 2.404 0 O-C-N 121.914 -0.491 . . . . 0.0 111.549 178.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.743 HD11 ' HB3' ' A' ' 23' ' ' LEU . 0.4 OUTLIER -77.19 -7.59 56.12 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 120.985 -1.072 . . . . 0.0 111.413 -179.86 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 26' ' ' LEU . . . -46.71 -31.73 3.12 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.441 -1.412 . . . . 0.0 108.977 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . 0.558 ' CD ' ' C ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -80.82 -2.12 45.9 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 120.081 -0.648 . . . . 0.0 111.502 -179.99 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.541 ' HB3' HG13 ' A' ' 34' ' ' ILE . 14.8 mtp -100.85 162.78 12.67 Favored 'General case' 0 C--N 1.313 -0.989 0 O-C-N 120.639 -1.288 . . . . 0.0 111.636 -179.004 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.722 ' O ' HD12 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -89.71 164.26 14.77 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.647 0.737 . . . . 0.0 110.563 178.502 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.576 ' O ' HG22 ' A' ' 35' ' ' ILE . 2.6 ttmm -55.62 -41.95 74.22 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.509 -0.744 . . . . 0.0 111.082 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.55 ' O ' HG22 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -63.69 -53.46 50.96 Favored 'General case' 0 N--CA 1.521 3.086 0 O-C-N 121.495 -0.753 . . . . 0.0 112.194 -178.346 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 34' ' ' ILE . 1.7 p30 -67.23 -40.56 86.35 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 120.415 -1.428 . . . . 0.0 109.312 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.722 HD12 ' O ' ' A' ' 30' ' ' ARG . 15.7 mt -61.91 -39.44 83.58 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 O-C-N 120.506 -1.371 . . . . 0.0 109.363 178.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.639 HG13 HD12 ' A' ' 6' ' ' LEU . 0.1 OUTLIER -67.59 -38.12 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.435 0 O-C-N 120.238 -1.539 . . . . 0.0 109.221 178.519 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 -62.28 -43.54 98.59 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.594 -1.316 . . . . 0.0 108.86 178.905 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 1.006 ' HB1' ' CD2' ' A' ' 23' ' ' LEU . . . -57.2 -54.66 44.27 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.413 -1.429 . . . . 0.0 108.501 178.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.632 HD12 HD11 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -54.59 -32.31 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 C-N-CA 117.402 -1.719 . . . . 0.0 109.345 179.088 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.553 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 11.1 mt -68.33 -40.66 81.52 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 120.299 -1.501 . . . . 0.0 109.35 178.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.463 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 3.4 mtpp -66.23 -38.78 88.73 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.001 -1.062 . . . . 0.0 110.684 178.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.845 ' HG3' HD11 ' A' ' 23' ' ' LEU . 1.1 mm-40 -75.9 -52.87 9.38 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.24 -0.913 . . . . 0.0 111.13 -179.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.592 ' CG ' ' CE ' ' A' ' 1' ' ' MET . 2.8 t-80 -64.26 -36.38 83.92 Favored 'General case' 0 N--CA 1.51 2.54 0 O-C-N 120.951 -1.093 . . . . 0.0 109.37 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.553 ' HB3' ' O ' ' A' ' 39' ' ' LEU . . . -77.28 -32.24 55.35 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.89 -1.131 . . . . 0.0 110.62 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -47.33 -44.04 23.39 Favored 'General case' 0 N--CA 1.481 1.116 0 O-C-N 120.411 -1.43 . . . . 0.0 108.972 178.548 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 25.4 m -66.81 -10.57 49.12 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 119.573 -0.851 . . . . 0.0 109.548 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . 65.78 31.53 80.09 Favored Glycine 0 N--CA 1.495 2.593 0 C-N-CA 120.401 -0.904 . . . . 0.0 111.156 178.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.555 ' OE2' ' ND1' ' A' ' 42' ' ' HIS . 3.4 pt-20 -85.15 170.13 13.2 Favored 'General case' 0 N--CA 1.484 1.226 0 O-C-N 120.408 -1.642 . . . . 0.0 109.225 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.543 ' C ' HG23 ' A' ' 49' ' ' ILE . 7.6 m-20 -61.54 138.07 58.27 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.14 -0.975 . . . . 0.0 111.934 -177.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.629 ' HA ' ' HA ' ' A' ' 1' ' ' MET . 0.5 OUTLIER -157.13 144.09 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 178.455 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.584 ' O ' ' HA ' ' A' ' 2' ' ' ASN . 24.6 p90 -141.93 168.17 20.38 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 115.616 -2.434 . . . . 0.0 115.504 -178.151 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -116.15 164.32 12.28 Favored Glycine 0 N--CA 1.499 2.867 0 N-CA-C 107.784 -2.126 . . . . 0.0 107.784 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.512 ' C ' ' CD2' ' A' ' 65' ' ' LEU . 5.8 p-10 -172.37 163.18 5.59 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 120.322 -1.693 . . . . 0.0 109.657 -179.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.45 ' HA3' ' O ' ' A' ' 66' ' ' ARG . . . 146.31 -139.74 8.31 Favored Glycine 0 N--CA 1.504 3.195 0 C-N-CA 117.991 -2.052 . . . . 0.0 111.131 179.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.611 ' HA ' ' O ' ' A' ' 95' ' ' ASP . 2.6 t -128.07 119.7 51.71 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.786 HD21 HG21 ' A' ' 81' ' ' VAL . 6.9 mt -62.76 164.25 8.14 Favored 'General case' 0 N--CA 1.504 2.254 0 C-N-CA 118.782 -1.167 . . . . 0.0 113.869 -175.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.528 ' HA ' ' OG1' ' A' ' 93' ' ' THR . 0.8 OUTLIER -141.78 119.35 11.67 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 178.384 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.583 ' CG1' ' HB ' ' A' ' 93' ' ' THR . 1.0 OUTLIER -80.19 162.63 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 119.903 -1.748 . . . . 0.0 109.265 -178.718 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.726 HD13 ' HA2' ' A' ' 63' ' ' GLY . 3.3 mp -132.12 136.19 46.96 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.426 -1.421 . . . . 0.0 109.675 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.453 ' C ' ' O ' ' A' ' 58' ' ' LEU . 2.0 tt0 -39.77 -36.37 0.42 Allowed 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.749 0.785 . . . . 0.0 110.102 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.458 ' HB2' ' CD1' ' A' ' 62' ' ' PHE . 66.6 m-20 -61.46 -5.94 2.04 Favored 'General case' 0 N--CA 1.501 2.092 0 C-N-CA 119.959 -0.696 . . . . 0.0 112.51 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.446 ' O ' ' HB3' ' A' ' 83' ' ' PRO . . . 89.85 11.91 62.95 Favored Glycine 1 N--CA 1.52 4.282 0 C-N-CA 118.71 -1.709 . . . . 0.0 112.185 178.089 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.616 ' CZ ' HD22 ' A' ' 58' ' ' LEU . 2.8 p90 -132.95 -176.93 4.28 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 103.865 -2.642 . . . . 0.0 103.865 177.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.726 ' HA2' HD13 ' A' ' 58' ' ' LEU . . . -158.75 172.39 35.58 Favored Glycine 0 N--CA 1.474 1.216 0 C-N-CA 116.933 -2.556 . . . . 0.0 111.706 -177.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.544 ' CE2' ' CE2' ' A' ' 62' ' ' PHE . 43.5 m-85 -129.7 154.29 47.31 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 119.99 1.895 . . . . 0.0 109.708 177.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.512 ' CD2' ' C ' ' A' ' 52' ' ' ASP 0.255 0.2 OUTLIER -98.39 134.33 41.54 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 107.005 -1.479 . . . . 0.0 107.005 176.892 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.45 ' O ' ' HA3' ' A' ' 53' ' ' GLY . 0.4 OUTLIER -135.99 -173.04 3.27 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.225 -1.547 . . . . 0.0 109.658 179.446 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 6.5 m . . . . . 0 N--CA 1.497 1.886 0 O-C-N 121.036 -1.04 . . . . 0.0 110.573 179.921 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.462 ' OD1' ' N ' ' A' ' 78' ' ' ASP . 3.2 m-20 . . . . . 0 N--CA 1.508 2.429 0 N-CA-C 109.632 -0.507 . . . . 0.0 109.632 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.435 ' HB ' ' CB ' ' A' ' 65' ' ' LEU . 4.4 mm -120.21 131.61 72.07 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.745 0 O-C-N 120.969 -1.082 . . . . 0.0 109.979 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.508 ' HB3' ' O ' ' A' ' 111' ' ' PHE . 10.4 t80 -76.71 147.35 37.44 Favored 'General case' 0 N--CA 1.518 2.934 0 CA-C-N 121.85 2.114 . . . . 0.0 109.462 179.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.786 HG21 HD21 ' A' ' 55' ' ' LEU . 11.1 t -145.51 116.8 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 120.151 -1.593 . . . . 0.0 110.2 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.564 ' O ' HG13 ' A' ' 86' ' ' ILE . 56.1 m -74.95 161.67 76.62 Favored Pre-proline 0 N--CA 1.51 2.555 0 O-C-N 120.34 -1.475 . . . . 0.0 112.248 -179.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.583 ' HA ' HG13 ' A' ' 86' ' ' ILE . 38.0 Cg_endo -65.19 -50.97 1.73 Allowed 'Trans proline' 0 C--N 1.313 -1.315 0 O-C-N 124.887 1.993 . . . . 0.0 108.554 178.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.572 ' O ' ' CG ' ' A' ' 88' ' ' ARG . 3.0 p -46.02 -41.53 12.08 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 177.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.525 ' OE1' ' HA ' ' A' ' 85' ' ' GLN . 6.6 mm100 -62.48 -58.07 8.92 Favored 'General case' 0 N--CA 1.511 2.586 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 178.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.583 HG13 ' HA ' ' A' ' 83' ' ' PRO . 0.4 OUTLIER -55.83 -56.26 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.262 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 178.386 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.482 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 9.7 mtt85 -58.41 -41.84 85.84 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-O 121.825 0.822 . . . . 0.0 111.731 -179.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.572 ' CG ' ' O ' ' A' ' 84' ' ' SER . 0.1 OUTLIER -60.04 -37.66 80.46 Favored 'General case' 0 N--CA 1.507 2.376 0 C-N-CA 119.612 -0.835 . . . . 0.0 111.938 -177.679 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 1.019 ' HB2' HD21 ' A' ' 91' ' ' LEU . 5.0 m-85 -109.58 11.85 24.59 Favored 'General case' 0 N--CA 1.503 2.206 0 C-N-CA 116.818 -1.953 . . . . 0.0 111.148 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.406 ' CB ' ' O ' ' A' ' 89' ' ' PHE . 1.5 t-20 63.74 53.6 1.97 Allowed 'General case' 0 N--CA 1.486 1.342 0 O-C-N 120.611 -1.306 . . . . 0.0 110.818 178.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 1.019 HD21 ' HB2' ' A' ' 89' ' ' PHE . 2.9 mt -89.7 -168.96 2.3 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 119.37 -0.932 . . . . 0.0 109.752 179.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.53 ' CG ' ' O ' ' A' ' 91' ' ' LEU . 0.2 OUTLIER -159.7 161.38 34.83 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 178.231 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.583 ' HB ' ' CG1' ' A' ' 57' ' ' ILE . 1.9 t -64.83 155.64 33.39 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 116.869 -1.932 . . . . 0.0 106.893 178.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . 0.407 ' C ' HG12 ' A' ' 54' ' ' VAL . . . 75.29 -9.09 14.6 Favored Glycine 0 N--CA 1.506 3.338 0 C-N-CA 117.299 -2.382 . . . . 0.0 110.388 179.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.611 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 15.4 m-20 -68.1 149.66 49.34 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.137 -1.802 . . . . 0.0 110.724 -178.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.493 ' O ' HG12 ' A' ' 97' ' ' ILE . 0.3 OUTLIER -91.58 121.19 33.04 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.621 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.53 HG23 HG22 ' A' ' 119' ' ' VAL . 1.4 mt -144.82 166.61 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 119.93 -1.732 . . . . 0.0 112.885 -178.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.493 ' OG ' ' HB2' ' A' ' 118' ' ' GLU . 96.7 p -150.93 139.76 20.85 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.999 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.494 ' O ' ' HB2' ' A' ' 50' ' ' PHE . . . -164.47 -179.66 38.72 Favored Glycine 0 N--CA 1.509 3.545 0 C-N-CA 117.643 -2.218 . . . . 0.0 114.609 -179.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.506 ' HD3' HD23 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -87.23 155.39 20.11 Favored 'General case' 0 N--CA 1.504 2.239 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 178.589 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.507 HG12 ' HA ' ' A' ' 50' ' ' PHE . 2.2 pt -122.46 158.56 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.643 0 CA-C-N 121.228 1.831 . . . . 0.0 114.435 -176.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.782 ' HB2' HD22 ' A' ' 114' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.488 1.427 0 O-C-N 120.651 -1.281 . . . . 0.0 109.642 179.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 3.6 mmp_? . . . . . 0 N--CA 1.513 2.712 0 CA-C-O 120.557 0.218 . . . . 0.0 111.357 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.536 ' N ' ' CD1' ' A' ' 110' ' ' TYR . 2.8 m-85 -109.26 154.75 22.0 Favored 'General case' 0 N--CA 1.518 2.938 0 O-C-N 120.581 -1.325 . . . . 0.0 107.72 177.066 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.508 ' O ' ' HB3' ' A' ' 80' ' ' TYR . 38.1 m-85 -66.9 165.56 15.18 Favored 'General case' 0 N--CA 1.508 2.427 0 O-C-N 119.135 -2.228 . . . . 0.0 107.273 178.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.433 ' HA ' ' HB3' ' A' ' 80' ' ' TYR . . . -123.24 152.87 40.88 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 119.905 -1.747 . . . . 0.0 111.216 -178.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.42 HD12 ' N ' ' A' ' 114' ' ' LEU . 0.1 OUTLIER -66.77 153.68 42.72 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 178.753 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.782 HD22 ' HB2' ' A' ' 102' ' ' ARG . 12.9 tp -130.86 -59.41 1.0 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 120.047 -1.658 . . . . 0.0 112.361 -178.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.49 ' HB3' ' HG2' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -114.05 139.97 48.85 Favored 'General case' 0 N--CA 1.512 2.646 0 O-C-N 120.383 -1.448 . . . . 0.0 108.767 179.206 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 23.7 t -92.27 128.78 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.804 0 O-C-N 120.477 -1.39 . . . . 0.0 111.37 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.423 ' CG ' ' HA2' ' A' ' 99' ' ' GLY . 4.8 m-20 -106.97 -38.5 6.03 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.355 -0.841 . . . . 0.0 109.947 178.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.574 ' C ' HG23 ' A' ' 119' ' ' VAL . 1.1 tt0 -143.5 157.21 44.62 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.786 -1.196 . . . . 0.0 109.803 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.574 HG23 ' C ' ' A' ' 118' ' ' GLU . 17.8 t -159.74 130.99 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 122.387 -0.196 . . . . 0.0 110.511 -178.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.521 3.081 0 O-C-N 120.309 -1.495 . . . . 0.0 111.481 178.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.668 ' HA ' ' HA ' ' A' ' 49' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . 0.561 ' HB3' ' HB2' ' A' ' 5' ' ' GLU . 39.3 t30 -78.46 94.18 4.88 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 120.85 -1.156 . . . . 0.0 108.137 178.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.901 HD12 HD12 ' A' ' 6' ' ' LEU . 0.5 OUTLIER -41.81 -42.29 2.62 Favored 'General case' 0 N--CA 1.519 3.007 0 O-C-N 120.518 -1.364 . . . . 0.0 110.241 -178.399 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.7 m -56.33 -36.46 68.74 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.983 -1.073 . . . . 0.0 108.311 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.561 ' HB2' ' HB3' ' A' ' 2' ' ' ASN . 3.0 mt-10 -76.54 -39.26 53.38 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.9 -1.125 . . . . 0.0 109.317 178.06 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.901 HD12 HD12 ' A' ' 3' ' ' LEU 0.267 90.7 mt -54.82 -49.2 71.61 Favored 'General case' 0 C--O 1.215 -0.752 0 O-C-N 120.31 -1.494 . . . . 0.0 109.174 177.984 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.04 -39.16 75.9 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.936 -1.103 . . . . 0.0 110.769 179.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -63.14 -22.48 66.89 Favored 'General case' 0 N--CA 1.507 2.405 0 O-C-N 121.1 -1.0 . . . . 0.0 111.221 -179.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.727 ' HB ' HD11 ' A' ' 14' ' ' LEU . 22.7 m -81.12 140.02 49.36 Favored Pre-proline 0 N--CA 1.505 2.278 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.537 ' HG2' ' HG3' ' A' ' 13' ' ' GLU . 41.6 Cg_endo -63.75 152.23 81.48 Favored 'Trans proline' 0 CA--C 1.566 2.088 0 O-C-N 122.293 0.628 . . . . 0.0 111.773 -177.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.506 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 1.5 p -47.58 -50.42 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.337 0 O-C-N 120.517 -1.364 . . . . 0.0 109.997 -178.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.502 ' N ' ' CG1' ' A' ' 11' ' ' VAL . 1.6 t -54.48 -43.72 71.98 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.011 -1.055 . . . . 0.0 110.763 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.56 ' HB3' ' CG2' ' A' ' 9' ' ' THR . 1.0 OUTLIER -68.31 -27.12 66.01 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 118.158 -1.417 . . . . 0.0 107.967 179.631 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.806 HD23 ' HG2' ' A' ' 31' ' ' LYS . 1.3 mp -70.11 -43.45 71.0 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.985 -1.072 . . . . 0.0 108.603 177.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.499 HG12 ' HB2' ' A' ' 26' ' ' LEU . 1.6 mp -66.55 -39.1 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 C-N-CA 118.148 -1.421 . . . . 0.0 108.822 178.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.502 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 58.8 m -64.89 -38.0 89.5 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 118.036 -1.466 . . . . 0.0 109.205 178.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.33 -36.82 83.91 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.792 -1.192 . . . . 0.0 108.907 178.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.519 ' HA2' HD13 ' A' ' 23' ' ' LEU . . . -67.91 -43.2 83.76 Favored Glycine 0 N--CA 1.515 3.961 0 N-CA-C 108.129 -1.989 . . . . 0.0 108.129 178.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -55.51 -46.39 76.98 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.631 -1.511 . . . . 0.0 107.685 178.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.502 ' OD1' ' O ' ' A' ' 16' ' ' THR . 25.2 m120 -59.53 -25.64 64.67 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 118.202 -1.399 . . . . 0.0 109.145 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.552 ' HB2' ' CD1' ' A' ' 23' ' ' LEU . 64.7 mmm -100.93 11.99 38.52 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.489 -0.757 . . . . 0.0 111.06 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 96.06 -17.15 59.82 Favored Glycine 0 N--CA 1.502 3.058 0 C-N-CA 118.804 -1.665 . . . . 0.0 111.408 179.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 1.0 HD23 ' HB1' ' A' ' 37' ' ' ALA . 4.1 mp -79.41 102.76 8.89 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.471 -1.605 . . . . 0.0 109.782 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.478 ' O ' ' HB2' ' A' ' 25' ' ' ASN . 2.0 pt-20 -114.85 -179.72 3.71 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.28 -0.888 . . . . 0.0 109.1 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.478 ' HB2' ' O ' ' A' ' 24' ' ' GLU . 1.8 m120 62.38 18.48 10.32 Favored 'General case' 0 N--CA 1.51 2.53 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.7 178.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 1.071 HD23 ' SD ' ' A' ' 29' ' ' MET . 1.2 mt -76.29 -18.22 59.07 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.196 -0.94 . . . . 0.0 111.408 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -47.27 -29.5 2.48 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.213 -1.555 . . . . 0.0 109.524 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -78.88 -30.4 44.97 Favored 'General case' 0 C--N 1.295 -1.795 0 C-N-CA 120.11 -0.636 . . . . 0.0 112.2 -179.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 1.071 ' SD ' HD23 ' A' ' 26' ' ' LEU . 6.6 ptm -93.22 166.99 12.05 Favored 'General case' 0 C--N 1.311 -1.073 0 O-C-N 120.426 -1.421 . . . . 0.0 111.084 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.999 ' O ' HD12 ' A' ' 34' ' ' ILE . 1.0 OUTLIER -89.39 -173.65 4.08 Favored 'General case' 0 N--CA 1.506 2.358 0 CA-C-O 122.219 1.009 . . . . 0.0 112.864 -178.428 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.806 ' HG2' HD23 ' A' ' 14' ' ' LEU . 0.3 OUTLIER -66.32 -35.67 80.97 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.522 -179.722 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -63.02 -58.82 6.01 Favored 'General case' 0 N--CA 1.515 2.796 0 O-C-N 120.766 -1.209 . . . . 0.0 109.667 -178.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.523 ' CG ' ' HE2' ' A' ' 29' ' ' MET . 3.6 p30 -66.3 -35.27 79.95 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.457 -0.777 . . . . 0.0 109.717 -179.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.999 HD12 ' O ' ' A' ' 30' ' ' ARG . 0.8 OUTLIER -60.9 -43.72 96.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 120.081 -1.637 . . . . 0.0 107.898 177.141 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.56 HG13 ' O ' ' A' ' 31' ' ' LYS . 86.7 mt -63.39 -45.38 98.19 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.854 0 O-C-N 120.318 -1.489 . . . . 0.0 110.357 178.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.418 ' HA ' HD12 ' A' ' 39' ' ' LEU . 3.6 m-30 -53.59 -40.15 65.43 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 119.203 -0.999 . . . . 0.0 108.566 -179.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 1.0 ' HB1' HD23 ' A' ' 23' ' ' LEU . . . -68.09 -54.28 19.36 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.614 -1.304 . . . . 0.0 109.606 178.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.526 HG13 ' O ' ' A' ' 34' ' ' ILE . 0.1 OUTLIER -53.49 -28.0 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 C-N-CA 117.545 -1.662 . . . . 0.0 110.007 -179.969 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.487 HD11 HG22 ' A' ' 35' ' ' ILE . 79.8 mt -71.13 -43.68 67.12 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 120.219 -1.551 . . . . 0.0 109.335 178.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.26 -39.69 92.98 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.979 -1.075 . . . . 0.0 110.581 178.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.781 ' CB ' HD11 ' A' ' 23' ' ' LEU . 1.4 mp0 -74.56 -51.22 15.24 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 121.146 -0.971 . . . . 0.0 110.726 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.64 ' CD2' ' CB ' ' A' ' 47' ' ' GLU . 9.9 t60 -61.99 -34.55 76.37 Favored 'General case' 0 N--CA 1.51 2.539 0 C-N-CA 118.65 -1.22 . . . . 0.0 108.573 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.451 ' O ' ' N ' ' A' ' 46' ' ' GLY . . . -70.51 -45.26 65.94 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.043 -1.036 . . . . 0.0 109.079 178.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -48.28 -45.66 34.97 Favored 'General case' 0 N--CA 1.484 1.252 0 O-C-N 120.752 -1.217 . . . . 0.0 109.138 178.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 68.4 m -66.99 -6.94 18.94 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-O 121.547 0.689 . . . . 0.0 109.696 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . 76.45 24.9 66.84 Favored Glycine 0 N--CA 1.498 2.801 0 C-N-CA 120.148 -1.025 . . . . 0.0 112.094 178.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.64 ' CB ' ' CD2' ' A' ' 42' ' ' HIS . 0.2 OUTLIER -79.42 166.74 21.71 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.129 -1.806 . . . . 0.0 109.086 178.817 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.432 ' C ' ' CG2' ' A' ' 49' ' ' ILE . 8.3 m-20 -88.66 150.02 23.23 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.07 -1.019 . . . . 0.0 109.391 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.668 ' HA ' ' HA ' ' A' ' 1' ' ' MET . 0.5 OUTLIER -148.98 143.28 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 120.668 -1.27 . . . . 0.0 108.46 179.246 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.584 ' HB2' ' O ' ' A' ' 99' ' ' GLY . 23.6 p90 -142.75 172.07 13.2 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 116.088 -2.245 . . . . 0.0 114.918 -177.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -126.23 168.94 18.23 Favored Glycine 0 N--CA 1.508 3.445 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 -178.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -169.67 166.51 9.85 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 120.429 -1.63 . . . . 0.0 110.315 -178.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.587 ' HA3' ' O ' ' A' ' 66' ' ' ARG . . . 142.47 -135.75 6.79 Favored Glycine 0 N--CA 1.506 3.306 0 C-N-CA 118.349 -1.882 . . . . 0.0 111.591 178.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.567 ' HA ' ' O ' ' A' ' 95' ' ' ASP . 2.6 t -128.44 120.04 51.9 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 O-C-N 121.235 -1.156 . . . . 0.0 108.292 -179.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.853 HD21 HG21 ' A' ' 81' ' ' VAL . 6.0 mt -62.92 161.2 13.3 Favored 'General case' 0 N--CA 1.503 2.22 0 C-N-CA 118.645 -1.222 . . . . 0.0 113.681 -175.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.504 ' HA ' ' OG1' ' A' ' 93' ' ' THR . 18.1 mm-40 -137.14 117.89 14.05 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 177.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.647 ' C ' HD12 ' A' ' 58' ' ' LEU . 1.4 mm -82.3 162.67 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 O-C-N 119.959 -1.713 . . . . 0.0 109.624 -178.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.956 HD22 ' CZ ' ' A' ' 62' ' ' PHE . 5.8 mp -129.95 137.64 50.44 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.531 -1.356 . . . . 0.0 109.462 179.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.458 ' C ' ' O ' ' A' ' 58' ' ' LEU . 1.8 mt-30 -42.09 -34.69 0.77 Allowed 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.951 0.881 . . . . 0.0 109.143 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -61.34 -7.17 2.69 Favored 'General case' 0 N--CA 1.499 2.012 0 C-N-CA 120.213 -0.595 . . . . 0.0 112.341 -179.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 90.99 7.51 65.87 Favored Glycine 1 N--CA 1.52 4.252 0 C-N-CA 118.804 -1.665 . . . . 0.0 112.225 178.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.956 ' CZ ' HD22 ' A' ' 58' ' ' LEU . 2.0 p90 -127.8 179.77 5.37 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 104.469 -2.419 . . . . 0.0 104.469 178.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.55 ' N ' ' CD1' ' A' ' 62' ' ' PHE . . . -156.22 171.48 33.99 Favored Glycine 0 N--CA 1.477 1.387 0 C-N-CA 117.186 -2.435 . . . . 0.0 111.879 -178.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.467 ' CE2' ' HE1' ' A' ' 62' ' ' PHE . 14.5 m-85 -128.99 149.11 50.96 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 119.861 1.831 . . . . 0.0 109.25 177.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.546 ' HB3' ' HB ' ' A' ' 79' ' ' ILE . 0.6 OUTLIER -99.42 165.35 11.7 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 176.392 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.587 ' O ' ' HA3' ' A' ' 53' ' ' GLY . 0.0 OUTLIER 172.49 -169.73 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.97 -1.081 . . . . 0.0 109.712 178.525 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 17.1 m . . . . . 0 N--CA 1.5 2.067 0 O-C-N 120.716 -1.24 . . . . 0.0 109.949 179.691 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 78' ' ' ASP . 0.8 OUTLIER . . . . . 0 N--CA 1.504 2.271 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.546 ' HB ' ' HB3' ' A' ' 65' ' ' LEU . 1.3 mp -117.88 127.64 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.721 0 C-N-CA 119.169 -1.012 . . . . 0.0 108.507 177.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.456 ' HB3' ' HA ' ' A' ' 112' ' ' ALA . 6.8 t80 -73.61 146.19 44.83 Favored 'General case' 0 N--CA 1.515 2.796 0 O-C-N 119.689 -1.882 . . . . 0.0 110.125 -178.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.853 HG21 HD21 ' A' ' 55' ' ' LEU . 34.5 t -140.36 112.02 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 120.324 -1.485 . . . . 0.0 110.603 -179.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.539 ' O ' HG13 ' A' ' 86' ' ' ILE . 57.9 m -74.67 165.99 49.0 Favored Pre-proline 0 N--CA 1.513 2.697 0 O-C-N 120.519 -1.363 . . . . 0.0 112.041 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.521 ' HD2' ' HB3' ' A' ' 82' ' ' SER . 40.1 Cg_endo -65.21 -50.24 2.17 Favored 'Trans proline' 0 C--N 1.315 -1.189 0 O-C-N 124.317 1.693 . . . . 0.0 109.287 179.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.554 ' O ' ' CG ' ' A' ' 88' ' ' ARG . 0.3 OUTLIER -47.92 -39.66 19.7 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 178.106 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.536 ' HB2' ' O ' ' A' ' 82' ' ' SER . 5.6 mm100 -63.56 -58.86 5.65 Favored 'General case' 0 N--CA 1.51 2.551 0 C-N-CA 119.375 -0.93 . . . . 0.0 108.68 178.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.539 HG13 ' O ' ' A' ' 82' ' ' SER . 0.3 OUTLIER -57.23 -54.22 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.417 0 O-C-N 121.076 -1.015 . . . . 0.0 108.76 178.848 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.46 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 0.2 OUTLIER -56.25 -43.83 79.06 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 121.924 0.869 . . . . 0.0 111.27 -179.519 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.554 ' CG ' ' O ' ' A' ' 84' ' ' SER . 0.1 OUTLIER -57.97 -36.71 72.98 Favored 'General case' 0 N--CA 1.506 2.369 0 C-N-CA 119.792 -0.763 . . . . 0.0 111.724 -177.694 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -113.73 13.76 18.62 Favored 'General case' 0 N--CA 1.502 2.153 0 C-N-CA 117.359 -1.736 . . . . 0.0 111.462 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 58.41 55.13 5.12 Favored 'General case' 0 N--CA 1.484 1.239 0 O-C-N 120.434 -1.416 . . . . 0.0 109.621 178.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.505 ' O ' ' HG2' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -89.11 -179.29 5.87 Favored 'General case' 0 N--CA 1.496 1.834 0 C-N-CA 119.521 -0.872 . . . . 0.0 109.968 -179.832 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.505 ' HG2' ' O ' ' A' ' 91' ' ' LEU . 10.6 mtt-85 -155.13 158.21 38.64 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.186 -0.946 . . . . 0.0 109.115 178.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.618 ' HB ' ' CG1' ' A' ' 57' ' ' ILE . 2.3 t -63.7 156.39 27.14 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 117.205 -1.798 . . . . 0.0 107.186 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 76.23 -10.33 16.24 Favored Glycine 0 N--CA 1.505 3.272 0 C-N-CA 117.007 -2.52 . . . . 0.0 110.233 179.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.567 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 25.4 m-20 -70.34 146.86 50.21 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.272 -1.723 . . . . 0.0 110.795 -178.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.497 ' O ' HG12 ' A' ' 97' ' ' ILE . 0.2 OUTLIER -90.09 121.22 31.95 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.209 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.56 HG23 HG22 ' A' ' 119' ' ' VAL . 1.5 mt -145.67 168.51 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 119.733 -1.854 . . . . 0.0 112.89 -178.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.51 ' OG ' ' HB2' ' A' ' 118' ' ' GLU . 98.5 p -148.49 137.55 21.74 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 178.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.584 ' O ' ' HB2' ' A' ' 50' ' ' PHE . . . -161.95 176.11 38.41 Favored Glycine 0 N--CA 1.506 3.324 0 C-N-CA 117.163 -2.446 . . . . 0.0 114.546 -178.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.801 ' HD3' HD23 ' A' ' 114' ' ' LEU . 2.9 ptmt -88.83 156.66 18.81 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 179.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.524 HG12 ' HA ' ' A' ' 50' ' ' PHE . 2.0 pt -125.55 156.36 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.432 0 CA-C-N 120.37 1.441 . . . . 0.0 113.588 -176.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.955 ' HG3' HD22 ' A' ' 114' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.466 0 O-C-N 120.56 -1.337 . . . . 0.0 109.5 179.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.497 1.919 0 N-CA-C 109.443 -0.576 . . . . 0.0 109.443 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 22.7 m-85 -107.92 152.35 24.56 Favored 'General case' 0 N--CA 1.516 2.85 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 176.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.431 ' O ' ' HB3' ' A' ' 80' ' ' TYR . 51.4 m-85 -67.32 168.16 11.11 Favored 'General case' 0 N--CA 1.507 2.424 0 O-C-N 119.246 -2.159 . . . . 0.0 108.252 179.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.456 ' HA ' ' HB3' ' A' ' 80' ' ' TYR . . . -122.87 154.93 37.64 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 119.994 -1.692 . . . . 0.0 110.883 -178.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.1 tp -68.38 148.41 50.73 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.955 HD22 ' HG3' ' A' ' 102' ' ' ARG . 9.7 tp -128.74 -55.18 1.22 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.315 -1.49 . . . . 0.0 112.616 -178.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.498 ' HB3' ' CG ' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -125.64 141.97 51.75 Favored 'General case' 0 N--CA 1.509 2.514 0 O-C-N 120.236 -1.54 . . . . 0.0 109.1 179.658 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.4 t -92.53 130.46 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.792 0 O-C-N 120.517 -1.364 . . . . 0.0 110.943 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -107.28 -38.73 5.88 Favored 'General case' 0 N--CA 1.506 2.375 0 O-C-N 121.393 -0.817 . . . . 0.0 110.012 178.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.533 ' C ' HG23 ' A' ' 119' ' ' VAL . 0.5 OUTLIER -143.24 158.33 43.72 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.853 -1.154 . . . . 0.0 109.435 179.722 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.56 HG22 HG23 ' A' ' 97' ' ' ILE . 44.3 t -158.8 133.62 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 -178.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 . . . . . 0 N--CA 1.521 3.102 0 O-C-N 120.313 -1.492 . . . . 0.0 111.231 179.706 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.658 ' HA ' ' HA ' ' A' ' 49' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . 0.54 ' HA ' ' O ' ' A' ' 50' ' ' PHE . 52.5 t30 -78.44 96.73 5.45 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.919 -1.113 . . . . 0.0 108.356 178.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.941 HD23 ' CD1' ' A' ' 79' ' ' ILE . 0.6 OUTLIER -41.78 -41.89 2.47 Favored 'General case' 0 N--CA 1.516 2.863 0 O-C-N 120.405 -1.435 . . . . 0.0 110.501 -178.397 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.411 ' OG1' ' OD1' ' A' ' 52' ' ' ASP . 1.7 m -57.77 -37.55 73.87 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.577 -1.327 . . . . 0.0 108.151 -179.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.517 ' HB3' ' HB3' ' A' ' 2' ' ' ASN . 0.8 OUTLIER -70.4 -45.28 66.27 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.06 -1.025 . . . . 0.0 108.59 177.932 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.873 HD12 HD12 ' A' ' 3' ' ' LEU 0.278 84.0 mt -51.27 -50.04 60.04 Favored 'General case' 0 C--N 1.315 -0.893 0 O-C-N 120.886 -1.133 . . . . 0.0 109.476 178.15 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.417 ' NZ ' ' OE1' ' A' ' 32' ' ' GLN . 5.7 mmtt -64.06 -36.49 84.17 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.241 -0.912 . . . . 0.0 110.085 179.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -61.93 -25.52 67.63 Favored 'General case' 0 N--CA 1.508 2.455 0 C-N-CA 119.282 -0.967 . . . . 0.0 111.031 -179.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.605 ' CG2' ' HB3' ' A' ' 13' ' ' GLU . 4.4 m -74.49 132.84 77.93 Favored Pre-proline 0 N--CA 1.504 2.256 0 O-C-N 121.675 -0.641 . . . . 0.0 109.687 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.501 ' HG2' ' HB2' ' A' ' 13' ' ' GLU . 45.0 Cg_endo -65.16 150.84 87.19 Favored 'Trans proline' 0 CA--C 1.567 2.149 0 CA-C-N 118.767 0.595 . . . . 0.0 110.67 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.584 HG23 ' HG3' ' A' ' 31' ' ' LYS . 1.7 p -42.44 -50.28 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.527 3.391 0 O-C-N 120.542 -1.348 . . . . 0.0 110.162 -178.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.552 ' N ' ' CG1' ' A' ' 11' ' ' VAL . 1.0 OUTLIER -57.67 -41.84 82.36 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.294 -0.879 . . . . 0.0 111.174 -179.266 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.805 ' O ' HD12 ' A' ' 17' ' ' LEU . 0.2 OUTLIER -69.25 -27.7 65.68 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 117.69 -1.604 . . . . 0.0 107.682 179.233 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.615 ' HB3' HG21 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -69.29 -43.1 74.52 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.828 -1.17 . . . . 0.0 108.754 176.906 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.529 HD12 ' O ' ' A' ' 11' ' ' VAL . 1.4 mp -65.61 -40.59 88.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 C-N-CA 117.752 -1.579 . . . . 0.0 108.599 178.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.56 ' HA ' ' HG2' ' A' ' 19' ' ' GLU . 33.0 m -62.61 -37.75 87.52 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 120.542 -1.349 . . . . 0.0 109.146 179.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.805 HD12 ' O ' ' A' ' 13' ' ' GLU . 0.2 OUTLIER -65.58 -36.82 84.87 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.923 -1.111 . . . . 0.0 108.609 178.343 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.507 ' HA2' HD13 ' A' ' 38' ' ' ILE . . . -67.39 -44.5 84.3 Favored Glycine 0 N--CA 1.513 3.829 0 N-CA-C 108.427 -1.869 . . . . 0.0 108.427 178.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.694 ' HG3' ' N ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -59.09 -38.63 79.97 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.435 -1.626 . . . . 0.0 108.298 178.889 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.694 ' N ' ' HG3' ' A' ' 19' ' ' GLU . 26.3 m120 -61.61 -28.57 69.46 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.514 -1.366 . . . . 0.0 109.337 178.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.565 ' HB2' ' CD1' ' A' ' 23' ' ' LEU . 17.6 mtp -101.81 13.03 36.03 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.325 -0.859 . . . . 0.0 111.128 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.4 -19.78 53.06 Favored Glycine 0 N--CA 1.501 2.97 0 C-N-CA 118.67 -1.728 . . . . 0.0 111.249 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.798 ' H ' HD12 ' A' ' 23' ' ' LEU . 3.4 mp -79.17 92.79 5.11 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 120.39 -1.653 . . . . 0.0 109.313 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.407 ' O ' ' CB ' ' A' ' 25' ' ' ASN . 3.4 pt-20 -106.86 179.63 4.21 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.119 -0.988 . . . . 0.0 109.384 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.407 ' CB ' ' O ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER 65.75 14.09 9.34 Favored 'General case' 0 N--CA 1.51 2.539 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.916 179.053 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.63 HD11 ' HB3' ' A' ' 23' ' ' LEU . 0.5 OUTLIER -77.14 -7.53 55.95 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.029 -1.044 . . . . 0.0 111.6 -179.839 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 26' ' ' LEU . . . -46.64 -35.02 5.52 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.45 -1.406 . . . . 0.0 109.076 -179.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.1 mmt-85 -82.65 1.36 38.74 Favored 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 120.059 -0.657 . . . . 0.0 111.644 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.509 ' HB3' ' OD1' ' A' ' 33' ' ' ASP . 11.4 mtp -101.01 159.5 15.17 Favored 'General case' 0 C--N 1.313 -0.979 0 O-C-N 120.659 -1.276 . . . . 0.0 112.08 -178.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.873 ' O ' HD12 ' A' ' 34' ' ' ILE . 3.8 ttm180 -89.81 173.88 8.01 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 121.965 0.888 . . . . 0.0 111.094 178.324 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.635 ' O ' HG22 ' A' ' 35' ' ' ILE . 3.4 mtpp -62.23 -40.15 95.17 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.663 -0.648 . . . . 0.0 111.309 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.544 ' O ' ' CG2' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -64.96 -54.79 25.07 Favored 'General case' 0 N--CA 1.524 3.263 0 CA-C-O 121.845 0.831 . . . . 0.0 110.876 -178.758 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.54 ' OD1' ' N ' ' A' ' 34' ' ' ILE . 1.9 p30 -65.81 -41.65 91.63 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.886 -1.134 . . . . 0.0 109.262 -178.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.873 HD12 ' O ' ' A' ' 30' ' ' ARG . 9.0 mt -62.21 -40.05 86.24 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 O-C-N 120.27 -1.519 . . . . 0.0 109.498 178.016 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.635 HG22 ' O ' ' A' ' 31' ' ' LYS . 0.4 OUTLIER -67.48 -34.39 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.625 0 O-C-N 120.125 -1.609 . . . . 0.0 109.46 178.543 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.461 ' CD2' ' O ' ' A' ' 32' ' ' GLN . 17.9 m-85 -66.05 -44.22 85.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.498 -1.376 . . . . 0.0 109.05 179.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.633 ' HB1' HD23 ' A' ' 23' ' ' LEU . . . -66.41 -54.15 27.64 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 120.539 -1.351 . . . . 0.0 109.622 178.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.603 HG23 ' N ' ' A' ' 39' ' ' LEU . 8.6 tp -50.5 -46.86 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.43 0 C-N-CA 117.239 -1.784 . . . . 0.0 108.239 179.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.804 HD21 HD11 ' A' ' 6' ' ' LEU . 58.9 mt -58.6 -40.01 82.05 Favored 'General case' 0 N--CA 1.508 2.432 0 O-C-N 120.851 -1.155 . . . . 0.0 109.669 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.2 mttm -63.38 -35.83 81.7 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.365 -0.834 . . . . 0.0 109.941 179.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.58 ' HG3' HD11 ' A' ' 23' ' ' LEU . 12.0 mm-40 -77.77 -52.26 9.21 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.581 -0.7 . . . . 0.0 111.106 -179.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.544 ' CD2' ' HB2' ' A' ' 47' ' ' GLU . 17.6 t60 -62.23 -34.38 76.38 Favored 'General case' 0 N--CA 1.51 2.558 0 C-N-CA 118.374 -1.331 . . . . 0.0 108.612 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.492 ' O ' ' N ' ' A' ' 46' ' ' GLY . . . -64.16 -43.71 94.34 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.959 -1.088 . . . . 0.0 108.493 177.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.0 tptt -48.01 -44.72 31.05 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 121.051 -1.03 . . . . 0.0 109.187 178.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.463 ' HB3' ' OE2' ' A' ' 47' ' ' GLU . 74.1 m -66.79 -8.16 26.48 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 121.675 0.75 . . . . 0.0 109.726 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . 73.39 29.63 63.75 Favored Glycine 0 N--CA 1.495 2.586 0 C-N-CA 120.055 -1.069 . . . . 0.0 111.636 178.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.544 ' HB2' ' CD2' ' A' ' 42' ' ' HIS . 0.3 OUTLIER -79.41 166.87 21.58 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.211 -1.758 . . . . 0.0 108.821 178.899 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.431 ' C ' HG23 ' A' ' 49' ' ' ILE . 53.3 m-20 -85.96 143.13 28.33 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.042 -1.036 . . . . 0.0 109.653 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.658 ' HA ' ' HA ' ' A' ' 1' ' ' MET . 0.6 OUTLIER -149.21 147.88 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.724 -1.235 . . . . 0.0 108.417 179.529 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.568 ' CD1' ' N ' ' A' ' 50' ' ' PHE . 11.3 p90 -141.22 164.8 29.26 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 116.163 -2.215 . . . . 0.0 114.504 -178.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -119.29 169.75 13.75 Favored Glycine 0 N--CA 1.5 2.924 0 N-CA-C 108.502 -1.839 . . . . 0.0 108.502 -178.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.527 ' C ' ' CD2' ' A' ' 65' ' ' LEU . 3.6 p30 -170.98 163.03 7.43 Favored 'General case' 0 N--CA 1.482 1.14 0 O-C-N 120.445 -1.621 . . . . 0.0 109.923 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.6 ' N ' HD21 ' A' ' 65' ' ' LEU . . . 150.15 -142.46 9.7 Favored Glycine 0 N--CA 1.503 3.101 0 C-N-CA 117.856 -2.116 . . . . 0.0 111.389 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.577 ' HA ' ' O ' ' A' ' 95' ' ' ASP . 2.8 t -128.81 121.35 54.41 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.765 HD21 HG21 ' A' ' 81' ' ' VAL . 7.0 mt -62.63 161.72 11.76 Favored 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 118.514 -1.274 . . . . 0.0 113.481 -175.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.509 ' HA ' ' OG1' ' A' ' 93' ' ' THR . 4.3 tt0 -139.05 117.85 12.34 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 178.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.694 ' C ' HD12 ' A' ' 58' ' ' LEU . 1.3 mm -82.57 161.07 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 CA-C-N 120.868 1.667 . . . . 0.0 109.572 -178.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.944 HD22 ' CZ ' ' A' ' 62' ' ' PHE . 6.7 mp -130.31 134.9 47.54 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.602 -1.311 . . . . 0.0 109.288 179.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.478 ' C ' ' O ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -38.59 -36.25 0.24 Allowed 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.665 0.745 . . . . 0.0 109.946 -179.725 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.404 ' HB2' ' CD2' ' A' ' 62' ' ' PHE . 5.5 m-20 -60.95 -7.08 2.17 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.689 -0.632 . . . . 0.0 112.53 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.422 ' O ' ' HB3' ' A' ' 83' ' ' PRO . . . 91.65 8.15 64.13 Favored Glycine 1 N--CA 1.518 4.113 0 C-N-CA 118.677 -1.725 . . . . 0.0 112.232 178.13 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.944 ' CZ ' HD22 ' A' ' 58' ' ' LEU . 2.2 p90 -127.9 -179.64 5.07 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 104.706 -2.331 . . . . 0.0 104.706 178.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.711 ' HA2' HD13 ' A' ' 58' ' ' LEU . . . -157.88 172.33 35.06 Favored Glycine 0 N--CA 1.478 1.491 0 C-N-CA 117.38 -2.343 . . . . 0.0 111.841 -178.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.448 ' CE2' ' HE1' ' A' ' 62' ' ' PHE . 10.3 m-85 -128.83 153.83 47.05 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 119.882 1.841 . . . . 0.0 109.319 177.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.6 HD21 ' N ' ' A' ' 53' ' ' GLY . 0.5 OUTLIER -100.24 124.02 45.18 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 177.487 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.534 ' CB ' ' OD2' ' A' ' 78' ' ' ASP . 2.6 ptm180 -129.42 -169.22 2.06 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 119.629 -1.919 . . . . 0.0 110.281 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.5 m . . . . . 0 N--CA 1.498 1.947 0 O-C-N 120.961 -1.087 . . . . 0.0 110.469 179.95 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.534 ' OD2' ' CB ' ' A' ' 66' ' ' ARG . 89.2 m-20 . . . . . 0 N--CA 1.514 2.771 0 CA-C-O 121.16 0.505 . . . . 0.0 111.807 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.941 ' CD1' HD23 ' A' ' 3' ' ' LEU . 6.7 mm -76.73 130.81 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.701 0 O-C-N 121.058 -1.026 . . . . 0.0 110.576 -177.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.526 ' HB3' ' O ' ' A' ' 111' ' ' PHE . 79.9 t80 -77.2 145.18 37.77 Favored 'General case' 0 N--CA 1.513 2.72 0 O-C-N 119.549 -1.969 . . . . 0.0 109.42 179.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.765 HG21 HD21 ' A' ' 55' ' ' LEU . 38.7 t -142.38 114.66 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 120.301 -1.499 . . . . 0.0 110.817 -179.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.573 ' O ' HG13 ' A' ' 86' ' ' ILE . 19.9 m -74.71 163.65 66.8 Favored Pre-proline 0 N--CA 1.512 2.665 0 O-C-N 120.357 -1.464 . . . . 0.0 111.708 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.529 ' HA ' HG13 ' A' ' 86' ' ' ILE . 38.0 Cg_endo -65.33 -48.83 3.01 Favored 'Trans proline' 0 C--N 1.315 -1.233 0 O-C-N 124.321 1.695 . . . . 0.0 108.827 179.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.554 ' O ' ' CG ' ' A' ' 88' ' ' ARG . 80.1 p -46.59 -41.1 13.99 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 177.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.54 ' HB2' ' O ' ' A' ' 82' ' ' SER . 4.2 mm-40 -62.16 -58.08 9.14 Favored 'General case' 0 N--CA 1.51 2.529 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 177.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.596 HG23 ' HB2' ' A' ' 91' ' ' LEU . 0.9 OUTLIER -55.35 -55.27 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 O-C-N 121.153 -0.967 . . . . 0.0 108.55 178.382 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.467 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 0.2 OUTLIER -57.99 -42.23 84.7 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-O 121.787 0.804 . . . . 0.0 111.466 -179.518 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.554 ' CG ' ' O ' ' A' ' 84' ' ' SER . 0.0 OUTLIER -60.44 -36.52 78.39 Favored 'General case' 0 N--CA 1.506 2.355 0 C-N-CA 119.76 -0.776 . . . . 0.0 111.725 -177.714 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 1.032 ' HB2' HD21 ' A' ' 91' ' ' LEU . 20.1 m-85 -112.12 13.13 20.58 Favored 'General case' 0 N--CA 1.507 2.378 0 C-N-CA 117.12 -1.832 . . . . 0.0 111.664 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 61.46 53.5 3.37 Favored 'General case' 0 N--CA 1.484 1.242 0 O-C-N 120.389 -1.445 . . . . 0.0 110.3 178.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 1.032 HD21 ' HB2' ' A' ' 89' ' ' PHE . 3.5 mt -89.61 -173.44 3.95 Favored 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 119.304 -0.959 . . . . 0.0 110.277 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.533 ' CG ' ' O ' ' A' ' 91' ' ' LEU . 12.0 mtt-85 -160.1 160.27 32.85 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 177.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.594 ' HB ' ' CG1' ' A' ' 57' ' ' ILE . 1.8 t -64.18 155.94 30.14 Favored 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 116.983 -1.887 . . . . 0.0 106.841 178.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 77.57 -11.54 18.64 Favored Glycine 0 N--CA 1.506 3.343 0 C-N-CA 117.042 -2.504 . . . . 0.0 110.263 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.577 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 7.9 m-20 -68.18 148.59 50.66 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.14 -1.8 . . . . 0.0 110.465 -179.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.523 ' O ' HG12 ' A' ' 97' ' ' ILE . 0.1 OUTLIER -93.92 125.58 38.62 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.16 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.523 HG12 ' O ' ' A' ' 96' ' ' THR . 1.5 mt -145.78 164.89 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 C-N-CA 118.07 -1.452 . . . . 0.0 112.375 -179.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 89.9 p -149.69 139.29 21.64 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.45 ' O ' ' HB2' ' A' ' 50' ' ' PHE . . . -168.29 -175.41 37.89 Favored Glycine 0 N--CA 1.508 3.465 0 C-N-CA 116.859 -2.591 . . . . 0.0 115.406 -178.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.437 ' HG3' ' HG2' ' A' ' 115' ' ' LYS . 2.1 mtpt -88.23 150.98 22.98 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 2.8 pt -121.51 160.56 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.504 0 CA-C-N 121.463 1.938 . . . . 0.0 113.241 -177.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.847 ' CB ' HD13 ' A' ' 114' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.488 1.438 0 O-C-N 120.392 -1.442 . . . . 0.0 109.363 179.374 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 2.2 mmt85 . . . . . 0 N--CA 1.496 1.874 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -106.83 151.56 25.03 Favored 'General case' 0 N--CA 1.52 3.038 0 O-C-N 119.7 -1.875 . . . . 0.0 109.574 179.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.526 ' O ' ' HB3' ' A' ' 80' ' ' TYR . 3.3 m-85 -68.28 168.19 12.89 Favored 'General case' 0 N--CA 1.503 2.225 0 O-C-N 119.775 -1.828 . . . . 0.0 107.928 178.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -122.75 155.69 35.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.1 -1.625 . . . . 0.0 110.785 -179.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.97 153.71 39.77 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.847 HD13 ' CB ' ' A' ' 102' ' ' ARG . 14.5 tp -129.07 -56.36 1.18 Allowed 'General case' 0 N--CA 1.503 2.205 0 O-C-N 120.081 -1.637 . . . . 0.0 112.868 -178.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.437 ' HG2' ' HG3' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -125.28 142.77 51.31 Favored 'General case' 0 N--CA 1.507 2.404 0 O-C-N 120.343 -1.473 . . . . 0.0 108.536 179.666 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.474 HG21 ' CD2' ' A' ' 89' ' ' PHE . 37.4 t -92.89 130.55 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.955 0 O-C-N 120.406 -1.434 . . . . 0.0 112.091 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.447 ' CG ' ' HA2' ' A' ' 99' ' ' GLY . 11.3 m-20 -107.02 -39.93 5.6 Favored 'General case' 0 N--CA 1.51 2.567 0 O-C-N 121.469 -0.769 . . . . 0.0 109.871 178.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.584 ' C ' HG23 ' A' ' 119' ' ' VAL . 0.9 OUTLIER -143.45 160.07 41.25 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.989 -1.069 . . . . 0.0 109.463 179.578 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.584 HG23 ' C ' ' A' ' 118' ' ' GLU . 18.7 t -158.46 147.89 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -178.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.515 ' C ' ' O ' ' A' ' 119' ' ' VAL . 7.1 t-20 . . . . . 0 N--CA 1.524 3.273 0 O-C-N 121.456 -0.778 . . . . 0.0 111.481 -178.406 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.677 ' HA ' ' HA ' ' A' ' 49' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . 0.602 ' HB3' ' HB2' ' A' ' 5' ' ' GLU . 55.3 t30 -78.63 91.09 4.59 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.965 -1.085 . . . . 0.0 108.461 178.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.823 HD23 HD13 ' A' ' 79' ' ' ILE . 1.5 tp -42.19 -41.05 2.57 Favored 'General case' 0 N--CA 1.52 3.043 0 O-C-N 120.471 -1.393 . . . . 0.0 110.401 -178.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.8 m -57.35 -37.82 73.17 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.806 -1.183 . . . . 0.0 108.33 -179.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.602 ' HB2' ' HB3' ' A' ' 2' ' ' ASN . 0.3 OUTLIER -74.11 -39.31 63.44 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.783 -1.198 . . . . 0.0 108.776 178.021 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.81 HD12 ' HA ' ' A' ' 3' ' ' LEU 0.278 67.4 mt -54.77 -52.33 62.93 Favored 'General case' 0 C--O 1.215 -0.718 0 O-C-N 120.387 -1.445 . . . . 0.0 109.038 177.771 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.487 ' NZ ' ' HD2' ' A' ' 66' ' ' ARG . 0.2 OUTLIER -61.54 -40.35 94.35 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.019 -1.05 . . . . 0.0 109.264 178.468 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . 0.46 ' HB2' ' HA ' ' A' ' 5' ' ' GLU . 2.7 m-80 -62.08 -20.6 64.18 Favored 'General case' 0 N--CA 1.506 2.353 0 C-N-CA 119.438 -0.905 . . . . 0.0 110.732 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.804 ' O ' HD11 ' A' ' 14' ' ' LEU . 2.6 m -75.01 118.28 69.24 Favored Pre-proline 0 C--N 1.287 -2.14 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.512 ' HG2' ' CG ' ' A' ' 13' ' ' GLU . 37.3 Cg_endo -57.47 152.33 48.02 Favored 'Trans proline' 0 CA--C 1.563 1.952 0 O-C-N 122.408 0.688 . . . . 0.0 110.515 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.736 ' O ' HD12 ' A' ' 15' ' ' ILE . 1.7 p -41.31 -49.44 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.529 3.48 0 O-C-N 120.493 -1.379 . . . . 0.0 110.094 -178.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.536 ' N ' ' CG1' ' A' ' 11' ' ' VAL . 0.7 OUTLIER -60.56 -39.8 89.29 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.415 -0.803 . . . . 0.0 111.249 -179.629 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 1.028 ' O ' HD12 ' A' ' 17' ' ' LEU . 29.2 mt-10 -69.45 -32.21 71.0 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 118.015 -1.474 . . . . 0.0 108.488 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.804 HD11 ' O ' ' A' ' 9' ' ' THR . 6.2 mt -68.62 -42.29 78.3 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 120.841 -1.162 . . . . 0.0 108.845 177.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.736 HD12 ' O ' ' A' ' 11' ' ' VAL . 1.3 mp -64.64 -38.97 84.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 C-N-CA 117.714 -1.594 . . . . 0.0 108.451 178.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.501 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 59.0 m -64.24 -36.69 84.9 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 120.331 -1.481 . . . . 0.0 108.878 178.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 1.028 HD12 ' O ' ' A' ' 13' ' ' GLU . 0.3 OUTLIER -66.06 -38.82 89.3 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.822 -1.174 . . . . 0.0 108.936 178.432 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -68.0 -43.28 82.68 Favored Glycine 1 N--CA 1.521 4.305 0 N-CA-C 108.471 -1.852 . . . . 0.0 108.471 178.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.435 ' OE1' ' HG2' ' A' ' 24' ' ' GLU . 1.4 mm-40 -54.72 -44.9 73.9 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.886 -1.361 . . . . 0.0 107.737 178.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.501 ' OD1' ' O ' ' A' ' 16' ' ' THR . 28.8 m120 -59.57 -26.22 65.21 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 118.288 -1.365 . . . . 0.0 109.334 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.561 ' CE ' ' NE2' ' A' ' 41' ' ' GLN . 52.9 mmm -101.07 9.79 41.72 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.27 -0.894 . . . . 0.0 111.144 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.85 -21.11 39.31 Favored Glycine 0 N--CA 1.501 3.02 0 C-N-CA 118.634 -1.746 . . . . 0.0 111.589 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.834 ' HB3' HD11 ' A' ' 26' ' ' LEU . 4.0 mp -78.57 96.48 5.48 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 120.152 -1.793 . . . . 0.0 109.934 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.496 ' O ' ' CB ' ' A' ' 25' ' ' ASN . 16.9 mt-10 -105.98 171.14 7.5 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.255 -0.903 . . . . 0.0 109.276 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.496 ' CB ' ' O ' ' A' ' 24' ' ' GLU . 0.7 OUTLIER 71.15 15.67 6.45 Favored 'General case' 0 N--CA 1.514 2.733 0 O-C-N 121.517 -0.739 . . . . 0.0 111.838 179.314 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.834 HD11 ' HB3' ' A' ' 23' ' ' LEU . 0.4 OUTLIER -76.57 -10.88 59.71 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.005 -1.059 . . . . 0.0 111.672 -179.883 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 26' ' ' LEU . . . -46.57 -35.73 6.13 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.515 -1.366 . . . . 0.0 109.07 -179.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.92 3.53 25.98 Favored 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 119.849 -0.74 . . . . 0.0 111.545 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.593 ' HE2' ' OD1' ' A' ' 33' ' ' ASP . 7.5 mtp -99.97 156.61 17.06 Favored 'General case' 0 C--N 1.314 -0.95 0 O-C-N 120.72 -1.238 . . . . 0.0 111.774 -178.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.539 ' C ' HD12 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -89.46 139.22 30.74 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.413 -0.804 . . . . 0.0 110.936 179.239 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.58 ' O ' HG22 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -31.66 -44.81 0.08 Allowed 'General case' 0 N--CA 1.5 2.055 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.885 179.197 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.582 ' O ' ' CG2' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -63.27 -53.28 55.38 Favored 'General case' 0 N--CA 1.521 3.08 0 O-C-N 121.319 -0.863 . . . . 0.0 111.941 -178.233 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.593 ' OD1' ' HE2' ' A' ' 29' ' ' MET . 1.9 p30 -66.92 -39.73 87.46 Favored 'General case' 0 C--N 1.293 -1.873 0 O-C-N 119.965 -1.709 . . . . 0.0 109.226 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.574 HD11 ' HB2' ' A' ' 29' ' ' MET . 4.4 mt -61.93 -39.18 82.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 O-C-N 120.459 -1.401 . . . . 0.0 109.444 178.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.582 ' CG2' ' O ' ' A' ' 32' ' ' GLN . 0.3 OUTLIER -66.91 -40.6 86.09 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.555 0 O-C-N 120.345 -1.472 . . . . 0.0 109.246 178.518 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 6.1 m-30 -60.3 -43.9 95.88 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 120.803 -1.186 . . . . 0.0 108.531 179.28 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.718 ' HB1' ' CD2' ' A' ' 23' ' ' LEU . . . -59.28 -51.32 70.45 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.49 -1.381 . . . . 0.0 108.821 178.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.554 HG13 ' O ' ' A' ' 34' ' ' ILE . 0.1 OUTLIER -56.17 -31.88 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 C-N-CA 117.618 -1.633 . . . . 0.0 109.643 179.23 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.733 HD21 HD13 ' A' ' 6' ' ' LEU . 98.6 mt -69.21 -44.88 71.19 Favored 'General case' 0 N--CA 1.505 2.308 0 O-C-N 120.07 -1.644 . . . . 0.0 109.557 178.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.65 -34.11 77.44 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.023 -1.048 . . . . 0.0 111.396 179.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.561 ' NE2' ' CE ' ' A' ' 21' ' ' MET . 0.0 OUTLIER -79.5 -51.71 8.97 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.212 -0.93 . . . . 0.0 109.977 -178.9 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.539 ' CE1' ' HG3' ' A' ' 47' ' ' GLU . 5.1 t-160 -64.95 -38.61 91.53 Favored 'General case' 0 N--CA 1.507 2.378 0 C-N-CA 117.619 -1.632 . . . . 0.0 109.141 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.544 ' O ' ' N ' ' A' ' 46' ' ' GLY . . . -61.58 -38.86 89.08 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 120.918 -1.113 . . . . 0.0 108.594 178.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 12.2 tptt -48.25 -45.0 33.86 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 121.003 -1.061 . . . . 0.0 108.567 177.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 52.0 m -66.49 -10.09 41.04 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 121.724 0.773 . . . . 0.0 109.493 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . 70.71 29.53 69.42 Favored Glycine 0 N--CA 1.496 2.652 0 C-N-CA 120.621 -0.8 . . . . 0.0 111.752 178.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.539 ' HG3' ' CE1' ' A' ' 42' ' ' HIS . 3.7 pm0 -82.82 158.08 22.91 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.178 -1.777 . . . . 0.0 108.793 178.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -71.55 147.65 47.46 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.912 -1.117 . . . . 0.0 110.334 -178.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.677 ' HA ' ' HA ' ' A' ' 1' ' ' MET . 0.8 OUTLIER -146.63 145.0 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.077 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.6 ' O ' ' HA ' ' A' ' 2' ' ' ASN . 10.5 p90 -141.31 170.28 16.01 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 116.268 -2.173 . . . . 0.0 115.583 -177.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -114.46 162.37 12.43 Favored Glycine 0 N--CA 1.501 3.003 0 N-CA-C 107.88 -2.088 . . . . 0.0 107.88 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.49 ' C ' ' CD2' ' A' ' 65' ' ' LEU . 7.5 p-10 -172.78 162.91 4.99 Favored 'General case' 0 N--CA 1.483 1.196 0 O-C-N 120.364 -1.668 . . . . 0.0 110.369 -178.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.561 ' HA3' ' O ' ' A' ' 66' ' ' ARG . . . 138.35 -134.59 6.94 Favored Glycine 0 N--CA 1.503 3.155 0 C-N-CA 118.28 -1.914 . . . . 0.0 111.54 177.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.62 ' HA ' ' O ' ' A' ' 95' ' ' ASP . 2.5 t -127.94 117.75 46.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 O-C-N 121.45 -1.029 . . . . 0.0 108.396 -179.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 1.018 HD21 HG21 ' A' ' 81' ' ' VAL . 6.2 mt -63.36 165.41 7.67 Favored 'General case' 0 N--CA 1.503 2.18 0 C-N-CA 118.622 -1.231 . . . . 0.0 113.561 -176.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.53 ' O ' ' CG ' ' A' ' 56' ' ' GLU . 8.2 pt-20 -141.52 123.03 15.02 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 177.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.57 ' CG1' ' HB ' ' A' ' 93' ' ' THR . 1.2 mm -83.07 164.31 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 119.857 -1.777 . . . . 0.0 109.275 -178.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.641 HD13 ' HA2' ' A' ' 63' ' ' GLY . 3.1 mp -130.98 136.46 48.55 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.433 -1.417 . . . . 0.0 109.672 179.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.445 ' C ' ' O ' ' A' ' 58' ' ' LEU . 7.7 tt0 -39.57 -36.99 0.44 Allowed 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.637 0.732 . . . . 0.0 110.128 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.452 ' OD1' ' N ' ' A' ' 60' ' ' ASP . 5.8 m-20 -61.52 -6.65 2.52 Favored 'General case' 0 N--CA 1.5 2.029 0 C-N-CA 119.905 -0.718 . . . . 0.0 112.576 -179.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 92.53 8.15 62.69 Favored Glycine 1 N--CA 1.519 4.224 0 C-N-CA 118.688 -1.72 . . . . 0.0 112.612 177.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.614 ' CZ ' HD22 ' A' ' 58' ' ' LEU . 4.4 p90 -129.1 -177.04 4.06 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 104.29 -2.485 . . . . 0.0 104.29 177.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.641 ' HA2' HD13 ' A' ' 58' ' ' LEU . . . -157.63 172.75 34.97 Favored Glycine 0 N--CA 1.475 1.273 0 C-N-CA 116.672 -2.68 . . . . 0.0 112.109 -177.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.488 ' HB2' ' OE2' ' A' ' 56' ' ' GLU . 16.2 m-85 -130.25 151.97 50.18 Favored 'General case' 0 N--CA 1.483 1.215 0 O-C-N 120.223 -1.751 . . . . 0.0 109.574 177.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.525 HD12 ' HG ' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -97.91 168.23 10.42 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 176.221 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.561 ' O ' ' HA3' ' A' ' 53' ' ' GLY . 10.5 ttp85 177.09 -173.91 0.11 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.004 -1.06 . . . . 0.0 109.662 179.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.497 1.88 0 O-C-N 120.707 -1.246 . . . . 0.0 109.834 179.554 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.507 ' OD2' ' HD3' ' A' ' 66' ' ' ARG . 3.7 m-20 . . . . . 0 N--CA 1.504 2.249 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.823 HD13 HD23 ' A' ' 3' ' ' LEU . 5.0 mm -111.6 129.15 67.51 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.599 0 O-C-N 121.137 -0.977 . . . . 0.0 109.224 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.417 ' HB3' ' HA ' ' A' ' 112' ' ' ALA . 15.2 t80 -74.87 147.22 41.25 Favored 'General case' 0 N--CA 1.518 2.928 0 CA-C-N 121.987 2.176 . . . . 0.0 110.052 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 1.018 HG21 HD21 ' A' ' 55' ' ' LEU . 8.9 t -142.57 110.92 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 120.188 -1.57 . . . . 0.0 110.113 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.535 ' O ' HG13 ' A' ' 86' ' ' ILE . 6.2 m -74.27 164.02 64.19 Favored Pre-proline 0 N--CA 1.511 2.597 0 O-C-N 120.361 -1.462 . . . . 0.0 111.983 -179.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.55 ' HA ' HG13 ' A' ' 86' ' ' ILE . 38.1 Cg_endo -65.26 -54.29 0.66 Allowed 'Trans proline' 0 C--N 1.315 -1.23 0 O-C-N 124.621 1.853 . . . . 0.0 109.182 178.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.558 ' O ' ' CG ' ' A' ' 88' ' ' ARG . 52.9 p -46.34 -39.33 10.06 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 178.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.515 ' HB2' ' O ' ' A' ' 82' ' ' SER . 6.7 mm100 -63.23 -58.92 5.58 Favored 'General case' 0 N--CA 1.51 2.536 0 C-N-CA 119.421 -0.912 . . . . 0.0 108.742 178.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.57 HG22 ' HB2' ' A' ' 91' ' ' LEU . 0.2 OUTLIER -55.83 -54.03 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.313 0 O-C-N 121.107 -0.996 . . . . 0.0 108.601 178.801 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.468 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 0.1 OUTLIER -56.69 -43.39 80.43 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-O 121.933 0.873 . . . . 0.0 110.876 -179.659 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.558 ' CG ' ' O ' ' A' ' 84' ' ' SER . 1.3 mmm180 -59.6 -36.63 76.66 Favored 'General case' 0 N--CA 1.505 2.281 0 C-N-CA 119.795 -0.762 . . . . 0.0 111.702 -177.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 0.431 ' CD2' ' O ' ' A' ' 85' ' ' GLN . 5.4 m-85 -109.81 11.89 24.17 Favored 'General case' 0 N--CA 1.501 2.116 0 C-N-CA 117.518 -1.673 . . . . 0.0 111.114 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 59.58 53.96 4.78 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 120.575 -1.328 . . . . 0.0 109.816 178.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.57 ' HB2' HG22 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -90.04 -177.75 5.26 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 119.681 -0.807 . . . . 0.0 110.176 -179.948 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.47 ' O ' ' OD2' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -156.8 161.64 39.75 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.337 -0.852 . . . . 0.0 108.704 178.235 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.57 ' HB ' ' CG1' ' A' ' 57' ' ' ILE . 1.6 t -64.42 155.23 33.23 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 117.119 -1.833 . . . . 0.0 107.428 179.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 75.66 -8.56 20.05 Favored Glycine 0 N--CA 1.502 3.05 0 C-N-CA 117.123 -2.465 . . . . 0.0 110.114 179.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.626 ' CG ' HD11 ' A' ' 97' ' ' ILE . 7.8 p30 -69.57 149.04 48.62 Favored 'General case' 0 N--CA 1.483 1.222 0 O-C-N 120.127 -1.808 . . . . 0.0 110.515 -178.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.479 ' C ' ' CG1' ' A' ' 97' ' ' ILE . 0.3 OUTLIER -94.92 121.33 36.42 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.825 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.626 HD11 ' CG ' ' A' ' 95' ' ' ASP . 2.3 mt -148.03 168.75 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 119.925 -1.734 . . . . 0.0 112.648 -178.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.522 ' OG ' ' HB2' ' A' ' 118' ' ' GLU . 92.1 p -148.54 137.89 21.91 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.544 ' O ' ' HB2' ' A' ' 50' ' ' PHE . . . -161.43 177.49 37.72 Favored Glycine 0 N--CA 1.51 3.599 0 C-N-CA 117.958 -2.068 . . . . 0.0 114.209 -178.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.805 ' HD3' HD23 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -87.73 157.02 19.16 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 178.594 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.538 HG12 ' HA ' ' A' ' 50' ' ' PHE . 1.5 pt -123.26 155.67 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.463 0 CA-C-N 120.815 1.643 . . . . 0.0 113.408 -177.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 1.001 ' CB ' HD13 ' A' ' 114' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.483 1.179 0 O-C-N 120.571 -1.331 . . . . 0.0 109.553 179.484 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . 0.585 ' HD2' ' CE1' ' A' ' 110' ' ' TYR . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.77 0 N-CA-C 109.834 -0.432 . . . . 0.0 109.834 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.585 ' CE1' ' HD2' ' A' ' 109' ' ' ARG . 42.2 m-85 -107.73 149.14 28.51 Favored 'General case' 0 N--CA 1.522 3.141 0 O-C-N 120.179 -1.576 . . . . 0.0 107.704 176.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.574 ' CE1' HD13 ' A' ' 39' ' ' LEU . 78.2 m-85 -68.35 159.42 31.48 Favored 'General case' 0 N--CA 1.509 2.509 0 O-C-N 119.161 -2.212 . . . . 0.0 108.056 178.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.417 ' HA ' ' HB3' ' A' ' 80' ' ' TYR . . . -124.15 142.83 50.89 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 119.975 -1.703 . . . . 0.0 111.434 -178.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.45 HD22 ' HA ' ' A' ' 113' ' ' LEU . 0.2 OUTLIER -51.2 147.02 5.9 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 179.117 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 1.001 HD13 ' CB ' ' A' ' 102' ' ' ARG . 6.4 tp -128.28 -58.32 1.2 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 120.22 -1.55 . . . . 0.0 111.549 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.501 ' HB3' ' HG2' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -120.73 140.09 52.14 Favored 'General case' 0 N--CA 1.509 2.487 0 O-C-N 120.336 -1.478 . . . . 0.0 108.405 178.835 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.6 t -92.53 134.16 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.854 0 O-C-N 120.215 -1.553 . . . . 0.0 111.318 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.41 ' CG ' ' HA2' ' A' ' 99' ' ' GLY . 2.8 m-20 -107.5 -42.41 4.8 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.552 -0.718 . . . . 0.0 109.586 178.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.591 ' O ' HG23 ' A' ' 97' ' ' ILE . 1.2 mt-10 -143.71 159.84 41.77 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.879 -1.138 . . . . 0.0 109.783 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.551 HG11 HD11 ' A' ' 91' ' ' LEU . 5.1 t -158.22 140.44 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.982 -0.449 . . . . 0.0 110.075 -178.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.516 2.869 0 O-C-N 120.34 -1.475 . . . . 0.0 110.666 179.715 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.983 ' HG3' HG22 ' A' ' 49' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.396 0.617 . . . . 0.0 110.083 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . 0.59 ' HB2' ' CZ ' ' A' ' 50' ' ' PHE . 19.6 t30 -77.91 101.35 6.78 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.303 -0.873 . . . . 0.0 109.049 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 0.657 ' HA ' HD12 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -41.5 -41.95 2.24 Favored 'General case' 0 N--CA 1.518 2.951 0 O-C-N 120.535 -1.353 . . . . 0.0 110.192 -178.753 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.472 ' OG1' ' OD1' ' A' ' 52' ' ' ASP . 1.6 m -58.65 -36.78 74.66 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.892 -1.13 . . . . 0.0 108.51 -179.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.512 ' HB3' ' HB3' ' A' ' 2' ' ' ASN . 0.7 OUTLIER -72.15 -45.41 60.56 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.149 -0.97 . . . . 0.0 108.682 178.245 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.874 HD22 HG23 ' A' ' 35' ' ' ILE 0.276 86.2 mt -51.37 -47.91 62.67 Favored 'General case' 0 C--N 1.315 -0.894 0 O-C-N 120.903 -1.123 . . . . 0.0 109.409 178.322 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . 0.647 ' HZ3' HD12 ' A' ' 3' ' ' LEU . 0.1 OUTLIER -66.94 -39.82 87.39 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.028 -1.045 . . . . 0.0 110.142 178.869 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -63.12 -29.27 70.67 Favored 'General case' 0 N--CA 1.507 2.399 0 C-N-CA 119.352 -0.939 . . . . 0.0 111.191 -179.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.681 HG22 ' CB ' ' A' ' 13' ' ' GLU . 3.2 m -75.02 123.5 88.96 Favored Pre-proline 0 C--N 1.285 -2.198 0 O-C-N 121.613 -0.679 . . . . 0.0 109.596 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.565 ' HG2' ' CG ' ' A' ' 13' ' ' GLU . 39.8 Cg_endo -61.29 151.3 80.11 Favored 'Trans proline' 0 CA--C 1.567 2.148 0 O-C-N 122.372 0.67 . . . . 0.0 110.856 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.6 ' O ' HD12 ' A' ' 15' ' ' ILE . 1.6 p -41.74 -49.86 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.525 3.318 0 O-C-N 120.643 -1.286 . . . . 0.0 109.707 -178.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.551 ' N ' ' CG1' ' A' ' 11' ' ' VAL . 0.7 OUTLIER -57.07 -40.78 77.56 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.294 -0.879 . . . . 0.0 111.076 -179.87 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 1.074 ' O ' HD12 ' A' ' 17' ' ' LEU . 52.6 mm-40 -68.95 -30.39 68.82 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 118.02 -1.472 . . . . 0.0 107.776 179.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.666 ' HB3' HG21 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -68.5 -42.31 78.78 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.993 -1.067 . . . . 0.0 109.058 177.104 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.6 HD12 ' O ' ' A' ' 11' ' ' VAL . 1.4 mp -66.26 -38.67 82.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 C-N-CA 118.133 -1.427 . . . . 0.0 108.621 178.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.561 ' HA ' ' HG2' ' A' ' 19' ' ' GLU . 44.2 m -64.88 -37.58 88.12 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 120.379 -1.45 . . . . 0.0 109.163 178.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 1.074 HD12 ' O ' ' A' ' 13' ' ' GLU . 0.9 OUTLIER -66.11 -37.46 85.81 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.85 -1.156 . . . . 0.0 109.069 178.652 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.452 ' O ' HD12 ' A' ' 23' ' ' LEU . . . -70.07 -42.76 66.97 Favored Glycine 0 N--CA 1.516 3.977 0 C-N-CA 118.6 -1.762 . . . . 0.0 108.864 178.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.69 ' HG3' ' N ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -59.81 -37.6 79.61 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.294 -1.71 . . . . 0.0 108.047 179.047 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.69 ' N ' ' HG3' ' A' ' 19' ' ' GLU . 28.2 m120 -61.05 -26.79 67.88 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 118.309 -1.356 . . . . 0.0 109.371 178.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.648 ' CE ' ' CG ' ' A' ' 42' ' ' HIS . 43.7 mmm -101.94 11.52 38.42 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.193 -0.942 . . . . 0.0 111.261 -179.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.21 -25.33 25.32 Favored Glycine 0 N--CA 1.497 2.758 0 C-N-CA 118.654 -1.736 . . . . 0.0 110.897 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.854 ' CD2' ' HB1' ' A' ' 37' ' ' ALA . 1.7 mp -78.62 91.77 4.66 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.414 -1.639 . . . . 0.0 109.027 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.478 ' O ' ' CB ' ' A' ' 25' ' ' ASN . 41.7 mt-10 -106.23 169.9 8.24 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.311 -0.868 . . . . 0.0 108.93 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.478 ' CB ' ' O ' ' A' ' 24' ' ' GLU . 0.7 OUTLIER 69.06 21.17 7.45 Favored 'General case' 0 N--CA 1.507 2.417 0 O-C-N 121.518 -0.738 . . . . 0.0 111.532 179.505 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.672 HD11 ' HB3' ' A' ' 23' ' ' LEU . 0.4 OUTLIER -76.78 -3.83 40.31 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 120.813 -1.179 . . . . 0.0 110.976 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.436 ' C ' ' O ' ' A' ' 26' ' ' LEU . . . -46.64 -32.92 3.81 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.602 -1.311 . . . . 0.0 108.685 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -80.84 -2.56 47.81 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.477 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.588 ' O ' HD11 ' A' ' 34' ' ' ILE . 7.9 mtp -100.73 150.61 22.59 Favored 'General case' 0 C--N 1.311 -1.076 0 O-C-N 120.748 -1.22 . . . . 0.0 111.33 -178.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.575 ' C ' HD12 ' A' ' 34' ' ' ILE . 17.4 tpp180 -89.32 141.23 28.73 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.252 -0.905 . . . . 0.0 110.407 178.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.609 ' HG3' HD23 ' A' ' 14' ' ' LEU . 7.8 ttmt -29.88 -47.57 0.08 Allowed 'General case' 0 N--CA 1.501 2.082 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.774 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.53 ' OE1' ' N ' ' A' ' 33' ' ' ASP . 1.3 pp0? -59.57 -56.04 26.94 Favored 'General case' 0 N--CA 1.518 2.953 0 O-C-N 121.385 -0.822 . . . . 0.0 111.976 -177.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.534 ' OD1' ' HE2' ' A' ' 29' ' ' MET . 2.8 p30 -66.09 -35.95 81.88 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 120.795 -1.19 . . . . 0.0 109.112 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.666 HG21 ' HB3' ' A' ' 14' ' ' LEU . 3.3 mt -61.52 -37.79 78.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 O-C-N 120.313 -1.492 . . . . 0.0 108.094 177.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.874 HG23 HD22 ' A' ' 6' ' ' LEU . 0.5 OUTLIER -60.21 -46.83 94.12 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.494 0 O-C-N 120.076 -1.64 . . . . 0.0 109.506 177.446 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -54.36 -40.56 68.22 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.751 -0.779 . . . . 0.0 109.525 -179.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.854 ' HB1' ' CD2' ' A' ' 23' ' ' LEU . . . -71.74 -52.02 19.85 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 120.745 -1.222 . . . . 0.0 110.626 179.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.567 HD11 HG22 ' A' ' 34' ' ' ILE . 2.5 mt -58.41 -28.19 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 C-N-CA 117.131 -1.827 . . . . 0.0 109.999 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.438 HD23 ' HA ' ' A' ' 39' ' ' LEU . 25.7 mt -72.39 -41.95 65.74 Favored 'General case' 0 N--CA 1.506 2.341 0 O-C-N 120.06 -1.65 . . . . 0.0 109.451 178.054 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.33 -36.77 85.05 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.903 -1.123 . . . . 0.0 110.286 178.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.629 ' CB ' HD11 ' A' ' 23' ' ' LEU . 22.5 mm-40 -78.66 -51.69 9.5 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.273 -0.892 . . . . 0.0 111.2 -179.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.648 ' CG ' ' CE ' ' A' ' 21' ' ' MET . 0.2 OUTLIER -63.51 -36.48 83.91 Favored 'General case' 0 N--CA 1.505 2.279 0 C-N-CA 118.179 -1.408 . . . . 0.0 108.728 179.871 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.47 ' O ' ' N ' ' A' ' 46' ' ' GLY . . . -55.15 -45.06 75.64 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 177.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -49.98 -44.52 50.94 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-O 122.067 0.937 . . . . 0.0 108.65 177.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.45 ' HB2' ' O ' ' A' ' 42' ' ' HIS . 49.7 m -66.41 -8.14 23.84 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.579 0.704 . . . . 0.0 109.658 179.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . 80.98 20.98 64.04 Favored Glycine 0 N--CA 1.497 2.713 0 C-N-CA 120.107 -1.044 . . . . 0.0 112.642 178.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -78.72 164.75 24.31 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-N 120.298 2.049 . . . . 0.0 108.65 178.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.411 ' O ' ' CG ' ' A' ' 1' ' ' MET . 4.2 m-20 -88.69 152.66 21.67 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.019 -1.05 . . . . 0.0 110.233 -179.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.983 HG22 ' HG3' ' A' ' 1' ' ' MET . 9.0 pt -141.47 133.37 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.024 -1.048 . . . . 0.0 108.601 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.59 ' CZ ' ' HB2' ' A' ' 2' ' ' ASN . 20.8 p90 -140.85 164.61 29.78 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 116.542 -2.063 . . . . 0.0 114.303 -179.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -121.97 166.83 14.61 Favored Glycine 0 N--CA 1.502 3.08 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -177.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.472 ' OD1' ' OG1' ' A' ' 4' ' ' THR . 43.4 p30 -167.54 164.48 14.77 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 120.587 -1.537 . . . . 0.0 109.57 -179.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.519 ' HA3' ' O ' ' A' ' 66' ' ' ARG . . . 141.61 -137.25 7.91 Favored Glycine 0 N--CA 1.501 2.998 0 C-N-CA 118.074 -2.012 . . . . 0.0 111.039 178.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.583 ' HA ' ' O ' ' A' ' 95' ' ' ASP . 2.9 t -129.01 121.41 54.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 O-C-N 121.361 -1.081 . . . . 0.0 108.467 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.966 HD21 HG21 ' A' ' 81' ' ' VAL . 6.9 mt -62.81 165.98 6.06 Favored 'General case' 0 N--CA 1.504 2.23 0 C-N-CA 118.785 -1.166 . . . . 0.0 114.008 -175.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.492 ' HA ' ' OG1' ' A' ' 93' ' ' THR . 2.0 mm-40 -139.64 117.66 11.81 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 178.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.869 ' O ' HD12 ' A' ' 58' ' ' LEU . 1.6 mm -84.92 161.91 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 CA-C-N 120.824 1.647 . . . . 0.0 110.316 -178.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.869 HD12 ' O ' ' A' ' 57' ' ' ILE . 7.6 mp -130.97 143.68 50.91 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.496 -1.377 . . . . 0.0 109.691 178.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.41 ' C ' ' O ' ' A' ' 58' ' ' LEU . 0.9 OUTLIER -42.35 -37.06 1.43 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.304 -0.872 . . . . 0.0 110.337 -179.58 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.468 ' OD1' ' N ' ' A' ' 60' ' ' ASP . 4.5 m-20 -61.01 -6.79 2.05 Favored 'General case' 0 N--CA 1.502 2.126 0 C-N-CA 119.814 -0.754 . . . . 0.0 112.575 -178.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.423 ' O ' ' HB3' ' A' ' 83' ' ' PRO . . . 91.59 7.09 65.27 Favored Glycine 1 N--CA 1.519 4.204 0 C-N-CA 118.515 -1.803 . . . . 0.0 112.091 177.859 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.5 ' CE2' ' CE2' ' A' ' 64' ' ' PHE . 2.7 p90 -127.76 179.38 5.57 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 104.645 -2.354 . . . . 0.0 104.645 178.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -160.46 176.25 37.13 Favored Glycine 0 N--CA 1.477 1.427 0 C-N-CA 117.065 -2.493 . . . . 0.0 111.547 -177.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.5 ' CE2' ' CE2' ' A' ' 62' ' ' PHE . 55.2 m-85 -129.98 155.49 46.0 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 120.112 1.956 . . . . 0.0 109.926 177.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.557 ' HB3' ' HB ' ' A' ' 79' ' ' ILE . 0.3 OUTLIER -98.92 161.65 13.51 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 176.506 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.519 ' O ' ' HA3' ' A' ' 53' ' ' GLY . 0.0 OUTLIER 178.61 -163.45 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.351 -0.843 . . . . 0.0 109.313 179.38 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.497 1.898 0 O-C-N 121.008 -1.058 . . . . 0.0 110.462 -179.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.475 ' HB3' ' O ' ' A' ' 65' ' ' LEU . 5.4 m-20 . . . . . 0 N--CA 1.516 2.845 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.557 ' HB ' ' HB3' ' A' ' 65' ' ' LEU . 1.4 mp -92.9 130.21 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.012 0 C-N-CA 117.479 -1.688 . . . . 0.0 108.956 179.008 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.524 ' HB3' ' O ' ' A' ' 111' ' ' PHE . 5.8 t80 -79.84 146.19 32.36 Favored 'General case' 0 N--CA 1.517 2.876 0 CA-C-N 121.263 1.847 . . . . 0.0 110.429 -179.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.966 HG21 HD21 ' A' ' 55' ' ' LEU . 49.8 t -140.8 113.47 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 120.278 -1.513 . . . . 0.0 110.622 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.581 ' O ' HG13 ' A' ' 86' ' ' ILE . 14.0 m -74.99 162.81 71.9 Favored Pre-proline 0 N--CA 1.514 2.769 0 O-C-N 120.516 -1.365 . . . . 0.0 111.757 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.518 ' HA ' HG13 ' A' ' 86' ' ' ILE . 38.8 Cg_endo -66.02 -49.09 2.26 Favored 'Trans proline' 0 C--N 1.315 -1.193 0 O-C-N 124.465 1.771 . . . . 0.0 109.295 179.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.548 ' O ' ' CG ' ' A' ' 88' ' ' ARG . 23.3 t -47.27 -40.63 17.14 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 178.088 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.522 ' HB2' ' O ' ' A' ' 82' ' ' SER . 7.9 mm100 -63.58 -56.58 14.82 Favored 'General case' 0 N--CA 1.51 2.548 0 C-N-CA 119.498 -0.881 . . . . 0.0 108.642 178.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.581 HG13 ' O ' ' A' ' 82' ' ' SER . 1.0 OUTLIER -55.87 -54.67 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.245 0 O-C-N 120.942 -1.099 . . . . 0.0 108.871 178.679 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.454 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 0.0 OUTLIER -56.51 -41.95 77.55 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-O 121.941 0.877 . . . . 0.0 111.17 -179.384 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.548 ' CG ' ' O ' ' A' ' 84' ' ' SER . 2.5 mmt180 -60.3 -37.45 80.6 Favored 'General case' 0 N--CA 1.507 2.382 0 C-N-CA 119.739 -0.784 . . . . 0.0 111.9 -177.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -113.27 14.21 19.28 Favored 'General case' 0 N--CA 1.502 2.135 0 C-N-CA 117.507 -1.677 . . . . 0.0 111.459 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 58.95 53.27 5.75 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 120.363 -1.461 . . . . 0.0 109.543 178.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.524 ' O ' ' HG3' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -89.41 173.66 8.23 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 119.862 -0.735 . . . . 0.0 109.503 179.883 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.524 ' HG3' ' O ' ' A' ' 91' ' ' LEU . 21.1 mtp180 -152.06 164.1 37.94 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.928 -1.108 . . . . 0.0 109.249 178.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.591 ' HB ' ' CG1' ' A' ' 57' ' ' ILE . 1.5 t -65.42 155.52 35.2 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 117.014 -1.874 . . . . 0.0 106.964 179.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 76.66 -10.5 17.71 Favored Glycine 0 N--CA 1.505 3.235 0 C-N-CA 117.161 -2.447 . . . . 0.0 110.073 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.583 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 9.9 m-20 -67.04 144.75 55.97 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.216 -1.755 . . . . 0.0 110.706 -178.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.504 ' O ' HG12 ' A' ' 97' ' ' ILE . 0.2 OUTLIER -90.18 120.5 31.4 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.238 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.542 HG23 HG22 ' A' ' 119' ' ' VAL . 1.6 mt -146.43 168.66 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 119.845 -1.784 . . . . 0.0 112.985 -178.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.545 ' OG ' ' HB2' ' A' ' 118' ' ' GLU . 68.7 p -149.38 138.8 21.56 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.516 ' O ' ' HB2' ' A' ' 50' ' ' PHE . . . -165.88 179.56 40.03 Favored Glycine 0 N--CA 1.505 3.256 0 C-N-CA 117.379 -2.343 . . . . 0.0 114.422 -179.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.566 ' HD3' HD23 ' A' ' 114' ' ' LEU . 5.7 ptmt -90.6 156.0 18.45 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 179.154 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.523 HG12 ' HA ' ' A' ' 50' ' ' PHE . 2.3 pt -129.03 154.87 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.582 0 CA-C-N 121.02 1.736 . . . . 0.0 113.145 -177.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.804 ' HB2' HD22 ' A' ' 114' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.488 1.428 0 O-C-N 120.359 -1.463 . . . . 0.0 109.363 179.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 3.6 tpp85 . . . . . 0 N--CA 1.499 2.004 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -107.27 150.85 26.2 Favored 'General case' 0 N--CA 1.514 2.738 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 175.662 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.524 ' O ' ' HB3' ' A' ' 80' ' ' TYR . 53.4 m-85 -67.31 159.37 29.4 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 119.055 -2.278 . . . . 0.0 107.717 179.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.429 ' HA ' ' HB3' ' A' ' 80' ' ' TYR . . . -122.31 154.23 37.9 Favored 'General case' 0 N--CA 1.484 1.271 0 O-C-N 119.932 -1.73 . . . . 0.0 110.508 -179.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.4 tp -59.26 144.02 47.47 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.804 HD22 ' HB2' ' A' ' 102' ' ' ARG . 18.0 tp -121.89 -54.48 1.93 Allowed 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.593 -1.317 . . . . 0.0 111.867 -178.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.564 ' HB3' ' CD ' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -130.63 141.54 50.43 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 120.457 -1.402 . . . . 0.0 108.924 179.116 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.6 t -92.49 129.08 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.754 0 O-C-N 120.732 -1.23 . . . . 0.0 111.253 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . 0.42 ' C ' ' HG2' ' A' ' 118' ' ' GLU . 6.5 m-20 -106.64 -39.02 5.96 Favored 'General case' 0 N--CA 1.506 2.349 0 O-C-N 121.368 -0.833 . . . . 0.0 109.841 178.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.569 ' C ' HG23 ' A' ' 119' ' ' VAL . 12.6 mm-40 -143.15 155.87 44.65 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.817 -1.177 . . . . 0.0 109.339 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.569 HG23 ' C ' ' A' ' 118' ' ' GLU . 16.7 t -158.33 132.59 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -178.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.517 2.907 0 O-C-N 120.255 -1.528 . . . . 0.0 110.874 -179.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.626 ' HA ' ' HA ' ' A' ' 49' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.685 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . 0.575 ' HA ' ' O ' ' A' ' 50' ' ' PHE . 34.8 t30 -78.29 94.23 4.78 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.884 -1.135 . . . . 0.0 108.675 178.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 1.047 HD23 HD13 ' A' ' 79' ' ' ILE . 1.0 OUTLIER -41.79 -40.61 2.1 Favored 'General case' 0 N--CA 1.517 2.889 0 O-C-N 120.599 -1.313 . . . . 0.0 110.357 -178.711 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.469 ' OG1' ' OD1' ' A' ' 52' ' ' ASP . 1.5 m -60.94 -36.44 79.35 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.891 -1.13 . . . . 0.0 108.239 -179.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.542 ' HB3' ' HB3' ' A' ' 2' ' ' ASN . 2.8 pt-20 -70.11 -45.37 67.05 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.981 -1.074 . . . . 0.0 108.432 178.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.528 HD12 HD12 ' A' ' 3' ' ' LEU 0.277 14.8 mt -52.77 -48.82 66.53 Favored 'General case' 0 C--N 1.315 -0.924 0 O-C-N 120.906 -1.121 . . . . 0.0 109.536 178.129 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 32.4 mttm -64.51 -34.92 79.34 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.227 -0.921 . . . . 0.0 110.332 179.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -62.08 -24.67 67.25 Favored 'General case' 0 N--CA 1.507 2.415 0 O-C-N 121.135 -0.978 . . . . 0.0 111.145 -179.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.724 HG22 ' CB ' ' A' ' 13' ' ' GLU . 2.8 m -73.52 133.64 80.06 Favored Pre-proline 0 N--CA 1.505 2.322 0 O-C-N 121.72 -0.613 . . . . 0.0 109.652 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.564 ' HG2' ' CG ' ' A' ' 13' ' ' GLU . 44.0 Cg_endo -64.12 151.86 83.53 Favored 'Trans proline' 0 CA--C 1.565 2.051 0 N-CA-C 110.036 -0.794 . . . . 0.0 110.036 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.534 ' CG1' ' N ' ' A' ' 12' ' ' SER . 1.7 p -43.25 -50.29 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.529 3.515 0 O-C-N 120.286 -1.509 . . . . 0.0 110.174 -178.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.534 ' N ' ' CG1' ' A' ' 11' ' ' VAL . 0.8 OUTLIER -57.5 -41.59 81.07 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.294 -0.879 . . . . 0.0 111.044 -179.485 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.724 ' CB ' HG22 ' A' ' 9' ' ' THR . 3.5 mm-40 -69.06 -26.77 65.12 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 118.115 -1.434 . . . . 0.0 107.662 179.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.759 ' HB3' HG21 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -70.44 -43.72 69.31 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.165 -0.959 . . . . 0.0 108.917 176.898 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.487 HD12 ' O ' ' A' ' 11' ' ' VAL . 1.7 mp -67.22 -38.68 81.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 C-N-CA 117.653 -1.619 . . . . 0.0 108.952 178.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.565 ' HA ' ' HG2' ' A' ' 19' ' ' GLU . 62.9 m -64.94 -38.54 91.32 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.368 -1.458 . . . . 0.0 109.172 178.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.522 ' O ' ' HG3' ' A' ' 21' ' ' MET . 0.1 OUTLIER -65.09 -38.27 90.17 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.91 -1.119 . . . . 0.0 108.879 178.561 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . 0.504 ' HA2' HD13 ' A' ' 23' ' ' LEU . . . -67.67 -41.95 88.47 Favored Glycine 0 N--CA 1.515 3.936 0 N-CA-C 108.505 -1.838 . . . . 0.0 108.505 178.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.713 ' HG3' ' N ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -59.68 -38.5 81.7 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.286 -1.714 . . . . 0.0 108.035 178.855 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.713 ' N ' ' HG3' ' A' ' 19' ' ' GLU . 26.1 m120 -61.68 -28.9 69.73 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 118.429 -1.308 . . . . 0.0 109.609 178.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.59 ' HB2' HD12 ' A' ' 23' ' ' LEU . 21.1 mtp -100.28 10.79 40.71 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.187 -0.946 . . . . 0.0 111.207 -179.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.52 -17.02 57.29 Favored Glycine 0 N--CA 1.5 2.9 0 C-N-CA 118.446 -1.835 . . . . 0.0 111.843 179.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.841 ' CD2' ' HB1' ' A' ' 37' ' ' ALA . 1.7 mp -79.06 104.61 9.81 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.079 -1.836 . . . . 0.0 109.385 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.404 ' O ' ' CB ' ' A' ' 25' ' ' ASN . 1.4 pt-20 -115.19 178.95 4.1 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.236 -0.915 . . . . 0.0 109.398 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.404 ' CB ' ' O ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER 65.88 15.28 10.0 Favored 'General case' 0 N--CA 1.512 2.634 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.716 178.963 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 1.089 HD23 ' SD ' ' A' ' 29' ' ' MET . 1.1 mt -76.79 -15.78 59.65 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.154 -0.966 . . . . 0.0 112.066 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -47.02 -28.49 1.69 Allowed 'General case' 0 N--CA 1.497 1.925 0 O-C-N 120.315 -1.491 . . . . 0.0 109.392 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.9 mtt180 -79.1 -37.82 37.74 Favored 'General case' 0 C--N 1.295 -1.798 0 C-N-CA 120.075 -0.65 . . . . 0.0 111.906 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 1.089 ' SD ' HD23 ' A' ' 26' ' ' LEU . 5.8 ptm -85.87 169.64 13.12 Favored 'General case' 0 N--CA 1.482 1.156 0 O-C-N 120.545 -1.347 . . . . 0.0 111.529 -179.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 1.033 ' O ' HD12 ' A' ' 34' ' ' ILE . 1.0 OUTLIER -89.67 -176.26 4.93 Favored 'General case' 0 N--CA 1.504 2.274 0 CA-C-O 122.534 1.159 . . . . 0.0 113.529 -178.238 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.624 ' O ' HG22 ' A' ' 35' ' ' ILE . 4.4 ptmt -68.14 -33.25 74.13 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.122 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.58 ' O ' ' CG2' ' A' ' 35' ' ' ILE . 3.2 mm100 -65.19 -55.26 19.57 Favored 'General case' 0 N--CA 1.525 3.297 0 CA-C-O 122.166 0.984 . . . . 0.0 109.753 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 34' ' ' ILE . 2.0 p30 -66.5 -39.36 88.66 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.904 -1.123 . . . . 0.0 108.967 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 1.033 HD12 ' O ' ' A' ' 30' ' ' ARG . 1.7 mt -61.2 -40.83 87.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.194 -1.566 . . . . 0.0 109.281 177.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.624 HG22 ' O ' ' A' ' 31' ' ' LYS . 0.3 OUTLIER -66.79 -36.07 76.32 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.585 0 O-C-N 120.292 -1.505 . . . . 0.0 109.544 179.437 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.468 ' CD2' ' O ' ' A' ' 32' ' ' GLN . 21.6 m-85 -60.45 -43.63 96.66 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.813 -1.18 . . . . 0.0 108.78 179.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.841 ' HB1' ' CD2' ' A' ' 23' ' ' LEU . . . -65.44 -54.14 32.84 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.516 -1.365 . . . . 0.0 109.634 178.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.542 HG13 ' O ' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -53.76 -30.07 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 C-N-CA 117.541 -1.663 . . . . 0.0 109.743 179.57 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.721 HD11 HD11 ' A' ' 3' ' ' LEU . 34.2 mt -67.95 -42.53 80.8 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 119.865 -1.772 . . . . 0.0 109.224 178.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 mttt -66.0 -40.23 90.96 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.946 -1.096 . . . . 0.0 110.722 178.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.502 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 9.3 mm100 -73.51 -51.13 18.15 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.095 -1.003 . . . . 0.0 110.757 -179.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.526 ' HB3' ' HE2' ' A' ' 1' ' ' MET . 2.9 t-80 -62.51 -36.85 83.86 Favored 'General case' 0 N--CA 1.509 2.502 0 C-N-CA 118.885 -1.126 . . . . 0.0 108.739 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.579 ' O ' ' N ' ' A' ' 46' ' ' GLY . . . -67.01 -31.54 72.17 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.0 -1.063 . . . . 0.0 109.239 178.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.502 ' HB2' ' O ' ' A' ' 41' ' ' GLN . 9.0 tptt -47.54 -40.77 19.68 Favored 'General case' 0 N--CA 1.481 1.121 0 O-C-N 120.65 -1.281 . . . . 0.0 108.808 177.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 46.9 m -66.03 -11.07 45.65 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 119.452 -0.899 . . . . 0.0 109.056 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.579 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . 68.53 29.71 72.97 Favored Glycine 0 N--CA 1.496 2.642 0 C-N-CA 120.531 -0.842 . . . . 0.0 111.616 177.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.508 ' OE1' ' N ' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -88.82 169.17 11.83 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 120.105 -1.821 . . . . 0.0 108.788 178.921 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . 0.508 ' N ' ' OE1' ' A' ' 47' ' ' GLU . 9.1 m-20 -71.66 151.08 43.98 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.024 -1.048 . . . . 0.0 111.226 -178.006 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.626 ' HA ' ' HA ' ' A' ' 1' ' ' MET . 0.5 OUTLIER -150.81 144.08 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 178.625 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.575 ' O ' ' HA ' ' A' ' 2' ' ' ASN . 28.7 p90 -141.43 172.2 13.01 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 115.867 -2.333 . . . . 0.0 114.608 -177.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -124.77 166.71 17.33 Favored Glycine 0 N--CA 1.502 3.065 0 N-CA-C 108.762 -1.735 . . . . 0.0 108.762 -178.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.524 ' C ' ' CD2' ' A' ' 65' ' ' LEU . 3.0 p30 -172.28 163.48 5.74 Favored 'General case' 0 N--CA 1.485 1.281 0 O-C-N 120.346 -1.679 . . . . 0.0 110.065 -179.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.42 ' N ' HD21 ' A' ' 65' ' ' LEU . . . 146.94 -139.66 8.1 Favored Glycine 0 N--CA 1.504 3.233 0 C-N-CA 118.146 -1.978 . . . . 0.0 110.986 178.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.599 ' HA ' ' O ' ' A' ' 95' ' ' ASP . 4.6 t -128.75 122.74 57.76 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 1.025 HD21 HG21 ' A' ' 81' ' ' VAL . 6.0 mt -62.9 161.24 13.17 Favored 'General case' 0 N--CA 1.502 2.17 0 C-N-CA 118.486 -1.286 . . . . 0.0 114.043 -175.099 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.512 ' HA ' ' OG1' ' A' ' 93' ' ' THR . 0.0 OUTLIER -137.7 116.24 12.06 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 177.998 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.662 ' C ' HD12 ' A' ' 58' ' ' LEU . 1.4 mm -84.14 159.74 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 CA-C-N 121.087 1.767 . . . . 0.0 109.616 -178.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.864 HD22 ' CZ ' ' A' ' 62' ' ' PHE . 5.6 mp -130.1 135.76 48.58 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.443 -1.41 . . . . 0.0 109.602 179.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.472 ' C ' ' O ' ' A' ' 58' ' ' LEU . 0.8 OUTLIER -38.47 -35.15 0.16 Allowed 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.701 0.762 . . . . 0.0 109.909 -179.683 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.503 ' OD1' ' N ' ' A' ' 60' ' ' ASP . 1.0 OUTLIER -61.05 -7.66 2.72 Favored 'General case' 0 N--CA 1.499 2.012 0 C-N-CA 120.038 -0.665 . . . . 0.0 112.183 -179.531 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 90.64 8.6 65.46 Favored Glycine 1 N--CA 1.52 4.283 0 C-N-CA 118.845 -1.645 . . . . 0.0 112.184 178.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.864 ' CZ ' HD22 ' A' ' 58' ' ' LEU . 2.3 p90 -127.95 178.77 5.96 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 104.491 -2.411 . . . . 0.0 104.491 177.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.554 ' HA2' HD13 ' A' ' 58' ' ' LEU . . . -155.49 172.67 33.65 Favored Glycine 0 N--CA 1.477 1.432 0 C-N-CA 117.142 -2.456 . . . . 0.0 111.63 -178.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.441 ' CE2' ' HE1' ' A' ' 62' ' ' PHE . 10.9 m-85 -128.88 154.78 46.16 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 119.851 1.826 . . . . 0.0 108.909 177.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.528 ' CB ' ' HB ' ' A' ' 79' ' ' ILE . 0.2 OUTLIER -99.45 133.23 44.06 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 177.075 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.538 ' CB ' ' OD2' ' A' ' 78' ' ' ASP . 17.2 ptt180 -158.45 -148.34 0.19 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.544 -1.347 . . . . 0.0 110.065 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.497 1.912 0 O-C-N 121.384 -0.822 . . . . 0.0 110.235 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.538 ' OD2' ' CB ' ' A' ' 66' ' ' ARG . 47.1 m-20 . . . . . 0 N--CA 1.513 2.713 0 CA-C-O 120.78 0.324 . . . . 0.0 111.073 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 1.047 HD13 HD23 ' A' ' 3' ' ' LEU . 5.5 mm -83.18 127.97 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.891 0 O-C-N 120.628 -1.295 . . . . 0.0 110.373 -178.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.494 ' HB3' ' O ' ' A' ' 111' ' ' PHE . 8.6 t80 -74.62 145.4 43.31 Favored 'General case' 0 N--CA 1.515 2.807 0 CA-C-N 121.658 2.026 . . . . 0.0 109.81 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 1.025 HG21 HD21 ' A' ' 55' ' ' LEU . 17.2 t -138.34 112.44 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 120.26 -1.525 . . . . 0.0 110.57 -179.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.551 ' O ' HG13 ' A' ' 86' ' ' ILE . 49.9 m -75.28 164.6 60.01 Favored Pre-proline 0 N--CA 1.513 2.701 0 O-C-N 120.776 -1.203 . . . . 0.0 112.166 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.518 ' HD2' ' HB3' ' A' ' 82' ' ' SER . 39.8 Cg_endo -65.9 -50.05 1.87 Allowed 'Trans proline' 0 C--N 1.315 -1.21 0 O-C-N 124.443 1.759 . . . . 0.0 109.101 178.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.559 ' O ' ' CG ' ' A' ' 88' ' ' ARG . 0.5 OUTLIER -47.45 -40.28 17.75 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 178.156 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.527 ' HB2' ' O ' ' A' ' 82' ' ' SER . 6.4 mm100 -63.24 -57.21 11.21 Favored 'General case' 0 N--CA 1.511 2.582 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.558 ' HA ' HD23 ' A' ' 91' ' ' LEU . 0.6 OUTLIER -56.97 -54.95 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.42 0 O-C-N 120.891 -1.131 . . . . 0.0 108.792 178.649 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.8 mmt180 -57.67 -42.88 84.45 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-O 121.882 0.848 . . . . 0.0 111.568 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.559 ' CG ' ' O ' ' A' ' 84' ' ' SER . 4.4 mtt180 -58.87 -36.02 73.95 Favored 'General case' 0 N--CA 1.506 2.329 0 C-N-CA 119.783 -0.767 . . . . 0.0 111.773 -177.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -116.32 15.61 15.82 Favored 'General case' 0 N--CA 1.504 2.255 0 C-N-CA 117.268 -1.773 . . . . 0.0 111.755 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 57.84 56.12 4.97 Favored 'General case' 0 N--CA 1.482 1.159 0 O-C-N 120.339 -1.476 . . . . 0.0 109.193 178.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 0.558 HD23 ' HA ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -88.64 -178.78 5.89 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 119.852 -0.739 . . . . 0.0 109.601 -179.639 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.5 ' CG ' ' O ' ' A' ' 91' ' ' LEU . 68.5 mtt-85 -157.09 158.18 35.94 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.011 -1.056 . . . . 0.0 109.048 178.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.609 ' HB ' ' CG1' ' A' ' 57' ' ' ILE . 1.5 t -64.61 154.66 35.66 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 117.212 -1.795 . . . . 0.0 107.076 179.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 77.68 -11.18 20.76 Favored Glycine 0 N--CA 1.502 3.072 0 C-N-CA 116.961 -2.542 . . . . 0.0 110.442 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.702 ' OD2' HD11 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -74.45 156.79 36.59 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-N 120.097 1.948 . . . . 0.0 109.945 -179.192 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.505 ' O ' HG12 ' A' ' 97' ' ' ILE . 0.2 OUTLIER -97.34 127.12 43.03 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -179.201 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.702 HD11 ' OD2' ' A' ' 95' ' ' ASP . 1.9 mt -147.76 166.22 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 117.767 -1.573 . . . . 0.0 112.247 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.462 ' OG ' ' HB2' ' A' ' 118' ' ' GLU . 88.3 p -148.51 136.82 21.2 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.06 179.056 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . 0.532 ' O ' ' HB2' ' A' ' 50' ' ' PHE . . . -162.18 179.64 37.39 Favored Glycine 0 N--CA 1.505 3.257 0 C-N-CA 117.183 -2.437 . . . . 0.0 114.853 -178.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.6 mttt -88.77 151.68 22.25 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 178.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.56 HG12 ' HA ' ' A' ' 50' ' ' PHE . 2.6 pt -121.66 157.05 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.627 0 CA-C-N 121.514 1.961 . . . . 0.0 114.026 -176.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.973 ' CB ' HD13 ' A' ' 114' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.422 0 O-C-N 120.523 -1.361 . . . . 0.0 109.397 179.282 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.502 2.133 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.407 ' CD2' ' HZ ' ' A' ' 64' ' ' PHE . 17.5 m-85 -106.62 152.52 23.64 Favored 'General case' 0 N--CA 1.522 3.168 0 O-C-N 119.967 -1.708 . . . . 0.0 109.422 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . 0.494 ' O ' ' HB3' ' A' ' 80' ' ' TYR . 11.6 m-85 -68.05 166.4 16.02 Favored 'General case' 0 N--CA 1.506 2.365 0 O-C-N 119.729 -1.857 . . . . 0.0 108.065 178.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.454 ' HA ' ' HB3' ' A' ' 80' ' ' TYR . . . -123.61 155.5 37.56 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.055 -1.653 . . . . 0.0 111.054 -179.08 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.02 153.99 40.7 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 106.287 -1.746 . . . . 0.0 106.287 178.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.973 HD13 ' CB ' ' A' ' 102' ' ' ARG . 3.0 tp -130.99 -63.19 0.87 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.066 -1.646 . . . . 0.0 111.727 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.35 147.15 40.83 Favored 'General case' 0 N--CA 1.51 2.545 0 O-C-N 120.289 -1.507 . . . . 0.0 109.666 178.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 24.8 t -94.1 130.94 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.987 0 O-C-N 121.021 -1.049 . . . . 0.0 112.772 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -107.33 -39.7 5.6 Favored 'General case' 0 N--CA 1.509 2.509 0 O-C-N 121.504 -0.747 . . . . 0.0 109.856 177.747 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.577 ' C ' HG23 ' A' ' 119' ' ' VAL . 1.3 tt0 -143.4 159.05 43.09 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.651 -1.281 . . . . 0.0 109.115 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.577 HG23 ' C ' ' A' ' 118' ' ' GLU . 17.9 t -156.84 143.06 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -178.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.469 ' C ' ' O ' ' A' ' 119' ' ' VAL . 0.1 OUTLIER . . . . . 0 N--CA 1.515 2.812 0 O-C-N 121.0 -1.062 . . . . 0.0 110.88 -177.581 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.589 ' HA ' ' HA ' ' A' ' 49' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 110.027 -0.361 . . . . 0.0 110.027 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' ASN . . . . . 0.598 ' HB3' ' HB3' ' A' ' 5' ' ' GLU . 47.5 t30 -78.75 92.73 4.83 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.802 -1.186 . . . . 0.0 108.42 178.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' LEU . . . . . 1.065 HD23 HD11 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -42.55 -43.39 3.72 Favored 'General case' 0 N--CA 1.515 2.779 0 O-C-N 120.607 -1.308 . . . . 0.0 110.472 -178.594 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.487 ' OG1' ' OD2' ' A' ' 52' ' ' ASP . 1.9 m -57.29 -34.54 68.79 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.775 -1.203 . . . . 0.0 108.149 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.598 ' HB3' ' HB3' ' A' ' 2' ' ' ASN . 0.0 OUTLIER -70.83 -44.35 66.69 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 177.498 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' LEU . . . . . 0.875 HD22 HG23 ' A' ' 35' ' ' ILE 0.277 15.6 mt -52.33 -49.43 64.28 Favored 'General case' 0 C--N 1.316 -0.88 0 O-C-N 120.748 -1.22 . . . . 0.0 109.613 178.088 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 9.8 mttt -65.37 -37.66 87.69 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.08 -1.012 . . . . 0.0 110.589 179.192 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -63.01 -18.66 63.56 Favored 'General case' 0 N--CA 1.507 2.387 0 O-C-N 121.119 -0.988 . . . . 0.0 111.182 -179.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.717 ' O ' HD11 ' A' ' 14' ' ' LEU . 2.2 m -86.56 116.32 65.48 Favored Pre-proline 0 C--N 1.284 -2.249 0 O-C-N 121.761 -0.587 . . . . 0.0 109.642 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . 0.541 ' CG ' ' HG3' ' A' ' 13' ' ' GLU . 37.0 Cg_endo -58.51 155.1 38.04 Favored 'Trans proline' 0 CA--C 1.557 1.657 0 N-CA-C 109.288 -1.082 . . . . 0.0 109.288 179.127 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . 0.703 ' HA ' HD12 ' A' ' 14' ' ' LEU . 1.5 p -41.54 -50.11 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.532 3.657 0 O-C-N 120.173 -1.58 . . . . 0.0 110.463 -177.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . 0.516 ' N ' ' CG1' ' A' ' 11' ' ' VAL . 1.9 t -58.96 -42.15 89.19 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.188 -0.945 . . . . 0.0 111.156 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLU . . . . . 0.581 ' CB ' HG22 ' A' ' 9' ' ' THR . 2.2 mm-40 -69.13 -27.79 65.88 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 118.15 -1.42 . . . . 0.0 108.336 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.717 HD11 ' O ' ' A' ' 9' ' ' THR . 9.8 mt -71.56 -40.66 69.83 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 120.917 -1.114 . . . . 0.0 108.765 176.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' ILE . . . . . 0.612 HD12 ' O ' ' A' ' 11' ' ' VAL . 1.4 mp -68.05 -40.49 83.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 C-N-CA 117.543 -1.663 . . . . 0.0 108.945 178.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.602 ' HA ' ' HG2' ' A' ' 19' ' ' GLU . 85.0 m -65.42 -37.22 86.27 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.272 -1.517 . . . . 0.0 109.413 179.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LEU . . . . . 0.517 HD21 HG21 ' A' ' 38' ' ' ILE . 1.3 tp -63.16 -45.04 93.71 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 120.912 -1.117 . . . . 0.0 108.048 178.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -60.94 -43.72 99.03 Favored Glycine 0 N--CA 1.514 3.882 0 N-CA-C 108.288 -1.925 . . . . 0.0 108.288 179.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLU . . . . . 0.7 ' HG3' ' N ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -57.71 -38.73 75.74 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.582 -1.54 . . . . 0.0 107.845 178.904 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASN . . . . . 0.7 ' N ' ' HG3' ' A' ' 19' ' ' GLU . 28.7 m120 -61.1 -27.4 68.34 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 118.538 -1.265 . . . . 0.0 109.341 178.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.567 ' HB2' ' CD1' ' A' ' 23' ' ' LEU . 31.4 mtp -101.44 11.3 39.36 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.339 -0.851 . . . . 0.0 111.348 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.86 -22.75 35.97 Favored Glycine 0 N--CA 1.5 2.92 0 C-N-CA 118.547 -1.787 . . . . 0.0 111.143 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' LEU . . . . . 0.783 ' CD2' ' HB1' ' A' ' 37' ' ' ALA . 3.0 mp -78.91 94.67 5.26 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 120.372 -1.663 . . . . 0.0 109.225 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLU . . . . . 0.519 ' O ' ' CB ' ' A' ' 25' ' ' ASN . 87.0 mt-10 -111.7 170.38 8.17 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.204 -0.935 . . . . 0.0 109.035 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.519 ' CB ' ' O ' ' A' ' 24' ' ' GLU . 0.9 OUTLIER 70.79 17.35 6.48 Favored 'General case' 0 N--CA 1.512 2.671 0 O-C-N 121.404 -0.81 . . . . 0.0 111.796 179.485 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.591 ' CD1' ' O ' ' A' ' 23' ' ' LEU . 1.1 mt -76.9 -6.05 50.92 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 120.841 -1.162 . . . . 0.0 111.372 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 26' ' ' LEU . . . -46.59 -31.21 2.68 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.477 -1.389 . . . . 0.0 108.81 -179.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 52.1 mtp180 -80.12 -6.57 57.93 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 120.047 -0.661 . . . . 0.0 111.386 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' MET . . . . . 0.546 ' HE2' ' OD1' ' A' ' 33' ' ' ASP . 14.8 mtp -101.01 158.67 15.83 Favored 'General case' 0 C--N 1.313 -0.999 0 O-C-N 120.768 -1.208 . . . . 0.0 111.473 -179.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ARG . . . . . 0.96 ' O ' HD12 ' A' ' 34' ' ' ILE . 4.4 ttm180 -89.65 171.99 9.27 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.374 -0.829 . . . . 0.0 110.166 177.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LYS . . . . . 0.571 ' O ' ' CG1' ' A' ' 35' ' ' ILE . 11.0 pttm -60.5 -42.49 96.45 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.43 -0.794 . . . . 0.0 110.547 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLN . . . . . 0.471 ' OE1' ' HB3' ' A' ' 33' ' ' ASP . 0.0 OUTLIER -60.55 -56.45 21.21 Favored 'General case' 0 N--CA 1.517 2.918 0 O-C-N 121.306 -0.871 . . . . 0.0 111.632 -178.166 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.546 ' OD1' ' HE2' ' A' ' 29' ' ' MET . 2.1 p30 -65.74 -36.29 83.17 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.802 -1.186 . . . . 0.0 109.166 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ILE . . . . . 0.96 HD12 ' O ' ' A' ' 30' ' ' ARG . 2.0 mt -60.78 -38.49 79.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 O-C-N 120.348 -1.47 . . . . 0.0 107.569 177.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ILE . . . . . 0.875 HG23 HD22 ' A' ' 6' ' ' LEU . 0.8 OUTLIER -59.3 -50.2 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.319 0 O-C-N 120.291 -1.506 . . . . 0.0 109.562 177.665 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -51.29 -41.6 60.57 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.514 -0.874 . . . . 0.0 109.154 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ALA . . . . . 0.783 ' HB1' ' CD2' ' A' ' 23' ' ' LEU . . . -63.49 -53.24 55.14 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.689 -1.257 . . . . 0.0 109.108 178.101 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.517 HG21 HD21 ' A' ' 17' ' ' LEU . 0.2 OUTLIER -55.51 -27.45 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 C-N-CA 117.451 -1.7 . . . . 0.0 109.705 179.549 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' LEU . . . . . 0.672 HD21 HD11 ' A' ' 6' ' ' LEU . 23.7 mt -71.34 -42.33 68.67 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.129 -1.607 . . . . 0.0 109.115 177.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.2 mttt -64.11 -40.21 95.71 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.936 -1.103 . . . . 0.0 110.313 178.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLN . . . . . 0.738 ' HG2' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -75.96 -53.12 8.88 Favored 'General case' 0 N--CA 1.508 2.425 0 O-C-N 121.033 -1.042 . . . . 0.0 111.125 -179.261 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' HIS . . . . . 0.583 ' HB2' ' HE3' ' A' ' 1' ' ' MET . 1.4 t-80 -61.24 -35.18 76.53 Favored 'General case' 0 N--CA 1.513 2.72 0 O-C-N 121.229 -0.919 . . . . 0.0 109.192 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ALA . . . . . 0.544 ' O ' ' N ' ' A' ' 46' ' ' GLY . . . -81.15 -32.08 33.84 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.306 -0.871 . . . . 0.0 110.961 179.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . 0.597 ' HD3' ' N ' ' A' ' 45' ' ' SER 0.254 0.0 OUTLIER -49.08 -50.37 37.11 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.333 -1.48 . . . . 0.0 107.782 178.089 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . 0.597 ' N ' ' HD3' ' A' ' 44' ' ' LYS . 72.5 m -65.61 -9.37 26.36 Favored 'General case' 0 C--N 1.287 -2.149 0 CA-C-N 114.57 -1.195 . . . . 0.0 109.302 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . 64.46 32.14 83.22 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 178.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . 0.52 ' CD ' ' ND1' ' A' ' 42' ' ' HIS . 9.8 pt-20 -87.19 166.85 14.64 Favored 'General case' 0 C--N 1.309 -1.183 0 O-C-N 120.46 -1.612 . . . . 0.0 109.2 179.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -55.11 135.98 48.67 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.067 -1.021 . . . . 0.0 111.914 -177.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.589 ' HA ' ' HA ' ' A' ' 1' ' ' MET . 4.5 pt -146.57 137.8 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 178.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PHE . . . . . 0.569 ' CD1' ' N ' ' A' ' 50' ' ' PHE . 16.7 p90 -144.07 164.09 31.65 Favored 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 115.55 -2.46 . . . . 0.0 115.655 -178.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -119.19 166.17 13.15 Favored Glycine 0 N--CA 1.5 2.936 0 N-CA-C 107.425 -2.27 . . . . 0.0 107.425 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.487 ' OD2' ' OG1' ' A' ' 4' ' ' THR . 5.9 p-10 -171.88 167.98 6.13 Favored 'General case' 0 N--CA 1.482 1.156 0 O-C-N 120.132 -1.805 . . . . 0.0 109.617 -178.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' GLY . . . . . 0.44 ' N ' HD21 ' A' ' 65' ' ' LEU . . . 142.3 -137.18 7.68 Favored Glycine 0 N--CA 1.504 3.184 0 C-N-CA 118.247 -1.93 . . . . 0.0 110.741 178.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' VAL . . . . . 0.583 ' HA ' ' O ' ' A' ' 95' ' ' ASP . 3.3 t -128.28 120.62 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 O-C-N 121.382 -1.07 . . . . 0.0 108.419 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.822 HD21 HG21 ' A' ' 81' ' ' VAL . 6.5 mt -62.73 162.38 10.91 Favored 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 -175.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLU . . . . . 0.504 ' HA ' ' OG1' ' A' ' 93' ' ' THR . 1.4 tt0 -137.99 120.4 15.95 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 177.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ILE . . . . . 0.739 ' C ' HD12 ' A' ' 58' ' ' LEU . 1.2 mm -82.48 161.53 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 119.863 -1.773 . . . . 0.0 109.177 -179.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' LEU . . . . . 0.895 HD22 ' CZ ' ' A' ' 62' ' ' PHE . 7.1 mp -130.86 137.06 49.19 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.347 -1.47 . . . . 0.0 109.701 179.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLN . . . . . 0.463 ' C ' ' O ' ' A' ' 58' ' ' LEU . 1.4 tt0 -39.49 -36.54 0.39 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.525 -0.734 . . . . 0.0 110.006 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASP . . . . . 0.538 ' HB2' ' CD2' ' A' ' 62' ' ' PHE . 30.5 m-20 -61.4 -5.69 1.85 Allowed 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.676 -0.64 . . . . 0.0 112.574 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLY . . . . . 0.449 ' O ' ' HB3' ' A' ' 83' ' ' PRO . . . 88.25 11.37 67.07 Favored Glycine 1 N--CA 1.519 4.181 0 C-N-CA 118.601 -1.761 . . . . 0.0 111.954 178.307 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' PHE . . . . . 0.895 ' CZ ' HD22 ' A' ' 58' ' ' LEU . 4.0 p90 -127.94 -179.17 4.83 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 104.341 -2.466 . . . . 0.0 104.341 177.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' GLY . . . . . 0.506 ' HA2' HD13 ' A' ' 58' ' ' LEU . . . -156.07 168.08 33.43 Favored Glycine 0 N--CA 1.474 1.176 0 C-N-CA 117.181 -2.438 . . . . 0.0 111.577 -177.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PHE . . . . . 0.425 ' CD1' ' HE1' ' A' ' 62' ' ' PHE . 2.6 m-85 -129.07 151.18 50.04 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 119.926 1.863 . . . . 0.0 109.26 177.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . 0.537 ' HB3' ' HB ' ' A' ' 79' ' ' ILE . 0.3 OUTLIER -98.68 153.9 18.37 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 176.707 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.479 ' HB3' ' O ' ' A' ' 65' ' ' LEU . 0.5 OUTLIER 178.08 -151.71 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.246 -0.909 . . . . 0.0 109.657 179.364 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.6 m . . . . . 0 N--CA 1.5 2.047 0 O-C-N 121.383 -0.823 . . . . 0.0 110.64 -179.842 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . 0.762 ' C ' HD12 ' A' ' 79' ' ' ILE . 27.6 m-20 . . . . . 0 N--CA 1.505 2.28 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 1.065 HD11 HD23 ' A' ' 3' ' ' LEU . 2.1 mp -142.34 136.51 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.629 0 C-N-CA 119.241 -0.983 . . . . 0.0 109.928 178.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.471 ' HB3' ' HA ' ' A' ' 112' ' ' ALA . 12.2 t80 -78.11 147.46 34.64 Favored 'General case' 0 N--CA 1.52 3.049 0 O-C-N 119.635 -1.916 . . . . 0.0 110.014 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' VAL . . . . . 0.822 HG21 HD21 ' A' ' 55' ' ' LEU . 39.8 t -143.36 115.89 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 120.157 -1.589 . . . . 0.0 110.505 -179.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' SER . . . . . 0.547 ' O ' HG13 ' A' ' 86' ' ' ILE . 68.0 m -74.65 163.42 68.39 Favored Pre-proline 0 N--CA 1.514 2.737 0 O-C-N 120.5 -1.375 . . . . 0.0 112.688 -179.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' PRO . . . . . 0.581 ' HA ' HG13 ' A' ' 86' ' ' ILE . 39.4 Cg_endo -65.33 -51.7 1.39 Allowed 'Trans proline' 0 C--N 1.315 -1.215 0 O-C-N 124.779 1.936 . . . . 0.0 108.571 178.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' SER . . . . . 0.537 ' O ' ' CG ' ' A' ' 88' ' ' ARG . 57.1 p -47.3 -39.94 15.77 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 177.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.528 ' HB2' ' O ' ' A' ' 82' ' ' SER . 4.9 mm-40 -62.38 -60.03 4.14 Favored 'General case' 0 N--CA 1.509 2.49 0 C-N-CA 119.089 -1.044 . . . . 0.0 108.225 178.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' ILE . . . . . 0.614 HG22 ' HB2' ' A' ' 91' ' ' LEU . 0.2 OUTLIER -55.42 -55.04 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.305 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.512 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ARG . . . . . 0.498 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 0.0 OUTLIER -57.39 -42.59 82.51 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-O 121.811 0.815 . . . . 0.0 111.238 -179.49 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . 0.537 ' CG ' ' O ' ' A' ' 84' ' ' SER . 10.8 mmm180 -59.4 -38.03 79.52 Favored 'General case' 0 N--CA 1.505 2.322 0 C-N-CA 119.84 -0.744 . . . . 0.0 111.816 -177.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . 1.082 ' HB2' HD21 ' A' ' 91' ' ' LEU . 9.1 m-85 -110.16 12.41 23.44 Favored 'General case' 0 N--CA 1.505 2.315 0 C-N-CA 116.976 -1.89 . . . . 0.0 111.359 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . 0.408 ' CB ' ' O ' ' A' ' 89' ' ' PHE . 0.1 OUTLIER 62.24 53.43 2.87 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 120.523 -1.36 . . . . 0.0 110.64 178.336 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' LEU . . . . . 1.082 HD21 ' HB2' ' A' ' 89' ' ' PHE . 2.8 mt -89.61 -169.45 2.48 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 119.199 -1.001 . . . . 0.0 110.043 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ARG . . . . . 0.532 ' CG ' ' O ' ' A' ' 91' ' ' LEU . 53.0 mtp180 -159.92 162.38 34.47 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.542 -0.724 . . . . 0.0 109.083 178.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . 0.598 ' HB ' ' CG1' ' A' ' 57' ' ' ILE . 1.6 t -65.25 156.55 31.56 Favored 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 116.993 -1.883 . . . . 0.0 106.672 178.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 76.12 -10.3 15.77 Favored Glycine 0 N--CA 1.505 3.284 0 C-N-CA 116.954 -2.546 . . . . 0.0 110.191 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.583 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 7.7 m-20 -66.65 147.38 53.35 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.184 -1.774 . . . . 0.0 110.864 -178.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' THR . . . . . 0.481 ' O ' HG12 ' A' ' 97' ' ' ILE . 0.3 OUTLIER -90.52 120.36 31.55 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.193 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' ILE . . . . . 0.508 HG23 HG22 ' A' ' 119' ' ' VAL . 1.4 mt -144.11 167.84 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 119.778 -1.826 . . . . 0.0 112.929 -178.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' SER . . . . . 0.49 ' OG ' ' CB ' ' A' ' 118' ' ' GLU . 94.5 p -150.14 138.51 20.51 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.445 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -164.29 179.26 39.22 Favored Glycine 0 N--CA 1.506 3.319 0 C-N-CA 117.037 -2.506 . . . . 0.0 115.16 -179.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.9 mmtt -88.21 148.87 24.16 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.3 pt -124.59 153.54 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.706 0 CA-C-N 121.25 1.841 . . . . 0.0 113.566 -176.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ARG . . . . . 0.745 ' HB2' HD22 ' A' ' 114' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.744 0 O-C-N 120.372 -1.455 . . . . 0.0 109.875 179.013 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.501 2.083 0 N-CA-C 108.936 -0.764 . . . . 0.0 108.936 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -107.42 147.22 30.69 Favored 'General case' 0 N--CA 1.518 2.945 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 176.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -68.36 161.66 26.99 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 119.237 -2.165 . . . . 0.0 108.062 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' ALA . . . . . 0.471 ' HA ' ' HB3' ' A' ' 80' ' ' TYR . . . -122.18 154.74 37.05 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 119.979 -1.701 . . . . 0.0 110.049 -179.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.46 HD23 ' CG ' ' A' ' 85' ' ' GLN . 3.0 tp -62.84 145.2 55.6 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' LEU . . . . . 0.745 HD22 ' HB2' ' A' ' 102' ' ' ARG . 11.5 tp -123.45 -55.36 1.74 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.45 -1.406 . . . . 0.0 112.179 -178.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 8.0 tptp -127.68 144.28 51.09 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 120.318 -1.488 . . . . 0.0 108.84 179.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.632 HG21 ' CD2' ' A' ' 89' ' ' PHE . 33.7 t -93.08 129.89 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.901 0 O-C-N 120.707 -1.246 . . . . 0.0 111.458 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -107.69 -38.74 5.79 Favored 'General case' 0 N--CA 1.508 2.451 0 O-C-N 121.257 -0.902 . . . . 0.0 110.053 178.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' GLU . . . . . 0.594 ' C ' HG23 ' A' ' 119' ' ' VAL . 7.0 tt0 -143.24 157.92 44.07 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 120.948 -1.095 . . . . 0.0 109.619 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' VAL . . . . . 0.594 HG23 ' C ' ' A' ' 118' ' ' GLU . 33.7 t -159.62 131.62 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -178.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.52 3.039 0 O-C-N 120.329 -1.482 . . . . 0.0 111.779 179.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.538 ' CA ' ' HA ' ' A' ' 49' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.661 0 N-CA-C 109.828 -0.434 . . . . 0.0 109.828 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.583 ' HB2' ' CE2' ' A' ' 50' ' ' PHE 0.25 4.2 t30 -78.38 116.74 19.01 Favored 'General case' 0 N--CA 1.504 2.259 0 O-C-N 120.555 -1.34 . . . . 0.0 109.402 -179.827 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.833 HD13 HD12 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -49.68 -46.54 49.96 Favored 'General case' 0 N--CA 1.517 2.915 0 O-C-N 120.157 -1.59 . . . . 0.0 110.352 -178.934 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.8 m -56.35 -34.92 67.06 Favored 'General case' 0 N--CA 1.499 2.008 0 O-C-N 120.742 -1.224 . . . . 0.0 108.186 -179.533 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.508 ' HB3' ' HB3' ' A' ' 2' ' ' ASN . 0.0 OUTLIER -66.99 -45.7 76.83 Favored 'General case' 0 N--CA 1.486 1.363 0 N-CA-C 107.883 -1.155 . . . . 0.0 107.883 177.73 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.833 HD12 HD13 ' A' ' 3' ' ' LEU 0.274 68.5 mt -53.3 -51.4 62.44 Favored 'General case' 0 C--N 1.313 -0.981 0 O-C-N 120.626 -1.296 . . . . 0.0 109.078 177.738 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.26 -33.61 69.57 Favored 'General case' 0 N--CA 1.502 2.154 0 O-C-N 121.044 -1.035 . . . . 0.0 109.726 178.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.504 ' HB2' ' O ' ' A' ' 5' ' ' GLU . 4.8 m-80 -61.42 -16.54 47.7 Favored 'General case' 0 N--CA 1.504 2.263 0 C-N-CA 119.013 -1.075 . . . . 0.0 110.357 -179.796 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.745 ' O ' HD11 ' A' ' 14' ' ' LEU . 2.6 m -89.48 121.32 69.37 Favored Pre-proline 0 N--CA 1.502 2.153 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 179.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.545 ' HG2' ' CG ' ' A' ' 13' ' ' GLU . 37.1 Cg_endo -57.79 151.3 57.07 Favored 'Trans proline' 0 CA--C 1.562 1.922 0 N-CA-C 109.971 -0.819 . . . . 0.0 109.971 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.799 ' HA ' HD12 ' A' ' 14' ' ' LEU . 1.6 p -41.85 -49.21 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.529 3.475 0 O-C-N 120.303 -1.498 . . . . 0.0 110.252 -178.071 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.504 ' N ' ' CG1' ' A' ' 11' ' ' VAL . 1.8 t -58.32 -41.97 85.69 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 121.314 -0.866 . . . . 0.0 111.161 -179.874 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.675 ' CB ' HG22 ' A' ' 9' ' ' THR . 0.2 OUTLIER -68.97 -30.52 68.97 Favored 'General case' 0 N--CA 1.487 1.389 0 C-N-CA 118.237 -1.385 . . . . 0.0 108.21 -179.964 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.799 HD12 ' HA ' ' A' ' 11' ' ' VAL . 9.3 mt -68.76 -41.2 79.19 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 120.883 -1.136 . . . . 0.0 108.813 176.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.633 HG23 ' HB2' ' A' ' 26' ' ' LEU . 1.2 mp -66.68 -40.33 85.88 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.723 0 C-N-CA 117.892 -1.523 . . . . 0.0 108.678 178.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.488 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 84.8 m -64.25 -35.52 81.11 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.36 -1.462 . . . . 0.0 108.963 179.088 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.504 ' O ' ' HG2' ' A' ' 21' ' ' MET . 35.5 tp -64.99 -43.85 91.23 Favored 'General case' 0 N--CA 1.503 2.189 0 O-C-N 120.934 -1.104 . . . . 0.0 108.237 178.365 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.566 ' HA2' ' OE1' ' A' ' 41' ' ' GLN . . . -61.69 -43.56 99.09 Favored Glycine 1 N--CA 1.518 4.11 0 N-CA-C 108.15 -1.98 . . . . 0.0 108.15 178.43 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.451 ' OE2' ' HG2' ' A' ' 24' ' ' GLU . 1.0 OUTLIER -53.75 -44.3 69.86 Favored 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.999 -1.295 . . . . 0.0 107.517 178.188 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.488 ' OD1' ' O ' ' A' ' 16' ' ' THR . 27.7 m120 -59.57 -26.97 65.84 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 118.679 -1.208 . . . . 0.0 109.465 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.571 ' HE2' ' HG3' ' A' ' 41' ' ' GLN . 37.7 mmm -97.65 9.86 41.44 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 121.27 -0.894 . . . . 0.0 110.438 179.73 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 99.7 -18.23 56.37 Favored Glycine 0 N--CA 1.501 2.992 0 C-N-CA 118.802 -1.666 . . . . 0.0 111.352 179.549 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.94 ' HB3' HD11 ' A' ' 26' ' ' LEU . 5.4 mp -79.56 94.91 5.72 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 120.359 -1.671 . . . . 0.0 109.753 179.856 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.511 ' O ' ' CB ' ' A' ' 25' ' ' ASN . 46.6 mt-10 -103.67 170.57 7.86 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.231 -0.918 . . . . 0.0 109.179 179.646 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.511 ' CB ' ' O ' ' A' ' 24' ' ' GLU . 1.3 t-20 70.37 18.15 6.79 Favored 'General case' 0 N--CA 1.511 2.578 0 O-C-N 121.528 -0.733 . . . . 0.0 111.785 179.33 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.94 HD11 ' HB3' ' A' ' 23' ' ' LEU . 0.3 OUTLIER -76.42 -8.66 57.61 Favored 'General case' 0 N--CA 1.505 2.304 0 O-C-N 120.983 -1.073 . . . . 0.0 111.419 -179.798 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.433 ' C ' ' O ' ' A' ' 26' ' ' LEU . . . -46.85 -32.74 3.94 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 120.461 -1.399 . . . . 0.0 108.847 -179.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.413 ' NH2' ' HB3' ' A' ' 25' ' ' ASN . 11.9 ptt180 -80.96 0.85 33.66 Favored 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 120.193 -0.603 . . . . 0.0 111.363 179.867 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.637 ' HE2' ' OD1' ' A' ' 33' ' ' ASP . 7.1 mtp -100.79 149.13 24.15 Favored 'General case' 0 C--N 1.314 -0.976 0 O-C-N 120.837 -1.165 . . . . 0.0 111.864 -178.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.504 ' C ' HD12 ' A' ' 34' ' ' ILE . 2.4 mtt85 -89.12 142.13 27.91 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 121.449 -0.782 . . . . 0.0 110.772 178.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.565 ' O ' HG13 ' A' ' 35' ' ' ILE . 12.1 ptpt -35.91 -34.54 0.05 Allowed 'General case' 0 N--CA 1.499 1.975 0 O-C-N 121.707 -0.621 . . . . 0.0 111.582 179.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.457 ' OE1' ' HG3' ' A' ' 31' ' ' LYS . 1.6 mm100 -63.78 -59.84 4.05 Favored 'General case' 0 N--CA 1.517 2.91 0 O-C-N 120.568 -1.332 . . . . 0.0 109.869 -179.105 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.637 ' OD1' ' HE2' ' A' ' 29' ' ' MET . 2.5 p30 -66.11 -37.61 86.16 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.586 -0.696 . . . . 0.0 110.162 -178.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.56 HD11 ' O ' ' A' ' 29' ' ' MET . 3.3 mt -61.15 -41.46 89.51 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.037 0 O-C-N 120.267 -1.521 . . . . 0.0 108.071 178.12 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.609 HG23 HD13 ' A' ' 6' ' ' LEU . 96.8 mt -60.93 -48.48 88.8 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.778 0 O-C-N 120.057 -1.652 . . . . 0.0 109.443 177.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 -52.7 -41.7 64.13 Favored 'General case' 0 N--CA 1.486 1.347 0 N-CA-C 107.859 -1.164 . . . . 0.0 107.859 -179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.611 ' HB1' ' CD2' ' A' ' 23' ' ' LEU . . . -62.34 -55.55 26.94 Favored 'General case' 0 C--O 1.2 -1.506 0 O-C-N 120.911 -1.118 . . . . 0.0 108.456 177.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.557 ' HA ' ' CD ' ' A' ' 41' ' ' GLN . 0.4 OUTLIER -51.22 -27.86 6.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.625 0 C-N-CA 117.301 -1.76 . . . . 0.0 110.358 179.853 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.782 HD23 ' CE2' ' A' ' 111' ' ' PHE . 3.1 mp -71.59 -45.55 61.87 Favored 'General case' 0 N--CA 1.509 2.5 0 C-N-CA 117.762 -1.575 . . . . 0.0 109.551 178.238 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.514 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 1.2 mtpp -65.83 -40.86 92.18 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.191 -0.943 . . . . 0.0 111.377 179.718 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.683 HE22 HD22 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -79.07 -41.58 28.43 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.962 -1.086 . . . . 0.0 111.512 -178.605 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.598 ' N ' ' HG2' ' A' ' 41' ' ' GLN . 1.3 m-70 -69.77 -33.94 73.08 Favored 'General case' 0 N--CA 1.493 1.715 0 C-N-CA 117.187 -1.805 . . . . 0.0 107.957 178.79 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.474 ' O ' ' N ' ' A' ' 46' ' ' GLY . . . -67.03 -51.66 52.03 Favored 'General case' 0 N--CA 1.485 1.288 0 O-C-N 120.641 -1.287 . . . . 0.0 107.842 177.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.514 ' HB2' ' O ' ' A' ' 40' ' ' LYS . 0.0 OUTLIER -49.31 -46.32 46.46 Favored 'General case' 0 N--CA 1.482 1.153 0 O-C-N 121.081 -1.012 . . . . 0.0 108.998 177.935 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 65.9 m -66.63 -6.35 15.04 Favored 'General case' 0 C--N 1.299 -1.589 0 C-N-CA 120.039 -0.664 . . . . 0.0 109.797 179.582 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.474 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . 90.62 7.94 66.24 Favored Glycine 0 N--CA 1.496 2.678 0 C-N-CA 119.883 -1.151 . . . . 0.0 113.328 177.662 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -79.03 159.14 27.72 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 120.754 2.277 . . . . 0.0 108.781 179.162 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -88.64 150.36 23.06 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 120.899 -1.125 . . . . 0.0 110.038 -179.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.574 HG13 HG13 ' A' ' 101' ' ' ILE . 0.7 OUTLIER -135.12 133.52 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.713 0 O-C-N 120.805 -1.185 . . . . 0.0 107.95 179.052 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.583 ' CE2' ' HB2' ' A' ' 2' ' ' ASN . 8.2 p90 -140.5 166.87 23.54 Favored 'General case' 0 C--N 1.306 -1.322 0 C-N-CA 116.558 -2.057 . . . . 0.0 114.255 -178.587 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -122.13 170.67 15.1 Favored Glycine 0 N--CA 1.5 2.953 0 N-CA-C 109.752 -1.339 . . . . 0.0 109.752 -177.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.469 ' C ' HD21 ' A' ' 65' ' ' LEU . 2.7 p30 -170.04 163.94 9.35 Favored 'General case' 0 N--CA 1.482 1.155 0 O-C-N 120.681 -1.482 . . . . 0.0 110.138 -179.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.46 ' N ' HD21 ' A' ' 65' ' ' LEU . . . 145.32 -140.25 8.91 Favored Glycine 0 N--CA 1.506 3.328 0 C-N-CA 118.356 -1.878 . . . . 0.0 110.962 178.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.593 ' HA ' ' O ' ' A' ' 95' ' ' ASP . 3.0 t -128.2 121.08 54.97 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.041 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 -179.713 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.975 HD21 HG21 ' A' ' 81' ' ' VAL . 6.5 mt -62.79 163.91 8.68 Favored 'General case' 0 N--CA 1.505 2.277 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 -175.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.507 ' HA ' ' OG1' ' A' ' 93' ' ' THR . 73.0 mm-40 -137.92 117.98 13.45 Favored 'General case' 0 N--CA 1.498 1.95 0 N-CA-C 106.646 -1.613 . . . . 0.0 106.646 177.764 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.614 ' CG1' ' HB ' ' A' ' 93' ' ' THR . 1.3 mm -85.13 162.11 2.97 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.195 0 CA-C-N 121.001 1.728 . . . . 0.0 110.545 -178.043 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.716 HD22 ' CZ ' ' A' ' 62' ' ' PHE . 5.1 mp -129.16 136.0 49.59 Favored 'General case' 0 N--CA 1.497 1.903 0 O-C-N 120.682 -1.261 . . . . 0.0 108.941 178.503 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.45 ' C ' ' O ' ' A' ' 58' ' ' LEU . 1.1 mt-30 -41.25 -34.01 0.44 Allowed 'General case' 0 N--CA 1.501 2.092 0 CA-C-O 121.972 0.892 . . . . 0.0 109.301 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 18.3 m-20 -60.99 -7.82 2.75 Favored 'General case' 0 N--CA 1.498 1.963 0 C-N-CA 119.928 -0.709 . . . . 0.0 112.247 -179.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.494 ' O ' ' HB3' ' A' ' 83' ' ' PRO . . . 93.55 4.35 64.03 Favored Glycine 1 N--CA 1.517 4.08 0 C-N-CA 118.817 -1.659 . . . . 0.0 112.43 177.758 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.716 ' CZ ' HD22 ' A' ' 58' ' ' LEU . 5.0 p90 -127.66 179.92 5.27 Favored 'General case' 0 C--N 1.305 -1.345 0 N-CA-C 104.808 -2.293 . . . . 0.0 104.808 178.131 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.624 ' HA2' HD13 ' A' ' 58' ' ' LEU . . . -161.05 176.82 37.6 Favored Glycine 0 N--CA 1.476 1.343 0 C-N-CA 117.187 -2.435 . . . . 0.0 111.486 -177.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.447 ' CE2' ' HE2' ' A' ' 62' ' ' PHE . 23.2 m-85 -129.53 152.47 49.02 Favored 'General case' 0 N--CA 1.483 1.184 0 CA-C-N 119.968 1.884 . . . . 0.0 109.689 177.476 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.503 ' HB3' ' HB ' ' A' ' 79' ' ' ILE . 0.5 OUTLIER -97.72 156.28 16.63 Favored 'General case' 0 C--N 1.306 -1.306 0 N-CA-C 106.365 -1.717 . . . . 0.0 106.365 176.542 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.466 ' HB3' ' O ' ' A' ' 65' ' ' LEU . 1.1 ptp85 177.12 -154.21 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.45 0 O-C-N 120.96 -1.087 . . . . 0.0 109.999 179.671 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -65.2 -148.9 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.247 -0.908 . . . . 0.0 110.888 -179.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -114.0 -18.25 11.77 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 121.553 -0.717 . . . . 0.0 111.581 -179.06 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.3 p-10 -65.64 -162.18 0.02 OUTLIER 'General case' 0 N--CA 1.502 2.128 0 O-C-N 120.655 -1.278 . . . . 0.0 108.729 179.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.562 ' O ' ' CB ' ' A' ' 71' ' ' SER . 0.2 OUTLIER -126.74 -74.58 0.59 Allowed 'General case' 0 N--CA 1.499 2.002 0 O-C-N 119.86 -1.775 . . . . 0.0 110.689 -179.788 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.637 ' O ' ' HB2' ' A' ' 72' ' ' TYR . 0.1 OUTLIER 78.2 -10.93 1.27 Allowed 'General case' 0 N--CA 1.52 3.062 0 O-C-N 121.778 -0.576 . . . . 0.0 110.51 -179.208 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.637 ' HB2' ' O ' ' A' ' 71' ' ' SER . 93.2 m-85 75.38 -45.06 0.54 Allowed 'General case' 0 N--CA 1.523 3.211 0 O-C-N 122.106 -0.372 . . . . 0.0 111.511 179.817 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 34.6 mt -99.01 -179.94 4.42 Favored 'General case' 0 C--N 1.309 -1.191 0 O-C-N 120.556 -1.34 . . . . 0.0 109.991 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.68 -148.63 0.06 Allowed 'General case' 0 C--N 1.291 -1.941 0 CA-C-O 122.386 1.089 . . . . 0.0 109.394 178.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.431 ' N ' ' OD2' ' A' ' 78' ' ' ASP . . . -158.2 157.73 28.56 Favored Glycine 0 C--N 1.279 -2.635 0 N-CA-C 107.054 -2.418 . . . . 0.0 107.054 178.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 34.5 Cg_endo -65.51 -43.91 9.57 Favored 'Trans proline' 0 N--CA 1.488 1.17 0 CA-C-N 118.592 1.196 . . . . 0.0 112.202 -179.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 95.2 m-20 -89.4 18.86 4.86 Favored 'General case' 0 N--CA 1.507 2.417 0 O-C-N 120.973 -1.079 . . . . 0.0 112.342 -179.021 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.505 ' OD1' ' N ' ' A' ' 78' ' ' ASP . 2.0 m-20 -77.12 -158.44 0.11 Allowed 'General case' 0 N--CA 1.505 2.314 0 O-C-N 120.33 -1.481 . . . . 0.0 109.981 -179.955 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.503 ' HB ' ' HB3' ' A' ' 65' ' ' LEU . 4.6 mm -128.35 133.83 66.03 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.657 0 O-C-N 121.06 -1.025 . . . . 0.0 109.891 179.742 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.479 ' HB3' ' O ' ' A' ' 111' ' ' PHE . 81.4 t80 -78.45 147.51 33.94 Favored 'General case' 0 N--CA 1.516 2.846 0 O-C-N 119.399 -2.063 . . . . 0.0 109.347 179.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.975 HG21 HD21 ' A' ' 55' ' ' LEU . 10.2 t -140.58 114.09 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.108 0 O-C-N 120.12 -1.612 . . . . 0.0 110.664 -179.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.565 ' O ' HG13 ' A' ' 86' ' ' ILE . 58.6 m -75.25 163.6 66.7 Favored Pre-proline 0 N--CA 1.512 2.651 0 O-C-N 120.442 -1.411 . . . . 0.0 112.18 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.564 ' HA ' HG13 ' A' ' 86' ' ' ILE . 38.0 Cg_endo -65.49 -52.75 0.96 Allowed 'Trans proline' 0 C--N 1.314 -1.289 0 O-C-N 124.701 1.895 . . . . 0.0 108.904 178.589 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.527 ' O ' ' HB2' ' A' ' 88' ' ' ARG . 0.3 OUTLIER -45.66 -40.98 9.81 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 178.242 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.514 ' HB2' ' O ' ' A' ' 82' ' ' SER . 7.4 mm100 -62.41 -58.85 6.15 Favored 'General case' 0 N--CA 1.51 2.556 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 178.253 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.566 ' HA ' ' CD1' ' A' ' 91' ' ' LEU . 0.4 OUTLIER -55.98 -55.06 20.18 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.273 0 O-C-N 121.128 -0.982 . . . . 0.0 108.837 178.469 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.485 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 1.6 mtt85 -58.13 -42.6 86.2 Favored 'General case' 0 C--N 1.296 -1.741 0 CA-C-O 121.772 0.796 . . . . 0.0 111.644 -178.928 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.527 ' HB2' ' O ' ' A' ' 84' ' ' SER . 19.8 mtt-85 -60.76 -36.8 79.86 Favored 'General case' 0 N--CA 1.505 2.311 0 C-N-CA 119.34 -0.944 . . . . 0.0 111.884 -177.545 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 1.045 ' HB2' HD21 ' A' ' 91' ' ' LEU . 16.7 m-85 -110.99 13.02 22.08 Favored 'General case' 0 N--CA 1.503 2.189 0 C-N-CA 116.815 -1.954 . . . . 0.0 111.382 179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 61.19 55.04 3.09 Favored 'General case' 0 N--CA 1.483 1.21 0 O-C-N 120.509 -1.369 . . . . 0.0 110.458 178.307 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 1.045 HD21 ' HB2' ' A' ' 89' ' ' PHE . 3.9 mt -89.2 -170.75 2.99 Favored 'General case' 0 N--CA 1.497 1.902 0 C-N-CA 119.102 -1.039 . . . . 0.0 110.416 179.82 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.531 ' CG ' ' O ' ' A' ' 91' ' ' LEU . 86.5 mtt-85 -159.4 160.03 34.41 Favored 'General case' 0 N--CA 1.494 1.767 0 N-CA-C 108.786 -0.82 . . . . 0.0 108.786 178.679 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.614 ' HB ' ' CG1' ' A' ' 57' ' ' ILE . 1.7 t -64.36 156.9 27.73 Favored 'General case' 0 N--CA 1.496 1.849 0 C-N-CA 116.826 -1.949 . . . . 0.0 106.662 178.459 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.42 ' O ' ' CG1' ' A' ' 54' ' ' VAL . . . 75.54 -9.44 15.34 Favored Glycine 0 N--CA 1.506 3.329 0 C-N-CA 117.122 -2.466 . . . . 0.0 110.191 179.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.593 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 11.7 m-20 -66.79 147.98 52.53 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 120.235 -1.744 . . . . 0.0 110.778 -178.789 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.483 ' O ' HG12 ' A' ' 97' ' ' ILE . 0.2 OUTLIER -89.6 120.98 31.37 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 108.497 -0.927 . . . . 0.0 108.497 179.228 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.811 HG23 HG22 ' A' ' 119' ' ' VAL . 1.4 mt -144.06 162.05 15.37 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 119.934 -1.729 . . . . 0.0 112.803 -178.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.518 ' OG ' ' HB2' ' A' ' 118' ' ' GLU . 97.5 p -148.05 137.88 22.52 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 108.978 -0.749 . . . . 0.0 108.978 178.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.553 ' O ' ' HB2' ' A' ' 50' ' ' PHE . . . -168.05 -178.27 39.83 Favored Glycine 0 N--CA 1.507 3.415 0 C-N-CA 117.035 -2.507 . . . . 0.0 114.917 -178.962 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.619 ' CD ' HD23 ' A' ' 114' ' ' LEU . 1.8 ptmt -90.12 156.93 18.01 Favored 'General case' 0 N--CA 1.501 2.078 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 179.537 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.574 HG13 HG13 ' A' ' 49' ' ' ILE . 2.3 pt -125.61 155.75 34.97 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.523 0 CA-C-N 120.659 1.572 . . . . 0.0 113.227 -177.529 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.892 ' HB3' HD13 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -150.86 153.92 33.98 Favored Pre-proline 0 N--CA 1.486 1.356 0 O-C-N 120.58 -1.325 . . . . 0.0 109.25 179.765 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.545 ' N ' ' HG3' ' A' ' 102' ' ' ARG . 51.4 Cg_endo -82.5 136.09 8.46 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 O-C-N 123.965 1.508 . . . . 0.0 110.039 179.355 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.554 ' HD2' ' CG ' ' A' ' 108' ' ' GLU . 48.4 Cg_endo -72.17 -93.9 0.01 OUTLIER 'Trans proline' 0 C--N 1.305 -1.749 0 O-C-N 123.88 1.463 . . . . 0.0 110.284 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 2.4 tttt -139.56 -163.62 1.53 Allowed 'General case' 0 N--CA 1.499 2.013 0 O-C-N 121.472 -0.768 . . . . 0.0 109.919 179.947 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -52.24 -26.63 12.29 Favored 'General case' 0 C--N 1.313 -1.017 0 O-C-N 120.637 -1.289 . . . . 0.0 109.345 179.633 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -83.79 48.55 4.06 Favored Glycine 0 N--CA 1.494 2.541 0 N-CA-C 107.738 -2.145 . . . . 0.0 107.738 177.659 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.554 ' CG ' ' HD2' ' A' ' 104' ' ' PRO . 8.8 tm-20 -85.72 -78.68 0.26 Allowed 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.832 -1.393 . . . . 0.0 111.571 -178.611 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.46 ' HD2' ' CZ ' ' A' ' 110' ' ' TYR . 0.0 OUTLIER 65.08 -59.91 0.25 Allowed 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.176 -0.952 . . . . 0.0 109.076 -178.56 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.53 ' N ' ' O ' ' A' ' 108' ' ' GLU . 35.8 m-85 -109.04 144.26 37.27 Favored 'General case' 0 N--CA 1.515 2.805 0 O-C-N 120.32 -1.487 . . . . 0.0 108.082 176.734 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.782 ' CE2' HD23 ' A' ' 39' ' ' LEU . 3.3 m-85 -68.33 165.74 18.0 Favored 'General case' 0 N--CA 1.506 2.348 0 O-C-N 119.321 -2.112 . . . . 0.0 107.957 178.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.457 ' HA ' ' HB3' ' A' ' 80' ' ' TYR . . . -122.7 150.68 42.4 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 119.955 -1.715 . . . . 0.0 110.957 -179.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.41 ' CD2' HE21 ' A' ' 85' ' ' GLN . 4.3 tp -60.11 147.56 39.08 Favored 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 179.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.892 HD13 ' HB3' ' A' ' 102' ' ' ARG . 14.3 tp -127.84 -55.48 1.3 Allowed 'General case' 0 N--CA 1.502 2.136 0 O-C-N 120.357 -1.464 . . . . 0.0 112.345 -178.793 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.536 ' HB3' ' CD ' ' A' ' 100' ' ' LYS . 0.6 OUTLIER -124.68 139.79 53.54 Favored 'General case' 0 N--CA 1.506 2.329 0 O-C-N 120.321 -1.487 . . . . 0.0 108.598 179.448 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.41 HG11 HG21 ' A' ' 119' ' ' VAL . 29.2 t -92.47 129.75 42.59 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.735 0 O-C-N 120.671 -1.268 . . . . 0.0 111.52 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.414 ' CG ' ' HA2' ' A' ' 99' ' ' GLY . 5.1 m-20 -106.43 -39.81 5.78 Favored 'General case' 0 N--CA 1.506 2.339 0 O-C-N 121.409 -0.807 . . . . 0.0 109.496 178.308 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.579 ' C ' HG23 ' A' ' 119' ' ' VAL . 1.7 tt0 -143.31 154.49 43.83 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.797 -1.189 . . . . 0.0 109.515 178.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.811 HG22 HG23 ' A' ' 97' ' ' ILE . 83.3 t -159.99 128.21 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.183 0 C-N-CA 120.749 -0.38 . . . . 0.0 111.503 -178.349 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.457 ' O ' ' C ' ' A' ' 121' ' ' PHE . 0.6 OUTLIER 39.61 51.61 2.32 Favored 'General case' 0 N--CA 1.52 3.049 0 O-C-N 120.514 -1.366 . . . . 0.0 111.161 178.833 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.475 ' O ' ' OD1' ' A' ' 122' ' ' ASP . 3.4 t80 41.45 32.01 0.2 Allowed 'General case' 0 N--CA 1.519 2.994 0 C-N-CA 118.974 -1.09 . . . . 0.0 110.349 179.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.475 ' OD1' ' O ' ' A' ' 121' ' ' PHE . 1.9 m-20 -145.72 168.18 21.35 Favored 'General case' 0 N--CA 1.486 1.351 0 O-C-N 121.057 -1.027 . . . . 0.0 108.602 178.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 1.2 mmtp -78.35 160.45 72.87 Favored Pre-proline 0 N--CA 1.504 2.227 0 O-C-N 120.908 -1.12 . . . . 0.0 109.15 179.816 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.44 ' O ' ' HB2' ' A' ' 125' ' ' GLU . 44.7 Cg_endo -71.79 44.73 0.65 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.837 1.441 . . . . 0.0 110.881 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.532 ' O ' ' ND2' ' A' ' 126' ' ' ASN . 3.9 tt0 -177.51 -153.4 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.4 0 O-C-N 120.616 -1.303 . . . . 0.0 108.627 -179.491 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.699 ' O ' ' HB2' ' A' ' 127' ' ' ALA . 0.3 OUTLIER 167.0 -150.38 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.168 0 O-C-N 120.603 -1.311 . . . . 0.0 109.247 179.543 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.699 ' HB2' ' O ' ' A' ' 126' ' ' ASN . . . 172.88 33.17 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.392 -1.443 . . . . 0.0 111.218 -179.843 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.537 ' CZ ' ' OD1' ' A' ' 126' ' ' ASN . 0.2 OUTLIER -115.76 -27.02 7.18 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.963 -1.086 . . . . 0.0 110.197 179.661 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.528 ' N ' ' HG2' ' A' ' 128' ' ' ARG . 17.1 m-20 63.27 140.65 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.263 -0.898 . . . . 0.0 109.859 -179.893 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.523 ' OXT' ' CG ' ' A' ' 130' ' ' LYS . 1.5 ptmt . . . . . 0 N--CA 1.481 1.097 0 O-C-N 120.623 -1.298 . . . . 0.0 109.604 179.976 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.633 ' HA ' ' HA ' ' A' ' 49' ' ' ILE . 2.1 ptp . . . . . 0 N--CA 1.493 1.701 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.562 ' HB2' ' CZ ' ' A' ' 50' ' ' PHE . 8.7 t-20 -78.21 94.28 4.74 Favored 'General case' 0 N--CA 1.498 1.972 0 O-C-N 120.819 -1.175 . . . . 0.0 108.635 179.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.547 ' HA ' HD12 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -41.41 -41.27 1.96 Allowed 'General case' 0 N--CA 1.517 2.917 0 O-C-N 120.679 -1.263 . . . . 0.0 110.031 -178.797 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.412 ' OG1' ' OD2' ' A' ' 52' ' ' ASP . 1.8 m -59.13 -35.36 73.34 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 120.819 -1.176 . . . . 0.0 108.564 -179.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.515 ' N ' ' OD1' ' A' ' 2' ' ' ASN . 0.1 OUTLIER -74.12 -45.39 49.26 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.027 -1.046 . . . . 0.0 108.747 178.209 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.816 ' CD1' HD21 ' A' ' 39' ' ' LEU 0.275 77.9 mt -50.94 -49.72 59.26 Favored 'General case' 0 C--N 1.317 -0.817 0 O-C-N 120.806 -1.184 . . . . 0.0 109.216 178.266 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 3.8 mptp? -66.21 -39.78 89.86 Favored 'General case' 0 N--CA 1.504 2.238 0 O-C-N 121.046 -1.034 . . . . 0.0 110.142 178.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.3 m-80 -63.25 -28.09 69.79 Favored 'General case' 0 N--CA 1.508 2.429 0 O-C-N 121.226 -0.921 . . . . 0.0 111.251 -179.263 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.636 HG22 ' CB ' ' A' ' 13' ' ' GLU . 3.0 m -73.84 126.92 89.12 Favored Pre-proline 0 N--CA 1.505 2.321 0 O-C-N 121.538 -0.727 . . . . 0.0 109.549 -179.746 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.561 ' HG2' ' CG ' ' A' ' 13' ' ' GLU . 40.1 Cg_endo -61.16 150.47 84.31 Favored 'Trans proline' 0 CA--C 1.566 2.096 0 O-C-N 122.315 0.64 . . . . 0.0 110.84 179.844 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.55 ' CG1' ' N ' ' A' ' 12' ' ' SER . 1.4 p -43.43 -50.74 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.525 3.276 0 O-C-N 120.493 -1.379 . . . . 0.0 109.471 -178.71 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.55 ' N ' ' CG1' ' A' ' 11' ' ' VAL . 0.8 OUTLIER -56.21 -39.95 73.28 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.418 -0.801 . . . . 0.0 111.056 -179.856 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.899 ' O ' HD12 ' A' ' 17' ' ' LEU . 0.1 OUTLIER -69.26 -29.59 67.52 Favored 'General case' 0 C--N 1.306 -1.319 0 C-N-CA 117.96 -1.496 . . . . 0.0 107.711 179.178 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.711 ' HB3' HG21 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -68.54 -44.32 74.79 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.13 -0.981 . . . . 0.0 108.89 176.845 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.523 HD12 ' O ' ' A' ' 11' ' ' VAL . 1.5 mp -65.68 -37.17 79.34 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 C-N-CA 117.97 -1.492 . . . . 0.0 108.908 179.204 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.583 ' HA ' ' HG2' ' A' ' 19' ' ' GLU . 31.0 m -65.8 -38.64 89.53 Favored 'General case' 0 N--CA 1.484 1.247 0 O-C-N 120.338 -1.476 . . . . 0.0 109.123 178.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.899 HD12 ' O ' ' A' ' 13' ' ' GLU . 3.7 mt -65.34 -38.13 89.19 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 120.887 -1.133 . . . . 0.0 108.764 178.593 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.463 ' HA3' ' HB2' ' A' ' 23' ' ' LEU . . . -67.61 -43.5 85.41 Favored Glycine 0 N--CA 1.513 3.787 0 N-CA-C 108.49 -1.844 . . . . 0.0 108.49 178.467 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.697 ' HG3' ' N ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -58.62 -38.84 78.91 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 120.463 -1.61 . . . . 0.0 108.175 178.925 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.697 ' N ' ' HG3' ' A' ' 19' ' ' GLU . 24.8 m120 -61.81 -27.76 68.99 Favored 'General case' 0 N--CA 1.493 1.705 0 C-N-CA 118.13 -1.428 . . . . 0.0 109.313 178.633 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.533 ' HE2' ' NE2' ' A' ' 41' ' ' GLN . 21.5 mmm -102.5 10.81 38.64 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.314 -0.867 . . . . 0.0 111.511 -178.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.66 -18.23 50.99 Favored Glycine 0 N--CA 1.504 3.175 0 C-N-CA 118.537 -1.792 . . . . 0.0 112.102 179.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.991 ' HB3' HD11 ' A' ' 26' ' ' LEU . 5.0 mp -78.4 95.01 4.99 Favored 'General case' 0 N--CA 1.508 2.449 0 O-C-N 120.193 -1.769 . . . . 0.0 110.121 -179.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.474 ' O ' ' CB ' ' A' ' 25' ' ' ASN . 51.5 mt-10 -104.01 168.66 8.97 Favored 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.169 -0.957 . . . . 0.0 109.268 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.474 ' CB ' ' O ' ' A' ' 24' ' ' GLU . 0.1 OUTLIER 68.98 19.49 8.15 Favored 'General case' 0 N--CA 1.508 2.434 0 O-C-N 121.499 -0.751 . . . . 0.0 111.947 179.056 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.991 HD11 ' HB3' ' A' ' 23' ' ' LEU . 0.4 OUTLIER -76.21 -13.62 60.17 Favored 'General case' 0 N--CA 1.505 2.283 0 O-C-N 120.76 -1.212 . . . . 0.0 111.381 179.964 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 26' ' ' LEU . . . -46.99 -35.61 6.81 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.464 -1.398 . . . . 0.0 109.061 -179.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 10.6 mtt180 -81.16 2.48 27.39 Favored 'General case' 0 C--N 1.295 -1.79 0 C-N-CA 119.849 -0.74 . . . . 0.0 111.438 179.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.565 ' HB3' HG13 ' A' ' 34' ' ' ILE . 7.4 mtp -100.4 150.53 22.52 Favored 'General case' 0 C--N 1.313 -0.984 0 O-C-N 120.832 -1.167 . . . . 0.0 111.164 -179.356 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.53 ' C ' HD12 ' A' ' 34' ' ' ILE . 10.8 ttp85 -89.22 142.59 27.51 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.258 -0.901 . . . . 0.0 110.677 179.106 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.59 ' O ' ' CG1' ' A' ' 35' ' ' ILE . 7.7 tttp -31.95 -46.27 0.11 Allowed 'General case' 0 N--CA 1.493 1.72 0 CA-C-N 116.264 -0.426 . . . . 0.0 112.051 179.224 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.524 ' OE1' ' N ' ' A' ' 33' ' ' ASP . 1.2 pp0? -61.6 -53.88 50.37 Favored 'General case' 0 N--CA 1.52 3.066 0 O-C-N 121.325 -0.86 . . . . 0.0 112.101 -177.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.539 ' OD1' ' HE2' ' A' ' 29' ' ' MET . 2.1 p30 -66.73 -37.32 84.43 Favored 'General case' 0 C--N 1.294 -1.805 0 O-C-N 120.732 -1.23 . . . . 0.0 108.964 179.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.711 HG21 ' HB3' ' A' ' 14' ' ' LEU . 4.8 mt -61.17 -39.44 82.45 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.894 0 O-C-N 120.328 -1.482 . . . . 0.0 108.043 177.78 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.59 ' CG1' ' O ' ' A' ' 31' ' ' LYS . 0.6 OUTLIER -57.58 -47.51 85.17 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.558 0 O-C-N 120.085 -1.635 . . . . 0.0 109.271 177.577 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -53.18 -41.15 64.95 Favored 'General case' 0 N--CA 1.49 1.556 0 C-N-CA 119.405 -0.918 . . . . 0.0 108.526 -179.417 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.841 ' HB1' ' CD2' ' A' ' 23' ' ' LEU . . . -70.29 -53.09 18.27 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.971 -1.081 . . . . 0.0 109.953 178.114 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.662 ' HA ' ' CG ' ' A' ' 41' ' ' GLN . 0.1 OUTLIER -53.78 -28.26 16.41 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 C-N-CA 117.437 -1.705 . . . . 0.0 110.362 -179.786 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.816 HD21 ' CD1' ' A' ' 6' ' ' LEU . 64.7 mt -72.33 -44.3 62.86 Favored 'General case' 0 N--CA 1.502 2.15 0 O-C-N 120.409 -1.432 . . . . 0.0 109.696 178.477 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 10.9 mmtt -64.21 -41.63 96.95 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.046 -1.034 . . . . 0.0 110.501 179.014 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.662 ' CG ' ' HA ' ' A' ' 38' ' ' ILE . 0.0 OUTLIER -74.86 -46.41 36.54 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.065 -1.022 . . . . 0.0 111.359 -179.06 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.492 ' HB2' ' O ' ' A' ' 38' ' ' ILE . 0.3 OUTLIER -66.01 -34.47 78.17 Favored 'General case' 0 N--CA 1.505 2.309 0 O-C-N 120.543 -1.348 . . . . 0.0 108.984 179.539 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.565 ' O ' ' N ' ' A' ' 46' ' ' GLY . . . -67.32 -36.93 82.47 Favored 'General case' 0 N--CA 1.486 1.345 0 O-C-N 120.975 -1.078 . . . . 0.0 108.96 178.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -47.89 -43.73 28.89 Favored 'General case' 0 N--CA 1.482 1.162 0 O-C-N 120.799 -1.188 . . . . 0.0 108.966 178.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 70.8 m -66.66 -9.99 41.67 Favored 'General case' 0 C--N 1.297 -1.678 0 C-N-CA 119.59 -0.844 . . . . 0.0 109.265 179.72 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.565 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . 64.57 36.03 92.66 Favored Glycine 0 N--CA 1.493 2.458 0 N-CA-C 110.569 -1.012 . . . . 0.0 110.569 178.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.514 ' OE1' ' N ' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -92.62 166.72 12.35 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 120.432 -1.628 . . . . 0.0 108.841 179.214 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.514 ' N ' ' OE1' ' A' ' 47' ' ' GLU . 17.0 m-20 -61.58 137.09 58.23 Favored 'General case' 0 C--N 1.3 -1.547 0 O-C-N 121.122 -0.986 . . . . 0.0 110.792 -178.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.633 ' HA ' ' HA ' ' A' ' 1' ' ' MET . 3.0 pt -141.26 135.19 31.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 120.986 -1.071 . . . . 0.0 108.224 178.912 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.641 ' N ' ' CD1' ' A' ' 50' ' ' PHE . 7.4 p90 -144.86 163.26 34.63 Favored 'General case' 0 C--N 1.31 -1.12 0 C-N-CA 116.014 -2.274 . . . . 0.0 115.794 -178.422 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -120.79 170.6 14.5 Favored Glycine 0 N--CA 1.505 3.243 0 N-CA-C 108.686 -1.766 . . . . 0.0 108.686 -179.017 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.483 ' C ' ' CD2' ' A' ' 65' ' ' LEU . 52.5 p-10 -170.22 167.5 8.57 Favored 'General case' 0 N--CA 1.485 1.315 0 O-C-N 120.383 -1.657 . . . . 0.0 110.741 -178.574 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.536 ' HA3' ' O ' ' A' ' 66' ' ' ARG . . . 144.09 -139.19 8.49 Favored Glycine 0 N--CA 1.507 3.418 0 C-N-CA 118.368 -1.872 . . . . 0.0 111.472 177.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.58 ' HA ' ' O ' ' A' ' 95' ' ' ASP . 2.8 t -127.75 120.12 53.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.054 0 O-C-N 121.258 -1.142 . . . . 0.0 108.092 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.874 HD21 HG21 ' A' ' 81' ' ' VAL . 7.2 mt -62.92 162.78 10.66 Favored 'General case' 0 N--CA 1.502 2.132 0 N-CA-C 113.924 1.083 . . . . 0.0 113.924 -175.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.528 ' HA ' ' OG1' ' A' ' 93' ' ' THR . 0.0 OUTLIER -139.27 119.79 14.0 Favored 'General case' 0 N--CA 1.497 1.9 0 N-CA-C 107.444 -1.317 . . . . 0.0 107.444 178.03 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.584 ' CG1' ' HB ' ' A' ' 93' ' ' THR . 1.2 mm -78.65 162.07 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.065 0 O-C-N 119.733 -1.854 . . . . 0.0 109.18 -178.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 1.178 HD22 ' CZ ' ' A' ' 62' ' ' PHE . 1.3 mp -131.39 126.06 34.2 Favored 'General case' 0 N--CA 1.495 1.807 0 O-C-N 120.301 -1.499 . . . . 0.0 109.752 179.195 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.509 ' C ' ' O ' ' A' ' 58' ' ' LEU . 6.9 mm-40 -32.74 -37.05 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.458 0 CA-C-O 122.018 0.913 . . . . 0.0 109.715 -179.494 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.556 ' HB2' ' CD2' ' A' ' 62' ' ' PHE . 3.1 m-20 -60.92 -6.21 1.72 Allowed 'General case' 0 N--CA 1.5 2.033 0 C-N-CA 120.271 -0.571 . . . . 0.0 112.489 -179.176 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.467 ' N ' ' O ' ' A' ' 58' ' ' LEU . . . 89.14 11.9 64.22 Favored Glycine 1 N--CA 1.517 4.077 0 C-N-CA 118.672 -1.728 . . . . 0.0 111.944 178.365 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 1.178 ' CZ ' HD22 ' A' ' 58' ' ' LEU . 4.0 p90 -128.1 -178.85 4.69 Favored 'General case' 0 C--N 1.306 -1.313 0 N-CA-C 104.18 -2.526 . . . . 0.0 104.18 177.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.571 ' HA2' ' CD1' ' A' ' 58' ' ' LEU . . . -152.75 162.87 30.2 Favored Glycine 0 N--CA 1.475 1.292 0 C-N-CA 117.322 -2.37 . . . . 0.0 111.272 -177.885 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.442 ' CD1' ' HE1' ' A' ' 62' ' ' PHE . 2.0 m-30 -127.81 150.96 49.59 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 120.136 1.968 . . . . 0.0 109.156 177.728 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.502 ' HB3' ' HB ' ' A' ' 79' ' ' ILE . 0.3 OUTLIER -98.34 166.37 11.41 Favored 'General case' 0 C--N 1.303 -1.444 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 176.768 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.536 ' O ' ' HA3' ' A' ' 53' ' ' GLY . 21.0 tpt180 -178.42 -179.97 0.73 Allowed 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.057 -1.027 . . . . 0.0 109.02 179.301 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.506 ' HB2' ' OG ' ' A' ' 70' ' ' SER . 1.7 m -71.51 -159.12 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 120.45 -1.406 . . . . 0.0 109.86 179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -120.42 -85.76 0.66 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.32 -0.862 . . . . 0.0 110.212 -179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -69.09 56.06 0.1 Allowed 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.463 -0.773 . . . . 0.0 110.933 -179.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.507 ' O ' ' CB ' ' A' ' 71' ' ' SER . 0.3 OUTLIER -126.31 -19.48 4.67 Favored 'General case' 0 N--CA 1.498 1.943 0 O-C-N 120.121 -1.612 . . . . 0.0 111.036 -179.399 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.683 ' O ' ' HB2' ' A' ' 72' ' ' TYR . 0.3 OUTLIER 169.47 -14.84 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.439 0 O-C-N 120.822 -1.174 . . . . 0.0 111.973 -179.531 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.683 ' HB2' ' O ' ' A' ' 71' ' ' SER . 95.9 m-85 76.64 -42.57 0.43 Allowed 'General case' 0 N--CA 1.529 3.51 0 O-C-N 121.842 -0.536 . . . . 0.0 111.951 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.456 ' CD1' ' N ' ' A' ' 73' ' ' LEU . 6.7 mp -80.67 -174.78 4.9 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 120.268 -1.52 . . . . 0.0 109.639 179.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.54 -156.86 0.12 Allowed 'General case' 0 C--N 1.29 -1.982 0 CA-C-O 122.366 1.079 . . . . 0.0 109.755 179.522 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.519 ' N ' ' OD2' ' A' ' 78' ' ' ASP . . . -178.54 163.16 30.88 Favored Glycine 0 C--N 1.281 -2.482 0 N-CA-C 107.891 -2.084 . . . . 0.0 107.891 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -64.98 -39.14 25.61 Favored 'Trans proline' 0 N--CA 1.492 1.388 0 CA-C-N 118.312 1.056 . . . . 0.0 112.027 179.898 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.5 m-20 -86.5 18.32 3.36 Favored 'General case' 0 N--CA 1.504 2.226 0 O-C-N 121.118 -0.989 . . . . 0.0 112.101 -178.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.519 ' OD2' ' N ' ' A' ' 75' ' ' GLY . 1.1 m-20 -70.74 -154.05 0.02 OUTLIER 'General case' 0 N--CA 1.506 2.343 0 O-C-N 120.531 -1.356 . . . . 0.0 109.77 179.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.502 ' HB ' ' HB3' ' A' ' 65' ' ' LEU . 3.9 mm -126.56 138.67 54.0 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.65 0 O-C-N 121.16 -0.963 . . . . 0.0 110.11 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.5 ' HB3' ' O ' ' A' ' 111' ' ' PHE . 6.0 t80 -85.02 146.55 27.13 Favored 'General case' 0 N--CA 1.516 2.867 0 CA-C-N 121.502 1.955 . . . . 0.0 109.819 178.875 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.874 HG21 HD21 ' A' ' 55' ' ' LEU . 25.2 t -141.65 115.77 5.02 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 120.078 -1.639 . . . . 0.0 110.226 -179.675 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.556 ' O ' HG13 ' A' ' 86' ' ' ILE . 58.0 m -74.3 163.52 67.7 Favored Pre-proline 0 N--CA 1.515 2.799 0 O-C-N 120.262 -1.524 . . . . 0.0 112.131 -179.208 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.535 ' HA ' HG13 ' A' ' 86' ' ' ILE . 40.2 Cg_endo -66.62 -50.27 1.34 Allowed 'Trans proline' 0 C--N 1.314 -1.249 0 O-C-N 124.505 1.792 . . . . 0.0 108.958 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.539 ' O ' ' CG ' ' A' ' 88' ' ' ARG . 0.4 OUTLIER -47.2 -39.53 14.19 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 177.834 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.547 ' HB2' ' O ' ' A' ' 82' ' ' SER . 7.2 mm-40 -63.42 -57.78 9.2 Favored 'General case' 0 N--CA 1.511 2.587 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 178.215 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.59 ' HA ' HD23 ' A' ' 91' ' ' LEU . 0.8 OUTLIER -55.51 -53.59 34.6 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.336 0 O-C-N 120.938 -1.101 . . . . 0.0 108.647 178.848 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.469 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 0.1 OUTLIER -57.81 -41.72 82.76 Favored 'General case' 0 C--N 1.297 -1.683 0 CA-C-O 121.865 0.84 . . . . 0.0 111.364 -179.459 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.539 ' CG ' ' O ' ' A' ' 84' ' ' SER . 12.5 mtt180 -59.37 -37.46 77.96 Favored 'General case' 0 N--CA 1.507 2.407 0 C-N-CA 119.883 -0.727 . . . . 0.0 111.928 -177.606 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.453 ' CD2' HG21 ' A' ' 116' ' ' VAL . 19.3 m-85 -113.97 14.53 18.46 Favored 'General case' 0 N--CA 1.505 2.318 0 C-N-CA 117.274 -1.771 . . . . 0.0 111.412 -179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 58.45 56.5 4.32 Favored 'General case' 0 N--CA 1.481 1.108 0 O-C-N 120.31 -1.493 . . . . 0.0 109.084 179.067 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.59 HD23 ' HA ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -88.37 173.91 8.46 Favored 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 119.431 -0.908 . . . . 0.0 109.338 -179.831 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.535 ' CD ' ' O ' ' A' ' 91' ' ' LEU . 3.7 mmm180 -147.0 157.51 43.64 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.997 -1.065 . . . . 0.0 108.86 179.201 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.584 ' HB ' ' CG1' ' A' ' 57' ' ' ILE . 2.4 t -63.73 156.29 27.54 Favored 'General case' 0 N--CA 1.496 1.831 0 C-N-CA 116.948 -1.901 . . . . 0.0 106.993 179.133 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 76.34 -9.61 19.9 Favored Glycine 0 N--CA 1.504 3.189 0 C-N-CA 117.094 -2.479 . . . . 0.0 110.334 179.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.58 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 6.0 m-20 -69.36 147.75 50.63 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.228 -1.748 . . . . 0.0 110.752 -178.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.51 ' O ' HG12 ' A' ' 97' ' ' ILE . 0.2 OUTLIER -91.22 124.29 35.31 Favored 'General case' 0 N--CA 1.487 1.406 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 179.093 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.529 HG23 ' O ' ' A' ' 118' ' ' GLU . 1.7 mt -146.73 166.3 7.09 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 O-C-N 120.034 -1.666 . . . . 0.0 112.408 -179.087 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.533 ' OG ' ' HB2' ' A' ' 118' ' ' GLU . 82.4 p -148.93 139.82 22.87 Favored 'General case' 0 N--CA 1.486 1.358 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.233 178.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.502 ' O ' ' HB2' ' A' ' 50' ' ' PHE . . . -164.6 179.55 39.27 Favored Glycine 0 N--CA 1.506 3.346 0 C-N-CA 117.039 -2.505 . . . . 0.0 114.987 -179.118 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.541 ' HG2' ' HB3' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -87.76 152.88 21.78 Favored 'General case' 0 N--CA 1.501 2.083 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 178.772 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.542 HG13 HG13 ' A' ' 49' ' ' ILE . 2.4 pt -122.87 159.17 26.89 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.462 0 CA-C-N 120.982 1.719 . . . . 0.0 113.603 -176.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.599 ' CB ' HD13 ' A' ' 114' ' ' LEU . 1.5 tmm_? -145.39 143.85 21.37 Favored Pre-proline 0 N--CA 1.481 1.111 0 O-C-N 120.582 -1.324 . . . . 0.0 109.891 179.783 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.486 ' HB3' ' CE1' ' A' ' 111' ' ' PHE . 52.2 Cg_endo -88.36 117.75 1.02 Allowed 'Trans proline' 0 C--N 1.305 -1.732 0 O-C-N 124.246 1.656 . . . . 0.0 110.027 179.553 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.56 ' HG2' ' CB ' ' A' ' 108' ' ' GLU . 44.2 Cg_endo -68.48 -99.18 0.01 OUTLIER 'Trans proline' 0 C--N 1.304 -1.783 0 O-C-N 123.718 1.378 . . . . 0.0 109.592 179.891 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.434 ' O ' ' CD ' ' A' ' 108' ' ' GLU . 23.7 mttt -116.43 174.52 6.02 Favored 'General case' 0 C--N 1.293 -1.856 0 O-C-N 121.253 -0.905 . . . . 0.0 109.373 179.185 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -69.42 -23.78 63.75 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 120.838 -1.164 . . . . 0.0 109.774 -179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -85.16 34.94 3.17 Favored Glycine 0 N--CA 1.496 2.651 0 C-N-CA 118.68 -1.724 . . . . 0.0 109.923 179.025 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.56 ' CB ' ' HG2' ' A' ' 104' ' ' PRO . 0.7 OUTLIER -106.77 -23.94 12.25 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 120.487 -1.596 . . . . 0.0 110.235 179.831 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.526 ' N ' ' OE1' ' A' ' 108' ' ' GLU . 0.9 OUTLIER 66.37 -52.61 0.42 Allowed 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.549 -0.719 . . . . 0.0 111.245 -179.949 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.424 ' N ' ' O ' ' A' ' 108' ' ' GLU . 3.6 m-85 -108.4 148.04 30.71 Favored 'General case' 0 N--CA 1.521 3.078 0 O-C-N 120.07 -1.644 . . . . 0.0 109.542 178.625 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.5 ' O ' ' HB3' ' A' ' 80' ' ' TYR . 54.4 m-85 -69.13 172.03 7.44 Favored 'General case' 0 N--CA 1.509 2.514 0 O-C-N 119.735 -1.853 . . . . 0.0 108.034 178.317 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.435 ' HA ' ' HB3' ' A' ' 80' ' ' TYR . . . -122.08 154.96 36.65 Favored 'General case' 0 N--CA 1.495 1.8 0 O-C-N 119.924 -1.735 . . . . 0.0 110.842 -179.169 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -69.12 153.7 43.28 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 106.429 -1.693 . . . . 0.0 106.429 179.375 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.599 HD13 ' CB ' ' A' ' 102' ' ' ARG . 11.1 tp -132.79 -59.55 0.89 Allowed 'General case' 0 N--CA 1.501 2.077 0 O-C-N 120.135 -1.603 . . . . 0.0 112.22 -179.276 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.541 ' HB3' ' HG2' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -114.18 141.7 47.19 Favored 'General case' 0 N--CA 1.511 2.615 0 O-C-N 120.272 -1.518 . . . . 0.0 109.074 179.401 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.453 HG21 ' CD2' ' A' ' 89' ' ' PHE . 34.7 t -93.05 129.25 43.83 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.908 0 O-C-N 120.543 -1.348 . . . . 0.0 111.63 179.708 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.57 ' O ' ' HB3' ' A' ' 124' ' ' PRO . 7.1 m-20 -106.93 -39.05 5.87 Favored 'General case' 0 N--CA 1.507 2.423 0 O-C-N 121.463 -0.773 . . . . 0.0 109.918 178.324 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.548 ' C ' HG23 ' A' ' 119' ' ' VAL . 6.0 mm-40 -143.52 156.37 44.59 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.595 -1.316 . . . . 0.0 109.041 179.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.548 HG23 ' C ' ' A' ' 118' ' ' GLU . 6.4 t -156.17 139.81 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 N-CA-C 108.699 -0.852 . . . . 0.0 108.699 -178.229 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.467 ' C ' ' O ' ' A' ' 119' ' ' VAL . 0.1 OUTLIER -32.8 -31.54 0.01 OUTLIER 'General case' 0 N--CA 1.519 2.978 0 O-C-N 121.106 -0.996 . . . . 0.0 111.197 -177.535 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.545 ' N ' ' O ' ' A' ' 119' ' ' VAL . 0.4 OUTLIER -157.29 59.08 0.51 Allowed 'General case' 0 N--CA 1.493 1.721 0 C-N-CA 118.313 -1.355 . . . . 0.0 111.272 179.439 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.541 ' HB2' ' HB ' ' A' ' 119' ' ' VAL . 0.4 OUTLIER -151.19 167.41 27.86 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 118.534 -1.267 . . . . 0.0 109.762 177.968 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . . . . . . . . . 26.3 mmmt -79.04 156.3 76.94 Favored Pre-proline 0 N--CA 1.501 2.077 0 C-N-CA 119.458 -0.897 . . . . 0.0 108.884 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.57 ' HB3' ' O ' ' A' ' 117' ' ' ASN . 54.3 Cg_endo -79.58 31.24 0.48 Allowed 'Trans proline' 0 C--N 1.306 -1.709 0 O-C-N 123.853 1.449 . . . . 0.0 111.102 -178.854 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.535 ' O ' ' CB ' ' A' ' 126' ' ' ASN . 1.2 tp10 -179.12 -134.67 0.01 OUTLIER 'General case' 0 N--CA 1.489 1.476 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.535 ' CB ' ' O ' ' A' ' 125' ' ' GLU . 0.2 OUTLIER 167.58 -83.41 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.099 0 O-C-N 120.327 -1.483 . . . . 0.0 110.182 179.055 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.501 ' HB2' ' O ' ' A' ' 126' ' ' ASN . . . -179.55 -165.84 0.08 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 121.606 -0.683 . . . . 0.0 109.456 -179.751 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.552 ' CG ' ' O ' ' A' ' 128' ' ' ARG . 2.0 ptp180 -158.23 113.22 2.62 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.482 -1.386 . . . . 0.0 110.267 179.66 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -65.02 163.09 15.36 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.073 -1.017 . . . . 0.0 110.185 -179.804 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.387 0 CA-C-O 118.003 -0.999 . . . . 0.0 109.952 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.806 ' SD ' HG22 ' A' ' 49' ' ' ILE . 14.1 mmt . . . . . 0 N--CA 1.492 1.632 0 CA-C-O 121.097 0.475 . . . . 0.0 109.925 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.522 ' HA ' ' O ' ' A' ' 50' ' ' PHE . 39.8 t30 -78.86 110.04 13.69 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.007 -1.058 . . . . 0.0 108.84 178.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.662 ' HA ' HD12 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -44.09 -41.17 5.4 Favored 'General case' 0 N--CA 1.514 2.74 0 O-C-N 120.339 -1.476 . . . . 0.0 110.493 -178.695 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.43 ' OG1' ' OD1' ' A' ' 52' ' ' ASP . 1.7 m -58.4 -36.88 74.24 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 120.696 -1.253 . . . . 0.0 108.264 -179.014 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.51 ' HB3' ' HB3' ' A' ' 2' ' ' ASN . 1.8 pt-20 -70.53 -45.84 64.75 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.089 -1.007 . . . . 0.0 108.543 178.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.662 HD12 ' HA ' ' A' ' 3' ' ' LEU 0.281 82.3 mt -51.65 -49.5 62.19 Favored 'General case' 0 C--N 1.315 -0.916 0 O-C-N 121.008 -1.058 . . . . 0.0 109.521 178.397 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.485 ' HD2' ' HB2' ' A' ' 77' ' ' ASP . 0.3 OUTLIER -63.78 -38.58 91.65 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.288 -0.883 . . . . 0.0 110.094 179.137 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -62.58 -19.52 63.8 Favored 'General case' 0 N--CA 1.508 2.473 0 O-C-N 121.262 -0.899 . . . . 0.0 111.383 -179.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.617 ' HB ' ' CD1' ' A' ' 14' ' ' LEU . 3.2 m -83.17 117.85 69.87 Favored Pre-proline 0 C--N 1.284 -2.278 0 O-C-N 121.763 -0.585 . . . . 0.0 109.966 -179.602 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.53 ' HG2' ' HG3' ' A' ' 13' ' ' GLU . 38.5 Cg_endo -59.61 155.14 43.98 Favored 'Trans proline' 0 CA--C 1.564 2.0 0 O-C-N 122.471 0.722 . . . . 0.0 110.899 179.925 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.541 HG23 ' N ' ' A' ' 31' ' ' LYS . 1.7 p -42.81 -51.63 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.527 3.383 0 O-C-N 120.577 -1.327 . . . . 0.0 110.139 -178.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.519 ' N ' ' CG1' ' A' ' 11' ' ' VAL . 1.5 t -55.01 -43.23 73.45 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 121.12 -0.987 . . . . 0.0 111.239 -179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.74 ' O ' HD12 ' A' ' 17' ' ' LEU . 1.7 mm-40 -68.38 -27.32 66.13 Favored 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 117.947 -1.501 . . . . 0.0 107.59 179.85 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.617 ' CD1' ' HB ' ' A' ' 9' ' ' THR . 0.0 OUTLIER -70.61 -41.46 72.26 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.132 -0.98 . . . . 0.0 109.089 176.958 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.619 HG23 ' HB2' ' A' ' 26' ' ' LEU . 1.8 mp -69.81 -36.1 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 C-N-CA 117.824 -1.55 . . . . 0.0 109.216 179.11 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.568 ' HA ' ' HG2' ' A' ' 19' ' ' GLU . 86.8 m -69.31 -40.78 77.45 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.03 -1.669 . . . . 0.0 109.816 179.063 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.74 HD12 ' O ' ' A' ' 13' ' ' GLU . 1.9 mt -64.84 -37.62 88.22 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 120.696 -1.252 . . . . 0.0 108.923 178.869 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 1.041 ' HA2' HD13 ' A' ' 38' ' ' ILE . . . -68.2 -44.67 74.92 Favored Glycine 0 N--CA 1.507 3.395 0 N-CA-C 108.929 -1.668 . . . . 0.0 108.929 178.473 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.675 ' HG3' ' N ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -57.08 -37.11 71.42 Favored 'General case' 0 N--CA 1.484 1.232 0 O-C-N 120.496 -1.59 . . . . 0.0 107.463 178.896 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.675 ' N ' ' HG3' ' A' ' 19' ' ' GLU . 28.9 m120 -61.05 -24.44 66.2 Favored 'General case' 0 N--CA 1.489 1.492 0 C-N-CA 118.293 -1.363 . . . . 0.0 109.532 178.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.949 ' HG3' HD11 ' A' ' 38' ' ' ILE . 69.6 mmm -97.33 2.18 50.32 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.188 -0.945 . . . . 0.0 111.595 -179.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.55 -3.66 65.9 Favored Glycine 0 N--CA 1.498 2.799 0 C-N-CA 118.249 -1.929 . . . . 0.0 114.142 177.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 1.025 ' H ' HD13 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -103.52 63.98 0.8 Allowed 'General case' 0 N--CA 1.509 2.5 0 CA-C-N 121.644 2.722 . . . . 0.0 111.25 179.854 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.521 ' O ' ' CB ' ' A' ' 25' ' ' ASN . 5.1 pt-20 -57.11 -167.71 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.199 0 CA-C-O 122.367 1.08 . . . . 0.0 110.754 178.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.521 ' CB ' ' O ' ' A' ' 24' ' ' GLU . 0.7 OUTLIER 74.62 10.16 4.11 Favored 'General case' 0 N--CA 1.516 2.84 0 CA-C-N 115.154 -0.93 . . . . 0.0 111.571 179.723 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.833 HD11 ' O ' ' A' ' 23' ' ' LEU . 1.0 OUTLIER -77.14 -18.57 57.79 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.245 -0.909 . . . . 0.0 112.35 -179.358 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.408 ' C ' ' O ' ' A' ' 26' ' ' LEU . . . -46.99 -40.21 14.01 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.313 -1.492 . . . . 0.0 108.771 -179.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 28.0 mtt-85 -81.15 -0.56 40.82 Favored 'General case' 0 C--N 1.295 -1.786 0 C-N-CA 119.725 -0.79 . . . . 0.0 111.359 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.562 ' HB3' HG13 ' A' ' 34' ' ' ILE . 15.7 mtp -101.21 156.78 17.23 Favored 'General case' 0 C--N 1.312 -1.038 0 O-C-N 120.915 -1.116 . . . . 0.0 111.841 -178.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.834 ' O ' HD12 ' A' ' 34' ' ' ILE . 3.8 ttm180 -89.76 175.08 7.37 Favored 'General case' 0 N--CA 1.498 1.973 0 O-C-N 121.429 -0.794 . . . . 0.0 110.561 177.956 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.905 ' O ' HG22 ' A' ' 35' ' ' ILE . 9.2 pttm -66.41 -33.33 75.47 Favored 'General case' 0 N--CA 1.497 1.902 0 O-C-N 121.449 -0.782 . . . . 0.0 110.989 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.466 ' N ' ' HG3' ' A' ' 31' ' ' LYS . 1.3 mm100 -65.57 -55.02 19.98 Favored 'General case' 0 N--CA 1.523 3.192 0 CA-C-O 122.021 0.915 . . . . 0.0 110.018 -179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.55 ' OD1' ' N ' ' A' ' 34' ' ' ILE . 2.0 p30 -67.33 -41.91 84.45 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.074 -1.016 . . . . 0.0 109.685 -179.054 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.834 HD12 ' O ' ' A' ' 30' ' ' ARG . 29.0 mt -61.79 -40.84 88.36 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.282 0 O-C-N 120.357 -1.464 . . . . 0.0 109.637 178.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.905 HG22 ' O ' ' A' ' 31' ' ' LYS . 0.2 OUTLIER -66.92 -37.26 79.05 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.557 0 O-C-N 120.113 -1.617 . . . . 0.0 109.049 178.149 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 9.2 m-30 -67.02 -45.57 77.1 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.377 -1.452 . . . . 0.0 108.716 178.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.443 ' O ' ' C ' ' A' ' 38' ' ' ILE . . . -67.01 -53.46 31.16 Favored 'General case' 0 N--CA 1.499 1.991 0 O-C-N 120.49 -1.381 . . . . 0.0 109.487 178.053 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 1.041 HD13 ' HA2' ' A' ' 18' ' ' GLY . 5.9 tp -48.46 -49.99 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.095 0 C-N-CA 117.536 -1.665 . . . . 0.0 108.093 179.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.665 ' N ' HG23 ' A' ' 38' ' ' ILE . 5.6 tp -53.87 -41.56 67.65 Favored 'General case' 0 N--CA 1.52 3.052 0 O-C-N 120.76 -1.213 . . . . 0.0 109.1 179.431 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.48 ' O ' ' HD2' ' A' ' 44' ' ' LYS . 0.0 OUTLIER -60.59 -36.05 77.59 Favored 'General case' 0 N--CA 1.498 1.962 0 CA-C-O 121.628 0.727 . . . . 0.0 109.739 179.271 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.755 ' CG ' HD12 ' A' ' 23' ' ' LEU . 11.8 mm-40 -79.34 -51.4 9.46 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.663 -0.648 . . . . 0.0 111.354 -179.024 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.612 ' CG ' ' CE ' ' A' ' 21' ' ' MET . 0.2 OUTLIER -61.38 -31.59 71.5 Favored 'General case' 0 N--CA 1.503 2.204 0 C-N-CA 117.736 -1.586 . . . . 0.0 108.425 179.406 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 46' ' ' GLY . . . -58.96 -44.56 91.5 Favored 'General case' 0 N--CA 1.486 1.329 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 177.822 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.492 ' HB2' ' O ' ' A' ' 41' ' ' GLN . 0.0 OUTLIER -49.22 -45.24 44.19 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 122.11 0.957 . . . . 0.0 108.944 177.952 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 65.5 m -66.8 -8.36 28.0 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 121.639 0.733 . . . . 0.0 109.581 179.508 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.519 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . 74.53 29.5 61.61 Favored Glycine 0 N--CA 1.495 2.621 0 C-N-CA 120.186 -1.006 . . . . 0.0 111.774 178.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -79.03 166.65 22.09 Favored 'General case' 0 N--CA 1.494 1.739 0 O-C-N 120.173 -1.781 . . . . 0.0 108.975 178.818 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -88.1 130.22 35.08 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.234 -0.916 . . . . 0.0 109.739 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.806 HG22 ' SD ' ' A' ' 1' ' ' MET . 0.6 OUTLIER -131.0 135.8 59.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.562 -1.336 . . . . 0.0 107.655 178.97 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.522 ' O ' ' HA ' ' A' ' 2' ' ' ASN . 17.0 p90 -141.82 165.14 28.29 Favored 'General case' 0 C--N 1.304 -1.408 0 C-N-CA 116.28 -2.168 . . . . 0.0 114.834 -177.915 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -114.21 164.8 12.03 Favored Glycine 0 N--CA 1.503 3.117 0 N-CA-C 108.307 -1.917 . . . . 0.0 108.307 -179.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.461 ' OD1' ' N ' ' A' ' 52' ' ' ASP . 46.7 p-10 -169.79 164.63 9.91 Favored 'General case' 0 N--CA 1.48 1.047 0 O-C-N 120.36 -1.671 . . . . 0.0 110.298 -178.838 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.54 ' HA3' ' O ' ' A' ' 66' ' ' ARG . . . 140.87 -134.98 6.68 Favored Glycine 0 N--CA 1.504 3.227 0 C-N-CA 118.258 -1.925 . . . . 0.0 111.378 178.378 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.588 ' HA ' ' O ' ' A' ' 95' ' ' ASP . 2.6 t -128.17 119.85 51.92 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 O-C-N 121.414 -1.051 . . . . 0.0 108.265 -179.357 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.77 HD21 HG21 ' A' ' 81' ' ' VAL . 5.6 mt -62.29 161.61 11.15 Favored 'General case' 0 N--CA 1.501 2.124 0 C-N-CA 118.74 -1.184 . . . . 0.0 113.454 -175.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.512 ' HA ' ' OG1' ' A' ' 93' ' ' THR . 3.4 tp10 -137.31 116.35 12.45 Favored 'General case' 0 N--CA 1.496 1.847 0 N-CA-C 107.259 -1.385 . . . . 0.0 107.259 178.119 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.608 ' CG1' ' HB ' ' A' ' 93' ' ' THR . 1.3 mm -84.31 159.35 3.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 120.151 -1.593 . . . . 0.0 108.811 -179.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.637 HD22 ' HE1' ' A' ' 62' ' ' PHE . 2.8 mp -130.96 138.82 49.9 Favored 'General case' 0 N--CA 1.494 1.744 0 O-C-N 120.348 -1.47 . . . . 0.0 109.961 179.27 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.453 ' C ' ' O ' ' A' ' 58' ' ' LEU . 3.7 tt0 -38.24 -36.72 0.24 Allowed 'General case' 0 N--CA 1.492 1.63 0 CA-C-O 121.66 0.743 . . . . 0.0 110.414 -179.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 28.0 m-20 -60.99 -7.74 2.69 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 121.502 -0.749 . . . . 0.0 112.319 -179.209 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 91.34 8.39 64.39 Favored Glycine 1 N--CA 1.518 4.151 0 C-N-CA 118.729 -1.701 . . . . 0.0 112.255 177.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.637 ' HE1' HD22 ' A' ' 58' ' ' LEU . 0.0 OUTLIER -127.65 -179.68 5.06 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 104.883 -2.266 . . . . 0.0 104.883 178.098 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.438 ' HA2' HD13 ' A' ' 58' ' ' LEU . . . -158.56 170.77 35.22 Favored Glycine 0 N--CA 1.475 1.293 0 C-N-CA 116.712 -2.661 . . . . 0.0 111.784 -177.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.417 ' HE1' ' CE2' ' A' ' 62' ' ' PHE . 6.9 m-85 -129.9 153.0 48.76 Favored 'General case' 0 N--CA 1.481 1.103 0 CA-C-N 119.858 1.829 . . . . 0.0 109.753 177.478 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.513 ' HB3' ' HB ' ' A' ' 79' ' ' ILE . 0.3 OUTLIER -98.9 160.14 14.47 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 176.567 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.54 ' O ' ' HA3' ' A' ' 53' ' ' GLY . 0.0 OUTLIER 178.26 -162.75 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.196 -0.94 . . . . 0.0 109.561 179.191 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.487 ' N ' ' HG3' ' A' ' 66' ' ' ARG . 1.1 m -72.74 -156.8 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.923 0 O-C-N 120.98 -1.075 . . . . 0.0 110.282 179.477 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -127.3 -90.86 0.52 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.426 -0.796 . . . . 0.0 110.116 -179.824 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -73.36 48.36 0.24 Allowed 'General case' 0 N--CA 1.501 2.124 0 O-C-N 121.165 -0.959 . . . . 0.0 111.102 -179.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -123.34 -15.6 7.13 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.32 -1.488 . . . . 0.0 110.423 -179.798 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.554 ' O ' ' HB2' ' A' ' 72' ' ' TYR . 0.5 OUTLIER 177.86 -26.9 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.965 -1.084 . . . . 0.0 110.733 179.637 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.554 ' HB2' ' O ' ' A' ' 71' ' ' SER . 23.5 m-85 76.41 -43.54 0.46 Allowed 'General case' 0 N--CA 1.52 3.069 0 O-C-N 121.651 -0.656 . . . . 0.0 111.731 179.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.506 ' O ' ' HD2' ' A' ' 66' ' ' ARG . 6.9 mt -77.68 -172.09 2.46 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.355 -1.466 . . . . 0.0 109.626 179.89 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.18 -157.69 0.13 Allowed 'General case' 0 C--N 1.288 -2.095 0 CA-C-O 122.419 1.104 . . . . 0.0 109.571 179.704 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.414 ' CA ' ' OD1' ' A' ' 78' ' ' ASP . . . 176.49 164.93 31.32 Favored Glycine 0 C--N 1.278 -2.67 0 N-CA-C 107.789 -2.124 . . . . 0.0 107.789 179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -64.86 -40.16 22.55 Favored 'Trans proline' 0 N--CA 1.489 1.263 0 CA-C-N 118.364 1.082 . . . . 0.0 112.156 179.745 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.485 ' HB2' ' HD2' ' A' ' 7' ' ' LYS . 2.2 m-20 -86.78 16.49 4.75 Favored 'General case' 0 N--CA 1.507 2.38 0 O-C-N 121.112 -0.992 . . . . 0.0 112.488 -178.651 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.695 ' C ' HD12 ' A' ' 79' ' ' ILE . 0.6 OUTLIER -76.37 -152.91 0.04 OUTLIER 'General case' 0 N--CA 1.509 2.515 0 O-C-N 120.528 -1.358 . . . . 0.0 109.462 179.371 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.695 HD12 ' C ' ' A' ' 78' ' ' ASP . 1.7 mp -135.9 138.27 47.81 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.812 0 O-C-N 120.961 -1.087 . . . . 0.0 110.043 178.776 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.512 ' HB3' ' O ' ' A' ' 111' ' ' PHE . 5.9 t80 -80.8 146.34 30.99 Favored 'General case' 0 N--CA 1.518 2.955 0 O-C-N 119.685 -1.884 . . . . 0.0 110.028 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.77 HG21 HD21 ' A' ' 55' ' ' LEU . 38.4 t -142.44 112.9 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.757 0 O-C-N 120.24 -1.537 . . . . 0.0 110.117 -179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.552 ' O ' HG13 ' A' ' 86' ' ' ILE . 22.0 m -74.86 166.82 42.16 Favored Pre-proline 0 N--CA 1.512 2.643 0 O-C-N 120.58 -1.325 . . . . 0.0 112.133 -179.368 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.572 ' HA ' HG13 ' A' ' 86' ' ' ILE . 38.8 Cg_endo -65.19 -53.82 0.76 Allowed 'Trans proline' 0 C--N 1.314 -1.257 0 O-C-N 124.651 1.869 . . . . 0.0 109.08 178.823 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.56 ' O ' ' CG ' ' A' ' 88' ' ' ARG . 0.8 OUTLIER -45.14 -41.01 7.6 Favored 'General case' 0 N--CA 1.488 1.445 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 178.119 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.568 ' O ' ' CD2' ' A' ' 89' ' ' PHE . 6.6 mm100 -62.74 -57.81 9.65 Favored 'General case' 0 N--CA 1.509 2.517 0 C-N-CA 119.118 -1.033 . . . . 0.0 108.49 178.221 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.572 HG13 ' HA ' ' A' ' 83' ' ' PRO . 0.2 OUTLIER -59.15 -54.84 28.65 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.35 0 O-C-N 121.084 -1.01 . . . . 0.0 108.846 178.648 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.483 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 0.0 OUTLIER -56.22 -42.67 77.62 Favored 'General case' 0 C--N 1.295 -1.775 0 CA-C-O 121.83 0.824 . . . . 0.0 111.225 -179.102 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.56 ' CG ' ' O ' ' A' ' 84' ' ' SER . 1.4 mmt85 -60.42 -36.42 78.11 Favored 'General case' 0 N--CA 1.507 2.382 0 C-N-CA 119.647 -0.821 . . . . 0.0 111.871 -177.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.568 ' CD2' ' O ' ' A' ' 85' ' ' GLN . 4.7 m-85 -109.74 12.75 23.98 Favored 'General case' 0 N--CA 1.503 2.218 0 C-N-CA 117.494 -1.682 . . . . 0.0 111.174 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 59.52 52.88 5.41 Favored 'General case' 0 N--CA 1.485 1.308 0 O-C-N 120.524 -1.36 . . . . 0.0 109.686 178.906 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.55 ' HB2' HG22 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -90.12 174.39 7.66 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.486 -0.758 . . . . 0.0 109.757 179.867 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.533 ' HG2' ' O ' ' A' ' 91' ' ' LEU . 10.3 mtm180 -147.56 159.82 43.33 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 121.173 -0.955 . . . . 0.0 108.678 178.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.608 ' HB ' ' CG1' ' A' ' 57' ' ' ILE . 1.9 t -63.54 156.28 26.92 Favored 'General case' 0 N--CA 1.497 1.876 0 C-N-CA 117.143 -1.823 . . . . 0.0 107.031 179.381 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 77.2 -11.21 17.34 Favored Glycine 0 N--CA 1.505 3.251 0 C-N-CA 117.177 -2.439 . . . . 0.0 110.107 179.34 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.588 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 12.5 m-20 -68.26 146.93 52.87 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.211 -1.758 . . . . 0.0 110.943 -178.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.499 ' O ' HG12 ' A' ' 97' ' ' ILE . 0.2 OUTLIER -90.05 120.91 31.64 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.179 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.519 HG23 ' O ' ' A' ' 118' ' ' GLU . 1.5 mt -145.95 167.51 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.802 0 O-C-N 119.871 -1.768 . . . . 0.0 112.81 -178.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.527 ' OG ' ' HB2' ' A' ' 118' ' ' GLU . 99.8 p -149.25 138.95 21.8 Favored 'General case' 0 N--CA 1.483 1.201 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.988 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.52 ' O ' ' HB2' ' A' ' 50' ' ' PHE . . . -163.11 178.09 38.91 Favored Glycine 0 N--CA 1.507 3.42 0 C-N-CA 117.405 -2.331 . . . . 0.0 114.757 -178.87 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.503 ' HG2' ' HB3' ' A' ' 115' ' ' LYS . 0.0 OUTLIER -88.06 155.88 19.58 Favored 'General case' 0 N--CA 1.499 2.024 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 178.982 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.521 HG13 HG13 ' A' ' 49' ' ' ILE . 1.7 pt -123.04 161.89 23.98 Favored 'Isoleucine or valine' 0 N--CA 1.506 2.369 0 CA-C-N 120.636 1.562 . . . . 0.0 113.586 -177.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.949 ' HB2' HD22 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -143.71 129.47 9.97 Favored Pre-proline 0 N--CA 1.485 1.308 0 O-C-N 120.608 -1.307 . . . . 0.0 108.808 179.695 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.517 ' HD2' ' CD ' ' A' ' 102' ' ' ARG . 49.7 Cg_endo -75.89 115.6 4.21 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 O-C-N 124.204 1.634 . . . . 0.0 110.853 -179.154 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 45.1 Cg_endo -71.65 -152.06 0.03 OUTLIER 'Trans proline' 0 C--N 1.305 -1.724 0 O-C-N 123.979 1.515 . . . . 0.0 109.346 179.376 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 8.3 mttm -83.26 168.8 16.37 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 120.837 -1.165 . . . . 0.0 109.209 179.225 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -61.86 -22.76 65.8 Favored 'General case' 0 C--N 1.309 -1.174 0 O-C-N 120.683 -1.26 . . . . 0.0 109.896 179.944 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -67.26 2.79 4.99 Favored Glycine 0 N--CA 1.501 2.984 0 C-N-CA 119.054 -1.546 . . . . 0.0 111.387 179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.53 ' O ' ' HB3' ' A' ' 109' ' ' ARG . 0.5 OUTLIER -106.87 -26.42 11.24 Favored 'General case' 0 N--CA 1.494 1.73 0 CA-C-N 120.236 2.018 . . . . 0.0 110.078 179.819 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.53 ' HB3' ' O ' ' A' ' 108' ' ' GLU . 4.9 tpp180 68.84 -41.42 0.47 Allowed 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.529 -0.732 . . . . 0.0 112.628 179.541 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 13.5 m-85 -106.57 148.56 28.12 Favored 'General case' 0 N--CA 1.52 3.055 0 O-C-N 120.126 -1.609 . . . . 0.0 109.678 179.712 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.64 ' CE2' HD23 ' A' ' 39' ' ' LEU . 3.4 m-30 -67.72 168.09 12.0 Favored 'General case' 0 N--CA 1.503 2.219 0 O-C-N 119.851 -1.781 . . . . 0.0 108.093 178.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.431 ' HA ' ' HB3' ' A' ' 80' ' ' TYR . . . -121.85 154.15 37.44 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.237 -1.539 . . . . 0.0 110.345 -179.195 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -64.54 150.52 46.62 Favored 'General case' 0 N--CA 1.492 1.661 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.949 HD22 ' HB2' ' A' ' 102' ' ' ARG . 20.0 tp -127.93 -55.9 1.28 Allowed 'General case' 0 N--CA 1.501 2.088 0 O-C-N 120.282 -1.511 . . . . 0.0 112.373 -178.945 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.503 ' HB3' ' HG2' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -123.98 142.58 51.04 Favored 'General case' 0 N--CA 1.509 2.513 0 O-C-N 120.32 -1.487 . . . . 0.0 109.263 179.417 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 10.8 t -92.98 130.7 41.67 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.831 0 O-C-N 120.468 -1.395 . . . . 0.0 111.057 179.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -107.17 -40.93 5.28 Favored 'General case' 0 N--CA 1.505 2.317 0 O-C-N 121.357 -0.839 . . . . 0.0 109.725 178.653 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.562 ' C ' HG23 ' A' ' 119' ' ' VAL . 0.0 OUTLIER -143.67 159.48 42.41 Favored 'General case' 0 N--CA 1.488 1.463 0 O-C-N 120.872 -1.142 . . . . 0.0 109.74 179.483 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.562 HG23 ' C ' ' A' ' 118' ' ' GLU . 13.1 t -158.5 138.14 3.7 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 N-CA-C 109.509 -0.552 . . . . 0.0 109.509 -178.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.472 ' O ' ' C ' ' A' ' 121' ' ' PHE . 0.1 OUTLIER 48.28 41.5 16.25 Favored 'General case' 0 N--CA 1.516 2.853 0 O-C-N 120.332 -1.48 . . . . 0.0 110.643 -179.985 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.472 ' C ' ' O ' ' A' ' 120' ' ' ASN . 0.1 OUTLIER 38.12 33.45 0.06 Allowed 'General case' 0 N--CA 1.52 3.049 0 O-C-N 121.048 -1.033 . . . . 0.0 110.01 179.827 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.425 ' N ' ' O ' ' A' ' 120' ' ' ASN . 0.1 OUTLIER -154.67 174.87 14.4 Favored 'General case' 0 N--CA 1.484 1.255 0 O-C-N 120.989 -1.069 . . . . 0.0 109.228 179.386 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.541 ' HB3' ' HD2' ' A' ' 124' ' ' PRO . 11.6 mmtt -60.63 168.39 2.55 Favored Pre-proline 0 N--CA 1.506 2.328 0 N-CA-C 108.4 -0.963 . . . . 0.0 108.4 179.709 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.541 ' HD2' ' HB3' ' A' ' 123' ' ' LYS . 44.8 Cg_endo -72.66 41.75 0.55 Allowed 'Trans proline' 0 C--N 1.308 -1.58 0 O-C-N 123.399 1.21 . . . . 0.0 111.168 -179.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.518 ' O ' ' ND2' ' A' ' 126' ' ' ASN . 3.0 tp10 -178.17 -135.22 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.582 0 O-C-N 120.946 -1.096 . . . . 0.0 108.213 -179.708 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.518 ' ND2' ' O ' ' A' ' 125' ' ' GLU . 0.2 OUTLIER 167.69 -66.68 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.145 0 O-C-N 120.412 -1.43 . . . . 0.0 109.71 179.32 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.513 ' O ' ' HB3' ' A' ' 128' ' ' ARG . . . -150.52 177.61 9.86 Favored 'General case' 0 C--N 1.295 -1.798 0 C-N-CA 119.883 -0.727 . . . . 0.0 109.519 179.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.513 ' HB3' ' O ' ' A' ' 127' ' ' ALA . 0.0 OUTLIER 174.29 -30.11 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.982 0 O-C-N 120.47 -1.394 . . . . 0.0 110.129 -179.724 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 6.1 m-80 -82.75 163.65 21.14 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.485 -0.76 . . . . 0.0 110.65 -179.221 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 2.1 mmtt . . . . . 0 N--CA 1.487 1.383 0 CA-C-O 117.977 -1.011 . . . . 0.0 109.604 179.625 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.629 ' HA ' ' HA ' ' A' ' 49' ' ' ILE . 1.0 OUTLIER . . . . . 0 N--CA 1.492 1.664 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.584 ' HA ' ' O ' ' A' ' 50' ' ' PHE . 63.5 t30 -78.5 91.06 4.5 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 120.725 -1.234 . . . . 0.0 108.444 178.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.552 ' CD1' HD11 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -41.59 -40.4 1.88 Allowed 'General case' 0 N--CA 1.52 3.035 0 O-C-N 120.598 -1.314 . . . . 0.0 110.371 -178.186 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.467 ' OG1' ' CG ' ' A' ' 52' ' ' ASP . 1.9 m -60.13 -35.07 74.45 Favored 'General case' 0 N--CA 1.497 1.904 0 C-N-CA 118.601 -1.24 . . . . 0.0 108.288 -179.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.566 ' HB3' ' HB3' ' A' ' 2' ' ' ASN . 0.9 OUTLIER -72.65 -44.57 61.7 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.922 -1.112 . . . . 0.0 108.245 177.386 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.639 HD12 HG13 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -51.01 -51.4 53.36 Favored 'General case' 0 N--CA 1.475 0.811 0 O-C-N 120.834 -1.167 . . . . 0.0 108.68 178.37 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 8.1 mttm -62.5 -40.92 98.27 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.121 -0.987 . . . . 0.0 109.831 178.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.405 ' HB2' ' HA ' ' A' ' 5' ' ' GLU . 2.7 m-80 -62.74 -20.65 65.15 Favored 'General case' 0 N--CA 1.508 2.456 0 CA-C-O 121.79 0.805 . . . . 0.0 111.141 -179.072 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.738 ' HB ' HD11 ' A' ' 14' ' ' LEU . 94.5 m -79.26 122.25 83.94 Favored Pre-proline 0 C--N 1.283 -2.289 0 N-CA-C 108.445 -0.946 . . . . 0.0 108.445 179.667 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.555 ' HG2' ' CG ' ' A' ' 13' ' ' GLU . 37.2 Cg_endo -57.48 155.55 30.36 Favored 'Trans proline' 0 N--CA 1.503 2.068 0 C-N-CA 120.488 0.792 . . . . 0.0 112.219 -177.609 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.56 ' CG1' ' N ' ' A' ' 12' ' ' SER . 1.6 p -45.24 -51.73 2.33 Favored 'Isoleucine or valine' 0 N--CA 1.53 3.541 0 O-C-N 120.502 -1.374 . . . . 0.0 110.44 -178.843 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.56 ' N ' ' CG1' ' A' ' 11' ' ' VAL . 0.9 OUTLIER -56.86 -41.57 78.19 Favored 'General case' 0 N--CA 1.498 1.946 0 O-C-N 121.081 -1.012 . . . . 0.0 110.646 -179.52 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.605 ' HB3' HG23 ' A' ' 9' ' ' THR . 48.2 mm-40 -68.95 -26.85 65.27 Favored 'General case' 0 C--N 1.305 -1.329 0 C-N-CA 118.155 -1.418 . . . . 0.0 107.975 179.375 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.738 HD11 ' HB ' ' A' ' 9' ' ' THR . 0.9 OUTLIER -70.35 -43.14 70.82 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 120.96 -1.087 . . . . 0.0 108.439 177.381 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.548 HD12 ' O ' ' A' ' 11' ' ' VAL . 1.4 mp -66.37 -40.15 85.94 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.709 0 C-N-CA 118.108 -1.437 . . . . 0.0 108.659 178.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.577 ' HA ' ' HG2' ' A' ' 19' ' ' GLU . 92.7 m -63.91 -38.03 89.59 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.394 -1.441 . . . . 0.0 109.267 179.16 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.534 ' CD1' ' O ' ' A' ' 13' ' ' GLU . 0.7 OUTLIER -65.81 -37.79 87.22 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.85 -1.156 . . . . 0.0 108.779 178.553 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.466 ' HA2' HD13 ' A' ' 23' ' ' LEU . . . -67.36 -43.5 87.7 Favored Glycine 0 N--CA 1.513 3.794 0 N-CA-C 108.505 -1.838 . . . . 0.0 108.505 178.51 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.687 ' HG3' ' N ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -59.33 -37.98 79.16 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.507 -1.584 . . . . 0.0 108.117 178.922 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.687 ' N ' ' HG3' ' A' ' 19' ' ' GLU . 28.1 m120 -61.32 -29.01 69.62 Favored 'General case' 0 N--CA 1.493 1.713 0 C-N-CA 118.201 -1.4 . . . . 0.0 109.405 178.633 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.516 ' HG3' ' O ' ' A' ' 17' ' ' LEU . 18.6 mtp -101.53 12.84 36.57 Favored 'General case' 0 N--CA 1.499 2.001 0 O-C-N 121.215 -0.928 . . . . 0.0 111.153 -179.85 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.66 -22.9 34.29 Favored Glycine 0 N--CA 1.502 3.082 0 C-N-CA 118.632 -1.747 . . . . 0.0 111.299 179.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 1.006 ' CD2' ' HB1' ' A' ' 37' ' ' ALA . 2.9 mp -79.45 93.63 5.42 Favored 'General case' 0 N--CA 1.5 2.039 0 O-C-N 120.396 -1.65 . . . . 0.0 109.776 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . . . . . . . . . 1.2 pt-20 -108.1 175.79 5.36 Favored 'General case' 0 C--N 1.304 -1.4 0 O-C-N 121.141 -0.974 . . . . 0.0 109.285 179.38 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER 62.99 21.1 12.7 Favored 'General case' 0 N--CA 1.507 2.404 0 O-C-N 121.914 -0.491 . . . . 0.0 111.549 178.998 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.743 HD11 ' HB3' ' A' ' 23' ' ' LEU . 0.4 OUTLIER -77.19 -7.59 56.12 Favored 'General case' 0 N--CA 1.504 2.261 0 O-C-N 120.985 -1.072 . . . . 0.0 111.413 -179.86 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.42 ' C ' ' O ' ' A' ' 26' ' ' LEU . . . -46.71 -31.73 3.12 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.441 -1.412 . . . . 0.0 108.977 -179.311 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . 0.558 ' CD ' ' C ' ' A' ' 28' ' ' ARG . 0.0 OUTLIER -80.82 -2.12 45.9 Favored 'General case' 0 C--N 1.296 -1.754 0 C-N-CA 120.081 -0.648 . . . . 0.0 111.502 -179.99 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.541 ' HB3' HG13 ' A' ' 34' ' ' ILE . 14.8 mtp -100.85 162.78 12.67 Favored 'General case' 0 C--N 1.313 -0.989 0 O-C-N 120.639 -1.288 . . . . 0.0 111.636 -179.004 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.722 ' O ' HD12 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -89.71 164.26 14.77 Favored 'General case' 0 N--CA 1.497 1.882 0 CA-C-O 121.647 0.737 . . . . 0.0 110.563 178.502 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.576 ' O ' HG22 ' A' ' 35' ' ' ILE . 2.6 ttmm -55.62 -41.95 74.22 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.509 -0.744 . . . . 0.0 111.082 179.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.55 ' O ' HG22 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -63.69 -53.46 50.96 Favored 'General case' 0 N--CA 1.521 3.086 0 O-C-N 121.495 -0.753 . . . . 0.0 112.194 -178.346 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.526 ' OD1' ' N ' ' A' ' 34' ' ' ILE . 1.7 p30 -67.23 -40.56 86.35 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 120.415 -1.428 . . . . 0.0 109.312 179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.722 HD12 ' O ' ' A' ' 30' ' ' ARG . 15.7 mt -61.91 -39.44 83.58 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.193 0 O-C-N 120.506 -1.371 . . . . 0.0 109.363 178.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.639 HG13 HD12 ' A' ' 6' ' ' LEU . 0.1 OUTLIER -67.59 -38.12 79.95 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.435 0 O-C-N 120.238 -1.539 . . . . 0.0 109.221 178.519 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.424 ' CZ ' ' OD1' ' A' ' 77' ' ' ASP . 5.3 m-85 -62.28 -43.54 98.59 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.594 -1.316 . . . . 0.0 108.86 178.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 1.006 ' HB1' ' CD2' ' A' ' 23' ' ' LEU . . . -57.2 -54.66 44.27 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 120.413 -1.429 . . . . 0.0 108.501 178.044 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.632 HD12 HD11 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -54.59 -32.31 24.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.669 0 C-N-CA 117.402 -1.719 . . . . 0.0 109.345 179.088 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.553 ' O ' ' HB3' ' A' ' 43' ' ' ALA . 11.1 mt -68.33 -40.66 81.52 Favored 'General case' 0 N--CA 1.504 2.273 0 O-C-N 120.299 -1.501 . . . . 0.0 109.35 178.22 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.463 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 3.4 mtpp -66.23 -38.78 88.73 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.001 -1.062 . . . . 0.0 110.684 178.795 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.845 ' HG3' HD11 ' A' ' 23' ' ' LEU . 1.1 mm-40 -75.9 -52.87 9.38 Favored 'General case' 0 N--CA 1.495 1.805 0 O-C-N 121.24 -0.913 . . . . 0.0 111.13 -179.132 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.592 ' CG ' ' CE ' ' A' ' 1' ' ' MET . 2.8 t-80 -64.26 -36.38 83.92 Favored 'General case' 0 N--CA 1.51 2.54 0 O-C-N 120.951 -1.093 . . . . 0.0 109.37 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.553 ' HB3' ' O ' ' A' ' 39' ' ' LEU . . . -77.28 -32.24 55.35 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.89 -1.131 . . . . 0.0 110.62 179.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.463 ' HB2' ' O ' ' A' ' 40' ' ' LYS . 0.1 OUTLIER -47.33 -44.04 23.39 Favored 'General case' 0 N--CA 1.481 1.116 0 O-C-N 120.411 -1.43 . . . . 0.0 108.972 178.548 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 25.4 m -66.81 -10.57 49.12 Favored 'General case' 0 C--N 1.298 -1.645 0 C-N-CA 119.573 -0.851 . . . . 0.0 109.548 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.525 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . 65.78 31.53 80.09 Favored Glycine 0 N--CA 1.495 2.593 0 C-N-CA 120.401 -0.904 . . . . 0.0 111.156 178.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.555 ' OE2' ' ND1' ' A' ' 42' ' ' HIS . 3.4 pt-20 -85.15 170.13 13.2 Favored 'General case' 0 N--CA 1.484 1.226 0 O-C-N 120.408 -1.642 . . . . 0.0 109.225 179.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.543 ' C ' HG23 ' A' ' 49' ' ' ILE . 7.6 m-20 -61.54 138.07 58.27 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.14 -0.975 . . . . 0.0 111.934 -177.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.629 ' HA ' ' HA ' ' A' ' 1' ' ' MET . 0.5 OUTLIER -157.13 144.09 10.1 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.962 0 N-CA-C 107.179 -1.415 . . . . 0.0 107.179 178.455 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.584 ' O ' ' HA ' ' A' ' 2' ' ' ASN . 24.6 p90 -141.93 168.17 20.38 Favored 'General case' 0 C--N 1.312 -1.061 0 C-N-CA 115.616 -2.434 . . . . 0.0 115.504 -178.151 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -116.15 164.32 12.28 Favored Glycine 0 N--CA 1.499 2.867 0 N-CA-C 107.784 -2.126 . . . . 0.0 107.784 -179.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.512 ' C ' ' CD2' ' A' ' 65' ' ' LEU . 5.8 p-10 -172.37 163.18 5.59 Favored 'General case' 0 N--CA 1.481 1.106 0 O-C-N 120.322 -1.693 . . . . 0.0 109.657 -179.102 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.45 ' HA3' ' O ' ' A' ' 66' ' ' ARG . . . 146.31 -139.74 8.31 Favored Glycine 0 N--CA 1.504 3.195 0 C-N-CA 117.991 -2.052 . . . . 0.0 111.131 179.131 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.611 ' HA ' ' O ' ' A' ' 95' ' ' ASP . 2.6 t -128.07 119.7 51.71 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.112 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -179.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.786 HD21 HG21 ' A' ' 81' ' ' VAL . 6.9 mt -62.76 164.25 8.14 Favored 'General case' 0 N--CA 1.504 2.254 0 C-N-CA 118.782 -1.167 . . . . 0.0 113.869 -175.701 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.528 ' HA ' ' OG1' ' A' ' 93' ' ' THR . 0.8 OUTLIER -141.78 119.35 11.67 Favored 'General case' 0 N--CA 1.495 1.812 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 178.384 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.583 ' CG1' ' HB ' ' A' ' 93' ' ' THR . 1.0 OUTLIER -80.19 162.63 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 119.903 -1.748 . . . . 0.0 109.265 -178.718 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.726 HD13 ' HA2' ' A' ' 63' ' ' GLY . 3.3 mp -132.12 136.19 46.96 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.426 -1.421 . . . . 0.0 109.675 179.39 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.453 ' C ' ' O ' ' A' ' 58' ' ' LEU . 2.0 tt0 -39.77 -36.37 0.42 Allowed 'General case' 0 N--CA 1.49 1.549 0 CA-C-O 121.749 0.785 . . . . 0.0 110.102 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.458 ' HB2' ' CD1' ' A' ' 62' ' ' PHE . 66.6 m-20 -61.46 -5.94 2.04 Favored 'General case' 0 N--CA 1.501 2.092 0 C-N-CA 119.959 -0.696 . . . . 0.0 112.51 -179.247 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.446 ' O ' ' HB3' ' A' ' 83' ' ' PRO . . . 89.85 11.91 62.95 Favored Glycine 1 N--CA 1.52 4.282 0 C-N-CA 118.71 -1.709 . . . . 0.0 112.185 178.089 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.616 ' CZ ' HD22 ' A' ' 58' ' ' LEU . 2.8 p90 -132.95 -176.93 4.28 Favored 'General case' 0 C--N 1.307 -1.262 0 N-CA-C 103.865 -2.642 . . . . 0.0 103.865 177.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.726 ' HA2' HD13 ' A' ' 58' ' ' LEU . . . -158.75 172.39 35.58 Favored Glycine 0 N--CA 1.474 1.216 0 C-N-CA 116.933 -2.556 . . . . 0.0 111.706 -177.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.544 ' CE2' ' CE2' ' A' ' 62' ' ' PHE . 43.5 m-85 -129.7 154.29 47.31 Favored 'General case' 0 N--CA 1.483 1.216 0 CA-C-N 119.99 1.895 . . . . 0.0 109.708 177.48 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.512 ' CD2' ' C ' ' A' ' 52' ' ' ASP 0.255 0.2 OUTLIER -98.39 134.33 41.54 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 107.005 -1.479 . . . . 0.0 107.005 176.892 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.45 ' O ' ' HA3' ' A' ' 53' ' ' GLY . 0.4 OUTLIER -135.99 -173.04 3.27 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.225 -1.547 . . . . 0.0 109.658 179.446 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.479 ' HB2' ' OG ' ' A' ' 70' ' ' SER . 6.5 m -76.71 -161.17 0.18 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.036 -1.04 . . . . 0.0 110.573 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -127.68 -89.73 0.53 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.445 -0.785 . . . . 0.0 109.659 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 30.4 m-20 -77.24 44.69 0.42 Allowed 'General case' 0 N--CA 1.502 2.152 0 O-C-N 121.148 -0.97 . . . . 0.0 111.245 179.852 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.479 ' OG ' ' HB2' ' A' ' 67' ' ' SER . 0.1 OUTLIER -126.35 -7.68 6.4 Favored 'General case' 0 N--CA 1.499 2.006 0 O-C-N 120.17 -1.581 . . . . 0.0 110.464 -179.665 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.69 ' O ' ' HB2' ' A' ' 72' ' ' TYR . 0.6 OUTLIER 175.37 -20.45 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.229 0 O-C-N 120.851 -1.156 . . . . 0.0 111.537 -179.831 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.69 ' HB2' ' O ' ' A' ' 71' ' ' SER . 10.2 m-30 75.0 -40.76 0.45 Allowed 'General case' 0 N--CA 1.528 3.459 0 O-C-N 121.849 -0.532 . . . . 0.0 112.104 179.376 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.411 HD23 ' HA ' ' A' ' 73' ' ' LEU . 7.0 mt -88.37 -173.57 4.25 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 120.279 -1.513 . . . . 0.0 109.904 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.03 -153.01 0.08 Allowed 'General case' 0 C--N 1.292 -1.934 0 CA-C-O 122.46 1.124 . . . . 0.0 109.725 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.521 ' N ' ' OD2' ' A' ' 78' ' ' ASP . . . -176.29 162.5 31.31 Favored Glycine 0 C--N 1.28 -2.532 0 N-CA-C 107.724 -2.15 . . . . 0.0 107.724 179.614 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -65.16 -41.2 17.19 Favored 'Trans proline' 0 N--CA 1.489 1.215 0 CA-C-N 118.608 1.204 . . . . 0.0 112.077 179.842 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.471 ' O ' ' O ' ' A' ' 78' ' ' ASP . 4.7 m-20 -87.45 19.83 3.13 Favored 'General case' 0 N--CA 1.506 2.353 0 O-C-N 120.93 -1.106 . . . . 0.0 112.461 -178.648 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.521 ' OD2' ' N ' ' A' ' 75' ' ' GLY . 3.2 m-20 -58.97 -154.65 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.429 0 O-C-N 120.415 -1.428 . . . . 0.0 109.632 179.751 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.435 ' HB ' ' CB ' ' A' ' 65' ' ' LEU . 4.4 mm -120.21 131.61 72.07 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.745 0 O-C-N 120.969 -1.082 . . . . 0.0 109.979 179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.508 ' HB3' ' O ' ' A' ' 111' ' ' PHE . 10.4 t80 -76.71 147.35 37.44 Favored 'General case' 0 N--CA 1.518 2.934 0 CA-C-N 121.85 2.114 . . . . 0.0 109.462 179.261 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.786 HG21 HD21 ' A' ' 55' ' ' LEU . 11.1 t -145.51 116.8 1.95 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 120.151 -1.593 . . . . 0.0 110.2 -179.513 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.564 ' O ' HG13 ' A' ' 86' ' ' ILE . 56.1 m -74.95 161.67 76.62 Favored Pre-proline 0 N--CA 1.51 2.555 0 O-C-N 120.34 -1.475 . . . . 0.0 112.248 -179.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.583 ' HA ' HG13 ' A' ' 86' ' ' ILE . 38.0 Cg_endo -65.19 -50.97 1.73 Allowed 'Trans proline' 0 C--N 1.313 -1.315 0 O-C-N 124.887 1.993 . . . . 0.0 108.554 178.569 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.572 ' O ' ' CG ' ' A' ' 88' ' ' ARG . 3.0 p -46.02 -41.53 12.08 Favored 'General case' 0 N--CA 1.486 1.359 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 177.718 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.525 ' OE1' ' HA ' ' A' ' 85' ' ' GLN . 6.6 mm100 -62.48 -58.07 8.92 Favored 'General case' 0 N--CA 1.511 2.586 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 178.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.583 HG13 ' HA ' ' A' ' 83' ' ' PRO . 0.4 OUTLIER -55.83 -56.26 13.47 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.262 0 N-CA-C 108.477 -0.934 . . . . 0.0 108.477 178.386 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.482 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 9.7 mtt85 -58.41 -41.84 85.84 Favored 'General case' 0 C--N 1.294 -1.821 0 CA-C-O 121.825 0.822 . . . . 0.0 111.731 -179.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.572 ' CG ' ' O ' ' A' ' 84' ' ' SER . 0.1 OUTLIER -60.04 -37.66 80.46 Favored 'General case' 0 N--CA 1.507 2.376 0 C-N-CA 119.612 -0.835 . . . . 0.0 111.938 -177.679 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 1.019 ' HB2' HD21 ' A' ' 91' ' ' LEU . 5.0 m-85 -109.58 11.85 24.59 Favored 'General case' 0 N--CA 1.503 2.206 0 C-N-CA 116.818 -1.953 . . . . 0.0 111.148 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.406 ' CB ' ' O ' ' A' ' 89' ' ' PHE . 1.5 t-20 63.74 53.6 1.97 Allowed 'General case' 0 N--CA 1.486 1.342 0 O-C-N 120.611 -1.306 . . . . 0.0 110.818 178.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 1.019 HD21 ' HB2' ' A' ' 89' ' ' PHE . 2.9 mt -89.7 -168.96 2.3 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 119.37 -0.932 . . . . 0.0 109.752 179.259 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.53 ' CG ' ' O ' ' A' ' 91' ' ' LEU . 0.2 OUTLIER -159.7 161.38 34.83 Favored 'General case' 0 N--CA 1.495 1.813 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 178.231 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.583 ' HB ' ' CG1' ' A' ' 57' ' ' ILE . 1.9 t -64.83 155.64 33.39 Favored 'General case' 0 N--CA 1.495 1.804 0 C-N-CA 116.869 -1.932 . . . . 0.0 106.893 178.505 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . 0.407 ' C ' HG12 ' A' ' 54' ' ' VAL . . . 75.29 -9.09 14.6 Favored Glycine 0 N--CA 1.506 3.338 0 C-N-CA 117.299 -2.382 . . . . 0.0 110.388 179.329 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.611 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 15.4 m-20 -68.1 149.66 49.34 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.137 -1.802 . . . . 0.0 110.724 -178.784 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.493 ' O ' HG12 ' A' ' 97' ' ' ILE . 0.3 OUTLIER -91.58 121.19 33.04 Favored 'General case' 0 N--CA 1.49 1.556 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 179.621 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.53 HG23 HG22 ' A' ' 119' ' ' VAL . 1.4 mt -144.82 166.61 11.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 119.93 -1.732 . . . . 0.0 112.885 -178.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.493 ' OG ' ' HB2' ' A' ' 118' ' ' GLU . 96.7 p -150.93 139.76 20.85 Favored 'General case' 0 N--CA 1.487 1.415 0 CA-C-N 115.911 -0.586 . . . . 0.0 109.999 179.556 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.494 ' O ' ' HB2' ' A' ' 50' ' ' PHE . . . -164.47 -179.66 38.72 Favored Glycine 0 N--CA 1.509 3.545 0 C-N-CA 117.643 -2.218 . . . . 0.0 114.609 -179.214 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.506 ' HD3' HD23 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -87.23 155.39 20.11 Favored 'General case' 0 N--CA 1.504 2.239 0 N-CA-C 106.324 -1.732 . . . . 0.0 106.324 178.589 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.507 HG12 ' HA ' ' A' ' 50' ' ' PHE . 2.2 pt -122.46 158.56 26.52 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.643 0 CA-C-N 121.228 1.831 . . . . 0.0 114.435 -176.846 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.782 ' HB2' HD22 ' A' ' 114' ' ' LEU . 0.1 OUTLIER -163.89 167.47 10.87 Favored Pre-proline 0 N--CA 1.488 1.427 0 O-C-N 120.651 -1.281 . . . . 0.0 109.642 179.311 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.419 ' HD2' ' HD3' ' A' ' 102' ' ' ARG . 48.6 Cg_endo -89.62 122.8 1.17 Allowed 'Trans proline' 0 C--N 1.306 -1.673 0 O-C-N 124.068 1.562 . . . . 0.0 110.391 179.671 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.538 ' HD2' ' HB2' ' A' ' 108' ' ' GLU . 43.2 Cg_endo -68.31 -93.11 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.651 0 O-C-N 123.903 1.475 . . . . 0.0 111.019 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 2.9 mmtp -116.76 -177.96 3.31 Favored 'General case' 0 N--CA 1.5 2.053 0 O-C-N 121.401 -0.812 . . . . 0.0 110.464 -179.249 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -56.34 -25.97 50.95 Favored 'General case' 0 C--N 1.313 -1.01 0 O-C-N 120.693 -1.255 . . . . 0.0 109.357 179.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -85.13 43.3 3.23 Favored Glycine 0 N--CA 1.496 2.64 0 N-CA-C 108.504 -1.838 . . . . 0.0 108.504 178.154 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.566 ' O ' ' C ' ' A' ' 109' ' ' ARG . 0.7 OUTLIER -93.51 35.02 1.13 Allowed 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.709 -1.465 . . . . 0.0 111.397 -179.004 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.566 ' C ' ' O ' ' A' ' 108' ' ' GLU . 3.6 mmp_? -25.13 -45.08 0.01 OUTLIER 'General case' 0 N--CA 1.513 2.712 0 O-C-N 121.793 -0.567 . . . . 0.0 111.357 -179.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.536 ' N ' ' CD1' ' A' ' 110' ' ' TYR . 2.8 m-85 -109.26 154.75 22.0 Favored 'General case' 0 N--CA 1.518 2.938 0 O-C-N 120.581 -1.325 . . . . 0.0 107.72 177.066 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.508 ' O ' ' HB3' ' A' ' 80' ' ' TYR . 38.1 m-85 -66.9 165.56 15.18 Favored 'General case' 0 N--CA 1.508 2.427 0 O-C-N 119.135 -2.228 . . . . 0.0 107.273 178.58 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.433 ' HA ' ' HB3' ' A' ' 80' ' ' TYR . . . -123.24 152.87 40.88 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 119.905 -1.747 . . . . 0.0 111.216 -178.504 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.42 HD12 ' N ' ' A' ' 114' ' ' LEU . 0.1 OUTLIER -66.77 153.68 42.72 Favored 'General case' 0 N--CA 1.485 1.314 0 N-CA-C 105.789 -1.93 . . . . 0.0 105.789 178.753 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.782 HD22 ' HB2' ' A' ' 102' ' ' ARG . 12.9 tp -130.86 -59.41 1.0 Allowed 'General case' 0 N--CA 1.5 2.066 0 O-C-N 120.047 -1.658 . . . . 0.0 112.361 -178.313 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.49 ' HB3' ' HG2' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -114.05 139.97 48.85 Favored 'General case' 0 N--CA 1.512 2.646 0 O-C-N 120.383 -1.448 . . . . 0.0 108.767 179.206 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 23.7 t -92.27 128.78 43.67 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.804 0 O-C-N 120.477 -1.39 . . . . 0.0 111.37 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.423 ' CG ' ' HA2' ' A' ' 99' ' ' GLY . 4.8 m-20 -106.97 -38.5 6.03 Favored 'General case' 0 N--CA 1.508 2.426 0 O-C-N 121.355 -0.841 . . . . 0.0 109.947 178.624 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.574 ' C ' HG23 ' A' ' 119' ' ' VAL . 1.1 tt0 -143.5 157.21 44.62 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 120.786 -1.196 . . . . 0.0 109.803 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.574 HG23 ' C ' ' A' ' 118' ' ' GLU . 17.8 t -159.74 130.99 0.92 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.012 0 O-C-N 122.387 -0.196 . . . . 0.0 110.511 -178.532 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.43 ' O ' ' C ' ' A' ' 121' ' ' PHE . 0.1 OUTLIER 47.95 48.24 18.11 Favored 'General case' 0 N--CA 1.521 3.081 0 O-C-N 120.309 -1.495 . . . . 0.0 111.481 178.902 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.43 ' C ' ' O ' ' A' ' 120' ' ' ASN . 0.6 OUTLIER 42.81 32.16 0.37 Allowed 'General case' 0 N--CA 1.52 3.056 0 O-C-N 120.557 -1.339 . . . . 0.0 110.43 179.152 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 65.2 m-20 -139.61 165.87 26.1 Favored 'General case' 0 N--CA 1.486 1.356 0 O-C-N 121.05 -1.031 . . . . 0.0 108.455 178.983 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.451 ' CD ' ' H ' ' A' ' 123' ' ' LYS . 0.0 OUTLIER -78.47 143.73 64.45 Favored Pre-proline 0 N--CA 1.504 2.229 0 O-C-N 120.564 -1.335 . . . . 0.0 109.109 -179.971 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.459 ' O ' ' HB2' ' A' ' 125' ' ' GLU . 46.6 Cg_endo -73.65 42.63 0.71 Allowed 'Trans proline' 0 C--N 1.309 -1.536 0 O-C-N 123.879 1.462 . . . . 0.0 110.855 -179.711 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.561 ' O ' ' CB ' ' A' ' 126' ' ' ASN . 5.3 tp10 -179.25 -144.73 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.561 ' CB ' ' O ' ' A' ' 125' ' ' GLU . 0.3 OUTLIER 162.74 -90.14 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.266 0 O-C-N 120.874 -1.141 . . . . 0.0 109.29 179.428 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.505 ' C ' ' HG2' ' A' ' 128' ' ' ARG . . . -149.32 6.72 0.67 Allowed 'General case' 0 N--CA 1.498 1.941 0 O-C-N 121.206 -0.934 . . . . 0.0 111.099 179.566 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.505 ' HG2' ' C ' ' A' ' 127' ' ' ALA . 0.8 OUTLIER -139.8 166.86 23.5 Favored 'General case' 0 N--CA 1.501 2.084 0 O-C-N 121.462 -0.774 . . . . 0.0 109.655 179.569 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -117.78 145.6 44.4 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.114 -0.991 . . . . 0.0 109.621 179.679 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 N--CA 1.482 1.129 0 O-C-N 120.708 -1.245 . . . . 0.0 109.755 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.668 ' HA ' ' HA ' ' A' ' 49' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.598 0 N-CA-C 109.889 -0.411 . . . . 0.0 109.889 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.561 ' HB3' ' HB2' ' A' ' 5' ' ' GLU . 39.3 t30 -78.46 94.18 4.88 Favored 'General case' 0 N--CA 1.5 2.043 0 O-C-N 120.85 -1.156 . . . . 0.0 108.137 178.836 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.901 HD12 HD12 ' A' ' 6' ' ' LEU . 0.5 OUTLIER -41.81 -42.29 2.62 Favored 'General case' 0 N--CA 1.519 3.007 0 O-C-N 120.518 -1.364 . . . . 0.0 110.241 -178.399 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.7 m -56.33 -36.46 68.74 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.983 -1.073 . . . . 0.0 108.311 -179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.561 ' HB2' ' HB3' ' A' ' 2' ' ' ASN . 3.0 mt-10 -76.54 -39.26 53.38 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.9 -1.125 . . . . 0.0 109.317 178.06 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.901 HD12 HD12 ' A' ' 3' ' ' LEU 0.267 90.7 mt -54.82 -49.2 71.61 Favored 'General case' 0 C--O 1.215 -0.752 0 O-C-N 120.31 -1.494 . . . . 0.0 109.174 177.984 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.04 -39.16 75.9 Favored 'General case' 0 N--CA 1.499 2.007 0 O-C-N 120.936 -1.103 . . . . 0.0 110.769 179.15 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.1 m-80 -63.14 -22.48 66.89 Favored 'General case' 0 N--CA 1.507 2.405 0 O-C-N 121.1 -1.0 . . . . 0.0 111.221 -179.119 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.727 ' HB ' HD11 ' A' ' 14' ' ' LEU . 22.7 m -81.12 140.02 49.36 Favored Pre-proline 0 N--CA 1.505 2.278 0 N-CA-C 108.599 -0.889 . . . . 0.0 108.599 179.671 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.537 ' HG2' ' HG3' ' A' ' 13' ' ' GLU . 41.6 Cg_endo -63.75 152.23 81.48 Favored 'Trans proline' 0 CA--C 1.566 2.088 0 O-C-N 122.293 0.628 . . . . 0.0 111.773 -177.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.506 ' O ' ' HB2' ' A' ' 14' ' ' LEU . 1.5 p -47.58 -50.42 8.62 Favored 'Isoleucine or valine' 0 N--CA 1.526 3.337 0 O-C-N 120.517 -1.364 . . . . 0.0 109.997 -178.811 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.502 ' N ' ' CG1' ' A' ' 11' ' ' VAL . 1.6 t -54.48 -43.72 71.98 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 121.011 -1.055 . . . . 0.0 110.763 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.56 ' HB3' ' CG2' ' A' ' 9' ' ' THR . 1.0 OUTLIER -68.31 -27.12 66.01 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 118.158 -1.417 . . . . 0.0 107.967 179.631 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.806 HD23 ' HG2' ' A' ' 31' ' ' LYS . 1.3 mp -70.11 -43.45 71.0 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.985 -1.072 . . . . 0.0 108.603 177.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.499 HG12 ' HB2' ' A' ' 26' ' ' LEU . 1.6 mp -66.55 -39.1 83.09 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 C-N-CA 118.148 -1.421 . . . . 0.0 108.822 178.945 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.502 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 58.8 m -64.89 -38.0 89.5 Favored 'General case' 0 N--CA 1.49 1.557 0 C-N-CA 118.036 -1.466 . . . . 0.0 109.205 178.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.33 -36.82 83.91 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 120.792 -1.192 . . . . 0.0 108.907 178.709 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.519 ' HA2' HD13 ' A' ' 23' ' ' LEU . . . -67.91 -43.2 83.76 Favored Glycine 0 N--CA 1.515 3.961 0 N-CA-C 108.129 -1.989 . . . . 0.0 108.129 178.166 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . . . . . . . . . 1.4 mm-40 -55.51 -46.39 76.98 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 120.631 -1.511 . . . . 0.0 107.685 178.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.502 ' OD1' ' O ' ' A' ' 16' ' ' THR . 25.2 m120 -59.53 -25.64 64.67 Favored 'General case' 0 N--CA 1.493 1.682 0 C-N-CA 118.202 -1.399 . . . . 0.0 109.145 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.552 ' HB2' ' CD1' ' A' ' 23' ' ' LEU . 64.7 mmm -100.93 11.99 38.52 Favored 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.489 -0.757 . . . . 0.0 111.06 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 96.06 -17.15 59.82 Favored Glycine 0 N--CA 1.502 3.058 0 C-N-CA 118.804 -1.665 . . . . 0.0 111.408 179.31 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 1.0 HD23 ' HB1' ' A' ' 37' ' ' ALA . 4.1 mp -79.41 102.76 8.89 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.471 -1.605 . . . . 0.0 109.782 -179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.478 ' O ' ' HB2' ' A' ' 25' ' ' ASN . 2.0 pt-20 -114.85 -179.72 3.71 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.28 -0.888 . . . . 0.0 109.1 179.676 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.478 ' HB2' ' O ' ' A' ' 24' ' ' GLU . 1.8 m120 62.38 18.48 10.32 Favored 'General case' 0 N--CA 1.51 2.53 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.7 178.851 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 1.071 HD23 ' SD ' ' A' ' 29' ' ' MET . 1.2 mt -76.29 -18.22 59.07 Favored 'General case' 0 N--CA 1.504 2.233 0 O-C-N 121.196 -0.94 . . . . 0.0 111.408 179.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -47.27 -29.5 2.48 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.213 -1.555 . . . . 0.0 109.524 -179.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -78.88 -30.4 44.97 Favored 'General case' 0 C--N 1.295 -1.795 0 C-N-CA 120.11 -0.636 . . . . 0.0 112.2 -179.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 1.071 ' SD ' HD23 ' A' ' 26' ' ' LEU . 6.6 ptm -93.22 166.99 12.05 Favored 'General case' 0 C--N 1.311 -1.073 0 O-C-N 120.426 -1.421 . . . . 0.0 111.084 -179.956 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.999 ' O ' HD12 ' A' ' 34' ' ' ILE . 1.0 OUTLIER -89.39 -173.65 4.08 Favored 'General case' 0 N--CA 1.506 2.358 0 CA-C-O 122.219 1.009 . . . . 0.0 112.864 -178.428 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.806 ' HG2' HD23 ' A' ' 14' ' ' LEU . 0.3 OUTLIER -66.32 -35.67 80.97 Favored 'General case' 0 N--CA 1.498 1.933 0 CA-C-N 115.892 -0.595 . . . . 0.0 111.522 -179.722 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -63.02 -58.82 6.01 Favored 'General case' 0 N--CA 1.515 2.796 0 O-C-N 120.766 -1.209 . . . . 0.0 109.667 -178.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.523 ' CG ' ' HE2' ' A' ' 29' ' ' MET . 3.6 p30 -66.3 -35.27 79.95 Favored 'General case' 0 C--N 1.305 -1.334 0 O-C-N 121.457 -0.777 . . . . 0.0 109.717 -179.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.999 HD12 ' O ' ' A' ' 30' ' ' ARG . 0.8 OUTLIER -60.9 -43.72 96.36 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.483 0 O-C-N 120.081 -1.637 . . . . 0.0 107.898 177.141 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.56 HG13 ' O ' ' A' ' 31' ' ' LYS . 86.7 mt -63.39 -45.38 98.19 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.854 0 O-C-N 120.318 -1.489 . . . . 0.0 110.357 178.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.418 ' HA ' HD12 ' A' ' 39' ' ' LEU . 3.6 m-30 -53.59 -40.15 65.43 Favored 'General case' 0 N--CA 1.487 1.381 0 C-N-CA 119.203 -0.999 . . . . 0.0 108.566 -179.051 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 1.0 ' HB1' HD23 ' A' ' 23' ' ' LEU . . . -68.09 -54.28 19.36 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.614 -1.304 . . . . 0.0 109.606 178.221 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.526 HG13 ' O ' ' A' ' 34' ' ' ILE . 0.1 OUTLIER -53.49 -28.0 15.2 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 C-N-CA 117.545 -1.662 . . . . 0.0 110.007 -179.969 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.487 HD11 HG22 ' A' ' 35' ' ' ILE . 79.8 mt -71.13 -43.68 67.12 Favored 'General case' 0 N--CA 1.501 2.109 0 O-C-N 120.219 -1.551 . . . . 0.0 109.335 178.191 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -65.26 -39.69 92.98 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.979 -1.075 . . . . 0.0 110.581 178.832 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.781 ' CB ' HD11 ' A' ' 23' ' ' LEU . 1.4 mp0 -74.56 -51.22 15.24 Favored 'General case' 0 N--CA 1.504 2.225 0 O-C-N 121.146 -0.971 . . . . 0.0 110.726 -179.417 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.64 ' CD2' ' CB ' ' A' ' 47' ' ' GLU . 9.9 t60 -61.99 -34.55 76.37 Favored 'General case' 0 N--CA 1.51 2.539 0 C-N-CA 118.65 -1.22 . . . . 0.0 108.573 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.451 ' O ' ' N ' ' A' ' 46' ' ' GLY . . . -70.51 -45.26 65.94 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.043 -1.036 . . . . 0.0 109.079 178.349 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -48.28 -45.66 34.97 Favored 'General case' 0 N--CA 1.484 1.252 0 O-C-N 120.752 -1.217 . . . . 0.0 109.138 178.274 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 68.4 m -66.99 -6.94 18.94 Favored 'General case' 0 C--N 1.297 -1.68 0 CA-C-O 121.547 0.689 . . . . 0.0 109.696 179.736 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.451 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . 76.45 24.9 66.84 Favored Glycine 0 N--CA 1.498 2.801 0 C-N-CA 120.148 -1.025 . . . . 0.0 112.094 178.329 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.64 ' CB ' ' CD2' ' A' ' 42' ' ' HIS . 0.2 OUTLIER -79.42 166.74 21.71 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.129 -1.806 . . . . 0.0 109.086 178.817 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.432 ' C ' ' CG2' ' A' ' 49' ' ' ILE . 8.3 m-20 -88.66 150.02 23.23 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.07 -1.019 . . . . 0.0 109.391 179.554 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.668 ' HA ' ' HA ' ' A' ' 1' ' ' MET . 0.5 OUTLIER -148.98 143.28 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 120.668 -1.27 . . . . 0.0 108.46 179.246 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.584 ' HB2' ' O ' ' A' ' 99' ' ' GLY . 23.6 p90 -142.75 172.07 13.2 Favored 'General case' 0 C--N 1.305 -1.336 0 C-N-CA 116.088 -2.245 . . . . 0.0 114.918 -177.992 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -126.23 168.94 18.23 Favored Glycine 0 N--CA 1.508 3.445 0 N-CA-C 109.13 -1.588 . . . . 0.0 109.13 -178.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 2.7 p30 -169.67 166.51 9.85 Favored 'General case' 0 N--CA 1.486 1.335 0 O-C-N 120.429 -1.63 . . . . 0.0 110.315 -178.904 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.587 ' HA3' ' O ' ' A' ' 66' ' ' ARG . . . 142.47 -135.75 6.79 Favored Glycine 0 N--CA 1.506 3.306 0 C-N-CA 118.349 -1.882 . . . . 0.0 111.591 178.326 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.567 ' HA ' ' O ' ' A' ' 95' ' ' ASP . 2.6 t -128.44 120.04 51.9 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.191 0 O-C-N 121.235 -1.156 . . . . 0.0 108.292 -179.467 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.853 HD21 HG21 ' A' ' 81' ' ' VAL . 6.0 mt -62.92 161.2 13.3 Favored 'General case' 0 N--CA 1.503 2.22 0 C-N-CA 118.645 -1.222 . . . . 0.0 113.681 -175.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.504 ' HA ' ' OG1' ' A' ' 93' ' ' THR . 18.1 mm-40 -137.14 117.89 14.05 Favored 'General case' 0 N--CA 1.499 1.994 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 177.86 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.647 ' C ' HD12 ' A' ' 58' ' ' LEU . 1.4 mm -82.3 162.67 3.29 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.137 0 O-C-N 119.959 -1.713 . . . . 0.0 109.624 -178.591 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.956 HD22 ' CZ ' ' A' ' 62' ' ' PHE . 5.8 mp -129.95 137.64 50.44 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 120.531 -1.356 . . . . 0.0 109.462 179.107 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.458 ' C ' ' O ' ' A' ' 58' ' ' LEU . 1.8 mt-30 -42.09 -34.69 0.77 Allowed 'General case' 0 N--CA 1.497 1.902 0 CA-C-O 121.951 0.881 . . . . 0.0 109.143 -179.779 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -61.34 -7.17 2.69 Favored 'General case' 0 N--CA 1.499 2.012 0 C-N-CA 120.213 -0.595 . . . . 0.0 112.341 -179.279 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 90.99 7.51 65.87 Favored Glycine 1 N--CA 1.52 4.252 0 C-N-CA 118.804 -1.665 . . . . 0.0 112.225 178.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.956 ' CZ ' HD22 ' A' ' 58' ' ' LEU . 2.0 p90 -127.8 179.77 5.37 Favored 'General case' 0 N--CA 1.486 1.353 0 N-CA-C 104.469 -2.419 . . . . 0.0 104.469 178.087 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.55 ' N ' ' CD1' ' A' ' 62' ' ' PHE . . . -156.22 171.48 33.99 Favored Glycine 0 N--CA 1.477 1.387 0 C-N-CA 117.186 -2.435 . . . . 0.0 111.879 -178.111 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.467 ' CE2' ' HE1' ' A' ' 62' ' ' PHE . 14.5 m-85 -128.99 149.11 50.96 Favored 'General case' 0 N--CA 1.484 1.253 0 CA-C-N 119.861 1.831 . . . . 0.0 109.25 177.238 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.546 ' HB3' ' HB ' ' A' ' 79' ' ' ILE . 0.6 OUTLIER -99.42 165.35 11.7 Favored 'General case' 0 N--CA 1.489 1.507 0 N-CA-C 106.874 -1.528 . . . . 0.0 106.874 176.392 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.587 ' O ' ' HA3' ' A' ' 53' ' ' GLY . 0.0 OUTLIER 172.49 -169.73 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.97 -1.081 . . . . 0.0 109.712 178.525 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.465 ' HB2' ' OG ' ' A' ' 70' ' ' SER . 17.1 m -71.94 -159.96 0.06 Allowed 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.716 -1.24 . . . . 0.0 109.949 179.691 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -107.03 -76.02 0.62 Allowed 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 119.697 -0.801 . . . . 0.0 110.048 -179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.1 p30 -73.28 51.39 0.32 Allowed 'General case' 0 N--CA 1.501 2.09 0 O-C-N 121.305 -0.872 . . . . 0.0 110.824 179.831 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.546 ' O ' ' CB ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -110.56 -18.62 13.15 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 120.399 -1.438 . . . . 0.0 110.3 -179.717 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.623 ' O ' ' HB2' ' A' ' 72' ' ' TYR . 0.4 OUTLIER 165.65 -12.95 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.423 0 O-C-N 121.282 -0.886 . . . . 0.0 111.184 -179.689 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.623 ' HB2' ' O ' ' A' ' 71' ' ' SER . 69.7 m-85 77.52 -45.94 0.46 Allowed 'General case' 0 N--CA 1.524 3.234 0 O-C-N 121.798 -0.564 . . . . 0.0 110.764 -179.265 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 11.2 mt -87.77 -171.49 3.45 Favored 'General case' 0 N--CA 1.485 1.29 0 O-C-N 120.63 -1.294 . . . . 0.0 108.794 178.827 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.03 -162.21 0.37 Allowed 'General case' 0 C--N 1.289 -2.055 0 CA-C-O 122.026 0.917 . . . . 0.0 109.113 179.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . . . . . . . . . . . -174.3 162.37 32.7 Favored Glycine 0 C--N 1.278 -2.64 0 N-CA-C 107.876 -2.09 . . . . 0.0 107.876 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.524 ' O ' ' CD1' ' A' ' 110' ' ' TYR . 35.7 Cg_endo -65.27 -41.49 15.99 Favored 'Trans proline' 0 N--CA 1.49 1.324 0 CA-C-N 118.352 1.076 . . . . 0.0 112.42 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -86.42 13.88 7.57 Favored 'General case' 0 N--CA 1.509 2.484 0 O-C-N 120.894 -1.129 . . . . 0.0 112.51 -178.471 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.529 ' OD1' ' N ' ' A' ' 78' ' ' ASP . 0.8 OUTLIER -77.43 -150.03 0.04 OUTLIER 'General case' 0 N--CA 1.504 2.271 0 O-C-N 120.451 -1.405 . . . . 0.0 109.174 179.296 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.546 ' HB ' ' HB3' ' A' ' 65' ' ' LEU . 1.3 mp -117.88 127.64 75.13 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.721 0 C-N-CA 119.169 -1.012 . . . . 0.0 108.507 177.548 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.456 ' HB3' ' HA ' ' A' ' 112' ' ' ALA . 6.8 t80 -73.61 146.19 44.83 Favored 'General case' 0 N--CA 1.515 2.796 0 O-C-N 119.689 -1.882 . . . . 0.0 110.125 -178.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.853 HG21 HD21 ' A' ' 55' ' ' LEU . 34.5 t -140.36 112.02 4.49 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.943 0 O-C-N 120.324 -1.485 . . . . 0.0 110.603 -179.563 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.539 ' O ' HG13 ' A' ' 86' ' ' ILE . 57.9 m -74.67 165.99 49.0 Favored Pre-proline 0 N--CA 1.513 2.697 0 O-C-N 120.519 -1.363 . . . . 0.0 112.041 -179.422 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.521 ' HD2' ' HB3' ' A' ' 82' ' ' SER . 40.1 Cg_endo -65.21 -50.24 2.17 Favored 'Trans proline' 0 C--N 1.315 -1.189 0 O-C-N 124.317 1.693 . . . . 0.0 109.287 179.092 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.554 ' O ' ' CG ' ' A' ' 88' ' ' ARG . 0.3 OUTLIER -47.92 -39.66 19.7 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 178.106 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.536 ' HB2' ' O ' ' A' ' 82' ' ' SER . 5.6 mm100 -63.56 -58.86 5.65 Favored 'General case' 0 N--CA 1.51 2.551 0 C-N-CA 119.375 -0.93 . . . . 0.0 108.68 178.378 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.539 HG13 ' O ' ' A' ' 82' ' ' SER . 0.3 OUTLIER -57.23 -54.22 33.32 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.417 0 O-C-N 121.076 -1.015 . . . . 0.0 108.76 178.848 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.46 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 0.2 OUTLIER -56.25 -43.83 79.06 Favored 'General case' 0 C--N 1.298 -1.662 0 CA-C-O 121.924 0.869 . . . . 0.0 111.27 -179.519 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.554 ' CG ' ' O ' ' A' ' 84' ' ' SER . 0.1 OUTLIER -57.97 -36.71 72.98 Favored 'General case' 0 N--CA 1.506 2.369 0 C-N-CA 119.792 -0.763 . . . . 0.0 111.724 -177.694 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 8.5 m-85 -113.73 13.76 18.62 Favored 'General case' 0 N--CA 1.502 2.153 0 C-N-CA 117.359 -1.736 . . . . 0.0 111.462 -179.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 58.41 55.13 5.12 Favored 'General case' 0 N--CA 1.484 1.239 0 O-C-N 120.434 -1.416 . . . . 0.0 109.621 178.656 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.505 ' O ' ' HG2' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -89.11 -179.29 5.87 Favored 'General case' 0 N--CA 1.496 1.834 0 C-N-CA 119.521 -0.872 . . . . 0.0 109.968 -179.832 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.505 ' HG2' ' O ' ' A' ' 91' ' ' LEU . 10.6 mtt-85 -155.13 158.21 38.64 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.186 -0.946 . . . . 0.0 109.115 178.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.618 ' HB ' ' CG1' ' A' ' 57' ' ' ILE . 2.3 t -63.7 156.39 27.14 Favored 'General case' 0 N--CA 1.496 1.836 0 C-N-CA 117.205 -1.798 . . . . 0.0 107.186 179.345 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 76.23 -10.33 16.24 Favored Glycine 0 N--CA 1.505 3.272 0 C-N-CA 117.007 -2.52 . . . . 0.0 110.233 179.133 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.567 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 25.4 m-20 -70.34 146.86 50.21 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 120.272 -1.723 . . . . 0.0 110.795 -178.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.497 ' O ' HG12 ' A' ' 97' ' ' ILE . 0.2 OUTLIER -90.09 121.22 31.95 Favored 'General case' 0 N--CA 1.488 1.467 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 179.209 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.56 HG23 HG22 ' A' ' 119' ' ' VAL . 1.5 mt -145.67 168.51 7.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 O-C-N 119.733 -1.854 . . . . 0.0 112.89 -178.109 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.51 ' OG ' ' HB2' ' A' ' 118' ' ' GLU . 98.5 p -148.49 137.55 21.74 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 178.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.584 ' O ' ' HB2' ' A' ' 50' ' ' PHE . . . -161.95 176.11 38.41 Favored Glycine 0 N--CA 1.506 3.324 0 C-N-CA 117.163 -2.446 . . . . 0.0 114.546 -178.893 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.801 ' HD3' HD23 ' A' ' 114' ' ' LEU . 2.9 ptmt -88.83 156.66 18.81 Favored 'General case' 0 N--CA 1.497 1.888 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 179.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.524 HG12 ' HA ' ' A' ' 50' ' ' PHE . 2.0 pt -125.55 156.36 35.0 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.432 0 CA-C-N 120.37 1.441 . . . . 0.0 113.588 -176.965 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.955 ' HG3' HD22 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -154.34 169.24 10.38 Favored Pre-proline 0 N--CA 1.488 1.466 0 O-C-N 120.56 -1.337 . . . . 0.0 109.5 179.289 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 51.0 Cg_endo -83.98 133.97 5.98 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 O-C-N 123.964 1.507 . . . . 0.0 110.495 -179.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.519 ' HD2' ' HG3' ' A' ' 108' ' ' GLU . 49.5 Cg_endo -80.12 -95.77 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.736 0 O-C-N 123.985 1.519 . . . . 0.0 110.448 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -134.59 -175.79 4.0 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.49 -0.756 . . . . 0.0 110.067 -179.669 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -50.43 -26.45 5.04 Favored 'General case' 0 N--CA 1.477 0.912 0 O-C-N 120.517 -1.364 . . . . 0.0 109.179 179.572 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -84.64 46.79 3.73 Favored Glycine 0 N--CA 1.494 2.528 0 N-CA-C 107.735 -2.146 . . . . 0.0 107.735 177.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.558 ' O ' ' N ' ' A' ' 110' ' ' TYR . 4.2 tm-20 -86.01 -71.32 0.54 Allowed 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.879 -1.365 . . . . 0.0 111.077 -178.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.501 ' HB3' ' O ' ' A' ' 108' ' ' GLU . 0.4 OUTLIER 64.22 -58.06 0.22 Allowed 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.535 -0.728 . . . . 0.0 109.443 -178.803 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.558 ' N ' ' O ' ' A' ' 108' ' ' GLU . 22.7 m-85 -107.92 152.35 24.56 Favored 'General case' 0 N--CA 1.516 2.85 0 N-CA-C 107.252 -1.388 . . . . 0.0 107.252 176.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.431 ' O ' ' HB3' ' A' ' 80' ' ' TYR . 51.4 m-85 -67.32 168.16 11.11 Favored 'General case' 0 N--CA 1.507 2.424 0 O-C-N 119.246 -2.159 . . . . 0.0 108.252 179.275 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.456 ' HA ' ' HB3' ' A' ' 80' ' ' TYR . . . -122.87 154.93 37.64 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 119.994 -1.692 . . . . 0.0 110.883 -178.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.1 tp -68.38 148.41 50.73 Favored 'General case' 0 N--CA 1.491 1.586 0 N-CA-C 107.13 -1.433 . . . . 0.0 107.13 179.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.955 HD22 ' HG3' ' A' ' 102' ' ' ARG . 9.7 tp -128.74 -55.18 1.22 Allowed 'General case' 0 N--CA 1.5 2.026 0 O-C-N 120.315 -1.49 . . . . 0.0 112.616 -178.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.498 ' HB3' ' CG ' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -125.64 141.97 51.75 Favored 'General case' 0 N--CA 1.509 2.514 0 O-C-N 120.236 -1.54 . . . . 0.0 109.1 179.658 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.4 t -92.53 130.46 41.6 Favored 'Isoleucine or valine' 0 N--CA 1.515 2.792 0 O-C-N 120.517 -1.364 . . . . 0.0 110.943 179.501 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 3.6 m-20 -107.28 -38.73 5.88 Favored 'General case' 0 N--CA 1.506 2.375 0 O-C-N 121.393 -0.817 . . . . 0.0 110.012 178.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.533 ' C ' HG23 ' A' ' 119' ' ' VAL . 0.5 OUTLIER -143.24 158.33 43.72 Favored 'General case' 0 N--CA 1.487 1.421 0 O-C-N 120.853 -1.154 . . . . 0.0 109.435 179.722 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.56 HG22 HG23 ' A' ' 97' ' ' ILE . 44.3 t -158.8 133.62 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.062 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 -178.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.467 ' O ' ' C ' ' A' ' 121' ' ' PHE . 4.9 t-20 51.03 44.95 28.4 Favored 'General case' 0 N--CA 1.521 3.102 0 O-C-N 120.313 -1.492 . . . . 0.0 111.231 179.706 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.467 ' C ' ' O ' ' A' ' 120' ' ' ASN . 0.5 OUTLIER 39.41 35.9 0.19 Allowed 'General case' 0 N--CA 1.521 3.102 0 O-C-N 120.795 -1.19 . . . . 0.0 110.19 179.546 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -154.46 175.87 13.06 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.17 -0.956 . . . . 0.0 108.989 179.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.494 ' HB3' ' HD2' ' A' ' 124' ' ' PRO . 0.0 OUTLIER -64.04 166.91 8.96 Favored Pre-proline 0 N--CA 1.506 2.371 0 O-C-N 121.023 -1.048 . . . . 0.0 108.935 -179.974 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.494 ' HD2' ' HB3' ' A' ' 123' ' ' LYS . 45.7 Cg_endo -72.86 44.13 0.75 Allowed 'Trans proline' 0 C--N 1.307 -1.647 0 O-C-N 123.816 1.429 . . . . 0.0 111.17 -179.343 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.526 ' O ' ' ND2' ' A' ' 126' ' ' ASN . 0.7 OUTLIER -176.55 -153.29 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -179.986 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.526 ' ND2' ' O ' ' A' ' 125' ' ' GLU . 0.2 OUTLIER 168.34 31.15 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.302 0 O-C-N 120.339 -1.476 . . . . 0.0 110.5 179.734 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -124.83 15.43 8.64 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.716 -1.24 . . . . 0.0 110.52 -179.921 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.482 ' HD3' ' OE1' ' A' ' 125' ' ' GLU . 0.2 OUTLIER -159.0 165.04 34.94 Favored 'General case' 0 N--CA 1.498 1.957 0 O-C-N 121.41 -0.806 . . . . 0.0 110.546 -179.962 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -128.3 165.76 19.93 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.4 -0.813 . . . . 0.0 110.148 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.414 ' OXT' ' HG2' ' A' ' 130' ' ' LYS . 0.0 OUTLIER . . . . . 0 C--N 1.304 -1.389 0 CA-C-O 117.969 -1.015 . . . . 0.0 109.796 -179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.658 ' HA ' ' HA ' ' A' ' 49' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.606 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.54 ' HA ' ' O ' ' A' ' 50' ' ' PHE . 52.5 t30 -78.44 96.73 5.45 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.919 -1.113 . . . . 0.0 108.356 178.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.941 HD23 ' CD1' ' A' ' 79' ' ' ILE . 0.6 OUTLIER -41.78 -41.89 2.47 Favored 'General case' 0 N--CA 1.516 2.863 0 O-C-N 120.405 -1.435 . . . . 0.0 110.501 -178.397 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.411 ' OG1' ' OD1' ' A' ' 52' ' ' ASP . 1.7 m -57.77 -37.55 73.87 Favored 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.577 -1.327 . . . . 0.0 108.151 -179.489 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.517 ' HB3' ' HB3' ' A' ' 2' ' ' ASN . 0.8 OUTLIER -70.4 -45.28 66.27 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.06 -1.025 . . . . 0.0 108.59 177.932 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.873 HD12 HD12 ' A' ' 3' ' ' LEU 0.278 84.0 mt -51.27 -50.04 60.04 Favored 'General case' 0 C--N 1.315 -0.893 0 O-C-N 120.886 -1.133 . . . . 0.0 109.476 178.15 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.467 ' HE3' ' HA ' ' A' ' 74' ' ' ALA . 5.7 mmtt -64.06 -36.49 84.17 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.241 -0.912 . . . . 0.0 110.085 179.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.4 m-80 -61.93 -25.52 67.63 Favored 'General case' 0 N--CA 1.508 2.455 0 C-N-CA 119.282 -0.967 . . . . 0.0 111.031 -179.035 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.605 ' CG2' ' HB3' ' A' ' 13' ' ' GLU . 4.4 m -74.49 132.84 77.93 Favored Pre-proline 0 N--CA 1.504 2.256 0 O-C-N 121.675 -0.641 . . . . 0.0 109.687 -179.899 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.501 ' HG2' ' HB2' ' A' ' 13' ' ' GLU . 45.0 Cg_endo -65.16 150.84 87.19 Favored 'Trans proline' 0 CA--C 1.567 2.149 0 CA-C-N 118.767 0.595 . . . . 0.0 110.67 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.584 HG23 ' HG3' ' A' ' 31' ' ' LYS . 1.7 p -42.44 -50.28 1.0 Allowed 'Isoleucine or valine' 0 N--CA 1.527 3.391 0 O-C-N 120.542 -1.348 . . . . 0.0 110.162 -178.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.552 ' N ' ' CG1' ' A' ' 11' ' ' VAL . 1.0 OUTLIER -57.67 -41.84 82.36 Favored 'General case' 0 N--CA 1.498 1.952 0 O-C-N 121.294 -0.879 . . . . 0.0 111.174 -179.266 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.805 ' O ' HD12 ' A' ' 17' ' ' LEU . 0.2 OUTLIER -69.25 -27.7 65.68 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 117.69 -1.604 . . . . 0.0 107.682 179.233 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.615 ' HB3' HG21 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -69.29 -43.1 74.52 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 120.828 -1.17 . . . . 0.0 108.754 176.906 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.529 HD12 ' O ' ' A' ' 11' ' ' VAL . 1.4 mp -65.61 -40.59 88.44 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 C-N-CA 117.752 -1.579 . . . . 0.0 108.599 178.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.56 ' HA ' ' HG2' ' A' ' 19' ' ' GLU . 33.0 m -62.61 -37.75 87.52 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 120.542 -1.349 . . . . 0.0 109.146 179.198 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.805 HD12 ' O ' ' A' ' 13' ' ' GLU . 0.2 OUTLIER -65.58 -36.82 84.87 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 120.923 -1.111 . . . . 0.0 108.609 178.343 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.507 ' HA2' HD13 ' A' ' 38' ' ' ILE . . . -67.39 -44.5 84.3 Favored Glycine 0 N--CA 1.513 3.829 0 N-CA-C 108.427 -1.869 . . . . 0.0 108.427 178.296 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.694 ' HG3' ' N ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -59.09 -38.63 79.97 Favored 'General case' 0 N--CA 1.489 1.512 0 O-C-N 120.435 -1.626 . . . . 0.0 108.298 178.889 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.694 ' N ' ' HG3' ' A' ' 19' ' ' GLU . 26.3 m120 -61.61 -28.57 69.46 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.514 -1.366 . . . . 0.0 109.337 178.563 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.565 ' HB2' ' CD1' ' A' ' 23' ' ' LEU . 17.6 mtp -101.81 13.03 36.03 Favored 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.325 -0.859 . . . . 0.0 111.128 -179.626 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.4 -19.78 53.06 Favored Glycine 0 N--CA 1.501 2.97 0 C-N-CA 118.67 -1.728 . . . . 0.0 111.249 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.798 ' H ' HD12 ' A' ' 23' ' ' LEU . 3.4 mp -79.17 92.79 5.11 Favored 'General case' 0 N--CA 1.501 2.077 0 O-C-N 120.39 -1.653 . . . . 0.0 109.313 179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.407 ' O ' ' CB ' ' A' ' 25' ' ' ASN . 3.4 pt-20 -106.86 179.63 4.21 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.119 -0.988 . . . . 0.0 109.384 179.71 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.407 ' CB ' ' O ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER 65.75 14.09 9.34 Favored 'General case' 0 N--CA 1.51 2.539 0 CA-C-N 116.002 -0.544 . . . . 0.0 111.916 179.053 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.63 HD11 ' HB3' ' A' ' 23' ' ' LEU . 0.5 OUTLIER -77.14 -7.53 55.95 Favored 'General case' 0 N--CA 1.502 2.157 0 O-C-N 121.029 -1.044 . . . . 0.0 111.6 -179.839 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 26' ' ' LEU . . . -46.64 -35.02 5.52 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.45 -1.406 . . . . 0.0 109.076 -179.164 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 8.1 mmt-85 -82.65 1.36 38.74 Favored 'General case' 0 C--N 1.295 -1.792 0 C-N-CA 120.059 -0.657 . . . . 0.0 111.644 179.69 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.509 ' HB3' ' OD1' ' A' ' 33' ' ' ASP . 11.4 mtp -101.01 159.5 15.17 Favored 'General case' 0 C--N 1.313 -0.979 0 O-C-N 120.659 -1.276 . . . . 0.0 112.08 -178.551 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.873 ' O ' HD12 ' A' ' 34' ' ' ILE . 3.8 ttm180 -89.81 173.88 8.01 Favored 'General case' 0 N--CA 1.498 1.961 0 CA-C-O 121.965 0.888 . . . . 0.0 111.094 178.324 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.635 ' O ' HG22 ' A' ' 35' ' ' ILE . 3.4 mtpp -62.23 -40.15 95.17 Favored 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.663 -0.648 . . . . 0.0 111.309 -179.791 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.544 ' O ' ' CG2' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -64.96 -54.79 25.07 Favored 'General case' 0 N--CA 1.524 3.263 0 CA-C-O 121.845 0.831 . . . . 0.0 110.876 -178.758 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.54 ' OD1' ' N ' ' A' ' 34' ' ' ILE . 1.9 p30 -65.81 -41.65 91.63 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 120.886 -1.134 . . . . 0.0 109.262 -178.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.873 HD12 ' O ' ' A' ' 30' ' ' ARG . 9.0 mt -62.21 -40.05 86.24 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.237 0 O-C-N 120.27 -1.519 . . . . 0.0 109.498 178.016 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.635 HG22 ' O ' ' A' ' 31' ' ' LYS . 0.4 OUTLIER -67.48 -34.39 68.19 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.625 0 O-C-N 120.125 -1.609 . . . . 0.0 109.46 178.543 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.461 ' CD2' ' O ' ' A' ' 32' ' ' GLN . 17.9 m-85 -66.05 -44.22 85.22 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 120.498 -1.376 . . . . 0.0 109.05 179.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.633 ' HB1' HD23 ' A' ' 23' ' ' LEU . . . -66.41 -54.15 27.64 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 120.539 -1.351 . . . . 0.0 109.622 178.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.603 HG23 ' N ' ' A' ' 39' ' ' LEU . 8.6 tp -50.5 -46.86 27.37 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.43 0 C-N-CA 117.239 -1.784 . . . . 0.0 108.239 179.194 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.804 HD21 HD11 ' A' ' 6' ' ' LEU . 58.9 mt -58.6 -40.01 82.05 Favored 'General case' 0 N--CA 1.508 2.432 0 O-C-N 120.851 -1.155 . . . . 0.0 109.669 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 1.2 mttm -63.38 -35.83 81.7 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.365 -0.834 . . . . 0.0 109.941 179.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.58 ' HG3' HD11 ' A' ' 23' ' ' LEU . 12.0 mm-40 -77.77 -52.26 9.21 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.581 -0.7 . . . . 0.0 111.106 -179.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.544 ' CD2' ' HB2' ' A' ' 47' ' ' GLU . 17.6 t60 -62.23 -34.38 76.38 Favored 'General case' 0 N--CA 1.51 2.558 0 C-N-CA 118.374 -1.331 . . . . 0.0 108.612 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.492 ' O ' ' N ' ' A' ' 46' ' ' GLY . . . -64.16 -43.71 94.34 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 120.959 -1.088 . . . . 0.0 108.493 177.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 4.0 tptt -48.01 -44.72 31.05 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 121.051 -1.03 . . . . 0.0 109.187 178.275 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.463 ' HB3' ' OE2' ' A' ' 47' ' ' GLU . 74.1 m -66.79 -8.16 26.48 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 121.675 0.75 . . . . 0.0 109.726 179.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.492 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . 73.39 29.63 63.75 Favored Glycine 0 N--CA 1.495 2.586 0 C-N-CA 120.055 -1.069 . . . . 0.0 111.636 178.601 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.544 ' HB2' ' CD2' ' A' ' 42' ' ' HIS . 0.3 OUTLIER -79.41 166.87 21.58 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.211 -1.758 . . . . 0.0 108.821 178.899 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.431 ' C ' HG23 ' A' ' 49' ' ' ILE . 53.3 m-20 -85.96 143.13 28.33 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 121.042 -1.036 . . . . 0.0 109.653 -179.781 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.658 ' HA ' ' HA ' ' A' ' 1' ' ' MET . 0.6 OUTLIER -149.21 147.88 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 120.724 -1.235 . . . . 0.0 108.417 179.529 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.568 ' N ' ' CD1' ' A' ' 50' ' ' PHE . 11.3 p90 -141.22 164.8 29.26 Favored 'General case' 0 C--N 1.304 -1.378 0 C-N-CA 116.163 -2.215 . . . . 0.0 114.504 -178.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -119.29 169.75 13.75 Favored Glycine 0 N--CA 1.5 2.924 0 N-CA-C 108.502 -1.839 . . . . 0.0 108.502 -178.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.527 ' C ' ' CD2' ' A' ' 65' ' ' LEU . 3.6 p30 -170.98 163.03 7.43 Favored 'General case' 0 N--CA 1.482 1.14 0 O-C-N 120.445 -1.621 . . . . 0.0 109.923 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.6 ' N ' HD21 ' A' ' 65' ' ' LEU . . . 150.15 -142.46 9.7 Favored Glycine 0 N--CA 1.503 3.101 0 C-N-CA 117.856 -2.116 . . . . 0.0 111.389 179.292 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.577 ' HA ' ' O ' ' A' ' 95' ' ' ASP . 2.8 t -128.81 121.35 54.41 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.078 0 N-CA-C 107.709 -1.219 . . . . 0.0 107.709 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.765 HD21 HG21 ' A' ' 81' ' ' VAL . 7.0 mt -62.63 161.72 11.76 Favored 'General case' 0 N--CA 1.498 1.935 0 C-N-CA 118.514 -1.274 . . . . 0.0 113.481 -175.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.509 ' HA ' ' OG1' ' A' ' 93' ' ' THR . 4.3 tt0 -139.05 117.85 12.34 Favored 'General case' 0 N--CA 1.495 1.823 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 178.041 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.694 ' C ' HD12 ' A' ' 58' ' ' LEU . 1.3 mm -82.57 161.07 3.59 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 CA-C-N 120.868 1.667 . . . . 0.0 109.572 -178.436 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.944 HD22 ' CZ ' ' A' ' 62' ' ' PHE . 6.7 mp -130.31 134.9 47.54 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.602 -1.311 . . . . 0.0 109.288 179.088 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.478 ' C ' ' O ' ' A' ' 58' ' ' LEU . 0.0 OUTLIER -38.59 -36.25 0.24 Allowed 'General case' 0 N--CA 1.493 1.71 0 CA-C-O 121.665 0.745 . . . . 0.0 109.946 -179.725 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.404 ' HB2' ' CD2' ' A' ' 62' ' ' PHE . 5.5 m-20 -60.95 -7.08 2.17 Favored 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.689 -0.632 . . . . 0.0 112.53 -179.408 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.422 ' O ' ' HB3' ' A' ' 83' ' ' PRO . . . 91.65 8.15 64.13 Favored Glycine 1 N--CA 1.518 4.113 0 C-N-CA 118.677 -1.725 . . . . 0.0 112.232 178.13 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.944 ' CZ ' HD22 ' A' ' 58' ' ' LEU . 2.2 p90 -127.9 -179.64 5.07 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 104.706 -2.331 . . . . 0.0 104.706 178.127 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.711 ' HA2' HD13 ' A' ' 58' ' ' LEU . . . -157.88 172.33 35.06 Favored Glycine 0 N--CA 1.478 1.491 0 C-N-CA 117.38 -2.343 . . . . 0.0 111.841 -178.133 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.448 ' CE2' ' HE1' ' A' ' 62' ' ' PHE . 10.3 m-85 -128.83 153.83 47.05 Favored 'General case' 0 N--CA 1.489 1.514 0 CA-C-N 119.882 1.841 . . . . 0.0 109.319 177.282 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.6 HD21 ' N ' ' A' ' 53' ' ' GLY . 0.5 OUTLIER -100.24 124.02 45.18 Favored 'General case' 0 N--CA 1.487 1.396 0 N-CA-C 107.803 -1.184 . . . . 0.0 107.803 177.487 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.534 ' CB ' ' OD2' ' A' ' 78' ' ' ASP . 2.6 ptm180 -129.42 -169.22 2.06 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 119.629 -1.919 . . . . 0.0 110.281 -179.989 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.746 ' HB3' HD23 ' A' ' 73' ' ' LEU . 1.5 m -76.76 -153.66 0.05 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 O-C-N 120.961 -1.087 . . . . 0.0 110.469 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -129.43 -6.88 4.72 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.467 -0.77 . . . . 0.0 110.663 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.568 ' HB2' HD22 ' A' ' 73' ' ' LEU . 8.9 t0 -78.54 -155.52 0.09 Allowed 'General case' 0 N--CA 1.513 2.702 0 O-C-N 121.019 -1.05 . . . . 0.0 109.452 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -123.76 -14.65 7.18 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 120.211 -1.556 . . . . 0.0 110.82 -179.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.688 ' O ' ' HB2' ' A' ' 72' ' ' TYR . 1.0 OUTLIER -163.77 178.1 8.13 Favored 'General case' 0 N--CA 1.501 2.093 0 O-C-N 120.885 -1.134 . . . . 0.0 109.7 179.654 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.688 ' HB2' ' O ' ' A' ' 71' ' ' SER . 38.5 m-85 72.63 -38.25 0.41 Allowed 'General case' 0 N--CA 1.525 3.314 0 CA-C-N 119.869 1.213 . . . . 0.0 111.103 179.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.746 HD23 ' HB3' ' A' ' 67' ' ' SER . 6.2 mp -82.41 -160.89 0.41 Allowed 'General case' 0 N--CA 1.489 1.484 0 O-C-N 120.806 -1.184 . . . . 0.0 109.62 179.687 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.711 ' HB1' ' OD1' ' A' ' 78' ' ' ASP . . . -57.16 -153.66 0.0 OUTLIER 'General case' 0 C--N 1.29 -1.994 0 CA-C-O 122.225 1.012 . . . . 0.0 110.396 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.49 ' O ' ' CG ' ' A' ' 78' ' ' ASP . . . -147.37 -163.48 10.61 Favored Glycine 0 N--CA 1.504 3.214 0 C-N-CA 120.433 -0.889 . . . . 0.0 111.182 -178.272 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 37.3 Cg_endo -69.09 -36.04 13.4 Favored 'Trans proline' 0 N--CA 1.497 1.677 0 O-C-N 122.655 0.818 . . . . 0.0 112.291 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.569 ' HB3' ' CE1' ' A' ' 110' ' ' TYR . 23.4 m-20 -85.42 25.11 1.07 Allowed 'General case' 0 N--CA 1.509 2.477 0 O-C-N 121.228 -0.92 . . . . 0.0 111.294 -178.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.711 ' OD1' ' HB1' ' A' ' 74' ' ' ALA . 89.2 m-20 -54.07 -115.03 0.0 OUTLIER 'General case' 0 N--CA 1.514 2.771 0 O-C-N 120.983 -1.073 . . . . 0.0 111.807 -179.661 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.941 ' CD1' HD23 ' A' ' 3' ' ' LEU . 6.7 mm -76.73 130.81 35.87 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.701 0 O-C-N 121.058 -1.026 . . . . 0.0 110.576 -177.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.526 ' HB3' ' O ' ' A' ' 111' ' ' PHE . 79.9 t80 -77.2 145.18 37.77 Favored 'General case' 0 N--CA 1.513 2.72 0 O-C-N 119.549 -1.969 . . . . 0.0 109.42 179.123 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.765 HG21 HD21 ' A' ' 55' ' ' LEU . 38.7 t -142.38 114.66 3.52 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 O-C-N 120.301 -1.499 . . . . 0.0 110.817 -179.472 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.573 ' O ' HG13 ' A' ' 86' ' ' ILE . 19.9 m -74.71 163.65 66.8 Favored Pre-proline 0 N--CA 1.512 2.665 0 O-C-N 120.357 -1.464 . . . . 0.0 111.708 -179.647 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.529 ' HA ' HG13 ' A' ' 86' ' ' ILE . 38.0 Cg_endo -65.33 -48.83 3.01 Favored 'Trans proline' 0 C--N 1.315 -1.233 0 O-C-N 124.321 1.695 . . . . 0.0 108.827 179.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.554 ' O ' ' CG ' ' A' ' 88' ' ' ARG . 80.1 p -46.59 -41.1 13.99 Favored 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 177.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.54 ' HB2' ' O ' ' A' ' 82' ' ' SER . 4.2 mm-40 -62.16 -58.08 9.14 Favored 'General case' 0 N--CA 1.51 2.529 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 177.849 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.596 HG23 ' HB2' ' A' ' 91' ' ' LEU . 0.9 OUTLIER -55.35 -55.27 17.72 Favored 'Isoleucine or valine' 0 N--CA 1.502 2.14 0 O-C-N 121.153 -0.967 . . . . 0.0 108.55 178.382 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.467 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 0.2 OUTLIER -57.99 -42.23 84.7 Favored 'General case' 0 C--N 1.295 -1.792 0 CA-C-O 121.787 0.804 . . . . 0.0 111.466 -179.518 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.554 ' CG ' ' O ' ' A' ' 84' ' ' SER . 0.0 OUTLIER -60.44 -36.52 78.39 Favored 'General case' 0 N--CA 1.506 2.355 0 C-N-CA 119.76 -0.776 . . . . 0.0 111.725 -177.714 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 1.032 ' HB2' HD21 ' A' ' 91' ' ' LEU . 20.1 m-85 -112.12 13.13 20.58 Favored 'General case' 0 N--CA 1.507 2.378 0 C-N-CA 117.12 -1.832 . . . . 0.0 111.664 179.839 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 61.46 53.5 3.37 Favored 'General case' 0 N--CA 1.484 1.242 0 O-C-N 120.389 -1.445 . . . . 0.0 110.3 178.58 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 1.032 HD21 ' HB2' ' A' ' 89' ' ' PHE . 3.5 mt -89.61 -173.44 3.95 Favored 'General case' 0 N--CA 1.498 1.936 0 C-N-CA 119.304 -0.959 . . . . 0.0 110.277 179.698 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.533 ' CG ' ' O ' ' A' ' 91' ' ' LEU . 12.0 mtt-85 -160.1 160.27 32.85 Favored 'General case' 0 N--CA 1.495 1.786 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 177.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.594 ' HB ' ' CG1' ' A' ' 57' ' ' ILE . 1.8 t -64.18 155.94 30.14 Favored 'General case' 0 N--CA 1.497 1.901 0 C-N-CA 116.983 -1.887 . . . . 0.0 106.841 178.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 77.57 -11.54 18.64 Favored Glycine 0 N--CA 1.506 3.343 0 C-N-CA 117.042 -2.504 . . . . 0.0 110.263 179.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.577 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 7.9 m-20 -68.18 148.59 50.66 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.14 -1.8 . . . . 0.0 110.465 -179.038 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.523 ' O ' HG12 ' A' ' 97' ' ' ILE . 0.1 OUTLIER -93.92 125.58 38.62 Favored 'General case' 0 N--CA 1.482 1.171 0 N-CA-C 108.321 -0.992 . . . . 0.0 108.321 179.16 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.523 HG12 ' O ' ' A' ' 96' ' ' THR . 1.5 mt -145.78 164.89 10.38 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.48 0 C-N-CA 118.07 -1.452 . . . . 0.0 112.375 -179.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . . . . . . . . . 89.9 p -149.69 139.29 21.64 Favored 'General case' 0 N--CA 1.482 1.15 0 N-CA-C 109.3 -0.63 . . . . 0.0 109.3 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.45 ' O ' ' HB2' ' A' ' 50' ' ' PHE . . . -168.29 -175.41 37.89 Favored Glycine 0 N--CA 1.508 3.465 0 C-N-CA 116.859 -2.591 . . . . 0.0 115.406 -178.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.437 ' HG3' ' HG2' ' A' ' 115' ' ' LYS . 2.1 mtpt -88.23 150.98 22.98 Favored 'General case' 0 N--CA 1.498 1.947 0 N-CA-C 107.087 -1.449 . . . . 0.0 107.087 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 2.8 pt -121.51 160.56 22.75 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.504 0 CA-C-N 121.463 1.938 . . . . 0.0 113.241 -177.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.847 ' CB ' HD13 ' A' ' 114' ' ' LEU . 0.6 OUTLIER -144.68 132.97 10.79 Favored Pre-proline 0 N--CA 1.488 1.438 0 O-C-N 120.392 -1.442 . . . . 0.0 109.363 179.374 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 48.7 Cg_endo -75.34 119.45 5.56 Favored 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 123.949 1.5 . . . . 0.0 110.513 -179.272 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 43.3 Cg_endo -71.56 -152.68 0.04 OUTLIER 'Trans proline' 0 C--N 1.305 -1.746 0 O-C-N 124.024 1.539 . . . . 0.0 109.588 179.728 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.463 ' O ' ' O ' ' A' ' 106' ' ' GLU . 7.5 mttp -106.05 179.52 4.24 Favored 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.838 -1.164 . . . . 0.0 109.747 179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.463 ' O ' ' O ' ' A' ' 105' ' ' LYS 0.253 0.0 OUTLIER -51.56 178.32 0.01 OUTLIER 'General case' 0 C--N 1.31 -1.152 0 O-C-N 120.792 -1.193 . . . . 0.0 108.321 179.128 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 77.92 -37.76 1.72 Allowed Glycine 0 N--CA 1.499 2.835 0 C-N-CA 118.014 -2.041 . . . . 0.0 110.3 -179.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.492 ' O ' ' N ' ' A' ' 110' ' ' TYR . 1.3 mt-10 -84.46 -29.77 25.8 Favored 'General case' 0 N--CA 1.495 1.811 0 O-C-N 120.183 -1.774 . . . . 0.0 110.355 -179.487 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.482 ' HB2' ' O ' ' A' ' 108' ' ' GLU . 2.2 mmt85 59.54 -37.25 0.07 Allowed 'General case' 0 N--CA 1.496 1.874 0 N-CA-C 113.758 1.021 . . . . 0.0 113.758 178.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.569 ' CE1' ' HB3' ' A' ' 77' ' ' ASP . 10.3 m-85 -106.83 151.56 25.03 Favored 'General case' 0 N--CA 1.52 3.038 0 O-C-N 119.7 -1.875 . . . . 0.0 109.574 179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.526 ' O ' ' HB3' ' A' ' 80' ' ' TYR . 3.3 m-85 -68.28 168.19 12.89 Favored 'General case' 0 N--CA 1.503 2.225 0 O-C-N 119.775 -1.828 . . . . 0.0 107.928 178.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . . . . . . . . . . . -122.75 155.69 35.99 Favored 'General case' 0 N--CA 1.49 1.549 0 O-C-N 120.1 -1.625 . . . . 0.0 110.785 -179.015 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -64.97 153.71 39.77 Favored 'General case' 0 N--CA 1.493 1.725 0 N-CA-C 106.906 -1.516 . . . . 0.0 106.906 179.248 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.847 HD13 ' CB ' ' A' ' 102' ' ' ARG . 14.5 tp -129.07 -56.36 1.18 Allowed 'General case' 0 N--CA 1.503 2.205 0 O-C-N 120.081 -1.637 . . . . 0.0 112.868 -178.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.437 ' HG2' ' HG3' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -125.28 142.77 51.31 Favored 'General case' 0 N--CA 1.507 2.404 0 O-C-N 120.343 -1.473 . . . . 0.0 108.536 179.666 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.474 HG21 ' CD2' ' A' ' 89' ' ' PHE . 37.4 t -92.89 130.55 41.81 Favored 'Isoleucine or valine' 0 N--CA 1.518 2.955 0 O-C-N 120.406 -1.434 . . . . 0.0 112.091 -179.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.57 ' HA ' ' HB3' ' A' ' 124' ' ' PRO . 11.3 m-20 -107.02 -39.93 5.6 Favored 'General case' 0 N--CA 1.51 2.567 0 O-C-N 121.469 -0.769 . . . . 0.0 109.871 178.122 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.584 ' C ' HG23 ' A' ' 119' ' ' VAL . 0.9 OUTLIER -143.45 160.07 41.25 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.989 -1.069 . . . . 0.0 109.463 179.578 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.584 HG23 ' C ' ' A' ' 118' ' ' GLU . 18.7 t -158.46 147.89 8.53 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.671 0 N-CA-C 108.854 -0.795 . . . . 0.0 108.854 -178.755 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.515 ' C ' ' O ' ' A' ' 119' ' ' VAL . 7.1 t-20 -24.48 -41.98 0.01 OUTLIER 'General case' 0 N--CA 1.524 3.273 0 O-C-N 121.456 -0.778 . . . . 0.0 111.481 -178.406 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.563 ' N ' ' O ' ' A' ' 119' ' ' VAL . 0.3 OUTLIER -160.91 56.72 0.31 Allowed 'General case' 0 N--CA 1.499 2.009 0 C-N-CA 118.776 -1.17 . . . . 0.0 111.055 179.149 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.476 ' OD1' ' O ' ' A' ' 121' ' ' PHE . 0.3 OUTLIER -156.02 156.43 34.42 Favored 'General case' 0 N--CA 1.485 1.292 0 O-C-N 120.878 -1.139 . . . . 0.0 109.535 178.291 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.536 ' HB3' ' HD2' ' A' ' 124' ' ' PRO . 0.2 OUTLIER -80.64 -170.67 0.25 Allowed Pre-proline 0 N--CA 1.497 1.913 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 178.343 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.57 ' HB3' ' HA ' ' A' ' 117' ' ' ASN . 50.5 Cg_endo -85.45 21.56 1.07 Allowed 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 123.409 1.215 . . . . 0.0 110.867 -179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.473 ' HB2' ' O ' ' A' ' 124' ' ' PRO . 1.5 tt0 -177.79 -127.35 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.442 -0.786 . . . . 0.0 108.961 -179.536 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.449 ' HB2' ' O ' ' A' ' 125' ' ' GLU . 0.4 OUTLIER 173.65 -143.72 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.09 0 O-C-N 120.083 -1.636 . . . . 0.0 109.721 179.664 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.477 ' O ' ' HG2' ' A' ' 128' ' ' ARG . . . -137.42 14.32 2.99 Favored 'General case' 0 N--CA 1.496 1.827 0 O-C-N 120.681 -1.262 . . . . 0.0 110.01 179.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.477 ' HG2' ' O ' ' A' ' 127' ' ' ALA . 0.6 OUTLIER -141.76 -50.39 0.4 Allowed 'General case' 0 N--CA 1.5 2.038 0 O-C-N 121.659 -0.651 . . . . 0.0 109.778 179.61 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -73.4 164.05 27.21 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.397 -0.814 . . . . 0.0 110.067 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.46 ' HG2' ' O ' ' A' ' 130' ' ' LYS . 0.6 OUTLIER . . . . . 0 N--CA 1.487 1.415 0 CA-C-O 118.013 -0.994 . . . . 0.0 109.679 179.826 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.677 ' HA ' ' HA ' ' A' ' 49' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.577 0 N-CA-C 109.727 -0.471 . . . . 0.0 109.727 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.602 ' HB3' ' HB2' ' A' ' 5' ' ' GLU . 55.3 t30 -78.63 91.09 4.59 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.965 -1.085 . . . . 0.0 108.461 178.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.823 HD23 HD13 ' A' ' 79' ' ' ILE . 1.5 tp -42.19 -41.05 2.57 Favored 'General case' 0 N--CA 1.52 3.043 0 O-C-N 120.471 -1.393 . . . . 0.0 110.401 -178.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.8 m -57.35 -37.82 73.17 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.806 -1.183 . . . . 0.0 108.33 -179.269 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.602 ' HB2' ' HB3' ' A' ' 2' ' ' ASN . 0.3 OUTLIER -74.11 -39.31 63.44 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 120.783 -1.198 . . . . 0.0 108.776 178.021 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.81 HD12 ' HA ' ' A' ' 3' ' ' LEU 0.278 67.4 mt -54.77 -52.33 62.93 Favored 'General case' 0 C--O 1.215 -0.718 0 O-C-N 120.387 -1.445 . . . . 0.0 109.038 177.771 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.487 ' NZ ' ' HD2' ' A' ' 66' ' ' ARG . 0.2 OUTLIER -61.54 -40.35 94.35 Favored 'General case' 0 N--CA 1.503 2.224 0 O-C-N 121.019 -1.05 . . . . 0.0 109.264 178.468 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . 0.46 ' HB2' ' HA ' ' A' ' 5' ' ' GLU . 2.7 m-80 -62.08 -20.6 64.18 Favored 'General case' 0 N--CA 1.506 2.353 0 C-N-CA 119.438 -0.905 . . . . 0.0 110.732 -179.401 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.804 ' O ' HD11 ' A' ' 14' ' ' LEU . 2.6 m -75.01 118.28 69.24 Favored Pre-proline 0 C--N 1.287 -2.14 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 179.764 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.512 ' HG2' ' CG ' ' A' ' 13' ' ' GLU . 37.3 Cg_endo -57.47 152.33 48.02 Favored 'Trans proline' 0 CA--C 1.563 1.952 0 O-C-N 122.408 0.688 . . . . 0.0 110.515 179.926 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.736 ' O ' HD12 ' A' ' 15' ' ' ILE . 1.7 p -41.31 -49.44 0.76 Allowed 'Isoleucine or valine' 0 N--CA 1.529 3.48 0 O-C-N 120.493 -1.379 . . . . 0.0 110.094 -178.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.536 ' N ' ' CG1' ' A' ' 11' ' ' VAL . 0.7 OUTLIER -60.56 -39.8 89.29 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.415 -0.803 . . . . 0.0 111.249 -179.629 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 1.028 ' O ' HD12 ' A' ' 17' ' ' LEU . 29.2 mt-10 -69.45 -32.21 71.0 Favored 'General case' 0 N--CA 1.489 1.514 0 C-N-CA 118.015 -1.474 . . . . 0.0 108.488 179.678 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.804 HD11 ' O ' ' A' ' 9' ' ' THR . 6.2 mt -68.62 -42.29 78.3 Favored 'General case' 0 N--CA 1.485 1.321 0 O-C-N 120.841 -1.162 . . . . 0.0 108.845 177.171 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.736 HD12 ' O ' ' A' ' 11' ' ' VAL . 1.3 mp -64.64 -38.97 84.02 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.662 0 C-N-CA 117.714 -1.594 . . . . 0.0 108.451 178.433 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.501 ' O ' ' OD1' ' A' ' 20' ' ' ASN . 59.0 m -64.24 -36.69 84.9 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 120.331 -1.481 . . . . 0.0 108.878 178.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 1.028 HD12 ' O ' ' A' ' 13' ' ' GLU . 0.3 OUTLIER -66.06 -38.82 89.3 Favored 'General case' 0 N--CA 1.492 1.666 0 O-C-N 120.822 -1.174 . . . . 0.0 108.936 178.432 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -68.0 -43.28 82.68 Favored Glycine 1 N--CA 1.521 4.305 0 N-CA-C 108.471 -1.852 . . . . 0.0 108.471 178.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.435 ' OE1' ' HG2' ' A' ' 24' ' ' GLU . 1.4 mm-40 -54.72 -44.9 73.9 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.886 -1.361 . . . . 0.0 107.737 178.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.501 ' OD1' ' O ' ' A' ' 16' ' ' THR . 28.8 m120 -59.57 -26.22 65.21 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 118.288 -1.365 . . . . 0.0 109.334 179.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.561 ' CE ' ' NE2' ' A' ' 41' ' ' GLN . 52.9 mmm -101.07 9.79 41.72 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.27 -0.894 . . . . 0.0 111.144 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 103.85 -21.11 39.31 Favored Glycine 0 N--CA 1.501 3.02 0 C-N-CA 118.634 -1.746 . . . . 0.0 111.589 179.282 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.834 ' HB3' HD11 ' A' ' 26' ' ' LEU . 4.0 mp -78.57 96.48 5.48 Favored 'General case' 0 N--CA 1.503 2.205 0 O-C-N 120.152 -1.793 . . . . 0.0 109.934 -179.8 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.496 ' O ' ' CB ' ' A' ' 25' ' ' ASN . 16.9 mt-10 -105.98 171.14 7.5 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.255 -0.903 . . . . 0.0 109.276 179.844 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.496 ' CB ' ' O ' ' A' ' 24' ' ' GLU . 0.7 OUTLIER 71.15 15.67 6.45 Favored 'General case' 0 N--CA 1.514 2.733 0 O-C-N 121.517 -0.739 . . . . 0.0 111.838 179.314 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.834 HD11 ' HB3' ' A' ' 23' ' ' LEU . 0.4 OUTLIER -76.57 -10.88 59.71 Favored 'General case' 0 N--CA 1.502 2.169 0 O-C-N 121.005 -1.059 . . . . 0.0 111.672 -179.883 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.404 ' C ' ' O ' ' A' ' 26' ' ' LEU . . . -46.57 -35.73 6.13 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 120.515 -1.366 . . . . 0.0 109.07 -179.225 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.92 3.53 25.98 Favored 'General case' 0 C--N 1.295 -1.799 0 C-N-CA 119.849 -0.74 . . . . 0.0 111.545 -179.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.593 ' HE2' ' OD1' ' A' ' 33' ' ' ASP . 7.5 mtp -99.97 156.61 17.06 Favored 'General case' 0 C--N 1.314 -0.95 0 O-C-N 120.72 -1.238 . . . . 0.0 111.774 -178.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.539 ' C ' HD12 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -89.46 139.22 30.74 Favored 'General case' 0 N--CA 1.497 1.916 0 O-C-N 121.413 -0.804 . . . . 0.0 110.936 179.239 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.58 ' O ' HG22 ' A' ' 35' ' ' ILE . 0.0 OUTLIER -31.66 -44.81 0.08 Allowed 'General case' 0 N--CA 1.5 2.055 0 CA-C-N 116.267 -0.424 . . . . 0.0 111.885 179.197 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.582 ' O ' ' CG2' ' A' ' 35' ' ' ILE . 0.0 OUTLIER -63.27 -53.28 55.38 Favored 'General case' 0 N--CA 1.521 3.08 0 O-C-N 121.319 -0.863 . . . . 0.0 111.941 -178.233 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.593 ' OD1' ' HE2' ' A' ' 29' ' ' MET . 1.9 p30 -66.92 -39.73 87.46 Favored 'General case' 0 C--N 1.293 -1.873 0 O-C-N 119.965 -1.709 . . . . 0.0 109.226 179.773 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.574 HD11 ' HB2' ' A' ' 29' ' ' MET . 4.4 mt -61.93 -39.18 82.69 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.188 0 O-C-N 120.459 -1.401 . . . . 0.0 109.444 178.457 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.582 ' CG2' ' O ' ' A' ' 32' ' ' GLN . 0.3 OUTLIER -66.91 -40.6 86.09 Favored 'Isoleucine or valine' 0 N--CA 1.51 2.555 0 O-C-N 120.345 -1.472 . . . . 0.0 109.246 178.518 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.574 ' CE1' ' OD1' ' A' ' 77' ' ' ASP . 6.1 m-30 -60.3 -43.9 95.88 Favored 'General case' 0 N--CA 1.486 1.347 0 O-C-N 120.803 -1.186 . . . . 0.0 108.531 179.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.718 ' HB1' ' CD2' ' A' ' 23' ' ' LEU . . . -59.28 -51.32 70.45 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 120.49 -1.381 . . . . 0.0 108.821 178.042 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.554 HG13 ' O ' ' A' ' 34' ' ' ILE . 0.1 OUTLIER -56.17 -31.88 33.03 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.767 0 C-N-CA 117.618 -1.633 . . . . 0.0 109.643 179.23 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.733 HD21 HD13 ' A' ' 6' ' ' LEU . 98.6 mt -69.21 -44.88 71.19 Favored 'General case' 0 N--CA 1.505 2.308 0 O-C-N 120.07 -1.644 . . . . 0.0 109.557 178.759 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -65.65 -34.11 77.44 Favored 'General case' 0 N--CA 1.499 1.987 0 O-C-N 121.023 -1.048 . . . . 0.0 111.396 179.114 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.561 ' NE2' ' CE ' ' A' ' 21' ' ' MET . 0.0 OUTLIER -79.5 -51.71 8.97 Favored 'General case' 0 N--CA 1.5 2.027 0 O-C-N 121.212 -0.93 . . . . 0.0 109.977 -178.9 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.539 ' CE1' ' HG3' ' A' ' 47' ' ' GLU . 5.1 t-160 -64.95 -38.61 91.53 Favored 'General case' 0 N--CA 1.507 2.378 0 C-N-CA 117.619 -1.632 . . . . 0.0 109.141 179.496 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.544 ' O ' ' N ' ' A' ' 46' ' ' GLY . . . -61.58 -38.86 89.08 Favored 'General case' 0 N--CA 1.486 1.341 0 O-C-N 120.918 -1.113 . . . . 0.0 108.594 178.311 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 12.2 tptt -48.25 -45.0 33.86 Favored 'General case' 0 N--CA 1.484 1.248 0 O-C-N 121.003 -1.061 . . . . 0.0 108.567 177.774 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 52.0 m -66.49 -10.09 41.04 Favored 'General case' 0 C--N 1.3 -1.545 0 CA-C-O 121.724 0.773 . . . . 0.0 109.493 179.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . 70.71 29.53 69.42 Favored Glycine 0 N--CA 1.496 2.652 0 C-N-CA 120.621 -0.8 . . . . 0.0 111.752 178.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.539 ' HG3' ' CE1' ' A' ' 42' ' ' HIS . 3.7 pm0 -82.82 158.08 22.91 Favored 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.178 -1.777 . . . . 0.0 108.793 178.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 10.6 m-20 -71.55 147.65 47.46 Favored 'General case' 0 C--N 1.302 -1.478 0 O-C-N 120.912 -1.117 . . . . 0.0 110.334 -178.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.677 ' HA ' ' HA ' ' A' ' 1' ' ' MET . 0.8 OUTLIER -146.63 145.0 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 N-CA-C 107.985 -1.117 . . . . 0.0 107.985 179.077 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.6 ' O ' ' HA ' ' A' ' 2' ' ' ASN . 10.5 p90 -141.31 170.28 16.01 Favored 'General case' 0 C--N 1.308 -1.238 0 C-N-CA 116.268 -2.173 . . . . 0.0 115.583 -177.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -114.46 162.37 12.43 Favored Glycine 0 N--CA 1.501 3.003 0 N-CA-C 107.88 -2.088 . . . . 0.0 107.88 -179.248 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.49 ' C ' ' CD2' ' A' ' 65' ' ' LEU . 7.5 p-10 -172.78 162.91 4.99 Favored 'General case' 0 N--CA 1.483 1.196 0 O-C-N 120.364 -1.668 . . . . 0.0 110.369 -178.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.561 ' HA3' ' O ' ' A' ' 66' ' ' ARG . . . 138.35 -134.59 6.94 Favored Glycine 0 N--CA 1.503 3.155 0 C-N-CA 118.28 -1.914 . . . . 0.0 111.54 177.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.62 ' HA ' ' O ' ' A' ' 95' ' ' ASP . 2.5 t -127.94 117.75 46.86 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.008 0 O-C-N 121.45 -1.029 . . . . 0.0 108.396 -179.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 1.018 HD21 HG21 ' A' ' 81' ' ' VAL . 6.2 mt -63.36 165.41 7.67 Favored 'General case' 0 N--CA 1.503 2.18 0 C-N-CA 118.622 -1.231 . . . . 0.0 113.561 -176.145 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.53 ' O ' ' CG ' ' A' ' 56' ' ' GLU . 8.2 pt-20 -141.52 123.03 15.02 Favored 'General case' 0 N--CA 1.495 1.814 0 N-CA-C 106.951 -1.5 . . . . 0.0 106.951 177.654 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.57 ' CG1' ' HB ' ' A' ' 93' ' ' THR . 1.2 mm -83.07 164.31 2.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.938 0 O-C-N 119.857 -1.777 . . . . 0.0 109.275 -178.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.641 HD13 ' HA2' ' A' ' 63' ' ' GLY . 3.1 mp -130.98 136.46 48.55 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.433 -1.417 . . . . 0.0 109.672 179.239 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.445 ' C ' ' O ' ' A' ' 58' ' ' LEU . 7.7 tt0 -39.57 -36.99 0.44 Allowed 'General case' 0 N--CA 1.489 1.513 0 CA-C-O 121.637 0.732 . . . . 0.0 110.128 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.452 ' OD1' ' N ' ' A' ' 60' ' ' ASP . 5.8 m-20 -61.52 -6.65 2.52 Favored 'General case' 0 N--CA 1.5 2.029 0 C-N-CA 119.905 -0.718 . . . . 0.0 112.576 -179.157 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 92.53 8.15 62.69 Favored Glycine 1 N--CA 1.519 4.224 0 C-N-CA 118.688 -1.72 . . . . 0.0 112.612 177.784 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.614 ' CZ ' HD22 ' A' ' 58' ' ' LEU . 4.4 p90 -129.1 -177.04 4.06 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 104.29 -2.485 . . . . 0.0 104.29 177.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.641 ' HA2' HD13 ' A' ' 58' ' ' LEU . . . -157.63 172.75 34.97 Favored Glycine 0 N--CA 1.475 1.273 0 C-N-CA 116.672 -2.68 . . . . 0.0 112.109 -177.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.488 ' HB2' ' OE2' ' A' ' 56' ' ' GLU . 16.2 m-85 -130.25 151.97 50.18 Favored 'General case' 0 N--CA 1.483 1.215 0 O-C-N 120.223 -1.751 . . . . 0.0 109.574 177.602 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.525 HD12 ' HG ' ' A' ' 55' ' ' LEU . 0.2 OUTLIER -97.91 168.23 10.42 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 106.586 -1.635 . . . . 0.0 106.586 176.221 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.561 ' O ' ' HA3' ' A' ' 53' ' ' GLY . 10.5 ttp85 177.09 -173.91 0.11 Allowed 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.004 -1.06 . . . . 0.0 109.662 179.336 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . 0.509 ' HB2' ' OG ' ' A' ' 70' ' ' SER . 0.7 OUTLIER -74.72 -155.51 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.88 0 O-C-N 120.707 -1.246 . . . . 0.0 109.834 179.554 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -117.72 -87.35 0.62 Allowed 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.301 -0.874 . . . . 0.0 110.517 -179.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.7 m-20 -78.05 60.99 2.51 Favored 'General case' 0 N--CA 1.503 2.178 0 O-C-N 121.344 -0.847 . . . . 0.0 111.599 -179.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.509 ' OG ' ' HB2' ' A' ' 67' ' ' SER . 0.1 OUTLIER -125.98 -4.94 6.86 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 119.971 -1.706 . . . . 0.0 110.46 -179.879 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.584 ' O ' ' HB2' ' A' ' 72' ' ' TYR . 0.3 OUTLIER 170.74 -21.13 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.192 0 O-C-N 120.928 -1.108 . . . . 0.0 111.15 -179.997 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.584 ' HB2' ' O ' ' A' ' 71' ' ' SER . 24.6 m-85 77.24 -43.65 0.43 Allowed 'General case' 0 N--CA 1.523 3.196 0 O-C-N 121.769 -0.582 . . . . 0.0 111.853 179.79 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 6.7 mp -87.31 -173.81 4.56 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.38 -1.45 . . . . 0.0 109.573 179.704 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -79.66 -156.82 0.12 Allowed 'General case' 0 C--N 1.291 -1.975 0 CA-C-O 122.522 1.153 . . . . 0.0 109.775 179.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.54 ' N ' ' OD2' ' A' ' 78' ' ' ASP . . . -177.43 156.6 20.42 Favored Glycine 0 C--N 1.28 -2.574 0 N-CA-C 107.18 -2.368 . . . . 0.0 107.18 179.802 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 36.3 Cg_endo -65.19 -38.24 28.39 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 CA-C-N 118.742 1.271 . . . . 0.0 112.382 -179.672 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.574 ' OD1' ' CE1' ' A' ' 36' ' ' PHE . 13.6 m-20 -86.59 15.77 5.28 Favored 'General case' 0 N--CA 1.506 2.337 0 O-C-N 121.089 -1.007 . . . . 0.0 112.953 -178.15 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.54 ' OD2' ' N ' ' A' ' 75' ' ' GLY . 3.7 m-20 -67.18 -155.74 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.249 0 O-C-N 120.224 -1.547 . . . . 0.0 109.424 179.495 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.823 HD13 HD23 ' A' ' 3' ' ' LEU . 5.0 mm -111.6 129.15 67.51 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.599 0 O-C-N 121.137 -0.977 . . . . 0.0 109.224 179.478 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.417 ' HB3' ' HA ' ' A' ' 112' ' ' ALA . 15.2 t80 -74.87 147.22 41.25 Favored 'General case' 0 N--CA 1.518 2.928 0 CA-C-N 121.987 2.176 . . . . 0.0 110.052 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 1.018 HG21 HD21 ' A' ' 55' ' ' LEU . 8.9 t -142.57 110.92 2.1 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.884 0 O-C-N 120.188 -1.57 . . . . 0.0 110.113 -179.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.535 ' O ' HG13 ' A' ' 86' ' ' ILE . 6.2 m -74.27 164.02 64.19 Favored Pre-proline 0 N--CA 1.511 2.597 0 O-C-N 120.361 -1.462 . . . . 0.0 111.983 -179.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.55 ' HA ' HG13 ' A' ' 86' ' ' ILE . 38.1 Cg_endo -65.26 -54.29 0.66 Allowed 'Trans proline' 0 C--N 1.315 -1.23 0 O-C-N 124.621 1.853 . . . . 0.0 109.182 178.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.558 ' O ' ' CG ' ' A' ' 88' ' ' ARG . 52.9 p -46.34 -39.33 10.06 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 107.888 -1.152 . . . . 0.0 107.888 178.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.515 ' HB2' ' O ' ' A' ' 82' ' ' SER . 6.7 mm100 -63.23 -58.92 5.58 Favored 'General case' 0 N--CA 1.51 2.536 0 C-N-CA 119.421 -0.912 . . . . 0.0 108.742 178.499 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.57 HG22 ' HB2' ' A' ' 91' ' ' LEU . 0.2 OUTLIER -55.83 -54.03 31.14 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.313 0 O-C-N 121.107 -0.996 . . . . 0.0 108.601 178.801 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.468 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 0.1 OUTLIER -56.69 -43.39 80.43 Favored 'General case' 0 C--N 1.296 -1.745 0 CA-C-O 121.933 0.873 . . . . 0.0 110.876 -179.659 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.558 ' CG ' ' O ' ' A' ' 84' ' ' SER . 1.3 mmm180 -59.6 -36.63 76.66 Favored 'General case' 0 N--CA 1.505 2.281 0 C-N-CA 119.795 -0.762 . . . . 0.0 111.702 -177.86 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 0.431 ' CD2' ' O ' ' A' ' 85' ' ' GLN . 5.4 m-85 -109.81 11.89 24.17 Favored 'General case' 0 N--CA 1.501 2.116 0 C-N-CA 117.518 -1.673 . . . . 0.0 111.114 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 59.58 53.96 4.78 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 120.575 -1.328 . . . . 0.0 109.816 178.669 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.57 ' HB2' HG22 ' A' ' 86' ' ' ILE . 0.0 OUTLIER -90.04 -177.75 5.26 Favored 'General case' 0 N--CA 1.494 1.756 0 C-N-CA 119.681 -0.807 . . . . 0.0 110.176 -179.948 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.47 ' O ' ' OD2' ' A' ' 95' ' ' ASP . 0.0 OUTLIER -156.8 161.64 39.75 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.337 -0.852 . . . . 0.0 108.704 178.235 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.57 ' HB ' ' CG1' ' A' ' 57' ' ' ILE . 1.6 t -64.42 155.23 33.23 Favored 'General case' 0 N--CA 1.497 1.887 0 C-N-CA 117.119 -1.833 . . . . 0.0 107.428 179.583 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 75.66 -8.56 20.05 Favored Glycine 0 N--CA 1.502 3.05 0 C-N-CA 117.123 -2.465 . . . . 0.0 110.114 179.1 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.626 ' CG ' HD11 ' A' ' 97' ' ' ILE . 7.8 p30 -69.57 149.04 48.62 Favored 'General case' 0 N--CA 1.483 1.222 0 O-C-N 120.127 -1.808 . . . . 0.0 110.515 -178.711 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.479 ' C ' ' CG1' ' A' ' 97' ' ' ILE . 0.3 OUTLIER -94.92 121.33 36.42 Favored 'General case' 0 N--CA 1.49 1.525 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 179.825 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.626 HD11 ' CG ' ' A' ' 95' ' ' ASP . 2.3 mt -148.03 168.75 3.89 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.84 0 O-C-N 119.925 -1.734 . . . . 0.0 112.648 -178.713 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.522 ' OG ' ' HB2' ' A' ' 118' ' ' GLU . 92.1 p -148.54 137.89 21.91 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 178.889 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.544 ' O ' ' HB2' ' A' ' 50' ' ' PHE . . . -161.43 177.49 37.72 Favored Glycine 0 N--CA 1.51 3.599 0 C-N-CA 117.958 -2.068 . . . . 0.0 114.209 -178.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.805 ' HD3' HD23 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -87.73 157.02 19.16 Favored 'General case' 0 N--CA 1.498 1.951 0 N-CA-C 106.582 -1.636 . . . . 0.0 106.582 178.594 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.538 HG12 ' HA ' ' A' ' 50' ' ' PHE . 1.5 pt -123.26 155.67 29.28 Favored 'Isoleucine or valine' 0 N--CA 1.508 2.463 0 CA-C-N 120.815 1.643 . . . . 0.0 113.408 -177.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 1.001 ' CB ' HD13 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -157.54 170.13 9.46 Favored Pre-proline 0 N--CA 1.483 1.179 0 O-C-N 120.571 -1.331 . . . . 0.0 109.553 179.484 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.441 ' HD3' ' HG2' ' A' ' 102' ' ' ARG . 51.2 Cg_endo -92.71 140.35 1.94 Allowed 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 121.798 1.666 . . . . 0.0 110.368 179.707 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.479 ' HD2' ' CD ' ' A' ' 108' ' ' GLU . 47.7 Cg_endo -81.43 -89.71 0.0 OUTLIER 'Trans proline' 0 C--N 1.303 -1.824 0 O-C-N 123.961 1.506 . . . . 0.0 109.752 179.561 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 5.8 ttmt -136.89 -160.13 1.03 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.641 -0.662 . . . . 0.0 109.95 179.665 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -56.83 -22.77 39.04 Favored 'General case' 0 C--N 1.31 -1.13 0 O-C-N 120.76 -1.212 . . . . 0.0 109.589 179.681 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -84.37 44.85 3.4 Favored Glycine 0 N--CA 1.496 2.644 0 N-CA-C 108.571 -1.812 . . . . 0.0 108.571 178.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.546 ' HG3' ' N ' ' A' ' 109' ' ' ARG . 3.1 tp10 -85.56 -81.34 0.2 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.649 -1.501 . . . . 0.0 111.044 -179.191 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.585 ' HD2' ' CE1' ' A' ' 110' ' ' TYR . 0.0 OUTLIER 64.4 -55.29 0.26 Allowed 'General case' 0 N--CA 1.494 1.77 0 O-C-N 121.37 -0.831 . . . . 0.0 109.834 -178.653 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.585 ' CE1' ' HD2' ' A' ' 109' ' ' ARG . 42.2 m-85 -107.73 149.14 28.51 Favored 'General case' 0 N--CA 1.522 3.141 0 O-C-N 120.179 -1.576 . . . . 0.0 107.704 176.943 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.574 ' CE1' HD13 ' A' ' 39' ' ' LEU . 78.2 m-85 -68.35 159.42 31.48 Favored 'General case' 0 N--CA 1.509 2.509 0 O-C-N 119.161 -2.212 . . . . 0.0 108.056 178.965 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.417 ' HA ' ' HB3' ' A' ' 80' ' ' TYR . . . -124.15 142.83 50.89 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 119.975 -1.703 . . . . 0.0 111.434 -178.863 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.45 HD22 ' HA ' ' A' ' 113' ' ' LEU . 0.2 OUTLIER -51.2 147.02 5.9 Favored 'General case' 0 N--CA 1.498 1.931 0 N-CA-C 107.044 -1.465 . . . . 0.0 107.044 179.117 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 1.001 HD13 ' CB ' ' A' ' 102' ' ' ARG . 6.4 tp -128.28 -58.32 1.2 Allowed 'General case' 0 N--CA 1.499 2.016 0 O-C-N 120.22 -1.55 . . . . 0.0 111.549 -179.741 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.501 ' HB3' ' HG2' ' A' ' 100' ' ' LYS . 0.0 OUTLIER -120.73 140.09 52.14 Favored 'General case' 0 N--CA 1.509 2.487 0 O-C-N 120.336 -1.478 . . . . 0.0 108.405 178.835 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 6.6 t -92.53 134.16 31.48 Favored 'Isoleucine or valine' 0 N--CA 1.516 2.854 0 O-C-N 120.215 -1.553 . . . . 0.0 111.318 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.41 ' CG ' ' HA2' ' A' ' 99' ' ' GLY . 2.8 m-20 -107.5 -42.41 4.8 Favored 'General case' 0 N--CA 1.504 2.257 0 O-C-N 121.552 -0.718 . . . . 0.0 109.586 178.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.591 ' O ' HG23 ' A' ' 97' ' ' ILE . 1.2 mt-10 -143.71 159.84 41.77 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.879 -1.138 . . . . 0.0 109.783 179.553 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.551 HG11 HD11 ' A' ' 91' ' ' LEU . 5.1 t -158.22 140.44 5.55 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.982 -0.449 . . . . 0.0 110.075 -178.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.479 ' O ' ' C ' ' A' ' 121' ' ' PHE . 0.1 OUTLIER 46.52 40.01 7.58 Favored 'General case' 0 N--CA 1.516 2.869 0 O-C-N 120.34 -1.475 . . . . 0.0 110.666 179.715 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.479 ' C ' ' O ' ' A' ' 120' ' ' ASN . 0.3 OUTLIER 38.23 33.57 0.06 Allowed 'General case' 0 N--CA 1.518 2.934 0 O-C-N 121.054 -1.029 . . . . 0.0 109.622 179.857 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.464 ' HB2' ' O ' ' A' ' 120' ' ' ASN . 0.2 OUTLIER -154.93 175.6 13.58 Favored 'General case' 0 N--CA 1.486 1.353 0 O-C-N 121.02 -1.05 . . . . 0.0 109.767 179.772 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.439 ' HB2' ' ND2' ' A' ' 126' ' ' ASN . 1.1 mmmm -58.58 158.14 16.4 Favored Pre-proline 0 N--CA 1.506 2.362 0 C-N-CA 119.544 -0.862 . . . . 0.0 109.066 179.829 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_endo -72.69 48.59 1.36 Allowed 'Trans proline' 0 C--N 1.304 -1.8 0 O-C-N 124.071 1.564 . . . . 0.0 110.746 -179.575 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -170.69 -122.49 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.759 0 O-C-N 120.62 -1.3 . . . . 0.0 110.365 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.439 ' ND2' ' HB2' ' A' ' 123' ' ' LYS . 11.5 m-80 50.68 -132.7 1.83 Allowed 'General case' 0 N--CA 1.508 2.475 0 O-C-N 120.17 -1.581 . . . . 0.0 109.531 -179.562 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.495 ' O ' ' HG2' ' A' ' 128' ' ' ARG . . . -170.13 -172.27 1.29 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.706 -1.246 . . . . 0.0 109.532 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.495 ' HG2' ' O ' ' A' ' 127' ' ' ALA . 1.2 mtp-105 -140.64 -169.39 2.78 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 120.445 -1.41 . . . . 0.0 110.052 179.73 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . 0.525 ' O ' ' C ' ' A' ' 130' ' ' LYS . 54.2 t30 -114.28 166.88 11.2 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.16 -0.963 . . . . 0.0 110.006 179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . 0.525 ' C ' ' O ' ' A' ' 129' ' ' ASN . 0.9 OUTLIER . . . . . 0 N--CA 1.514 2.768 0 CA-C-O 118.0 -1.0 . . . . 0.0 111.162 179.607 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.983 ' HG3' HG22 ' A' ' 49' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.565 0 CA-C-O 121.396 0.617 . . . . 0.0 110.083 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.59 ' HB2' ' CZ ' ' A' ' 50' ' ' PHE . 19.6 t30 -77.91 101.35 6.78 Favored 'General case' 0 N--CA 1.5 2.048 0 O-C-N 121.303 -0.873 . . . . 0.0 109.049 179.417 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.657 ' HA ' HD12 ' A' ' 6' ' ' LEU . 0.0 OUTLIER -41.5 -41.95 2.24 Favored 'General case' 0 N--CA 1.518 2.951 0 O-C-N 120.535 -1.353 . . . . 0.0 110.192 -178.753 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.472 ' OG1' ' OD1' ' A' ' 52' ' ' ASP . 1.6 m -58.65 -36.78 74.66 Favored 'General case' 0 N--CA 1.499 1.992 0 O-C-N 120.892 -1.13 . . . . 0.0 108.51 -179.345 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.512 ' HB3' ' HB3' ' A' ' 2' ' ' ASN . 0.7 OUTLIER -72.15 -45.41 60.56 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.149 -0.97 . . . . 0.0 108.682 178.245 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.874 HD22 HG23 ' A' ' 35' ' ' ILE 0.276 86.2 mt -51.37 -47.91 62.67 Favored 'General case' 0 C--N 1.315 -0.894 0 O-C-N 120.903 -1.123 . . . . 0.0 109.409 178.322 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.64 ' NZ ' HD12 ' A' ' 35' ' ' ILE . 0.1 OUTLIER -66.94 -39.82 87.39 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 121.028 -1.045 . . . . 0.0 110.142 178.869 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -63.12 -29.27 70.67 Favored 'General case' 0 N--CA 1.507 2.399 0 C-N-CA 119.352 -0.939 . . . . 0.0 111.191 -179.111 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.681 HG22 ' CB ' ' A' ' 13' ' ' GLU . 3.2 m -75.02 123.5 88.96 Favored Pre-proline 0 C--N 1.285 -2.198 0 O-C-N 121.613 -0.679 . . . . 0.0 109.596 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.565 ' HG2' ' CG ' ' A' ' 13' ' ' GLU . 39.8 Cg_endo -61.29 151.3 80.11 Favored 'Trans proline' 0 CA--C 1.567 2.148 0 O-C-N 122.372 0.67 . . . . 0.0 110.856 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.6 ' O ' HD12 ' A' ' 15' ' ' ILE . 1.6 p -41.74 -49.86 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.525 3.318 0 O-C-N 120.643 -1.286 . . . . 0.0 109.707 -178.997 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.551 ' N ' ' CG1' ' A' ' 11' ' ' VAL . 0.7 OUTLIER -57.07 -40.78 77.56 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 121.294 -0.879 . . . . 0.0 111.076 -179.87 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 1.074 ' O ' HD12 ' A' ' 17' ' ' LEU . 52.6 mm-40 -68.95 -30.39 68.82 Favored 'General case' 0 N--CA 1.486 1.331 0 C-N-CA 118.02 -1.472 . . . . 0.0 107.776 179.402 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.666 ' HB3' HG21 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -68.5 -42.31 78.78 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.993 -1.067 . . . . 0.0 109.058 177.104 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.6 HD12 ' O ' ' A' ' 11' ' ' VAL . 1.4 mp -66.26 -38.67 82.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.663 0 C-N-CA 118.133 -1.427 . . . . 0.0 108.621 178.734 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.561 ' HA ' ' HG2' ' A' ' 19' ' ' GLU . 44.2 m -64.88 -37.58 88.12 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 120.379 -1.45 . . . . 0.0 109.163 178.928 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 1.074 HD12 ' O ' ' A' ' 13' ' ' GLU . 0.9 OUTLIER -66.11 -37.46 85.81 Favored 'General case' 0 N--CA 1.491 1.619 0 O-C-N 120.85 -1.156 . . . . 0.0 109.069 178.652 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.452 ' O ' HD12 ' A' ' 23' ' ' LEU . . . -70.07 -42.76 66.97 Favored Glycine 0 N--CA 1.516 3.977 0 C-N-CA 118.6 -1.762 . . . . 0.0 108.864 178.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.69 ' HG3' ' N ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -59.81 -37.6 79.61 Favored 'General case' 0 N--CA 1.487 1.423 0 O-C-N 120.294 -1.71 . . . . 0.0 108.047 179.047 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.69 ' N ' ' HG3' ' A' ' 19' ' ' GLU . 28.2 m120 -61.05 -26.79 67.88 Favored 'General case' 0 N--CA 1.493 1.719 0 C-N-CA 118.309 -1.356 . . . . 0.0 109.371 178.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.648 ' CE ' ' CG ' ' A' ' 42' ' ' HIS . 43.7 mmm -101.94 11.52 38.42 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 121.193 -0.942 . . . . 0.0 111.261 -179.366 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 105.21 -25.33 25.32 Favored Glycine 0 N--CA 1.497 2.758 0 C-N-CA 118.654 -1.736 . . . . 0.0 110.897 179.554 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.854 ' CD2' ' HB1' ' A' ' 37' ' ' ALA . 1.7 mp -78.62 91.77 4.66 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.414 -1.639 . . . . 0.0 109.027 179.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.478 ' O ' ' CB ' ' A' ' 25' ' ' ASN . 41.7 mt-10 -106.23 169.9 8.24 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.311 -0.868 . . . . 0.0 108.93 179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.478 ' CB ' ' O ' ' A' ' 24' ' ' GLU . 0.7 OUTLIER 69.06 21.17 7.45 Favored 'General case' 0 N--CA 1.507 2.417 0 O-C-N 121.518 -0.738 . . . . 0.0 111.532 179.505 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.672 HD11 ' HB3' ' A' ' 23' ' ' LEU . 0.4 OUTLIER -76.78 -3.83 40.31 Favored 'General case' 0 N--CA 1.502 2.138 0 O-C-N 120.813 -1.179 . . . . 0.0 110.976 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.436 ' C ' ' O ' ' A' ' 26' ' ' LEU . . . -46.64 -32.92 3.81 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.602 -1.311 . . . . 0.0 108.685 -179.52 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -80.84 -2.56 47.81 Favored 'General case' 0 N--CA 1.492 1.649 0 C-N-CA 120.147 -0.621 . . . . 0.0 111.477 179.74 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.588 ' O ' HD11 ' A' ' 34' ' ' ILE . 7.9 mtp -100.73 150.61 22.59 Favored 'General case' 0 C--N 1.311 -1.076 0 O-C-N 120.748 -1.22 . . . . 0.0 111.33 -178.876 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.575 ' C ' HD12 ' A' ' 34' ' ' ILE . 17.4 tpp180 -89.32 141.23 28.73 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.252 -0.905 . . . . 0.0 110.407 178.796 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.609 ' HG3' HD23 ' A' ' 14' ' ' LEU . 7.8 ttmt -29.88 -47.57 0.08 Allowed 'General case' 0 N--CA 1.501 2.082 0 CA-C-N 116.434 -0.348 . . . . 0.0 111.774 179.644 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.53 ' OE1' ' N ' ' A' ' 33' ' ' ASP . 1.3 pp0? -59.57 -56.04 26.94 Favored 'General case' 0 N--CA 1.518 2.953 0 O-C-N 121.385 -0.822 . . . . 0.0 111.976 -177.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.534 ' OD1' ' HE2' ' A' ' 29' ' ' MET . 2.8 p30 -66.09 -35.95 81.88 Favored 'General case' 0 C--N 1.297 -1.704 0 O-C-N 120.795 -1.19 . . . . 0.0 109.112 179.822 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.666 HG21 ' HB3' ' A' ' 14' ' ' LEU . 3.3 mt -61.52 -37.79 78.65 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 O-C-N 120.313 -1.492 . . . . 0.0 108.094 177.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.874 HG23 HD22 ' A' ' 6' ' ' LEU . 0.5 OUTLIER -60.21 -46.83 94.12 Favored 'Isoleucine or valine' 0 N--CA 1.509 2.494 0 O-C-N 120.076 -1.64 . . . . 0.0 109.506 177.446 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 28.9 m-85 -54.36 -40.56 68.22 Favored 'General case' 0 N--CA 1.493 1.708 0 C-N-CA 119.751 -0.779 . . . . 0.0 109.525 -179.325 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.854 ' HB1' ' CD2' ' A' ' 23' ' ' LEU . . . -71.74 -52.02 19.85 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 120.745 -1.222 . . . . 0.0 110.626 179.187 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.567 HD11 HG22 ' A' ' 34' ' ' ILE . 2.5 mt -58.41 -28.19 35.16 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 C-N-CA 117.131 -1.827 . . . . 0.0 109.999 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.438 HD23 ' HA ' ' A' ' 39' ' ' LEU . 25.7 mt -72.39 -41.95 65.74 Favored 'General case' 0 N--CA 1.506 2.341 0 O-C-N 120.06 -1.65 . . . . 0.0 109.451 178.054 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -65.33 -36.77 85.05 Favored 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.903 -1.123 . . . . 0.0 110.286 178.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.629 ' CB ' HD11 ' A' ' 23' ' ' LEU . 22.5 mm-40 -78.66 -51.69 9.5 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.273 -0.892 . . . . 0.0 111.2 -179.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.648 ' CG ' ' CE ' ' A' ' 21' ' ' MET . 0.2 OUTLIER -63.51 -36.48 83.91 Favored 'General case' 0 N--CA 1.505 2.279 0 C-N-CA 118.179 -1.408 . . . . 0.0 108.728 179.871 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.47 ' O ' ' N ' ' A' ' 46' ' ' GLY . . . -55.15 -45.06 75.64 Favored 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 177.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -49.98 -44.52 50.94 Favored 'General case' 0 N--CA 1.483 1.202 0 CA-C-O 122.067 0.937 . . . . 0.0 108.65 177.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.45 ' HB2' ' O ' ' A' ' 42' ' ' HIS . 49.7 m -66.41 -8.14 23.84 Favored 'General case' 0 C--N 1.3 -1.551 0 CA-C-O 121.579 0.704 . . . . 0.0 109.658 179.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.47 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . 80.98 20.98 64.04 Favored Glycine 0 N--CA 1.497 2.713 0 C-N-CA 120.107 -1.044 . . . . 0.0 112.642 178.028 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.5 mm-40 -78.72 164.75 24.31 Favored 'General case' 0 N--CA 1.497 1.913 0 CA-C-N 120.298 2.049 . . . . 0.0 108.65 178.612 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.411 ' O ' ' CG ' ' A' ' 1' ' ' MET . 4.2 m-20 -88.69 152.66 21.67 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.019 -1.05 . . . . 0.0 110.233 -179.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.983 HG22 ' HG3' ' A' ' 1' ' ' MET . 9.0 pt -141.47 133.37 28.3 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.729 0 O-C-N 121.024 -1.048 . . . . 0.0 108.601 179.586 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.59 ' CZ ' ' HB2' ' A' ' 2' ' ' ASN . 20.8 p90 -140.85 164.61 29.78 Favored 'General case' 0 C--N 1.313 -1.015 0 C-N-CA 116.542 -2.063 . . . . 0.0 114.303 -179.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -121.97 166.83 14.61 Favored Glycine 0 N--CA 1.502 3.08 0 N-CA-C 109.406 -1.478 . . . . 0.0 109.406 -177.859 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.472 ' OD1' ' OG1' ' A' ' 4' ' ' THR . 43.4 p30 -167.54 164.48 14.77 Favored 'General case' 0 N--CA 1.477 0.911 0 O-C-N 120.587 -1.537 . . . . 0.0 109.57 -179.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.519 ' HA3' ' O ' ' A' ' 66' ' ' ARG . . . 141.61 -137.25 7.91 Favored Glycine 0 N--CA 1.501 2.998 0 C-N-CA 118.074 -2.012 . . . . 0.0 111.039 178.807 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.583 ' HA ' ' O ' ' A' ' 95' ' ' ASP . 2.9 t -129.01 121.41 54.19 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.983 0 O-C-N 121.361 -1.081 . . . . 0.0 108.467 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.966 HD21 HG21 ' A' ' 81' ' ' VAL . 6.9 mt -62.81 165.98 6.06 Favored 'General case' 0 N--CA 1.504 2.23 0 C-N-CA 118.785 -1.166 . . . . 0.0 114.008 -175.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.492 ' HA ' ' OG1' ' A' ' 93' ' ' THR . 2.0 mm-40 -139.64 117.66 11.81 Favored 'General case' 0 N--CA 1.499 1.984 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 178.055 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.869 ' O ' HD12 ' A' ' 58' ' ' LEU . 1.6 mm -84.92 161.91 3.03 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.197 0 CA-C-N 120.824 1.647 . . . . 0.0 110.316 -178.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.869 HD12 ' O ' ' A' ' 57' ' ' ILE . 7.6 mp -130.97 143.68 50.91 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 120.496 -1.377 . . . . 0.0 109.691 178.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.41 ' C ' ' O ' ' A' ' 58' ' ' LEU . 0.9 OUTLIER -42.35 -37.06 1.43 Allowed 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.304 -0.872 . . . . 0.0 110.337 -179.58 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.468 ' OD1' ' N ' ' A' ' 60' ' ' ASP . 4.5 m-20 -61.01 -6.79 2.05 Favored 'General case' 0 N--CA 1.502 2.126 0 C-N-CA 119.814 -0.754 . . . . 0.0 112.575 -178.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.423 ' O ' ' HB3' ' A' ' 83' ' ' PRO . . . 91.59 7.09 65.27 Favored Glycine 1 N--CA 1.519 4.204 0 C-N-CA 118.515 -1.803 . . . . 0.0 112.091 177.859 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.5 ' CE2' ' CE2' ' A' ' 64' ' ' PHE . 2.7 p90 -127.76 179.38 5.57 Favored 'General case' 0 C--N 1.307 -1.253 0 N-CA-C 104.645 -2.354 . . . . 0.0 104.645 178.063 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . . . . . . . . . . . -160.46 176.25 37.13 Favored Glycine 0 N--CA 1.477 1.427 0 C-N-CA 117.065 -2.493 . . . . 0.0 111.547 -177.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.59 ' CE1' ' O ' ' A' ' 76' ' ' PRO . 55.2 m-85 -129.98 155.49 46.0 Favored 'General case' 0 N--CA 1.485 1.283 0 CA-C-N 120.112 1.956 . . . . 0.0 109.926 177.667 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.557 ' HB3' ' HB ' ' A' ' 79' ' ' ILE . 0.3 OUTLIER -98.92 161.65 13.51 Favored 'General case' 0 N--CA 1.487 1.393 0 N-CA-C 107.193 -1.41 . . . . 0.0 107.193 176.506 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.519 ' O ' ' HA3' ' A' ' 53' ' ' GLY . 0.0 OUTLIER 178.61 -163.45 0.04 OUTLIER 'General case' 0 N--CA 1.488 1.439 0 O-C-N 121.351 -0.843 . . . . 0.0 109.313 179.38 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -71.43 -155.25 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.008 -1.058 . . . . 0.0 110.462 -179.976 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . 0.45 ' O ' ' O ' ' A' ' 69' ' ' ASP . . . -100.55 -47.67 4.8 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.552 -0.717 . . . . 0.0 110.208 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.45 ' O ' ' O ' ' A' ' 68' ' ' ALA . 3.0 p-10 -62.97 -141.03 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.089 0 O-C-N 121.25 -0.906 . . . . 0.0 108.576 179.3 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.515 ' O ' ' CB ' ' A' ' 71' ' ' SER . 0.2 OUTLIER -62.55 -71.23 0.16 Allowed 'General case' 0 N--CA 1.503 2.224 0 O-C-N 120.044 -1.66 . . . . 0.0 109.327 179.514 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.659 ' O ' ' HB2' ' A' ' 72' ' ' TYR . 0.5 OUTLIER 167.2 -23.89 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.204 0 O-C-N 121.425 -0.797 . . . . 0.0 110.437 179.449 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.659 ' HB2' ' O ' ' A' ' 71' ' ' SER . 3.3 m-85 74.22 -41.09 0.47 Allowed 'General case' 0 N--CA 1.526 3.334 0 N-CA-C 112.053 0.39 . . . . 0.0 112.053 179.446 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.516 ' HA ' HD23 ' A' ' 73' ' ' LEU . 5.0 mt -90.56 -168.83 2.2 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 120.448 -1.407 . . . . 0.0 109.964 -179.962 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.826 ' HB3' ' HB2' ' A' ' 77' ' ' ASP . . . -78.81 60.84 2.91 Favored 'General case' 0 C--N 1.289 -2.043 0 CA-C-N 115.758 -0.656 . . . . 0.0 111.39 -179.474 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.493 ' C ' ' O ' ' A' ' 74' ' ' ALA . . . 12.76 -71.39 0.0 OUTLIER Glycine 1 N--CA 1.543 5.816 0 CA-C-O 119.398 -0.668 . . . . 0.0 112.714 178.823 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.606 ' N ' ' O ' ' A' ' 74' ' ' ALA . 23.3 Cg_endo -53.19 -31.31 54.73 Favored 'Trans proline' 0 N--CA 1.487 1.11 0 N-CA-C 109.549 -0.981 . . . . 0.0 109.549 -179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.826 ' HB2' ' HB3' ' A' ' 74' ' ' ALA . 6.8 m-20 -84.42 -2.48 57.25 Favored 'General case' 0 C--N 1.285 -2.202 0 C-N-CA 119.996 -0.681 . . . . 0.0 112.089 179.486 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.534 ' O ' ' O ' ' A' ' 77' ' ' ASP . 5.4 m-20 -58.6 -137.95 0.0 OUTLIER 'General case' 0 N--CA 1.516 2.845 0 O-C-N 120.287 -1.508 . . . . 0.0 109.382 178.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.557 ' HB ' ' HB3' ' A' ' 65' ' ' LEU . 1.4 mp -92.9 130.21 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.519 3.012 0 C-N-CA 117.479 -1.688 . . . . 0.0 108.956 179.008 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.524 ' HB3' ' O ' ' A' ' 111' ' ' PHE . 5.8 t80 -79.84 146.19 32.36 Favored 'General case' 0 N--CA 1.517 2.876 0 CA-C-N 121.263 1.847 . . . . 0.0 110.429 -179.211 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.966 HG21 HD21 ' A' ' 55' ' ' LEU . 49.8 t -140.8 113.47 4.68 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 120.278 -1.513 . . . . 0.0 110.622 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.581 ' O ' HG13 ' A' ' 86' ' ' ILE . 14.0 m -74.99 162.81 71.9 Favored Pre-proline 0 N--CA 1.514 2.769 0 O-C-N 120.516 -1.365 . . . . 0.0 111.757 -179.569 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.518 ' HA ' HG13 ' A' ' 86' ' ' ILE . 38.8 Cg_endo -66.02 -49.09 2.26 Favored 'Trans proline' 0 C--N 1.315 -1.193 0 O-C-N 124.465 1.771 . . . . 0.0 109.295 179.044 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.548 ' O ' ' CG ' ' A' ' 88' ' ' ARG . 23.3 t -47.27 -40.63 17.14 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 178.088 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.522 ' HB2' ' O ' ' A' ' 82' ' ' SER . 7.9 mm100 -63.58 -56.58 14.82 Favored 'General case' 0 N--CA 1.51 2.548 0 C-N-CA 119.498 -0.881 . . . . 0.0 108.642 178.067 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.581 HG13 ' O ' ' A' ' 82' ' ' SER . 1.0 OUTLIER -55.87 -54.67 24.05 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.245 0 O-C-N 120.942 -1.099 . . . . 0.0 108.871 178.679 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.454 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 0.0 OUTLIER -56.51 -41.95 77.55 Favored 'General case' 0 C--N 1.297 -1.707 0 CA-C-O 121.941 0.877 . . . . 0.0 111.17 -179.384 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.548 ' CG ' ' O ' ' A' ' 84' ' ' SER . 2.5 mmt180 -60.3 -37.45 80.6 Favored 'General case' 0 N--CA 1.507 2.382 0 C-N-CA 119.739 -0.784 . . . . 0.0 111.9 -177.773 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 7.5 m-85 -113.27 14.21 19.28 Favored 'General case' 0 N--CA 1.502 2.135 0 C-N-CA 117.507 -1.677 . . . . 0.0 111.459 -179.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 58.95 53.27 5.75 Favored 'General case' 0 N--CA 1.486 1.346 0 O-C-N 120.363 -1.461 . . . . 0.0 109.543 178.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.524 ' O ' ' HG3' ' A' ' 92' ' ' ARG . 0.0 OUTLIER -89.41 173.66 8.23 Favored 'General case' 0 N--CA 1.495 1.787 0 C-N-CA 119.862 -0.735 . . . . 0.0 109.503 179.883 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.524 ' HG3' ' O ' ' A' ' 91' ' ' LEU . 21.1 mtp180 -152.06 164.1 37.94 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.928 -1.108 . . . . 0.0 109.249 178.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.591 ' HB ' ' CG1' ' A' ' 57' ' ' ILE . 1.5 t -65.42 155.52 35.2 Favored 'General case' 0 N--CA 1.498 1.965 0 C-N-CA 117.014 -1.874 . . . . 0.0 106.964 179.035 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 76.66 -10.5 17.71 Favored Glycine 0 N--CA 1.505 3.235 0 C-N-CA 117.161 -2.447 . . . . 0.0 110.073 179.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.583 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 9.9 m-20 -67.04 144.75 55.97 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 120.216 -1.755 . . . . 0.0 110.706 -178.745 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.504 ' O ' HG12 ' A' ' 97' ' ' ILE . 0.2 OUTLIER -90.18 120.5 31.4 Favored 'General case' 0 N--CA 1.489 1.504 0 N-CA-C 108.67 -0.863 . . . . 0.0 108.67 179.238 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.542 HG23 HG22 ' A' ' 119' ' ' VAL . 1.6 mt -146.43 168.66 6.12 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.673 0 O-C-N 119.845 -1.784 . . . . 0.0 112.985 -178.284 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.545 ' OG ' ' HB2' ' A' ' 118' ' ' GLU . 68.7 p -149.38 138.8 21.56 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 109.127 -0.694 . . . . 0.0 109.127 178.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.516 ' O ' ' HB2' ' A' ' 50' ' ' PHE . . . -165.88 179.56 40.03 Favored Glycine 0 N--CA 1.505 3.256 0 C-N-CA 117.379 -2.343 . . . . 0.0 114.422 -179.382 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.566 ' HD3' HD23 ' A' ' 114' ' ' LEU . 5.7 ptmt -90.6 156.0 18.45 Favored 'General case' 0 N--CA 1.498 1.949 0 N-CA-C 106.791 -1.559 . . . . 0.0 106.791 179.154 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.523 HG12 ' HA ' ' A' ' 50' ' ' PHE . 2.3 pt -129.03 154.87 40.64 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.582 0 CA-C-N 121.02 1.736 . . . . 0.0 113.145 -177.216 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.804 ' HB2' HD22 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -160.65 151.17 15.12 Favored Pre-proline 0 N--CA 1.488 1.428 0 O-C-N 120.359 -1.463 . . . . 0.0 109.363 179.309 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.672 ' N ' ' HD3' ' A' ' 104' ' ' PRO . 54.9 Cg_endo -101.35 19.14 0.25 Allowed 'Trans proline' 0 CA--C 1.558 1.72 0 C-N-CA 121.527 1.484 . . . . 0.0 114.193 -178.994 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.672 ' HD3' ' N ' ' A' ' 103' ' ' PRO . 56.1 Cg_endo -86.96 47.62 1.65 Allowed 'Trans proline' 0 N--CA 1.489 1.228 0 CA-C-N 119.343 0.801 . . . . 0.0 111.893 -178.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -156.99 -171.53 3.68 Favored 'General case' 0 N--CA 1.499 1.976 0 O-C-N 120.078 -1.639 . . . . 0.0 110.809 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -60.72 -15.52 30.06 Favored 'General case' 0 C--N 1.309 -1.167 0 N-CA-C 108.053 -1.092 . . . . 0.0 108.053 178.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . -79.95 48.24 3.49 Favored Glycine 0 N--CA 1.487 2.081 0 N-CA-C 108.722 -1.751 . . . . 0.0 108.722 178.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.584 ' O ' ' N ' ' A' ' 110' ' ' TYR . 2.4 tt0 -82.83 -169.48 2.52 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 120.626 -1.514 . . . . 0.0 108.855 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.527 ' HB3' ' O ' ' A' ' 108' ' ' GLU . 3.6 tpp85 64.48 -59.11 0.23 Allowed 'General case' 0 N--CA 1.499 2.004 0 O-C-N 121.222 -0.924 . . . . 0.0 108.518 -177.571 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.584 ' N ' ' O ' ' A' ' 108' ' ' GLU . 13.7 m-85 -107.27 150.85 26.2 Favored 'General case' 0 N--CA 1.514 2.738 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 175.662 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.524 ' O ' ' HB3' ' A' ' 80' ' ' TYR . 53.4 m-85 -67.31 159.37 29.4 Favored 'General case' 0 N--CA 1.503 2.195 0 O-C-N 119.055 -2.278 . . . . 0.0 107.717 179.542 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.429 ' HA ' ' HB3' ' A' ' 80' ' ' TYR . . . -122.31 154.23 37.9 Favored 'General case' 0 N--CA 1.484 1.271 0 O-C-N 119.932 -1.73 . . . . 0.0 110.508 -179.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.4 tp -59.26 144.02 47.47 Favored 'General case' 0 N--CA 1.491 1.587 0 N-CA-C 107.279 -1.378 . . . . 0.0 107.279 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.804 HD22 ' HB2' ' A' ' 102' ' ' ARG . 18.0 tp -121.89 -54.48 1.93 Allowed 'General case' 0 N--CA 1.499 1.985 0 O-C-N 120.593 -1.317 . . . . 0.0 111.867 -178.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.564 ' HB3' ' CD ' ' A' ' 100' ' ' LYS . 0.1 OUTLIER -130.63 141.54 50.43 Favored 'General case' 0 N--CA 1.506 2.356 0 O-C-N 120.457 -1.402 . . . . 0.0 108.924 179.116 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 11.6 t -92.49 129.08 43.6 Favored 'Isoleucine or valine' 0 N--CA 1.514 2.754 0 O-C-N 120.732 -1.23 . . . . 0.0 111.253 179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.42 ' C ' ' HG2' ' A' ' 118' ' ' GLU . 6.5 m-20 -106.64 -39.02 5.96 Favored 'General case' 0 N--CA 1.506 2.349 0 O-C-N 121.368 -0.833 . . . . 0.0 109.841 178.552 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.569 ' C ' HG23 ' A' ' 119' ' ' VAL . 12.6 mm-40 -143.15 155.87 44.65 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.817 -1.177 . . . . 0.0 109.339 179.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.569 HG23 ' C ' ' A' ' 118' ' ' GLU . 16.7 t -158.33 132.59 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.9 0 N-CA-C 109.594 -0.521 . . . . 0.0 109.594 -178.739 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.468 ' O ' ' C ' ' A' ' 121' ' ' PHE . 0.1 OUTLIER 49.56 44.93 24.42 Favored 'General case' 0 N--CA 1.517 2.907 0 O-C-N 120.255 -1.528 . . . . 0.0 110.874 -179.981 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.468 ' C ' ' O ' ' A' ' 120' ' ' ASN . 0.1 OUTLIER 38.24 34.19 0.07 Allowed 'General case' 0 N--CA 1.521 3.111 0 O-C-N 120.89 -1.132 . . . . 0.0 110.314 179.722 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.408 ' N ' ' O ' ' A' ' 120' ' ' ASN . 5.1 m-20 -154.57 172.87 17.13 Favored 'General case' 0 N--CA 1.486 1.329 0 O-C-N 121.123 -0.985 . . . . 0.0 109.474 179.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.599 ' HB3' ' HD2' ' A' ' 124' ' ' PRO . 39.9 mmtt -57.32 169.4 0.75 Allowed Pre-proline 0 N--CA 1.51 2.569 0 O-C-N 121.083 -1.01 . . . . 0.0 108.547 179.694 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.599 ' HD2' ' HB3' ' A' ' 123' ' ' LYS . 40.6 Cg_endo -67.29 48.08 0.32 Allowed 'Trans proline' 0 C--N 1.31 -1.456 0 O-C-N 123.375 1.197 . . . . 0.0 111.332 -179.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.499 ' O ' ' CB ' ' A' ' 126' ' ' ASN . 0.2 OUTLIER -177.21 -171.87 0.36 Allowed 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 179.668 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.499 ' CB ' ' O ' ' A' ' 125' ' ' GLU . 0.3 OUTLIER 171.06 -146.14 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.183 0 O-C-N 120.112 -1.617 . . . . 0.0 110.227 179.726 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.406 ' C ' ' HG2' ' A' ' 128' ' ' ARG . . . -138.52 -160.69 1.09 Allowed 'General case' 0 N--CA 1.494 1.737 0 O-C-N 120.861 -1.149 . . . . 0.0 109.009 179.692 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.406 ' HG2' ' C ' ' A' ' 127' ' ' ALA . 13.4 mmt180 -134.12 -172.09 2.91 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 120.228 -1.545 . . . . 0.0 110.708 179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 9.1 t30 -90.18 172.68 8.63 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.557 -0.714 . . . . 0.0 110.721 -179.501 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.555 0 CA-C-O 118.024 -0.989 . . . . 0.0 109.826 179.608 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.626 ' HA ' ' HA ' ' A' ' 49' ' ' ILE . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.685 0 N-CA-C 109.885 -0.413 . . . . 0.0 109.885 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.575 ' HA ' ' O ' ' A' ' 50' ' ' PHE . 34.8 t30 -78.29 94.23 4.78 Favored 'General case' 0 N--CA 1.499 2.023 0 O-C-N 120.884 -1.135 . . . . 0.0 108.675 178.949 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 1.047 HD23 HD13 ' A' ' 79' ' ' ILE . 1.0 OUTLIER -41.79 -40.61 2.1 Favored 'General case' 0 N--CA 1.517 2.889 0 O-C-N 120.599 -1.313 . . . . 0.0 110.357 -178.711 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.469 ' OG1' ' OD1' ' A' ' 52' ' ' ASP . 1.5 m -60.94 -36.44 79.35 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 120.891 -1.13 . . . . 0.0 108.239 -179.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.542 ' HB3' ' HB3' ' A' ' 2' ' ' ASN . 2.8 pt-20 -70.11 -45.37 67.05 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 120.981 -1.074 . . . . 0.0 108.432 178.033 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.528 HD12 HD12 ' A' ' 3' ' ' LEU 0.277 14.8 mt -52.77 -48.82 66.53 Favored 'General case' 0 C--N 1.315 -0.924 0 O-C-N 120.906 -1.121 . . . . 0.0 109.536 178.129 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . . . . . . . . . 32.4 mttm -64.51 -34.92 79.34 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.227 -0.921 . . . . 0.0 110.332 179.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 3.3 m-80 -62.08 -24.67 67.25 Favored 'General case' 0 N--CA 1.507 2.415 0 O-C-N 121.135 -0.978 . . . . 0.0 111.145 -179.053 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.724 HG22 ' CB ' ' A' ' 13' ' ' GLU . 2.8 m -73.52 133.64 80.06 Favored Pre-proline 0 N--CA 1.505 2.322 0 O-C-N 121.72 -0.613 . . . . 0.0 109.652 -179.804 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.564 ' HG2' ' CG ' ' A' ' 13' ' ' GLU . 44.0 Cg_endo -64.12 151.86 83.53 Favored 'Trans proline' 0 CA--C 1.565 2.051 0 N-CA-C 110.036 -0.794 . . . . 0.0 110.036 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.534 ' CG1' ' N ' ' A' ' 12' ' ' SER . 1.7 p -43.25 -50.29 1.29 Allowed 'Isoleucine or valine' 0 N--CA 1.529 3.515 0 O-C-N 120.286 -1.509 . . . . 0.0 110.174 -178.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.534 ' N ' ' CG1' ' A' ' 11' ' ' VAL . 0.8 OUTLIER -57.5 -41.59 81.07 Favored 'General case' 0 N--CA 1.499 1.993 0 O-C-N 121.294 -0.879 . . . . 0.0 111.044 -179.485 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.724 ' CB ' HG22 ' A' ' 9' ' ' THR . 3.5 mm-40 -69.06 -26.77 65.12 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 118.115 -1.434 . . . . 0.0 107.662 179.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.759 ' HB3' HG21 ' A' ' 34' ' ' ILE . 0.0 OUTLIER -70.44 -43.72 69.31 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.165 -0.959 . . . . 0.0 108.917 176.898 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.487 HD12 ' O ' ' A' ' 11' ' ' VAL . 1.7 mp -67.22 -38.68 81.5 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.717 0 C-N-CA 117.653 -1.619 . . . . 0.0 108.952 178.993 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.565 ' HA ' ' HG2' ' A' ' 19' ' ' GLU . 62.9 m -64.94 -38.54 91.32 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 120.368 -1.458 . . . . 0.0 109.172 178.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.522 ' O ' ' HG3' ' A' ' 21' ' ' MET . 0.1 OUTLIER -65.09 -38.27 90.17 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 120.91 -1.119 . . . . 0.0 108.879 178.561 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . 0.504 ' HA2' HD13 ' A' ' 23' ' ' LEU . . . -67.67 -41.95 88.47 Favored Glycine 0 N--CA 1.515 3.936 0 N-CA-C 108.505 -1.838 . . . . 0.0 108.505 178.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.713 ' HG3' ' N ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -59.68 -38.5 81.7 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 120.286 -1.714 . . . . 0.0 108.035 178.855 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.713 ' N ' ' HG3' ' A' ' 19' ' ' GLU . 26.1 m120 -61.68 -28.9 69.73 Favored 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 118.429 -1.308 . . . . 0.0 109.609 178.844 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.59 ' HB2' HD12 ' A' ' 23' ' ' LEU . 21.1 mtp -100.28 10.79 40.71 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.187 -0.946 . . . . 0.0 111.207 -179.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.52 -17.02 57.29 Favored Glycine 0 N--CA 1.5 2.9 0 C-N-CA 118.446 -1.835 . . . . 0.0 111.843 179.192 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.841 ' CD2' ' HB1' ' A' ' 37' ' ' ALA . 1.7 mp -79.06 104.61 9.81 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 120.079 -1.836 . . . . 0.0 109.385 -179.826 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.404 ' O ' ' CB ' ' A' ' 25' ' ' ASN . 1.4 pt-20 -115.19 178.95 4.1 Favored 'General case' 0 N--CA 1.487 1.384 0 O-C-N 121.236 -0.915 . . . . 0.0 109.398 -179.92 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.404 ' CB ' ' O ' ' A' ' 24' ' ' GLU . 0.0 OUTLIER 65.88 15.28 10.0 Favored 'General case' 0 N--CA 1.512 2.634 0 CA-C-N 116.09 -0.505 . . . . 0.0 111.716 178.963 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 1.089 HD23 ' SD ' ' A' ' 29' ' ' MET . 1.1 mt -76.79 -15.78 59.65 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 121.154 -0.966 . . . . 0.0 112.066 -179.602 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . . . . . . . . . . . -47.02 -28.49 1.69 Allowed 'General case' 0 N--CA 1.497 1.925 0 O-C-N 120.315 -1.491 . . . . 0.0 109.392 -179.267 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 2.9 mtt180 -79.1 -37.82 37.74 Favored 'General case' 0 C--N 1.295 -1.798 0 C-N-CA 120.075 -0.65 . . . . 0.0 111.906 -179.37 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 1.089 ' SD ' HD23 ' A' ' 26' ' ' LEU . 5.8 ptm -85.87 169.64 13.12 Favored 'General case' 0 N--CA 1.482 1.156 0 O-C-N 120.545 -1.347 . . . . 0.0 111.529 -179.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 1.033 ' O ' HD12 ' A' ' 34' ' ' ILE . 1.0 OUTLIER -89.67 -176.26 4.93 Favored 'General case' 0 N--CA 1.504 2.274 0 CA-C-O 122.534 1.159 . . . . 0.0 113.529 -178.238 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.624 ' O ' HG22 ' A' ' 35' ' ' ILE . 4.4 ptmt -68.14 -33.25 74.13 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-N 115.394 -0.821 . . . . 0.0 111.122 -179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.58 ' O ' ' CG2' ' A' ' 35' ' ' ILE . 3.2 mm100 -65.19 -55.26 19.57 Favored 'General case' 0 N--CA 1.525 3.297 0 CA-C-O 122.166 0.984 . . . . 0.0 109.753 179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.522 ' OD1' ' N ' ' A' ' 34' ' ' ILE . 2.0 p30 -66.5 -39.36 88.66 Favored 'General case' 0 C--N 1.301 -1.542 0 O-C-N 120.904 -1.123 . . . . 0.0 108.967 -179.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 1.033 HD12 ' O ' ' A' ' 30' ' ' ARG . 1.7 mt -61.2 -40.83 87.25 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 O-C-N 120.194 -1.566 . . . . 0.0 109.281 177.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.624 HG22 ' O ' ' A' ' 31' ' ' LYS . 0.3 OUTLIER -66.79 -36.07 76.32 Favored 'Isoleucine or valine' 0 N--CA 1.511 2.585 0 O-C-N 120.292 -1.505 . . . . 0.0 109.544 179.437 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.468 ' CD2' ' O ' ' A' ' 32' ' ' GLN . 21.6 m-85 -60.45 -43.63 96.66 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 120.813 -1.18 . . . . 0.0 108.78 179.259 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.841 ' HB1' ' CD2' ' A' ' 23' ' ' LEU . . . -65.44 -54.14 32.84 Favored 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.516 -1.365 . . . . 0.0 109.634 178.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.542 HG13 ' O ' ' A' ' 34' ' ' ILE . 0.0 OUTLIER -53.76 -30.07 18.5 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.613 0 C-N-CA 117.541 -1.663 . . . . 0.0 109.743 179.57 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.721 HD11 HD11 ' A' ' 3' ' ' LEU . 34.2 mt -67.95 -42.53 80.8 Favored 'General case' 0 N--CA 1.504 2.258 0 O-C-N 119.865 -1.772 . . . . 0.0 109.224 178.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.4 mttt -66.0 -40.23 90.96 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.946 -1.096 . . . . 0.0 110.722 178.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.502 ' O ' ' HB2' ' A' ' 44' ' ' LYS . 9.3 mm100 -73.51 -51.13 18.15 Favored 'General case' 0 N--CA 1.502 2.171 0 O-C-N 121.095 -1.003 . . . . 0.0 110.757 -179.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.526 ' HB3' ' HE2' ' A' ' 1' ' ' MET . 2.9 t-80 -62.51 -36.85 83.86 Favored 'General case' 0 N--CA 1.509 2.502 0 C-N-CA 118.885 -1.126 . . . . 0.0 108.739 179.51 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.579 ' O ' ' N ' ' A' ' 46' ' ' GLY . . . -67.01 -31.54 72.17 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.0 -1.063 . . . . 0.0 109.239 178.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.502 ' HB2' ' O ' ' A' ' 41' ' ' GLN . 9.0 tptt -47.54 -40.77 19.68 Favored 'General case' 0 N--CA 1.481 1.121 0 O-C-N 120.65 -1.281 . . . . 0.0 108.808 177.98 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 46.9 m -66.03 -11.07 45.65 Favored 'General case' 0 C--N 1.3 -1.555 0 C-N-CA 119.452 -0.899 . . . . 0.0 109.056 179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.579 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . 68.53 29.71 72.97 Favored Glycine 0 N--CA 1.496 2.642 0 C-N-CA 120.531 -0.842 . . . . 0.0 111.616 177.972 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.508 ' OE1' ' N ' ' A' ' 48' ' ' ASP . 0.0 OUTLIER -88.82 169.17 11.83 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 120.105 -1.821 . . . . 0.0 108.788 178.921 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . 0.508 ' N ' ' OE1' ' A' ' 47' ' ' GLU . 9.1 m-20 -71.66 151.08 43.98 Favored 'General case' 0 C--N 1.301 -1.507 0 O-C-N 121.024 -1.048 . . . . 0.0 111.226 -178.006 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.626 ' HA ' ' HA ' ' A' ' 1' ' ' MET . 0.5 OUTLIER -150.81 144.08 16.92 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 178.625 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.575 ' O ' ' HA ' ' A' ' 2' ' ' ASN . 28.7 p90 -141.43 172.2 13.01 Favored 'General case' 0 C--N 1.306 -1.312 0 C-N-CA 115.867 -2.333 . . . . 0.0 114.608 -177.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -124.77 166.71 17.33 Favored Glycine 0 N--CA 1.502 3.065 0 N-CA-C 108.762 -1.735 . . . . 0.0 108.762 -178.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.524 ' C ' ' CD2' ' A' ' 65' ' ' LEU . 3.0 p30 -172.28 163.48 5.74 Favored 'General case' 0 N--CA 1.485 1.281 0 O-C-N 120.346 -1.679 . . . . 0.0 110.065 -179.161 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.42 ' N ' HD21 ' A' ' 65' ' ' LEU . . . 146.94 -139.66 8.1 Favored Glycine 0 N--CA 1.504 3.233 0 C-N-CA 118.146 -1.978 . . . . 0.0 110.986 178.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.599 ' HA ' ' O ' ' A' ' 95' ' ' ASP . 4.6 t -128.75 122.74 57.76 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.127 0 N-CA-C 107.787 -1.19 . . . . 0.0 107.787 179.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 1.025 HD21 HG21 ' A' ' 81' ' ' VAL . 6.0 mt -62.9 161.24 13.17 Favored 'General case' 0 N--CA 1.502 2.17 0 C-N-CA 118.486 -1.286 . . . . 0.0 114.043 -175.099 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.512 ' HA ' ' OG1' ' A' ' 93' ' ' THR . 0.0 OUTLIER -137.7 116.24 12.06 Favored 'General case' 0 N--CA 1.496 1.841 0 N-CA-C 106.757 -1.571 . . . . 0.0 106.757 177.998 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.662 ' C ' HD12 ' A' ' 58' ' ' LEU . 1.4 mm -84.14 159.74 3.48 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.063 0 CA-C-N 121.087 1.767 . . . . 0.0 109.616 -178.485 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.864 HD22 ' CZ ' ' A' ' 62' ' ' PHE . 5.6 mp -130.1 135.76 48.58 Favored 'General case' 0 N--CA 1.496 1.832 0 O-C-N 120.443 -1.41 . . . . 0.0 109.602 179.262 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.472 ' C ' ' O ' ' A' ' 58' ' ' LEU . 0.8 OUTLIER -38.47 -35.15 0.16 Allowed 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 121.701 0.762 . . . . 0.0 109.909 -179.683 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.503 ' OD1' ' N ' ' A' ' 60' ' ' ASP . 1.0 OUTLIER -61.05 -7.66 2.72 Favored 'General case' 0 N--CA 1.499 2.012 0 C-N-CA 120.038 -0.665 . . . . 0.0 112.183 -179.531 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . . . . . . . . . . . 90.64 8.6 65.46 Favored Glycine 1 N--CA 1.52 4.283 0 C-N-CA 118.845 -1.645 . . . . 0.0 112.184 178.146 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.864 ' CZ ' HD22 ' A' ' 58' ' ' LEU . 2.3 p90 -127.95 178.77 5.96 Favored 'General case' 0 N--CA 1.484 1.27 0 N-CA-C 104.491 -2.411 . . . . 0.0 104.491 177.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.554 ' HA2' HD13 ' A' ' 58' ' ' LEU . . . -155.49 172.67 33.65 Favored Glycine 0 N--CA 1.477 1.432 0 C-N-CA 117.142 -2.456 . . . . 0.0 111.63 -178.31 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.574 ' CD2' ' O ' ' A' ' 76' ' ' PRO . 10.9 m-85 -128.88 154.78 46.16 Favored 'General case' 0 N--CA 1.484 1.256 0 CA-C-N 119.851 1.826 . . . . 0.0 108.909 177.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.528 ' CB ' ' HB ' ' A' ' 79' ' ' ILE . 0.2 OUTLIER -99.45 133.23 44.06 Favored 'General case' 0 N--CA 1.484 1.227 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 177.075 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.538 ' CB ' ' OD2' ' A' ' 78' ' ' ASP . 17.2 ptt180 -158.45 -148.34 0.19 Allowed 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.544 -1.347 . . . . 0.0 110.065 -179.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -70.66 -153.64 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.384 -0.822 . . . . 0.0 110.235 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -112.47 -69.42 0.87 Allowed 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.452 -0.78 . . . . 0.0 110.424 -179.739 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.503 ' OD1' ' N ' ' A' ' 70' ' ' SER . 1.1 p30 -78.34 -152.09 0.06 Allowed 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.314 -0.867 . . . . 0.0 109.141 179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.533 ' O ' ' CB ' ' A' ' 71' ' ' SER . 0.7 OUTLIER -68.78 -134.84 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.266 0 O-C-N 120.166 -1.584 . . . . 0.0 109.404 179.628 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.548 ' O ' ' CB ' ' A' ' 72' ' ' TYR . 0.3 OUTLIER 167.61 -22.93 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.256 0 O-C-N 120.877 -1.139 . . . . 0.0 110.828 179.75 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.548 ' CB ' ' O ' ' A' ' 71' ' ' SER . 4.0 m-85 76.6 -43.57 0.46 Allowed 'General case' 0 N--CA 1.521 3.106 0 O-C-N 121.578 -0.701 . . . . 0.0 111.127 -179.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . 0.475 ' O ' ' O ' ' A' ' 74' ' ' ALA . 3.9 mp -77.44 -162.69 0.32 Allowed 'General case' 0 N--CA 1.494 1.733 0 O-C-N 120.65 -1.281 . . . . 0.0 109.732 179.61 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.475 ' O ' ' O ' ' A' ' 73' ' ' LEU . . . -57.82 -145.96 0.0 OUTLIER 'General case' 0 C--N 1.291 -1.969 0 CA-C-O 122.282 1.039 . . . . 0.0 109.848 179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.559 ' N ' ' HD2' ' A' ' 76' ' ' PRO . . . 141.11 -52.53 0.68 Allowed Glycine 0 N--CA 1.508 3.439 0 C-N-CA 119.823 -1.18 . . . . 0.0 112.526 -179.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . 0.574 ' O ' ' CD2' ' A' ' 64' ' ' PHE . 24.7 Cg_endo -54.13 -36.96 87.0 Favored 'Trans proline' 0 N--CA 1.49 1.28 0 O-C-N 122.751 0.869 . . . . 0.0 110.761 -178.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.506 ' CG ' ' CE1' ' A' ' 110' ' ' TYR . 97.7 m-20 -86.58 13.59 8.27 Favored 'General case' 0 C--N 1.283 -2.302 0 C-N-CA 119.816 -0.754 . . . . 0.0 111.517 179.547 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.538 ' OD2' ' CB ' ' A' ' 66' ' ' ARG . 47.1 m-20 -58.9 -124.77 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.713 0 O-C-N 120.655 -1.278 . . . . 0.0 111.073 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 1.047 HD13 HD23 ' A' ' 3' ' ' LEU . 5.5 mm -83.18 127.97 39.19 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.891 0 O-C-N 120.628 -1.295 . . . . 0.0 110.373 -178.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.494 ' HB3' ' O ' ' A' ' 111' ' ' PHE . 8.6 t80 -74.62 145.4 43.31 Favored 'General case' 0 N--CA 1.515 2.807 0 CA-C-N 121.658 2.026 . . . . 0.0 109.81 179.694 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 1.025 HG21 HD21 ' A' ' 55' ' ' LEU . 17.2 t -138.34 112.44 8.17 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.999 0 O-C-N 120.26 -1.525 . . . . 0.0 110.57 -179.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.551 ' O ' HG13 ' A' ' 86' ' ' ILE . 49.9 m -75.28 164.6 60.01 Favored Pre-proline 0 N--CA 1.513 2.701 0 O-C-N 120.776 -1.203 . . . . 0.0 112.166 -179.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.518 ' HD2' ' HB3' ' A' ' 82' ' ' SER . 39.8 Cg_endo -65.9 -50.05 1.87 Allowed 'Trans proline' 0 C--N 1.315 -1.21 0 O-C-N 124.443 1.759 . . . . 0.0 109.101 178.824 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.559 ' O ' ' CG ' ' A' ' 88' ' ' ARG . 0.5 OUTLIER -47.45 -40.28 17.75 Favored 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 107.453 -1.314 . . . . 0.0 107.453 178.156 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.527 ' HB2' ' O ' ' A' ' 82' ' ' SER . 6.4 mm100 -63.24 -57.21 11.21 Favored 'General case' 0 N--CA 1.511 2.582 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 178.323 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.558 ' HA ' HD23 ' A' ' 91' ' ' LEU . 0.6 OUTLIER -56.97 -54.95 23.39 Favored 'Isoleucine or valine' 0 N--CA 1.507 2.42 0 O-C-N 120.891 -1.131 . . . . 0.0 108.792 178.649 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . . . . . . . . . 6.8 mmt180 -57.67 -42.88 84.45 Favored 'General case' 0 C--N 1.297 -1.716 0 CA-C-O 121.882 0.848 . . . . 0.0 111.568 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.559 ' CG ' ' O ' ' A' ' 84' ' ' SER . 4.4 mtt180 -58.87 -36.02 73.95 Favored 'General case' 0 N--CA 1.506 2.329 0 C-N-CA 119.783 -0.767 . . . . 0.0 111.773 -177.508 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 18.7 m-85 -116.32 15.61 15.82 Favored 'General case' 0 N--CA 1.504 2.255 0 C-N-CA 117.268 -1.773 . . . . 0.0 111.755 -179.869 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 57.84 56.12 4.97 Favored 'General case' 0 N--CA 1.482 1.159 0 O-C-N 120.339 -1.476 . . . . 0.0 109.193 178.821 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 0.558 HD23 ' HA ' ' A' ' 86' ' ' ILE . 0.0 OUTLIER -88.64 -178.78 5.89 Favored 'General case' 0 N--CA 1.494 1.739 0 C-N-CA 119.852 -0.739 . . . . 0.0 109.601 -179.639 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.5 ' CG ' ' O ' ' A' ' 91' ' ' LEU . 68.5 mtt-85 -157.09 158.18 35.94 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.011 -1.056 . . . . 0.0 109.048 178.752 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.609 ' HB ' ' CG1' ' A' ' 57' ' ' ILE . 1.5 t -64.61 154.66 35.66 Favored 'General case' 0 N--CA 1.495 1.815 0 C-N-CA 117.212 -1.795 . . . . 0.0 107.076 179.325 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 77.68 -11.18 20.76 Favored Glycine 0 N--CA 1.502 3.072 0 C-N-CA 116.961 -2.542 . . . . 0.0 110.442 179.074 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.702 ' OD2' HD11 ' A' ' 97' ' ' ILE . 0.0 OUTLIER -74.45 156.79 36.59 Favored 'General case' 0 N--CA 1.493 1.696 0 CA-C-N 120.097 1.948 . . . . 0.0 109.945 -179.192 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.505 ' O ' HG12 ' A' ' 97' ' ' ILE . 0.2 OUTLIER -97.34 127.12 43.03 Favored 'General case' 0 N--CA 1.487 1.415 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -179.201 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.702 HD11 ' OD2' ' A' ' 95' ' ' ASP . 1.9 mt -147.76 166.22 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.437 0 C-N-CA 117.767 -1.573 . . . . 0.0 112.247 179.8 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.462 ' OG ' ' HB2' ' A' ' 118' ' ' GLU . 88.3 p -148.51 136.82 21.2 Favored 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.06 179.056 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . 0.532 ' O ' ' HB2' ' A' ' 50' ' ' PHE . . . -162.18 179.64 37.39 Favored Glycine 0 N--CA 1.505 3.257 0 C-N-CA 117.183 -2.437 . . . . 0.0 114.853 -178.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 8.6 mttt -88.77 151.68 22.25 Favored 'General case' 0 N--CA 1.5 2.047 0 N-CA-C 106.51 -1.663 . . . . 0.0 106.51 178.904 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.56 HG12 ' HA ' ' A' ' 50' ' ' PHE . 2.6 pt -121.66 157.05 25.72 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.627 0 CA-C-N 121.514 1.961 . . . . 0.0 114.026 -176.383 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.973 ' CB ' HD13 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -145.89 146.22 27.94 Favored Pre-proline 0 N--CA 1.487 1.422 0 O-C-N 120.523 -1.361 . . . . 0.0 109.397 179.282 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.528 ' HD2' ' HG3' ' A' ' 102' ' ' ARG . 49.5 Cg_endo -90.7 110.37 0.36 Allowed 'Trans proline' 0 C--N 1.307 -1.627 0 O-C-N 123.876 1.461 . . . . 0.0 110.996 -179.493 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.539 ' HG2' ' CG ' ' A' ' 108' ' ' GLU . 37.2 Cg_endo -62.58 -139.08 0.0 OUTLIER 'Trans proline' 0 C--N 1.306 -1.699 0 O-C-N 123.921 1.485 . . . . 0.0 109.889 179.034 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.575 ' O ' ' HG2' ' A' ' 108' ' ' GLU . 1.4 mppt? -106.74 177.4 4.87 Favored 'General case' 0 N--CA 1.502 2.129 0 O-C-N 120.47 -1.394 . . . . 0.0 110.832 -178.642 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . 0.502 ' O ' ' O ' ' A' ' 105' ' ' LYS 0.255 0.1 OUTLIER -50.08 179.77 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.173 0 O-C-N 120.747 -1.22 . . . . 0.0 108.546 179.148 . . . . . . . . 4 4 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . . . . . . . . . . . 79.98 -33.16 2.19 Favored Glycine 0 N--CA 1.498 2.831 0 C-N-CA 117.877 -2.106 . . . . 0.0 110.332 -179.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.575 ' HG2' ' O ' ' A' ' 105' ' ' LYS . 0.0 OUTLIER -83.08 -36.26 25.02 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 120.151 -1.794 . . . . 0.0 111.063 -179.233 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.491 ' N ' ' OE1' ' A' ' 108' ' ' GLU . 0.4 OUTLIER 66.19 -40.31 0.34 Allowed 'General case' 0 N--CA 1.502 2.133 0 O-C-N 120.692 -1.255 . . . . 0.0 113.143 178.633 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.55 ' N ' ' OE1' ' A' ' 108' ' ' GLU . 17.5 m-85 -106.62 152.52 23.64 Favored 'General case' 0 N--CA 1.522 3.168 0 O-C-N 119.967 -1.708 . . . . 0.0 109.422 179.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . 0.494 ' O ' ' HB3' ' A' ' 80' ' ' TYR . 11.6 m-85 -68.05 166.4 16.02 Favored 'General case' 0 N--CA 1.506 2.365 0 O-C-N 119.729 -1.857 . . . . 0.0 108.065 178.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.454 ' HA ' ' HB3' ' A' ' 80' ' ' TYR . . . -123.61 155.5 37.56 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 120.055 -1.653 . . . . 0.0 111.054 -179.08 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -66.02 153.99 40.7 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 106.287 -1.746 . . . . 0.0 106.287 178.928 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.973 HD13 ' CB ' ' A' ' 102' ' ' ARG . 3.0 tp -130.99 -63.19 0.87 Allowed 'General case' 0 N--CA 1.498 1.951 0 O-C-N 120.066 -1.646 . . . . 0.0 111.727 -178.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -115.35 147.15 40.83 Favored 'General case' 0 N--CA 1.51 2.545 0 O-C-N 120.289 -1.507 . . . . 0.0 109.666 178.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 24.8 t -94.1 130.94 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.519 2.987 0 O-C-N 121.021 -1.049 . . . . 0.0 112.772 -179.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . 0.561 ' O ' ' HB3' ' A' ' 124' ' ' PRO . 7.9 m-20 -107.33 -39.7 5.6 Favored 'General case' 0 N--CA 1.509 2.509 0 O-C-N 121.504 -0.747 . . . . 0.0 109.856 177.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.577 ' C ' HG23 ' A' ' 119' ' ' VAL . 1.3 tt0 -143.4 159.05 43.09 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 120.651 -1.281 . . . . 0.0 109.115 179.639 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.577 HG23 ' C ' ' A' ' 118' ' ' GLU . 17.9 t -156.84 143.06 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.579 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -178.663 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.469 ' C ' ' O ' ' A' ' 119' ' ' VAL . 0.1 OUTLIER -35.08 -29.97 0.01 OUTLIER 'General case' 0 N--CA 1.515 2.812 0 O-C-N 121.0 -1.062 . . . . 0.0 110.88 -177.581 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.531 ' N ' ' O ' ' A' ' 119' ' ' VAL . 0.1 OUTLIER -160.45 59.15 0.33 Allowed 'General case' 0 N--CA 1.492 1.651 0 C-N-CA 118.401 -1.32 . . . . 0.0 111.136 179.157 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.516 ' HB2' ' HB ' ' A' ' 119' ' ' VAL . 0.2 OUTLIER -154.25 164.37 38.66 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 120.562 -1.336 . . . . 0.0 109.982 178.12 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.501 ' HB3' ' HD2' ' A' ' 124' ' ' PRO . 12.4 mmtp -79.72 166.02 43.81 Favored Pre-proline 0 N--CA 1.502 2.131 0 O-C-N 121.47 -0.769 . . . . 0.0 109.037 179.742 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . 0.561 ' HB3' ' O ' ' A' ' 117' ' ' ASN . 50.7 Cg_endo -77.16 40.66 0.84 Allowed 'Trans proline' 0 C--N 1.302 -1.902 0 O-C-N 123.769 1.405 . . . . 0.0 110.511 -179.817 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.541 ' O ' ' CB ' ' A' ' 126' ' ' ASN . 1.7 tp10 -176.47 -143.99 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.38 0 O-C-N 120.769 -1.207 . . . . 0.0 108.706 -179.111 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.541 ' CB ' ' O ' ' A' ' 125' ' ' GLU . 0.2 OUTLIER 166.22 29.37 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.225 0 O-C-N 120.491 -1.38 . . . . 0.0 110.357 179.793 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . . . . . . . . . . . -149.79 28.88 0.76 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 120.698 -1.251 . . . . 0.0 110.262 -179.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . . . . . . . . . 8.6 mtm180 -128.23 -76.3 0.56 Allowed 'General case' 0 N--CA 1.5 2.034 0 O-C-N 121.387 -0.821 . . . . 0.0 110.142 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -64.55 160.61 19.15 Favored 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.146 -0.971 . . . . 0.0 109.969 179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.307 -1.26 0 O-C-N 121.134 -0.979 . . . . 0.0 109.867 -179.807 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.589 ' HA ' ' HA ' ' A' ' 49' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.491 1.609 0 N-CA-C 110.027 -0.361 . . . . 0.0 110.027 . . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' ASN . . . . . 0.598 ' HB3' ' HB3' ' A' ' 5' ' ' GLU . 47.5 t30 -78.75 92.73 4.83 Favored 'General case' 0 N--CA 1.497 1.881 0 O-C-N 120.802 -1.186 . . . . 0.0 108.42 178.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 1.065 HD23 HD11 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -42.55 -43.39 3.72 Favored 'General case' 0 N--CA 1.515 2.779 0 O-C-N 120.607 -1.308 . . . . 0.0 110.472 -178.594 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.487 ' OG1' ' OD2' ' A' ' 52' ' ' ASP . 1.9 m -57.29 -34.54 68.79 Favored 'General case' 0 N--CA 1.501 2.115 0 O-C-N 120.775 -1.203 . . . . 0.0 108.149 -179.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.598 ' HB3' ' HB3' ' A' ' 2' ' ' ASN . 0.0 OUTLIER -70.83 -44.35 66.69 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 177.498 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' LEU . . . . . 0.875 HD22 HG23 ' A' ' 35' ' ' ILE 0.277 15.6 mt -52.33 -49.43 64.28 Favored 'General case' 0 C--N 1.316 -0.88 0 O-C-N 120.748 -1.22 . . . . 0.0 109.613 178.088 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LYS . . . . . 0.468 ' HE2' ' HB2' ' A' ' 77' ' ' ASP . 9.8 mttt -65.37 -37.66 87.69 Favored 'General case' 0 N--CA 1.499 2.003 0 O-C-N 121.08 -1.012 . . . . 0.0 110.589 179.192 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ASN . . . . . . . . . . . . . 2.5 m-80 -63.01 -18.66 63.56 Favored 'General case' 0 N--CA 1.507 2.387 0 O-C-N 121.119 -0.988 . . . . 0.0 111.182 -179.176 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.717 ' O ' HD11 ' A' ' 14' ' ' LEU . 2.2 m -86.56 116.32 65.48 Favored Pre-proline 0 C--N 1.284 -2.249 0 O-C-N 121.761 -0.587 . . . . 0.0 109.642 -179.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . 0.541 ' CG ' ' HG3' ' A' ' 13' ' ' GLU . 37.0 Cg_endo -58.51 155.1 38.04 Favored 'Trans proline' 0 CA--C 1.557 1.657 0 N-CA-C 109.288 -1.082 . . . . 0.0 109.288 179.127 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . 0.703 ' HA ' HD12 ' A' ' 14' ' ' LEU . 1.5 p -41.54 -50.11 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.532 3.657 0 O-C-N 120.173 -1.58 . . . . 0.0 110.463 -177.689 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . 0.516 ' N ' ' CG1' ' A' ' 11' ' ' VAL . 1.9 t -58.96 -42.15 89.19 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.188 -0.945 . . . . 0.0 111.156 -179.817 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLU . . . . . 0.581 ' CB ' HG22 ' A' ' 9' ' ' THR . 2.2 mm-40 -69.13 -27.79 65.88 Favored 'General case' 0 N--CA 1.486 1.348 0 C-N-CA 118.15 -1.42 . . . . 0.0 108.336 -179.89 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.717 HD11 ' O ' ' A' ' 9' ' ' THR . 9.8 mt -71.56 -40.66 69.83 Favored 'General case' 0 N--CA 1.484 1.256 0 O-C-N 120.917 -1.114 . . . . 0.0 108.765 176.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' ILE . . . . . 0.612 HD12 ' O ' ' A' ' 11' ' ' VAL . 1.4 mp -68.05 -40.49 83.2 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.693 0 C-N-CA 117.543 -1.663 . . . . 0.0 108.945 178.764 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.602 ' HA ' ' HG2' ' A' ' 19' ' ' GLU . 85.0 m -65.42 -37.22 86.27 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 120.272 -1.517 . . . . 0.0 109.413 179.334 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LEU . . . . . 0.517 HD21 HG21 ' A' ' 38' ' ' ILE . 1.3 tp -63.16 -45.04 93.71 Favored 'General case' 0 N--CA 1.501 2.075 0 O-C-N 120.912 -1.117 . . . . 0.0 108.048 178.414 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' GLY . . . . . . . . . . . . . . . -60.94 -43.72 99.03 Favored Glycine 0 N--CA 1.514 3.882 0 N-CA-C 108.288 -1.925 . . . . 0.0 108.288 179.051 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLU . . . . . 0.7 ' HG3' ' N ' ' A' ' 20' ' ' ASN . 0.0 OUTLIER -57.71 -38.73 75.74 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 120.582 -1.54 . . . . 0.0 107.845 178.904 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASN . . . . . 0.7 ' N ' ' HG3' ' A' ' 19' ' ' GLU . 28.7 m120 -61.1 -27.4 68.34 Favored 'General case' 0 N--CA 1.493 1.69 0 C-N-CA 118.538 -1.265 . . . . 0.0 109.341 178.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.567 ' HB2' ' CD1' ' A' ' 23' ' ' LEU . 31.4 mtp -101.44 11.3 39.36 Favored 'General case' 0 N--CA 1.498 1.96 0 O-C-N 121.339 -0.851 . . . . 0.0 111.348 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 102.86 -22.75 35.97 Favored Glycine 0 N--CA 1.5 2.92 0 C-N-CA 118.547 -1.787 . . . . 0.0 111.143 179.734 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' LEU . . . . . 0.783 ' CD2' ' HB1' ' A' ' 37' ' ' ALA . 3.0 mp -78.91 94.67 5.26 Favored 'General case' 0 N--CA 1.5 2.065 0 O-C-N 120.372 -1.663 . . . . 0.0 109.225 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLU . . . . . 0.519 ' O ' ' CB ' ' A' ' 25' ' ' ASN . 87.0 mt-10 -111.7 170.38 8.17 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.204 -0.935 . . . . 0.0 109.035 179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.519 ' CB ' ' O ' ' A' ' 24' ' ' GLU . 0.9 OUTLIER 70.79 17.35 6.48 Favored 'General case' 0 N--CA 1.512 2.671 0 O-C-N 121.404 -0.81 . . . . 0.0 111.796 179.485 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.591 ' CD1' ' O ' ' A' ' 23' ' ' LEU . 1.1 mt -76.9 -6.05 50.92 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 120.841 -1.162 . . . . 0.0 111.372 -179.809 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ALA . . . . . 0.424 ' C ' ' O ' ' A' ' 26' ' ' LEU . . . -46.59 -31.21 2.68 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 120.477 -1.389 . . . . 0.0 108.81 -179.373 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' ARG . . . . . . . . . . . . . 52.1 mtp180 -80.12 -6.57 57.93 Favored 'General case' 0 C--N 1.297 -1.694 0 C-N-CA 120.047 -0.661 . . . . 0.0 111.386 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' MET . . . . . 0.546 ' HE2' ' OD1' ' A' ' 33' ' ' ASP . 14.8 mtp -101.01 158.67 15.83 Favored 'General case' 0 C--N 1.313 -0.999 0 O-C-N 120.768 -1.208 . . . . 0.0 111.473 -179.208 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ARG . . . . . 0.96 ' O ' HD12 ' A' ' 34' ' ' ILE . 4.4 ttm180 -89.65 171.99 9.27 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.374 -0.829 . . . . 0.0 110.166 177.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LYS . . . . . 0.571 ' O ' ' CG1' ' A' ' 35' ' ' ILE . 11.0 pttm -60.5 -42.49 96.45 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.43 -0.794 . . . . 0.0 110.547 179.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLN . . . . . 0.471 ' OE1' ' HB3' ' A' ' 33' ' ' ASP . 0.0 OUTLIER -60.55 -56.45 21.21 Favored 'General case' 0 N--CA 1.517 2.918 0 O-C-N 121.306 -0.871 . . . . 0.0 111.632 -178.166 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.546 ' OD1' ' HE2' ' A' ' 29' ' ' MET . 2.1 p30 -65.74 -36.29 83.17 Favored 'General case' 0 C--N 1.299 -1.591 0 O-C-N 120.802 -1.186 . . . . 0.0 109.166 179.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ILE . . . . . 0.96 HD12 ' O ' ' A' ' 30' ' ' ARG . 2.0 mt -60.78 -38.49 79.03 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 O-C-N 120.348 -1.47 . . . . 0.0 107.569 177.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ILE . . . . . 0.875 HG23 HD22 ' A' ' 6' ' ' LEU . 0.8 OUTLIER -59.3 -50.2 80.69 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.319 0 O-C-N 120.291 -1.506 . . . . 0.0 109.562 177.665 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -51.29 -41.6 60.57 Favored 'General case' 0 N--CA 1.491 1.593 0 C-N-CA 119.514 -0.874 . . . . 0.0 109.154 -179.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ALA . . . . . 0.783 ' HB1' ' CD2' ' A' ' 23' ' ' LEU . . . -63.49 -53.24 55.14 Favored 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.689 -1.257 . . . . 0.0 109.108 178.101 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.517 HG21 HD21 ' A' ' 17' ' ' LEU . 0.2 OUTLIER -55.51 -27.45 21.1 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.56 0 C-N-CA 117.451 -1.7 . . . . 0.0 109.705 179.549 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' LEU . . . . . 0.672 HD21 HD11 ' A' ' 6' ' ' LEU . 23.7 mt -71.34 -42.33 68.67 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.129 -1.607 . . . . 0.0 109.115 177.704 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 4.2 mttt -64.11 -40.21 95.71 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 120.936 -1.103 . . . . 0.0 110.313 178.462 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLN . . . . . 0.738 ' HG2' HD11 ' A' ' 23' ' ' LEU . 0.0 OUTLIER -75.96 -53.12 8.88 Favored 'General case' 0 N--CA 1.508 2.425 0 O-C-N 121.033 -1.042 . . . . 0.0 111.125 -179.261 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' HIS . . . . . 0.583 ' HB2' ' HE3' ' A' ' 1' ' ' MET . 1.4 t-80 -61.24 -35.18 76.53 Favored 'General case' 0 N--CA 1.513 2.72 0 O-C-N 121.229 -0.919 . . . . 0.0 109.192 179.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ALA . . . . . 0.544 ' O ' ' N ' ' A' ' 46' ' ' GLY . . . -81.15 -32.08 33.84 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.306 -0.871 . . . . 0.0 110.961 179.615 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.597 ' HD3' ' N ' ' A' ' 45' ' ' SER 0.254 0.0 OUTLIER -49.08 -50.37 37.11 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 120.333 -1.48 . . . . 0.0 107.782 178.089 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . 0.597 ' N ' ' HD3' ' A' ' 44' ' ' LYS . 72.5 m -65.61 -9.37 26.36 Favored 'General case' 0 C--N 1.287 -2.149 0 CA-C-N 114.57 -1.195 . . . . 0.0 109.302 -179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.544 ' N ' ' O ' ' A' ' 43' ' ' ALA . . . 64.46 32.14 83.22 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 110.926 -0.87 . . . . 0.0 110.926 178.427 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . 0.52 ' CD ' ' ND1' ' A' ' 42' ' ' HIS . 9.8 pt-20 -87.19 166.85 14.64 Favored 'General case' 0 C--N 1.309 -1.183 0 O-C-N 120.46 -1.612 . . . . 0.0 109.2 179.286 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -55.11 135.98 48.67 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.067 -1.021 . . . . 0.0 111.914 -177.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.589 ' HA ' ' HA ' ' A' ' 1' ' ' MET . 4.5 pt -146.57 137.8 18.61 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.869 0 N-CA-C 107.067 -1.457 . . . . 0.0 107.067 178.14 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PHE . . . . . 0.569 ' N ' ' CD1' ' A' ' 50' ' ' PHE . 16.7 p90 -144.07 164.09 31.65 Favored 'General case' 0 C--N 1.31 -1.147 0 C-N-CA 115.55 -2.46 . . . . 0.0 115.655 -178.224 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -119.19 166.17 13.15 Favored Glycine 0 N--CA 1.5 2.936 0 N-CA-C 107.425 -2.27 . . . . 0.0 107.425 179.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.487 ' OD2' ' OG1' ' A' ' 4' ' ' THR . 5.9 p-10 -171.88 167.98 6.13 Favored 'General case' 0 N--CA 1.482 1.156 0 O-C-N 120.132 -1.805 . . . . 0.0 109.617 -178.747 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' GLY . . . . . 0.44 ' N ' HD21 ' A' ' 65' ' ' LEU . . . 142.3 -137.18 7.68 Favored Glycine 0 N--CA 1.504 3.184 0 C-N-CA 118.247 -1.93 . . . . 0.0 110.741 178.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' VAL . . . . . 0.583 ' HA ' ' O ' ' A' ' 95' ' ' ASP . 3.3 t -128.28 120.62 53.67 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.99 0 O-C-N 121.382 -1.07 . . . . 0.0 108.419 -179.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.822 HD21 HG21 ' A' ' 81' ' ' VAL . 6.5 mt -62.73 162.38 10.91 Favored 'General case' 0 N--CA 1.502 2.139 0 N-CA-C 113.839 1.051 . . . . 0.0 113.839 -175.642 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLU . . . . . 0.504 ' HA ' ' OG1' ' A' ' 93' ' ' THR . 1.4 tt0 -137.99 120.4 15.95 Favored 'General case' 0 N--CA 1.497 1.877 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 177.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ILE . . . . . 0.739 ' C ' HD12 ' A' ' 58' ' ' LEU . 1.2 mm -82.48 161.53 3.51 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 O-C-N 119.863 -1.773 . . . . 0.0 109.177 -179.081 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' LEU . . . . . 0.895 HD22 ' CZ ' ' A' ' 62' ' ' PHE . 7.1 mp -130.86 137.06 49.19 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.347 -1.47 . . . . 0.0 109.701 179.06 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLN . . . . . 0.463 ' C ' ' O ' ' A' ' 58' ' ' LEU . 1.4 tt0 -39.49 -36.54 0.39 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.525 -0.734 . . . . 0.0 110.006 -179.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASP . . . . . 0.538 ' HB2' ' CD2' ' A' ' 62' ' ' PHE . 30.5 m-20 -61.4 -5.69 1.85 Allowed 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.676 -0.64 . . . . 0.0 112.574 -179.491 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLY . . . . . 0.449 ' O ' ' HB3' ' A' ' 83' ' ' PRO . . . 88.25 11.37 67.07 Favored Glycine 1 N--CA 1.519 4.181 0 C-N-CA 118.601 -1.761 . . . . 0.0 111.954 178.307 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' PHE . . . . . 0.895 ' CZ ' HD22 ' A' ' 58' ' ' LEU . 4.0 p90 -127.94 -179.17 4.83 Favored 'General case' 0 C--N 1.308 -1.215 0 N-CA-C 104.341 -2.466 . . . . 0.0 104.341 177.774 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' GLY . . . . . 0.506 ' HA2' HD13 ' A' ' 58' ' ' LEU . . . -156.07 168.08 33.43 Favored Glycine 0 N--CA 1.474 1.176 0 C-N-CA 117.181 -2.438 . . . . 0.0 111.577 -177.815 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PHE . . . . . 0.425 ' CD1' ' HE1' ' A' ' 62' ' ' PHE . 2.6 m-85 -129.07 151.18 50.04 Favored 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 119.926 1.863 . . . . 0.0 109.26 177.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . 0.537 ' HB3' ' HB ' ' A' ' 79' ' ' ILE . 0.3 OUTLIER -98.68 153.9 18.37 Favored 'General case' 0 C--N 1.306 -1.285 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 176.707 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.479 ' HB3' ' O ' ' A' ' 65' ' ' LEU . 0.5 OUTLIER 178.08 -151.71 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.246 -0.909 . . . . 0.0 109.657 179.364 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.6 m -65.7 -151.08 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.047 0 O-C-N 121.383 -0.823 . . . . 0.0 110.64 -179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ALA . . . . . . . . . . . . . . . -118.47 -14.95 9.68 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.471 -0.768 . . . . 0.0 111.321 -179.101 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 1.8 p-10 -70.66 -153.0 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.187 0 O-C-N 120.888 -1.132 . . . . 0.0 108.816 179.635 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . 0.59 ' O ' ' CB ' ' A' ' 71' ' ' SER . 0.1 OUTLIER -125.66 -154.07 0.6 Allowed 'General case' 0 N--CA 1.497 1.916 0 O-C-N 119.9 -1.75 . . . . 0.0 109.708 179.652 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.669 ' O ' ' HB2' ' A' ' 72' ' ' TYR . 0.6 OUTLIER 159.55 -19.83 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.486 0 O-C-N 121.382 -0.824 . . . . 0.0 110.046 179.999 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.669 ' HB2' ' O ' ' A' ' 71' ' ' SER . 80.1 m-85 75.69 -48.9 0.61 Allowed 'General case' 0 N--CA 1.524 3.241 0 O-C-N 122.266 -0.271 . . . . 0.0 110.775 -179.468 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' LEU . . . . . . . . . . . . . 47.2 mt -99.17 -178.33 3.89 Favored 'General case' 0 C--N 1.308 -1.205 0 O-C-N 120.554 -1.341 . . . . 0.0 109.304 179.141 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -80.01 -150.73 0.07 Allowed 'General case' 0 C--N 1.292 -1.93 0 CA-C-O 122.33 1.062 . . . . 0.0 109.137 178.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLY . . . . . 0.49 ' N ' ' OD2' ' A' ' 78' ' ' ASP . . . -166.85 153.18 22.69 Favored Glycine 0 C--N 1.277 -2.719 0 N-CA-C 107.304 -2.318 . . . . 0.0 107.304 178.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' PRO . . . . . . . . . . . . . 34.3 Cg_endo -64.18 -41.15 22.99 Favored 'Trans proline' 0 N--CA 1.489 1.246 0 CA-C-N 118.622 1.211 . . . . 0.0 112.488 -179.28 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.468 ' HB2' ' HE2' ' A' ' 7' ' ' LYS . 73.6 m-20 -86.54 7.68 25.18 Favored 'General case' 0 N--CA 1.508 2.465 0 O-C-N 120.957 -1.089 . . . . 0.0 113.27 -178.128 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . 0.762 ' C ' HD12 ' A' ' 79' ' ' ILE . 27.6 m-20 -78.27 -151.55 0.05 Allowed 'General case' 0 N--CA 1.505 2.28 0 O-C-N 120.092 -1.63 . . . . 0.0 109.458 179.197 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 1.065 HD11 HD23 ' A' ' 3' ' ' LEU . 2.1 mp -142.34 136.51 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.512 2.629 0 C-N-CA 119.241 -0.983 . . . . 0.0 109.928 178.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.471 ' HB3' ' HA ' ' A' ' 112' ' ' ALA . 12.2 t80 -78.11 147.46 34.64 Favored 'General case' 0 N--CA 1.52 3.049 0 O-C-N 119.635 -1.916 . . . . 0.0 110.014 -179.549 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' VAL . . . . . 0.822 HG21 HD21 ' A' ' 55' ' ' LEU . 39.8 t -143.36 115.89 3.09 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 120.157 -1.589 . . . . 0.0 110.505 -179.407 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' SER . . . . . 0.547 ' O ' HG13 ' A' ' 86' ' ' ILE . 68.0 m -74.65 163.42 68.39 Favored Pre-proline 0 N--CA 1.514 2.737 0 O-C-N 120.5 -1.375 . . . . 0.0 112.688 -179.062 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PRO . . . . . 0.581 ' HA ' HG13 ' A' ' 86' ' ' ILE . 39.4 Cg_endo -65.33 -51.7 1.39 Allowed 'Trans proline' 0 C--N 1.315 -1.215 0 O-C-N 124.779 1.936 . . . . 0.0 108.571 178.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' SER . . . . . 0.537 ' O ' ' CG ' ' A' ' 88' ' ' ARG . 57.1 p -47.3 -39.94 15.77 Favored 'General case' 0 N--CA 1.486 1.34 0 N-CA-C 107.728 -1.212 . . . . 0.0 107.728 177.93 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.528 ' HB2' ' O ' ' A' ' 82' ' ' SER . 4.9 mm-40 -62.38 -60.03 4.14 Favored 'General case' 0 N--CA 1.509 2.49 0 C-N-CA 119.089 -1.044 . . . . 0.0 108.225 178.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' ILE . . . . . 0.614 HG22 ' HB2' ' A' ' 91' ' ' LEU . 0.2 OUTLIER -55.42 -55.04 19.07 Favored 'Isoleucine or valine' 0 N--CA 1.505 2.305 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 178.512 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ARG . . . . . 0.498 ' HB2' ' O ' ' A' ' 83' ' ' PRO . 0.0 OUTLIER -57.39 -42.59 82.51 Favored 'General case' 0 C--N 1.296 -1.729 0 CA-C-O 121.811 0.815 . . . . 0.0 111.238 -179.49 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . 0.537 ' CG ' ' O ' ' A' ' 84' ' ' SER . 10.8 mmm180 -59.4 -38.03 79.52 Favored 'General case' 0 N--CA 1.505 2.322 0 C-N-CA 119.84 -0.744 . . . . 0.0 111.816 -177.648 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . 1.082 ' HB2' HD21 ' A' ' 91' ' ' LEU . 9.1 m-85 -110.16 12.41 23.44 Favored 'General case' 0 N--CA 1.505 2.315 0 C-N-CA 116.976 -1.89 . . . . 0.0 111.359 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . 0.408 ' CB ' ' O ' ' A' ' 89' ' ' PHE . 0.1 OUTLIER 62.24 53.43 2.87 Favored 'General case' 0 N--CA 1.483 1.224 0 O-C-N 120.523 -1.36 . . . . 0.0 110.64 178.336 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' LEU . . . . . 1.082 HD21 ' HB2' ' A' ' 89' ' ' PHE . 2.8 mt -89.61 -169.45 2.48 Favored 'General case' 0 N--CA 1.495 1.819 0 C-N-CA 119.199 -1.001 . . . . 0.0 110.043 179.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ARG . . . . . 0.532 ' CG ' ' O ' ' A' ' 91' ' ' LEU . 53.0 mtp180 -159.92 162.38 34.47 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.542 -0.724 . . . . 0.0 109.083 178.225 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.598 ' HB ' ' CG1' ' A' ' 57' ' ' ILE . 1.6 t -65.25 156.55 31.56 Favored 'General case' 0 N--CA 1.496 1.833 0 C-N-CA 116.993 -1.883 . . . . 0.0 106.672 178.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLY . . . . . . . . . . . . . . . 76.12 -10.3 15.77 Favored Glycine 0 N--CA 1.505 3.284 0 C-N-CA 116.954 -2.546 . . . . 0.0 110.191 179.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.583 ' O ' ' HA ' ' A' ' 54' ' ' VAL . 7.7 m-20 -66.65 147.38 53.35 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 120.184 -1.774 . . . . 0.0 110.864 -178.874 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' THR . . . . . 0.481 ' O ' HG12 ' A' ' 97' ' ' ILE . 0.3 OUTLIER -90.52 120.36 31.55 Favored 'General case' 0 N--CA 1.489 1.524 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 179.193 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' ILE . . . . . 0.508 HG23 HG22 ' A' ' 119' ' ' VAL . 1.4 mt -144.11 167.84 11.62 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.711 0 O-C-N 119.778 -1.826 . . . . 0.0 112.929 -178.4 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' SER . . . . . 0.49 ' OG ' ' CB ' ' A' ' 118' ' ' GLU . 94.5 p -150.14 138.51 20.51 Favored 'General case' 0 N--CA 1.483 1.189 0 CA-C-N 115.847 -0.615 . . . . 0.0 109.445 179.71 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' GLY . . . . . . . . . . . . . . . -164.29 179.26 39.22 Favored Glycine 0 N--CA 1.506 3.319 0 C-N-CA 117.037 -2.506 . . . . 0.0 115.16 -179.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 3.9 mmtt -88.21 148.87 24.16 Favored 'General case' 0 N--CA 1.497 1.884 0 N-CA-C 106.568 -1.641 . . . . 0.0 106.568 179.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 3.3 pt -124.59 153.54 31.4 Favored 'Isoleucine or valine' 0 N--CA 1.513 2.706 0 CA-C-N 121.25 1.841 . . . . 0.0 113.566 -176.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ARG . . . . . 0.745 ' HB2' HD22 ' A' ' 114' ' ' LEU . 0.0 OUTLIER -160.28 154.48 19.85 Favored Pre-proline 0 N--CA 1.494 1.744 0 O-C-N 120.372 -1.455 . . . . 0.0 109.875 179.013 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.642 ' N ' ' CD ' ' A' ' 104' ' ' PRO . 56.0 Cg_endo -103.38 20.26 0.16 Allowed 'Trans proline' 0 CA--C 1.557 1.628 0 C-N-CA 121.609 1.539 . . . . 0.0 113.513 179.735 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.642 ' CD ' ' N ' ' A' ' 103' ' ' PRO . 56.8 Cg_endo -81.74 34.33 0.55 Allowed 'Trans proline' 0 N--CA 1.493 1.454 0 CA-C-N 119.049 0.696 . . . . 0.0 111.855 -178.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' LYS . . . . . 0.421 ' CG ' ' H ' ' A' ' 107' ' ' GLY . 0.3 OUTLIER -162.59 -153.85 0.28 Allowed 'General case' 0 N--CA 1.498 1.975 0 O-C-N 120.381 -1.449 . . . . 0.0 110.13 -179.41 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -54.39 -13.76 1.01 Allowed 'General case' 0 C--N 1.317 -0.826 0 O-C-N 120.496 -1.378 . . . . 0.0 108.838 178.26 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' GLY . . . . . 0.94 ' HA3' ' HB2' ' A' ' 112' ' ' ALA . . . -69.73 41.45 0.42 Allowed Glycine 0 N--CA 1.495 2.622 0 C-N-CA 119.633 -1.27 . . . . 0.0 110.897 179.116 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' GLU . . . . . 0.543 ' O ' ' HB3' ' A' ' 109' ' ' ARG . 0.1 OUTLIER -83.83 164.51 19.45 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 120.13 -1.806 . . . . 0.0 107.72 178.266 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ARG . . . . . 0.543 ' HB3' ' O ' ' A' ' 108' ' ' GLU . 0.2 OUTLIER 64.46 -58.85 0.23 Allowed 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.163 -0.961 . . . . 0.0 108.936 -177.753 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.539 ' N ' ' O ' ' A' ' 108' ' ' GLU . 18.2 m-85 -107.42 147.22 30.69 Favored 'General case' 0 N--CA 1.518 2.945 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 176.238 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' PHE . . . . . . . . . . . . . 4.8 m-85 -68.36 161.66 26.99 Favored 'General case' 0 N--CA 1.504 2.231 0 O-C-N 119.237 -2.165 . . . . 0.0 108.062 179.301 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' ALA . . . . . 0.94 ' HB2' ' HA3' ' A' ' 107' ' ' GLY . . . -122.18 154.74 37.05 Favored 'General case' 0 N--CA 1.486 1.375 0 O-C-N 119.979 -1.701 . . . . 0.0 110.049 -179.572 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.46 HD23 ' CG ' ' A' ' 85' ' ' GLN . 3.0 tp -62.84 145.2 55.6 Favored 'General case' 0 N--CA 1.49 1.55 0 N-CA-C 107.388 -1.338 . . . . 0.0 107.388 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' LEU . . . . . 0.745 HD22 ' HB2' ' A' ' 102' ' ' ARG . 11.5 tp -123.45 -55.36 1.74 Allowed 'General case' 0 N--CA 1.498 1.95 0 O-C-N 120.45 -1.406 . . . . 0.0 112.179 -178.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 8.0 tptp -127.68 144.28 51.09 Favored 'General case' 0 N--CA 1.504 2.25 0 O-C-N 120.318 -1.488 . . . . 0.0 108.84 179.13 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.632 HG21 ' CD2' ' A' ' 89' ' ' PHE . 33.7 t -93.08 129.89 42.93 Favored 'Isoleucine or valine' 0 N--CA 1.517 2.901 0 O-C-N 120.707 -1.246 . . . . 0.0 111.458 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ASN . . . . . . . . . . . . . 7.9 m-20 -107.69 -38.74 5.79 Favored 'General case' 0 N--CA 1.508 2.451 0 O-C-N 121.257 -0.902 . . . . 0.0 110.053 178.454 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' GLU . . . . . 0.594 ' C ' HG23 ' A' ' 119' ' ' VAL . 7.0 tt0 -143.24 157.92 44.07 Favored 'General case' 0 N--CA 1.487 1.379 0 O-C-N 120.948 -1.095 . . . . 0.0 109.619 179.739 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' VAL . . . . . 0.594 HG23 ' C ' ' A' ' 118' ' ' GLU . 33.7 t -159.62 131.62 1.03 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.998 0 N-CA-C 109.992 -0.373 . . . . 0.0 109.992 -178.646 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.47 ' O ' ' C ' ' A' ' 121' ' ' PHE . 0.1 OUTLIER 55.66 46.31 22.92 Favored 'General case' 0 N--CA 1.52 3.039 0 O-C-N 120.329 -1.482 . . . . 0.0 111.779 179.28 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' PHE . . . . . 0.47 ' C ' ' O ' ' A' ' 120' ' ' ASN . 0.1 OUTLIER 40.73 40.83 1.02 Allowed 'General case' 0 N--CA 1.521 3.095 0 O-C-N 120.574 -1.329 . . . . 0.0 110.139 179.42 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -154.25 173.74 15.73 Favored 'General case' 0 C--N 1.304 -1.377 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 179.144 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LYS . . . . . 0.539 ' HD3' ' ND2' ' A' ' 126' ' ' ASN . 7.9 ptmt -74.18 154.55 88.39 Favored Pre-proline 0 N--CA 1.504 2.266 0 C-N-CA 118.496 -1.282 . . . . 0.0 108.851 -179.843 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -78.51 22.86 0.62 Allowed 'Trans proline' 0 C--N 1.308 -1.573 0 O-C-N 123.994 1.523 . . . . 0.0 111.03 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' GLU . . . . . 0.502 ' O ' ' ND2' ' A' ' 126' ' ' ASN . 2.2 tt0 -168.15 -142.65 0.04 OUTLIER 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.539 ' ND2' ' HD3' ' A' ' 123' ' ' LYS . 0.3 OUTLIER 170.08 -51.87 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.144 0 O-C-N 120.129 -1.607 . . . . 0.0 110.471 179.317 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ALA . . . . . 0.421 ' C ' ' HG3' ' A' ' 128' ' ' ARG . . . -141.37 20.98 2.23 Favored 'General case' 0 C--N 1.295 -1.79 0 CA-C-O 121.641 0.734 . . . . 0.0 109.956 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' ARG . . . . . 0.448 ' O ' ' OE2' ' A' ' 125' ' ' GLU . 2.4 mtp180 -128.95 46.84 2.56 Favored 'General case' 0 N--CA 1.496 1.867 0 C-N-CA 119.904 -0.718 . . . . 0.0 109.873 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -47.17 164.31 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.303 -0.873 . . . . 0.0 110.13 -179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' LYS . . . . . . . . . . . . . 22.6 pttt . . . . . 0 C--N 1.304 -1.391 0 CA-C-O 118.025 -0.988 . . . . 0.0 109.697 179.972 . . . . . . . . 0 0 . 1 stop_ save_